Page last updated: 2024-12-06

ropivacaine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Ropivacaine: An anilide used as a long-acting local anesthetic. It has a differential blocking effect on sensory and motor neurons. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ropivacaine : The piperidinecarboxamide obtained by the formal condensation of N-propylpipecolic acid and 2,6-dimethylaniline. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

(S)-ropivacaine : A piperidinecarboxamide-based amide-type local anaesthetic (amide caine) in which (S)-N-propylpipecolic acid and 2,6-dimethylaniline are combined to form the amide bond. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID175805
CHEMBL ID1077896
CHEBI ID8890
SCHEMBL ID33292
MeSH IDM0113809
PubMed CID175804
CHEMBL ID1889140
CHEBI ID60803
SCHEMBL ID236432
MeSH IDM0113809

Synonyms (127)

Synonym
BIDD:GT0203
lea-103
ropivacaine
84057-95-4
C07532
(s)-(-)-1-propyl-2',6'-pipecoloxylidide
l-n-n-propylpipecolic acid-2,6-xylidide
(s)-ropivacaine
DB00296
ropivacaina [inn-spanish]
al-381
ropivacainum [inn-latin]
lea 103
(-)-1-propyl-2',6'-dimethyl-2-piperidylcarboxyanilid
(-)-1-propyl-2',6'-pipecoloxylidide
ropivacaina [spanish]
ropivacaine [inn]
1-propyl-2',6'-pipecoloxylidide
(2s)-n-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide
D08490
ropivacaine (inn)
naropin (tn)
CHEMBL1077896
chebi:8890 ,
ropivicaine
tlc590
tlc-590
(2s)-n-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide
A840710
(2s)-n-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide
ropivacaine [inn:ban]
narop
noropine
unii-7io5lya57n
7io5lya57n ,
s-ropivacaine
ropivacaina
ropivacainum
(-)-1-propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
ropivacaine [usp-rs]
ropivacaine [mi]
(s)-(-)-1-propylpiperidine-2-carboxylic acid (2,6-dimethylphenyl)amide
ropivacaine [who-dd]
(s)-(-)-1-propyl-2',6'-pipecoloxylidine
ropivacaine [vandf]
S5504
AKOS017343283
gtpl7602
AB00698466-07
SCHEMBL33292
ZKMNUMMKYBVTFN-HNNXBMFYSA-N
Q-201677
2-piperidinecarboxamide, n-(2,6-dimethylphenyl)-1-propyl-, (2s)-
(s)-n-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide
AB00698466_10
DTXSID4040187 ,
lea-103 hcl
mfcd00864425
HY-B0563
CS-0009514
BBL102321
STL556120
ropivacaine base
Q279504
AS-35173
CCG-267197
1 propyl 2',6' pipecoloxylidide
narop; noropine; lea-103
EN300-7436767
R0251
(s)-n-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide
Z2235811359
dtxcid2020187
ropivacaine (usp-rs)
ropivacainum (inn-latin)
ropivacaina (inn-spanish)
n01bb09
98717-15-8
ropivacaine hydrochloride
naropin
ropivacaine monohydrochloride
2-piperidinecarboxamide, n-(2,6-dimethylphenyl)-1-propyl-, monohydrochloride, (s)-
ropivacaine hcl
smr000469137
MLS001401363
NCGC00164597-01
(2s)-n-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride
n-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide; hydron; chloride
35504lbe2t ,
unii-35504lbe2t
dtxsid2048379 ,
dtxcid2028353
cas-98717-15-8
tox21_112221
S4058
mfcd02102164
AKOS015994752
CCG-101108
CHEBI:60803 ,
AKOS015900322
(s)-(-)-1-propylpiperidine-2-carboxylic acid (2,6-dimethylphenyl)amide hydrochloride
ropivacaine hydrochloride [mi]
ropivacaine hydrochloride [mart.]
ropivacaine hydrochloride anhydrous
ropivacaine hydrochloride [who-dd]
(s)-(-)-1-propyl-2',6'-pipecoloxylidine hydrochloride
CHEMBL1889140
SCHEMBL236432
NC00358
NDNSIBYYUOEUSV-RSAXXLAASA-N
tox21_112221_1
NCGC00164597-02
KS-5134
(s)-ropivacaine hydrochloride
Q-201678
(2s)-n-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide;hydrochloride
F19623
(s)-n-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride
SW197738-2
Q27128599
ropivacaine (hydrochloride)
CS-0013146
HY-B0563B
phosphorylcholine (chloride calcium)
phosphocholine (chloride calcium)
2-piperidinecarboxamide, n-(2,6-dimethylphenyl)-1-propyl-,monohydrochloride, (2s)-
EN300-18608390

Research Excerpts

Toxicity

Ropivacaine is not safe when intrathecally administered with lidocaine at the concentrations used in this study. The toxic threshold of ropvacaine remains unclear, and the dose should be calculated in relation to the weight of the patient.

ExcerptReferenceRelevance
" There were no significant differences between the two groups of animals in the doses and plasma concentrations of ropivacaine associated with each toxic manifestations."( Systemic toxicity of ropivacaine during ovine pregnancy.
Arthur, GR; Covino, BG; Finster, M; Morishima, HO; Pedersen, H; Santos, AC, 1991
)
0.28
" They were familiarized with the central nervous system (CNS) toxic effects of local anesthetics by receiving a preliminary intravenous injection of lidocaine."( Acute toxicity of ropivacaine compared with that of bupivacaine.
Bloomfield, P; Bowler, GM; Fagan, D; Lee, A; Lundh, R; Scott, DB, 1989
)
0.28
" Arterial blood samples were obtained before infusion and at the onset of toxic manifestations, which appeared in the following sequence: convulsions, hypotension, apnea, and circulatory collapse."( Comparative systemic toxicity of ropivacaine and bupivacaine in nonpregnant and pregnant ewes.
Arthur, GR; De Armas, P; Finster, M; Morishima, HO; Santos, AC; Wlody, D, 1995
)
0.29
"There were no significant differences between non-pregnant and pregnant animals in the doses or serum concentrations of either drug required to elicit toxic manifestations."( Comparative systemic toxicity of ropivacaine and bupivacaine in nonpregnant and pregnant ewes.
Arthur, GR; De Armas, P; Finster, M; Morishima, HO; Santos, AC; Wlody, D, 1995
)
0.29
" Greater doses of ropivacaine, as compared to bupivacaine, are needed to produce toxic manifestations in pregnant animals."( Comparative systemic toxicity of ropivacaine and bupivacaine in nonpregnant and pregnant ewes.
Arthur, GR; De Armas, P; Finster, M; Morishima, HO; Santos, AC; Wlody, D, 1995
)
0.29
" No unexpected adverse events were registered."( Spinal anesthesia with ropivacaine: a double-blind study on the efficacy and safety of 0.5% and 0.75% solutions in patients undergoing minor lower limb surgery.
Burm, AG; van Kleef, JW; Veering, BT, 1994
)
0.29
" The results suggest an increased safety margin before onset of toxic side effects after treatment with ropivacaine, compared to bupivacaine, in pregnant rase."( Toxicity of bupivacaine and ropivacaine in relation to free plasma concentrations in pregnant rats: a comparative study.
Arvidsson, T; Böö, EL; Danielson, MK; Danielsson, BR; Halldin, MM, 1997
)
0.3
" These high doses, however, resulted in severe toxic CNS symptoms."( Two instances of central nervous system toxicity in the same patient following repeated ropivacaine-induced brachial plexus block.
Ala-Kokko, TI; Alahuhta, S; Löppönen, A, 2000
)
0.31
" The timing of the occurrence of local anesthetic-induced toxic events (defined as the first QRS modification, dysrhythmia, seizures, moderate and severe bradycardia and hypotension, final systole) was recorded and the dose calculated."( The comparative toxicity of ropivacaine and bupivacaine at equipotent doses in rats.
Cuignet, O; De Kock, M; Dewinde, V; Dony, P; Gautier, P; Lavand'homme, P; Legrand, E; Vanderick, B, 2000
)
0.31
" Additionally, they are less toxic to the CNS than bupivacaine judging by the larger doses tolerated before the onset of seizures."( Cardiotoxicity with modern local anaesthetics: is there a safer choice?
Chang, DH; Mather, LE, 2001
)
0.31
" Arterial blood samples were obtained before infusion and at the onset of toxic manifestations."( Systemic toxicity of levobupivacaine, bupivacaine, and ropivacaine during continuous intravenous infusion to nonpregnant and pregnant ewes.
DeArmas, PI; Santos, AC, 2001
)
0.31
" The mean cumulative dose and serum concentration at each toxic manifestation was lowest for bupivacaine, intermediate for levobupivacaine, and highest for ropivacaine in both pregnant and nonpregnant animals."( Systemic toxicity of levobupivacaine, bupivacaine, and ropivacaine during continuous intravenous infusion to nonpregnant and pregnant ewes.
DeArmas, PI; Santos, AC, 2001
)
0.31
"Central and regional block procedures have a well-defined role as safe and effective methods in modern anesthesia and analgesia with long-acting local anesthetics."( The cardiotoxicity of local anesthetics: the place of ropivacaine.
Graf, BM, 2001
)
0.31
" Vital signs and any adverse effects related to spinal anesthesia were also recorded."( Spinal anesthesia with two different dosages of 0.75% glucose-free ropivacaine: a comparison of efficacy and safety in Chinese parturients undergoing cesarean section.
Cheu, NW; Leung, PO; Tan, TD; Tseng, KF; Wong, JO, 2003
)
0.32
" Otherwise, there were no differences in adverse effects during or after surgery."( Spinal anesthesia with two different dosages of 0.75% glucose-free ropivacaine: a comparison of efficacy and safety in Chinese parturients undergoing cesarean section.
Cheu, NW; Leung, PO; Tan, TD; Tseng, KF; Wong, JO, 2003
)
0.32
" Ectopic overexpression of the secreted form of clusterin/apoliporotein J or Bcl-2 decreased the sensitivity of HaCaT cells to toxic effects of ropivacaine as demonstrated by DNA fragmentation, the proteolytic cleavage of PARP and by a reduction in procaspase-3 expression."( Ectopic expression of clusterin/apolipoprotein J or Bcl-2 decreases the sensitivity of HaCaT cells to toxic effects of ropivacaine.
Gonos, ES; Kalfakakou, V; Kolettas, E; Kontargiris, E; Trougakos, IP; Vadalouca, A, 2004
)
0.32
"5 million adverse drug reaction (ADR) reports for 8620 drugs/biologics that are listed for 1191 Coding Symbols for Thesaurus of Adverse Reaction (COSTAR) terms of adverse effects."( Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL, 2004
)
0.32
" In this limited sample, extending the infusion period from the presently approved 48 hours to 96 hours seems to be a safe alternative and/or adjunct to standard opiate analgesia after colorectal surgery using a right lateral transverse incision, hence reducing the incidence of opiate adverse effects and enhancing recovery."( Safety of 96-hour incision-site continuous infusion of ropivacaine for postoperative analgesia after bowel cancer resection.
Corso, OH; Hewett, PJ; Karatassas, A; Morris, RG, 2007
)
0.34
" Aim of this short paper is to describe, primarily from a subjective point of view, CNS symptoms a patient (one of the Authors) suffered by an acute toxic reaction during an epidural block, and to stress the need to pay attention to safety measures in the practice of loco-regional anaesthesia and epidural blockade."( Ropivacaine induced acute neurotoxicity after epidural injection.
Anastasi, F; Rodolà, F; Vergari, A,
)
0.13
"To investigate the toxic effects of ropivacaine on corneal endothelium by using the impression cytological method."( Investigation of the toxic effects of ropivacaine corneal endothelium by the impression cytological method.
Buyukbayram, H; Cakmak, S; Nergiz, Y; Olmez, G; Soker, S, 2007
)
0.34
"Blurring at cell membrane borders, vacuolization at cell cytoplasm, hydropic degeneration and increase in toxic granulation were observed in the 1% ropivacaine group."( Investigation of the toxic effects of ropivacaine corneal endothelium by the impression cytological method.
Buyukbayram, H; Cakmak, S; Nergiz, Y; Olmez, G; Soker, S, 2007
)
0.34
" However, the toxic threshold of ropivacaine remains unclear, and the dose should be calculated in relation to the weight of the patient to prevent severe toxic complications."( Ropivacaine-induced toxicity with overdose suspected after axillary brachial plexus block.
Kamada, Y; Kimura, A; Kimura, Y; Orimo, K, 2007
)
0.34
" Experience from this case suggests that local anesthesia toxicity can happen within safe dose limits and without intravascular placement despite careful attention to needle and catheter placement, fractionated dosing and frequent aspirations."( Case report: ropivacaine neurotoxicity at clinical doses in interscalene brachial plexus block.
Athwal, GS; Dhir, S; Ganapathy, S; Lindsay, P, 2007
)
0.34
"General anesthesia produced physiological perturbations, exacerbated local anesthetic-induced cardiovascular depression, and changed the pharmacokinetics of toxic doses of local anesthetics."( The effects of general anesthesia on the central nervous and cardiovascular system toxicity of local anesthetics.
Copeland, SE; Gu, XQ; Ladd, LA; Mather, LE, 2008
)
0.35
" We investigated the hypotheses that these drugs (A) are less neurotoxic than the prototype local anesthetic, lidocaine (B) are selectively toxic for subcategories of dorsal root ganglion neurons and (C) induce activation of either p38 MAPK or related enzymes, such as the c-jun terminal N-kinase (JNK) and extracellular signal-regulated kinase (ERK)."( In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity.
Colvin, HP; Gerner, P; Haller, I; Klimaschewski, L; Lang, L; Lirk, P; Tomaselli, B, 2008
)
0.35
" Patients tolerated the treatment well, with no adverse outcomes."( Safety of combined use of local anesthetic infiltration and reinfusion drains in total knee arthroplasty.
Coolican, MR; Dewall, MJ; Graham, DA; Mather, LE; Parker, DA, 2009
)
0.35
" The present article provides a concise review of the toxic potencies of levobupivacaine and ropivacaine."( The toxicity of local anesthetics: the place of ropivacaine and levobupivacaine.
Graf, BM; Zink, W, 2008
)
0.35
" Experimental studies and case reports confirm this hypothesis, showing that ropivacaine is characterized by fewer (cardio) toxic effects and, most probably, a greater margin of safety."( The toxicity of local anesthetics: the place of ropivacaine and levobupivacaine.
Graf, BM; Zink, W, 2008
)
0.35
" Despite the differences between these preclinical studies and clinical conditions, we suggest RVC(LUV) as a potential new formulation, since RVC is a new and safe local anaesthetic agent."( Pharmacological and local toxicity studies of a liposomal formulation for the novel local anaesthetic ropivacaine.
Braga, Ade F; Brunetto, GB; Cereda, CM; de Araujo, DR; de Oliveira, AL; de Paula, E; Fraceto, LF; Neto, HS; Pierucci, A; Vomero, VU, 2008
)
0.35
" Only one previous study has reported adverse events of CPNB in a high number of pediatric cases."( Continuous peripheral nerve blocks for postoperative analgesia in children: feasibility and side effects in a cohort study of 339 catheters.
Bringuier, S; Canaud, N; Capdevila, X; Dadure, C; Lubrano-Lavadera, JF; Raux, O; Rochette, A; Troncin, R, 2009
)
0.35
" In the postoperative period, demographic data, quality of analgesia, amount of rescue analgesic medication, child/parent satisfaction, and adverse events were recorded in our Departmental Regional Anesthesia registry."( Continuous peripheral nerve blocks for postoperative analgesia in children: feasibility and side effects in a cohort study of 339 catheters.
Bringuier, S; Canaud, N; Capdevila, X; Dadure, C; Lubrano-Lavadera, JF; Raux, O; Rochette, A; Troncin, R, 2009
)
0.35
" There were no major adverse events."( Continuous peripheral nerve blocks for postoperative analgesia in children: feasibility and side effects in a cohort study of 339 catheters.
Bringuier, S; Canaud, N; Capdevila, X; Dadure, C; Lubrano-Lavadera, JF; Raux, O; Rochette, A; Troncin, R, 2009
)
0.35
" Our results demonstrate that CPNBs are feasible in the pediatric setting, and in skilled hands, they promote prolonged analgesia in the majority of patients without major adverse events."( Continuous peripheral nerve blocks for postoperative analgesia in children: feasibility and side effects in a cohort study of 339 catheters.
Bringuier, S; Canaud, N; Capdevila, X; Dadure, C; Lubrano-Lavadera, JF; Raux, O; Rochette, A; Troncin, R, 2009
)
0.35
" All children were assessed for pain, sedation, time until first oral intake, and adverse effects for 48 h postoperatively."( Incisional continuous fascia iliaca block provides more effective pain relief and fewer side effects than opioids after pelvic osteotomy in children.
Gardeniers, J; Lako, SJ; Staals, LM; Steegers, MA; van Egmond, J; van Geffen, GJ, 2009
)
0.35
"The use of a combined prilocaine/ ropivacaine (300 mg/75 mg) dose regimen in patients given single dose for brachial plexus blockade can generally be regarded as safe with regard to peak plasma concentrations and cardiovascular toxicity and this holds true for patients with a higher perioperative risk profile (ASA III grading, American Society of Anesthesiologists)."( Pharmacokinetics and clinical toxicity of prilocaine and ropivacaine following combined drug administration in brachial plexus anesthesia.
Huschak, G; Kaisers, UX; Meinecke, CD; Preiss, R; Regenthal, R; Rüffert, H; Taubert, MH; Wehner, M, 2009
)
0.35
"Although 2 patients demonstrated isolated serum ropivacaine concentration spikes into a previously identified toxic range, continuous peripheral nerve block catheter management and local anesthetic doses as practiced at Walter Reed Army Medical Center did not result in clinically evident systemic ropivacaine toxicity."( Serum ropivacaine concentrations and systemic local anesthetic toxicity in trauma patients receiving long-term continuous peripheral nerve block catheters.
Bina, S; Bleckner, LL; Buckenmaier, CC; Dragovich, A; Kwon, KH; McKnight, G, 2010
)
0.36
" The onset of toxic manifestations (seizure, dysrhythmia, and cardiac arrest) was recorded, and then the doses of local anesthetics were calculated."( Effects of mixture of lidocaine and ropivacaine at different concentrations on the central nervous system and cardiovascular toxicity in rats.
Bo, YL; Li, HB; Li, WZ; Wan, QX, 2010
)
0.36
" We highlight how these toxic effects have motivated the search for a safe and long-acting local anesthetic."( Local anesthetic systemic toxicity.
Dillane, D; Finucane, BT, 2010
)
0.36
" Local anaesthesia is however associated with potential risks and adverse reactions including toxicity."( Local anaesthetic toxicity.
Maher, AJ; Metcalfe, SA; Parr, S, 2008
)
0.35
"Local anaesthesia although safe has the potential to cause serious harm in the event of toxicity."( Local anaesthetic toxicity.
Maher, AJ; Metcalfe, SA; Parr, S, 2008
)
0.35
" This concentration was a factor of 6 below the published safe level."( Is peri-articular multimodal drug infiltration in knee arthroplasty safe when used in conjunction with autologous retransfusion drains?
Busch, CA; Gallagher, K; Gill, I, 2010
)
0.36
"The theoretical risk of local anaesthesia toxicity when these systems are used together is negligible and we conclude that peri-articular multimodal drug infiltration is safe in conjunction with the use of autotransfusion drains."( Is peri-articular multimodal drug infiltration in knee arthroplasty safe when used in conjunction with autologous retransfusion drains?
Busch, CA; Gallagher, K; Gill, I, 2010
)
0.36
" Adverse effects were rare and unrelated to the choice of drug."( Evidence-based clinical update: Which local anesthetic drug for pediatric caudal block provides optimal efficacy with the fewest side effects?
Cox, RG; Dobereiner, EF; Ewen, A; Lardner, DR, 2010
)
0.36
" Adverse effects in human studies are rare, mild, and unrelated to the choice of drug."( Evidence-based clinical update: Which local anesthetic drug for pediatric caudal block provides optimal efficacy with the fewest side effects?
Cox, RG; Dobereiner, EF; Ewen, A; Lardner, DR, 2010
)
0.36
" Knowing that morphine provides comparable to even prolonged pain reduction after ACL reconstruction, the presented in vitro study suggests morphine as a potentially less toxic analgetic drug for intraarticular application in clinical practice."( Bupivacaine, ropivacaine, and morphine: comparison of toxicity on human hamstring-derived stem/progenitor cells.
Docheva, D; Grote, S; Haasters, F; Kohler, J; Mutschler, W; Polzer, H; Prall, WC; Saller, MM; Schieker, M, 2011
)
0.37
" However, recent studies have confirmed the toxic effect of lidocaine on ganglion cells."( Cataract surgery complications: an in vitro model of toxic effects of ropivacaine and lidocaine.
Nebbioso, M; Pescosolido, N; Scarsella, G; Tafani, M, 2011
)
0.37
"Our in vitro studies confirm that ropivacaine is less toxic than lidocaine to these cells."( Cataract surgery complications: an in vitro model of toxic effects of ropivacaine and lidocaine.
Nebbioso, M; Pescosolido, N; Scarsella, G; Tafani, M, 2011
)
0.37
" A 30-minute exposure to lidocaine alone was significantly toxic to the tenocytes in a dose-dependent manner, but a 30-minute exposure to ropivacaine or dexamethasone alone was not significantly toxic."( A comparison of lidocaine, ropivacaine and dexamethasone toxicity on bovine tenocytes in culture.
Feeley, BT; Kim, HT; Laron, D; Liu, X; Manzano, G; Pattnaik, T; Piper, SL, 2012
)
0.38
" In this study, we assessed whether PVB via an intrathoracic approach was also safe for the patients ineligible for epidural block because of, for example, anticoagulation or antiplatelet therapy."( Safety of the paravertebral block in patients ineligible for epidural block undergoing pulmonary resection.
Hamaishi, M; Hirai, S; Katayama, T; Kobayashi, R; Mitsui, N; Okada, T, 2012
)
0.38
"This study suggests that PVB is safe in patients ineligible for epidural block and can contribute to their pain relief following pulmonary resection procedure including video-assisted thoracic surgery."( Safety of the paravertebral block in patients ineligible for epidural block undergoing pulmonary resection.
Hamaishi, M; Hirai, S; Katayama, T; Kobayashi, R; Mitsui, N; Okada, T, 2012
)
0.38
" It appears to be safe to transfuse autologous blood in combination with LIA."( Safety of retransfusing shed blood after local infiltration analgesia in total knee arthroplasty.
in 't Veld, BA; Pool, L; Stienstra, R; Thomassen, BJ; Van Der Flier, R, 2012
)
0.38
" The neurotoxicity of apoptosis with concomitant cell death, mediated by ropivacaine, may offer an explanation for its adverse effects (e."( In vivo and in vitro evidence of the neurotoxic effects of ropivacaine: the role of the Akt signaling pathway.
Guo, Q; Liu, H; Sun, Z; Wang, N; Xu, X; Zhang, Z, 2012
)
0.38
"To assess the effects of lipid on ropivacaine-induced convulsion and LD50 in rats and compare with those of the traditional anticonvulsants midazolam and propofol."( [Effects of pretreatment of lipid, midazolam and propofol on ropivacaine-induced convulsion and LD50 in rats].
Lü, XL; Wan, FH; Zuo, YX, 2012
)
0.38
" Protocol 2: Additional 100 male SD rats were used for the measurements of ropivacaine LD50 with different pretreatments including lipid, midazolam, propofol and saline through the up-and-down method."( [Effects of pretreatment of lipid, midazolam and propofol on ropivacaine-induced convulsion and LD50 in rats].
Lü, XL; Wan, FH; Zuo, YX, 2012
)
0.38
" The LD50 of ropivacaine in group C was 64."( [Effects of pretreatment of lipid, midazolam and propofol on ropivacaine-induced convulsion and LD50 in rats].
Lü, XL; Wan, FH; Zuo, YX, 2012
)
0.38
" Previous studies have shown that the commonly used drugs lidocaine, ropivacaine, and bupivacaine can be toxic to human chondrocytes."( Cytotoxicity of local anesthetics on human mesenchymal stem cells.
Dang, AC; Kim, HT; Kuo, AC; Rahnama, R; Wang, M, 2013
)
0.39
"79), and 2% lidocaine was found to be significantly more toxic than all doses of bupivacaine and ropivacaine."( Cytotoxicity of local anesthetics on human mesenchymal stem cells.
Dang, AC; Kim, HT; Kuo, AC; Rahnama, R; Wang, M, 2013
)
0.39
" Since other studies have shown ropivacaine to be less toxic to chondrocytes than bupivacaine, ropivacaine may be a safer intra-articular anesthetic."( Cytotoxicity of local anesthetics on human mesenchymal stem cells.
Dang, AC; Kim, HT; Kuo, AC; Rahnama, R; Wang, M, 2013
)
0.39
" The incidence of adverse events was compared with the chi-square or Fisher test."( Comparative study related to cardiovascular safety between bupivacaine (S75-R25) and ropivacaine in brachial plexus block.
Auler, JO; de Rezende, MR; Hamaji, A; Mattar, R; Vieira, JE,
)
0.13
" In addition, the results showed that lidocaine was the most toxic of the three local anesthetics and that ropivacaine presented less cytotoxicity than lidocaine and bupivacaine."( Comparison of toxicity effects of ropivacaine, bupivacaine, and lidocaine on rabbit intervertebral disc cells in vitro.
Cai, XY; Ding, F; Gao, F; Shao, ZW; Xie, M; Xiong, LM; Yang, SH, 2014
)
0.4
" We report a case of Leriche's syndrome treated with safe and effective analgesia after laparotomy by abdominal wall block and continuous infusion."( [Case of Leriche's syndrome treated with safe and effective analgesia after laparotomy by transversus abdominis plane block, rectus sheath block, and continuous wound infusion with ropivacaine].
Hakata, S; Hotta, A; Kukida, A; Nakamoto, A; Oohira, N; Shimizu, M; Tatekawa, S; Tsumura, Y; Yagi, Y; Yoshikawa, N, 2013
)
0.39
" The incidence of adverse events was compared with the chi-square or Fisher test."( Comparative study related to cardiovascular safety between bupivacaine (S75-R25) and ropivacaine in brachial plexus block.
Auler, JO; Hamaji, A; Mattar, R; Rezende, MR; Vieira, JE,
)
0.13
"Labor analgesia by patient-controlled lumbar epidural combined anesthesia accompanied with Doula with ropivacaine and sufentanil is effective, safe, reliable, has no adverse effects, and reduces cesarean section rate."( Investigation on delivery analgesia effect of combined spinal epidural anesthesia plus Doula and safety of mother and baby.
Feng, BB; Wang, L; Zhai, JJ, 2013
)
0.39
" The outcomes of clinical safety were measured using plasma concentration of local anesthetics and occurrence of toxic symptoms."( [Analgesic efficacy and clinical safety of intraperitoneal instillation combined with rectus sheath block using ropivacaine for pain relief after laparoscopic gynecological surgery].
Hashimoto, H; Hirota, K; Kitayama, M; Kudo, M; Kudo, T; Niwa, H; Yakoshi, C, 2014
)
0.4
"5% ropivacaine, none of analyzed concentrations was above the toxic ones."( [Analgesic efficacy and clinical safety of intraperitoneal instillation combined with rectus sheath block using ropivacaine for pain relief after laparoscopic gynecological surgery].
Hashimoto, H; Hirota, K; Kitayama, M; Kudo, M; Kudo, T; Niwa, H; Yakoshi, C, 2014
)
0.4
"The present study showed that the combination of rectus sheath block with intraperitoneal instillation of ropivacaine was safe and potent enough to relieve pain after laparoscopic surgery."( [Analgesic efficacy and clinical safety of intraperitoneal instillation combined with rectus sheath block using ropivacaine for pain relief after laparoscopic gynecological surgery].
Hashimoto, H; Hirota, K; Kitayama, M; Kudo, M; Kudo, T; Niwa, H; Yakoshi, C, 2014
)
0.4
"Ropivacaine is not safe when intrathecally administered with lidocaine at the concentrations used in this study."( Intrathecal lidocaine neurotoxicity: combination with bupivacaine and ropivacaine and effect of nerve growth factor.
Chen, W; Ding, X; Guo, Y; Zhao, G, 2014
)
0.4
" Of the evaluated anesthetics, ropivacaine is the least toxic in the clinically used concentration."( Cytotoxic effects of ropivacaine, bupivacaine, and lidocaine on rotator cuff tenofibroblasts.
Hah, YS; Kim, JS; Kim, RJ; Lee, SJ; Nam, JB; Park, HB; Sung, CM, 2014
)
0.4
"To compare the anesthetic efficacy and adverse effects associated with peribulbar injection of ropivacaine (1% solution) performed with and without ultrasound guidance (UG) in dogs."( Comparison of anesthetic efficacy and adverse effects associated with peribulbar injection of ropivacaine performed with and without ultrasound guidance in dogs.
Deschk, M; Ferreira, JZ; Fioravanti, H; Floriano, BP; Gasparello, IF; Oliva, VN; Wagatsuma, JT, 2014
)
0.4
"Scalp block with a mixture of lidocaine and ropivacaine seems to provide effective and safe anesthetic management in patients undergoing awake craniotomy."( Efficacy and Safety of a Lidocaine and Ropivacaine Mixture for Scalp Nerve Block and Local Infiltration Anesthesia in Patients Undergoing Awake Craniotomy.
Chaki, T; Hatakeyama, Y; Hayase, T; Ishioka, Y; Janicki, PK; Kaneuchi-Yamashita, M; Kohri, N; Sugino, S; Yamakage, M, 2016
)
0.43
" In addition to these 12 patients, 3 other patients had adverse events related to the interscalene CPNB."( Safety of pediatric continuous interscalene block catheters placed under general anesthesia: a single center's experience.
Cucchiaro, G; Ganesh, A; Gurnaney, H; Kraemer, FW; Muhly, WT, 2015
)
0.42
"Use of intrathecal admixtures is widespread, but compounding these is sometimes challenging and may result in errors and complications causing super-potency or sub potency adverse events in patients or malfunctions in the pump itself."( Rationale for Prospective Assays of Intrathecal Mixtures Including Morphine, Ropivacaine and Ziconotide: Prevention of Adverse Events and Feasibility in Clinical Practice.
Bazin, C; Boré, F; Devys, C; Dubois, PY; Dupoiron, D; Folliard, C; Kieffer, H; Lebrec, N,
)
0.13
"This study is monocentric and limitations include also its non-randomized nature with no clinical comparison of the rate of adverse events with a refill process without control of each component concentrations."( Rationale for Prospective Assays of Intrathecal Mixtures Including Morphine, Ropivacaine and Ziconotide: Prevention of Adverse Events and Feasibility in Clinical Practice.
Bazin, C; Boré, F; Devys, C; Dubois, PY; Dupoiron, D; Folliard, C; Kieffer, H; Lebrec, N,
)
0.13
" Secondary outcomes were pain scores from 24 to 72 h, intraoperative and postoperative opioid consumption, time to onset of bowel movement and side effect profiles."( Comparison of efficacy and safety of lateral-to-medial continuous transversus abdominis plane block with thoracic epidural analgesia in patients undergoing abdominal surgery: A randomised, open-label feasibility study.
Brookes, J; Das Adhikary, S; Ganapathy, S; Sondekoppam, RV; Subramanian, L; Terlecki, M, 2015
)
0.42
"Although intrathecal drug infusion has been commonly adopted for terminal cancer pain relief, its adverse effects have made many clinicians reluctant to employ it for intractable cancer pain."( Efficacy and Safety of Ropivacaine Addition to Intrathecal Morphine for Pain Management in Intractable Cancer.
Huang, Y; Li, X; Lin, J; Tao, G; Zhu, T, 2015
)
0.42
" Adverse effects and complications on postoperative days 1, 3, 7, and 15 were also analyzed."( Efficacy and Safety of Ropivacaine Addition to Intrathecal Morphine for Pain Management in Intractable Cancer.
Huang, Y; Li, X; Lin, J; Tao, G; Zhu, T, 2015
)
0.42
"Morphine and ropivacaine administration through intrathecal access ports is efficacious and safe and significantly improves quality of life."( Efficacy and Safety of Ropivacaine Addition to Intrathecal Morphine for Pain Management in Intractable Cancer.
Huang, Y; Li, X; Lin, J; Tao, G; Zhu, T, 2015
)
0.42
" We observed a significant reduction in morphine adverse effects (31% versus 69% for groups R and P, respectively; P<0."( Impact of preoperative continuous femoral blockades on morphine consumption and morphine side effects in hip-fracture patients: A randomized, placebo-controlled study.
Bouhours, G; Chaudet, A; Hamel, JF; Lasocki, S; Leblanc, D; Rineau, E; Steiger, V, 2016
)
0.43
" The patients' satisfaction, heart rate, the chages of blood pressure before and after the block, detachment of tubes, and adverse drug reaction were recorded."( [Stellate ganglion catheter retention with discontinuous block on efficacy and safety in the treatment of sudden deafness].
Gao, H; Guo, W; Zhang, G; Zhang, Z, 2015
)
0.42
" Moreover, no adverse drug reaction and detachment of tubes were observed."( [Stellate ganglion catheter retention with discontinuous block on efficacy and safety in the treatment of sudden deafness].
Gao, H; Guo, W; Zhang, G; Zhang, Z, 2015
)
0.42
"It is a safe and effective administration of stellate ganglion catheter retention with interrupted ropivacaine block."( [Stellate ganglion catheter retention with discontinuous block on efficacy and safety in the treatment of sudden deafness].
Gao, H; Guo, W; Zhang, G; Zhang, Z, 2015
)
0.42
" Moreover, in spite of boluses that were within the manufacturer's recommendation for epidural and major nerve blocks, and an infusion rate that was only slightly higher than what appeared to be safe for epidural infusion, potentially toxic total plasma ropivacaine concentrations were common."( Local anaesthetic toxicity after bilateral thoracic paravertebral block in patients undergoing coronary artery bypass surgery.
Chan, SK; Ho, AM; Joynt, GM; Karmakar, MK; Ng, CS; Ng, SK; Wan, S; Wong, RH, 2016
)
0.43
" There were no adverse events such as postoperative nausea and vomiting."( Preoperative flap-site injection with ropivacaine and epinephrine in BABA robotic and endoscopic thyroidectomy safely reduces postoperative pain: A CONSORT-compliant double-blinded randomized controlled study (PAIN-BREKOR trial).
Choi, JY; Kwon, H; Lee, JH; Lee, KE; Song, RY; Suh, YJ; Yi, JW; Yu, HW, 2017
)
0.46
" However, its practical use is highly limited by certain drawbacks including high viscosity, involved toxic organic solvents and fast drug release."( An in situ-forming phospholipid-based phase transition gel prolongs the duration of local anesthesia for ropivacaine with minimal toxicity.
Deng, J; Fu, Q; Lan, L; Li, H; Liu, T; Shi, S; Wu, W; Zhu, Y, 2017
)
0.46
"The peak total ropivacaine concentration was below quoted toxic concentrations (2."( Plasma Ropivacaine Concentrations Following Local Infiltration Analgesia in Total Knee Arthroplasty: A Pharmacokinetic Study to Determine Safety Following Fixed-Dose Administration.
Cameron, AJ; Dimech, J; Lightfoot, NJ; Miller, RJ; Orec, RJ, 2018
)
0.48
" Rectus sheath block reduces the pain intensity and the consumption of opioids and declines the incidence of the adverse effects, therefore improving the quality of analgesia and postoperative comfort ofpatient."( EFFICIENCY AND SAFETY OF BILATERAL ULTRASOUND RECTUS SHEATH BLOCK IN URGENT LAPAROTOMY.
Antipin, EE; Karpunov, AA; Lovkov, IA; Nedashkovskiv, EV; Ushakov, AA; Uvarov, DN, 2017
)
0.46
"BACKGROUND Regional nerve blocks ideally provide safe and effective post-operative pain control, decrease opiate requirements, and enhance recovery from intense pain following major thoracic, abdominal, and musculoskeletal surgeries."( Safe and Effective Use of Bilateral Erector Spinae Block in Patient Suffering from Post-Operative Coagulopathy Following Hepatectomy.
Fernandez, L; Johnson, C; Kazior, MR; Maarouf, R; Maddineni, U, 2020
)
0.56
"Continuous TAP blockade is an effective and safe technique."( Effectiveness and Safety of Continuous Transverse Abdominal Plane Blocks vs Epidural Analgesia in Donor Nephroureterectomy.
Calixto-Flores, A; Díaz-Angúlo, W, 2020
)
0.56
"Infiltration of ropivacaine and Diprospan can achieve satisfactory postoperative pain relief after craniotomy; it is a simple, easy, and safe technique, worth clinical promotion."( Postoperative Analgesic Efficacy and Safety of Ropivacaine Plus Diprospan for Preemptive Scalp Infiltration in Patients Undergoing Craniotomy: A Prospective Randomized Controlled Trial.
Han, X; Ji, N; Luo, F; Ren, T; Wang, Y, 2022
)
0.72
"Sufentanil combined with ropivacaine is commonly used for epidural labor analgesia, but it may cause some adverse effects."( Efficacy and safety of dexmedetomidine-ropivacaine versus sufentanil-ropivacaine for epidural labor analgesia: a randomized controlled trial.
Cao, R; Fan, M; Hu, L; Li, J; Lu, S, 2022
)
0.72
" Secondary outcomes included the duration of labor stages and adverse reactions of parturient women and newborns."( Efficacy and safety of dexmedetomidine-ropivacaine versus sufentanil-ropivacaine for epidural labor analgesia: a randomized controlled trial.
Cao, R; Fan, M; Hu, L; Li, J; Lu, S, 2022
)
0.72
" The incidence of adverse reactions in parturient women and newborns was low in both groups."( Efficacy and safety of dexmedetomidine-ropivacaine versus sufentanil-ropivacaine for epidural labor analgesia: a randomized controlled trial.
Cao, R; Fan, M; Hu, L; Li, J; Lu, S, 2022
)
0.72
"4 min, but exacerbating ropivacaine adverse effects (reduced survival by 13."( Local Anesthetic Cardiac Toxicity Is Mediated by Cardiomyocyte Calcium Dynamics.
Coles, JG; Estrada, M; Lonnqvist, PA; Maynes, JT; Plakhotnik, J; Zhang, L, 2022
)
0.72
"4%) of severe itching in women, in group I such an adverse reaction was absent."( SAFETY OF USING DURAL PUNCTURE EPIDURAL ANALGESIA AS A METHOD OF LABOR ANALGESIA.
Loskutov, OA; Sulimenko, YM; Zhezher, AO, 2022
)
0.72
"Day stay surgery for anterior cruciate ligament (ACL) reconstructions is an increasingly common practice and has driven clinicians to develop postoperative pain regimes that allow same day mobilization and a safe and timely discharge."( Safety and efficacy of intraosseous ropivacaine in lower extremity (SORE) study.
Hannam, J; Nicholson, L; Rahardja, R; Stowers, MDJ; Svirskis, D; Young, SW, 2023
)
0.91
"This study demonstrates that IO ropivacaine is both safe and effective in reducing perioperative pain in patients undergoing ACL reconstruction."( Safety and efficacy of intraosseous ropivacaine in lower extremity (SORE) study.
Hannam, J; Nicholson, L; Rahardja, R; Stowers, MDJ; Svirskis, D; Young, SW, 2023
)
0.91
" Secondary outcomes were intraoperative VAS scores assessed at multiple timepoints; intraoperative rescue analgesic requirement; postoperative VAS scores; disability scale; patients' satisfaction with anesthesia; adverse events; and radiographic outcomes."( Effectiveness and safety of intrathecal morphine for percutaneous endoscopic lumbar discectomy under low-dose ropivacaine: a prospective, randomized, double-blind clinical trial.
Lin, Z; Mu, G; Shang, M; Sun, H; Yue, L; Zhang, F, 2023
)
0.91
" For adverse events, 8/43 of ITM and 1/44 of control participants experienced pruritus (p=."( Effectiveness and safety of intrathecal morphine for percutaneous endoscopic lumbar discectomy under low-dose ropivacaine: a prospective, randomized, double-blind clinical trial.
Lin, Z; Mu, G; Shang, M; Sun, H; Yue, L; Zhang, F, 2023
)
0.91
"Subcutaneous CLIA is a technically feasible and safe procedure without major adverse events but with reduced postoperative pain scores (at rest and during mobilization) and opioid consumption."( The efficacy and safety of subcutaneous continuous local infiltration analgesia with ropivacaine in patients undergoing total knee arthroplasty: a comparative study.
Al-Mohrej, OA; Al-Saati, MF; Alaqaili, SI; Albaiz, AA; Alshammari, FA; ElRaei, MAN; Tushinski, D, 2023
)
0.91
"The local analgesic efficacy and adverse effects of a new Long-acting Ropivacaine formulation were examined based on pharmacokinetic-pharmacodynamic (PK-PD) modelling in Bama minipigs."( LC-MS/MS quantification of ropivacaine and local analgesic and adverse effects of Long-acting Ropivacaine Injection based on pharmacokinetic-pharmacodynamic modelling in Bama minipigs.
Bian, J; Cai, C; Chen, R; Chen, Y; Cui, H; Lyu, L; Xu, S; Xu, ZR, 2023
)
0.91
" Pharmacokinetic data are needed to guide safe dosing."( Population pharmacokinetic and safety analysis of ropivacaine used for erector spinae plane blocks.
Abulfathi, AA; Baratta, JL; Gebhart, A; Kaushal, G; Lam, E; Mohamod, D; Rochani, A; Roy, AB; Sarna, RR; Schmidt, S; Schwenk, ES; Viscusi, ER; Witzeling, SD; Zhao, JL, 2023
)
0.91
"Spontaneous reports notified to the French Pharmacovigilance Network were retrieved and followed by a case-by-case review, according to the following criteria: LA as suspected drug, age < 18 years, adverse drug reactions related to nervous system, cardiac, respiratory, psychiatric or general disorders."( Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database.
Bouazza, N; Boyer-Gervoise, M; Callot, D; Chouchana, L; Lesage, F; Oualha, M; Paret, N; Schweitzer-Chaput, A; Treluyer, JM, 2023
)
0.91
" Using the lowest possible dose of anesthetic that provides painless delivery with the lowest adverse events is a major concern."( Safety and efficacy of combined ropivacaine and sufentanil compared with ropivacaine for cesarean sections: A systematic review and meta-analysis.
Abdalla, AM; Albadrani, MS; Azeem, FM; El-Amin, EI; Elhusein, AM; Elhussain, MY; Fadlalmola, HA; Masada, HK, 2023
)
0.91
" The primary endpoint was a safe dose or a maximum dose of ropivacaine (400 mg)."( A randomized trial: The safety, pharmacokinetics and preliminary pharmacodynamics of ropivacaine oil delivery depot in healthy subjects.
Cao, YX; Chi, P; Dong, JP; Hui, MQ; Jiao, YQ; Lu, WD; Ma, B; Tian, Y; Wang, MX; Yang, B; Yang, Y; Zhang, HB; Zhang, M; Zhao, DL, 2023
)
0.91
" Multineedle subcutaneous injection of RODD in the abdomens of subjects was safe, and all adverse events were no more severe than grade II."( A randomized trial: The safety, pharmacokinetics and preliminary pharmacodynamics of ropivacaine oil delivery depot in healthy subjects.
Cao, YX; Chi, P; Dong, JP; Hui, MQ; Jiao, YQ; Lu, WD; Ma, B; Tian, Y; Wang, MX; Yang, B; Yang, Y; Zhang, HB; Zhang, M; Zhao, DL, 2023
)
0.91
" Efficacy indicators consisting of maternal vital signs, obstetric transfer, neonatal prognostic indicators, and adverse effects were recorded before and after analgesia across groups."( Cytochrome P4503A4 gene polymorphisms guide safe sufentanil analgesic doses in pregnant Chinese mothers: a multicenter, randomized, prospective study.
Chi, L; Shu, X; Yan, Y; Yu, J, 2024
)
1.44

Pharmacokinetics

Epidural ropivacaine displays dose-proportional pharmacokinetic behaviour for doses of 125 mg to 250 mg.

ExcerptReferenceRelevance
" Pharmacokinetic parameters were derived using serum concentration-time data."( Pharmacodynamics and pharmacokinetics of epidural ropivacaine in humans.
Bridenbaugh, PO; Denson, DD; Helton, SH; Katz, JA; Knarr, DC, 1990
)
0.28
" Thus the difference in the elimination half-life was only minimal: 74."( Pharmacokinetics of ropivacaine in nonpregnant and pregnant ewes.
Arthur, GR; Covino, BG; Finster, M; Johnson, HV; Morishima, HO; Pedersen, H; Sallusto, JA; Santos, AC, 1990
)
0.28
" After epidural injections (ropivacaine n = 6; bupivacaine n = 5), a dose-related increase in Cmax was observed with both drugs."( Comparative pharmacokinetics of bupivacaine and ropivacaine, a new amide local anesthetic.
Arthur, GR; Covino, BG; Feldman, HS, 1988
)
0.27
"The clinical and pharmacokinetic properties of ropivacaine and bupivacaine, both 5 mg/mL, used in axillary plexus block were compared in 60 patients in this randomized, double-blind, parallel-group study."( A clinical and pharmacokinetic comparison of ropivacaine and bupivacaine in axillary plexus block.
Haavisto, ET; Hollmén, AI; Huha, TM; Jozwiak, HM; Korpi, KJ; Magnusson, AA; Nuutinen, LS; Vainionpää, VA, 1995
)
0.29
" The purpose of this study was to determine the pharmacokinetic properties of ropivacaine and bupivacaine after bilateral intercostal blockade."( Pharmacokinetics of ropivacaine and bupivacaine for bilateral intercostal blockade in healthy male volunteers.
Carpenter, RL; Emanuelsson, BM; Kopacz, DJ; Stephenson, CA; Thompson, GE, 1994
)
0.29
" The terminal half-life (t1/2 beta) of ropivacaine (2."( Pharmacokinetics of ropivacaine and bupivacaine for bilateral intercostal blockade in healthy male volunteers.
Carpenter, RL; Emanuelsson, BM; Kopacz, DJ; Stephenson, CA; Thompson, GE, 1994
)
0.29
" The concentration of bupivacaine in patients determined by this method agreed well with the values obtained from an alternative method, making the technique applicable for pharmacokinetic studies in humans."( Direct injection of large volumes of plasma in a column-switching system for the analysis of local anaesthetics. II. Determination of bupivacaine in human plasma with an alkyldiol silica precolumn.
Westerlund, D; Yu, Z, 1996
)
0.29
" The relationship between V(d)beta and CL was such that the elimination half-life (T(1/2)beta) was not altered."( Comparative pharmacokinetics of ropivacaine and bupivacaine in nonpregnant and pregnant ewes.
Arthur, GR; Finster, M; Lehning, EJ; Santos, AC, 1997
)
0.3
" Arterial blood samples were drawn for serum drug concentration determinations and pharmacokinetic analysis."( Comparative local anesthetic efficacy and pharmacokinetics of epidurally administered ropivacaine and bupivacaine in the sheep.
Ask, AL; Doucette, AM; Dvoskin, S; Feldman, HS; Halldin, MH,
)
0.13
" Study parameters included sensory and motor blockade, circulatory response, intraoperative pain and discomfort, neonatal evaluation and pharmacokinetic determinations."( Ropivacaine 7.5 mg/ml for elective caesarean section. A clinical and pharmacokinetic comparison of 150 mg and 187.5 mg.
Ekblom, A; Emanuelsson, BM; Irestedt, L; Olofsson, C; Reventlid, H, 1997
)
0.3
" In the pharmacokinetic part of this study the objectives were to 1) determine the dose proportionality in the pharmacokinetics of epidural ropivacaine, and 2) compare the pharmacokinetics of 125 mg ropivacaine and 125 mg bupivacaine."( Pharmacokinetics of three doses of epidural ropivacaine during hysterectomy and comparison with bupivacaine.
Arlander, E; Callahan-Enright, SO; Chan, V; Finucane, BT; Friedlander, M; Milner, A; Muzyka, D; Sandler, AN; Taddio, A, 1998
)
0.3
" Pharmacokinetic variables were derived from plasma concentration-time curve data."( Pharmacokinetics of three doses of epidural ropivacaine during hysterectomy and comparison with bupivacaine.
Arlander, E; Callahan-Enright, SO; Chan, V; Finucane, BT; Friedlander, M; Milner, A; Muzyka, D; Sandler, AN; Taddio, A, 1998
)
0.3
" Apparent plasma clearance (CL) and the terminal half-life (t1/2) were similar in the three ropivacaine groups."( Pharmacokinetics of three doses of epidural ropivacaine during hysterectomy and comparison with bupivacaine.
Arlander, E; Callahan-Enright, SO; Chan, V; Finucane, BT; Friedlander, M; Milner, A; Muzyka, D; Sandler, AN; Taddio, A, 1998
)
0.3
"Epidural ropivacaine displays dose-proportional pharmacokinetic behaviour for doses of 125 mg to 250 mg."( Pharmacokinetics of three doses of epidural ropivacaine during hysterectomy and comparison with bupivacaine.
Arlander, E; Callahan-Enright, SO; Chan, V; Finucane, BT; Friedlander, M; Milner, A; Muzyka, D; Sandler, AN; Taddio, A, 1998
)
0.3
" The relevant pharmacokinetic differences include a lower lipid solubility, a slightly higher plasma clearance and shorter elimination half-life (t 1/2 beta) compared with racemic bupivacaine, with a similar degree of plasma protein binding."( Recent advances in the pharmacokinetics of local anaesthetics. Long-acting amide enantiomers and continuous infusions.
Schug, SA; Thomas, JM, 1999
)
0.3
" Pharmacokinetic data were obtained from 22 subjects."( Clinical efficacy and pharmacokinetics of 1% ropivacaine and 0.75% bupivacaine in peribulbar anaesthesia for cataract surgery.
Ala-Kokko, TI; Alahuhta, S; Huha, T; Salomäki, T, 1999
)
0.3
" However, the pharmacokinetic results obtained suggest that even larger doses (0."( Pharmacokinetics and pharmacodynamics of ropivacaine 2 mg/mL, 5 mg/mL, or 7.5 mg/mL after ilioinguinal blockade for inguinal hernia repair in adults.
Behnke, H; Böhle, AS; Worthmann, F; Wulf, H, 1999
)
0.3
" We therefore designed this study to determine the pharmacokinetic variables of ropivacaine relevant to the risk of toxicity, after caudal administration in children."( Pharmacokinetics of ropivacaine following caudal analgesia in children.
Bergesio, R; Habre, W; Hackett, P; Johnson, C; Joyce, D; Sims, C, 2000
)
0.31
" There were no significant changes in the pharmacokinetic parameters of the parent ropivacaine after ingestion of clarithromycin or itraconazole."( Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine.
Ahonen, J; Jokinen, MJ; Neuvonen, PJ; Olkkola, KT, 2001
)
0.31
" Population pharmacokinetic modeling was performed to yield estimates of clearance, volume of distribution, and absorption rate constant."( Caudal ropivacaine in infants: population pharmacokinetics and plasma concentrations.
Bergesio, R; Hackett, LP; Hansen, TG; Ilett, KF; Lim, SI; Reid, C, 2001
)
0.31
" Pharmacokinetic variables of the total population were best described by a one-compartment model with first-order absorption."( Caudal ropivacaine in infants: population pharmacokinetics and plasma concentrations.
Bergesio, R; Hackett, LP; Hansen, TG; Ilett, KF; Lim, SI; Reid, C, 2001
)
0.31
"The pharmacokinetic variables of ropivacaine were characterized after epidural bolus injection in pediatric patients."( The pharmacokinetics of epidural ropivacaine in infants and young children.
Auble, SG; Berde, CB; Hope, T; Mazoit, JX; McCann, ME; Rifai, N; Sakamoto, M; Sethna, NF; Sullivan, L, 2001
)
0.31
"This study revealed that the pharmacokinetic variables of lumbar epidural bolus ropivacaine in pediatric patients aged 3 to 48 mo are similar to those of adults, except that drug clearance was less in infants compared with older children."( The pharmacokinetics of epidural ropivacaine in infants and young children.
Auble, SG; Berde, CB; Hope, T; Mazoit, JX; McCann, ME; Rifai, N; Sakamoto, M; Sethna, NF; Sullivan, L, 2001
)
0.31
" Pharmacokinetic parameters were calculated with noncompartmental methods, and t tests were used for comparisons between the phases and between the smokers and nonsmokers."( Effect of rifampin and tobacco smoking on the pharmacokinetics of ropivacaine.
Ahonen, J; Jokinen, MJ; Neuvonen, PJ; Olkkola, KT, 2001
)
0.31
"There were no statistically significant differences in the area under the plasma concentration-time curve (AUC), plasma clearance (CL), or half-life (t(1/2)) of ropivacaine between the smokers and nonsmokers."( Effect of rifampin and tobacco smoking on the pharmacokinetics of ropivacaine.
Ahonen, J; Jokinen, MJ; Neuvonen, PJ; Olkkola, KT, 2001
)
0.31
" Fifteen venous blood samples were obtained from each patient for pharmacokinetic measurements over a 24-h period."( Pharmacokinetics and efficacy of 40 ml ropivacaine 7.5 mg/ml (300 mg), for axillary brachial plexus block--an open pilot study.
Büttner, J; Emanuelson, BM; Maier, KR; Selander, D; Wank, W,
)
0.13
" Maximal concentration (C(max)) and time to peak concentration (T(max)) were obtained from the data, terminal half-life (T(1/2z)), clearance (Cl) and volume of distribution (Vd) were estimated by a non-compartmental approach."( In children, the addition of epinephrine modifies the pharmacokinetics of ropivacaine injected caudally.
Roelants, FA; Van Obbergh, LJ; Verbeeck, RK; Veyckemans, F,
)
0.13
" The tmax and toxicity data were obtained from the literature."( Lipophilicity affects the pharmacokinetics and toxicity of local anaesthetic agents administered by caudal block.
Bello-Ramírez, AM; Nava-Ocampo, AA,
)
0.13
" The elimination half-life of ropivacaine was significantly less than that of bupivacaine (5."( [Clinical effects and pharmacokinetics of ropivacaine and bupivacaine for epidural analgesia during labor].
Barros Núñez, C; Cánovas Martínez, L; Castro Méndez, A; Gallardo, E; González González, D; López Piñeiro, S, 2004
)
0.32
" Pharmacokinetic data were characterized by population analysis."( Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block.
Austin, S; Boos, K; Gädeke, V; Gustafsson, U; Huledal, G; Krohn, S; Larsson, LE; Molnár, V; Motsch, J; Rapp, HJ; Williams, DG, 2004
)
0.32
" Apparent volume of distribution is unchanged, apparent unbound clearance increases and the terminal half-life decreases with age in 0-12-month-old neonates and infants."( Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block.
Austin, S; Boos, K; Gädeke, V; Gustafsson, U; Huledal, G; Krohn, S; Larsson, LE; Molnár, V; Motsch, J; Rapp, HJ; Williams, DG, 2004
)
0.32
"Epinephrine reduced the peak plasma concentrations and delayed the time of peak concentration of ropivacaine in both the arterial and venous blood."( Arterial and venous pharmacokinetics of ropivacaine with and without epinephrine after thoracic paravertebral block.
Gin, T; Ho, AM; Karmakar, MK; Law, BK; Shafer, SL; Wong, AS, 2005
)
0.33
" Our preliminary pharmacokinetic data showed that ropivacaine viscous could be used safely based on the plasma ropivacaine concentrations (C(max): 89-125 ng/ml) for pain relief in oral mucosa."( Liquid chromatographic determination of plasma ropivacaine for assessing pharmacokinetics of the viscous preparation.
Homma, M; Inomata, S; Kakiuchi, Y; Kawata, T; Kobayashi, D; Kohda, Y; Miyabe, M; Morimoto, Y, 2005
)
0.33
"2-fold longer half-life (P<0."( Pharmacokinetics of ropivacaine in patients with chronic end-stage liver disease.
Ahonen, J; Askemark, Y; Breuer, O; Höckerstedt, K; Jokinen, MJ; Lindgren, L; Neuvonen, PJ; Olkkola, KT; Sjövall, J, 2007
)
0.34
" Resulting dialysate and plasma concentrations were used to calculate pharmacokinetic parameters for ropivacaine and bupivacaine."( Effect of epinephrine on epidural, intrathecal, and plasma pharmacokinetics of ropivacaine and bupivacaine in sheep.
Chevanne, F; Dollo, G; Ecoffey, C; Estebe, JP; Le Corre, P; Malinovsky, JM; Ratajczak-Enselme, M; Rose, FX; Wodey, E, 2007
)
0.34
" Plasma Cmax for bupivacaine was decreased."( Effect of epinephrine on epidural, intrathecal, and plasma pharmacokinetics of ropivacaine and bupivacaine in sheep.
Chevanne, F; Dollo, G; Ecoffey, C; Estebe, JP; Le Corre, P; Malinovsky, JM; Ratajczak-Enselme, M; Rose, FX; Wodey, E, 2007
)
0.34
" pharmacokinetic data on 670 drugs representing, to our knowledge, the largest publicly available set of human clinical pharmacokinetic data."( Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Lombardo, F; Obach, RS; Waters, NJ, 2008
)
0.35
"After epidural administration of ropivacaine-loaded microspheres, Cmax in plasma was around 100 ng/ml while epidural and intrathecal Cmax of ropivacaine were close to 600 and 150 microg/ml, respectively."( Epidural, intrathecal and plasma pharmacokinetic study of epidural ropivacaine in PLGA-microspheres in sheep model.
Bec, D; Chevanne, F; Dollo, G; Ecoffey, C; Estebe, JP; Le Corre, P; Malinovsky, JM; Ratajczak-Enselme, M, 2009
)
0.35
"During orthopaedic surgery of the limb, we performed a prospective, double blind controlled study on three parallel groups in 30 patients to evaluate the pharmacokinetic and pharmacodynamic effect of infiltration of the iliac crest bone graft harvest site with 20 ml of bupivacaine (100 mg), ropivacaine (150 mg) or saline as control group (n = 10 in each group)."( Local anaesthetic use for the iliac crest-donor site: pharmacokinetic and pharmacodynamic evaluations.
Chevanne, F; Ecoffey, C; Eliat, C; Estebe, JP; Husson, JL; Le Corre, P; Le Naoures, A, 2009
)
0.35
" The main pharmacokinetic parameters in group A and B were: Cmax (3."( [Clinical efficacy and pharmacokinetics of different concentrations of ropivacaine with the same dosage on blocking lumbar plexus with sciatic nerves].
Cao, W; Xu, HW; Zhang, L; Zhang, WS; Zhang, X, 2009
)
0.35
" The plasma concentration-time curve for ropivacaine fits into a two-compartment pharmacokinetic model."( [Clinical efficacy and pharmacokinetics of different concentrations of ropivacaine with the same dosage on blocking lumbar plexus with sciatic nerves].
Cao, W; Xu, HW; Zhang, L; Zhang, WS; Zhang, X, 2009
)
0.35
" After blood samples collection, ropivacaine serum concentrations and pharmacokinetic parameters were determined."( Effects of induced hyperthermia on pharmacokinetics of ropivacaine in rats.
Boulamery, A; Bruguerolle, B; Deluca, B; Deturmeny, E; Guilhaumou, R, 2010
)
0.36
" Pharmacokinetic parameters were calculated using both noncompartmental and compartmental analysis."( The pharmacokinetics of ropivacaine after intraperitoneal administration: instillation versus nebulization.
Betton, D; Diemunsch, P; Greib, N; Joshi, GP; Schlotterbeck, H; Ubeaud-Sequier, G, 2010
)
0.36
"The pharmacokinetic profile of ropivacaine nebulization is similar to direct intraperitoneal instillation, but with a lower absorption rate."( The pharmacokinetics of ropivacaine after intraperitoneal administration: instillation versus nebulization.
Betton, D; Diemunsch, P; Greib, N; Joshi, GP; Schlotterbeck, H; Ubeaud-Sequier, G, 2010
)
0.36
" The relationship between pharmacokinetic parameters and creatinine clearance (CL(CR)) was assessed."( Pharmacokinetics of ropivacaine in patients with chronic renal failure.
Ekstrand, A; Henriksson, J; Honkanen, E; Pere, PJ; Rosenberg, PH; Salonen, M; Sjövall, J, 2011
)
0.37
"One-compartment first-order pharmacokinetic models incorporating linear binding of ropivacaine and PPX to α(1)-acid glycoprotein were used."( Population pharmacokinetic analysis of ropivacaine and its metabolite 2',6'-pipecoloxylidide from pooled data in neonates, infants, and children.
Aarons, L; Henriksson, J; Molnár, V; Pitsiu, M; Sadler, B; Sjövall, J, 2011
)
0.37
"To investigate the pharmacokinetic profile of ropivacaine after bilateral TAP blocks."( Potentially toxic concentrations in blood of total ropivacaine after bilateral transversus abdominis plane blocks; a pharmacokinetic study.
Breindahl, T; Hansen, EG; Mitchell, AU; Møller, AM; Rosenberg, J; Torup, H, 2012
)
0.38
"Prospective observational pharmacokinetic study."( Potentially toxic concentrations in blood of total ropivacaine after bilateral transversus abdominis plane blocks; a pharmacokinetic study.
Breindahl, T; Hansen, EG; Mitchell, AU; Møller, AM; Rosenberg, J; Torup, H, 2012
)
0.38
"No pharmacokinetic data exist on doses of ropivacaine larger than 300 mg for peripheral nerve block in man, although in clinical practice higher doses are frequently used."( Pharmacokinetics of 450 mg ropivacaine with and without epinephrine for combined femoral and sciatic nerve block in lower extremity surgery. A pilot study.
Jack, NT; Schoenmakers, KP; Stienstra, R; van den Bemt, B; van Limbeek, J; Vree, TB, 2013
)
0.39
" Pharmacokinetic parameters were calculated using a non-compartmental approach."( Pharmacokinetics of 450 mg ropivacaine with and without epinephrine for combined femoral and sciatic nerve block in lower extremity surgery. A pilot study.
Jack, NT; Schoenmakers, KP; Stienstra, R; van den Bemt, B; van Limbeek, J; Vree, TB, 2013
)
0.39
" The purpose of this study was to develop a population pharmacokinetic model for ropivacaine after loco-regional administration and to identify patient characteristics that may influence the drug's absorption and disposition."( A population pharmacokinetic model for the complex systemic absorption of ropivacaine after femoral nerve block in patients undergoing knee surgery.
Drolet, P; Fallaha, M; Gaudreault, F; Varin, F, 2012
)
0.38
" Pharmacokinetic parameters were calculated using noncompartmental analysis."( Pharmacokinetics and efficacy of ropivacaine in Chinese patients following intra-articular administration.
Chen, S; Chen, Z; Jin, Y; Lin, J; Lin, X; Tian, Z; Xu, L; Xu, S; Zhu, M, 2013
)
0.39
"Ropivacaine 150 mg provided satisfactory postoperative pain relief and can be safely administered by intraarticular injection in Chinese patients after arthroscopic knee surgery and the pharmacokinetic profiles of ropivacaine exhibited marked variability among the subjects."( Pharmacokinetics and efficacy of ropivacaine in Chinese patients following intra-articular administration.
Chen, S; Chen, Z; Jin, Y; Lin, J; Lin, X; Tian, Z; Xu, L; Xu, S; Zhu, M, 2013
)
0.39
"The aim of this study was to develop a pharmacokinetic model in order to characterize the free and total ropivacaine concentrations after transversus abdominis plane block in a population of patients undergoing liver resection surgery."( Population pharmacokinetic model of free and total ropivacaine after transversus abdominis plane nerve block in patients undergoing liver resection.
Beauchesne, B; Bonnet, C; Delavenne, X; Heritier, F; Hodin, S; Molliex, S; Ollier, E, 2015
)
0.42
" A pharmacokinetic model was built using a nonlinear mixed-effect modelling approach."( Population pharmacokinetic model of free and total ropivacaine after transversus abdominis plane nerve block in patients undergoing liver resection.
Beauchesne, B; Bonnet, C; Delavenne, X; Heritier, F; Hodin, S; Molliex, S; Ollier, E, 2015
)
0.42
"Although large liver resections were associated with lower free ropivacaine clearance, the ropivacaine pharmacokinetic profile remained within the safe range after this type of surgery."( Population pharmacokinetic model of free and total ropivacaine after transversus abdominis plane nerve block in patients undergoing liver resection.
Beauchesne, B; Bonnet, C; Delavenne, X; Heritier, F; Hodin, S; Molliex, S; Ollier, E, 2015
)
0.42
" There are no pharmacodynamic data regarding the addition of dexmedetomidine to local anaesthetics for perineural administration."( A pharmacodynamic evaluation of dexmedetomidine as an additive drug to ropivacaine for peripheral nerve blockade: A randomised, triple-blind, controlled study in volunteers.
Keplinger, M; Kettner, SC; Kimberger, O; Marhofer, D; Marhofer, P; Zeitlinger, M, 2015
)
0.42
" Typical ke0 half-life was 34."( Modeling the anesthetic effect of ropivacaine after a femoral nerve block in orthopedic patients: a population pharmacokinetic-pharmacodynamic analysis.
Drolet, P; Fallaha, M; Gaudreault, F; Varin, F, 2015
)
0.42
" The safety profile of different drugs can be better estimated by comparing their pharmacokinetic profiles than by considering their objective side effects."( A Comparison of Differences Between the Systemic Pharmacokinetics of Levobupivacaine and Ropivacaine During Continuous Epidural Infusion: A Prospective, Randomized, Multicenter, Double-Blind Controlled Trial.
Allegri, M; Braschi, A; Cusato, M; De Andrés, J; Fanelli, G; Ingelmo, P; Niebel, TL; Perotti, L; Regazzi, M; Riva, F; Somaini, M; Tinelli, C, 2015
)
0.42
" The plasma concentrations of ropivacaine approached the Cmax significantly faster than those of levobupivacaine."( A Comparison of Differences Between the Systemic Pharmacokinetics of Levobupivacaine and Ropivacaine During Continuous Epidural Infusion: A Prospective, Randomized, Multicenter, Double-Blind Controlled Trial.
Allegri, M; Braschi, A; Cusato, M; De Andrés, J; Fanelli, G; Ingelmo, P; Niebel, TL; Perotti, L; Regazzi, M; Riva, F; Somaini, M; Tinelli, C, 2015
)
0.42
" Adjusting for weight and sex further improved the propofol pharmacokinetic model."( Epidural Blockade Affects the Pharmacokinetics of Propofol in Surgical Patients.
Dahan, A; Lesman, A; Olofsen, E; Sitsen, E; Vuyk, J, 2016
)
0.43
" An epidural-induced reduction in hepatic and/or renal blood flow may explain this pharmacokinetic interaction."( Epidural Blockade Affects the Pharmacokinetics of Propofol in Surgical Patients.
Dahan, A; Lesman, A; Olofsen, E; Sitsen, E; Vuyk, J, 2016
)
0.43
"There was no difference in Cmax (2."( A Novel Proliposomal Ropivacaine Oil: Pharmacokinetic-Pharmacodynamic Studies After Subcutaneous Administration in Pigs.
Aharon, A; Davidson, EM; Ginosar, Y; Haroutounian, S; Kagan, L; Naveh, M, 2016
)
0.43
" In this study, we present both pharmacodynamic and pharmacokinetic data in healthy volunteers after subcutaneous injection of this novel proliposomal preparation of ropivacaine."( Proliposomal Ropivacaine Oil: Pharmacokinetic and Pharmacodynamic Data After Subcutaneous Administration in Volunteers.
Aharon, A; Davidson, EM; Ginosar, Y; Haroutounian, S; Kagan, L; Naveh, M, 2016
)
0.43
"The prolonged pharmacodynamic effect of proliposomal ropivacaine, together with its delayed elimination and prolonged redistribution to plasma, is compatible to depot-related slow-release and similar to the performance of other liposomal local anesthetics."( Proliposomal Ropivacaine Oil: Pharmacokinetic and Pharmacodynamic Data After Subcutaneous Administration in Volunteers.
Aharon, A; Davidson, EM; Ginosar, Y; Haroutounian, S; Kagan, L; Naveh, M, 2016
)
0.43
" This reservation is due to anatomical concerns and lack of pharmacokinetic data."( Feasibility and pharmacokinetics of caudal blockade in children and adolescents with 30-50 kg of body weight.
Keplinger, M; Kettner, SC; Klug, W; Korf, L; Marhofer, D; Marhofer, P; Reiter, B; Stimpfl, T; Triffterer, L; Zeitlinger, M, 2016
)
0.43
"Based on our pharmacodynamic and pharmacokinetic results, we suggest that the body weight of 50 kg it is feasible to perform effective and safe caudal blockade in children up to 50 kg body weight."( Feasibility and pharmacokinetics of caudal blockade in children and adolescents with 30-50 kg of body weight.
Keplinger, M; Kettner, SC; Klug, W; Korf, L; Marhofer, D; Marhofer, P; Reiter, B; Stimpfl, T; Triffterer, L; Zeitlinger, M, 2016
)
0.43
" Peak concentration was decreased by 26 to 30% in the subjects receiving Intralipid®."( Effect of Intralipid® on the Dose of Ropivacaine or Levobupivacaine Tolerated by Volunteers: A Clinical and Pharmacokinetic Study.
Benhamou, D; Charbit, B; Dureau, P; Mazoit, JX; Nicolas, N, 2016
)
0.43
" To observe the safety of administering different doses of ropivacaine for cesarean section and its pharmacodynamic mechanism, we randomly divided 180 pregnant women undergoing cesarean section into three groups: group A, 10 mg ropivacaine (0."( Safety and pharmacodynamic mechanism of ropivacaine lumbar anesthesia in Cesarean section.
Li, ML; Liu, Q; Qin, CW; Wang, JJ; Wang, YQ; Yan, HY,
)
0.13
" Despite the high doses of ropivacaine, LIA is considered safe, and this perception is sustained by pharmacokinetic data demonstrating that maximum concentrations of ropivacaine stay well below the toxic threshold in plasma."( Pharmacokinetics of 400 mg Locally Infiltrated Ropivacaine After Total Knee Arthroplasty Without Perioperative Tourniquet Use.
Bakker, SMK; Fenten, MGE; Heesterbeek, PJC; Scheffer, GJ; Stienstra, R; Touw, DJ; van den Bemt, BJF, 2018
)
0.48
" A population pharmacokinetic model was built using non-linear mixed-effects models."( Population pharmacokinetics of ropivacaine used for local infiltration anaesthesia during primary total unilateral and simultaneous bilateral knee arthroplasty.
Foss, NB; Grassin-Delyle, S; Gromov, K; Husted, H; Lamy, E; Nielsen, CS; Pedersen, LM; Troelsen, A; Urien, S, 2021
)
0.62
"Therapeutic agents with a short half-life need to be administered frequently to achieve sustained and effective concentrations."( Population pharmacokinetic analysis of ropivacaine extended-release from a temperature-responsive hydrogel in rats.
Bang, JY; Choi, BM; Hwang, CS; Lee, EK; Nam, S, 2021
)
0.62
" Pharmacokinetic data are needed to guide safe dosing."( Population pharmacokinetic and safety analysis of ropivacaine used for erector spinae plane blocks.
Abulfathi, AA; Baratta, JL; Gebhart, A; Kaushal, G; Lam, E; Mohamod, D; Rochani, A; Roy, AB; Sarna, RR; Schmidt, S; Schwenk, ES; Viscusi, ER; Witzeling, SD; Zhao, JL, 2023
)
0.91
" Second, the ropivacaine concentrations in plasma were determined, pharmacokinetic parameters were calculated, and the anesthetic effects of RODD were studied, including RODD onset time, duration and intensity of nerve block."( A randomized trial: The safety, pharmacokinetics and preliminary pharmacodynamics of ropivacaine oil delivery depot in healthy subjects.
Cao, YX; Chi, P; Dong, JP; Hui, MQ; Jiao, YQ; Lu, WD; Ma, B; Tian, Y; Wang, MX; Yang, B; Yang, Y; Zhang, HB; Zhang, M; Zhao, DL, 2023
)
0.91
" Compared with the 150 mg RHI group, Tmax was longer in the RODD groups."( A randomized trial: The safety, pharmacokinetics and preliminary pharmacodynamics of ropivacaine oil delivery depot in healthy subjects.
Cao, YX; Chi, P; Dong, JP; Hui, MQ; Jiao, YQ; Lu, WD; Ma, B; Tian, Y; Wang, MX; Yang, B; Yang, Y; Zhang, HB; Zhang, M; Zhao, DL, 2023
)
0.91
" Compared with the RHI group, Tmax was delayed in the RODD groups, and the duration of nerve block was long."( A randomized trial: The safety, pharmacokinetics and preliminary pharmacodynamics of ropivacaine oil delivery depot in healthy subjects.
Cao, YX; Chi, P; Dong, JP; Hui, MQ; Jiao, YQ; Lu, WD; Ma, B; Tian, Y; Wang, MX; Yang, B; Yang, Y; Zhang, HB; Zhang, M; Zhao, DL, 2023
)
0.91

Compound-Compound Interactions

The aim of this study was to evaluate the analgesic efficacy and safety of rectus sheath block combined with intraperitoneal instillation using two doses of ropivacaine. Epidural catheters were inserted at T8-T9 (upper abdominal surgery) or T9-T11 (lower abdominal surgery), and ropvacaine 0,5% 7-9 ml or 10-12 ml combined with sufentanil 30 mcg or with morphine 2 mg was injected.

ExcerptReferenceRelevance
"Our aim in this prospective, randomized, double-blinded study was to compare the analgesic effectiveness and side effects of epidural infusions with ropivacaine 2 mg/mL alone (Group R; n = 60) and in combination with fentanyl 1 microg/mL (R1F; n = 59), 2 microg/mL (R2F; n = 62), and 4 microg/mL (R4F; n = 63) for up to 72 h after major abdominal surgery."( A comparison of epidural ropivacaine infusion alone and in combination with 1, 2, and 4 microg/mL fentanyl for seventy-two hours of postoperative analgesia after major abdominal surgery.
Blake, D; Buckland, M; Etches, R; Gustafsson, U; Halliwell, R; Huizar, K; Marsland, C; Merridew, G; Murphy, D; Paech, M; Schug, SA; Scott, DA; Turner, G; Walker, S, 1999
)
0.3
" Epidural catheters were inserted at T8-T9 (upper abdominal surgery) or T9-T11 (lower abdominal surgery) and ropivacaine 0,5% 7-9 ml (upper abdominal surgery) or 10-12 ml (lower abdominal surgery) combined with sufentanil 30 mcg (group S, n=30) or with morphine 2 mg (group M, n=30) was injected."( [Sufentanil vs morphine combined with ropivacaine for thoracic epidural analgesia in major abdominal surgery].
Borghi, B; Clara, ME; De Paolis, P; Gianferrari, P; Marzullo, A; Montone, N; Voltolina, M, 2001
)
0.31
"Continuous administration of epidural ropivacaine combined with sufentanil or with morphine resulted in good analgesia."( [Sufentanil vs morphine combined with ropivacaine for thoracic epidural analgesia in major abdominal surgery].
Borghi, B; Clara, ME; De Paolis, P; Gianferrari, P; Marzullo, A; Montone, N; Voltolina, M, 2001
)
0.31
" An opioid can be combined with local anaesthetic to reduce the incidence of side-effects and to improve analgesia for the relief of labour pain."( Comparison of bupivacaine 0.2% and ropivacaine 0.2% combined with fentanyl for epidural analgesia during labour.
Alkiş, N; Aşik, I; Göktuğ, A; Gülay, I; Uysalel, A, 2002
)
0.31
"2% combined with fentanyl produced equivalent analgesia for pain relief during labour and delivery."( Comparison of bupivacaine 0.2% and ropivacaine 0.2% combined with fentanyl for epidural analgesia during labour.
Alkiş, N; Aşik, I; Göktuğ, A; Gülay, I; Uysalel, A, 2002
)
0.31
" Few data are available concerning dose requirements of epidural ROPI when combined with morphine."( A comparison of 0.1% and 0.2% ropivacaine and bupivacaine combined with morphine for postoperative patient-controlled epidural analgesia after major abdominal surgery.
Joris, JL; Lahaye-Goffart, B; Lamy, ML; Ledoux, D; Senard, M; Toussaint, PJ, 2002
)
0.31
"To investigate the pain-relieving effects of ropivacaine or its combination with fentanyl in postoperative patient-controlled epidural analgesia."( [Ropivacaine or its combination with fentanyl for postoperative patient-controlled epidural analgesia].
Chen, M; Chen, YM; Gu, MN; Liang, SW; Lin, CS; Xiao, JF, 2003
)
0.32
" In this study, we compared the efficacy, dose requirements, side effects, and motor block observed with epidural levobupivacaine and ropivacaine when given in combination with small-dose morphine for 60 h after major abdominal surgery."( Epidural levobupivacaine 0.1% or ropivacaine 0.1% combined with morphine provides comparable analgesia after abdominal surgery.
Geortay, MN; Honoré, PD; Jacquemin, MJ; Joris, JL; Kaba, A; Lamy, ML; Maquoi, LM; Senard, M, 2004
)
0.32
"1%) of epidural levobupivacaine and ropivacaine combined with morphine (0."( Epidural levobupivacaine 0.1% or ropivacaine 0.1% combined with morphine provides comparable analgesia after abdominal surgery.
Geortay, MN; Honoré, PD; Jacquemin, MJ; Joris, JL; Kaba, A; Lamy, ML; Maquoi, LM; Senard, M, 2004
)
0.32
"Using ropivacaine combined with sufentanil, we determined the analgesic efficacy of parturient-controlled epidural analgesia (PCEA) with or without (demand-only PCEA) continuous background infusion in reducing labor pain in 66 parturients."( Comparison of continuous background infusion plus demand dose and demand-only parturient-controlled epidural analgesia (PCEA) using ropivacaine combined with sufentanil for labor and delivery.
Ackermann, HH; Bremerich, DH; Byhahn, C; Meininger, D; Mierdl, S; Waibel, HJ; Zwissler, BC, 2005
)
0.33
" Thoracic epidural anesthesia (TEA) is one of the regional anesthetic techniques that can be done by using a low dose of local anesthetic in combination with ipsilateral brachial plexus block (BPB) for axillary node dissection."( Thoracic epidural anesthesia (TEA) with 0.2% ropivacaine in combination with ipsilateral brachial plexus block (BPB) for modified radical mastectomy (MRM).
Kongdan, Y; Pasutharnchat, K; Sundarathiti, P; Suranutkarin, PE, 2005
)
0.33
"To compare and estimate the safety and efficacy of a new viscoelastic substance combined with anaesthetic used in phacoemulsification surgery."( The use of a new viscoelastic substance combined with anaesthetic in cataract surgery by phacoemulsification.
Bournas, P; Condilis, N; Kanellas, D; Lioumi, D; Syndikakis, K; Vaikoussis, E,
)
0.13
"To investigate the effects, side-effects and security of bupivacaine, ropivacaine combined with fentanyl in postoperative continuous epidural analgesia."( [Security evaluation of bupivacaine, ropivacaine combined with fentanyl in postoperative continuous epidural analgesia].
Huang, HQ; Huang, QQ; Su, MX; Wan, LJ; Wan, XH, 2006
)
0.33
" The current trial describes the dose-response relation of levobupivacaine, ropivacaine, and bupivacaine, combined with sufentanil, when used for intrathecal labor analgesia."( Determination of the full dose-response relation of intrathecal bupivacaine, levobupivacaine, and ropivacaine, combined with sufentanil, for labor analgesia.
Deprest, J; Dreelinck, R; Dubois, J; Kumar, A; Lewi, L; Van de Velde, M; Vandermeersch, E, 2007
)
0.34
"Although caudal morphine may result in more sustained initial analgesia, caudal clonidine combined with nurse-controlled analgesia appears to provide comparable analgesia with fewer side effects."( A comparison of single-dose caudal clonidine, morphine, or hydromorphone combined with ropivacaine in pediatric patients undergoing ureteral reimplantation.
Carvallo, D; Johnson, JL; Mazurek, MS; Presson, RG; Vetter, TR, 2007
)
0.34
"125%), all in combination with sufentanil 1 microg/mL with regard to postoperative pain relief and absence of motor block in a patient-controlled epidural analgesia setting."( Postoperative epidural analgesia after total knee arthroplasty with sufentanil 1 microg/ml combined with ropivacaine 0.2%, ropivacaine 0.125%, or levobupivacaine 0.125%: a randomized, double-blind comparison.
Dahan, A; Rose, L; Sitsen, E; Stienstra, R; van Alphen, W; van Poorten, F,
)
0.13
"To investigate the effect of epidural ropivacaine in combination with fentanyl for labor analgesia on the clinical outcome of labor."( [Influence of epidural ropivacaine in combination with fentanyl for labor analgesia on the clinical outcome of labor].
Chen, TM; Li, CX; Li, Q; Liu, Y; Xue, WN, 2008
)
0.35
"15% ropivacaine in combination with fentany (1microg/ml) and 175 without epidural analgesia."( [Influence of epidural ropivacaine in combination with fentanyl for labor analgesia on the clinical outcome of labor].
Chen, TM; Li, CX; Li, Q; Liu, Y; Xue, WN, 2008
)
0.35
"Epidural ropivacaine in combination with fentanyl in labor can decrease the incidence of cesarean section, and the duration of the active stage can be shortened with application of ocytocin."( [Influence of epidural ropivacaine in combination with fentanyl for labor analgesia on the clinical outcome of labor].
Chen, TM; Li, CX; Li, Q; Liu, Y; Xue, WN, 2008
)
0.35
"This study evaluated the effectiveness of a continuous interscalene block (CISB) by comparing it with that of a single interscalene block combined with a continuous intra-bursal infusion of ropivacaine (ISB-IB) after arthroscopic rotator cuff repair."( Comparison of analgesic efficacy between single interscalene block combined with a continuous intra-bursal infusion of ropivacaine and continuous interscalene block after arthroscopic rotator cuff repair.
Kim, SH; Lee, JW; Lee, PB; Lee, SJ; Oh, JH; Rhee, KY, 2009
)
0.35
"In interscalene block combined with lidocaine, ropivacaine had slower onset of motor block and longer duration of both blocks than bupivacaine."( Comparison of the motor and sensory block by ropivacaine and bupivacaine in combination with lidocaine in interscalene block.
Nishiyama, T, 2012
)
0.38
" We designed this study to investigate whether epidural anaesthesia with a goal-directed approach, when combined with general anaesthesia, improved haemodynamic stability in elderly patients undergoing major abdominal surgery."( Epidural anaesthesia with goal-directed administration of ropivacaine improves haemodynamic stability when combined with general anaesthesia in elderly patients undergoing major abdominal surgery.
Xiao, WP; Yun, X; Zhou, QH, 2013
)
0.39
"To compare haemodynamic effects of general anaesthesia in combination with epidural block and without it during kidney transplantation in Pediatric patients."( [Haemodynamics during kidney transplantation and general anaesthesia in combination with epidural block and without it in pediatric patients].
Ectov, DB; Kochkin, VS; Lazarev, VV; Salmasi, KG; Tsypin, LE; Valov, AL,
)
0.13
"1 mg kg(-1) dexamethasone combined with ropivacaine improves analgesic efficacy in children undergoing day-case orchiopexy."( Analgesic efficacy of caudal dexamethasone combined with ropivacaine in children undergoing orchiopexy.
Im, YJ; Kim, EM; Koo, BN; Lee, JH; Lee, JR; Oh, HJ, 2014
)
0.4
"The aim of this study was to evaluate the analgesic efficacy and safety of rectus sheath block combined with intraperitoneal instillation using two doses of ropivacaine in patients undergoing laparoscopic gynecological surgery."( [Analgesic efficacy and clinical safety of intraperitoneal instillation combined with rectus sheath block using ropivacaine for pain relief after laparoscopic gynecological surgery].
Hashimoto, H; Hirota, K; Kitayama, M; Kudo, M; Kudo, T; Niwa, H; Yakoshi, C, 2014
)
0.4
"The aim of this study was to compare the results of ultrasonographically guided axillary nerve block (ANB) combined with suprascapular nerve block (SSNB) with those of SSNB alone on postoperative pain and satisfaction within the first 48 hours after arthroscopic rotator cuff repair."( Effect of ultrasonographically guided axillary nerve block combined with suprascapular nerve block in arthroscopic rotator cuff repair: a randomized controlled trial.
Hwang, JT; Hwang, SM; Jo, YG; Kim, DY; Kim, GH; Lee, JJ; Lee, SS, 2014
)
0.4
"Ultrasonographically guided ANB combined with SSNB in arthroscopic rotator cuff repair showed an improved mean VAS in the first 24 hours after surgery compared with SSNB alone."( Effect of ultrasonographically guided axillary nerve block combined with suprascapular nerve block in arthroscopic rotator cuff repair: a randomized controlled trial.
Hwang, JT; Hwang, SM; Jo, YG; Kim, DY; Kim, GH; Lee, JJ; Lee, SS, 2014
)
0.4
" The purpose of this systematic review and meta-analysis is to compare the efficacy and safety of bupivacaine with ropivacaine and levobupivacaine in combination with sufentanil (BUPI-, ROPI-, and LBUPI-SUF respectively) in epidural analgesia for labor."( Efficacy and safety of local anesthetics bupivacaine, ropivacaine and levobupivacaine in combination with sufentanil in epidural anesthesia for labor and delivery: a meta-analysis.
Fang, F; Lv, BS; Mi, WD; Wang, JH; Wang, W; Wang, XW; Wang, ZQ, 2014
)
0.4
"The neurotoxicity of lidocaine was significantly increased when combined with ropivacaine."( Intrathecal lidocaine neurotoxicity: combination with bupivacaine and ropivacaine and effect of nerve growth factor.
Chen, W; Ding, X; Guo, Y; Zhao, G, 2014
)
0.4
"Ropivacaine is not safe when intrathecally administered with lidocaine at the concentrations used in this study."( Intrathecal lidocaine neurotoxicity: combination with bupivacaine and ropivacaine and effect of nerve growth factor.
Chen, W; Ding, X; Guo, Y; Zhao, G, 2014
)
0.4
"To explore the anesthetic effect and neonatal effects of dexmedetomidine combined with ropivacaine in the cesarean section under epidural anesthesia."( [Application of dexmedetomidine combined with ropivacaine in the cesarean section under epidural anesthesia].
Ding, Z; Han, C; Jiang, X; Wu, X, 2014
)
0.4
"Administration of dexmedetomidine combined with ropivacaine can provide early onset, establishment of sensory anesthesia, much better sedation levels, decrease the degree of traction reaction and the incidence of shivering, and without adverse neonatal effects."( [Application of dexmedetomidine combined with ropivacaine in the cesarean section under epidural anesthesia].
Ding, Z; Han, C; Jiang, X; Wu, X, 2014
)
0.4
"To investigate cardiorespiratory effects and serum concentration of ropivacaine combined with morphine at different doses."( Effects of ropivacaine combined with morphine at 0.15 and 0.2 mg kg(-1) in bitches undergoing epidural anesthesia.
Albuquerque, VB; Araújo, MA; Arruda, AM; Ferreira, GT; Fonseca, MW; Oliva, VN; ShiChen, L, 2015
)
0.42
"In combination with fentanyl, bupivacaine and ropivacaine exhibit comparable efficacy and safety."( Epidural analgesia with amide local anesthetics, bupivacaine, and ropivacaine in combination with fentanyl for labor pain relief: a meta-analysis.
Fan, Y; Hu, C; Li, Y; Wang, H; Xu, H, 2015
)
0.42
" We investigated the efficacy of the continuous intravenous infuion of fentanyl combined with intercostal nerve block, in comparison with the continuous epidural analgesia."( [Postoperative Analgesia for Video-assisted Thoracoscopic Surgery--Continuous Intravenous Infusion of Fentanyl Combined with Intercostal Nerve Block v.s. Continuous Epidural Analgesia].
Hiro, K; Kurata, M; Oi, Y; Okuda, M; Sugiyama, T, 2016
)
0.43
"Continuous intravenous infusion of fentanyl combined with intercostal nerve block is effective in the postoperative analgesia for VATS, as well as continuous epidural analgesia."( [Postoperative Analgesia for Video-assisted Thoracoscopic Surgery--Continuous Intravenous Infusion of Fentanyl Combined with Intercostal Nerve Block v.s. Continuous Epidural Analgesia].
Hiro, K; Kurata, M; Oi, Y; Okuda, M; Sugiyama, T, 2016
)
0.43
"Low-dose ropivacaine combined with intrathecal fentanyl can provide adequate anaesthesia with minimal haemodynamic variation."( EFFECT OF PREOPERATIVE INTRAVENOUS OXYCODONE ON LOW-DOSE ROPIVACAINE SPINAL ANESTHESIA COMBINED WITH INTRATHECAL FENTANYL.
Fu, Y; Wang, J; Wang, N; Zhang, S, 2016
)
0.43
"To assess the efficacy of preoperative intravenous oxycodone on transurethral resection of prostate (TURP) under 10 mg ropivacaine spinal anaesthesia combined with intrathecal 25 pg fentanyl."( EFFECT OF PREOPERATIVE INTRAVENOUS OXYCODONE ON LOW-DOSE ROPIVACAINE SPINAL ANESTHESIA COMBINED WITH INTRATHECAL FENTANYL.
Fu, Y; Wang, J; Wang, N; Zhang, S, 2016
)
0.43
"125%) combined with dexmedetomidine (0."( Effect of Epidural Dexmedetomidine Combined With Ropivacaine in Labor Analgesia: A Randomized Double-Blinded Controlled Study.
Liu, Y; Xin, Y; Yi, X; Zhao, Y, 2017
)
0.46
" The incidence of adverse events and the analgesic effect of ropivacaine combined with dexmedetomidine for incision infiltration were recorded."( The Analgesic Effect of Ropivacaine Combined With Dexmedetomidine for Incision Infiltration After Laparoscopic Cholecystectomy.
Dong, CS; Lu, Y; Sun, H; Wu, C; Yu, JM; Zhang, Y, 2016
)
0.43
" They were randomly divided into 2 groups (n=50 each): CFNB group, CFNB combined with PLIA group (PLIA group)."( [Effect of continuous femoral nerve block combined with periarticular local infiltration analgesia on early operative functional recovery after total knee arthroplasty: a randomized double-blind controlled study].
Deng, Y; Guo, XY; Jiang, TL; Li, M; Wang, J; Yang, XX, 2017
)
0.46
"To observe the anesthetic effect and safety of different doses of dexmedetomidine combined with ropivacaine for brachial plexus nerve block in children undergoing polydactyly surgery."( [Effects of different doses of dexmedetomidine combined with ropivacaine for brachial plexus nerve block in children undergoing polydactyly surgery].
Chen, XN; Li, YL; Qi, DM; Sun, WG; Sun, YJ; Yang, SH, 2017
)
0.46
" The aim of this study was to observe clinical and imaging outcomes of application of gelatin sponge impregnated with a mixture of 3 drugs to intraoperative nerve root block combined with robot-assisted minimally invasive transforaminal lumbar interbody fusion surgery in to treat adult degenerative lumbar scoliosis."( Application of Gelatin Sponge Impregnated with a Mixture of 3 Drugs to Intraoperative Nerve Root Block Combined with Robot-Assisted Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgery in the Treatment of Adult Degenerative Scoliosis: A Clini
Chang Liu, S; Du, JP; Fan, Y; Hao, D; Liu, JJ; Zhang, JN, 2017
)
0.46
"From January 2012 to November 2014, 108 patients with adult degenerative lumbar scoliosis were treated with robot-assisted minimally invasive transforaminal lumbar interbody fusion surgery combined with intraoperative gelatin sponge impregnated with a mixture of 3 drugs."( Application of Gelatin Sponge Impregnated with a Mixture of 3 Drugs to Intraoperative Nerve Root Block Combined with Robot-Assisted Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgery in the Treatment of Adult Degenerative Scoliosis: A Clini
Chang Liu, S; Du, JP; Fan, Y; Hao, D; Liu, JJ; Zhang, JN, 2017
)
0.46
"Application of gelatin sponge impregnated with 3 drugs combined with robot-assisted minimally invasive transforaminal lumbar interbody fusion for treatment of adult degenerative lumbar scoliosis is safe and feasible with advantages of good short-term analgesia effect, minimal invasiveness, short length of stay, and good long-term clinical outcomes."( Application of Gelatin Sponge Impregnated with a Mixture of 3 Drugs to Intraoperative Nerve Root Block Combined with Robot-Assisted Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgery in the Treatment of Adult Degenerative Scoliosis: A Clini
Chang Liu, S; Du, JP; Fan, Y; Hao, D; Liu, JJ; Zhang, JN, 2017
)
0.46
"This study assessed the utility of ultrasound-guided lateral transversus abdominis plane (TAP) block combined with rectus sheath (RS) block for peritoneal dialysis catheter placement surgery."( Ultrasound-guided left lateral transversus abdominis plane block combined with rectus sheath block in peritoneal dialysis catheter placement.
Dai, W; Liu, J; Liu, X; Lu, Y; Mei, B; Tang, L, 2018
)
0.48
"This randomized controlled study investigated the analgesic effect of ropivacaine in combination with dexmedetomidine versus ropivacaine alone on brachial plexus block to provide alternative anesthetic means for upper limb trauma surgery."( Analgesic effect of Ropivacaine combined with Dexmedetomidine on brachial plexus block.
Hua, H; Jiang, M; Liu, Z; Xu, T, 2018
)
0.48
" The patients were randomized to ropivacaine alone (the control group) or ropivacaine combined with dexmedetomidine (the combination group)."( Analgesic effect of Ropivacaine combined with Dexmedetomidine on brachial plexus block.
Hua, H; Jiang, M; Liu, Z; Xu, T, 2018
)
0.48
"The brachial plexus blocking effect of ropivacaine combined with dexmedetomidine was superior to that of ropivacaine alone, mainly intra-operatively and postoperatively."( Analgesic effect of Ropivacaine combined with Dexmedetomidine on brachial plexus block.
Hua, H; Jiang, M; Liu, Z; Xu, T, 2018
)
0.48
"Analgesic Effect of Ropivacaine Combined with Dexmedetomidine on Brachial Plexus Block, ChiCTR1800017372, retrospectively registered on July 26, 2018."( Analgesic effect of Ropivacaine combined with Dexmedetomidine on brachial plexus block.
Hua, H; Jiang, M; Liu, Z; Xu, T, 2018
)
0.48
"The aim of the current study was to evaluate the clinical effects of the regular intermittent epidural injection combined with different puncture points (RIEI-dPP) in suppressing breakthrough pain during a labour analgesia."( Clinical observation of regular intermittent epidural injection combined with different puncture points in suppressing breakthrough pain in labour analgesia.
Jiang, H; Shi, B; Wu, C, 2019
)
0.51
"BACKGROUND This study aimed to investigate the effectiveness of perioperative parecoxib sodium combined with transversus abdominis plane (TAP) block on postoperative pain management following hepatectomy in patients with hepatocellular carcinoma (HCC)."( Effectiveness of Parecoxib Sodium Combined with Transversus Abdominis Plane Block for Pain Management After Hepatectomy for Hepatocellular Carcinoma: A Prospective Controlled Study.
Jia, WD; Li, YQ; Lv, JG; Qiao, XF; Zhou, H, 2019
)
0.51
"This study aims to investigate the clinical effect of dexmedetomidine (DEX) combined with low concentrations of ropivacaine in ultrasound-guided continuous fem-oral nerve block for postoperative analgesia in elderly patients with total knee arthroplasty (TKA)."( Ultrasound-Guided Continuous Femoral Nerve Block with Dexmedetomidine Combined with Low Concentrations of Ropivacaine for Postoperative Analgesia in Elderly Knee Arthroplasty.
Bai, XL; Cheng, ZJ; Guo, Z; Jia, PY; Li, YN; Yang, JX; Zhang, EF; Zhao, XY, 2019
)
0.51
"To explore the effect of local infiltration of ropivacaine combined with multimodal analgesia with parecoxib for perioperative pain management in patients undergoing pancreaticoduodenectomy."( [Efficacy of local infiltration of ropivacaine combined with multimodal analgesia with parecoxib for perioperative analgesia in patients undergoing pancreaticoduodenectomy].
Feng, H; Feng, J; Gao, M; Han, Q; Li, K; Xu, R, 2019
)
0.51
"In patients undergoing pancreaticoduodenectomy, local infiltration of ropivacaine combined with multimodal analgesia with ropivacaine can effectively relieve perioperative pain, reduce the use of relief analgesics, lower the incidence of adverse reactions, and promote the recovery after the surgery."( [Efficacy of local infiltration of ropivacaine combined with multimodal analgesia with parecoxib for perioperative analgesia in patients undergoing pancreaticoduodenectomy].
Feng, H; Feng, J; Gao, M; Han, Q; Li, K; Xu, R, 2019
)
0.51
"To explore the analgesic effect of dizocine combined with ropivacaine on recurrent neuropathic pain in rat model of peripheral nerve compression."( Analgesic Effect of Dizocine Combined with Ropivacaine on Recurrent Neuropathic Pain in Peripheral Nerve Compression Rats.
Chu, C; Liu, Z; Ma, C; Sun, J; Zhang, X, 2020
)
0.56
" The aim of this study was to compare the effects of DEX combined with ISB with ISB alone on postoperative pain, satisfaction, and pain-related cytokines within the first 48 h after arthroscopic rotator cuff repair."( Dexmedetomidine combined with interscalene brachial plexus block has a synergistic effect on relieving postoperative pain after arthroscopic rotator cuff repair.
Hwang, JT; Hwang, SM; Jang, JS; Kim, DY; Kim, YB; Lee, HN; Lee, JJ; Lee, S; Lee, SS; Song, DK, 2020
)
0.56
"To compare the application and efficacy of ropivacaine combined with sufentanil for continuous epidural anesthesia (CEA) and combined spinal-epidural anesthesia (CSEA) in labor analgesia."( Comparison of ropivacaine combined with sufentanil for epidural anesthesia and spinal-epidural anesthesia in labor analgesia.
Wang, Y; Xu, M, 2020
)
0.56
" Ropivacaine combined with sufentanil were used in all subjects."( Comparison of ropivacaine combined with sufentanil for epidural anesthesia and spinal-epidural anesthesia in labor analgesia.
Wang, Y; Xu, M, 2020
)
0.56
"Considering ropivacaine combined with sufentanil for CSEA achieved a shorter onset time and labor period, significant analgesic effect, lower adverse drug reactions rates and higher subject satisfaction than CEA, it may be worthy of clinical promotion and application."( Comparison of ropivacaine combined with sufentanil for epidural anesthesia and spinal-epidural anesthesia in labor analgesia.
Wang, Y; Xu, M, 2020
)
0.56
" In this current study, we aimed to explore the effect of tumescence solution (TS) combined with negative pressure wound therapy (NPWT) on the relief of subcutaneous ecchymosis and pain after THLS of great saphenous vein."( Effectiveness of tumescent solution combined with negative pressure wound therapy in traditional high ligation and stripping of the great saphenous vein.
Cheng, L; Su, F; Tong, Q, 2020
)
0.56
"Infiltration of the surgical site with local anesthetics combined with nonsteroidal anti-inflammatory drugs may play an important role in improving perioperative pain control."( Comparison of perioperative analgesia using the infiltration of the surgical site with ropivacaine alone and in combination with meloxicam in cats undergoing ovariohysterectomy.
Bruno, TS; Cassu, RN; Costa Júnior, JS; de O L Carapeba, G; Giuffrida, R; Nicácio, GM; Nicácio, IPGA; Stelle, ABF; Teixeira Neto, FJ, 2020
)
0.56
"To evaluate ultrasound-guided inactivation of myofascial trigger points (MTrPs) combined with abdominal muscle fascia stripping by liquid knife in the treatment of postherpetic neuralgia (PHN) complicated with abdominal myofascial pain syndrome (AMPS)."( Ultrasound-Guided Inactivation of Trigger Points Combined with Muscle Fascia Stripping by Liquid Knife in Treatment of Postherpetic Neuralgia Complicated with Abdominal Myofascial Pain Syndrome: A Prospective and Controlled Clinical Study.
Chang, XL; Gou, XJ; Liu, SL; Lu, XH; Xu, JY, 2020
)
0.56
" However, patients with PHN complicated with AMPS need to be treated with ultrasound-guided MTrPs inactivation combined with muscle fascia stripping by liquid knife as soon as possible."( Ultrasound-Guided Inactivation of Trigger Points Combined with Muscle Fascia Stripping by Liquid Knife in Treatment of Postherpetic Neuralgia Complicated with Abdominal Myofascial Pain Syndrome: A Prospective and Controlled Clinical Study.
Chang, XL; Gou, XJ; Liu, SL; Lu, XH; Xu, JY, 2020
)
0.56
"This prospective, randomized, controlled study aimed to explore the efficacy of dexmedetomidine combined with epidural blockade on postoperative recovery of elderly patients after radical resection for colorectal cancer."( Protective effect of dexmedetomidine infusion combined with epidural blockade on postoperative complications after surgery: A prospective randomized controlled clinical trial.
He, Z; Liu, Y; Sun, Z; Wu, X; Zhong, J; Zhu, X, 2020
)
0.56
"To understand the effectiveness and safety of LA combined with ropivacaine in pain control for ankle arthroscopy."( Local anesthesia combined with intra-articular ropivacaine can provide satisfactory pain control in ankle arthroscopic surgery: A retrospective cohort study.
An, M; Dong, C; Gao, F; Hu, B; Li, C; Liu, Y; Qi, W; Su, X; Wei, M; Zhang, B,
)
0.13
"This study aimed to investigate the effect of dexmedetomidine combined with ropivacaine on inflammatory factors in children with axillary brachial plexus block."( Application of dexmedetomidine combined with ropivacaine in axillary brachial plexus block in children and its effect on inflammatory factors.
Fan, W; Sun, J; Wang, B; Yang, H; Yang, Y; Zhang, H; Zhou, J, 2020
)
0.56
"08% epidural ropivacaine via the DPE and CEI techniques combined with the PIEB mode of maintenance."( A randomized trial of the dural puncture epidural technique combined with programmed intermittent epidural boluses for labor analgesia.
Wang, J; Wang, Y; Xiao, P; Zhang, L; Zheng, L; Zhou, M, 2021
)
0.62
" This study compared the effectiveness of epidural nalbuphine and sufentanil in combination with ropivacaine for labor analgesia, respectively."( The Effect of Epidural Nalbuphine Combined With Ropivacaine on Epidural Analgesia During Labor: A Multicenter, Randomized, Double-blind, Controlled Study.
Cao, R; Chen, Z; Huang, S; Sun, X; Tang, S; Zhou, M; Zhou, Q, 2021
)
0.62
" We compared the efficiency and safety of ropivacaine alone (R group) and ropivacaine combined with dexmedetomidine (RD group)."( Evaluation of ropivacaine combined with dexmedetomidine versus ropivacaine alone for epidural anesthesia: A meta-analysis.
Deng, F; Liao, C; Wang, L; Wu, Q; Zhang, W; Zhao, J, 2021
)
0.62
"This study aimed to evaluate the impact of Infiltration between the Popliteal Artery and Capsule of the posterior Knee (IPACK) combined with an adductor canal block under the guidance of ultrasound on early motor function after Total Knee Arthroplasty (TKA)."( The impact of IPACK combined with adductor canal block under ultrasound guidance on early motor function after total knee arthroplasty.
Chu, HC; Huang, H; Liu, YB; Liu, YZ; Ma, XJ; Xu, S; Zheng, FY,
)
0.13
"A sample of 60 cases who were scheduled for elective unilateral TKA were divided into two groups using random number table method: a group with IPACK combined with an adductor canal block (I group, n = 30), and a group with femoral nerve block combined with superior popliteal sciatic nerve block (FS group, n = 30)."( The impact of IPACK combined with adductor canal block under ultrasound guidance on early motor function after total knee arthroplasty.
Chu, HC; Huang, H; Liu, YB; Liu, YZ; Ma, XJ; Xu, S; Zheng, FY,
)
0.13
"Compared with femoral nerve block combined with superior popliteal sciatic nerve block, IPACK combined with adductor canal block had a mild impact on early motor functions after TKA."( The impact of IPACK combined with adductor canal block under ultrasound guidance on early motor function after total knee arthroplasty.
Chu, HC; Huang, H; Liu, YB; Liu, YZ; Ma, XJ; Xu, S; Zheng, FY,
)
0.13
"To evaluate the effects of using ropivacaine combined with dexmedetomidine for sciatic and saphenous nerve blocks in dogs."( Effects of perineural administration of ropivacaine combined with perineural or intravenous administration of dexmedetomidine for sciatic and saphenous nerve blocks in dogs.
Ida, KK; Markuszewski, MJ; Marolf, V; Sandersen, C; Siluk, D; Struck-Lewicka, W, 2021
)
0.62
"5% ropivacaine in combination with dexmedetomidine (1 μg/kg) for locoregional anesthesia in dogs seemed to balance the benefit of prolonging sensory nerve blockade while minimizing adverse effects."( Effects of perineural administration of ropivacaine combined with perineural or intravenous administration of dexmedetomidine for sciatic and saphenous nerve blocks in dogs.
Ida, KK; Markuszewski, MJ; Marolf, V; Sandersen, C; Siluk, D; Struck-Lewicka, W, 2021
)
0.62
"Whether epidural administered sufentanil combined with low-concentration ropivacaine affected labor progress as well as maternal and neonatal outcomes still remained unknown."( Impact of epidural labor analgesia using sufentanil combined with low-concentration ropivacaine on maternal and neonatal outcomes: a retrospective cohort study.
Li, Y; Xu, C; Zhang, L, 2021
)
0.62
"To study the effects of dexmedetomidine in combination with ropivacaine in patients undergoing craniocerebral surgery and their efficiency on cognitive function and inflammatory response of patients."( Effect of Dexmedetomidine Combined with Ropivacaine on Cognitive Dysfunction and Inflammatory Response in Patients Undergoing Craniocerebral Surgery.
Liu, Y; Zhang, H; Zhang, W, 2021
)
0.62
"Dexmedetomidine combined with ropivacaine has high application value in craniocerebral surgery."( Effect of Dexmedetomidine Combined with Ropivacaine on Cognitive Dysfunction and Inflammatory Response in Patients Undergoing Craniocerebral Surgery.
Liu, Y; Zhang, H; Zhang, W, 2021
)
0.62
"This research was aimed to study CT image features based on the backprojection filtering reconstruction algorithm and evaluate the effect of ropivacaine combined with dexamethasone and dexmedetomidine on assisted thoracoscopic lobectomy to provide reference for clinical diagnosis."( Computerized Tomography Image Features under the Reconstruction Algorithm in the Evaluation of the Effect of Ropivacaine Combined with Dexamethasone and Dexmedetomidine on Assisted Thoracoscopic Lobectomy.
Cui, Y; Lei, J; Sun, Y; Xia, M; Yao, D, 2021
)
0.62
"Total knee arthroplasty (TKA) is a severe traumatic procedure, and femoral nerve block (FNB) combined with a sciatic nerve block (SNB) is widely used in TKA."( Dexmedetomidine Combined with Femoral Nerve Block Provides Effective Analgesia Similar to Femoral Nerve Combined with Sciatic Nerve Block in Patients Undergoing Total Knee Arthroplasty: A Randomized Controlled Study.
Jin, XB; Liu, C; Liu, LF; Luo, YR; Xiao, R; Xu, GH; Zhou, W, 2022
)
0.72
"DEX combined with FNB could provide effective analgesia similar to SNB combined with FNB in TKA."( Dexmedetomidine Combined with Femoral Nerve Block Provides Effective Analgesia Similar to Femoral Nerve Combined with Sciatic Nerve Block in Patients Undergoing Total Knee Arthroplasty: A Randomized Controlled Study.
Jin, XB; Liu, C; Liu, LF; Luo, YR; Xiao, R; Xu, GH; Zhou, W, 2022
)
0.72
" This study aimed to observe the analgesic effect of dexmedetomidine combined with ropivacaine erector spinae plane block (ESPB) used in posterior lumbar spine surgery."( Dexmedetomidine combined with ropivacaine for erector spinae plane block after posterior lumbar spine surgery: a randomized controlled trial.
Jie-Ting, L; Jun, L; Min, W; Rong, T; Sheng-Hui, H; Yan, Z; Yi, L; Yi-Han, W, 2022
)
0.72
"To evaluate the efficacy of a perineural injection of dexmedetomidine combined with ropivacaine for reducing postoperative methadone requirements in dogs after tibial plateau levelling osteotomy (TPLO)."( Effects of perineural dexmedetomidine combined with ropivacaine on postoperative methadone requirements in dogs after tibial plateau levelling osteotomy: a two-centre study.
Marolf, V; Picavet, P; Sandersen, C; Selz, J; Spadavecchia, C; Tutunaru, A, 2022
)
0.72
"Perineural dexmedetomidine combined with ropivacaine did not reduce postoperative methadone requirements in dogs after TPLO, but results may differ from one centre to another."( Effects of perineural dexmedetomidine combined with ropivacaine on postoperative methadone requirements in dogs after tibial plateau levelling osteotomy: a two-centre study.
Marolf, V; Picavet, P; Sandersen, C; Selz, J; Spadavecchia, C; Tutunaru, A, 2022
)
0.72
"This review and meta-analysis comprehensively elaborated the analgesic and sedative effects of ropivacaine combined with dexmedetomidine in epidural labor analgesia, and its possible resulting motor block and adverse reactions."( Evaluation of the effect of dexmedetomidine combined with ropivacaine in epidural labor analgesia: a systematic review and meta-analysis.
Guo, G; Liu, W; Wen, J; Zhao, Y; Zhou, H, 2022
)
0.72
"PubMed, Web of science, Cochrane, China National Knowledge Infrastructure and WANFANG DATA were searched for randomized controlled trials (RCTs) on the efficacy and safety of ropivacaine combined with dexmedetomidine in epidural labor analgesia."( Evaluation of the effect of dexmedetomidine combined with ropivacaine in epidural labor analgesia: a systematic review and meta-analysis.
Guo, G; Liu, W; Wen, J; Zhao, Y; Zhou, H, 2022
)
0.72
"The present study aimed to investigate whether intratracheal dexmedetomidine combined with ropivacaine reduces the severity and incidence of postoperative sore throat after tracheal intubation under general anaesthesia."( Effect of intratracheal dexmedetomidine combined with ropivacaine on postoperative sore throat: a prospective randomised double-blinded controlled trial.
He, Y; Hu, R; Ning, R; Niu, J; Sun, H; Yang, N; Yu, J, 2022
)
0.72
" The purpose of this study was to evaluate whether ACB combined with a LIA cocktail of ropivacaine, morphine, and betamethasone has superior analgesic effect than LIA for TKA."( Adductor canal block combined with local infiltration analgesia with morphine and betamethasone show superior analgesic effect than local infiltration analgesia alone for total knee arthroplasty: a prospective randomized controlled trial.
Chen, X; Luo, ZY; Wang, HY; Xiao, Q; Yu, QP; Zeng, WN; Zhou, Z, 2022
)
0.72
" ACB combined with LIA had significantly lower resting and active VAS pain scores, better ROM, better sleeping quality and higher satisfaction rates than LIA alone within 72 h postoperatively (P < 0."( Adductor canal block combined with local infiltration analgesia with morphine and betamethasone show superior analgesic effect than local infiltration analgesia alone for total knee arthroplasty: a prospective randomized controlled trial.
Chen, X; Luo, ZY; Wang, HY; Xiao, Q; Yu, QP; Zeng, WN; Zhou, Z, 2022
)
0.72
"Adductor canal block combined with Local infiltration analgesia provide better early pain control."( Adductor canal block combined with local infiltration analgesia with morphine and betamethasone show superior analgesic effect than local infiltration analgesia alone for total knee arthroplasty: a prospective randomized controlled trial.
Chen, X; Luo, ZY; Wang, HY; Xiao, Q; Yu, QP; Zeng, WN; Zhou, Z, 2022
)
0.72
"This study aimed to investigate the effect of ropivacaine with dexmedetomidine or dexamethasone in a thoracic paravertebral nerve block (TPVB) combined with an erector spinae plane block (ESPB) for thoracoscopic lobectomy analgesia."( Ropivacaine with Dexmedetomidine or Dexamethasone in a Thoracic Paravertebral Nerve Block Combined with an Erector Spinae Plane Block for Thoracoscopic Lobectomy Analgesia: A Randomized Controlled Trial.
Feng, XY; Lei, YJ; Wang, XR; Wang, ZH; Yang, J; Zhang, JW; Zhang, XR; Zhao, M, 2022
)
0.72
" Ultrasound-guided TPVB combined with an erector spinae plane block was given after anesthesia induction."( Ropivacaine with Dexmedetomidine or Dexamethasone in a Thoracic Paravertebral Nerve Block Combined with an Erector Spinae Plane Block for Thoracoscopic Lobectomy Analgesia: A Randomized Controlled Trial.
Feng, XY; Lei, YJ; Wang, XR; Wang, ZH; Yang, J; Zhang, JW; Zhang, XR; Zhao, M, 2022
)
0.72
"Ropivacaine with dexmedetomidine or dexamethasone in TPVB combined with ESPB could prolong the time to first postoperative remedial analgesia, reduce perioperative sufentanil and postoperative remedial analgesic drug consumption, and decrease the postoperative NRS score in patients undergoing thoracoscopic lobectomy."( Ropivacaine with Dexmedetomidine or Dexamethasone in a Thoracic Paravertebral Nerve Block Combined with an Erector Spinae Plane Block for Thoracoscopic Lobectomy Analgesia: A Randomized Controlled Trial.
Feng, XY; Lei, YJ; Wang, XR; Wang, ZH; Yang, J; Zhang, JW; Zhang, XR; Zhao, M, 2022
)
0.72
"This study aimed to investigate the clinical effect of ultrasound-guided ropivacaine combined with butorphanol continuous paravertebral block in preventing postoperative pain syndrome of breast cancer."( Study of ultrasound-guided ropivacaine combined with butorphanol continuous paravertebral block to prevent pain syndrome by evaluating ccl2 gene expression after radical mastectomy.
Cui, W; Ji, X; Liu, X; Shan, S; Wang, L; Zhang, B, 2022
)
0.72
" All patients who received ACB and iPACK block were randomly divided into a dexamethasone group (Group D, ropivacaine combined with dexamethasone) and a control group (Group C, ropivacaine only)."( Adding Dexamethasone to Adductor Canal Block Combined With iPACK Block Improve Postoperative Analgesia of Total Knee Arthroplasty.
Hu, J; Wang, Q; Yang, J; Zeng, Y, 2022
)
0.72
"Compared with using ropivacaine alone, ultrasonic-guided ACB combined with iPACK using ropivacaine and dexamethasone could prolong the duration of postoperative analgesia and strength analgesic intensity and promote the early rehabilitation exercise of patients undergoing TKA."( Adding Dexamethasone to Adductor Canal Block Combined With iPACK Block Improve Postoperative Analgesia of Total Knee Arthroplasty.
Hu, J; Wang, Q; Yang, J; Zeng, Y, 2022
)
0.72
"To investigate the analgesic effect and rehabilitation quality of patients undergoing thoracoscopic wedge resection of the lung under erector spinae plane (ESP) block with dexmedetomidine combined with the same dose and different concentrations of ropivacaine."( Effects of ultrasound-guided erector spinae plane block with dexmedetomidine combined with ropivacaine of the same dose and different concentrations on analgesic effect and rehabilitation quality of patients undergoing thoracoscopic wedge resection of the
Fu, H; Jian, C; Shen, Y; Yu, L, 2022
)
0.72
" We aimed to determine the optimal dose of dexmedetomidine for preemptive analgesia when combined with TAP block after colon cancer surgery."( Optimal Dose of Dexmedetomidine for Preemptive Analgesia Combined with Transversus Abdominis Plane Block after Colon Cancer Surgery.
Hao, D; Zhang, Z, 2022
)
0.72
"The analgesic effect of IV self-controlled analgesia combined with ropivacaine is quick, but the maintenance time is short."( Methylene Blue Combined with Ropivacaine for Intercostal Nerve Block After Autologous Costal Cartilage Removal in Juvenile Patients.
Chen, Z; Liu, Y; Lu, X; Ren, J; Sun, P, 2022
)
0.72
" These findings implied that the application of dexmedetomidine in combination with RO in TPVB has a good postoperative analgesic effect, as well as anti-inflammatory and immune-enhancing effects."( Postoperative analgesic effect of dexmedetomidine combined with TPVB applied to open gastrectomy for gastric cancer.
Hou, Z; Qiu, Q; Wan, W, 2023
)
0.91
"To observe the effect of methylene blue combined with ropivacaine intercostal nerve block on postoperative analgesia after autologous costal cartilage augmentation rhinoplasty."( Application of methylene blue combined with ropivacaine intercostal nerve block in postoperative analgesia of autologous costal cartilage augmentation rhinoplasty.
Guoyu, J; Tao, W; Xi, Y, 2022
)
0.72
" In the experimental group methylene blue was combined with ropivacaine intercostal nerve block as patient controlled intravenous analgesia (PCIA), and the control group was ropivacaine intercostal nerve block combined with PCIA."( Application of methylene blue combined with ropivacaine intercostal nerve block in postoperative analgesia of autologous costal cartilage augmentation rhinoplasty.
Guoyu, J; Tao, W; Xi, Y, 2022
)
0.72
"Intercostal nerve block with methylene blue combined with ropivacaine can achieve good postoperative analgesic effects in augmentation rhinoplasty with autologous costal cartilage."( Application of methylene blue combined with ropivacaine intercostal nerve block in postoperative analgesia of autologous costal cartilage augmentation rhinoplasty.
Guoyu, J; Tao, W; Xi, Y, 2022
)
0.72
"This review aimed to conduct a meta-analysis of published randomized controlled studies (RCTs) comparing the effectiveness of dexmedetomidine (DEX) combined with ropivacaine versus single ropivacaine in transversus abdominis plane block (TAPB) for postoperative analgesia after laparoscopic cholecystectomy (LC)."( Analgesic Effects of Ropivacaine Combined With Dexmedetomidine in Transversus Abdominis Plane Block in Patients Undergoing Laparoscopic Cholecystectomy: A Systematic Review and Meta-Analysis.
Sun, W; Zhu, M, 2023
)
0.91
"Five electronic database systems were searched for RCTs on the effects of DEX combined with ropivacaine (joint group) and single ropivacaine on postoperative analgesia in LC."( Analgesic Effects of Ropivacaine Combined With Dexmedetomidine in Transversus Abdominis Plane Block in Patients Undergoing Laparoscopic Cholecystectomy: A Systematic Review and Meta-Analysis.
Sun, W; Zhu, M, 2023
)
0.91
" The results showed that compared with single ropivacaine, DEX combined with ropivacaine in TAPB had better analgesia and lighter sedative effect in patients after LC."( Analgesic Effects of Ropivacaine Combined With Dexmedetomidine in Transversus Abdominis Plane Block in Patients Undergoing Laparoscopic Cholecystectomy: A Systematic Review and Meta-Analysis.
Sun, W; Zhu, M, 2023
)
0.91
" This study compared the analgesic effect and early rehabilitation quality between adductor canal block combined with general analgesia (ACB + GA) and single general analgesia (SGA) after recurrent patellar dislocation (RPD) for "3-in-1" procedure surgery."( Adductor Canal Block Combined with General Analgesia for Patients with Recurrent Patellar Dislocation Undergoing "3-in-1" Procedure Surgery: A Prospective Randomized Controlled Trial.
Li, J; Li, Q; Li, S; Li, X; Lin, Y; Wang, D; Xiong, Y, 2023
)
0.91
"This study aims to evaluate the onset, maintenance, side effects s and the effect on newborns of dural puncture epidural (DPE) technique combined with programmed intermittent epidural bolus (PIEB) mode for labor analgesia as compared to conventional epidural (EP) technique combined with continuous epidural infusion (CEI) mode."( Application of dural puncture epidural technique combined with programmed intermittent epidural bolus mode in labor analgesia: A randomized clinical trial.
Cui, E; Sun, J; Wang, Q; Yan, M; Zhang, Y; Zhou, J, 2023
)
0.91
"DPE technique can provide faster analgesia than conventional EP technique, combined with PIEB mode maybe superior to traditional methods as a labor analgesia regimen."( Application of dural puncture epidural technique combined with programmed intermittent epidural bolus mode in labor analgesia: A randomized clinical trial.
Cui, E; Sun, J; Wang, Q; Yan, M; Zhang, Y; Zhou, J, 2023
)
0.91
"To investigate the effects of a single injection technique with ultrasound-guided superficial cervical fascia block combined with brachial plexus block in clavicular surgery."( Single injection technique with ultrasound-guided superficial cervical fascia block combined with brachial plexus block in clavicular surgery: a prospective randomized comparative trial.
Cheng, Y; Duan, Y; He, M; Jiang, M; Qin, D; Wang, Y; Zhou, A, 2023
)
0.91
"The application of the single injection technique with ultrasound-guided superficial cervical fascia block combined with brachial plexus block in clavicular surgery is beneficial because it shortens the operation time, has a faster onset, produces a more effective block and prolongs the longer analgesia time."( Single injection technique with ultrasound-guided superficial cervical fascia block combined with brachial plexus block in clavicular surgery: a prospective randomized comparative trial.
Cheng, Y; Duan, Y; He, M; Jiang, M; Qin, D; Wang, Y; Zhou, A, 2023
)
0.91

Bioavailability

Ropivacaine's biphasic absorption and bioavailability are similar to those of other amide local anesthetics. The absorption rate constant (slower phase) of ropvacaine was affected by age.

ExcerptReferenceRelevance
" Ropivacaine's biphasic absorption and bioavailability are similar to those of other amide local anesthetics."( Pharmacokinetics of intravenous and epidural ropivacaine in the rhesus monkey.
Bridenbaugh, PO; Coyle, D; Denson, DD; Katz, JA; Sehlhorst, CS; Thompson, GA, 1993
)
0.29
" However, alkalinization of local anesthetic solutions may cause precipitation, thereby decreasing bioavailability and anesthetic activity."( Alkalinization and precipitation characteristics of 0.2% ropivacaine.
Fulling, PD; Peterfreund, RA,
)
0.13
" Population pharmacokinetic modeling was performed to yield estimates of clearance, volume of distribution, and absorption rate constant."( Caudal ropivacaine in infants: population pharmacokinetics and plasma concentrations.
Bergesio, R; Hackett, LP; Hansen, TG; Ilett, KF; Lim, SI; Reid, C, 2001
)
0.31
") absolute bioavailability (%F) was 56 (18)%."( Rectal ropivacaine is absorbed proportionally to the dose, with low intraindividual variability.
Arlander, E; Gustafsson, LL; Norsten-Höög, C; Sjövall, J; Sörstad, J, 2003
)
0.32
" Mean bioavailability was about 60% and not influenced by variations in the enema volume."( Rectal ropivacaine is absorbed proportionally to the dose, with low intraindividual variability.
Arlander, E; Gustafsson, LL; Norsten-Höög, C; Sjövall, J; Sörstad, J, 2003
)
0.32
" Subsequently, in order to determine the absorption rate (Ka) and to reduce to number of blood samples, 25 other children, receiving plain R and another group of 25 receiving the E solution were studied using a population approach (NONMEM)."( In children, the addition of epinephrine modifies the pharmacokinetics of ropivacaine injected caudally.
Roelants, FA; Van Obbergh, LJ; Verbeeck, RK; Veyckemans, F,
)
0.13
" The median bioavailability of the rapid component was approximately 20% higher when epinephrine was not used."( Arterial and venous pharmacokinetics of ropivacaine with and without epinephrine after thoracic paravertebral block.
Gin, T; Ho, AM; Karmakar, MK; Law, BK; Shafer, SL; Wong, AS, 2005
)
0.33
" The intrathecal bioavailability after epidural administration was 11."( Epidural, intrathecal pharmacokinetics, and intrathecal bioavailability of ropivacaine.
Bec, D; Chevanne, F; Dollo, G; Ecoffey, C; Estebe, JP; Le Corre, P; Malinovsky, JM; Ratajczak, M; Rose, FX; Wodey, E, 2007
)
0.34
"Using an animal model, we showed that drug dispositions in the intrathecal and epidural compartments are different, and that the intrathecal bioavailability of ropivacaine after epidural administration is low, and highly variable."( Epidural, intrathecal pharmacokinetics, and intrathecal bioavailability of ropivacaine.
Bec, D; Chevanne, F; Dollo, G; Ecoffey, C; Estebe, JP; Le Corre, P; Malinovsky, JM; Ratajczak, M; Rose, FX; Wodey, E, 2007
)
0.34
" Maximum plasma concentrations (C(max)), time to C(max) (t(max)), the absorption rate constant (k(a)), the speed of rise of the plasma concentration at Time 0 (dC(0)/dt), and area under the curve value (AUC) were determined."( Ultrasound versus landmark-based technique for ilioinguinal-iliohypogastric nerve blockade in children: the implications on plasma levels of ropivacaine.
Bsenberg, A; Kapral, S; Kettner, SC; Koppatz, K; Lönnqvist, PA; Lundblad, M; Marhofer, P; Turnheim, K; Weintraud, M; Willschke, H, 2009
)
0.35
"Following epidural administration, cerebrospinal fluid bioavailability of local anesthetics is low, one major limiting factor being diffusion across the arachnoid mater barrier."( Ex vivo and in vivo diffusion of ropivacaine through spinal meninges: influence of absorption enhancers.
Brandhonneur, N; Chevanne, F; Deniau, AL; Dollo, G; Estèbe, JP; Le Corre, P; Legrand, A; Ratajczak-Enselme, M, 2011
)
0.37
" The apparent infusion dosing half-life t(1/2,DP) is the most appropriate parameter to predict drug accumulation upon epidural infusion since it appears to better reflect the interplay interference between volume distribution and absorption rate during the accumulation phase."( Flip-flop kinetics of ropivacaine during continuous epidural infusion influences its accumulation rate.
Allegri, M; Braschi, A; Broglia, M; Cusato, M; Ingelmo, P; Niebel, T; Regazzi, M, 2011
)
0.37
" Population pharmacokinetic modeling was performed to yield estimates of clearance, volume of distribution, and absorption rate constant."( Pharmacokinetics and efficacy of ropivacaine in Chinese patients following intra-articular administration.
Chen, S; Chen, Z; Jin, Y; Lin, J; Lin, X; Tian, Z; Xu, L; Xu, S; Zhu, M, 2013
)
0.39
" Peak plasma dexmedetomidine concentrations were reached after 15 minutes with DEX1PN (mean ± SD, 348 ± 200 pg/mL) and after 30 minutes DEX2PN (816 ± 607 pg/mL), and bioavailability was 54 ± 40% and 73 ± 43%, respectively."( Effects of perineural administration of ropivacaine combined with perineural or intravenous administration of dexmedetomidine for sciatic and saphenous nerve blocks in dogs.
Ida, KK; Markuszewski, MJ; Marolf, V; Sandersen, C; Siluk, D; Struck-Lewicka, W, 2021
)
0.62
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

Intraoperative ropivacaine injection into both uterosacral ligaments during LM can reduce the dosage of opioid analgesics. Secondary endpoints include pain intensity as assessed with the numerical rating scale (NRS) for pain.

ExcerptRelevanceReference
" In this controlled double-blind study in man, the dose-response relation of ropivacaine was examined in peripheral nerve block and its potency was compared to that of bupivacaine."( Local anesthetic efficacy of ropivacaine (LEA 103) in ulnar nerve block.
Edström, HH; Fruhstorfer, H; Nolte, H,
)
0.13
" Although both drugs caused evidence of depression of conductivity and contractility, these appeared at lower dosage and lower plasma concentrations with bupivacaine than with ropivacaine."( Acute toxicity of ropivacaine compared with that of bupivacaine.
Bloomfield, P; Bowler, GM; Fagan, D; Lee, A; Lundh, R; Scott, DB, 1989
)
0.28
" At high K+ concentration, both local anaesthetics induced effects similar to those observed with low K+, but the dose-response curves for contractility and dV/dtmax were shifted leftward."( [The potential dependence of the effect of bupivacaine and ropivacaine on the heart. In-vitro studies on the effect of local anesthetics on the force of contraction and the action potential in left guinea pig atria].
Gödicke, J; Petry, A; Wulf, H, 1993
)
0.29
" The main aim of this study was to investigate the dose-response relationship of extradural infusion of ropivacaine."( Postoperative analgesia by continuous extradural infusion of ropivacaine after upper abdominal surgery.
Hägglöf, B; Mooney, PH; Payne, J; Schug, SA; Scott, DA, 1996
)
0.29
" The purpose of this double-blind study was: to investigate the dose-response relationship of increasing doses of ropivacaine on the quality of anaesthesia and the duration of both motor and sensory blockade, and to compare these results with an established local anaesthetic, bupivacaine."( A double-blind comparison of ropivacaine 0.5%, 0.75%, 1.0% and bupivacaine 0.5%, injected epidurally, in patients undergoing abdominal hysterectomy.
Chan, V; Finucane, BT; Friedlander, M; McKenna, J; Milner, AL; Muzyka, D; O'Callaghan-Enright, S; Reid, D; Sandler, AN, 1996
)
0.29
" The greater degree of separation between motor and sensory blockade seen with ropivacaine relative to bupivacaine is more apparent at the lower end of the dosage scale."( Ropivacaine. A review of its pharmacology and therapeutic use in regional anaesthesia.
Faulds, D; Markham, A, 1996
)
0.29
" The objective of this study was the investigation of the efficacy and appropriate dosage of isobaric ropivacaine for spinal anaesthesia in humans."( [Ropivacaine for spinal anesthesia. A dose-finding study].
Klein, P; Nolte, H; Wahedi, W, 1996
)
0.29
"To assess the effect of preoperative local anaesthesia with ropivacaine and find out if there was a dose-response relationship with postoperative pain after inguinal hernia repair."( Preoperative local infiltration with ropivacaine for postoperative pain relief after inguinal hernia repair. A randomised controlled trial.
Edwin, B; Glise, H; Hallerbäck, B; Janbu, T; Johansson, B; Solhaug, JH; Stubberöd, A, 1997
)
0.3
"We have assessed the dose-response relationship of a solution of ropivacaine 2 mg ml-1, given as a continuous extradural infusion to women in labour."( Continuous extradural infusion of ropivacaine 2 mg ml-1 for pain relief during labour.
Benhamou, D; Dailland, P; Eledjam, JJ; Hamza, J; Heeroma, K; Milon, D; Palot, M; Seebacher, J, 1997
)
0.3
"3 to 26 mg/kg) were selected based upon the proposed human dosage and the known pharmacological activity of the compounds."( Toxicity of bupivacaine and ropivacaine in relation to free plasma concentrations in pregnant rats: a comparative study.
Arvidsson, T; Böö, EL; Danielson, MK; Danielsson, BR; Halldin, MM, 1997
)
0.3
" The present pilot study was undertaken to find indications for an optimal dosage by comparing the clinical effects, quality of anaesthesia and pharmacokinetics of ropivacaine 150 mg (lower dose = LD) vs 187."( Ropivacaine 7.5 mg/ml for elective caesarean section. A clinical and pharmacokinetic comparison of 150 mg and 187.5 mg.
Ekblom, A; Emanuelsson, BM; Irestedt, L; Olofsson, C; Reventlid, H, 1997
)
0.3
" However, its relative potency to bupivacaine and its dose-response characteristics are unknown."( Hyperbaric spinal ropivacaine: a comparison to bupivacaine in volunteers.
Kopacz, DJ; Liu, SS; McDonald, SB; Stephenson, CA, 1999
)
0.3
" As the surgical wound was being closed, the catheters were dosed with fentanyl and hydromorphone followed by a continuous infusion of ropivacaine plus hydromorphone."( A dual epidural catheter technique to provide analgesia following posterior spinal fusion for scoliosis in children and adolescents.
Bildner, C; Gaines, RW; Kittle, D; Lowry, KJ; Tobias, JD, 2001
)
0.31
" We hypothesised that the use of a very low concentration technique (ropivacaine/fentanyl) might result in excessive dosing in the PCEA group, more motor blockade and a negative impact on spontaneous delivery rate."( Ropivacaine 1 mg/ml, plus fentanyl 2 microg/ml for epidural analgesia during labour. Is mode of administration important?
Gjessing, L; Smedvig, JP; Soreide, E, 2001
)
0.31
" However, there have been few formal dose-response studies of ropivacaine in this setting."( Dose-response study of epidural ropivacaine for labor analgesia.
Lee, BB; Liu, JY; Ngan Kee, WD; Wong, EL, 2001
)
0.31
"In a traditional dose-response study, the ED50 of ropivacaine required to initiate epidural analgesia in early labor was found to be 18."( Dose-response study of epidural ropivacaine for labor analgesia.
Lee, BB; Liu, JY; Ngan Kee, WD; Wong, EL, 2001
)
0.31
"To present the authors' technique for epidural catheter placement and dosing protocol, and to demonstrate the results from postoperative pain control after anterior spinal instrumented fusion for 10 consecutive patients."( Postoperative pain control using epidural catheters after anterior spinal fusion for adolescent scoliosis.
Burd, T; Gaines, RW; Kittle, D; Lowry, KJ; Tobias, J, 2001
)
0.31
" The authors believe that this lack of consensus stems from varied epidural dosing protocols and techniques in catheter placement, which they have witnessed anecdotally at their own institution."( Postoperative pain control using epidural catheters after anterior spinal fusion for adolescent scoliosis.
Burd, T; Gaines, RW; Kittle, D; Lowry, KJ; Tobias, J, 2001
)
0.31
" Dosing consisted of fentanyl (1 microg/kg) and hydromorphone (5 microg/kg) diluted in preservative-free saline (0."( Postoperative pain control using epidural catheters after anterior spinal fusion for adolescent scoliosis.
Burd, T; Gaines, RW; Kittle, D; Lowry, KJ; Tobias, J, 2001
)
0.31
"By following the dosing protocol described, epidural catheters can be used safely and effectively to control postoperative pain after anterior instrumentation and spinal fusion for adolescent scoliosis."( Postoperative pain control using epidural catheters after anterior spinal fusion for adolescent scoliosis.
Burd, T; Gaines, RW; Kittle, D; Lowry, KJ; Tobias, J, 2001
)
0.31
" We investigated the dose-response relationship for epidural clonidine when added to a continuous postoperative epidural infusion of ropivacaine."( The dose-response relationship for clonidine added to a postoperative continuous epidural infusion of ropivacaine in children.
De Negri, P; De Vivo, P; Ivani, G; Lonnqvist, PA; Visconti, C, 2001
)
0.31
"The dose-response relation for spinal ropivacaine is undetermined, and there are few data available for obstetric patients."( Spinal ropivacaine for cesarean section: a dose-finding study.
Chung, R; Khaw, KS; Liu, JY; Ngan Kee, WD; Wong, EL, 2001
)
0.31
" A sigmoid dose-response curve and a probit log dose-response plot were obtained, and the authors determined the ED50 (95% confidence interval) to be 16."( Spinal ropivacaine for cesarean section: a dose-finding study.
Chung, R; Khaw, KS; Liu, JY; Ngan Kee, WD; Wong, EL, 2001
)
0.31
" Because the smaller dosage (2 x 50 mg) provided similar analgesia and was associated with significantly smaller plasma concentrations than the larger dosage (2 x 150 mg), this smaller dosage seems more appropriate."( The clinical efficacy and pharmacokinetics of intraperitoneal ropivacaine for laparoscopic cholecystectomy.
Benhamou, D; Franco, D; Labaille, T; Mazoit, JX; Paqueron, X, 2002
)
0.31
" Peripheral venous plasma samples and urine were collected over 12 h after dosing and analysed for ropivacaine base by gas chromatography and (2H3)ropivacaine by gas chromatography-mass spectrometry."( Rectal ropivacaine is absorbed proportionally to the dose, with low intraindividual variability.
Arlander, E; Gustafsson, LL; Norsten-Höög, C; Sjövall, J; Sörstad, J, 2003
)
0.32
" Varying clinical dosage recommendations exist."( Increasing the injection volume by dilution improves the onset of motor blockade, but not sensory blockade of ropivacaine for brachial plexus block.
Balogh, B; Deusch, E; Fitzgerald, RD; Jellinek, H; Krenn, H; Oczenski, W; Plainer-Zöchling, E, 2003
)
0.32
" This study was undertaken to seek for a suitable dosage of ropivacaine in postoperative analgesia for Taiwanese patients whose average physicality is not entirely compatible with the pharmacopeially recommended dosage for western people."( Epidural ropivacaine for postoperative analgesia in Taiwanese patients.
Au, CF; Lee, LS; Lee, WK; Li, CH; Tang, CS; Yu, KL, 2003
)
0.32
"In the dosage used here, epinephrine did not improve epidural lumbar analgesia."( Epinephrine added to a lumbar epidural infusion of a small-dose ropivacaine-fentanyl mixture after arterial bypass surgery of the lower extremities.
Aromaa, U; Förster, JG; Neuvonen, PJ; Niemi, TT; Rosenberg, PH; Seppälä, TA, 2003
)
0.32
"2% ropivacaine delivered as a continuous infusion combined with patient-controlled bolus doses via an infraclavicular perineural catheter optimizes analgesia while minimizing oral analgesic use compared with basal- or bolus-only dosing regimens."( Infraclavicular perineural local anesthetic infusion: a comparison of three dosing regimens for postoperative analgesia.
Enneking, FK; Ilfeld, BM; Morey, TE, 2004
)
0.32
" In view of these results, we recommend the use of lower ropivacaine dosage during FIC block in children."( High plasma ropivacaine concentrations after fascia iliaca compartment block in children.
Bruguerolle, B; Camboulives, J; Lacroix, F; Lavrut, T; Meyrieux, V; Paut, O; Schreiber, E; Simon, N, 2004
)
0.32
" Sufentanil is a widely used opioid agent, but its optimal dosage has not yet been defined."( Epidural analgesia in abdominal surgery: 0.2% ropivacaine with sufentanil.
Adducci, E; Beccia, G; De Cosmo, G; Fiorenti, M; Primieri, P, 2004
)
0.32
"Continuous spinal anaesthesia with spinal catheters allows incremental dosing of local anaesthetic and, consequently, less haemodynamic changes."( Minimum effective local anaesthetic dose of isobaric levobupivacaine and ropivacaine administered via a spinal catheter for hip replacement surgery.
Aantaa, R; Jalonen, J; Olkkola, KT; Sell, A, 2005
)
0.33
" The myocardial depressant potential of these drugs in sublethal dosage is unknown."( The myocardial and vascular effects of bupivacaine, levobupivacaine, and ropivacaine using pressure volume loops.
Royse, AG; Royse, CF, 2005
)
0.33
" The cumulative dose-response relations of contraction and intracellular Ca2+ concentration to ropivacaine were tested, using isometric force transducers and a fluorometer, respectively."( Involvement of Ca2+ sensitization in ropivacaine-induced contraction of rat aortic smooth muscle.
Hatano, Y; Kuriyama, T; Mizumoto, K; Tokinaga, Y; Uematsu, N; Yu, J, 2005
)
0.33
" The dose-response relation for spinal hyperbaric ropivacaine is undetermined."( Dose-response study of spinal hyperbaric ropivacaine for cesarean section.
Chen, H; Chen, XZ; Lou, AF; Lü, CC, 2006
)
0.33
" Because of wide interindividual differences in pharmacokinetics in patients with liver disease, no definitive dosing instructions can be given."( Pharmacokinetics of ropivacaine in patients with chronic end-stage liver disease.
Ahonen, J; Askemark, Y; Breuer, O; Höckerstedt, K; Jokinen, MJ; Lindgren, L; Neuvonen, PJ; Olkkola, KT; Sjövall, J, 2007
)
0.34
" Although minimum local analgesic concentration studies suggested that they are less potent than bupivacaine, full dose-response studies have not been performed."( Determination of the full dose-response relation of intrathecal bupivacaine, levobupivacaine, and ropivacaine, combined with sufentanil, for labor analgesia.
Deprest, J; Dreelinck, R; Dubois, J; Kumar, A; Lewi, L; Van de Velde, M; Vandermeersch, E, 2007
)
0.34
" Group-specific dose-response curves were constructed using a probit regression model."( Determination of the full dose-response relation of intrathecal bupivacaine, levobupivacaine, and ropivacaine, combined with sufentanil, for labor analgesia.
Deprest, J; Dreelinck, R; Dubois, J; Kumar, A; Lewi, L; Van de Velde, M; Vandermeersch, E, 2007
)
0.34
"This full dose-response study suggests that ropivacaine and levobupivacaine are of similar potency, whereas bupivacaine is more potent than both other drugs."( Determination of the full dose-response relation of intrathecal bupivacaine, levobupivacaine, and ropivacaine, combined with sufentanil, for labor analgesia.
Deprest, J; Dreelinck, R; Dubois, J; Kumar, A; Lewi, L; Van de Velde, M; Vandermeersch, E, 2007
)
0.34
" Secondary aims were to determine the dose-response curve for spinal anesthesia including the clinically relevant ED95 dose and to describe the duration of motor block following ropivacaine spinal anesthesia."( Ropivacaine spinal anesthesia in neonates: a dose range finding study.
Frawley, G; Skinner, A; Smith, S; Thomas, J, 2007
)
0.34
"2% ropivacaine hydrochloride per hour with 10-mL bolus) epidural dosing groups."( Hemodynamic stability during labor and delivery with continuous epidural infusion.
Gerhardt, MA; Gunka, VB; Miller, RJ, 2006
)
0.33
"2% ropivacaine hydrochloride without bolus administration reduces the incidence of hypotension by 67% and is safer than traditional bolus dosing for routine labor."( Hemodynamic stability during labor and delivery with continuous epidural infusion.
Gerhardt, MA; Gunka, VB; Miller, RJ, 2006
)
0.33
" During this period, the side effects, the dosage of rescue analgesia required, and the range of knee flexion were recorded for each group."( Intra-synovial ropivacaine and morphine for pain relief after total knee arthroplasty: a prospective, randomized, double blind study.
Han, CD; Lee, DH; Yang, IH, 2007
)
0.34
" Further studies of dosage (high/low) and duration of intraarticular treatment are warranted."( Reduced hospital stay and narcotic consumption, and improved mobilization with local and intraarticular infiltration after hip arthroplasty: a randomized clinical trial of an intraarticular technique versus epidural infusion in 80 patients.
Andersen, KV; Haraldsted, V; Pfeiffer-Jensen, M; Søballe, K, 2007
)
0.34
"The dose-response relationship for spinal ropivacaine in patients undergoing surgery of the lower extremity has not been fully determined."( Spinal ropivacaine for lower limb surgery: a dose response study.
Chang, HK; Gin, T; Lee, YY; Ngan Kee, WD; So, CL, 2007
)
0.34
"75% with 5 doses each side, total dosage 40 mL (300 mg), via parasternal intercostal injection or saline before insertion of the sternal wires and closure of the sternal wound."( Parasternal intercostal block with ropivacaine for pain management after cardiac surgery: a double-blind, randomized, controlled trial.
Almeida, AA; Barr, AM; Tutungi, E, 2007
)
0.34
" Experience from this case suggests that local anesthesia toxicity can happen within safe dose limits and without intravascular placement despite careful attention to needle and catheter placement, fractionated dosing and frequent aspirations."( Case report: ropivacaine neurotoxicity at clinical doses in interscalene brachial plexus block.
Athwal, GS; Dhir, S; Ganapathy, S; Lindsay, P, 2007
)
0.34
" The initial dose was 10 mg of bupivacaine or 20 mg of ropivacaine; the dosing intervals were 1 mg and 2 mg, respectively."( Median effective local anesthetic doses of plain bupivacaine and ropivacaine for spinal anesthesia administered via a spinal catheter for brachytherapy of the lower abdomen.
Chiari, A; Deusch, E; Heinzl, H; Kozek-Langenecker, SA; Michalek-Sauberer, A,
)
0.13
" The hypotheses that no toxic plasma concentrations of ropivacaine would be reached and that proportionality exists among plasma concentrations and dosage used were tested."( Continuous extrapleural infusion of ropivacaine 0.2% after cardiovascular surgery via the lateral thoracotomy approach.
Blumenthal, S; Maurer, K; Rentsch, KM; Schmid, ER, 2008
)
0.35
" No proportionality of plasma concentrations of ropivacaine existed when the 2 dosing regimens were compared."( Continuous extrapleural infusion of ropivacaine 0.2% after cardiovascular surgery via the lateral thoracotomy approach.
Blumenthal, S; Maurer, K; Rentsch, KM; Schmid, ER, 2008
)
0.35
" Immediately after surgery, there was less pain, higher satisfaction, and lower morphine use among patients on continuous FNB regardless of ropivacaine dosage used."( Continuous femoral nerve block in total knee arthroplasty: immediate and two-year outcomes.
Chong, HC; Lo, NN; Shum, CF; Yang, KY; Yeo, SJ; Yeo, SN, 2009
)
0.35
" Doppler ultrasound indices of vascular resistance were assessed at baseline and after each 24 h dosing period in both uterine arteries."( Antepartum continuous epidural ropivacaine therapy reduces uterine artery vascular resistance in pre-eclampsia: a randomized, dose-ranging, placebo-controlled study.
Davidson, EM; Elchalal, U; Firman, N; Ginosar, Y; Hoffman, A; Nadjari, M; Rosen, L; Weiniger, CF; Weissman, C, 2009
)
0.35
" Therefore, we performed a prospective, randomized, double-blind study to determine the minimum local analgesic concentrations of a caudal single shot of ropivacaine and levobupivacaine in children and to describe the upper dose-response curve."( Relative analgesic potencies of levobupivacaine and ropivacaine for caudal anesthesia in children.
Astuto, M; Disma, N; Donath, S; Duffy, C; Frawley, G; Fumagalli, R; Gullo, A; Ingelmo, P; Rosano, G, 2009
)
0.35
"We performed a two-stage prospective, randomized, double-blind study comparing the dose-response curves of caudal ropivacaine and levobupivacaine in children."( Relative analgesic potencies of levobupivacaine and ropivacaine for caudal anesthesia in children.
Astuto, M; Disma, N; Donath, S; Duffy, C; Frawley, G; Fumagalli, R; Gullo, A; Ingelmo, P; Rosano, G, 2009
)
0.35
" Cumulative dose-response curves were generated with concentrations of 10(-5) to 10(-3) M ropivacaine enantiomer in the presence or absence of quinacrine dihydrochloride, nordihydroguaiaretic acid, quinacrine dihydrochloride plus nordihydroguaiaretic acid, indomethacin, fluconazole, AA-861, and verapamil."( Direct effect of ropivacaine involves lipoxygenase pathway activation in rat aortic smooth muscle.
Baik, JS; Hwang, EM; Ogawa, K; Park, JY; Sohn, JT; Sung, HJ, 2009
)
0.35
"To test the clinical efficacy and pharmacokinetics of different concentrations of ropivacaine with the same dosage on blocking lumbar plexus with sciatic nerves."( [Clinical efficacy and pharmacokinetics of different concentrations of ropivacaine with the same dosage on blocking lumbar plexus with sciatic nerves].
Cao, W; Xu, HW; Zhang, L; Zhang, WS; Zhang, X, 2009
)
0.35
" The dose for the first patient in each group was 8 mg, and the dosing increment was set at 1 mg."( The median effective dose of bupivacaine, levobupivacaine, and ropivacaine after intrathecal injection in lower limb surgery.
Fong, SY; Gin, T; Lee, YY; Liu, JT; Ngan Kee, WD, 2009
)
0.35
" In phase 2, a further 70 patients were randomly allocated to receive spinal anaesthesia with doses in the upper dose-response range to define the ED95."( Relative potencies of bupivacaine, levobupivacaine, and ropivacaine for neonatal spinal anaesthesia.
Frawley, G; Ingelmo, P; Smith, KR, 2009
)
0.35
") analgesia in labor is well recognized, but information on dosing is limited."( On the ropivacaine-reducing effect of low-dose sufentanil in intrathecal labor analgesia.
Faybik, P; Grabovica, J; Gustorff, B; Kimberger, O; Ortner, CM; Posch, M; Roessler, B; Rützler, K, 2010
)
0.36
" In phase one, sufentanil dose-response was calculated using logistic regression."( On the ropivacaine-reducing effect of low-dose sufentanil in intrathecal labor analgesia.
Faybik, P; Grabovica, J; Gustorff, B; Kimberger, O; Ortner, CM; Posch, M; Roessler, B; Rützler, K, 2010
)
0.36
" Increasing dosage implicates no clinical benefit."( On the ropivacaine-reducing effect of low-dose sufentanil in intrathecal labor analgesia.
Faybik, P; Grabovica, J; Gustorff, B; Kimberger, O; Ortner, CM; Posch, M; Roessler, B; Rützler, K, 2010
)
0.36
" These findings may have implications for dosing of local anesthetics in diabetic patients undergoing regional analgesia with nerve blocks."( Local anesthetic sciatic nerve block and nerve fiber damage in diabetic rats.
Buvanendran, A; Kerns, JM; Kroin, JS; Moric, M; Tuman, KJ; Wagenaar, B; Williams, DK,
)
0.13
"The potencies of bupivacaine and ropivacaine have been compared using up-and-down methodology, but their complete dose-response curves have not been compared."( Determination and comparison of graded dose-response curves for epidural bupivacaine and ropivacaine for analgesia in laboring nulliparous women.
Gin, T; Khaw, KS; Lee, A; Ng, FF; Ngan Kee, WD, 2010
)
0.36
" Response was defined by the percentage decrease in pain score from baseline at 30 min, and dose-response data were analyzed by using nonlinear regression."( Determination and comparison of graded dose-response curves for epidural bupivacaine and ropivacaine for analgesia in laboring nulliparous women.
Gin, T; Khaw, KS; Lee, A; Ng, FF; Ngan Kee, WD, 2010
)
0.36
"Ropivacaine is less potent than bupivacaine, but otherwise they have similar dose-response characteristics."( Determination and comparison of graded dose-response curves for epidural bupivacaine and ropivacaine for analgesia in laboring nulliparous women.
Gin, T; Khaw, KS; Lee, A; Ng, FF; Ngan Kee, WD, 2010
)
0.36
" The infusion dosing period half-life (t(1/2,DP)=0."( Flip-flop kinetics of ropivacaine during continuous epidural infusion influences its accumulation rate.
Allegri, M; Braschi, A; Broglia, M; Cusato, M; Ingelmo, P; Niebel, T; Regazzi, M, 2011
)
0.37
" The apparent infusion dosing half-life t(1/2,DP) is the most appropriate parameter to predict drug accumulation upon epidural infusion since it appears to better reflect the interplay interference between volume distribution and absorption rate during the accumulation phase."( Flip-flop kinetics of ropivacaine during continuous epidural infusion influences its accumulation rate.
Allegri, M; Braschi, A; Broglia, M; Cusato, M; Ingelmo, P; Niebel, T; Regazzi, M, 2011
)
0.37
"The presence of cases of subtotal anaesthetic coverage (with necessity to recur to general anaesthesia), and others with good anaesthetic coverage, but difficultly treatable hypotensions show that the best dosage of these local anaesthetics is to be found yet."( [Ropivacaina 0.5% vs Levobupivacaina 0.5 endoscopic urological surgery].
Baldini, C; Fasciolo, A,
)
0.13
" Baseline tissue oxygen saturation values were obtained prior to dosing of the nerve block, and measurements were recorded every 5 min thereafter."( Noninvasive tissue oxygen saturation determined by near-infrared spectroscopy following peripheral nerve block.
Boezaart, AP; Elliott, CE; Lucas, SD; Tighe, PJ, 2011
)
0.37
"We investigated the safety and efficacy of the bilateral periarticular multimodal drug injection (PMDI) at a reduced dosage in patients undergoing simultaneous bilateral total knee arthroplasty (SBTKA)."( Use of reduced-dose periarticular injection for pain management in simultaneous bilateral total knee arthroplasty.
Chang, CB; Jeon, YT; Kang, YG; Kim, TK; Koh, IJ; Song, J, 2012
)
0.38
" Only the age-effect was considered as relevant for possible dosing adjustments."( A population pharmacokinetic model for the complex systemic absorption of ropivacaine after femoral nerve block in patients undergoing knee surgery.
Drolet, P; Fallaha, M; Gaudreault, F; Varin, F, 2012
)
0.38
"Describing the relationship between magnitude of response, probability of response, dose and time is difficult using traditional two-dimensional dose-response curves."( Multi-dimensional response-probability-dose curves for bupivacaine and ropivacaine epidural labour analgesia.
Lee, A; Ngan Kee, WD, 2013
)
0.39
" However, the protocol was amended for the subsequent 16 subjects, to a weight-based dosing regimen."( Plasma ropivacaine concentrations during bilateral transversus abdominis plane infusions.
Bjorksten, AR; Evans, BE; Hessian, EC; Kinkel, E; Taylor, DJ; Woods, JA, 2013
)
0.39
"Given the potential for high plasma concentrations from a bilateral TAP infusion technique, attention should be paid to individualized dosing strategies."( Plasma ropivacaine concentrations during bilateral transversus abdominis plane infusions.
Bjorksten, AR; Evans, BE; Hessian, EC; Kinkel, E; Taylor, DJ; Woods, JA, 2013
)
0.39
"This prospective randomized single-blinded study was conducted to determine whether there were differences in consumption, demand dosing and postoperative analgesia quality between PCEA using ropivacaine and levobupivacaine."( The effectiveness of patient-controlled epidural analgesia with ropivacaine 0.165% with fentanyl 2.0 miroc g/ml or levobupivacaine 0.125% with fentanyl 2.0 micro g/ml as a method of postoperative analgesia after major orthopaedic surgery.
Misiran, KB; Yahaya, LS, 2013
)
0.39
" Nonlinear regression analysis was used to describe the dose-response relationships for the aepEX, the BIS, and propofol plasma concentrations (Cp)."( Evaluation of the aepEX™ monitor of hypnotic depth in pediatric patients receiving propofol-remifentanil anesthesia.
Cheung, YM; Hoeks, SE; Scoones, GP; Stolker, RJ; Weber, F, 2013
)
0.39
" Ropivacaine could make dose-response curve of the GABA up, EC50 is 23."( [Effects of ropivacaine on GABA-activated currents in isolated dorsal root ganglion neurons in rats].
Cheng, HJ; Fan, C; Li, L; Ma, KT; Si, JQ; Yang, Y, 2013
)
0.39
" Total postoperative ropivacaine dosage and analgesic consumption were recorded."( Catheter-based distal sciatic nerve block in patients with Charcot-Marie-Tooth disease.
Huber, H; Huberth, S; Münster, T; Schmitt, HJ, 2014
)
0.4
" Despite this, an ideal approach and dosing regimen for cervical plexus block remain elusive."( Ropivacaine 0.375% vs. 0.75% with prilocaine for intermediate cervical plexus block for carotid endarterectomy: A randomised trial.
Felder, TK; Gerner, P; Koköfer, A; Mader, N; Nawratil, J; Stundner, O, 2015
)
0.42
"This was a prospective randomized double-blind dose-response study."( Sparing effects of sufentanil on epidural ropivacaine in elderly patients undergoing transurethral resection of prostate surgery.
He, R; Li, H; Li, Y, 2015
)
0.42
" The analgesic effect of dexmedetomidine (2 μg/kg body weight) as an adjunct to ropivacaine in knee arthroscopic knee procedures was studied to determine whether this would achieve longer post-operative analgesia and whether the study dosage of dexmedetomidine was safe and free of adverse effects."( Intra-articular Adjuvant Analgesics following Knee Arthroscopy: Comparison between Single and Double Dose Dexmedetomidine and Ropivacaine A Multicenter Prospective Double-blind Trial.
Mahapatra, AK; Palo, N; Panigrahi, R; Prasad, A; Priyadarshi, A; Roy, R, 2015
)
0.42
" This study was to determine the dose-response of intrathecal ropivacaine in patients with scarred uterus undergoing cesarean delivery under combined spinal-epidural anesthesia."( The Dose-response of Intrathecal Ropivacaine Co-administered with Sufentanil for Cesarean Delivery under Combined Spinal-epidural Anesthesia in Patients with Scarred Uterus.
Liu, L; Liu, X; Wang, LZ; Xiao, F; Xu, WP; Zhang, YF, 2015
)
0.42
" At an epidural ropivacaine dose that blocks 20 segments, the propofol dosage or target concentration may be reduced by 30% compared with when no epidural blockade is present."( Epidural Blockade Affects the Pharmacokinetics of Propofol in Surgical Patients.
Dahan, A; Lesman, A; Olofsen, E; Sitsen, E; Vuyk, J, 2016
)
0.43
"To compare the effect of interscalene brachial plexus block (ISBPB) on the incidence of diaphragmatic paralysis, respiratory function and post-operative pain control using same dosage of local anesthetics diluted into two different volume and concentrations."( [A study on diaphragm function after interscalene brachial plexus block using a fixed dose of ropivacaine with different concentrations].
Guo, XY; Li, M; Wang, XD; Zhai, WW, 2016
)
0.43
" However, we believe that the bolus dosage and the injection rate we used for BTPB were both too high, and caution other clinicians against the use of these doses."( Local anaesthetic toxicity after bilateral thoracic paravertebral block in patients undergoing coronary artery bypass surgery.
Chan, SK; Ho, AM; Joynt, GM; Karmakar, MK; Ng, CS; Ng, SK; Wan, S; Wong, RH, 2016
)
0.43
" Future studies should focus on tailoring ropivacaine and epinephrine dosage for individuals."( Preoperative flap-site injection with ropivacaine and epinephrine in BABA robotic and endoscopic thyroidectomy safely reduces postoperative pain: A CONSORT-compliant double-blinded randomized controlled study (PAIN-BREKOR trial).
Choi, JY; Kwon, H; Lee, JH; Lee, KE; Song, RY; Suh, YJ; Yi, JW; Yu, HW, 2017
)
0.46
" Subjects in both groups were further randomly assigned to one of nine subgroups based on the dosage of intrathecal isobaric ropivacaine to be administered (7, 8, 9, 10, 11, 12, 13, 14 or 15 mg respectively)."( Body height and the spread of spinal anaesthesia for caesarean section: a prospective controlled trial.
She, YJ; Song, XR; Tan, YH; Zeng, MT; Zhao, BS; Zheng, X, 2017
)
0.46
"These results indicate that TAT-decorated NCs systems are useful for overcoming the barrier function of the skin, decreasing the dosage of RVC and enhancing the anesthetic effect."( A novel local anesthetic system: transcriptional transactivator peptide-decorated nanocarriers for skin delivery of ropivacaine.
Chen, C; You, P, 2017
)
0.46
"This was a retrospective analysis of data previously collected during dose-response studies of levobupivacaine and ropivacaine spinal anesthetics."( Infant spinal anesthesia: Do girls need a larger dose of local anesthetic?
Frawley, G; Huque, MH, 2017
)
0.46
"Bupivacaine, levobupivacaine, and ropivacaine are often given intrathecally for labor analgesia, but limited data are available for their dose-response properties in this context."( Dose-Response Curves for Intrathecal Bupivacaine, Levobupivacaine, and Ropivacaine Given for Labor Analgesia in Nulliparous Women.
Khaw, KS; Koo, AGP; Ng, FF; Ngan Kee, WD; Tang, SPY,
)
0.13
" Logistic sigmoidal dose-response curves were fitted to the data using nonlinear regression, and D50 values were calculated for each drug."( Dose-Response Curves for Intrathecal Bupivacaine, Levobupivacaine, and Ropivacaine Given for Labor Analgesia in Nulliparous Women.
Khaw, KS; Koo, AGP; Ng, FF; Ngan Kee, WD; Tang, SPY,
)
0.13
" The results suggested that adding a small dosage of DEM could improve the anesthesia efficacy of RVP to a large content."( Local anaesthetic pain relief therapy: In vitro and in vivo evaluation of a nanotechnological formulation co-loaded with ropivacaine and dexamethasone.
Chang, M; Yue, Y; Zhang, Y, 2017
)
0.46
"The aim of the present study was to evaluate the optimum dose of ropivacaine by comparing three different dosing regimens of isobaric ropivacaine 1% (naropin 10 mg/ml, Astra Zeneca) administered intrathecally and to demonstrate the effects of anesthesia in pregnant women scheduled for cesarean section."( Intrathecal ropivacaine in cesarean delivery.
Ateser, RY; Kayacan, N, 2017
)
0.46
"Ropivacaine administration produced rapid induction of anesthesia and satisfactory anesthesia level, ropivacaine 15 mg and 20 mg dosing regimens are satisfactory for spinal anesthesia."( Intrathecal ropivacaine in cesarean delivery.
Ateser, RY; Kayacan, N, 2017
)
0.46
" Local anesthetics have been commonly used in interventional procedures for alleviating pain, but local anesthetics may have negative impact on MSC dosing because of cytotoxicity or other biological effects."( Cytotoxicity of Local Anesthetics in Mesenchymal Stem Cells.
Erwin, PJ; Nie, H; Qu, W; Smith, J; van Wijnen, AJ; Wang, Z; Wu, T, 2018
)
0.48
"Ultrasound-guided OSTAP block with ropivacaine can significantly decrease the perioperative cumulative dosage of analgesics and improve analgesic effect without obvious side effects for the patients who underwent an open liver resection with Mercedes incision when compared tothe ultrasound-guided OSTAP block with saline."( The analgesic efficacy of subcostal transversus abdominis plane block with Mercedes incision.
Feng, ZY; Guo, JG; Li, HL; Pei, QQ, 2018
)
0.48
"Intraoperative ropivacaine injection into both uterosacral ligaments during LM can reduce the dosage of opioid analgesics."( Postoperative pain control with ropivacaine following laparoscopic myomectomy: A randomized double-blind, pilot study.
Ahn, KH; Kwack, JY; Kwon, YS, 2019
)
0.51
" Secondary outcomes were dosage of remedial analgesics, time to perform the block, side effects and satisfaction of patients."( Comparison between ultrasound-guided paravertebral nerve block and subarachnoid block for elderly male patients under unilateral-opened inguinal hernia repair operation: A randomised controlled trial.
Li, ZF; Wu, YM; Xie, PC; Yang, JL; Zhang, NN, 2019
)
0.51
" Few data deal with the initial dosage of each drug."( Optimizing Initial Intrathecal Drug Ratio for Refractory Cancer-Related Pain for Early Pain Relief. A Retrospective Monocentric Study.
Bore, F; Carvajal, G; Delorme, T; Demelliez-Merceron, S; Dubois, PY; Dupoiron, D; Jubier-Hamon, S; Leblanc, D; Lebrec, N; Pechard, M; Robard, S; Seegers, V, 2019
)
0.51
" The present study tested the hypothesis that multimodal analgesia with combined ropivacaine wound infiltration and intravenous flurbiprofen axetil after radical thyroidectomy provided better analgesia than a single dosage of tramadol."( Multimodal analgesia with ropivacaine wound infiltration and intravenous flurbiprofen axetil provides enhanced analgesic effects after radical thyroidectomy: a randomized controlled trial.
Li, X; Tan, H; Yang, J; Yu, L, 2019
)
0.51
" The in vivo anesthesia antinociception study displayed that NLCs showed stronger and longer anesthesia antinociceptive effect when compared with single drugs loaded NLCs and drugs solution even at a lower dosage of drugs."( Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer.
Chao, L; Liu, Y; Qiu, D; Yang, Y, 2019
)
0.51
" The dosage of 10 mg improves the quality of the anesthesia with less incidence of side effects."( Efficacy of Nalbuphine as an Adjuvant to Ropivacaine in Ultrasound-guided Supraclavicular Brachial Block: A Prospective Randomized Controlled Study.
Kalika, P; Ran, R; Xiao, Y; Xue, R; Zhen, M; Zheng, J, 2020
)
0.56
" Secondary endpoints include pain intensity as assessed with the numerical rating scale (NRS) for pain, time to return of intestinal function (defined as the time to first flatus and the time to the first postoperative intake of solid food), time to first mobilization, the incidence of postoperative nausea and vomiting during the first 24 h, length of stay on the post anesthesia care unit (PACU) and in the hospital, the extent of sensory block at two time points (admission to and discharge from the PACU), the doses of morphine IV as requested by the patient from the PCA pump, the total dosage of morphine administered IV, the need for and dose of rescue analgesics (ketamine, clonidine), free plasma ropivacaine levels after induction and at discharge from the PACU, and the incidence of adverse events during treatment (in particular, signs of local anesthetic systemic toxicity (LAST))."( Transmuscular quadratus lumborum (TQL) block for laparoscopic colorectal surgery: study protocol for a double-blind, prospective randomized placebo-controlled trial.
Coppens, S; D'Hoore, A; Dewinter, G; Fieuws, S; Neyrinck, A; Rex, S, 2020
)
0.56
" The primary endpoint was the total dosage of oxycodone."( Changes of Opioid Consumption After Lumbar Fusion Using Ultrasound-Guided Lumbar Erector Spinae Plane Block: A Randomized Controlled Trial.
Chen, L; Li, J; Wang, M; Wang, X; Wang, Y; Zhu, L, 2021
)
0.62
" However, there is no unified consensus on the exact dosage of sufentanil with the combination of ropivacaine in the induction of epidural analgesia in the early first stage of labor."( The 90% Effective Dose of Sufentanil for Epidural Analgesia in the Early First Stage of Labor: A Double-blind, Sequential Dose-Finding Study.
Shen, T; Shen, Y; Xu, T; Xu, Z; Zhang, C; Zheng, J, 2021
)
0.62
"Sufentanil at a dosage of 2 μg is recommended for the administration of epidural analgesia in parturients in the early first stage of labor."( The 90% Effective Dose of Sufentanil for Epidural Analgesia in the Early First Stage of Labor: A Double-blind, Sequential Dose-Finding Study.
Shen, T; Shen, Y; Xu, T; Xu, Z; Zhang, C; Zheng, J, 2021
)
0.62
"The main objective of the study was to evaluate the safety, efficacy by pain assessment, to analyze drug dosage changes, to report adverse events (AEs) and conversion ratios switching from ropivacaine to bupivacaine."( First Evaluation Switching From Ropivacaine to Highly Concentrated Bupivacaine in Intrathecal Mixtures for Cancer Pain.
Bellanger, M; Bienfait, F; Boré, F; Delorme, T; Dupoiron, D; Jaoul, V; Jubier-Hamon, S; Lebrec, N; Pluchon, YM; Robert, J; Seegers, V; Sorrieul, J, 2021
)
0.62
"The IAI does not appear to reduce postoperative pain scores or MMEs dosed for THA patients."( Does the Use of an Intra-Articular Local Anesthetic Injection During Total Hip Arthroplasty Reduce Patient Reported Pain Scores or Patient Opioid Consumption?
Geiselmann, MT; Goldberg, LK; Strecker, SE; Witmer, DK, 2022
)
0.72
" The objective of this study was to determine the dose-response relationship of epidural dexmedetomidine (combined with ropivacaine) for labor analgesia."( Determination of the Dose-Response Relationship of Epidural Dexmedetomidine Combined with Ropivacaine for Labor Analgesia.
Feng, JL; Mei, Z; Ni, JX; Ni, LF; Qian, XW; Song, CZ; Song, SB; Yao, SJ; Yu, J, 2022
)
0.72
" The dose-response relationship of dexmedetomidine (with ropivacaine) for epidural labor analgesia was performed using probit regression."( Determination of the Dose-Response Relationship of Epidural Dexmedetomidine Combined with Ropivacaine for Labor Analgesia.
Feng, JL; Mei, Z; Ni, JX; Ni, LF; Qian, XW; Song, CZ; Song, SB; Yao, SJ; Yu, J, 2022
)
0.72
" There was also a significant increase in intraoperative esmolol dosage in the CFNB group (65."( Combined femoral artery block and femoral nerve block reduces thigh tourniquet-induced hypertension.
Gao, F; Li, W; Li, Y; Wang, Q; Wang, X; Xu, F; Yin, C; Yu, J; Zhu, L, 2023
)
0.91
"The present study demonstrated that modified femoral nerve block reduced intraoperative esmolol dosage and the incidence of TH."( Combined femoral artery block and femoral nerve block reduces thigh tourniquet-induced hypertension.
Gao, F; Li, W; Li, Y; Wang, Q; Wang, X; Xu, F; Yin, C; Yu, J; Zhu, L, 2023
)
0.91
" The dosing of sufentanil was determined by the assessor when the NRS score was 1 to 3 points."( Could C3, 4, and 5 Nerve Root Block be a Better Alternative to Interscalene Block Plus Intermediate Cervical Plexus Block for Patients Undergoing Surgery for Midshaft and Medial Clavicle Fractures? A Randomized Controlled Trial.
Gu, C; Han, J; Shan, Y; Wang, A; Xie, Y; Xu, Y, 2023
)
0.91
" Larger studies are needed to confirm the findings, with accurate records of the dosage and administration route of local anesthetics."( Postmortem concentrations of ropivacaine, bupivacaine, and lidocaine in femoral venous blood after hip fracture surgery.
Kriikku, P; Nurkkala, J; Ojanperä, I; Oura, P; Virtanen, A, 2023
)
0.91
" Arterial blood samples were obtained over 12 hours and analyzed using non-linear mixed effects modeling, which allowed for conducting simulations of clinically relevant dosing scenarios."( Population pharmacokinetic and safety analysis of ropivacaine used for erector spinae plane blocks.
Abulfathi, AA; Baratta, JL; Gebhart, A; Kaushal, G; Lam, E; Mohamod, D; Rochani, A; Roy, AB; Sarna, RR; Schmidt, S; Schwenk, ES; Viscusi, ER; Witzeling, SD; Zhao, JL, 2023
)
0.91
" Weight-based ropivacaine dosing could reduce toxicity risk."( Population pharmacokinetic and safety analysis of ropivacaine used for erector spinae plane blocks.
Abulfathi, AA; Baratta, JL; Gebhart, A; Kaushal, G; Lam, E; Mohamod, D; Rochani, A; Roy, AB; Sarna, RR; Schmidt, S; Schwenk, ES; Viscusi, ER; Witzeling, SD; Zhao, JL, 2023
)
0.91
" However, the optimal dosage regimen for intrathecal dexmedetomidine combined with plain ropivacaine for cesarean section (CS) remains undetermined."( Intrathecal dexmedetomidine as an adjuvant to plain ropivacaine for spinal anesthesia during cesarean section: a prospective, double-blinded, randomized trial for ED
Chen, J; Feng, J; Huang, F; Mo, X; Wu, X; Zeng, J, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
local anaestheticAny member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block.
local anaestheticAny member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
piperidinecarboxamide
ropivacaineThe piperidinecarboxamide obtained by the formal condensation of N-propylpipecolic acid and 2,6-dimethylaniline.
hydrochlorideA salt formally resulting from the reaction of hydrochloric acid with an organic base.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Ropivacaine Action Pathway3111

Protein Targets (12)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
lamin isoform A-delta10Homo sapiens (human)Potency2.51190.891312.067628.1838AID1487
TDP1 proteinHomo sapiens (human)Potency23.71500.000811.382244.6684AID686979
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency25.15670.001022.650876.6163AID1224838; AID1224893
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency20.44850.01237.983543.2770AID1346984; AID1645841
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency6.00700.000214.376460.0339AID720691
cytochrome P450 2D6Homo sapiens (human)Potency4.89750.00108.379861.1304AID1645840
chromobox protein homolog 1Homo sapiens (human)Potency100.00000.006026.168889.1251AID540317
potassium voltage-gated channel subfamily H member 2 isoform dHomo sapiens (human)Potency31.62280.01789.637444.6684AID588834
transcriptional regulator ERG isoform 3Homo sapiens (human)Potency11.22020.794321.275750.1187AID624246
gemininHomo sapiens (human)Potency0.92000.004611.374133.4983AID624296
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Potassium channel subfamily K member 3Homo sapiens (human)IC50 (µMol)53.00000.00700.89855.1000AID1525553
Bile salt export pumpHomo sapiens (human)IC50 (µMol)646.40000.11007.190310.0000AID1449628
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (33)

Processvia Protein(s)Taxonomy
potassium ion transportPotassium channel subfamily K member 3Homo sapiens (human)
chemical synaptic transmissionPotassium channel subfamily K member 3Homo sapiens (human)
response to xenobiotic stimulusPotassium channel subfamily K member 3Homo sapiens (human)
monoatomic ion transmembrane transportPotassium channel subfamily K member 3Homo sapiens (human)
negative regulation of cytosolic calcium ion concentrationPotassium channel subfamily K member 3Homo sapiens (human)
regulation of resting membrane potentialPotassium channel subfamily K member 3Homo sapiens (human)
cellular response to zinc ionPotassium channel subfamily K member 3Homo sapiens (human)
cellular response to hypoxiaPotassium channel subfamily K member 3Homo sapiens (human)
cochlea developmentPotassium channel subfamily K member 3Homo sapiens (human)
potassium ion transmembrane transportPotassium channel subfamily K member 3Homo sapiens (human)
stabilization of membrane potentialPotassium channel subfamily K member 3Homo sapiens (human)
fatty acid metabolic processBile salt export pumpHomo sapiens (human)
bile acid biosynthetic processBile salt export pumpHomo sapiens (human)
xenobiotic metabolic processBile salt export pumpHomo sapiens (human)
xenobiotic transmembrane transportBile salt export pumpHomo sapiens (human)
response to oxidative stressBile salt export pumpHomo sapiens (human)
bile acid metabolic processBile salt export pumpHomo sapiens (human)
response to organic cyclic compoundBile salt export pumpHomo sapiens (human)
bile acid and bile salt transportBile salt export pumpHomo sapiens (human)
canalicular bile acid transportBile salt export pumpHomo sapiens (human)
protein ubiquitinationBile salt export pumpHomo sapiens (human)
regulation of fatty acid beta-oxidationBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transportBile salt export pumpHomo sapiens (human)
bile acid signaling pathwayBile salt export pumpHomo sapiens (human)
cholesterol homeostasisBile salt export pumpHomo sapiens (human)
response to estrogenBile salt export pumpHomo sapiens (human)
response to ethanolBile salt export pumpHomo sapiens (human)
xenobiotic export from cellBile salt export pumpHomo sapiens (human)
lipid homeostasisBile salt export pumpHomo sapiens (human)
phospholipid homeostasisBile salt export pumpHomo sapiens (human)
positive regulation of bile acid secretionBile salt export pumpHomo sapiens (human)
regulation of bile acid metabolic processBile salt export pumpHomo sapiens (human)
transmembrane transportBile salt export pumpHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
monoatomic ion channel activityPotassium channel subfamily K member 3Homo sapiens (human)
open rectifier potassium channel activityPotassium channel subfamily K member 3Homo sapiens (human)
potassium channel activityPotassium channel subfamily K member 3Homo sapiens (human)
potassium ion leak channel activityPotassium channel subfamily K member 3Homo sapiens (human)
S100 protein bindingPotassium channel subfamily K member 3Homo sapiens (human)
outward rectifier potassium channel activityPotassium channel subfamily K member 3Homo sapiens (human)
protein bindingBile salt export pumpHomo sapiens (human)
ATP bindingBile salt export pumpHomo sapiens (human)
ABC-type xenobiotic transporter activityBile salt export pumpHomo sapiens (human)
bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
canalicular bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transporter activityBile salt export pumpHomo sapiens (human)
ABC-type bile acid transporter activityBile salt export pumpHomo sapiens (human)
ATP hydrolysis activityBile salt export pumpHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (13)

Processvia Protein(s)Taxonomy
plasma membranePotassium channel subfamily K member 3Homo sapiens (human)
synapsePotassium channel subfamily K member 3Homo sapiens (human)
plasma membranePotassium channel subfamily K member 3Homo sapiens (human)
basolateral plasma membraneBile salt export pumpHomo sapiens (human)
Golgi membraneBile salt export pumpHomo sapiens (human)
endosomeBile salt export pumpHomo sapiens (human)
plasma membraneBile salt export pumpHomo sapiens (human)
cell surfaceBile salt export pumpHomo sapiens (human)
apical plasma membraneBile salt export pumpHomo sapiens (human)
intercellular canaliculusBile salt export pumpHomo sapiens (human)
intracellular canaliculusBile salt export pumpHomo sapiens (human)
recycling endosomeBile salt export pumpHomo sapiens (human)
recycling endosome membraneBile salt export pumpHomo sapiens (human)
extracellular exosomeBile salt export pumpHomo sapiens (human)
membraneBile salt export pumpHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (85)

Assay IDTitleYearJournalArticle
AID588219FDA HLAED, gamma-glutamyl transferase (GGT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID625281Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625288Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID748682Antiarrhythmic activity in iv dosed Swiss albino mouse assessed as inhibition of calcium chloride-induced cardiac arrhythmia after 15 mins2013European journal of medicinal chemistry, May, Volume: 63Synthesis, local anaesthetic and antiarrhythmic activities of N-alkyl derivatives of proline anilides.
AID625290Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID540212Mean residence time in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID613109Cardiotoxicity in dog assessed as free plasma concentration causing cardiovascular collapse measured after 20 mins2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
Stereostructure-based differences in the interactions of cardiotoxic local anesthetics with cholesterol-containing biomimetic membranes.
AID588214FDA HLAED, liver enzyme composite activity2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID467613Volume of distribution at steady state in human2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
AID625280Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID467611Dissociation constant, pKa of the compound2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
AID588216FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID625291Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625285Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID540211Fraction unbound in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID625286Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID588215FDA HLAED, alkaline phosphatase increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID625289Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625283Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID748686Anesthetic effect in Wistar rat assessed as time taken for blockage of muscle contraction by infiltration local anaesthetic activity assay2013European journal of medicinal chemistry, May, Volume: 63Synthesis, local anaesthetic and antiarrhythmic activities of N-alkyl derivatives of proline anilides.
AID748680Anesthetic effect in Wistar rat assessed as duration of blockage of muscle contraction by infiltration local anaesthetic activity assay2013European journal of medicinal chemistry, May, Volume: 63Synthesis, local anaesthetic and antiarrhythmic activities of N-alkyl derivatives of proline anilides.
AID588217FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID1525553Inhibition of human TASK1 expressed in Xenopus oocytes by whole cell voltage clamp assay2019Journal of medicinal chemistry, 11-27, Volume: 62, Issue:22
TASK Channels Pharmacology: New Challenges in Drug Design.
AID540209Volume of distribution at steady state in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID613103Cardiotoxicity in dog assessed as total plasma concentration causing cardiovascular collapse measured after 20 mins2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
Stereostructure-based differences in the interactions of cardiotoxic local anesthetics with cholesterol-containing biomimetic membranes.
AID588218FDA HLAED, lactate dehydrogenase (LDH) increase2004Current drug discovery technologies, Dec, Volume: 1, Issue:4
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
AID625292Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625282Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625287Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID540213Half life in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID540210Clearance in human after iv administration2008Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 36, Issue:7
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
AID748683Toxicity in iv dosed Swiss albino mouse after 72 hrs2013European journal of medicinal chemistry, May, Volume: 63Synthesis, local anaesthetic and antiarrhythmic activities of N-alkyl derivatives of proline anilides.
AID625284Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID467612Fraction unbound in human plasma2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
AID748681Antiarrhythmic index, ratio of LD50 for Swiss albino mouse to ED50 for calcium chloride-induced Swiss albino mouse2013European journal of medicinal chemistry, May, Volume: 63Synthesis, local anaesthetic and antiarrhythmic activities of N-alkyl derivatives of proline anilides.
AID625279Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID613104Increase in membrane fluidity in DPH-labeled liposomal membrane containing 40 mol% cholesterol assessed as change in DPH fluorescence polarization at 200 uM after 5 mins by spectrofluorometry relative to control2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
Stereostructure-based differences in the interactions of cardiotoxic local anesthetics with cholesterol-containing biomimetic membranes.
AID748685Anesthetic effect in Wistar rat assessed as duration of complete blockage of muscle contraction by infiltration local anaesthetic activity assay2013European journal of medicinal chemistry, May, Volume: 63Synthesis, local anaesthetic and antiarrhythmic activities of N-alkyl derivatives of proline anilides.
AID1449628Inhibition of human BSEP expressed in baculovirus transfected fall armyworm Sf21 cell membranes vesicles assessed as reduction in ATP-dependent [3H]-taurocholate transport into vesicles incubated for 5 mins by Topcount based rapid filtration method2012Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 40, Issue:12
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
AID748687Surface anesthetic effect in New Zealand white rabbit assessed as time duration2013European journal of medicinal chemistry, May, Volume: 63Synthesis, local anaesthetic and antiarrhythmic activities of N-alkyl derivatives of proline anilides.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1346758Human Nav1.5 (Voltage-gated sodium channels)2015Anesthesia and analgesia, Jun, Volume: 120, Issue:6
A Comparative Analysis of Bupivacaine and Ropivacaine Effects on Human Cardiac SCN5A Channels.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (3,457)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (0.43)18.7374
1990's238 (6.88)18.2507
2000's1204 (34.83)29.6817
2010's1420 (41.08)24.3611
2020's580 (16.78)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1,982 (51.23%)5.53%
Trials0 (0.00%)5.53%
Reviews133 (3.44%)6.00%
Reviews0 (0.00%)6.00%
Case Studies405 (10.47%)4.05%
Case Studies0 (0.00%)4.05%
Observational50 (1.29%)0.25%
Observational0 (0.00%)0.25%
Other1,299 (33.57%)84.16%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (962)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Transversus Abdominis Plane (TAP) Block in Open Abdominal Aortic Surgery : Randomized Controlled Doubled-blind Trial Comparing Ropivacaine 0.2% Versus Placebo [NCT03657979]Phase 450 participants (Actual)Interventional2011-09-05Completed
Pilot Study: Extended Regional Anesthesia to Prevent Chronic Pain After Ankle Fracture Surgery [NCT02950558]Phase 414 participants (Actual)Interventional2018-05-29Completed
Ultrasound Guided Transversus Abdominus Plane Block for Patients Undergoing Laparoscopic Hand-assisted Nephrectomy. [NCT01054469]21 participants (Actual)Interventional2010-03-31Completed
Local Anesthetic Activity of Liposomal Formulations in Dentistry [NCT01054547]Phase 180 participants (Actual)Interventional2006-09-30Completed
A Preemptive Epidural Ropivacaine for Postoperative Pain Relief in Degenerative Lumbar Spine Surgery: A Prospective Randomized Study [NCT01117610]Phase 460 participants (Anticipated)Interventional2010-05-31Not yet recruiting
Perioperative Analgetic Therapy After Knee Arthroplasty [NCT01225484]Phase 4123 participants (Anticipated)Interventional2010-10-31Recruiting
RePPAIR -Reducing Procedural Pain and Improving Recovery of Quality of Life in Pediatric Neuroblastoma Patients Undergoing Bone Marrow Procedures: A Prospective Randomized Cross-over Clinical Trial [NCT02924324]56 participants (Actual)Interventional2016-10-31Completed
Postoperative Analgesic Efficacy of Local Infiltration Analgesia Versus Adductor Canal Block After Anterior Cruciate Ligament Reconstruction: A Randomised Controlled Double-blinded Trial [NCT02524652]Phase 4104 participants (Actual)Interventional2015-09-30Completed
Evaluation of Optimal Dose of Local Anesthetics for Patient Controlled Continuous Femoral Nerve Block With Sciatic Nerve Block After Total Knee Arthroplasty [NCT01198340]60 participants (Anticipated)Interventional2010-09-30Recruiting
A Phase-4, Multicenter, Randomized, Active-Controlled Study to Evaluate the Efficacy and Safety of EXPAREL When Administered Via Fascia Iliaca Compartment Block Versus Fascia Iliaca Compartment Block With Continuous Infusion of Ropivacaine Per Standard of [NCT03955458]Phase 40 participants (Actual)Interventional2019-08-26Withdrawn(stopped due to Recruitment difficulties)
Erectus Nerve Block for Lumbar Spine Surgery : a Prospective Randomized Study [NCT04473508]Phase 350 participants (Actual)Interventional2019-11-27Completed
Effect of Continuous Paravertebral Block on Postoperative Quality of Recovery After Hepatectomy [NCT03777644]76 participants (Actual)Interventional2018-11-01Completed
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for Acute Headache in Aneurysmal Subarachnoid Hemorrhage [NCT06008795]Phase 2195 participants (Anticipated)Interventional2023-11-27Recruiting
Regional Block for Postoperative Free Flap Care [NCT04080739]Phase 4100 participants (Actual)Interventional2020-01-13Completed
The Effect of Adductor-Canal-Block (ACB) in Patients After Anterior Cruciate Ligament (ACL) Reconstruction in Day Case Surgery [NCT01212666]Phase 450 participants (Actual)Interventional2010-05-31Completed
Comparison of the Analgesic Effect Between Intrathecal Morphine and IV-fentanyl Patient Controlled Analgesia (ITM-IVPCA) and Epidural PCA (PCEA) in Patients Undergoing Gastrectomy -Randomized Allocation Study- [NCT01234272]Phase 459 participants (Actual)Interventional2010-08-31Completed
Dexmedetomidine and Morphine as Adjuvants to US Guided Erector Spinae Plane Blocks in Elective Thoracic Surgeries [NCT05843344]90 participants (Anticipated)Interventional2023-05-01Not yet recruiting
Trial Evaluating the Efficacy of the Combination of ROpivacaine With Reference XYlocaine in the Evaluation of Pain During the Installation of Percutaneous Radiological GASTrostomy [NCT04250805]Phase 2124 participants (Anticipated)Interventional2020-10-27Recruiting
Do Peritoneal Nebulization of Ropivacaine Reduce the Use of Morphine After Short Gynecologic Laparoscopic Surgery? [NCT01142622]Phase 3140 participants (Anticipated)Interventional2010-04-30Completed
Pharmacokinetic Profile and Dermatomal Coverage of the Erector Spinae Plane Block: a Comparison of Bolus Dosing and Continuous Infusion [NCT03874806]Phase 40 participants (Actual)Interventional2019-07-01Withdrawn(stopped due to Did not receive funding)
Transversus Abdominis Plane Blocks in Patients Scheduled for an Abdominoplasty. A Prospective, Randomized, Double Blind, Comparison Between the Posterior Approach and Placebo. [NCT01278264]Phase 460 participants (Anticipated)Interventional2011-06-30Not yet recruiting
A Randomized Controlled Trial Comparing Intraoperative Surgeon-Performed Versus Anesthesiologist-Performed Adductor Canal Blockade After Primary Total Knee Arthroplasty [NCT03864588]Phase 4164 participants (Anticipated)Interventional2018-10-01Enrolling by invitation
Application of Iced Normal Saline Combined With Cocktail Perfusion in Total Knee Arthroplasty: Randomized Controlled Trial [NCT05204056]60 participants (Actual)Interventional2018-03-02Completed
A Phase I/II, Randomized, Double-blind, Comparator-controlled, Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of TLC590 for Postsurgical Pain Management Following Inguinal Hernia Repair [NCT03591146]Phase 1/Phase 265 participants (Actual)Interventional2018-07-31Completed
Post Operative Analgesia After Pediatric Hip Surgery - PCA, Epidural or Lumbar Plexus Catheter: A Prospective Randomized Control Trial [NCT03435692]42 participants (Actual)Interventional2011-07-15Terminated(stopped due to Funding was exhausted prior to enrolling intended number of patients.)
Evaluation of the Efficacy of a Topical Analgesic Treatment With ROPIVACAINE in Children and Young Adults With Hereditary Epidermolysis Bullosa [NCT03730584]10 participants (Actual)Interventional2017-02-27Completed
Analgesic Efficacy of a Combined Saphenous Nerve Block and IPACK Block Versus Local Infiltration Analgesia After Anterior Cruciate Ligament Reconstruction: a Randomized Controlled Double-blinded Trial. [NCT03680716]60 participants (Actual)Interventional2018-11-01Completed
A Phase 2b, Randomized, Double-Blind, Saline Placebo- and Active-Controlled, Multicenter Study of HTX-011 Via Infiltration for Postoperative Analgesia in Subjects Undergoing Total Knee Arthroplasty [NCT03015532]Phase 2285 participants (Actual)Interventional2017-01-13Completed
Ultrasound-guided Transmuscular Quadratus Lumborum Catheters for Elective Caesarean Section. A Double Blind, Randomise, Placebo Controlled Trial. [NCT03663478]Phase 432 participants (Actual)Interventional2018-09-04Completed
Pre vs. Postoperative Adductor Canal Block for Total Knee Arthroplasty: Prospective Randomized Trial [NCT05974501]Phase 484 participants (Anticipated)Interventional2023-09-29Recruiting
A Randomized Controlled Trial (RCT) Comparing Presacral Nerve Block Versus Sham Block on Post-operative Pain in Women Undergoing Total Laparoscopic Hysterectomy. [NCT05953766]Phase 260 participants (Anticipated)Interventional2023-08-02Not yet recruiting
Effects of Preoperative Scalp Nerve Block on Postoperative Recovery Quality in Patients Undergoing Excision of Intracranial Meningioma [NCT03648034]144 participants (Actual)Interventional2018-09-18Completed
Postoperative Analgesic Efficacy of Continuous Wound Infusion With Local Anesthetics After Laparoscopy (PAIN): a Randomized, Double-blind, Placebo-controlled Trial [NCT03645304]66 participants (Anticipated)Interventional2019-01-21Recruiting
Ropivacaine Through Continuous Infusion Versus Epidural Morphine for Postoperative Analgesia After Emergency Cesarean Section [NCT02410317]Phase 3101 participants (Actual)Interventional2015-02-28Completed
Comparison of the Effects of Adding Dexamethasone at 0.25% Ropivacaine With 0.5% Ropivacaine Alone in the Supraclavicular Brachial Plexus Block [NCT03572686]90 participants (Anticipated)Interventional2018-04-13Enrolling by invitation
Pain During Pars Plana Vitrectomy Comparing Peribulbar Anesthesia Versus Sub-tenon Injection Plus Topical Jelly Anesthesia [NCT03902925]Phase 1/Phase 256 participants (Actual)Interventional2019-01-01Completed
The Efficacy of Adductor-Canal-Block (ACB) in Patients After Knee Arthroscopy [NCT01254825]Phase 472 participants (Actual)Interventional2010-11-30Completed
The Randomised Epidural Analgesia in Term Delivering Women Trial [NCT01261689]488 participants (Actual)Interventional2008-09-30Completed
Double-blind Randomized Prospective Phase III Study of a Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment of the Postoperative Pain From Hospital to Home [NCT02525211]Phase 359 participants (Actual)Interventional2012-10-31Terminated(stopped due to Recruitment defect)
A Double-blind Placebo-controlled Evaluation of Ropivacaine Efficacy by Local Per and Post Hepatectomy Infiltrations for Adult Pain Management [NCT01194843]85 participants (Actual)Interventional2009-03-31Completed
Pudendal Nerve Block in Patient Treated for Hemorrhoidectomy Under Spinal Anaesthesia: Prospective Randomized Double-blind Controlled Trial [NCT04251884]49 participants (Actual)Interventional2018-01-01Completed
Ropivacaine Volume for Ultrasound-guided Retrograde Infraclavicular Brachial Plexus Block [NCT01334619]Phase 430 participants (Actual)Interventional2010-03-31Completed
Preoperative Versus Postoperative Ultrasound-guided Rectus Sheath Block for Improving Pain, Sleep Quality and Cytokine Levels of Patients With Open Midline Incisions Undergoing Transabdominal Gynaecological Operation [NCT02477098]Phase 477 participants (Actual)Interventional2015-10-31Completed
Evaluation of Trigeminal Nerve Blockade in the Pterygopalatine Fossa for Cleft Palate Repair: a Pilot Study [NCT03632044]Early Phase 140 participants (Anticipated)Interventional2018-11-20Enrolling by invitation
The Effects of Ultrasound-guided Transversus Abdominis Plane Block on Acute and Chronic Postsurgical Pain After Robotic Partial Nephrectomy. A Prospective, Randomized, Clinical Trial [NCT02460640]96 participants (Actual)Interventional2015-05-31Completed
Comparison Between Epidural and Patient Controlled Analgesia on Immunological and Inflammatory Systems Following Radical Retropubic Prostatectomy [NCT01367418]Phase 326 participants (Actual)Interventional2010-09-30Completed
Comparison of TAP, Anterior QL, or ESP Block for Elective Cesarean Section [NCT03695172]Phase 412 participants (Actual)Interventional2019-09-12Terminated(stopped due to Decline of eligible participants)
The Impact of a Preoperative Nerve Block on the Consumption of Sevoflurane [NCT03533452]Phase 2/Phase 327 participants (Actual)Interventional2019-05-01Completed
Efficacy of Regional Analgesia Techniques (Quadratus Lumborum Block and Transversus Abdominis Plane Block) in Acute and Chronic Pain Treatment in Patients After Cesarean Delivery [NCT03244540]Phase 4105 participants (Actual)Interventional2017-09-04Completed
Epidural or Patient-controlled Analgesia for Colorectal Cancer Surgery. Long-term Outcomes. [NCT01318161]Phase 3221 participants (Actual)Interventional2011-03-31Terminated(stopped due to Difficulty in recruiting)
Local Infiltration Analgesia in Total Knee Arthroplasty: A Randomized, Prospective, Placebo Controlled, Double Blinded Study. [NCT03206554]Phase 240 participants (Actual)Interventional2015-09-30Completed
The Effect of Intraperitoneal Local Anaesthetic on Functional Recovery Following Bowel Resection: A Prospective Randomised Blinded Trial [NCT02449720]Phase 486 participants (Actual)Interventional2015-05-31Completed
Ropivacaine Infusion to Alleviate Postoperative Pain After Cardiac Surgery [NCT02449486]Phase 490 participants (Actual)Interventional2014-01-31Completed
Can the Association of Dexamethasone and Local Anaesthetic in a Single-shot Femoral and Sciatic Nerve Block Improve Analgesia Postoperatively in Patients Submitted to Total Knee Arthroplasty [NCT02436694]56 participants (Anticipated)Interventional2015-04-30Recruiting
Intérêt du TFP (Transversalis Fascia Plane) Bloc échoguidé Pour l'analgésie du prélèvement Osseux de crête Iliaque [NCT02398474]Phase 446 participants (Actual)Interventional2015-05-12Completed
Interest of Parasternal Block to Limit the Doses of Anesthetics Necessary for the Maintenance of Arterial Blood Pressure and Heart Rate in the Recommended Values During Sternotomy in Patients Undergoing Coronary Artery Bypass Graft [NCT03734159]Phase 435 participants (Actual)Interventional2018-12-13Completed
Comparison of Programmed Intermittent Epidural Boluses With Continuous Epidural Infusion for Maintenance of Labor Analgesia [NCT02949271]Phase 4179 participants (Actual)Interventional2016-11-08Completed
Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure [NCT02391142]100 participants (Anticipated)Interventional2014-06-30Recruiting
Efficacy of Parietal Continuous Infiltration of Local Anesthesic on Diaphragmatic Function After Upper Abdominal Surgery Through a Subcostal Incision [NCT02353702]Phase 331 participants (Actual)Interventional2014-07-31Completed
Effect of Nervus Cutaneous Femoris Lateralis-Blockade on Moderate Pain Responders After Total Hip Arthroplasty [NCT02344264]Phase 460 participants (Actual)Interventional2015-01-31Completed
A Randomized Controlled Trial Comparing Single Shot Fascia Iliaca Block With Femoral Nerve Block for Analgesia Following Surgical Fixation of Hip Fractures [NCT02330302]30 participants (Actual)Interventional2014-08-31Completed
The Effect of Pectoralis Block on Analgesia After Simple Mastectomy [NCT03143530]Phase 40 participants (Actual)Interventional2017-12-31Withdrawn(stopped due to Extensive protocol revisions initiated.)
Effectiveness of Preoperative iPACK on Postoperative Pain From Hamstring Autograft for ACL Repair [NCT05080348]40 participants (Anticipated)Interventional2021-12-31Not yet recruiting
Comparison of Ultrasound-guided PENG Block and Supra-inguinal Fascia Iliaca Compartment Block for Postoperative Opioids Consumption and Early Motor Recovery After Total Hip Arthroplasty: a Randomized Controlled Non-inferiority Clinical Trial. [NCT04690023]Phase 482 participants (Anticipated)Interventional2022-01-01Recruiting
A Randomized, Sham-procedure-controlled, Blinded Study to Evaluate the Effectiveness and Acceptability of Right-sided Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder Symptoms [NCT03077919]113 participants (Actual)Interventional2016-05-25Completed
A Comparison of Lidocaine Versus Ropivacaine for Bilateral Continuous Thoracic Paravertebral Nerve Blocks for Post-bowel Surgery Analgesia [NCT02849678]68 participants (Actual)Interventional2008-01-31Completed
Multimodal Anesthesia and Analgesia for Total Shoulder and Reverse Total Shoulder Arthroplasty: A Randomized Controlled Trial [NCT03586934]Phase 30 participants (Actual)Interventional2018-06-01Withdrawn(stopped due to Difficult to enroll patients for the study)
Sole Epidural Local Anesthetic Versus Opioid Plus Local Anesthetic in Epidural Labor Pain Control [NCT02036242]Phase 4500 participants (Actual)Interventional2013-09-30Completed
Tranversus Abdominis Plane (TAP) Block vs. Systemic Lidocaine to Improve Quality of Recovery After Outpatient Laparoscopic Surgery: A Non-inferiority, Randomized, Double Blinded, Placebo Controlled Trial [NCT02053558]0 participants (Actual)Interventional2014-11-03Withdrawn(stopped due to Could not obtain dedicated ultrasound device.)
Health Related Quality of Life and Pain Managment Using Infiltration or Suprascapular Nerve Block Ultrasound Guided in Patients With Glenohumeral Arthirtis [NCT03794505]Phase 340 participants (Actual)Interventional2018-04-01Completed
THE TAP BLOCK TECHNIQUE VIA THE ANTERIOR APPROACH IN ELECTIVE SURGERY OF THE SPINE: Prospective, Randomised, Double Blind Trial, Comparing TAP BLOCK With Continuous Infiltration of Ropivacaine Versus Placebo [NCT02055664]Phase 480 participants (Actual)Interventional2014-01-23Completed
Determination of the Efficay of the Transversus Abdominis Plane (TAP) Block as Part of a Multimodal Regimen for Post-cesarean Delivery Analgesia: a Double Blinded Placebo-controlled Study. [NCT00573963]100 participants (Actual)Interventional2007-12-31Completed
Does Ultrasound-guided Erector Spinae Plane Block Improve Postoperative Quality of Recovery After Video-assisted Thoracic Surgery [NCT03756987]76 participants (Actual)Interventional2018-12-28Completed
Application of Combined Lumbar Plexus and Sciatic Nerve Block in Unilateral Knee Replacement [NCT02084368]Phase 434 participants (Actual)Interventional2014-01-31Completed
Intrathecal Plain Bupivacaine, Ropivacaine and Levo-bupivacaine With or Without Fentanyl for Elective c Section. [NCT01582607]Phase 2/Phase 3130 participants (Anticipated)Interventional2010-01-31Recruiting
A MULTICENTER, RANDOMIZED, CONTROLLED STUDY OF EPIDURAL ANALGESIA FOR SEVERE ACUTE PANCREATITIS [NCT02126332]Phase 3148 participants (Actual)Interventional2014-06-06Completed
A Randomized Controlled Study of the Effect of Intraperitoneal Ropivacaine on Visceral Pain After Laparoscopic Gastrectomy [NCT06145945]72 participants (Anticipated)Interventional2023-11-25Not yet recruiting
Pre-Operative and Post-Operative Paravertebral Block on Patients With Thoracic Outlet Syndrome. [NCT05544721]Phase 450 participants (Anticipated)Interventional2022-10-05Enrolling by invitation
Erector Spinae Plane Block for Reduction of Early Postoperative Pain Scores and Opioid Use in Lumbar Spinal Fusion Surgery, a Prospective Double-blinded Randomized Placebo-controlled Trial [NCT05345249]Phase 476 participants (Anticipated)Interventional2022-06-01Recruiting
Effect of Perineural Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Ankle Surgery [NCT03332316]Phase 484 participants (Actual)Interventional2017-11-02Completed
Improving Postoperative Pain Management With the Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Laparoscopic Hand-assisted Nephrectomy and Robot-assisted Partiel Nephrectomy: A Double Blind, Randomized, Placebo Controlled Trial [NCT03571490]Phase 450 participants (Actual)Interventional2018-06-26Completed
Impact of Local Anesthetic Wound Infiltration on Postoperative Pain Following Cesarean Delivery [NCT02829944]Phase 484 participants (Actual)Interventional2016-11-30Completed
Local Infiltration Analgesia in Total Hip Arthroplasty - Efficacy of Multiple Bolus Injections With Ropivacaine and Ketorolac [NCT01344395]Phase 480 participants (Actual)Interventional2010-03-31Completed
Pre-emptive Scalp Infiltration With Dexamethasone Plus Ropivacaine vs. Ropivacaine for Relief of Postoperative Pain After Craniotomy in Adults [NCT03618264]Phase 4140 participants (Actual)Interventional2019-04-04Completed
Adductor Canal Block Versus Femoral Nerve Block for Total Knee Arthroplasty [NCT03133481]Phase 394 participants (Actual)Interventional2014-10-22Completed
Does the Use of Ropivacaine Facilitates Cholecystectomy by Laparoscopy in Ambulatory Surgery? [NCT02085902]Phase 4120 participants (Actual)Interventional2014-03-31Completed
The Transversus Abdominis Plane Block [NCT03634111]60 participants (Actual)Interventional2017-07-10Completed
Bilateral Transversus Abdominis Plane Block With or Without Magnesium for Total Abdominal Hysterectomy With or Without Salpingo-oophorectomy: a Randomized Controlled Trial [NCT02680626]Phase 486 participants (Actual)Interventional2016-01-31Terminated(stopped due to Pfannenstiel hysterectomies are now rarely performed so cannot recruit eligible patients)
A Randomized Controlled Trial of Combined Spinal Epidural Versus Dural Puncture Epidural Techniques for Labor Analgesia [NCT05068661]Phase 4100 participants (Anticipated)Interventional2021-11-21Recruiting
[NCT02163980]80 participants (Actual)Interventional2011-05-31Completed
Determination of the Minimal Effective Concentration (EC90) of Ropivacaine in Axillary Brachial Plexus Block With Intravenous Dexamethasone or Saline Injection [NCT03688269]Phase 3146 participants (Actual)Interventional2018-10-05Completed
The Effect of Phrenic Nerve Blockade on Acute and Chronic Shoulder Pain in Patients for Lobectomy and Pneumonectomy. [NCT02173418]Phase 476 participants (Actual)Interventional2012-11-30Completed
The Efficacy of Ultrasound-guided Suprainguinal Fascia Iliaca Compartment Block on Early Post-operative Analgesia After Total Hip Arthroplasty [NCT03069183]Phase 2/Phase 3133 participants (Actual)Interventional2018-08-30Completed
Does Regional Anesthesia Reduce Postoperative Opioid Consumption in Subjects Undergoing Fibula Free Flap Reconstruction of the Head and Neck: A Prospective Trial [NCT03906838]Early Phase 10 participants (Actual)Interventional2020-01-01Withdrawn(stopped due to funding not obtained)
Comparison of the Analgesic Effect of Femoral Nerve Block, Intraarticular Infiltration or a Combination of Both in the Control of Pain in Total Knee Arthroplasty [NCT01304212]Phase 4137 participants (Actual)Interventional2011-04-30Completed
Effect of Local Anesthetic Continuous Preperitoneal Wound Infiltration on Incisional Hyperalgesia Following Colorectal Laparoscopic Surgery [NCT01077752]Phase 395 participants (Actual)Interventional2010-02-28Completed
Thoracic Paravertebral Block: a Comparative Study of Ropivacaine With Ropivacaine and Sufentanil for Treating Pain After Video-assisted Thoracic Surgery. [NCT01082744]Phase 390 participants (Actual)Interventional2010-03-31Completed
Effect of Adding Sufentanil to Epidural Ropivacaine on Perioperative Metabolic and Stress Responses in Combined General/Epidural Anaesthesia for Geriatric Radical Retropubic Prostatectomy [NCT01086956]60 participants (Actual)Interventional2008-09-30Completed
Optimal Effective Local Anesthetic Volume for Pain Relief Using Brachial Plexus Block Utilizing Continuous Reassessment Method for Arthroscopic Rotator Cuff Shoulder Surgery [NCT05868993]Phase 4150 participants (Anticipated)Interventional2023-02-17Recruiting
Analgesic Effect of Bilateral Erector Spinae Plane Block With Ropivacaine After Sternotomy in Cardiac Surgery [NCT05160298]Phase 284 participants (Actual)Interventional2021-10-20Completed
Multimodal Periarticular Analgesic Injection With and Without Surgeon-Administered Adductor Canal Block During Total Knee Arthroplasty: A Randomized Controlled Trial [NCT04513145]Phase 2/Phase 3130 participants (Anticipated)Interventional2020-10-09Enrolling by invitation
Effectiveness of Interscalene Brachial Plexus Block and Intra-articular Injection of Ropivacaine for Post-operative Analgesia in Arthroscopic Shoulder Stabilization Surgery [NCT01589354]60 participants (Anticipated)Interventional2012-05-31Not yet recruiting
Ultrasound-guided Transmuscular Quadratus Lumborum Block for Laparoscopic Hysterectomy. A Double Blind, Randomized, Placebo Controlled Trial. [NCT03650998]Phase 470 participants (Actual)Interventional2018-09-28Completed
Improving Combined Spinal-epidural Anesthesia for Decreasing Hypotension in Pregnant Women Without Prophylactical Prehydration and Vasopressors [NCT03497364]930 participants (Anticipated)Interventional2018-05-01Recruiting
Stimulating Catheter for Lumbar Plexus Block: Better Postoperative Analgesia? [NCT02162121]Phase 464 participants (Actual)Interventional2014-05-31Completed
Magnetic Resonance Imaging of Local Anesthetic Distribution: A Comparison of 5 and 15 Milliliters of Ropivacaine 0,75% for Ultrasound Guided Interscalene Plexus Blockade [NCT02175069]Phase 430 participants (Actual)Interventional2013-12-31Completed
Minimum Effective Volume (MEV95%) of Ropivacaine 7.5 mg/ml to Block the Posterior and Lateral Cords of the Infraclavicular Brachial Plexus [NCT03329456]Phase 423 participants (Actual)Interventional2017-10-30Completed
Serratus Plain Block Versus Paravertebral Block Versus Serratus Plain Block and Paravertebral Block for Postoperative Pain Following Thoracoscopic Surgery [NCT04222010]155 participants (Actual)Interventional2020-01-02Completed
Evaluation of Magnesium as Adjuvant to Ropivacaine for Sciatic Block at Popliteal Level. [NCT02198547]60 participants (Anticipated)Interventional2014-03-31Enrolling by invitation
The Postoperative Analgesic Efficacy of Varied Concentrations of Ropivacaine Used for the Transverse Abdominis Plane (TAP) Block After Cesarean Delivery [NCT01170702]Phase 4120 participants (Actual)Interventional2010-01-31Completed
Flurbiprofen Axetil as an Adjuvant to Pre-emptive Scalp Infiltration for Post-craniotomy Pain [NCT05624359]216 participants (Anticipated)Interventional2023-11-01Recruiting
Median Effective Concentration of Ropivacaine for Ultrasound-guided Popliteal Sciatic Nerve Block in Patients Undergoing Diabetic Foot Surgery [NCT04981067]45 participants (Anticipated)Interventional2021-08-24Recruiting
Efficacy of Liposomal Bupivacaine in Arthroscopic Rotator Cuff Repair [NCT03738696]Phase 463 participants (Actual)Interventional2019-12-15Completed
Postoperative Analgesic Effect of Morphine Added to Ropivacaine for Fascia Iliaca Compartment Block Following Femoral Fracture Surgeries [NCT03875274]Phase 470 participants (Actual)Interventional2017-04-01Completed
Effective Pain Management During Shoulder Replacement Surgery With Either Continuous Ropivacaine Interscalene Nerve Block or Local Infiltration With EXPAREL After Single Shot Injection Ropivacaine Interscalene Nerve Block [NCT03474510]Phase 40 participants (Actual)Interventional2018-03-17Withdrawn(stopped due to Investigator Decision)
Comparative Study Between Different Routes of Ropivacaïne Administration to Reduce Post-operative Pain in Gynecological Laparoscopy, a Double Blind Randomized Trial. [NCT04459026]Phase 460 participants (Actual)Interventional2017-07-01Completed
Effect of a Single Shot Sciatic Nerve Block (SNB) Combined With a Continuous Femoral Block (CFNB) on Pain Scores After Knee Arthroplasty. A Randomized Controlled Trial [NCT01337115]50 participants (Actual)Interventional2011-04-30Completed
Intercostobrachial Nerve Block (ICBN) for Tourniquet Pain: Is it Necessary? [NCT03797924]Early Phase 146 participants (Actual)Interventional2019-04-25Completed
The Effect of The Serratus Block on Analgesia After Breast Surgery A Randomized Controlled Double-Blinded Study [NCT02453516]Phase 2/Phase 340 participants (Actual)Interventional2014-10-29Completed
Postoperative Analgesic Effects of Ultrasound-guided Bilateral Rectus Sheath Block for Robotic Single-port Gynecologic Surgery [NCT02450084]60 participants (Actual)Interventional2015-05-31Completed
The Effect of Dexmedetomidine as an Adjuvant for Lower Limb Nerve Blocks Following Oromaxillofacial Reconstruction [NCT03118076]Phase 440 participants (Anticipated)Interventional2017-04-20Not yet recruiting
Efficacy of Continuous Infusion of Local Anesthesia After Radical Cystectomy: A Randomized, Double Blind, Placebo Controlled Study [NCT02438852]Phase 30 participants (Actual)Interventional2019-02-25Withdrawn(stopped due to No funding)
Comparing Efficacy and Safety of Three Regional Anesthesia Regimens in Total Hip and Knee Arthroplasty: A Double Blind Randomized Control Trial [NCT04257682]Phase 4135 participants (Anticipated)Interventional2022-09-30Not yet recruiting
Ropivacaine For Post-POEM Pain Control [NCT03702647]20 participants (Actual)Interventional2019-06-01Completed
Continuous Infusion vs. Programmed Intermittent Bolus of Ropivacaine Through Peri-neural Femoral Nerve Catheter After Total Knee Arthroplasty: Impact on Analgesia Quality and Motor Block Frequency. [NCT03696095]Phase 470 participants (Actual)Interventional2018-04-16Completed
A Randomized Two-parallel Group Controlled Trial Comparing the Effects of 20mg Parecoxib as an Adjunct to 0.75% Ropivacaine in Ultrasound-guided Supraclavicular Block for Upper Limb Surgery [NCT03480165]Phase 386 participants (Actual)Interventional2016-06-20Completed
Development of Variable Volume Automated Mandatory Boluses (VVAMB) for Patient-controlled Epidural Analgesia During Labour and Delivery [NCT04011150]Phase 3216 participants (Anticipated)Interventional2020-08-11Recruiting
Effect of Local Infiltration Anesthesia With Ropivacaine on Pain After Primary Total Hip Arthroplasty [NCT02359136]116 participants (Actual)Interventional2013-03-31Completed
Extrafascial Injection Versus Subfascial Injection of Quadratus Lumborum Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy [NCT03421821]80 participants (Actual)Interventional2018-02-25Completed
Does Perineural Dexamethasone Prolong Duration of an Adductor Canal Block When Controlling for a Systemic Effect? A Paired, Randomized, Blinded, Study in Healthy Volunteers [NCT02351804]Phase 220 participants (Actual)Interventional2015-02-28Completed
A Randomised Controlled Trial Comparing Single Shot Adductor Canal Block With Femoral Nerve Block for Analgesia Post Total Knee Arthroplasty [NCT02033603]30 participants (Anticipated)Interventional2014-01-31Recruiting
Pectoral Nerves Block to Relieve Post-sternotomy Pain After Cardiac Surgery [NCT04282239]0 participants (Actual)Interventional2021-03-01Withdrawn(stopped due to Did not have the staff to conduct the study)
Spinal Ropivacaine for Cesarean Delivery: A Comparison of Commonly Hyperbaric and Marginally Hyperbaric Solutions [NCT03142880]120 participants (Anticipated)Interventional2017-05-31Not yet recruiting
The Association Between Epidural Labor Analgesia and Pregnancy Outcomes [NCT03381495]200 participants (Anticipated)Interventional2018-05-16Recruiting
Comparison of the Effectiveness of the Use of Ropivacaine and Midazolam by Intraarticular vs Epidural Administration on Post-operative Analgesia After Isolated Arthroscopic ACL Reconstruction With Hamstring Autograft. [NCT05078372]Phase 2108 participants (Actual)Interventional2019-01-31Completed
The Effect of Protracted Saphenous Nerve and Obturator Nerve Block Versus Saphenous Nerve Block Versus Local Infiltration Analgesia on Opioid Consumption, Pain, Block Duration of Action and Mobilization After Total Knee Arthroplasty. [NCT02067078]Phase 475 participants (Actual)Interventional2014-02-28Completed
The Analgesic Effect of Dexmedetomidine as an Adjunct to Local Anesthetics in Ultrasound-guided Interscalene Approach to Brachial Plexus Block for Shoulder Surgery: A Randomized Controlled Trial [NCT02225054]Phase 299 participants (Actual)Interventional2013-05-31Completed
Transversus Abdominis Plane Block During Kidney Transplant Surgery: Prospective Controlled Randomized Double-blind Trial Comparing Ropivacaine 0.2% With Placebo. [NCT02080728]Phase 450 participants (Actual)Interventional2013-07-23Completed
Comparison of Two Anesthetic Techniques in Blocking the Erector Plane of the Spine Bilateral in Cardiac Surgery: a Prospective Randomized Double-blinded Clinical Trial [NCT04313959]Phase 340 participants (Anticipated)Interventional2022-01-20Recruiting
Use of Tap Block in Patients After Hysterectomy [NCT02259374]54 participants (Anticipated)Interventional2014-10-31Not yet recruiting
Continuous Adductor Canal Block in Fast Track Total Knee Arthroplasty [NCT05962970]40 participants (Anticipated)Interventional2023-10-04Recruiting
Effect of the Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion on the Quality of Postoperative Recovery in Patients Undergoing VATS Lobectomy [NCT05930405]252 participants (Anticipated)Interventional2023-10-01Recruiting
A Volunteer Study to Determine the Anatomical Distribution of Injectate, the Extent of Sensory Block, and the Pharmacokinetics of Ropivacaine Following Erector Spinae Plane (ESP) Blocks. [NCT03476642]Phase 424 participants (Anticipated)Interventional2019-07-02Recruiting
A Randomized Control Trial Comparing Analgesic Benefits of Ultrasound-guided Single vs Continuous Quadratus Lumborum Blocks vs Intrathecal Morphine for Post Cesarean Section Pain [NCT04368364]Phase 43 participants (Actual)Interventional2020-05-22Terminated(stopped due to Study was stopped early due to a conflicting study in the same patient population at the study location.)
Prospective Randomized Clinical Trial to Evaluate the Use of Caudal Nerve Blocks in Adult Penile Prosthesis Surgery [NCT02740127]Phase 352 participants (Actual)Interventional2016-06-30Completed
Comparison of Epidural Labor Analgesia With Dexmedetomidine or Sufentanil [NCT03622047]1,800 participants (Anticipated)Interventional2018-08-15Recruiting
Transverse Versus Longitudinal Technique of Ultrasound-Guided Transmuscular Quadratus Lumborum Block:A Randomized Controlled Study Comparing Dermatomal Spread [NCT05001802]50 participants (Anticipated)Interventional2021-08-20Recruiting
Quadratus Lumborum Block Versus Erector Spinal Block - Comparison of the Effectiveness of the Analgesic Effect in Patients After Abdominal Surgery [NCT05446727]1,000 participants (Anticipated)Interventional2022-05-01Recruiting
Prevention of Pro-inflammatory Cytokines-associated Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block [NCT02144766]Phase 440 participants (Anticipated)Interventional2014-04-30Recruiting
Is PECS Block Equivalent to Paravertebral Block in Preventing Postoperative Pain After Breast Surgery? A Randomized, Controlled, Double-blind, Multicenter Trial [NCT02645474]Phase 486 participants (Anticipated)Interventional2018-01-01Recruiting
Efficacy of the 8th Cervical Nerve Root Block During Interscalene Brachial Plexus Block for Arthroscopic Shoulder Surgery: Prospective Randomized Controlled Study [NCT03487874]74 participants (Actual)Interventional2018-04-04Completed
Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Caesarean Section. A Double Blind, Randomized, Placebo Controlled Trial. [NCT03068260]Phase 472 participants (Actual)Interventional2017-03-15Completed
Ultrasound-guided Quadratus Lumborum Block for Postoperative Pain Control After Endoscopic Prostatectomy - Double Blinded, Placebo-controlled, Randomised Trial. [NCT03600129]50 participants (Actual)Interventional2018-07-25Completed
Peroperative Analgesia Following Cytoreductive Surgery. A Randomized, Double-blind, Comparison Between Intra-peritoneal Local Anesthesia and Placebo - Multicenter Study [NCT02256228]Phase 340 participants (Actual)Interventional2014-10-31Completed
The Effect of Tramadol on Interscalene Brachial Plexus Block With Ropivacaine in Shoulder Surgery. [NCT02182752]Phase 280 participants (Actual)Interventional2013-04-30Completed
Ropivacaine 0,2% Plus Dexamethasone Versus Ropivacaine 0,2% Plus Placebo in Modified Pectoral Block - a Randomized, Double-blind, Prospective Trial [NCT03700177]Phase 460 participants (Anticipated)Interventional2019-02-01Recruiting
0.25% Levobupivacaine Versus 0.375% Ropivacaine: a Comparative Study in Ultrasound-Guided Infraclavicular Brachial Plexus Block [NCT03679897]Phase 446 participants (Actual)Interventional2018-09-18Completed
Ultrasoundguided Transmuscular Quadratus Lumborum Block After Elective Laparoscopic Cholecystectomy. A Prospective, Randomized Clinical Trial. [NCT02225418]0 participants (Actual)Interventional2014-11-30Withdrawn(stopped due to Change of jobs)
The Use of Lumbar Erector Spinae Plane Block for Hip Arthroplasty at the L4 Interspace- a Randomized Controlled Study Comparing the 24-hour Opioid Requirements. [NCT03801863]65 participants (Actual)Observational2019-03-01Terminated(stopped due to "Study Administratively closed by Albert Einstein College of Medicine IRB as approval expired. PI no longer with institution. IRB approval expiry date used as Primary Completion date and Study Completion Date. Enrollment total derived from CTMS")
A Double-Blinded Randomized Controlled Trial Comparing the Adductor Canal Catheter (ACC) and Local Infiltration of Analgesia (LIA) Following Primary Total Knee Arthroplasty [NCT02603900]Phase 40 participants (Actual)Interventional2015-10-31Withdrawn
Therapeutic Effect of Botulinum Toxin A for the Treatment of Plantar Fasciitis. [NCT03054610]Phase 160 participants (Actual)Interventional2015-01-31Completed
Fascia Iliaca Compartment Block Versus Fentanyl for Positioning Patients With Hip Fractures for Central Nervous Blockade: a Randomized Trial. [NCT02037633]41 participants (Actual)Interventional2012-07-31Completed
Randomized Study of the Effect of Initial Ropivacaine Dosage During Continuous Popliteal Nerve Blocks on Rebound Pain in Foot and Ankle Surgery [NCT04872322]Phase 3128 participants (Anticipated)Interventional2017-08-31Enrolling by invitation
Adductor Canal Block: Single Injection vs Catheter for Pain Management of Total Knee Arthroplasty - A Randomized, Unblinded, Non-Inferiority Trial [NCT02798835]Phase 4180 participants (Actual)Interventional2016-07-31Completed
Effect of the Sheath of Rectus Abdominis Block Combined With the Transverse Plane Block on the Condition in Laparoscopic Gynecological Surgery. [NCT04850404]42 participants (Anticipated)Interventional2021-07-31Not yet recruiting
Combining Stellate Ganglion Block With Prolonged Exposure for PTSD: A Randomized Clinical Trial [NCT05889741]Phase 2140 participants (Anticipated)Interventional2024-01-31Not yet recruiting
Blood Ropivacaine Concentrations Following Unilateral Chest Wall Nerve Block and Continuous Infusion in Infants and Toddlers Undergoing Thoracotomies [NCT02860091]26 participants (Actual)Observational2018-10-01Active, not recruiting
Effects of Intra-Operative Ropivaciane Epidural Injection on Post-Operative Outcomes Following Elective Lumbar Fusion [NCT03035656]Phase 4228 participants (Anticipated)Interventional2019-03-01Not yet recruiting
Comparison of Local Anesthetic Infiltration, Trasversalis Fascia Block or Spinal Anesthesia for Inguinal Hernia Repair [NCT03128216]48 participants (Anticipated)Interventional2017-04-30Not yet recruiting
Comparison Between Femoral Nerve Block and Adductor Canal Block for Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Controlled Trial [NCT02604550]Phase 4115 participants (Actual)Interventional2015-11-30Completed
[NCT02084589]65 participants (Actual)Interventional2012-06-30Completed
Comparison of Transversus Abdominis Plane Block Versus Patient-controlled Epidural Analgesia for Patients on Buprenorphine or Methadone, After Cesarean Section [NCT02091297]0 participants (Actual)Interventional2014-04-30Withdrawn(stopped due to two other institutions that were in the center thought they weren't going to be able to recruit enough patients)
A Prospective, Randomized, Double-blind, Multicenter Trial on the Effects of the Early Femoral Nerve Block in Elderly With Hip Fracture [NCT03092466]600 participants (Anticipated)Interventional2017-02-26Recruiting
Comparison of Three Kinds of Postoperative Analgesia After Total Knee Arthroplasty :a Randomized Clinical Trial [NCT02094339]Phase 445 participants (Anticipated)Interventional2014-03-31Recruiting
Comparison of Two Kinds of Postoperative Analgesia After Amputation:a Randomized Clinical Trial [NCT02114463]Phase 436 participants (Anticipated)Interventional2014-03-31Recruiting
Ultrasound Guided Fascia Iliaca Block for Postoperative Analgesia After Elective Total Hip Arthroplasty [NCT02108847]42 participants (Actual)Interventional2014-04-30Completed
Quadratus Lumborum Block (QLB) With and Without Dexamethasone: the Effect on Postoperative Pain and Recovery After Laparoscopic Nephrectomy [NCT03339284]Phase 490 participants (Anticipated)Interventional2017-12-04Recruiting
Effect of Local Infiltration Anesthesia in a Hip Arthroplasty Fast Track Program. [NCT03513276]Phase 463 participants (Actual)Interventional2016-02-29Completed
Ultrasound-guided Continuous Femoral Nerve Block: The Influence of Catheter Orifice Configuration (Six-hole Versus End-hole) on Post-operative Analgesia After Total Knee Arthroplasty. A Randomized Trial. [NCT03376178]72 participants (Actual)Interventional2014-05-31Completed
Pain After Total Knee Arthroplasty: a Comparison of Combined Continuous Adductor Canal Block With Infiltration of Local Anesthetic Between the Popliteal Artery and Capsule of the Knee Block Versus Continuous Adductor Canal Block Alone on Postoperative Ana [NCT03921034]Phase 472 participants (Actual)Interventional2016-11-17Completed
COMBINATION OF CONTINUOUS FEMORAL BLOCK AND INTRAVENOUS PARECOXIB FOR POSTOPERATIVE ANALGESIA AFTER TOTAL KNEE ARTHROPLASTY. A DOUBLE BLIND PROSPECTIVE STUDY. [NCT02185924]Phase 2/Phase 390 participants (Actual)Interventional2009-01-31Completed
Effective Pain Management of Continuous Versus Single Shot Injection Interscalene Block During Shoulder Replacement Surgery [NCT02267044]76 participants (Actual)Interventional2014-08-31Completed
The Influence of the Femoral Nerve Block on the Quadriceps Strength After Total Knee Replacement [NCT01111513]135 participants (Actual)Interventional2007-11-30Completed
Monocentric, Non-blinded, Prospective Randomized Parallel Group Phase IV Clinical Study to Evaluate the Efficacy of Ultrasound Guided Single Shot Block of Nervus Tibialis Posterior for Postoperative Pain Relief After Hallux Valgus Surgery. [NCT02282956]Phase 460 participants (Anticipated)Interventional2014-10-31Recruiting
Quadratus Lumborum Nerve Blocks in Laparoscopic Myomectomy Patients [NCT03935815]Phase 126 participants (Actual)Interventional2019-05-01Terminated(stopped due to Closed prior to completion secondary to surgeon leaving UCLA)
Reducing Posterior Knee Pain Following Total Knee Arthroplasty Using an Intraoperative Posterior Cruciate Ligament (Transcruciate) Injection [NCT01345604]Phase 450 participants (Actual)Interventional2011-05-31Completed
The Analgesic Effect of Transversus Abdominis Plane (TAP) Block Versus Wound Infiltration Versus Placebo Following Open Radical Prostatectomy, a Double Blinded, Randomized Clinical Trial [NCT01317368]75 participants (Actual)Interventional2011-03-31Completed
The Effects of Difference in Pupil Size Between Bilateral Eyes on Cardiac Sympathetic Nervous Activity Following Interscalene Brachial Plexus Block [NCT03514342]48 participants (Actual)Observational2018-06-18Completed
Respiratory Impact of Local Anaesthetic Volume for an Interscalene Brachial Plexus Block With an Extrafascial Approach. [NCT04726280]Phase 460 participants (Actual)Interventional2021-02-01Completed
Pre-emptive Scalp Infiltration With Dexamethasone Lipid Microsphere Plus Ropivacaine for Postoperative Pain After Craniotomy [NCT04488315]Phase 4130 participants (Actual)Interventional2022-10-01Active, not recruiting
Comparison of Epidural Chloroprocaine 3% and Ropivacaine 0.75% for Unplanned Caesarean Section in Labouring Women Who Have an Epidural Catheter in Situ [NCT02919072]Phase 316 participants (Actual)Interventional2016-10-31Terminated(stopped due to The doctors involved in the study did not enroll any patients)
The Role of Nerve Blocks in Hip Arthroscopy [NCT03506620]Phase 40 participants (Actual)Interventional2019-01-31Withdrawn(stopped due to Unforeseen cost restrictions of the drug halted the execution of this study altogether.)
Ropivacaine Continuous Wound Infusion Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Delivery : A Randomized Controlled Trial [NCT03502642]Phase 460 participants (Actual)Interventional2017-05-29Completed
The Study of Ropivacaine Median Effective Concentration in Ultrasound-guided Supraclavicular Brachial Plexus Block [NCT02323282]Phase 460 participants (Anticipated)Interventional2014-10-31Recruiting
PEF-Block & Ribs Fractures Effect of Posterior Exo-thoracic Fascia Block in the Pain Management of Ribs Fractures: a Prospective, Randomized Study [NCT03396692]90 participants (Actual)Interventional2018-06-18Completed
The Efficacy of Adductor-Canal-Blockade on Pain and Morphine Consumption After Total Knee Arthroplasty [NCT01261897]Phase 440 participants (Anticipated)Interventional2011-01-31Completed
Ropivacaine 0.75% Versus Levobupivacaine 0.5% for Conversion of Labour Epidural to Surgical Anaesthesia for Emergency Caesarean Section. [NCT01160965]Phase 40 participants (Actual)Interventional2012-08-31Withdrawn(stopped due to Not able provide staff for recruting at present)
Evaluation of the Postoperative Analgesic Efficacy of Bilateral Superficial Cervical Block for Thyroidectomy and Mini Incision Under General Balanced Anesthesia: a Randomized, Triple Masked, Placebo Controlled Trial. [NCT01171885]Phase 4120 participants (Anticipated)Interventional2009-07-31Recruiting
Postoperative Analgesia After Cardiac Surgery: Effects of a Continuous Infusion of Ropivacaine Through Laterosternal Catheters [NCT01196767]Phase 440 participants (Actual)Interventional2010-07-31Completed
Analgesic Effects of Caudal S-ketamine for Supplementation of Ropivacaine Caudal Analgesia in Children With Hypospadias [NCT05922605]Phase 444 participants (Anticipated)Interventional2023-06-20Recruiting
Effectiveness of Pericapsular Nerve Group (PENG) Block Combined to Lateral Femoral Cutaneous Nerve (LFCN) Block on the Quality of Recovery After Total Hip Replacement [NCT04245280]74 participants (Anticipated)Interventional2021-05-04Recruiting
Pain Control After Total Knee Arthroplasty: A Prospective, Double-blind Randomized Controlled Trial Examining the Benefit of a Combined Adductor-canal Nerve Block With Periarticular Infiltration Versus Periarticular Injection Alone [NCT02740192]Early Phase 1128 participants (Actual)Interventional2016-04-30Completed
Postoperative Analgesia With Local Infiltration After Hip Fracture Of Intertrochanteric Type [NCT01119209]Phase 474 participants (Actual)Interventional2008-02-29Completed
Incidence of Urethrocutaneous Fistula Following Distal Hypospadias Repair With and Without Caudal Epidural Block - A Pilot Study [NCT03812731]30 participants (Actual)Interventional2019-02-22Completed
Lumbar Transversus Abdominal Plane (TAP) Block: Does Volume Make a Difference? [NCT01307215]31 participants (Actual)Interventional2011-04-30Completed
Does Caudal Block Increase the Incidence of Urethrocutaneous Fistula Formation Following Hypospadias Repair in Infants? A Multi-center Prospective Randomized Trial. [NCT02861950]Phase 4490 participants (Anticipated)Interventional2017-05-24Active, not recruiting
Extension of the Analgesia of an Interscalene Block of the Brachial Plexus by Combined Injection of Dexamethasone and Dexmedetomidine, After Arthroscopic Shoulder Surgery: Randomized, Controlled, Double-blind Trial [NCT04394481]Phase 4122 participants (Actual)Interventional2020-09-28Completed
Does the Addition of Liposomal Bupivacaine to the Adductor Canal Block Impact Narcotic Use After Primary Total Knee Arthroplasty: a Prospective, Blind Randomized Control Trial [NCT04539730]Phase 40 participants (Actual)Interventional2021-12-01Withdrawn(stopped due to Did not acquire funding to pursue study)
Analgesia by Transversus Abdominis Plane Nerve Block in Patients Undergoing Liver Resection [NCT02527577]39 participants (Actual)Interventional2010-04-30Terminated(stopped due to difficulties to recruit patients)
Influence of Intra-abdominal Ropivacaine 0.5% Spray on Postoperative Analgesia in Laparoscopic Surgery. [NCT05173090]120 participants (Anticipated)Interventional2022-01-15Not yet recruiting
SERRATHOR Trial : Analgesic Effect of Serratus Plane Block After Video-Assisted Thoracoscopic Surgery Lobectomy [NCT03867695]130 participants (Anticipated)Interventional2019-07-31Not yet recruiting
Comparison of Analgesic Efficacy of Local Wound Infiltration Plus Transversus Abdominis Plane Block and Local Wound Infiltration Only After Laparoscopic Colorectal Resection: a Randomized, Double-blind, Non-inferiority Trial [NCT03376048]108 participants (Actual)Interventional2017-12-20Completed
Catheter-based Peripheral Regional Anesthesia After Orthopedic Surgery to the Foot or Ankle: Comparison of Low Dose, Automated Periodic Infusions With Conventional High Dose, Continuous Infusion, and Patient-initiated Infusions Only [NCT03372304]Phase 485 participants (Actual)Interventional2017-11-29Completed
Analgesic Requirements for Post-operative Pain Control in Total Shoulder Replacement Patients: Comparison of Interscalene Single Shot Exparel (Bupivacaine Liposome) Injections to Cervical Paravertebral Catheter With Ropivacaine (0.2% Continuous Infusion) [NCT03739021]Phase 2/Phase 360 participants (Anticipated)Interventional2019-11-30Not yet recruiting
Is Postoperative Quality of Recovery After Unilateral Nephrectomy Related to the Type of Anesthesia and Analgesia? [NCT04521556]Phase 480 participants (Actual)Interventional2019-04-01Completed
The Effects of Clonidine on Postoperative Analgesia After Single Shot Femoral Nerve Block Following Arthroscopic Knee Surgery in Children [NCT01293149]Phase 20 participants (Actual)Interventional2011-04-30Withdrawn
The Efficacy of Adductor-Canal-Blockade on Pain and Morphine Consumption After Revision Knee Arthroplasty [NCT01191593]Phase 436 participants (Actual)Interventional2010-09-30Completed
Erector Spinae Plane Block for Video-assisted Thoracoscopic Surgery: a Randomized Controlled Trial [NCT03628040]Phase 382 participants (Anticipated)Interventional2019-09-01Not yet recruiting
Randomized Clinical Trial: Transverse Abdominis Plane Block Versus no Block in Laparoscopic Ventral Hernia Repair [NCT03342040]90 participants (Actual)Interventional2017-10-15Completed
Randomized Trials of Epidural Combined With General Anesthesia Versus General Anesthesia Alone to Evaluate the Changes of Blood Flow in Arterial Anastomosis of Free Flap Using Duplex Ultrasonography [NCT03330808]52 participants (Actual)Interventional2017-10-28Completed
WALANT Technique (Wide Awake Local Anesthesia No Tourniquet) in Association With Analgesic Troncular Blocks at the Wirst for Carpal Tunnel Release. [NCT04494100]60 participants (Actual)Interventional2020-09-11Completed
Comparison of Two Volumes of Local Anesthetics on the Efficiency and Safety of Stellate Ganglion Block for the Treatment of Complex Regional Pain Syndrome of the Arm [NCT03316066]0 participants (Actual)Interventional2018-10-20Withdrawn(stopped due to Not able to recruit enough patients)
Formulations of Liposomal Local Anesthetics for Dental Anesthesia [NCT01307969]Phase 140 participants (Actual)Interventional2007-02-28Completed
Effect of Intravenous Paracetamol in Combination With Caudal Ropivacaine on Quality of Postoperative Recovery in Paediatric Patients Undergoing Hypospadias Repair [NCT03781505]Phase 464 participants (Anticipated)Interventional2019-01-31Recruiting
The Effect of Fascia Iliaca Compartment Block in Acute and Chronic Pain Management in Hip Fracture Patients [NCT02479828]198 participants (Actual)Interventional2015-06-30Completed
Pericapsular Nerve Group Block: An Imaging Study for Determination of the Spread of the Injectate Using 3-D CT Scan [NCT06062134]10 participants (Actual)Interventional2023-05-15Completed
Effect of Dexmedetomidine Plus Ropivacaine Versus Sufentanil Plus Ropivacaine for Epidural Labor Analgesia on Neonatal Outcomes: a Pilot Randomized Trial [NCT05698407]Phase 4200 participants (Anticipated)Interventional2023-03-16Recruiting
Laparoscopic vs Ultrasound-Guided Transversus Abdominis Plane Block in Minimally Invasive Colon Surgery: A Randomized Controlled Multicentre Clinical Trial [NCT04311099]Phase 4360 participants (Anticipated)Interventional2021-01-14Recruiting
Labor Analgesia With Ropivacaine Added to Clonidine. A Randomized Clinical Trial [NCT00626977]32 participants (Actual)Observational2000-05-31Completed
Efficacy of the Intralesional Infusion of Local Anesthetic and Steroids After Major Abdominal Surgery: a Randomized Double Blind Phase III Trial [NCT02002663]Phase 3120 participants (Actual)Interventional2013-08-31Completed
Study of Ultrasound-guided Thoracic Paravertebral Block Using Ropivacaine With/Without Dexamethasone in Elective Thoracotomy [NCT02871193]68 participants (Actual)Interventional2016-06-01Completed
Testing Regional Anesthesia Techniques for Up and Early Discharge Following Knee Arthroplasty: Quality Of Recovery Through Patient Reporting - a Multisite Study [NCT06054750]Phase 4226 participants (Anticipated)Interventional2024-01-01Not yet recruiting
Efficacy of Pericapsular Nerve Group Block After Total Hip Arthroplasty Surgery [NCT04295408]60 participants (Anticipated)Interventional2020-04-01Recruiting
Spinal Analgesia Versus Epidural Analgesia in Minor Laparotomic Liver Surgery in an Enhanced Recovery Programme: A Randomized Controlled Trial [NCT02647047]40 participants (Anticipated)Interventional2016-01-31Not yet recruiting
A Randomized Controlled Trial Comparing Intrathecal Morphine With Quadratus Lumborum Block as Part of a Multimodal Analgesia Strategy for Post-cesarean Delivery Analgesia [NCT02871713]76 participants (Anticipated)Interventional2017-05-30Recruiting
Pre-emptive Scalp Infiltration With Dexamethasone Plus Ropivacaine for Post-Craniotomy Pain in Children [NCT04051723]Phase 480 participants (Actual)Interventional2019-09-02Completed
Transmuscular Quadratus Lumborum Block for Postoperative Pain After Total Abdominal Hysterectomy [NCT02586454]64 participants (Actual)Interventional2015-11-30Completed
The Use of Liposomal Bupivacaine Interscalene Brachial Plexus Block for Rotator Cuff Surgery: A Randomized, Double Blind, Clinical Trial [NCT04047745]132 participants (Anticipated)Interventional2019-09-30Not yet recruiting
Serratus Anterior Plane Block or Erector Spinae Plane Block Used as an Adjuvant for Hybrid Arrhythmia Ablation Surgery [NCT04868058]132 participants (Anticipated)Interventional2019-11-01Recruiting
Effects of Dexmedetomidine as an Adjunctive Analgesic Used in Continuous Thoracic Paravertebral Blocks for Post-thoracotomy Pain Syndrome [NCT02619513]Phase 460 participants (Actual)Interventional2014-12-31Completed
Postoperative Analgesia With Local Infiltration After Periacetabular Osteotomy For The Treatment Of Dysplasia [NCT00815503]Phase 470 participants (Actual)Interventional2009-01-31Completed
Intraoperative Use of Perineal Block for Hemorrhoidectomy [NCT04288349]100 participants (Anticipated)Interventional2020-02-20Recruiting
Efficacy and Safety of Periarticular Multimodal Drug Injections in Total Knee Arthroplasty [NCT00901628]Phase 4101 participants (Actual)Interventional2008-04-30Completed
Randomized Clinical Trial to Evaluate the Efficacy of Levobupivacaine 0.125% vs Ropivacaine 0.2%, in Hemodynamic Alterations in Pregnant Women in Labor and Their Fetal Repercussions [NCT05877131]Phase 440 participants (Anticipated)Interventional2023-06-01Not yet recruiting
The Pharmacokinetic of Ropivacaine in Patients Undergoing Ultrasound-guided Continuous Thoracic Paravertebral Block [NCT03721406]20 participants (Actual)Interventional2019-10-08Completed
Comparative Study Between Systemic Analgesia and Continuous Sciatic Nerve Block in Patients With Chronic Obstructive Arterial Disease and Ischemic Pain in Lower Limbs [NCT02841488]Phase 356 participants (Anticipated)Interventional2016-09-30Not yet recruiting
Management of Pain Post Hepatectomy : Infiltration of Local Anesthetics Versus Continuous Spinal Analgesia . [NCT03238430]Phase 2/Phase 3186 participants (Actual)Interventional2015-05-20Completed
Local Analgesia in Laparoscopic Surgery [NCT02826876]100 participants (Anticipated)Interventional2016-07-31Not yet recruiting
Prospective, Two-center , Randomized, ITT , Parallel Group Evaluating the Interest of the Instillation of Saline Intraperitoneally (INSI ) Versus Instillation of Naropin the Surgical Site Versus Lung Recruitment Maneuvers ( PVM ) in the Management of Pain [NCT02819544]Phase 30 participants (Actual)Interventional2016-09-30Withdrawn(stopped due to investigator choice)
Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Percutaneous Nephrolithotomy [NCT02818140]Phase 460 participants (Actual)Interventional2016-07-31Completed
Study of Caudal Ropivacaine With or Without Dexmedetomidine for Postoperative Analgesia in Pediatric Infra-umbilical Surgery: A Double-blinded Randomized Control Trial [NCT05979558]62 participants (Actual)Interventional2020-06-16Completed
[NCT00864409]Phase 412 participants (Anticipated)InterventionalRecruiting
The Effects of Dexamethasone on the Duration of Sciatic Nerve Blocks [NCT00616603]43 participants (Actual)Interventional2007-08-31Terminated(stopped due to PI is no longer here.)
Dexamethasone Compared With Dexmedetomidine as an Adjuvant to Ropivacaine for Supraclavicular Brachial Plexus Block [NCT02787018]Phase 3120 participants (Actual)Interventional2016-06-30Completed
The Intertransverse Process Block - Single or Multiple Injection? A Randomised, Procedure Related, Blinded Crossover Trial in Healthy Volunteers [NCT05753397]Phase 412 participants (Anticipated)Interventional2023-02-26Recruiting
Effectiveness of TAP (Transversus Abdominis Plane) Block for Postoperative Pain Relief After Abdominal Aortic Surgery [NCT05860452]40 participants (Anticipated)Interventional2023-06-01Recruiting
Evaluation of the Analgesic Effect of Ropivacaine in Topical Use at the Thin Skin Graft Donor Site [NCT01999153]Phase 388 participants (Anticipated)Interventional2013-12-31Recruiting
Comparison of Intravascular Injection Rates During Cervical and Lumbar Medial Branch Block Using Touhy or Quincke Type Needle [NCT05031936]67 participants (Actual)Interventional2021-08-12Completed
A Multicenter Randomized Controlled Trial in Elderly Patients With Hip Fractures Comparing Continuous Fascia Iliaca Compartment Block to Systemic Opioids and Its Effect on Delirium Occurrence [NCT02689024]Phase 4239 participants (Actual)Interventional2016-05-31Terminated(stopped due to recruitment too slow; intervention was standard care in patients who were not included; acute care pathways changed due to policy regarding hip fracture patients)
Efficacy of Compound Betamethasone Injection Combined With Ropivacaine in Ultrasound-guided Thoracic Paravertebral Nerve Block for Chronic Post-thoracotomy Pain [NCT05175001]Phase 4100 participants (Anticipated)Interventional2021-05-01Recruiting
Improvement of Analgesia With Addition of Pectoral Nerve Block to Thoracic Paravertebral Blocks in Unilateral Total Simple Mastectomy [NCT01943240]Phase 40 participants (Actual)Interventional2014-03-31Withdrawn(stopped due to Insufficient population of eligible patients; none enrolled)
The Effect of Dexamethasone Used Together With Low Volume Ropivacaine in a Single Shot Interscalene Block on the Pain Free Time Experienced by the Patient [NCT02178449]Phase 4109 participants (Anticipated)Interventional2014-03-31Recruiting
Erector Spinae Plane Block Versus Control for Pain Control Following Percutaneous Nephrolithotomy: A Randomized, Double-Blind, Placebo Controlled Study [NCT05024344]128 participants (Anticipated)Interventional2021-08-09Recruiting
The Influence of Different Doses of Local Anesthetic on the Distribution of Anesthesia of the Lateral Femoral Cutaneous Nerve - a Randomized, Blinded, Paired Study of Healthy Individuals [NCT03138668]Phase 220 participants (Actual)Interventional2017-05-19Completed
Ultrasound-guided Brachial Plexus Block With the Single-penetration Multiple-injection-technique for Upper Extremity Surgery [NCT01993290]120 participants (Anticipated)Interventional2013-04-30Completed
Comparative Evaluation of Newer Congeners i.e. Levobupivacaine and Ropivacaine With Bupivacaine, in Lumbar Epidural Anaesthesia for Hip Surgeries [NCT02513433]90 participants (Actual)Interventional2012-12-31Completed
Improving Perioperative Pain Management for Laparoscopic Surgery Due to Colon Cancer Using the Ultrasound-guided Transmuscular Quadratus Lumborum Block. A Double Blind, Randomized, Placebo Controlled Trial. [NCT03570541]Phase 469 participants (Actual)Interventional2018-06-28Completed
Peritoneal Nebulization of Ropivacaine for Postoperative Pain Control After Laparoscopic Cholecystectomy [NCT01143025]Phase 3165 participants (Anticipated)Interventional2010-03-31Completed
Effects of Methylprednisolone Plus Ropivacaine Infiltration Before Wound Closure on Laminoplasty or Laminectomy [NCT04493463]Phase 4132 participants (Actual)Interventional2020-07-31Completed
Does Perineural Dexmedetomidine Prolong the Duration of an Adductor Canal Block When Controlling for a Systemic Effect? - A Randomised Paired Trial in Healthy Volunteers. [NCT02488473]Phase 221 participants (Actual)Interventional2015-08-31Completed
Investigating Systemic Effects of Lidocaine Infusion for Transversus Abdominis Plane (TAP) Block Catheter [NCT03971708]80 participants (Actual)Interventional2015-06-30Completed
Dexamethasone as Adjuvant to Ropivacaine in Wound Infiltration for Postoperative Analgesia Following Spinal Surgery: A Randomized, Double-Blinded, Controlled Trial [NCT05871073]Phase 460 participants (Actual)Interventional2023-01-01Completed
Efficacy of the Anterior Quadratus Lumborum Block Versus the Transversus Abdominis Plane Block for Elective Laparoscopic Inguinal Hernia Repair: A Randomized Controlled Trial [NCT03023462]60 participants (Actual)Interventional2019-09-05Completed
Total Knee Arthroplasty & Outcome: A Prospective Randomized Comparison Between Adductor Canal Block and Femoral Nerve Block [NCT02082067]Phase 40 participants (Actual)Interventional2014-03-31Withdrawn
Effectiveness of Ultrasound-guided Scalp Block for Supratentorial Craniotomy: a Randomised, Double-blind, Placebo-controlled Trial [NCT06127628]60 participants (Anticipated)Interventional2023-12-31Not yet recruiting
The Safety of Ropivacaine Transversus Abdominis Plane Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer Surgery: a Single Center, Open Label Dose Escalation Study [NCT06006026]9 participants (Actual)Interventional2023-08-28Completed
Testing the Feasibility of Using Ropivacaine in Spinal Anesthesia for Patients With Lower Back Surgery [NCT05824338]Early Phase 145 participants (Anticipated)Interventional2024-01-01Not yet recruiting
Periarticular Bupivacaine + Meloxicam ER Solution Versus Standard Practice During Total Knee Arthroplasty: A Single Institution, Single-blinded, Randomized Clinical Trial [NCT05188053]Phase 498 participants (Anticipated)Interventional2022-02-07Enrolling by invitation
Postoperative Analgesia With a Catheter Under the Erector Spinae Muscle for Videothoracoscopic Lung Surgery [NCT04665531]50 participants (Actual)Interventional2020-02-19Completed
Comparison of a Single Shot Femoral Nerve Block to Femoral Nerve Block Shot Plus Continuous Femoral Nerve Catheter for Total Knee Replacement Surgery; a Randomized, Blinded Controlled Trial. [NCT02106481]99 participants (Actual)Interventional2014-04-30Completed
Randomized Controlled Study: Comparison of Continuous Femoral Nerve Block and Adductor Canal Block After Total Knee Replacement Therapy Relating to Early Mobilization and Analgesia [NCT02125903]44 participants (Actual)Interventional2013-05-31Completed
Assessment of Subarachnoid Anesthesia With Low Dose of Pethidine and Combination of Ropivacaine With Fentanyl for Urologic Surgical Operations. [NCT03260283]Phase 2/Phase 3104 participants (Actual)Interventional2017-08-16Completed
Comparison of Paracoracoid Subscapularis Plane Block to Interscalene Block for Arthroscopic Shoulder Surgery [NCT03073928]120 participants (Anticipated)Interventional2017-06-15Recruiting
Incidence of Transient Horner's Syndrome Following Thoracic Epidural Anesthesia for Mastectomy [NCT02130739]450 participants (Actual)Observational [Patient Registry]2010-09-30Completed
Evaluating Ropivacaine and Lidocaine in the Endotracheal Tube Cuff on Post-Operative Sore Throat Incidence and Severity - A Randomized Clinical Trial [NCT03563963]63 participants (Actual)Interventional2018-08-01Completed
Efficacy of Peri-Incisional Multimodal Drug Injection Following Operative Management of Femur Fractures: A Randomized Controlled Trial [NCT02793947]Phase 4102 participants (Actual)Interventional2015-05-31Completed
Up-down Sequential Allocation Study to Determine the Optimal Volume, Rate, and Interval of Bolus of Ropivacaine 0.2% in Interscalene Continuous Nerve Catheters for Shoulder Surgery [NCT02946268]Phase 40 participants (Actual)Interventional2017-02-21Withdrawn(stopped due to Insufficient staff)
Comparison of Long Acting vs. Short Acting Anesthetic Agents as a Tool for Improving Pain Management Post Ultrasound Guided Breast Biopsy [NCT02085239]Phase 40 participants (Actual)Interventional2013-08-31Withdrawn(stopped due to Study never got started; can't delete results)
A Comparison of Different Concentration Ropivacaine Combination With Fentanyl for Patient-controlled Epidural Analgesia After Cesarean Delivery [NCT03195309]Phase 1/Phase 2120 participants (Anticipated)Interventional2017-01-20Active, not recruiting
Does Perineural Clonidine Prolong the Duration of an Adductor Canal Block When Controlling for a Systemic Effect? - A Randomised Paired Trial in Healthy Volunteers. [NCT02444559]Phase 221 participants (Actual)Interventional2015-05-31Completed
Effectiveness of Bilateral Erector Spinae Plane Block (ESPB) in Laparoscopic Colectomies -A Randomized, Controlled, Double Blind, Prospective Trial [NCT04879004]40 participants (Anticipated)Interventional2021-01-01Recruiting
Ultrasound Guided 0.25% Ropivacaine Transversus Abdominis Plane Block in Addition to Intrathecal Morphine and Multimodal Analgesia for the Management of Postoperative Pain Among Women Undergoing Cesarean Delivery. [NCT01261637]Phase 486 participants (Actual)Interventional2009-07-31Completed
Effect of Different Labour Analgesics on Maternal UtA, Fetal UA and MCA Blood Flow Index Observed by Doppler Ultrasonography:a Prospective Randomized Double-blinded Controlled Trial [NCT06099938]90 participants (Actual)Observational2021-03-01Completed
Superficial Cervical Plexus Blockade for Clavicle Fracture Analgesia [NCT03187899]Phase 30 participants (Actual)Interventional2018-04-30Withdrawn(stopped due to Principal investigator was unable to pursue research further due to time constraints.)
Ropivacaine Use in Interscalene Block; What is the Minimal Effective Analgesic Concentration (MEAC 90) [NCT04833296]Phase 445 participants (Anticipated)Interventional2021-05-01Not yet recruiting
Application of Transversus Thoracis Muscle Plane Block Plus Rectus Sheath Block in the Perioperative Pain Management of Cardiac Surgery : Study Protocol of a Randomized Double-blind Controlled Trial [NCT04838132]80 participants (Anticipated)Interventional2021-03-16Recruiting
Comparing the Analgesic Effects of Ultrasonography-guided and Direct-surgical Rectus Sheath Block in Single-port Access Laparoscopy Patients [NCT02431065]Phase 230 participants (Anticipated)Interventional2015-05-31Not yet recruiting
Efficacy of Multimodal Periarticular Injections in Operatively Treated Ankle Fractures: A Randomized Controlled Trial [NCT02967172]Phase 4100 participants (Actual)Interventional2016-10-31Completed
Efficacy of Compound Betamethasone Injection Combined With Ropivacaine in Ultrasound-guided Slit Intercostals Nerve Block for Chronic Post-thoracotomy Pain:A Single Blind Randomized Control Trial [NCT05556122]100 participants (Anticipated)Interventional2022-07-04Recruiting
Transversus Abdominis Plane Block With or Without Buprenorphine After Inguinal Hernia Surgery [NCT05549492]Phase 164 participants (Actual)Interventional2021-01-01Completed
Ultrasound Guided Thoracic Erector Spinae Plane Blocks Within an Enhanced Recovery Program Decreases Opioids Consumption and Improves Patient Postoperative Rehabilitation After Open Cardiac Surgery: A Controlled Before-After Study [NCT03541837]40 participants (Actual)Interventional2017-10-20Completed
Comparison of the Hemodynamic Effect Between the Paravertebral Block and Thoracic Epidural in Esophageal Surgery With Thoracotomy . [NCT03185403]54 participants (Actual)Interventional2013-12-31Completed
Effects of Thoracic Epidural Administered Ropivacaine Versus Bupivacaine on Lower Urinary Tract Function: A Randomized, Controlled Study [NCT02414373]Phase 442 participants (Actual)Interventional2015-04-30Completed
Comparison Between Single-shot Femoral Nerve Block and Epidural Techniques for Total Knee Arthroplasty: a Randomized Controlled Trial [NCT02164825]60 participants (Actual)Interventional2014-01-31Completed
Intraoperative Wound Infiltration With Local Anaesthetic in Surgical Patients; Is There Any Late Effect on the Postoperative Pain and the Requirements of Analgesia ? A Randomized Control Trial. [NCT02171299]400 participants (Actual)Interventional2012-09-30Completed
Improving ObsQoR-11 With Continuous Wound Infusion Versus Intrathecal Morphine After Elective Cesarean Delivery: A Randomized Double-Blinded Controlled Trial Targeting Patients' Recovery and Satisfaction [NCT05696678]96 participants (Anticipated)Interventional2023-02-28Not yet recruiting
Postoperative Analgesia After Caesarean Section Under ALR: TAP Block Versus Catheter Scar Infiltration [NCT02184559]Phase 360 participants (Anticipated)Interventional2012-02-29Recruiting
Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty [NCT02933671]Phase 411 participants (Actual)Interventional2017-08-01Terminated(stopped due to Study halted prematurely and will not resume; participants are no longer being examined or receiving any intervention.)
Interspace Between the Popliteal Artery and Capsule of the Posterior Knee (iPACK) Block for Postoperative Rehabilitation in Total Knee Arthroplasty: a Randomized Control Trial [NCT06087562]Phase 4350 participants (Anticipated)Interventional2020-06-16Active, not recruiting
Quadratus Lumborum vs Erector Spinae Supplementary Blocks With Lumbar Plexus Blocks for Hip PAO [NCT04481451]Phase 4156 participants (Anticipated)Interventional2020-12-01Recruiting
Interpectoral and Pectoserratus Plane Block vs Local Anesthetic Infiltration for Partial Mastectomy - a Prospective Randomized Trial [NCT04824599]60 participants (Actual)Interventional2021-02-19Completed
The Effect of Continuous Femoral Nerve Block With Modulation of Depth of Anesthesia on Prognosis of Patients Receiving Total Knee Arthroplasty [NCT02576015]380 participants (Anticipated)Interventional2016-03-31Not yet recruiting
Adductor Canal Block With Continuous Infusion Versus Intermittent Boluses and Morphine Consumption: A Randomized, Triple-masked, Controlled Study [NCT02539628]Phase 4110 participants (Actual)Interventional2015-03-31Completed
Interest of Continuous Ropivacaine Administration Through an Elastomeric Pump (Pain Buster ) for the Surgery of Latissimus Dorsi and Serratus Micro Anastomotic Flaps [NCT00724685]Phase 434 participants (Actual)Interventional2008-01-31Terminated
Postoperative Pain Management Following Total Hip Arthroplasty. A Comparison Between Local Infiltration Analgesia and Ultrasound Guided 3-in-1 Block [NCT02568995]Phase 355 participants (Actual)Interventional2014-05-31Completed
Trans-Abdominis Plane Block Efficacy for Post-Cesarean Section Pain: A Randomized Double-Blinded Case Control Trial [NCT00945620]0 participants (Actual)Interventional2009-09-30Withdrawn(stopped due to PI was unable to locate appropriate population)
New Truncal Nerve Blocks for Thoracoscopic Surgery and Open Heart Surgery. [NCT03704753]Phase 4200 participants (Anticipated)Interventional2019-01-25Recruiting
Effect of the Injection of Local Analgesia With Epinephrine During Total Hip Arthroplasty on the Blood Losses Per and Operatively. [NCT00980616]Phase 2150 participants (Actual)Interventional2009-09-30Completed
Postoperative Pain After Pediatric Umbilical Hernia Repair: a Randomized Clinical Trial of Ultrasound-guided Bilateral Rectus Sheath Blocks Versus Local Anesthetic Infiltration [NCT01015053]53 participants (Actual)Interventional2009-11-30Completed
Addition of Popliteal Plexus Block to Continuous Femoral Nerve Block for Total Knee Arthroplasty [NCT04048889]66 participants (Anticipated)Interventional2019-07-22Recruiting
Local Infiltration Analgesia With Ropivacaine, Ketorolac and Epinephrine Intra- and Postoperatively in Total Knee Arthroplasty [NCT00799175]48 participants (Actual)Interventional2007-04-30Completed
Local Infiltration Analgesia or Intrathecal Morphine in Total Knee Arthroplasty [NCT00992082]50 participants (Anticipated)Interventional2009-08-31Recruiting
Continuous Thoracic Paravertebral Block for Open Hepatectomy [NCT03990922]76 participants (Actual)Interventional2019-06-20Completed
Perioperative Analgesia by Femoral Perineural Catheter for Femoral Neck Fracture - Study KTcol - [NCT01052974]Phase 460 participants (Actual)Interventional2009-03-26Completed
Ideal Initial Bolus and Infusion Rate for Erector Spinae Plane Block Catheters [NCT03961048]Phase 40 participants (Actual)Interventional2019-07-23Withdrawn(stopped due to Change in hospital protocol)
Prospective Randomized Clinical Trial Comparing Infraclavicular Versus Axillary Approach to Brachial Plexus Block. [NCT02208245]46 participants (Anticipated)Interventional2014-02-28Active, not recruiting
Postoperative Pain Treatment in Total Hip Arthroplasty A Randomized Double-blinded Placebo-controlled Study to Assess the Effect of Local Analgesia [NCT00603083]Phase 460 participants (Actual)Interventional2008-01-31Completed
Effect of Systemic Ropivacaine on Hyperalgesia, Flare Reaction and Peripheral [NCT00900913]Phase 434 participants (Anticipated)Interventional2010-01-31Completed
Phase 3 Prospective, Randomized, Controlled and Double-blinded Second Trial on Pain Relief by Continuous Intra-peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia, During Gynecological Laparoscopic Surgery [NCT00927979]Phase 340 participants (Actual)Interventional2009-06-30Completed
[NCT02813018]50 participants (Actual)Interventional2016-07-07Completed
Intermittent Bolus Administration of Ropivacaine for Epidural Labor Analgesia : an Observational Study [NCT02809742]500 participants (Actual)Observational2016-05-31Completed
Effectiveness of Intraoperative Exparel, a Bupivacaine Liposome Injectable Suspension, for Postoperative Pain Control in Total Knee Arthroplasty: A Prospective, Randomized, Double Blind, Controlled Study [NCT02808728]Phase 4100 participants (Actual)Interventional2014-05-31Active, not recruiting
Erector Spinae Plane Block Versus Intrapleural Intercostal Plane Block for Post-thoracotomy Pain: a Randomized Trial [NCT04013815]60 participants (Actual)Interventional2019-08-01Completed
The Prevention of Hypotension After Epidural Analgesia After Major Surgery by Adding Epinephrine to Infusions to Counteract Sympathectomy: a Double- Blind, Controlled, Randomized, Prospective Dose-finding Study [NCT02722746]66 participants (Actual)Interventional2016-11-15Completed
Efficacy of Multimodal Peri- and Intraarticular Drug Injections in Total Knee Arthroplasty [NCT00562627]Phase 4102 participants (Actual)Interventional2007-11-30Completed
EVALUATION OF ORAL USE OF DEXKETOPROFEN/TRAMADOL IN ACUTE POSTOPERATIVE PAIN IN PATIENTS UNDERGOING TOTAL HIP REPLACEMENT WITH A MINIMALLY INVASIVE ANTERIOR APPROACH (AMIS). [NCT04178109]Phase 2226 participants (Actual)Interventional2019-01-10Completed
Comparison of the Sensitive Cutaneous Block Distribution Following Femoral Nerve Block Using an Ultrasound Plus Neurostimulator Technique Versus an Approach Based on the Localization of the Femoral Artery. [NCT02721290]80 participants (Anticipated)Interventional2016-01-31Recruiting
Comparing the Delivery of Local Anesthetic by Programmed Intermittent Bolus Versus Continuous Infusion Through a Popliteal Sciatic Nerve Catheter for Analgesia Following Major Ankle Surgery [NCT02707874]Phase 460 participants (Anticipated)Interventional2014-10-31Recruiting
Postoperative Analgesia After Thoracotomy Without Thoracic Epidural Analgesia : Paravertebral Analgesia With a Catheter Associated With Intravenous Morphine Patient-controlled-analgesia (Pca) [NCT00620490]Phase 360 participants (Actual)Interventional2008-03-31Completed
[NCT02848157]Phase 440 participants (Actual)Interventional2016-06-17Completed
Effects of the Pectoral Blocks in the Prosthetic Breast Expansion Surgery : Prospective, Randomized, Double Blind Study. [NCT02682186]Phase 374 participants (Actual)Interventional2016-02-01Completed
Serratus Plane Block for the Prevention of Chronic Pain After Breast Cancer Surgery [NCT02838173]110 participants (Anticipated)Interventional2016-07-31Not yet recruiting
The Effect of the Body Temperature 0.75% Ropivacaine on the Time to Convert Labour Epidural Analgesia to Anaesthesia for Surgical Delivery [NCT02838329]90 participants (Anticipated)Interventional2016-07-31Recruiting
Parturient Satisfaction With Epidural Analgesia During Parturient Controlled Pump [NCT06094946]100 participants (Anticipated)Observational2023-12-31Not yet recruiting
Liposomal Bupivacaine/Bupivacaine A Single-Dose Bilateral Rectus Sheath Blocks Vs. Ropivacaine in Bilateral RS Blocks And Catheters, Comparing Pain Scores And Opioid Use Following Open Abdominal Vascular Surgery [NCT05972018]Phase 450 participants (Anticipated)Interventional2023-10-18Recruiting
Erector Spinae Plane Block for Uncomplicated Renal Colic [NCT05625802]Phase 260 participants (Anticipated)Interventional2023-02-08Recruiting
Impact of Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain in the Setting of Endoscopic Sinonasal Surgery. [NCT02821169]Phase 3184 participants (Actual)Interventional2015-04-30Completed
Comparison of Pudendal Nerve Block With Ropivacaine and Intravenous Tramadol for Prevention of Catheter-related Bladder Discomfort: a Randomized Controlled Trial [NCT02683070]94 participants (Anticipated)Interventional2016-03-31Not yet recruiting
Postoperative Pain in Children With Cerebral Palsy After Pelvic and Femoral Osteotomies. A Prospective, Randomized and Double-blinded Study [NCT00964639]Phase 412 participants (Actual)Interventional2009-08-31Completed
Evaluation of Dexketoprofen Given Intravenous or Intrathecal in Postoperative Pain in Patients Undergoing Total Knee Arthroplasty [NCT04161690]Phase 2120 participants (Anticipated)Interventional2019-11-06Recruiting
Comparison of the Effect of Intra-articular Administration of 2% Ropivacaine vs. 7.5% Ropivacaine as an Analgesic in the Immediate Postoperative Period of Knee Arthroscopy in Acute Injuries at the ABC Medical Center [NCT05807945]Phase 468 participants (Actual)Interventional2020-04-01Completed
Effect of Wound Infiltration With Tramadol, Dexmedetomidine, or Magnesium Sulfate as Adjuncts to the Local Anesthetic on Pain Relief After Spine Surgery [NCT04391855]Phase 472 participants (Actual)Interventional2020-05-10Completed
Application of Celiac Plexus Block in Postoperative Analgesia of Upper Abdominal Surgery [NCT05205720]Phase 466 participants (Anticipated)Interventional2022-03-09Recruiting
Surgical Anesthesia for Elective Hip Surgery - Hemodynamic Effect of Lumbosacral Plexus Blockade Compared to Spinal Anesthesia [NCT02544269]Phase 48 participants (Actual)Interventional2016-06-01Terminated(stopped due to After pilot study no difference in the primary end point was found between the two primary. Non-inferiority trial not deemed feasible.)
The Effect of Intravenous Infusion of Tramadol-ondansetron on Recovery After Caesarean Section. A Prospective, Observational and Non-inferiority Study Against Epidural Analgesia. [NCT05879536]312 participants (Anticipated)Observational2023-05-23Recruiting
Post-operative Pain Control With Sphenopalantine Ganglion Nerve Block in Septorhinoplasty Patients [NCT05667324]Phase 4120 participants (Anticipated)Interventional2023-04-12Recruiting
Comparative Study on Postoperative Analgesia With Transversus Abdominis Plane Block to Local Anesthetic Infiltration With Ropivacaine in Laparoscopic Abdominal Surgery [NCT05995301]100 participants (Actual)Interventional2022-03-12Completed
Does the Addition of Epinephrine to Bilateral Ultrasound Guided Pterygopalatine Ganglion Block Reduce Bleeding During Functional Endoscopic Sinus Surgery (FESS)? A Pilot Study [NCT03970655]Phase 1/Phase 280 participants (Anticipated)Interventional2019-09-25Recruiting
A Single Center, Single-blind, Randomized, Dose-escalation, Parallel, Placebo and Active-controlled, Single Dose, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GB-6002 Local Infiltration in Healthy M [NCT06095973]Phase 130 participants (Anticipated)Interventional2023-10-24Recruiting
Quadratus Lumborum Block for Perioperative Analgesia in Patients Treated With Abdominoplasty: A Randomised Controlled Trial [NCT02949778]Phase 450 participants (Actual)Interventional2016-11-07Completed
Continuous Erector Spinae Block Versus Continuous Paravertebral Block Following Thoracotomy: A Randomized, Controlled Non-Inferiority Study [NCT03768440]Phase 3100 participants (Anticipated)Interventional2019-04-16Recruiting
Effects of Sono-guided Femoral Nerve Block in Arthroscopic Surgery for Anterior Cruciate Reconstruction Under Spinal Anesthesia: A Randomized Controlled Trial [NCT06048874]100 participants (Anticipated)Interventional2023-09-18Not yet recruiting
Effects of Sono-guided Femoral Nerve Block in Arthroscopic Surgery for Anterior Cruciate Reconstruction Under General Anesthesia: A Randomized Controlled Trial [NCT06048848]100 participants (Anticipated)Interventional2023-09-18Not yet recruiting
Effects of Sono-guided Femoral Nerve Block in Arthroscopic Surgery for Meniscal Tear Under Spinal Anesthesia: A Randomized Controlled Trial [NCT06048341]100 participants (Anticipated)Interventional2023-09-18Not yet recruiting
Effects of Sono-guided Femoral Nerve Block in Arthroscopic Surgery for Meniscal Tear Under General Anesthesia: A Randomized Controlled Trial [NCT06045884]100 participants (Anticipated)Interventional2023-09-18Not yet recruiting
Erector Spinae Plane Block for Pediatric Idiopathic Scoliosis Surgery. A Prospective, Randomized, Double-blinded Clinical Trial. [NCT05938959]Phase 4100 participants (Anticipated)Interventional2023-05-01Recruiting
Thoracic Paravertebral Blocks in Open Nephrectomy. A Prospective, Randomized Study of Block Efficacy and Influence on Oxidative Stress and Patient Outcome. [NCT03428633]Phase 260 participants (Actual)Interventional2018-03-09Completed
The Effect of Local Anaesthetic Volume on Nerve Block Duration and Nerve Block Duration Variability. A Randomised, Blinded, Healthy Volunteer Study [NCT02829697]Phase 4120 participants (Actual)Interventional2016-07-31Completed
The Volume-concentration Relationship of Analgesic Efficacy With Intra-capsular Local Anesthetic in Total Knee Arthroplasty: a Randomized, Double-blind, Cross-over Trial. [NCT01012232]Phase 448 participants (Actual)Interventional2009-06-30Completed
Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters [NCT00678314]Phase 488 participants (Actual)Interventional2004-01-31Completed
Efficacy of Local Anesthetic TAP Blocks in Providing Pain Relief Following Laparoscopic and Open Abdominal Surgery [NCT00682136]Phase 1206 participants (Anticipated)Interventional2008-04-30Completed
A Randomized Trial Comparing the Efficacy on Post-operative Analgesia of Intra-articular Ropivacaine Added to a Femoral Block After Total Knee Replacement [NCT00910013]Phase 1/Phase 280 participants (Actual)Interventional2006-04-30Completed
A Randomised, Double-blind, Placebo-controlled Study to Assess the effectIveness of Pectoral Nerves Block (PECS) After Breast Surgery on Piritramide Consumption [NCT02655965]Phase 354 participants (Actual)Interventional2016-05-31Completed
Costoclavicular vs Paracoracoid Approach to Infraclavicular Brachial Plexus Block: a Feasibility Study [NCT02657291]70 participants (Actual)Interventional2015-12-31Completed
Sleep Quality After Stellate-ganglion Block of Patients Undergoing Breast Cancer Operation [NCT02651519]Phase 4105 participants (Actual)Interventional2016-01-31Completed
Local Infiltration With Ropivacaine Improves Postoperative Pain Control in Patients Undergoing Laparoscopic Cholecystectomy: a Prospective, Randomized, Placebo Controlled, Double-blind Trial [NCT02649179]140 participants (Actual)Interventional2016-08-31Completed
Comparison of the Analgesic Duration of 0.5% Bupivacaine With 1:200,000 Epinephrine Versus 0.5% Ropivicaine Versus 1 % Ropivicaine for Low Volume Ultrasound-guided Interscalene Brachial Plexus Block [NCT02643563]60 participants (Actual)Interventional2016-01-31Completed
Ultrasound Guided Adductor Canal Block vs Intra-Operative Trans-Articular Saphenous Nerve Block: A Prospective Trial [NCT04155983]Phase 4140 participants (Anticipated)Interventional2020-03-11Recruiting
Saphenous Nerve Block for Post-Op Pain Control After Tibial Plateau ORIF [NCT04314570]50 participants (Anticipated)Interventional2023-12-31Not yet recruiting
A Randomized, Blinded Study to Compare Exparel and Ropivacaine for Pain Relief Following Total Knee Arthroplasty [NCT02607579]200 participants (Anticipated)Interventional2015-01-31Active, not recruiting
Ultrasound-guided Subcostal Transversus Abdominis Plane Block in Gastric Cancer Patients Undergoing Laparoscopic Gastrectomy: A Randomized Controlled Double-blinded Study [NCT04138901]112 participants (Actual)Interventional2019-11-04Completed
Effects of Pre-emptive Scalp Infiltration With Ketorolac and Ropivacaine for Postoperative Pain Relief After Elective Supratentorial Craniotomy (PAINLESS) [NCT04141319]Phase 4100 participants (Anticipated)Interventional2021-12-31Not yet recruiting
Lokal Infiltrations Analgesi Med Ropivakain 1 % Versus Placebo VED Vaginale Descensusoperationer: ET Prospektivt Randomiseret, Dobbeltblindet, Placebo- Kontrolleret Studie [NCT00769054]Phase 448 participants (Anticipated)Interventional2008-10-31Completed
Ambulatory Continuous Peripheral Nerve Blocks for Treatment of Post-Amputation Phantom Limb and Stump Pain [NCT00768248]2 participants (Actual)Interventional2008-10-31Terminated(stopped due to No longer enrolling patients, not enough enrollment)
Effect of Laparoscopic-Guided Transversus Abdominus Plane (TAP) Block on Opioid Consumption Using Dual-Adjunct Therapy With Dexmedetomidine and Dexamethasone Versus Liposomal Bupivacaine (Exparel®) Following Minimally Invasive Colorectal Surgery: A Single [NCT05216055]Phase 20 participants (Actual)Interventional2022-04-19Withdrawn(stopped due to No Accrual. PI left Institution)
Location of Injection of Local Anesthetics in the Adductor Canal Block: A Randomized Controlled Trial of the Effect on Postoperative Analgesia and Motor Power [NCT02554864]108 participants (Actual)Interventional2016-02-22Completed
Epidural Anesthesia as an Alternative for Management in Acute Pancreatitis, a Randomised Clinical Trial [NCT02617199]Phase 2/Phase 360 participants (Anticipated)Interventional2015-11-30Recruiting
Does Magnesium Sulfate as a Supplement in Adductor Canal Blocks Improve Pain Control After Total Knee Arthroplasty? [NCT02581683]Phase 4130 participants (Actual)Interventional2015-09-30Completed
Obturator Nerve Block in Total Hip Arthrosplasty. a Randomized Controlled Double Blind Study [NCT04085640]60 participants (Actual)Interventional2020-01-14Completed
Ultrasound Guidance or Electrical Nerve Stimulation for Interscalene Brachial Plexus Block: a Randomized, Controlled Trial [NCT00702416]Phase 450 participants (Anticipated)Interventional2008-05-31Completed
Study of Effectiveness of a Ropivacaïne Continuous Sternal Infusion to Reduce Postoperative Hyperalgesia Induced by Sternotomy After Cardiac Surgery [NCT00802048]Phase 321 participants (Actual)Interventional2009-02-28Terminated
Suprascapular Nerve Block as Postoperative Analgesia After Artroscopic Shoulder Surgery - a Randomized, Blinded, Placebo Controlled Study [NCT02576223]Phase 440 participants (Anticipated)Interventional2015-10-31Not yet recruiting
Postoperative Narcotic Use After Laparoscopic Gynecologic Surgery: A Randomized, Double-blind, Placebo-controlled Trial Comparing Continuous Intraperitoneal Infusion of Ropivacaine Versus Saline for Post-operative Pain Control [NCT04118777]0 participants (Actual)Interventional2020-05-01Withdrawn(stopped due to Misregistered to wrong sponsor.)
Adductor Canal Block: Continuous Infusion Versus Automatic Intermittent Bolus For Postoperative Analgesia After Day-Case Anterior Cruciate Ligament Reconstruction [NCT02589288]80 participants (Actual)Interventional2015-11-30Completed
Pain Management and Functional Recovery After Adductor Canal Block Combined With iPACK Block for Total Knee Arthroplasty. A Prospective, Randomized, Double-blinded Clinical Trial. [NCT06086483]Phase 4361 participants (Actual)Interventional2020-06-18Completed
Randomised Double Blind Trial to Investigate the Effects of Intraperitoneal Local Anaesthetic Following Colonic Surgery. [NCT00722709]Phase 160 participants (Anticipated)Interventional2008-09-30Completed
Onset Time of Brachial Plexus Anesthesia With the Axillary or Infraclavicular Approach Under Real-Time Ultrasound Guidance: a Randomized Controlled Trial [NCT00724035]Phase 452 participants (Anticipated)Interventional2008-05-31Completed
Comparison Of The Analgesia Obtained By Infiltration Of Lidocaïne 1% And Ropivacaïne 0,75% Versus Placebo For The Joinings Of Episiotomies Among Parturients Under Epidural Analgesia [NCT00727935]Phase 4165 participants (Actual)Interventional2006-10-31Completed
Effects of Ultrasound-guided Adductor Canal Block Versus Femoral Nerve Block on Pain and Quadriceps Strength After Ambulatory Knee Arthroscopic Surgery [NCT05190120]Phase 4108 participants (Actual)Interventional2016-01-31Completed
Efficacy of Continous Regional Anesthesia Using m. Erector Spinae Catheter After Video-assisted Thoracic Surgery Procedures [NCT04062045]50 participants (Anticipated)Interventional2019-10-14Recruiting
Minimum Effective Dose of Intrathecal Ropivacaine Required for Cesarean Delivery: A Prospective, Randomized Comparison Between L2-3 and L3-4 Approach [NCT02565303]60 participants (Actual)Interventional2015-09-30Completed
Comparison Between Ropivacaine/Dexamethasone and 10% Lignocaine Injection in Distal Glossopharyngeal Nerve Block for Intractable Cancer Pain- A Randomized Trial [NCT04085120]60 participants (Anticipated)Interventional2019-08-23Recruiting
The Effect of Epidural Steroid Use on Pain Relief in Patients With Continuous Epidural Nerve Block in Postherpetic Neuralgia Patients. [NCT03995563]Phase 440 participants (Anticipated)Interventional2019-05-15Recruiting
Volume Versus Concentration: a Prospective, Double Blind, Parallel Study to Compare the Clinical Effectiveness of Bilateral Quadratus Lumborum Blocks Using High Volume/Low Concentration or Low Volume/ High Concentration Local Anesthetic in Nephrectomies [NCT04077398]Phase 40 participants (Actual)Interventional2020-01-22Withdrawn(stopped due to covid interrupted initial start, then trainees involved finished program and no one took it on)
Continuous Lumbar Plexus Block for Postoperative Pain Control After Total Hip Arthroplasty [NCT00790179]225 participants (Actual)Interventional2003-01-31Completed
A Analgesic Study of Adductor Canal &IPACK Block With Liposomal Bupivacaine in Knee Arthroplasty :A Randomized,Double-controlled,Parallel-controlled,Single-center Study [NCT06145165]Phase 190 participants (Anticipated)Interventional2023-12-01Recruiting
A Randomized Controlled Trial of Infraclavicular Nerve Blocks for Postoperative Pain Control in Operative Pediatric Lateral Condyle Fractures [NCT03796572]Phase 490 participants (Anticipated)Interventional2019-09-16Recruiting
Analgesic Efficacy of the Pectoral Nerve Block Type 1 for Breast Subpectoral Implant Surgery: A Randomized Controlled Study [NCT02849236]56 participants (Actual)Interventional2016-10-16Completed
A Dose-response Study of Spinally Administered Ropivacaine Combined With a Fix Dose of Fentanyl for Elective Caesarean Section in Tall Parturients Under Combined Spinal-epidural Anaesthesia [NCT03936790]40 participants (Anticipated)Interventional2019-06-02Enrolling by invitation
Effectiveness of Ultrasound Guided Supraclavicular Brachial Plexus Block With 20, 30, or 40 ml of Ropivacaine 0.5% [NCT00923494]0 participants (Actual)Interventional2009-05-31Withdrawn(stopped due to Unable to enroll. Change in patient population.)
Perioperative Multimodal General Anesthesia Focusing on Specific CNS Targets in Patients Undergoing Cardiac Surgeries [NCT04016740]Early Phase 122 participants (Actual)Interventional2019-08-20Completed
Evaluation of the Effect of Intraperitoneal Nebulized Ropivacaine on Morphine Consumption After Laparoscopic Appendectomy in Children. A Prospective, Randomized Double Blind Clinical Trial [NCT02624089]Phase 1/Phase 2200 participants (Anticipated)Interventional2016-01-31Recruiting
Comparison Between Ropivacaine and Liposomal Bupivacaine Periarticular Injections for Pain Relief After Total Knee Arthroplasty [NCT02616367]Phase 20 participants (Actual)Interventional2015-12-31Withdrawn(stopped due to Study never initiated)
Parecoxib as an Adjuvant to Scalp Nerve Blocks for Relief of Post-craniotomy Pain [NCT04034836]Phase 4132 participants (Anticipated)Interventional2019-10-12Recruiting
Perineural Dexamethasone Administered in Femural Nerve Block After Anterior Cruciate Ligament Reconstruction [NCT02749162]Phase 390 participants (Actual)Interventional2015-11-30Completed
Effect of Infraorbital and Infratrochlear Nerve Block on Emergence Agitation in Patients Undergoing Septorhinoplasty: A Randomized Controlled Trial [NCT02751268]Phase 466 participants (Actual)Interventional2016-04-30Enrolling by invitation
Treatment of Rotator Cuff Syndrome With Injection of Autologous Platelet Rich Plasma [NCT01123889]12 participants (Actual)Interventional2010-05-31Completed
Ultrasound-guided Serratus Plane Block for the Quality of Recovery After Modified Radical Mastectomy [NCT02691195]Phase 472 participants (Actual)Interventional2016-03-15Completed
Combined Pericapsular Nerve Group (PENG) and Lateral Femoral Cutaneous Nerve (LFCN) Block for Total Hip Arthroplasty: A Randomized Controlled Trial [NCT04996290]40 participants (Actual)Interventional2020-06-01Completed
Efficacy of Ropivacaine Continuous Wound Instillation Versus Single Shot After Spine Fusion Surgery [NCT00823576]Phase 460 participants (Actual)Interventional2008-12-31Terminated
Efficacy of Erector Spinae Block With Ropivacaine and Dexmedetomidine on Opioid Consumption After Lumar Spine Surgeries - A Randomised Controlled Trial [NCT05664542]Phase 442 participants (Anticipated)Interventional2022-12-15Recruiting
Femoral or Sciatic Nerve Block to Provide Analgesia After Proximal Tibial Osteotomy [NCT05728294]50 participants (Actual)Interventional2019-02-01Completed
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Active and Placebo Controlled Study to Evaluate the Efficacy and Safety of Local Administration of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy [NCT05769855]Phase 3294 participants (Actual)Interventional2023-03-21Active, not recruiting
Double Blind Randomized Trial of Wound Infiltration With Ropivacaine After Breast Cancer Surgery [NCT01404377]Phase 450 participants (Actual)Interventional2006-01-31Completed
Wound Infiltration With Dexmedetomidine in Cesarean Section: Effect on Postoperative Analgesia [NCT03382938]100 participants (Anticipated)Interventional2019-08-23Recruiting
Ultrasound-guided Popliteal Sciatic Nerve Block: an Evaluation of the Intraneural [NCT02589041]45 participants (Actual)Interventional2015-11-30Completed
Evaluation of the Value of Perianal Infiltration During Thermodestruction of Haemorrhoidal Disease by Radiofrequency [NCT05519189]Phase 4134 participants (Anticipated)Interventional2023-01-10Recruiting
Lokal Infiltrations Analgesi Med Ropivakain 0,5 % Versus Placebo VED Vaginal Hysterektomi: ET Prospektivt Randomiseret, Dobbeltblind ET, Placebo-kontrolleret Studie [NCT00768456]Phase 448 participants (Anticipated)Interventional2008-10-31Completed
Local Infiltration Analgesia in Bilateral Knee Arthroplasty - Efficacy of Subcutaneous Wound Infiltration With Local Anesthetic. [NCT00927225]Phase 416 participants (Actual)Interventional2008-09-30Completed
Evaluation of the Effect of Local Anesthetic Concentration on Rebound Pain After Interscalene Block for Shoulder Surgery [NCT04457557]60 participants (Anticipated)Interventional2020-07-10Recruiting
Ultrasound Guided Repeated Bilateral Transversus Thoracis Muscle Plane Block Via Catheter and Postoperative Pain in Cardiac Surgery [NCT04916418]Phase 4120 participants (Anticipated)Interventional2021-10-15Recruiting
Randomised and Double-blind Clinical Trial on Post-operative Analgesic Efficacy in Colorectal Surgery and Hepatic Surgery With Continuous Infusion of Local Anesthesia vs Saline Serum in the Surgical Incision. [NCT01075646]Phase 4225 participants (Actual)Interventional2009-03-31Completed
The MEC90 of Epidural Ropivacaine Blunting Hemodynamic Changes to Pneumoperitoneum in the Patients Undergoing Laparoscopic Gastrectomy [NCT04247373]50 participants (Anticipated)Interventional2020-01-31Not yet recruiting
Effect of Ultrasound-guided Transversus Abdominis Plane Block With Compound Lidocaine on Postoperative Pain in Patients Undergoing Gynecological Laparotomy:a Randomized Double-blind Controlled Trial [NCT04938882]164 participants (Actual)Interventional2021-08-15Completed
Dexamethasone as an Adjuvant to Ropivacaine for the Interscalene Brachial Plexus Block: a Dose-finding Study [NCT02818491]Phase 475 participants (Actual)Interventional2017-11-01Completed
[NCT02817321]76 participants (Actual)Interventional2016-11-30Completed
Intraartikulær Versus ekstraartikulær Bolus Injektion Med Ropivacain Ved Total knæalloplastik: et Prospektivt, Randomiseret, Dobbeltblindet, Kontrolleret Studie [NCT00632580]Phase 460 participants (Anticipated)Interventional2008-01-31Recruiting
The Analgesic Efficacy of Continuous Wound Instillation With Diclofenac or Ropivacaine Following Cesarean Section: a Randomized, Double-blind, Placebo Controlled Study [NCT00801528]Phase 475 participants (Anticipated)Interventional2008-04-30Completed
Postoperative Pain and Patient-controlled Epidural Analgesia Related Adverse Effects in Young and Elderly Patients [NCT02849730]2,435 participants (Actual)Observational2016-07-31Completed
A Single-Dose, Open-Label, Multi-Center Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of PRF110 in Bunionectomy Surgery [NCT02784327]Phase 215 participants (Anticipated)Interventional2016-08-31Not yet recruiting
Chronic Pain and Functional Prognosis After Total Knee Replacement: Continuous Locoregional Analgesia by Catheter to the Femoral Triangle Versus Tissue Infiltration as Part of an Improved Rehabilitation After Surgery Approach [NCT03998813]420 participants (Anticipated)Interventional2020-09-02Active, not recruiting
Determining the Minimum Effective Ropivacaine Dose for Unilateral Hypobaric Spinal Anaesthesia During Traumatic Femoral Neck Surgery in the Aged Person: Prospective Comparative Randomized Study [NCT01005550]Phase 464 participants (Actual)Interventional2009-04-30Completed
Erector Spinae Plane Block Versus Paravertebral Block for Analgesic Outcomes After Cardiac Surgery (PEPS): a Prospective Randomized Comparative Study. [NCT04546113]80 participants (Anticipated)Interventional2021-01-07Recruiting
Intraneural Injection of Ropivacaine for Subgluteal Sciatic Nerve Block Leads to Faster Onset and Higher Success Rates: a Randomized, Controlled Trial [NCT01999647]64 participants (Actual)Interventional2011-12-31Completed
Effect of Local Infiltration Analgesia With Ropivacaine in Total Hip Arthroplasty: a Prospective, Randomized, Double-blind, Placebo-controlled Trail [NCT00968955]Phase 4120 participants (Actual)Interventional2009-09-30Completed
The Effect of Continuous Administration of Ropivacaine by Bi-laterosternal Multiperforated Catheters Placed Before a Sternotomy for Cardiac Surgery [NCT04495504]Phase 232 participants (Actual)Interventional2020-07-22Completed
Sensory Distribution of Lateral Femoral Cutaneous Nerve Block - A Randomized, Blinded, Paired Trial in Healthy Volunteers [NCT02957903]Phase 420 participants (Actual)Interventional2016-11-30Completed
Influence of Epidural Analgesia in Elective Laparoscopic Colorectal Resections [NCT00512395]Phase 475 participants (Actual)Interventional2004-11-30Completed
Comparison Between Ropivacaine and Bupivacaine in Deep Topical Fornix Nerve Block Anesthesia in Patients Undergoing Cataract Surgery by Phacoemulsification. [NCT02925832]100 participants (Actual)Interventional2016-10-31Completed
A Single-center, Randomized, Placebo-controlled, Double-blind, Single-dose, Efficacy of PRF-108 4% and PRF-110 4% Versus Ropivacaine Solution 0.5% in an Experimental Pain Model [NCT00883194]Phase 1/Phase 215 participants (Actual)Interventional2010-10-31Completed
Ultrasound-guided Continous Quadratus Lumborum Block: Effect on Acute Pain and Quality of Recovery After Hepatic Surgery With Right Subcostal Incision [NCT02914015]40 participants (Actual)Interventional2018-08-01Terminated(stopped due to we change the study protocol)
Effect of Volume of Local Anesthetic for Adductor Canal Block on Quadriceps Muscle Function: A Dose Finding Study [NCT02541552]Phase 326 participants (Actual)Interventional2015-04-30Completed
Ultrasound Guided Quadratus Lumborum Block for Postoperative Pain in Abdominoplasty: A Randomized Controlled Study [NCT02932930]40 participants (Actual)Interventional2016-10-31Completed
Does it Worth to Reinforce With Additional Anesthesia to Improve Postoperative Course After Orthognathic Surgery? [NCT03974035]Phase 252 participants (Actual)Interventional2018-01-10Completed
Epidural Analgesia for Labor Pain and Infant Neurobehavior [NCT00987441]1,200 participants (Actual)Interventional2009-09-30Completed
Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty: a Single Center Randomized Controlled Trail (RCT) Study [NCT03977454]Phase 2192 participants (Actual)Interventional2019-11-11Completed
Phase III Study of the Addition of Sufentanil to Interscalene Block in Shoulder Surgery [NCT01025102]Phase 326 participants (Actual)Interventional2010-01-31Completed
Assessment of Spread of Transversus Abdominis Plane Block After Administration of 20 ml Ropivacaine 0,5% Bilaterally [NCT01024868]20 participants (Anticipated)Observational2009-12-31Completed
New Approach for Brachial Plexus Block: Clinical Research of Retrograde Infraclavicular Brachial Plexus Blockade [NCT01075503]90 participants (Actual)Interventional2008-03-31Completed
Comparison of Two Multimodal Analgesia Regimens for Total Knee Arthroplasty : a Randomized Controlled Trial [NCT03990038]2 participants (Actual)Interventional2019-08-01Terminated(stopped due to Recruitment problems making the study completion unlikely)
Blood Levels of Local Anaesthetic in Knee Arthroplasty: A Pharmacological Study of Ropivacaine Blood Levels During the Caledonian Technique for Knee Arthroplasty [NCT01873313]20 participants (Actual)Observational2012-08-31Completed
Transversus Abdominis Plane (TAP) Block Versus Intrathecal Morphine for Caesarean Section - Randomised Controlled Trial [NCT01931215]Phase 4180 participants (Actual)Interventional2013-09-30Completed
Comparative Study of the Effects of Two Local Anesthetics Administered Intrathecally: 0.5% Levobupivacaine and Ropivacaine 0.5% [NCT01935596]Phase 450 participants (Actual)Interventional2013-05-31Completed
Blood Levels of Local Anaesthetic in Knee Arthroplasty: A Pharmacological Study of Ropivacaine Blood Levels During the Caledonian Technique for Knee Arthroplasty [NCT01935648]30 participants (Anticipated)Observational2013-09-30Not yet recruiting
Adductor Canal Nerve Block Following Total Knee Arthroplasty: A Randomized, Prospective Study Comparing High vs. Low Volume Bolus of 0.33% Ropivacaine [NCT01939379]0 participants (Actual)Interventional2013-09-30Withdrawn(stopped due to PI left institution. Efforts made to contact PI unsuccessful. No study data available.)
Double Blinded Randomized Control Trial Comparing the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using Ropivacaine Versus Ropivacaine-Chloroprocaine Mixture [NCT01719237]Phase 460 participants (Actual)Interventional2009-08-31Completed
Multicentre Evaluation of a Novel Technique of Analgesia Following Open Liver Resection: Medial Open Transversus Abdominis Plane (MOTAP) Catheters [NCT01960049]Phase 4150 participants (Actual)Interventional2013-10-31Completed
Prospective Randomised Double-blind Study to Compare Ropivacaine 10mg/mL Alone Versus Ropivacaine 10mg/mL Associated With Clonidine 1µg/kg for Peribulbar Anesthesia in Posterior Eye Surgery [NCT01963299]Phase 260 participants (Actual)Interventional2013-08-16Completed
Monocentric Prospective Study, in Order to Assess Analgesia Provided by Continuous Sciatic Nerve Block, in Patients With Hypertensive Leg Ulcer. [NCT01964911]Phase 413 participants (Actual)Interventional2014-02-28Completed
Multicenter Randomized Double-blind Study Evaluating the Effects of Botulinum Toxin A Associated With ropivacaïne Versus ropivacaïne Alone in the Treatment of the Myofascial Pelviperineal Pain [NCT01967524]Phase 380 participants (Actual)Interventional2013-09-30Completed
A Randomized Controlled Trial of Surgical TAP-block After Cesarean Delivery: a Cost-effective Alternative to the Conventional TAP-block [NCT02571439]Phase 441 participants (Actual)Interventional2014-10-31Completed
Adductor Canal Block and Effect of 10 Versus 30 ml Ropivacaine on Muscle Strength: a Randomized Study in Healthy Volunteers [NCT01981746]Phase 426 participants (Actual)Interventional2013-11-30Completed
Blocco Del Nervo Sciatico al Poplite, Intraneurale o Extraneurale? Confronto Prospettico, Randomizzato in Cieco Tra la modalità di Iniezione di Anestetico Locale Per il Blocco Eco Guidato Del Nervo Sciatico al Poplite Nella Chirurgia Dell'Alluce Valgo [NCT01987128]Phase 488 participants (Actual)Interventional2013-11-30Completed
Evaluate the Analgesic Effect of Intraperitoneal Infiltration of Ropivacaine in Children Undergoing Laparoscopic Surgery [NCT01997593]Phase 270 participants (Actual)Interventional2013-11-30Completed
Is Postoperative Quality of Recovery After Radical Prostatectomy Related to the Type of Anesthesia and Analgesia? [NCT04587505]Phase 461 participants (Actual)Interventional2019-04-01Completed
Continuous Local Anesthesia Versus Continuous Femoral Nerve Bloc After Total Knee Arthroplasty: Impact on Mean Discharge Aptitude Delay [NCT02006355]Phase 436 participants (Actual)Interventional2014-04-30Terminated(stopped due to Recruitment difficulties)
Effect of Preventive Analgesia by Injection of a Local Anesthetic Before Vaginal Incision for Hysterectomy by vNOTES Approach: Randomized, Double-blind Study [NCT05969457]Phase 3108 participants (Anticipated)Interventional2023-10-01Not yet recruiting
A Three-Arm, Double-Blinded, Randomized Controlled Trial Comparing the Efficacy of Adductor Canal Pain Catheters Following Total Knee Arthroplasty [NCT05053087]Phase 372 participants (Actual)Interventional2022-04-13Completed
Percutaneous Rectus Sheath Block Versus Intra-operative Rectus Sheath Block for Pediatric Umbilical Hernia Repair: A Prospective, Randomized Study [NCT02341144]61 participants (Actual)Interventional2014-12-31Completed
Multimodal Pain Management After Robotic-Assisted Total Laparoscopic Hysterectomy [NCT04429022]Phase 368 participants (Actual)Interventional2020-11-24Completed
Effect of Continuous Femoral Analgesia on Quadriceps Muscle Strength-0.2% Ropivacaine Continuous Infusion Versus Patient Controlled Femoral Analgesia [NCT02007850]36 participants (Anticipated)Interventional2014-02-28Recruiting
Patient-Titrated Automated Intermittent Boluses of Local Anesthetic vs. a Continuous Infusion Via a Perineural Catheter for Postoperative Analgesia [NCT05091905]Phase 4140 participants (Anticipated)Interventional2022-02-14Enrolling by invitation
Epidural Dexamethasone for Labor Analgesia: the Effects on Ropivacaine Consumption and Labour Outcome. A Randomized Double Blind Placebo Study [NCT02857465]Phase 30 participants (Actual)Interventional2017-01-31Withdrawn(stopped due to French Agency for the Safety of Health Products refusal)
Routine Irrigation With Ropivacaine vs. Lidocaine vs. Saline of Surgical Bed in Sleeve Gastrectomy [NCT02023684]90 participants (Anticipated)Interventional2014-01-31Not yet recruiting
The Effects of Various Concentrations of Ropivacaine on the Onset and Duration of Ankle Block - a Randomized, Triple-blinded, Parallel-group Interventional Study [NCT06185608]126 participants (Anticipated)Interventional2024-03-01Not yet recruiting
Effect of Brachial Plexus Block on Outcomes of Upper Extremity Arteries After Intracranial Aneurysm Interventional Surgery Via Transradial Access: A Randomized Clinical Trial [NCT06035692]176 participants (Anticipated)Interventional2023-06-01Recruiting
Ropivacaine 0.75% vs Ropivacaine 0.75% Plus Mepivacaine 1.5% for Subgluteal Sciatic Bloc: a Prospective Double Blind Randomized Controlled Study [NCT00567450]Phase 430 participants (Anticipated)Interventional2007-09-30Completed
Comparison of Quadratus Lumborum Block With Medical Management for Pain Control After Lumbar Spine Fusion Surgery [NCT04588389]Phase 330 participants (Anticipated)Interventional2020-12-01Recruiting
A Phase II/III Study of Continuous Local Anesthetic Infusion in Median Sternotomy Following Cardiac Surgery [NCT00586976]Phase 2/Phase 3125 participants (Actual)Interventional2005-07-31Terminated(stopped due to Stopped by DSMB due to increased wound infection rate.)
Comparison of Ropivacaine Plasma Concentration With or Without Epinephrine for Posterior Quadratus Lumborum Block in Cesarean Section [NCT04562103]52 participants (Actual)Interventional2020-07-03Completed
A Phase I Study to Evaluate the Safety, Pharmacokinetics and Efficacy of HR18034 for Pain Management After Inguinal Hernia Repair [NCT04551924]Phase 164 participants (Anticipated)Interventional2020-10-01Recruiting
Can Post-operative TAP Block Improve Quality of Recovery After C-sections in Patients on Methadone Maintenance Therapy for Opioid Abstinence? [NCT01644864]Phase 40 participants (Actual)Interventional2012-07-31Withdrawn(stopped due to No participants were enrolled. The PI left the institution.)
Continuous Pre-uterine Wound Infiltration Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Section. Controlled Comparative Study. [NCT02279628]Phase 4150 participants (Anticipated)Interventional2014-07-31Recruiting
Epidural Analgesia and Troubles of Fetal Cardiaq Rythm : Effect of the Systemic Transfer of Ropivacaine and Sufentanil [NCT01686347]Phase 440 participants (Actual)Interventional2012-06-30Completed
Evaluation of a Continuous Saphenous Nerve Block to Supplement a Continuous Sciatic Nerve Block for Postoperative Analgesia Following Ankle Surgery [NCT01167907]32 participants (Actual)Interventional2010-07-31Completed
The Effect of Pre-operative Transversus Abdominis Plane (TAP) Block in the Quality of Recovery of Patients Undergoing Laparoscopic Hysterectomy: a Prospective, Randomized, Blinded Study [NCT01074229]75 participants (Actual)Interventional2010-03-31Completed
Lokal Infiltrations Analgesi Med Ropivakain 0,5 % Versus Placebo Ved Rygkirurgi for Spinalstenose: et Prospektivt Randomiseret, Dobbeltblindet, Placebo-kontrolleret Studie [NCT00771459]Phase 448 participants (Anticipated)Interventional2008-10-31Completed
Analgesic Efficacy of Ultrasound Guided Transversus Abdominis Plane Block After Cesarean Delivery in Patients With a BMI > 30 [NCT01217580]0 participants (Actual)Interventional2010-10-31Withdrawn(stopped due to The study was not feasible to perform at one institution with the amount of subjects that were needed to complete it.)
Postoperative Analgesia With Transversus Abdominis Plane Block or Quadratus Lumborum Block in Patients After Cesarian Delivery [NCT03404908]Phase 4105 participants (Actual)Interventional2018-02-07Completed
Lokal Infiltrations Analgesi Med Ropivakain 0,5 % Versus Ropivakain 0,2 % Versus Placebo Efter Sectio Caesarea: et Prospektivt, Dobbeltblindet, Placebokontrolleret Studie. [NCT00891540]Phase 490 participants (Anticipated)Interventional2009-07-31Completed
Ultrasound Guided Motor Sparing Knee Blocks With or Without Dexmedetomidine for Postoperative Analgesia Following Knee Arthroplasty: a Randomized Double Blinded Study [NCT02540070]Phase 3135 participants (Anticipated)Interventional2014-08-31Recruiting
Assessment of Efficacy and Safety of Continuous Wound Infiltration With Local Anesthesics Through a Parietal Paravertebral Catheter for Postoperative Analgesia After Posterior Lumbar Arthrodesis [NCT00825422]Phase 350 participants (Actual)Interventional2009-01-31Completed
Project Arthritis Recovering Quality of Life Through Education - Hip [NCT04018690]48 participants (Anticipated)Interventional2019-09-01Not yet recruiting
Ropivacaine Plasma Concentrations and Pharmacokinetics Following Erector Spinae Plane Block in the Pediatric Population [NCT04298099]Phase 424 participants (Anticipated)Interventional2020-12-17Recruiting
Comparative Evaluation of Lumbar Plexus and Suprainguinal Fascia Iliaca Compartment Blocks for Pain Management After Orthopedic Surgical Procedures Involving Hip and Femur in Pediatrics. [NCT03746951]Phase 2/Phase 315 participants (Actual)Interventional2019-04-24Completed
Evaluation of Postoperative Experience of Two WALANT-type Modes of Anesthesia (Lidocaine Alone or Combined With Ropivacaine) Used in Ambulatory Surgery of the Upper Limb. A Single-center Prospective Randomized, Single-blind Study [NCT05343299]Phase 191 participants (Actual)Interventional2022-05-30Completed
Effect of Scalp Nerve Block on the Quality of Recovery in Patients Undergoing Supratentorial Tumor Resection [NCT06157359]84 participants (Anticipated)Interventional2023-11-27Recruiting
Isobaric Ropivacaine 15 mg Versus Hyperbaric Bupivacaine 12.5 mg for Spinal Anesthesia in Geriatric Patients Undergoing Total Knee Arthroplasty [NCT02764723]52 participants (Actual)Interventional2013-01-31Completed
Use of Regional Anesthesia in Hip Arthroscopy [NCT02851888]Phase 470 participants (Anticipated)Interventional2016-07-31Recruiting
Pectoral Nerves Blocks and Their Effect on Chronic Pain After Breast Cancer Surgery [NCT02719795]Early Phase 1140 participants (Anticipated)Interventional2016-04-30Recruiting
The Efficacy and Safety of Local Anesthetic Infusion With Ropivacaine for the Management of Pain After Surgical Correction of Ureteropelvic Junction Stenosis [NCT00930046]15 participants (Actual)Interventional2009-04-24Terminated(stopped due to The institution transitioned from open surgical procedure to Robotic procedure)
Comparison of Programmed Intermittent Epidural Bolus With Continuous Epidural Infusion for Labor Epidural Analgesia [NCT02873091]186 participants (Anticipated)Interventional2016-09-30Recruiting
Double-blinded Randomised Controlled Trial (RCT) Comparing a High Ankle Block to Placebo in Patients Treated for Ankle Pathologies [NCT04292691]60 participants (Anticipated)Interventional2020-04-01Not yet recruiting
Triamcinolone Ketorolac (TriKe) Knee Trial Evaluating the Effectiveness and Possible Superiority of Ketorolac vs. Cortisone When Injected Intra-Articular in Subjects With Osteoarthrosis [NCT05336968]Phase 4150 participants (Anticipated)Interventional2022-09-15Enrolling by invitation
Intravenous Dexamethasone Versus Placebo for Ultrasound Guided Axillary Brachial Plexus Block With Ropivacaine: Randomised, Controlled, Clinical Trial [NCT02862327]Phase 399 participants (Actual)Interventional2016-12-01Completed
[NCT02841982]30 participants (Actual)Interventional2016-08-31Completed
Intra-abdominal Infusions of Ropivacaine Following Laparoscopic Ventral Hernia Repair: a Randomised Double-blind Controlled Trial. [NCT02785276]0 participants (Actual)Interventional2016-08-31Withdrawn(stopped due to Study not initiated)
Analgesic Efficacy of Transversus Abdominis Plane (TAP) Block After Lumbar Spine Surgery Through Anterior Approach (Anterior Lumbar or Direct Lateral Interbody Fusion): a Prospective, Randomized, Double-blind Placebo-controlled Study [NCT02778178]Phase 440 participants (Actual)Interventional2016-05-02Completed
The Effect of Dexamedetomidine for Interscalene Brachial Plexus Block on Plasma Cortisol and IL-6 After Rotator Cuff Repair: a Prospective Randomized Study [NCT02766556]50 participants (Actual)Interventional2014-08-31Completed
Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications [NCT02722096]78 participants (Actual)Interventional2014-03-31Completed
Comparison of the Analgesic Effect of the Local Anesthetics Ropicacaine, Levobupivacaine, and Levobupivacaine + Epinephrin Via Interscalene Nerve Block in Patients Undergoing Shoulder Arthroscopy Under General Anesthesia [NCT02691442]Phase 430 participants (Actual)Interventional2010-12-31Completed
A Prospective Randomized Parallel Study to Compare Post-operative Pain Control With Addition of Sensory Posterior Articular Nerve Block to Adductor Canal Block (SPANK) and Intraoperative Periarticular Infiltration in Total Knee Arthroplasty. [NCT04290442]Phase 40 participants (Actual)Interventional2021-01-01Withdrawn(stopped due to initially cessation due to covid, then fellow doing the study graduated with no time to complete the study; will take up again if a current fellow takes on the project)
Evaluation of Non-invasive Monitor of Physiodoloris Pain in Patients With Complex Regional Pain Syndrome Treated by Nerve Block (Prospective Monocenter Study) [NCT02663284]30 participants (Actual)Interventional2012-04-30Completed
Intraperitoneal Ropivacaine Irrigation in Patients Undergoing Bariatric Surgery [NCT02641288]Phase 3110 participants (Actual)Interventional2015-01-31Completed
Local Infiltration Analgesia (LIA) With Ropivacaine, Ketorolac and Epinephrine Intra- and Postoperatively in Unicompartmental Knee Arthroplasty [NCT00653926]40 participants (Actual)Interventional2005-09-30Completed
Ambulatory Continuous Peripheral Nerve Blocks for Treatment of Post-Amputation Phantom Limb and Stump Pain [NCT00667264]7 participants (Actual)Interventional2008-10-31Completed
Patient Outcomes With Periarticular Liposomal Bupivacaine Injection vs Adductor Canal Block After Primary Total Knee Arthroplasty [NCT02863120]Phase 463 participants (Actual)Interventional2016-07-31Completed
A Double-blind Randomized Trial of Interpectoral Nerve Block (Pecs 1 and 2) With Ropivacaine Versus Placebo Before Breast Cancer Surgery: Effects on Acute Postoperative Pain. (MIRs 04) [NCT04327063]Phase 3182 participants (Actual)Interventional2020-08-04Completed
Addition of Dexmedetomidine to Ropivacaine-induced Supraclavicular Plexus Block, a Randomized Controlled Study [NCT02630290]Phase 460 participants (Actual)Interventional2015-12-31Completed
Continuous Wound Infiltration for Diminution of Post-surgery Pain After Caesarean Section (Dip-Caesar) [NCT02828059]0 participants (Actual)Observational2016-08-31Withdrawn(stopped due to changed drug approval)
Remifentanil-dexmedetomidine Anesthesia as an Alternative Anesthetic for Elective Pediatric Surgery: a Pilot Study. [NCT02799589]Phase 40 participants (Actual)Interventional2016-07-31Withdrawn(stopped due to Difficulty in recruitment)
Efficacy of Direct Versus Peripheral Low-Dose Adjuvant Dexamethasone on Duration and Rebound Pain in Regional Anesthesia for Distal Radius Fracture Fixation: A Prospective Randomized Controlled Blinded Study [NCT05274113]Phase 350 participants (Anticipated)Interventional2022-03-10Enrolling by invitation
Periarticular Injection and Hamstring Block Versus Placebo for Pain Control in Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial [NCT05248724]44 participants (Actual)Interventional2017-08-01Completed
A Comparison of Pulsed Electromagnetic Fields (PEMF) and Pectoral (PEC) Interfascial Blocks on Postoperative Pain Reduction in Patients Undergoing Mastectomy and Tissue Expander Reconstruction [NCT03360214]Phase 460 participants (Actual)Interventional2017-07-05Completed
The Evaluation of the Efficacy of Local Infiltration Analgesia and Infusion for Total Hip Arthroplasty [NCT01409278]105 participants (Actual)Interventional2009-08-31Completed
Effect of Transversus Abdominis Plane (TAP) Block as Postoperative Pain Management After Laparoscopic Colon Surgery [NCT01418144]Phase 480 participants (Actual)Interventional2010-08-31Completed
A Multicentric, Randomized, Controlled, Double Blinded, Phase III Clinical Trial; Comparing Peritoneal Nebulization of Ropivacaine 150 mg With Peritoneal Nebulization of Saline [NCT01432496]Phase 3130 participants (Anticipated)Interventional2011-09-30Terminated(stopped due to There was insuficient recruitment in two centers)
The Effect of Phrenic Nerve Block on Postoperative Shoulder Pain in Patients for Liver Resection - a Double Blinded Randomised Controlled Trial. [NCT02903719]Phase 430 participants (Anticipated)Interventional2016-09-30Recruiting
Analgesic Efficacy of Adductor Canal Block (ACB) Before and After Primary Total Knee Arthroplasty (TKA): A Prospective Randomized Trial to Compare Postoperative Clinical Outcomes [NCT02908711]Phase 450 participants (Actual)Interventional2016-10-31Completed
Erector Spinae Plane Block Catheters: The Role in Acute Postoperative Pain After Hepatic Resection With Intrathecal Morphine [NCT04849455]Phase 470 participants (Anticipated)Interventional2021-05-24Recruiting
Influence of 0.75% Ropivacaine Topicalization on Emergence Agitation in Preschool-aged Children Undergoing Adenotonsillectomy [NCT02848287]84 participants (Anticipated)Interventional2016-08-31Not yet recruiting
Study of Posterior Lumbar Plexus Block for Pain Relief After Hip Surgery [NCT00150865]60 participants Interventional2001-09-30Completed
Effects of Local Anaesthetic Infusion Rates on Nerve Block Duration. A Randomised, Blinded, Healthy Volunteer Study [NCT02801799]Phase 160 participants (Actual)Interventional2016-10-10Terminated(stopped due to The trial was comprised of two parts. After the first part we could repudiate our hypothesis. Thus, no reason to carry on with the second part of the trial.)
[NCT02768493]80 participants (Actual)Interventional2016-05-31Completed
Administration of Ketamine to Branchial Plexus Block Using Axillary Approach : Comparative Study [NCT05297422]81 participants (Anticipated)Interventional2022-01-20Recruiting
Analgetic Efficiency of Single-shot Perineural Low Dose Dexamethasone Added to Infraclavicular Block Anesthesia for Upper Limb Surgery [NCT02698995]Phase 3180 participants (Actual)Interventional2015-11-30Completed
Effect of Local Infiltration Anesthesia With Ropivacaine on Postoperative Pain After Hip Hemiarthroplasty [NCT02585011]123 participants (Actual)Interventional2015-12-31Completed
Interscalene Block and Dysfunction Diaphragmatic: Effect of Low Volume of Ropivacaine 0,1%. A Randomised, Controlled Trial [NCT04173364]Phase 360 participants (Actual)Interventional2019-10-29Completed
ROPI Study: Evaluation of the Interest of Ropivacaine Streaming in Postoperative Pain After Mastectomy. [NCT01855529]Phase 2150 participants (Actual)Interventional2013-04-30Completed
Pericapsular Nerve Group (PENG) Block for Arthroscopic Hip Surgery: A Randomized, Placebo-controlled Trial [NCT04508504]70 participants (Actual)Interventional2020-12-01Completed
Blood Levels of Local Anaesthetic in Hip Arthroplasty: A Pharmacological Study of Ropivacaine Blood Levels During the Caledonian Technique for Hip Arthroplasty [NCT01869946]20 participants (Actual)Observational2012-08-31Completed
Pain Treatment in Posterior Thoracolumbar Operation a Randomized Study to Assess the Effect of Local Analgesia After Operation [NCT01872494]Phase 471 participants (Actual)Interventional2013-05-31Completed
Superficial Cervical Plexus Block for Improved Outcomes in Pediatric Otolaryngologic Surgery [NCT06023329]Phase 436 participants (Anticipated)Interventional2023-12-01Not yet recruiting
Analgesic Efficacy of Ropivacaine Alone or in Combination With Adjuvants on Post-operative Analgesia Following Video-Assisted Thoracoscopic Surgery (VATS) - A Randomized Controlled Trial. [NCT03809442]Phase 4120 participants (Anticipated)Interventional2019-06-25Recruiting
High Thoracic Epidural Anesthesia and Postoperative Analgesia With Ropivacaine or Levobupivacaine for Coronary Surgery: A Prospective Randomized Double-Blind Comparison [NCT00552864]Phase 461 participants (Actual)Interventional2003-01-31Completed
A Prospective Comparison of Pain and Analgesia in Patients With Continuous Peripheral Nerve Block Catheters Using Continuous Infusion or Scheduled Bolus Infusion [NCT03230565]Phase 4240 participants (Anticipated)Interventional2018-06-01Enrolling by invitation
PENG Block vs. ESP Block for Pediatric Hip Surgery. A Randomized, Prospective Double-blinded Clinical Trial. [NCT06087549]Phase 4150 participants (Anticipated)Interventional2023-11-30Not yet recruiting
Continuous Fascia Iliaca Block for Acute Hip Fractures: a Randomized Controlled Pilot Study [NCT03588689]Phase 430 participants (Actual)Interventional2018-05-07Completed
Transversus Abdominus Plane (TAP) Block Catheters vs Liposomal Bupivacaine for Pain Control After Colorectal Surgery: A Prospective Randomized Control Trial [NCT03080142]Phase 486 participants (Actual)Interventional2017-03-01Completed
A Comparison of Ropivacaine Alone Versus Ropivacaine With Dexamethasone or Clonidine Versus a Combination of Ropivacaine, Dexamethasone, and Clonidine for Supraclavicular Brachial Plexus Block Using Ultrasound:A Prospective, Observer-blinded, Randomized S [NCT02151487]97 participants (Actual)Observational2014-03-31Completed
Evaluation of Intra-articular Continuous Infusion Pump With Ropivacaine in Addition to Local Infiltration Analgesia (LIA) in Total Knee Arthroplasty (TKA). A Placebo Controlled Randomised Trial. [NCT01726686]Phase 4200 participants (Actual)Interventional2010-02-28Completed
Intermittent Bolus Versus Continuous Infusion Erector Spinae Catheters for Median Sternotomy Incisions: A Prospective Randomized Controlled Trial [NCT05642416]Phase 4240 participants (Anticipated)Interventional2022-10-15Recruiting
Comparison of Intra-articular Infiltration and Gabapentin With Epidural Analgesia After Total Knee Replacement Surgery [NCT01489631]81 participants (Actual)Interventional2013-03-31Completed
Minimum Effective Volume of Ropivacaine 7.5 mg/ml for the Lateral and Sagittal Infraclavicular Brachial Plexus Block When Using Guidance by Both Ultrasound and Nerve Stimulation. [NCT01493986]Phase 425 participants (Anticipated)Interventional2012-02-29Completed
A Single Center, Randomized, Parallel Group Study to Evaluate the Efficacy of Ropivacaine Administered by Ultrasound-guided Erector Spinae Plane Block for Major Upper Abdominal Surgery [NCT04702685]Phase 350 participants (Anticipated)Interventional2021-01-31Not yet recruiting
Double Blind Randomized Phase III Controlled Trial Comparing the Effect of Intraperitoneal Nebulization of Ropivacaine With Intraperitoneal Instillation of Ropivacaine on Pain Control After Laparoscopic Cholecystectomy [NCT01248819]Phase 360 participants (Actual)Interventional2008-04-30Completed
Dexmedetomidine as Adjunct Medication to Local Infiltration Anesthesia (LIA) vs Ultrasound-Guided Regional Anesthesia (USRA) in Regard to Patients' Need for Opioids, Wellbeing, Satisfaction, and Knee Functionality in Knee-endoprosthetics [NCT04697537]Phase 350 participants (Actual)Interventional2021-02-01Completed
Analgesia For Positioning Patient With Femur Fracture For Spinal Anaesthesia : Ultrasound-Guided Fascia Iliaca Compartment Block Versus Intravenous Fentanyl [NCT02983344]24 participants (Actual)Interventional2015-10-31Completed
Preventive Effect of Stellate Ganglion Block on Cerebral Vasospasm in Patients Undergoing Aneurysm Surgery [NCT02275247]40 participants (Anticipated)Interventional2014-08-31Enrolling by invitation
Postoperative Analgesia With Local Infiltration After Femoral Neck Fracture vs. Traditional Treatment of Pain With Opioids [NCT00529425]Phase 450 participants (Actual)Interventional2008-01-31Completed
[NCT00523289]Phase 448 participants (Anticipated)Interventional2007-10-31Active, not recruiting
Abdominal Wall Nerve Blockade: A Comparison With Local Port Site Injection as Well as Between the Use of Ultrasound and Laparoscopy to Guide Placement [NCT02945696]0 participants (Actual)Interventional2016-10-31Withdrawn(stopped due to Funding issues)
The Effect of 3 Ropivacaine Suprascapular Nerve Blocks in Subacute Adhesive Capsulitis: a Randomized Controlled Trial [NCT02944526]Phase 436 participants (Actual)Interventional2016-11-30Completed
Intercostal Cryoneurolysis Following Traumatic Rib Fractures [NCT04198662]Phase 420 participants (Actual)Interventional2020-04-03Active, not recruiting
A Randomized, Double-Blind, Placebo- and Active-Controlled, Dose Escalation and Optional Dose Expansion Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CPL-01 in Postoperative Pain After Open Inguinal Herniorrhaphy [NCT05080959]Phase 2105 participants (Actual)Interventional2021-07-28Completed
Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery? [NCT00547989]Phase 346 participants (Actual)Interventional2006-10-31Completed
Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management [NCT04567407]Phase 445 participants (Actual)Interventional2020-09-22Completed
Caudal vs. Pudendal Block for Early Postoperative Pain Control in a Pediatric Population Undergoing Lower Genitourinary Surgery [NCT05708989]Phase 4138 participants (Anticipated)Interventional2023-03-06Suspended(stopped due to Transitioning to new clinic)
Ropivacaine for Ultrasound-guided Interscalene Block: 3mL Provide Similar Analgesia to 5mL With Less Diaphragmatic Paralysis in Shoulder Arthroscopy Surgeries [NCT04317235]60 participants (Actual)Interventional2016-01-10Completed
Effect of Scalp Nerve Block Combined With Intercostal Nerve Block on Quality of Recovery After Deep Brain Stimulation in Patients With Parkinson's Disease [NCT05353764]88 participants (Anticipated)Interventional2022-04-20Recruiting
The Effect of Dexmedetomidine for Suprascapular Nerve Block With Axillary Nerve Block on Plasma Cortisol and Pain-related Cytokines After Arthroscopic Rotator Cuff Repair: a Randomized Controlled Trial [NCT04398589]Phase 446 participants (Actual)Interventional2015-05-20Completed
Optimizing Local Anesthetic Concentration for Continuous Lumbar Plexus Nerve Blocks [NCT00912873]Phase 450 participants (Actual)Interventional2008-05-31Completed
The Impact of a Preoperative Nerve Block in Foot and Ankle Surgery on the Consumption of Sevoflurane [NCT04022057]Phase 2/Phase 3100 participants (Anticipated)Interventional2019-08-01Recruiting
[NCT00956709]Phase 435 participants (Actual)Interventional2008-12-31Terminated
Preemptive Co-infiltration of Dexamethasone Palmitate Emulsion With Ropivacaine for Postoperative Pain in Patients Undergoing Major Spinal Surgery [NCT05693467]Phase 4124 participants (Anticipated)Interventional2023-03-01Recruiting
Clinical Outcome Following Arthroscopic Knee Surgery (COFAKS)-Addendum [NCT03704376]Phase 4125 participants (Actual)Interventional2016-02-01Completed
Comparison Between Single Shot Versus Continuous Infraclavicular Brachial Plexus Block for Postoperative Analgesia After Distal Radius Fracture: A Prospective Randomized Open Label Study [NCT02744352]8 participants (Actual)Interventional2016-10-31Terminated(stopped due to prior to its planned completion as anticipated by the protocol due to lack of resources)
Erector Spine Block in Patients Undergoing Back Surgery, Observational Feasibility Trial of the Effect on Postoperative Pain-scores and Opioid Consumption [NCT03214536]15 participants (Actual)Interventional2017-06-25Completed
Effect of Dexmedetomidine as Adjuvant to Ropivacaine for Brachial Plexus Block [NCT05767827]40 participants (Anticipated)Interventional2023-02-01Recruiting
Ultrasound Guided Nerve Block Combinations for Anterior Cruciate Ligament Reconstruction; Femoral, Saphenous and Obturator (Posterior Branch)Nerves. [NCT01840800]82 participants (Actual)Interventional2013-02-28Completed
Application of Ultrasound-Guided Thoracic Paravertebral Block in Pulmonary Ablation Surgery [NCT05437718]30 participants (Actual)Interventional2021-12-01Completed
Outcomes of Perioperative Epidural Analgesia in Gynecologic Oncology Patients: A Parallel Prospective Cohort and Randomized Clinical Study [NCT00295945]240 participants (Actual)Observational2005-03-31Completed
Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block [NCT04209504]60 participants (Anticipated)Observational2021-10-12Recruiting
Evaluation of a Peri-Operative Continuous Bilateral Erector Spinae Plane (ESP) Continuous Catheter After Open Cardiac Surgery in Adults [NCT03901612]Phase 40 participants (Actual)Interventional2019-01-05Withdrawn(stopped due to covid and surgeon left)
Impact of Ultrasound-Guided Transversus Abdominis Plane Block on Postoperative Nausea and Vomiting and Early Outcome After Laparoscopic Bariatric Surgery: a Randomized Double-Blinded Controlled Trial [NCT05016180]Phase 2120 participants (Anticipated)Interventional2020-09-25Recruiting
Surgeon Performed Saphenous Nerve Block at the Medial Femoral Condyle for Arthroscopic Partial Meniscectomy and Meniscus Repair: A Randomized Control Trial [NCT04717609]Phase 3160 participants (Actual)Interventional2021-01-25Enrolling by invitation
Paravertebral Block vs no Block in Open Pancreaticoduodenectomy: Prospective Randomized Controlled Trial [NCT05820997]Phase 440 participants (Anticipated)Interventional2023-04-24Recruiting
Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block for Pain Management in Pediatric Patients With Developmental Dysplasia Sia of the Hip Joint, Randomized Controlled Trial [NCT05543109]85 participants (Anticipated)Interventional2022-09-29Enrolling by invitation
Pre-operative Paravertebral Blocks to Decrease Post-operative Pain Following Mastectomy With Immediate Tissue Expander Reconstruction [NCT02161705]Phase 318 participants (Actual)Interventional2014-07-31Terminated(stopped due to Poor accrual due to change in standard of care procedure.)
Ultrasound-guided Intermediate Cervical Block Versus Superficial Cervical Block for Carotid : a Randomised Controlled Trial [NCT01742845]86 participants (Actual)Interventional2011-04-30Completed
Double Blind Randomized Phase III Controlled Trial Comparing the Effect of Preoperative and Postoperative Nebulization of Ropivacaine on Pain Control After Laparoscopic Cholecystectomy [NCT01247857]Phase 390 participants (Actual)Interventional2008-04-30Completed
Effect of Transversus Abdominis Plane Block Combined With Dexmedetomidine Infusion on the Prognosis in Elderly Patients Undergoing Abdominal Surgery [NCT04516174]180 participants (Anticipated)Interventional2020-09-01Not yet recruiting
Early and Late Postoperative Analgesia and Recovery Effects of Programmed Intermittent Bolus Infusion of Thoracic Paravertebral Block for Hepatectomy: A Prospective, Randomized, Double-blinded, Controlled Study [NCT04304274]76 participants (Actual)Interventional2020-03-10Completed
Pain Management of Anterior Cruciate Ligament Reconstruction: Evaluation of Adductor Canal Block Versus Oral Pain Regimen [NCT03365908]60 participants (Anticipated)Interventional2017-10-09Enrolling by invitation
Choose Between Two Different Concentration of Ropivacaine on TAP Block for Children Submitted of Open Appendectomy [NCT03005808]Phase 440 participants (Actual)Interventional2015-01-31Completed
A Double Blind, Multi-center, Randomized, Placebo-Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Ropivacaine 0.2% Pre-Filled Dispenser for the Treatment of Postsurgical Pain in Patients Undergoing Cesarean Delivery [NCT02959476]Phase 3132 participants (Actual)Interventional2017-03-13Completed
The Effect of Thoracolumbar Paravertebral Block or Intravenous Lidocaine and Ketamine Versus Standard Care on Acute and Chronic Pain After Inguinal Herniorrhaphy [NCT00720330]12 participants (Actual)Interventional2008-07-31Terminated(stopped due to Enrollment challenges prohibited study progression.)
The Effect of Dexamethasone on the Duration of Interscalene Nerve Blocks With Ropivacaine or Bupivacaine [NCT00801138]218 participants (Actual)Interventional2008-11-30Terminated(stopped due to A strong primary outcome crosses the efficacy boundary at the interim analysis)
Ultrasound Guided Supraclavicular Nerve Block: Comparison Between a Mixture of Mepivacaine and Ropivacaine, and Sequential Injection of Mepivacaine Followed by Ropivacaine [NCT00825786]Phase 3103 participants (Actual)Interventional2008-09-30Completed
Post Operative Analgesia Using the Transverse Abdominal Plan (TAP) Block in Patients Undergoing a Radical Retropubic Prostatectomy (RRP) [NCT00913068]110 participants (Actual)Interventional2009-07-31Completed
Comparison of Temporomandibular Joint Arthrocentesis With Infiltration of PRP + Ropivacaine Versus PRP: Does It Reduce Postoperative Pain? [NCT05817162]Phase 430 participants (Anticipated)Interventional2023-04-01Enrolling by invitation
Local Infiltration Analgesia for Postoperative Pain After Caesarean Section. A Prospective, Randomised, Controlled Trial [NCT01094106]Phase 470 participants (Actual)Interventional2010-04-30Completed
Prospective Randomized Study Comparing Regional Anesthetic Blocks and Periarticular Infiltration for the Management of Postoperative Pain After Total Knee Replacement. [NCT01163214]Phase 4160 participants (Actual)Interventional2010-07-31Completed
Perioperative Ropivacaine Wound Infusion in Laparoscopic Cholecystectomy. A Randomized Controlled Double-blind Trial [NCT01388946]110 participants (Actual)Interventional2010-05-31Completed
Minimum Effective Anesthetic Concentration of Supraclavicular Block, Infraclavicular Block, Femoral Nerve Block and Sciatic Nerve Block Via the Popliteal and Parasacral Approach [NCT01452126]Phase 249 participants (Actual)Interventional2011-06-30Terminated(stopped due to Departure of principal investigator)
Randomized Trial of Transversus Abdominal Plane (TAP) Block at Total Laparoscopic Hysterectomy: Effect of Regional Analgesia on Quality of Recovery [NCT01479270]56 participants (Actual)Interventional2011-05-31Completed
Comparing Intrathecal Morphine and Erector Spinae Plane Regional Anesthesia Against Intrathecal Morphine Alone for Post-Cesarean Section Pain [NCT06114121]Phase 4100 participants (Anticipated)Interventional2024-01-10Not yet recruiting
A Comparison of 0.1 and 0.2% Ropivacaine in Lumbar Plexus Catheters After Primary Total Hip Arthroplasty: a Comparison of Postoperative Analgesia and Motor Function. [NCT01556724]41 participants (Actual)Interventional2010-01-31Completed
Interventional Study of Antalgic Efficacy of the CycloMesh™ Implant Soaked in Ropivacaine Hydrochloride 10 mg/mL in the Treatment of Uncomplicated Inguinal Hernia. Randomized Comparative Study Versus CycloMesh™ Soaked in Physiological Saline Solution NaCl [NCT04033055]304 participants (Actual)Interventional2019-10-31Completed
Impact of Individualized Timing of Analgesia on the Effectiveness of Labor Analgesia: a Randomized Controlled Trial [NCT02920489]200 participants (Actual)Interventional2016-08-31Completed
Effects of Scalp Nerve Blocks on Systemic Inflammation After Meningeoma Resection Surgery:a Prospective Randomized Controlled Trial [NCT02939833]160 participants (Anticipated)Interventional2017-01-31Not yet recruiting
Antepartum Chronic Epidural Therapy (ACET) Using Ropivacaine to Improve Uteroplacental Blood Flow in Pre-Eclampsia and Intrauterine Growth Restriction [NCT00197340]Phase 320 participants (Anticipated)Interventional2003-08-31Completed
Randomized Trial to Evaluate the Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery [NCT00210132]Phase 290 participants (Actual)Interventional2003-10-31Completed
Pain Relief by Continuous Intra-Peritoneal Nebulization of Ropivacaine During Gynecological Laparoscopic Surgery [NCT00433316]Phase 340 participants (Actual)Interventional2007-02-28Completed
Outcomes Of Perioperative Pregabalin On Total Knee Arthroplasty: A Randomized Controlled Trial [NCT02954484]Phase 3116 participants (Actual)Interventional2015-04-30Completed
Impact of Intraperitonael Nebulization of Local Anesthetic on Postoperative Pain Associated With Laparoscopic Surgery [NCT01512914]Phase 3120 participants (Actual)Interventional2008-05-31Completed
Evaluating Pain Outcomes of Caudal vs Ilioinguinal Nerve Block in Children Undergoing Orchiopexy Repair [NCT03041935]90 participants (Actual)Interventional2015-09-01Completed
A Prospective, Randomized, Single-Blind Study to Evaluate the Efficacy of Transversus Abdominis Plane Versus Paravertebral Regional Blockade in Patients Undergoing Laparoscopic Colectomy [NCT02164929]17 participants (Actual)Interventional2013-12-31Terminated(stopped due to Poor recruitment)
Postoperative Analgesia in Third Molar Surgery Under General Anesthesia: Ropivacaine Versus Placebo [NCT01541059]Phase 4100 participants (Actual)Interventional2012-06-30Completed
Low Dose IV Dexamethasone in Prolonging Caudal Anesthesia in Children Undergoing Genitourinary Surgery [NCT02436265]Phase 48 participants (Actual)Interventional2015-02-28Terminated(stopped due to Lack of enrollment/lack of potential subjects fitting criteria)
The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Function After Robot-assisted Prostatectomy [NCT01547416]Phase 450 participants (Actual)Interventional2011-11-30Completed
Effect of Adductor-Canal-Blockade on High Pain Responders the 1. or 2. Postoperative Day After Total Knee Arthroplasty [NCT01549704]Phase 450 participants (Actual)Interventional2012-02-29Completed
Analgesic Efficiency of the Type 3 Quadratum Lumborum Block in Patients Undergoing Total Hip Arthroplasty : a Randomized Double Blinded Trial [NCT04555291]60 participants (Anticipated)Interventional2022-01-05Recruiting
Analgesic and Hemodynamic Effects of Continuous Epidural Analgesia Compared to Paravertebral Block in Liver Resection Patients [NCT02909322]Phase 450 participants (Anticipated)Interventional2016-04-30Recruiting
Comparative, Randomized Trial of SPI-directed Intravenous Analgesia Using Metamizole With Tramadol Versus Preemptive Wound Infiltration Using 0,2 % Ropivacaine With Fentanyl or 0,2 % Bupivacaine With Fentanyl for Lumbar Discectomy [NCT02971540]132 participants (Actual)Interventional2016-02-29Completed
" Analgesic Efficacy of Continuous Infusion of Local Anaesthetic Versus Single-shot Injection Interscalene Brachial Plexus Block in Patients Receiving a Large Multimodal Analgesia: a Randomized Controlled Trial " [NCT04394130]60 participants (Actual)Interventional2020-05-12Completed
Comparison Between Infraclavicular Brachial Plexus Block Versus Local Infiltration for Postoperative Analgesia After Wrist Arthroscopy, a Prospective Randomized Open Label Study [NCT02970097]0 participants (Actual)Interventional2016-09-30Withdrawn(stopped due to lack of resources)
Examination of the LIA (Local Infiltration) Versus Regional Blockade as Pain Management for Open-wedge High Tibial Osteotomy [NCT01537146]Phase 460 participants (Actual)Interventional2010-04-30Completed
A Prospective, Randomised, Non-inferiority Study of Chloroprocaine 2% and the Active Control Ropivacaine 0.75% (AstraZeneca) in Ultrasound-guided Axillary Nerve Block for Short-duration Distal Upper Limb Surgery [NCT02385097]Phase 3211 participants (Actual)Interventional2015-04-30Completed
A Randomized Comparison of a Continuous Posterior Tibial Nerve Block and Single Injection Posterior Tibial Nerve Block in Patients Undergoing Forefoot Surgery [NCT01555216]0 participants (Actual)Interventional2011-10-31Withdrawn(stopped due to Lack of participant recruitment)
Optimal Pain Control After Prothetic Knee Surgery Either by Selective Tibial Nerve Block Versus Local Infiltration Analgesia [NCT03698006]60 participants (Actual)Interventional2021-02-12Completed
Autologous Blood Transfusion After Local Infiltration Analgesia With Ropivacaine in Total Knee and Hip Arthroplasty [NCT01576263]52 participants (Actual)Observational2010-03-31Completed
A Phase Ⅱ Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Single Injection Intercostal Nerve Block With HR18034 for Postoperative Pain Management [NCT05744674]Phase 296 participants (Anticipated)Interventional2023-02-21Recruiting
Ultrasound-guided Lumbar Plexus Combined With Quadratus Lumborum Block Using Single-needle Technique With Shamrock Method for Hip Arthroplasty [NCT04266236]84 participants (Anticipated)Interventional2020-07-09Recruiting
Study on the Efficacy of Infiltration of Upper Cluneal Nerves in Chronic Pain Related to Cluneal Syndrome [NCT05423132]0 participants (Actual)Interventional2022-06-30Withdrawn(stopped due to Investigator left the team)
Role of Ropivacaine Postincisional Infiltration With Intraperitoneal Instillation Analgesia in Postoperative Pain Relief in Patients Undergoing Non Descent Vaginal Hysterectomy: Randomized Controlled Trial [NCT03099720]Phase 448 participants (Actual)Interventional2017-04-04Completed
Axillary Block in Association With Analgesic Truncal Blocks of the Median and Radial Nerves at the Elbow for Wrist Surgery. [NCT04046744]150 participants (Actual)Interventional2019-10-07Completed
Effect of Ultrasound-guided Quadratus Lumborum Block With Compound Lidocaine and Esketamine on Postoperative Pain in Patients Undergoing Colorectal Surgery: a Randomized Double-blind Controlled Trial [NCT05964985]160 participants (Anticipated)Interventional2023-08-06Not yet recruiting
Can Erector Spinae Plane (ESP) Block Better Relieve Acute Renal Colic Pain Than Standard of Care [NCT05323175]Phase 424 participants (Anticipated)Interventional2022-04-25Recruiting
The Evaluation of Erector Spinae Plane Block for the Pain Control of Thoracic Postherpetic Neuralgia [NCT03595046]0 participants (Actual)Interventional2018-07-31Withdrawn(stopped due to It was difficult to recruit subjects.)
Paravertebral Catheter Use for Postoperative Pain Control in Patients After Lung Transplant Surgery: A Prospective Observational Study [NCT02380417]33 participants (Actual)Observational2013-10-31Completed
The Minimal Effective Volume (MEV90) of Ropivacaine 0.75% for Ultrasound-guided Transmuscular Quadratus Lumborum Block for Unilateral Percutaneous Nephrolitotomy: a Study Protocol for a Dose Finding Trial [NCT04196270]Phase 440 participants (Anticipated)Interventional2020-01-05Not yet recruiting
Fascia Iliaca Block for Post-Operative Pain Control After Total Hip Arthroplasty: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study [NCT02299271]Phase 472 participants (Actual)Interventional2014-06-30Terminated(stopped due to Preliminary analysis showed no difference between groups.)
Incidence Of Hemidiaphragmatic Paralysis With Patient Controlled Infusion Of Low Volume Of Ropivacaine After Usg Guided Low Dose Interscalene Brachial Plexus Block [NCT03081728]56 participants (Actual)Interventional2017-04-01Completed
The Effect of Ultrasound Guided Blockade of the Femoral Nerve, the Anterior Division of the Obturator Nerve, and the Lateral Femoral Cutaneous Nerve on Postoperative Pain, Morphine Consumption, and Mobilization After Total Hip Arthroplasty. [NCT01276925]81 participants (Anticipated)Interventional2011-08-31Recruiting
Effects of Thoracic Epidural Anesthesia With Different Local Anesthetics on Propofol Induction [NCT02000973]Phase 480 participants (Actual)Interventional2013-11-30Completed
Efficacy of Hematoma Block on Postoperative Pain After Femoral Intramedullary Rodding: A Randomized Trial [NCT04860856]Phase 488 participants (Actual)Interventional2019-08-17Completed
A Pilot Study to Assess the Feasibility of a Future Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Role of Intra-Peritoneal Ropivacaine in Gastric Bypass Surgery: INOPAIN Trial [NCT02154763]Phase 3120 participants (Actual)Interventional2014-07-31Completed
Decision Support for Intraoperative Low Blood Pressure [NCT02726620]22,435 participants (Actual)Interventional2017-01-05Completed
Trans-incisional Rectus Sheath Block Versus Laparoscopic Guided Rectus Sheath Block for Pediatric Single Incision Laparoscopic Cholecystectomy: A Prospective, Randomized Study [NCT02494336]48 participants (Actual)Interventional2015-06-30Completed
Efficacy of Infiltration of Chlorhydrate of Ropivacaine in the Prevention of Chronic Breast Pain After Surgery for Breast Cancer. [NCT00370240]Phase 4260 participants (Actual)Interventional2006-09-30Completed
Proximal Lower Limb Intramuscular Block : Effects on Hemiparetic Gait [NCT05519592]30 participants (Anticipated)Interventional2022-09-09Not yet recruiting
Efficacy of Multimodal Perioperative Analgesia Protocol With Periarticular Drug Injection in Total Knee Arthroplasty: A Randomized, Double Blind Study [NCT01042093]160 participants (Actual)Interventional2010-01-31Completed
Ultrasound Guided Distal Sciatic Nerve Block - a Randomised Comparison With Nerve Stimulator Technique [NCT01643616]250 participants (Actual)Interventional2010-11-30Completed
Does Single Injection Adductor Canal Block Improve Postoperative Analgesia in Patients Receiving Periarticular Local Anesthesia Injections for Total Knee Arthroplasty? [NCT02276495]55 participants (Actual)Interventional2014-09-26Active, not recruiting
Analgesic Efficacy of Perineural Dexamethasone Added to Ropivacaine 0.5% With 1:400,000 Epinephrine During Single-injection Supraclavicular Block for Outpatient Hand Surgery [NCT02154048]Phase 25 participants (Actual)Interventional2012-04-30Terminated
Analgesic Efficacy of Transversus Abdominis Plane Block Versus Local Injection in Postoperative Pain Management Following Minimally Invasive Gynecological Surgery [NCT02314104]220 participants (Actual)Interventional2011-05-31Completed
Efficacy of Continuous Infusion Ropivacaine Interscalene Blocks Versus Placebo for Pain Control After Arthroscopic Rotator Cuff Repair [NCT02462382]Phase 451 participants (Actual)Interventional2013-09-01Completed
Impact of Peripheral Pain Perception on Central Sensitization and Movement Strategies in Patients With Chronic Achilles Tendinopathy [NCT03316378]Phase 2/Phase 346 participants (Actual)Interventional2016-01-28Completed
Comparative Study of Ropivacaine and Ropivacaine With Dexmeditomedine in Transversus Abdominis Plane (TAP) Block for Post-operative Analgesia in Patients Undergoing Cesarean Sections [NCT02472522]100 participants (Actual)Interventional2015-05-31Completed
Liposomal Bupivacaine Versus Interscalene Nerve Block for Pain Control After Shoulder Arthroplasty: A Prospective Randomized Trial [NCT02570022]Phase 457 participants (Actual)Interventional2014-10-31Completed
Optimal Postoperative Pain Management by Ultrasound-guided Abdominal Wall Nerve Blockade in Laparoscopic Surgery for Acute Appendicitis - a Randomised Controlled Trial. [NCT01825863]56 participants (Actual)Interventional2013-06-30Completed
Ultrasound-guided Fascia Iliaca Compartment Block Versus Periarticular Infiltration for Pain Management After Total Hip Arthroplasty: A Randomized Controlled Trial [NCT02658240]60 participants (Actual)Interventional2016-04-05Completed
Erector Spinae Plane Block (ESPB) vs. Iliopsoas Plane Block for Pain Management and Stress Response in Patients Undergoing Total Hip Arthroplasty. A Prospective, Randomized Trial. [NCT06083428]Phase 460 participants (Anticipated)Interventional2023-11-01Not yet recruiting
A Single-dose, Open-Label, Multi-center Study to Assess the Safety and Preliminary Efficacy of PRF 110 (Formerly LNP) in Open Herniorrhaphy Surgery [NCT01681966]Phase 215 participants (Actual)Interventional2012-09-30Completed
Postoperative Analgesia After Total Hip Arthroplasty. A Comparison of Continuous Epidural Infusion and Wound Infiltration With Intraarticular Bolus Injection. [NCT00289419]Phase 480 participants (Actual)Interventional2005-02-28Completed
Safety and Efficacy of Cocktail Periarticular Injection for Pain Management in Simultaneous Bilateral Total Knee Arthroplasty- A Prospective, Randomized Trial [NCT02270437]Phase 455 participants (Actual)Interventional2014-06-30Completed
Prevention of Systemic Toxicity Induced by Levobupivacaine and Ropivacaine by Intralipid® [NCT01602250]Phase 216 participants (Actual)Interventional2011-01-31Completed
The Erector Spinae Plane Block and Its Effect on Respiratory Status and Pain Management in Rib Fracture Patients [NCT03805360]Phase 14 participants (Actual)Interventional2019-05-24Terminated(stopped due to Insufficient enrollment)
Rotator Cuff Repair Under Isolated Loco-regional Anesthesia Versus General Anesthesia Combined With Loco-regional Anesthesia: Randomized Controlled Trial of Superiority. [NCT05848375]80 participants (Anticipated)Interventional2023-11-13Recruiting
A Phase 2/3, Randomized, Double-blind, Comparator- and Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TLC590 for Postsurgical Pain Management Following Inguinal Hernia Repair [NCT05161637]Phase 2/Phase 3415 participants (Anticipated)Interventional2023-11-30Not yet recruiting
[NCT01495624]16 participants (Actual)Interventional2011-12-31Terminated(stopped due to Accrual insufficient to complete study in a feasible time frame)
Effekt of Transversus Abdominis Plane (TAP) Block After Robot-assisted Laparocopic Hysterectomy [NCT01504386]Phase 470 participants (Actual)Interventional2011-12-31Terminated(stopped due to Due to local restructering, further recruting was not possible)
Effect of Dexamethasone on Duration of Analgesia After Ultrasound-Guided Femoral, Obturator, and Popliteal Blocks With Ropivacaine in Total Knee Arthroplasty [NCT01511211]Phase 40 participants (Actual)Interventional2012-09-30Withdrawn(stopped due to Other researchers have published results on a similar trial)
Intraperitoneal Atomization of Ropivacaine During Gynecologic Laparoscopic Surgery: Impact on Pain, Opioid Use and Length of Recovery Room Stay [NCT01623635]Phase 3200 participants (Anticipated)Interventional2012-02-29Recruiting
Whether Opioids Are Factor That Induced Postoperative Delirium? [NCT05596071]130 participants (Actual)Interventional2016-06-25Completed
Efficacy of Intraoperative Injections on Postoperative Pain Control During Total Hip Arthroplasty: A Prospective, Blinded, Randomized Controlled Study [NCT03119038]Phase 40 participants (Actual)Interventional2016-04-30Withdrawn(stopped due to Investigator no longer actively pursuing this study.)
Duration of Interscalene Nerve Blocks With Ropivacaine Alone, Ropivacaine Mixed With Dexamethasone, and Ropivacaine Alone Combined With Systemic Dexamethasone [NCT00519584]218 participants (Actual)Interventional2007-07-31Terminated(stopped due to Collected study data was not usable due to process miscommunications)
Continuous Right Thoracic Paravertebral Block on Postoperative Pain After Right Lobe Hepatectomy [NCT01691937]Phase 248 participants (Actual)Interventional2012-09-30Completed
Evaluation of Ropivacaine and Ropivacaine Plus Magnesium Sulphate Infiltration for Postoperative Analgesia in Patients Undergoing Thyroidectomy [NCT05294393]Phase 464 participants (Anticipated)Interventional2022-01-21Enrolling by invitation
The Effect of Preoperative Stellate Ganglion Block on Postoperative Atrial Fibrillation After Video-assisted Thoracoscopic Surgeries: A Randomized Controlled Trial [NCT05753644]480 participants (Anticipated)Interventional2023-03-27Recruiting
Postoperative Analgesia After Thoracotomy Without Thoracic Epidural Analgesia: Continuous Wound Catheter Analgesia Associated With Intravenous Morphine Patient-Controlled-Analgesia (PCA) [NCT01698203]Phase 492 participants (Actual)Interventional2012-10-14Completed
Pilot Study: A Non-Inferiority Trial of the Analgesic Effect of Paravertebral Analgesia to Epidural Analgesia for the Management of Post-Operative Pain After Thoracotomy [NCT01700491]Phase 321 participants (Actual)Interventional2012-10-31Terminated(stopped due to Difficulty in recruiting and maintenance of blinding necessary for the trial)
Determining the Minimal Effective Volume (MEAV95) for Interscalene Brachial Plexus Block for Surgical Anesthesia [NCT01703130]Phase 460 participants (Anticipated)Interventional2012-10-31Recruiting
[NCT01703351]Phase 279 participants (Actual)Interventional2012-10-04Completed
Comparison of Subgluteal Sciatic Nerve Block Duration in Type-2 Diabetic and Non Diabetic Patients [NCT01704612]Phase 470 participants (Actual)Interventional2011-07-31Completed
Patient Controlled Epidural Analgesia Versus Local Infiltration Analgesia Following Knee Arthroplasty Within an Enhanced Recovery Programme - a Randomised Controlled Trial [NCT02478372]242 participants (Actual)Interventional2010-04-30Completed
Interscalene Block on Ventilatory Function After Shoulder Surgery : Evaluation of Single or Continuous Injection [NCT01740453]Phase 470 participants (Actual)Interventional2012-01-31Completed
Ultrasound Guided Transversus Abdominis Plane Block With Ropivacaine vs Placebo for Abdominal Hysterectomy: a Double-blinded, Randomized Clinical Trial [NCT01743378]48 participants (Actual)Interventional2011-02-28Completed
Efficacy of Continuous Wound Infusion in Major Lumbar and Thoracic Spine Surgery : A Randomised, Double-blinded, Placebo-controlled Study [NCT01743794]Phase 2/Phase 360 participants (Actual)Interventional2011-01-31Completed
Comparison of Posterior Lumbar Plexus Block Plus Sciatic Nerve Block With Sciatic Plus Femoral Plus Obturator Nerve Block for Total Knee Replacement (TKR) [NCT01755117]100 participants (Anticipated)Interventional2012-12-31Recruiting
Safety and Feasibility Study of an Enhanced Recovery After Surgery Protocol in Patients Undergoing Elective Pancreaticoduodenectomy. [NCT01759706]123 participants (Actual)Interventional2010-10-31Completed
Influence of the Concentration of the Local Anesthetic Ropivacaine on the Quality of a Ultrasound Guided Block of the Regio Collis Lateralis for Carotid Endarterectomy: a Prospective, Randomized and Controlled Trail [NCT01759940]Phase 446 participants (Actual)Interventional2012-11-30Completed
A Randomised, Double-blind Study to Evaluate the Effect of Bilateral Dual Transversus Abdominis Plane Block on Postoperative Pain and Plasma Concentration of Ropivacaine After Robotic Assisted Laparoscopic Surgery [NCT01760161]80 participants (Anticipated)Interventional2014-04-30Terminated(stopped due to No signal on pain-score)
A Randomized Double Blind Trial Comparing the Effect of Transversus Abdominal Plane-catheter and Epidural Catheter on Postoperative Pain After Open Gynecologic Surgery [NCT01760174]0 participants (Actual)Interventional2016-01-31Withdrawn(stopped due to Because of logistic and practical reasons.)
Use of Pre-operative Nerve Blocks in Older Patients With Hip Fracture: A Pilot Study [NCT02450045]73 participants (Actual)Interventional2015-06-30Terminated(stopped due to PI no longer at institution)
Local Infiltration Analgesia After Abdominal Hysterectomy [NCT01782781]Phase 360 participants (Actual)Interventional2012-11-30Completed
Regional Haemodynamic Changes in Radial Artery Assessment With Continuous Pulsed-wave Doppler Ultrasound in Patients Undergoing Video-assisted Thoracic Surgery With Different Kinds of Anaesthesia Management [NCT03302221]Phase 40 participants (Actual)Interventional2017-10-15Withdrawn(stopped due to No participants enrolled)
Onset Time of Brachial Plexus Block Using Local Anaesthetic Diluted With 0.9% Saline vs 5% Dextrose [NCT01815944]55 participants (Actual)Interventional2011-12-31Completed
Postoperative Rehabilitation After Cardiac Surgery in Patients at Risk of Respiratory Complications. Effects of a Continuous Bi-laterosternal Infusion of Ropivacaine Through Multihole Catheters. [NCT01828788]Phase 2120 participants (Actual)Interventional2013-04-27Completed
Continuous Versus Intermittent Sciatic Block Combined With a Continuous Femoral Block for Patients Undergoing Total Knee Arthroplasty: a Prospective, Randomized Trial. [NCT01843153]Phase 4140 participants (Actual)Interventional2013-04-30Completed
Comparison of a Pain Pump Versus Injectable Medication for Analgesia in Knee Arthroscopy [NCT01242644]Phase 248 participants (Actual)Interventional2006-10-31Completed
Prospective Blinded Study Looking at PO/IV Analgesia Alone Versus PO/IV Analgesia With Superior Hypogastric Nerve Block for Uterine Artery Embolization Pain Management [NCT02270255]Phase 244 participants (Actual)Interventional2015-04-30Completed
Regional Scalp Block Versus IV Parecoxib for Post-operative Cranioplasty Surgery Pain: A Comparison of Pain Score. [NCT05442411]Phase 158 participants (Actual)Interventional2021-03-09Completed
The Effect of Sono-Guided Interscalene Brachial Plexus Block Combined With Arthroscopy-Guided Suprascapular Nerve Block in Arthroscopic Rotator Cuff Repair: A Randomized Controlled Trial [NCT02424630]52 participants (Actual)Interventional2013-08-31Completed
UCSF Sphenopalatine Ganglion Block Study- a Randomized Double Blind Placebo Controlled Trial to Compare Nasal Anesthetics for Migraine Prevention in Adults. [NCT03666663]Phase 410 participants (Actual)Interventional2019-02-01Completed
Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study [NCT03936387]Phase 310 participants (Actual)Interventional2019-07-01Completed
The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery. A Double Blind, Randomised, Placebo Controlled Trial. [NCT04248179]Phase 436 participants (Actual)Interventional2019-11-29Completed
Postoperative Analgesia After Total Knee Arthroplasty. A Comparison of Continuous Epidural Infusion and Wound Infiltration With Continuous Intraarticular Infusion [NCT00421967]Phase 480 participants (Actual)Interventional2007-01-31Terminated(stopped due to Interim analysis)
A Randomized Comparison of Single Injection vs. Continuous Saphenous Nerve Block to Supplement a Continuous Sciatic Nerve Block in Postoperative Pain Treatment After Major Ankle Surgery: Clinical Outcome and Cost Analysis [NCT01445210]50 participants (Actual)Interventional2011-09-30Completed
Selective Block of the Axillary Nerve in Postoperative Pain Management, a Randomised, Blinded, Placebo-controlled Trial [NCT01463865]60 participants (Actual)Interventional2011-11-30Completed
Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia: A Randomized Controlled Quadruple Blinded Non-Inferiority Trial (CLASSIER Trial) [NCT05487196]Phase 288 participants (Actual)Interventional2022-09-28Completed
A Safety Study of Ropivacaine Concentrations During Continuous Erector Spinae Plane Block for Thoracic Surgery [NCT04807504]20 participants (Actual)Observational2021-03-26Active, not recruiting
Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General Anesthesia [NCT03212456]146 participants (Actual)Interventional2017-01-12Active, not recruiting
TAP) Block in Morbid Obese Patients Undergoing Laparoscopic Gastric Bypass Surgery: A Prospective,Randomized, Blinded Study [NCT01075087]19 participants (Actual)Interventional2010-03-31Completed
A Randomised Single Blind Study Comparing the Molar Median Effective Dose of Levobupivacaine and Molar Median Effective Dose of Ropivacaine When Administered as a Femoral Perineural Infusion for Pain Relief After Total Knee Replacement [NCT01172197]Phase 414 participants (Actual)Interventional2009-01-31Terminated(stopped due to Terminated prior to its planned completion as anticipated by the protocol).)
Rebound Pain at Block Resolution After Operations for Distal Radius Fractures With a Volar Plate in Brachial Plexus Block [NCT03011905]Phase 353 participants (Actual)Interventional2017-01-31Completed
The Optimal Dosage of Ropivacaine for Arthroscopic Knee Surgery [NCT04759742]Early Phase 1115 participants (Actual)Interventional2021-03-01Completed
Transverse Abdominal Plane Blocks for Bariatric Surgery Patients: A Single Blinded Randomized Controlled Study [NCT04051684]Phase 1/Phase 223 participants (Actual)Interventional2013-04-30Completed
PATHOS Study Pain Assessment in Thoracic Oncologic Surgery: a Prospective Randomized Trial on Pain Management After Video Assisted Major Lung Resections. [NCT03134729]90 participants (Actual)Interventional2017-05-04Completed
Prospective Randomized Clinical Trial to Evaluate the Use of Paravertebral Blocks in Reconstructive Breast Surgery [NCT00542542]Phase 389 participants (Actual)Interventional2007-09-30Completed
Dexmedetomidine Added to Ropivacaine Single Shot vs Continuous Interscalene Nerve Block for Elective Arthroscopic Shoulder Surgery: a Prospective Randomized Control Trial [NCT05775861]96 participants (Anticipated)Interventional2022-08-23Recruiting
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel-Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Local Administration of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy [NCT05376904]Phase 286 participants (Actual)Interventional2022-06-13Completed
Efficacy of Liposomal Bupivacaine Versus Standard Analgesia in Pain Management of Total Joint Arthroplasty [NCT02197273]211 participants (Actual)Interventional2014-07-31Completed
Comparison Ropivacaine and Bupivacaine in Sphenopalatine Ganglion Block for Postoperative Analgesia After Functional Endoscopic Sinus Surgery: A Randomized Controlled Trial [NCT03013361]Phase 360 participants (Actual)Interventional2013-07-31Completed
Evaluation of Plasma Concentrations of Intravenous Lidocaine and Epidural Ropivacaine When Used in Combination in Major Abdominal Surgery [NCT05368753]Phase 450 participants (Anticipated)Interventional2022-03-09Recruiting
Chest Wall Block After Sternotomy: Randomized Controlled Trial in Cardiac Surgery: (PABLOS Study) [NCT05345639]Phase 3280 participants (Anticipated)Interventional2022-07-01Not yet recruiting
Single Shot Liposomal Bupivacaine (EXPAREL®)/Bupivicaine) Versus Continuous Erector Spinae Plane Block Catheter in Patients Undergoing Video Assisted Thoracoscopic (VAT) Surgery; Single Center, Non Inferiority, Open Label, Randomized Trial [NCT04559347]Phase 274 participants (Anticipated)Interventional2020-12-10Suspended(stopped due to Reviewing randomization process)
The Effect of Combined Popliteal and Saphenous Block in Addition to General Anesthesia in Surgical Fixation of Ankle Fractures: a Prospective Randomized Study [NCT01923623]Phase 40 participants (Actual)Interventional2013-07-01Withdrawn(stopped due to Study was redesigned and taken over by a ph.D-student)
The Dose Dependent Effect of Ropivacaine Transversus Abdominis Plane Blocks on Postoperative Analgesia After Cesarean Section [NCT02893423]51 participants (Actual)Interventional2013-01-01Terminated(stopped due to A better study with a better drug was started and thus this study was terminated)
Effect of the Transmuscular Quadratus Lumborum Block on Duration of Stay in Recovery: a Single-centre, Retrospective, Observational Study Based on Five Selected Randomised Controlled Trials [NCT04951752]307 participants (Actual)Observational2021-04-14Active, not recruiting
Perioperative Pain Management for Total Shoulder Arthroplasty: A Pilot Non-Inferiority Trial [NCT05908851]80 participants (Anticipated)Interventional2023-11-01Not yet recruiting
A Randomized Case Control Study of Pre-emptive Caudal Epidural Analgesia With Ropivacaine With and Without Dexamethasone for Lumbosacral Spine Surgery [NCT05904275]60 participants (Anticipated)Interventional2023-08-01Not yet recruiting
Transverse Abdominis Plane Block for Anterior Approach Spine Surgery: A Prospective Randomized Study [NCT02884440]Phase 243 participants (Actual)Interventional2016-11-07Completed
Optimal Timing of Intercostal Nerve Blocks During Video-Assisted Thoracic Surgeries [NCT02980835]Phase 436 participants (Actual)Interventional2016-09-28Completed
Minimum Effective Volume of 0.5% Ropivacaine for Ultrasound-Guided Infraclavicular Block [NCT03824717]55 participants (Anticipated)Interventional2019-01-31Not yet recruiting
Pudendal Block Versus Penian Block For Circumcision In Children: A Double Blind Randomised Controlled Trial [NCT03046290]60 participants (Anticipated)Interventional2017-01-31Recruiting
Impact of Dexmedetomidine Combined With Ropivacaine for Postoperative Continuous Femoral Nerve Block on Postoperative Delirium and Long-term Oucomes in Elderly Patients After Single Knee Arthroplasty [NCT03629483]Phase 4736 participants (Anticipated)Interventional2018-12-10Suspended(stopped due to Trial stopped by the sponsor because of no funding.)
Surgical Pain Control With Ropivacaine by Atomized Delivery [NCT01480089]Phase 456 participants (Actual)Interventional2011-11-30Completed
Does Administration of the Transmuscular Quadratus Lumborum Block Cause Quadriceps Muscle Weakness: A Randomised, Double-blinded Volunteer Study [NCT05023343]Phase 420 participants (Actual)Interventional2021-10-02Completed
Randomized and Controlled Phase IV Clinical Trial on the Analgesic Effectiveness of the Combined Blockade (Peng - Pericapsular Nerve Group- and the Femoral Lateral Cutaneous Nerve) in the Hip Fractures of the Elderly: Comparative Study Between Levobupivac [NCT04773301]Phase 4108 participants (Anticipated)Interventional2021-02-13Recruiting
Erector Spinae Plane Block for Minimally Invasive Mitral Surgery [NCT04770961]50 participants (Anticipated)Interventional2021-04-01Not yet recruiting
Comparison of Modified Programmed Intermittent Bolus (MPIB), Computer-integrated Patient Controlled Epidural Analgesia (CIPCEA) and Conventional Patient Controlled Epidural Analgesia (PCEA) During Labour [NCT02278601]Phase 3839 participants (Actual)Interventional2015-01-28Active, not recruiting
Ropivacaine Use in Femoral Nerve Block; What is the Minimal Effective Analgesic Concentration (MEAC 90) [NCT04834440]Phase 445 participants (Anticipated)Interventional2021-05-01Not yet recruiting
Transversus Abdominis Plane Catheter Following Kidney Transplantation [NCT04786470]Phase 3120 participants (Anticipated)Interventional2021-05-31Not yet recruiting
Combined Erector Muscle Spinae Plane Block and General Anaesthesia Versus General Anaesthesia Alone - Effect on Perioperative Opioid Consumption in Open Heart Surgery [NCT04338984]Phase 486 participants (Actual)Interventional2019-12-01Completed
Regional Anesthesia for Breast Cancer Surgery, Effects on Postoperative Wellbeing and Disease Recurrence. [NCT03117894]200 participants (Actual)Interventional2017-05-23Completed
Randomized Controlled Trial Evaluating Postoperative Analgesia and Muscle Strength Between Single Versus Continuous Adductor Canal Block for Ambulatory ACL Reconstruction. [NCT02584452]59 participants (Actual)Interventional2015-11-03Completed
Assessment of Knee Pain in Patients Receiving Continuous Femoral Nerve Block Combined With Either Ultrasound Guided Posterior Capsular Injection or Selective Tibial Nerve Block Following Total Knee Arthroplasty [NCT02701296]80 participants (Actual)Interventional2011-11-07Completed
Double Blinded Randomized Controlled Study Evaluating the Analgesic Duration of Dexmedetomidine Compared to Dexamethasone as Adjuncts to Single Shot Interscalene Block in Patients Undergoing Ambulatory Shoulder Surgery [NCT02653144]Phase 4105 participants (Actual)Interventional2016-03-31Completed
The Effect of Bilateral Infraorbital and Infratrochlear Nerve Block on Perioperative Analgesia After Endoscopic Binostril Transnasal Transsphenoidal Resection of Pituitary: a Prospective, Randomized Study [NCT05555147]120 participants (Anticipated)Interventional2022-09-01Active, not recruiting
Comparison of Intraoperative Intravenous Lidocaine Infusion and Transversus Abdominis Plane (TAP) Block for Post-operative Analgesia Following Laproscopic Cholecystectomy [NCT05231941]90 participants (Anticipated)Interventional2022-01-17Recruiting
Does Continuous Adductor Canal Nerve Block Improve the Quality of Recovery for Outpatient Total Knee Arthroplasty Patients? [NCT03038425]81 participants (Actual)Interventional2017-05-02Completed
The Efficacy of Pecto-intercostal Fascial Plane Catheters for Reduction of Sternal Pain in Cardiac Surgery Patients With Complete Median Sternotomy: A Randomized, Placebo-controlled Trial [NCT05054179]Phase 2/Phase 380 participants (Anticipated)Interventional2022-09-07Recruiting
Multimodal Post-Cesarean Analgesia With Spinal Morphine and Continuous Wound Infiltration of Ropivacaine Using the OnQ® Elastomeric Pump: A Dose-Ranging Study Using a High-Volume, Low-Dose Protocol [NCT02579629]Phase 464 participants (Actual)Interventional2015-07-31Completed
Augmenting Massed Prolonged Exposure With a Stellate Ganglion Block to Treat Posttraumatic Stress Disorder (PTSD) in Active Duty or Retired Service Members: A Pilot Study [NCT04302181]Early Phase 112 participants (Actual)Interventional2020-10-05Completed
The Benefit of Adding Ultrasound-guided ESP Block to PCA vs. PCA Alone for Postoperative Analgesia After Laparoscopic Nephrectomy Surgeries: a Pilot, Randomized Controlled Trial [NCT04085237]22 participants (Anticipated)Interventional2020-01-04Recruiting
Pain Management After Total Shoulder Arthroplasty: Continuous Interscalene Block Versus Local Tissue Infiltration With Liposomal Bupivacaine [NCT03219983]Phase 422 participants (Actual)Interventional2016-11-30Terminated
A Phase 2, Randomized, Double-blind, Comparator- and Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy [NCT03838133]Phase 2150 participants (Actual)Interventional2019-03-05Completed
Effect of Adductor Canal Block vs. Placebo on Muscle Strength, Mobilisation and Pain on the First Post-operative Day After Total Knee Arthroplasty [NCT02242591]Phase 464 participants (Actual)Interventional2014-08-31Completed
Propofol EC50 for Inducing Loss of Consciousness in Gastrectomy: Combined General and Epidural Anesthesia Versus General Anesthesia [NCT05124704]60 participants (Actual)Interventional2021-07-01Completed
Assessment of Sensory and Motor Block After Intrathecal Administration of Bupivacaine, Ropivacaine and Levo-bupivacaine Combined With Small Doses of Fentanyl, Followed by Administration of Normal Saline Epidurally:a Clinical Trial in Parturients Scheduled [NCT01558713]Phase 2/Phase 3120 participants (Anticipated)Interventional2010-01-31Recruiting
Effects of Epidurally Administered Ropivacaine Concentration on the Hemodynamic Parameters [NCT01559285]Phase 4120 participants (Actual)Interventional2011-11-16Completed
Method Study of Bilateral Transversus Abdominis Plane (TAP) Block With 24 Hours Infusion. Extent of Sensory Block, Analgetic Effect and Lung Function in Healthy Volunteers [NCT01577940]Phase 48 participants (Actual)Interventional2011-01-31Completed
Effectiveness of Adding Transverse Abdominus Plane (TAP) Catheter Blocks to Patient-controlled Analgesia (PCA) in Laparoscopic Colon Resections: a Prospective, Randomized Controlled Study [NCT01592630]Phase 30 participants (Actual)Interventional2012-05-31Withdrawn(stopped due to Investigator Left Institution)
[NCT01593319]Phase 437 participants (Actual)Interventional2012-01-31Terminated
Ultrasound Guided Intermediate Cervical Plexus Block -Randomized Evaluation Concerning the Significance of Additional Perivascular Local Anesthetic Infiltration [NCT02336958]40 participants (Actual)Interventional2013-09-30Completed
The Analgesic Efficacy of Continuous Infusion of Ketorolac and Ropivacaine at the Wound Site Using ON-Q Pump for Postoperative Pain Management [NCT00638508]Phase 467 participants (Actual)Interventional2007-06-30Completed
Continuous Preperitoneal Infusion of Ropivacaine After Open Liver Resection: Effect on Post-operative Recovery and Morbidity [NCT01890408]Phase 25 participants (Actual)Interventional2013-11-30Terminated(stopped due to promoter decision)
The Efficacy and Safety of Multimodal Analgesia in Children and Adolescents After the Ravitch Procedure and Thoracotomy - a Prospective Randomized Study [NCT03444636]Phase 494 participants (Actual)Interventional2015-03-02Completed
[NCT01726205]Phase 445 participants (Actual)Interventional2008-10-31Completed
Continuous Popliteal Sciatic Nerve Block Interest in Postoperative Pain Management for Patients With Leg Amputation [NCT00427947]Phase 36 participants (Actual)Interventional2006-12-31Terminated(stopped due to lack of patients)
Laparoscopic- Vs Ultrasound-guided Transversus Abdominis Plane Block in Laparoscopic Colectomy: a Prospective Randomized Controlled Trial [NCT04575233]116 participants (Actual)Interventional2018-01-15Completed
Effectiveness of Transversus Abdominis Plane Block in Reducing Immediate Postoperative Pain in Obese Women After Laparoscopic or Robotic Gynecologic Procedures [NCT01866917]Phase 1/Phase 235 participants (Actual)Interventional2013-04-30Terminated(stopped due to Pharmacy stopped dispensing study medication)
Comparison of Analgesic Efficacy of Quadratus Lumborum Block With Local Anesthesia and Quadratus Lumborum Block With Placebo Only After Ileostomy Repair: a Randomized, Double-blind, Non-inferiority Trial [NCT03411096]60 participants (Anticipated)Interventional2020-03-30Recruiting
The Post-Operative Pain Management of Pediatric Supracondylar Elbow Fractures [NCT01328782]124 participants (Actual)Interventional2008-06-30Completed
A Prospective, Randomized, Double-blinded, Active-comparator, Non-inferiority Study to Observe Relative Efficacy of Ultrasound-guided Transmuscular Quadratus Lumborum Block Versus Class Lumbar Plexus Block in Managing Post-operative Pain Following Total H [NCT03801265]Phase 446 participants (Actual)Interventional2019-03-19Completed
Quadratus Lumborum Block Reduced Postpartum Uterine Pain After Virginal Childbirth [NCT05371015]66 participants (Actual)Interventional2022-03-01Completed
Comparison of Postoperative Analgesic Efficacy of Adductor Canal Block With IPACK Versus Adductor Canal and Popliteal Sciatic Nerve Block in Patients Undergoing Arthroscopic Anterior Cruciate Ligament Reconstruction [NCT03983941]Phase 37 participants (Actual)Interventional2019-08-30Terminated(stopped due to PI leaving the institution, no subjects enrolled since 2019, and no other PI interested in taking it over.)
A Phase Ⅱ Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Single Injection Adductor Canal Block With HR18034 for Postoperative Pain Management [NCT05561309]Phase 296 participants (Anticipated)Interventional2022-10-20Recruiting
Exparel Pericapsular Injection: A Prospective Evaluation of Postoperative Pain in Bunion Surgery, First Metatarsophalangeal Joint Fusion, and Cheilectomy [NCT02499575]2 participants (Actual)Interventional2015-07-31Terminated(stopped due to Logistical issues prevent efficient enrollment)
Is Continuous Wound Infusion With Ropivacaine Better Than Intrathecal Morphine for Post-caesarean Analgesia? A Prospective, Randomized, Controlled, Double Blinded Study [NCT02264821]Phase 3192 participants (Actual)Interventional2012-02-29Completed
Are Preemptive Femoral and Lateral Femoral Cutaneous Nerve Blocks Given Immediately Prior to Hip Arthroscopy(THA) Effective for Acute Postoperative Pain Management? [NCT01997567]3 participants (Actual)Interventional2013-07-31Terminated(stopped due to Subject recruitment is too difficult and we foresee that this will not improve)
Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine: A Prospective, Randomized, Double-blinded, Controlled Study [NCT00616577]26 participants (Actual)Interventional2007-10-31Terminated(stopped due to PI is no longer here.)
Lateral Femoral Cutaneous Nerve and Pericapsular Nerve Group (PENG) Blocks Versus Suprainguinal Fascia Iliaca Block in Postoperative Analgesia of Hip Fractures: a Prospective, Controlled, Randomized and Double Blind Study [NCT05749367]66 participants (Anticipated)Interventional2023-03-06Not yet recruiting
Dexamethasone as an Adjuvant to Ropivacaine for Femoral Nerve Blocks in Children Undergoing Knee Arthroscopy [NCT01971645]Phase 377 participants (Actual)Interventional2014-07-31Completed
A Retrospective Investigation of Safety and Efficacy From Increasing Concentrations of Local Anesthetic in Pediatric Femoral Nerve Blocks [NCT02501135]281 participants (Actual)Observational2015-06-30Completed
ROPIVACAINE WITH CLONIDINE FOR PEDIATRIC RECTUS SHEATH BLOCKS- THE MAGIC COMBINATION? - A Double Blinded Prospective Study [NCT02439281]50 participants (Actual)Interventional2015-05-31Terminated(stopped due to The patients were discharged on the day of the surgery.)
Does Anesthetic Contribute to Symptomatic Relief in Corticosteroid Injections for Knee Osteoarthritis? A Double-Blind Randomized Trial Comparing Corticosteroid/Ropivacaine Versus Corticosteroid/Saline Injections [NCT02576249]Phase 429 participants (Actual)Interventional2015-10-31Completed
Optimizing Local Anesthetic Concentration for Continuous Popliteal-Sciatic Nerve Blocks [NCT01898689]Phase 424 participants (Actual)Interventional2013-07-31Completed
Correlation Between Perioperative Pain and Delirium in Geriatric Patients With Hip Fracture [NCT04404959]80 participants (Anticipated)Interventional2019-05-10Recruiting
Adductor Canal Mid-thigh and Adductor Canal Distal Thigh: Is Cutaneous Sensory Blockade Similar Among Block Techniques? [NCT02788019]Phase 452 participants (Actual)Interventional2016-05-26Terminated(stopped due to Unable to complete the sample size needed for 80% power due to changes in surgical approach to adductor block usage.)
The Effect of Continuous Interscalene Brachial Plexus Block With 0.125% Bupivacaine Versus 0.2% Ropivacaine on Diaphragmatic Motility and Ventilatory Function [NCT02059070]39 participants (Actual)Interventional2012-06-30Completed
the Safety and Effectiveness of the Effects on the Perioperative Pain Control Comparing Between the Thoracic Paravertebral Nerve Block Using the Camera Guided and the Intrathoracic Intercostals Nerve Block for the Management of Nonintubated Local Regional [NCT03086213]48 participants (Actual)Interventional2017-03-01Completed
Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies - the PATHFINDER II Study [NCT05279898]70 participants (Anticipated)Interventional2023-02-28Recruiting
Periarticular Infusion With Liposomal Bupivacaine or a Ropivacaine Cocktail Versus Continuous Femoral Nerve Catheters for Multimodal Pain Management Following Primary TKA: A Randomized Controlled Trial [NCT02369523]Early Phase 184 participants (Actual)Interventional2014-09-30Terminated(stopped due to Adequate enrollment was not reached for this study.)
A Randomised, Double-Blind, Multi-Centre, Parallel Group Study Comparing Efficacy and Safety of 5 mg/ml Ropivacaine and 5 mg/ml Bupivacaine for Spinal Anaesthesia in Patients Undergoing Unilateral Lower Limb Surgery [NCT00358280]Phase 3220 participants Interventional2006-04-30Completed
Supraclavicular Brachial Plexus Block Using Ropivacaine Alone or Combined With Dexmedetomidine for Upper Limb Surgery: A Prospective, Randomized, Double-blinded, Comparative Study [NCT02393677]80 participants (Actual)Interventional2011-07-31Completed
Analgesia After Total Shoulder Arthroplasty [NCT01782872]Phase 480 participants (Actual)Interventional2012-10-31Completed
Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks [NCT02523235]Phase 4117 participants (Actual)Interventional2015-08-31Completed
Dorsal Penile Nerve Block for Rigid Cystoscopy in Men: a Single-center, Randomized, Double-blind and Placebo-controlled Study [NCT02502487]258 participants (Actual)Interventional2015-06-30Completed
A Comparative Study Between Levobupivacaine 0.5% and Ropivacaine 0.75% in Patients Undergoing Spinal Anaesthesia for Lower Limb Orthopaedic Surgery. [NCT02201784]Phase 460 participants (Actual)Interventional2012-12-31Completed
Liposomal Bupivacaine Plus Bupivacaine Peripheral Nerve Blockade Versus Ropivacaine Plus Dexamethasone Peripheral Nerve Blockade for Arthroscopic Rotator Cuff Repair: a Prospective Randomized Trial [NCT04737980]Phase 492 participants (Actual)Interventional2019-07-18Completed
The Effectiveness of Bilateral Erector Spinae Plane Block (ESPB) in Laparoscopic Cholecystectomies. A Randomized, Controlled, Double Blind, Prospective, Trial [NCT04587973]60 participants (Actual)Interventional2020-06-01Completed
Comparison of Programmed Intermittent Bolus Infusions of Spinae Plane Block Versus Paravertebral Block for Analgesia in Minimally Invasive Direct Coronary Artery Bypass Grafting [NCT05320718]140 participants (Anticipated)Interventional2022-04-15Recruiting
Ropivacaine Versus Bupivacaine as Preemptive Analgesia in Surgical Site in Ankle Fracture Patients [NCT02949674]Phase 393 participants (Actual)Interventional2016-09-30Completed
A Prospective Triple-masked Randomized Controlled Trial Measuring Analgesia Duration of Dexamethasone, Buprenorphine, or Clonidine With Ropivacaine for Interscalene Nerve Block [NCT03117140]Phase 4160 participants (Actual)Interventional2013-12-31Completed
Serratus Anterior Plane Block: Sub-Serratus vs Supra-Serratus Plane Block for Pain Control in Patients Undergoing Mastectomy [NCT03154658]Phase 466 participants (Actual)Interventional2017-04-01Completed
Dose Escalation of Dexamethasone to Increase Duration of Transversus Abdominal Plane Block Following Cesarean Section: A Prospective Randomized Double-Blinded Clinical Study [NCT03098420]Phase 2/Phase 329 participants (Actual)Interventional2016-07-31Terminated(stopped due to Low enrollment; recruitment challenges due to competing studies in women and infant center)
Surgical Treatment of Proximal Femoral Fractures Under Peripheral Regional Anesthesia. A Prospective Pilot Study [NCT04005404]80 participants (Actual)Interventional2019-08-05Completed
Effects of Liposomal Bupivacaine for Acute Pain in Hip and Femur Fractures: a Randomized, Active Comparator-controlled, Blinded Trial [NCT02679560]Phase 23 participants (Actual)Interventional2017-10-01Terminated(stopped due to Poor recruitment)
The Effect of Saphenous Nerve and Obturator Nerve Block Combined With Systemic High Dose Glucocorticoid Versus Local Infiltration Analgesia Combined With a Systemic High Dose Glucocorticoid on Opioid Consumption and Pain After Total Knee Arthroplasty [NCT02374008]Phase 474 participants (Anticipated)Interventional2015-03-31Completed
An Open Label Pilot Study of Feasibility of a Dexmedetomidine-Remifentanil-Caudal Anaesthetic for Infant Lower Abdominal/Lower Extremity Surgery: The TREX Pilot Study [NCT02353182]Phase 460 participants (Actual)Interventional2015-05-31Completed
Femoral Nerve Block in Patient With Total Knee Arthroplasty; Analgesic Effect of Perineural Fentanyl Additive to Local Anesthetics [NCT02331576]100 participants (Anticipated)Interventional2015-01-31Recruiting
A Randomised Controlled Trial Comparing Ultrasound-guided Supraclavicular Brachial Plexus Block With Combined Supraclavicular and Pecs II Block in Patients Undergoing Arteriovenous Grafting Surgery [NCT02331030]36 participants (Actual)Interventional2014-12-31Completed
Perineural Versus Systemic Dexamethasone as an Analgesic Adjunct to Ultrasound-Guided Ropivacaine Interscalene Blockade in Arthroscopic Rotator Cuff Repair [NCT01450007]Phase 4130 participants (Actual)Interventional2012-05-31Completed
Local Anesthetic Concentration and Nerve Block Duration: A Randomized, Blinded Study in Healthy Volunteers [NCT03326609]Phase 460 participants (Actual)Interventional2017-10-04Completed
A Randomized Controlled Trial of Continuous Gastrocnemius Plane Block and Intravenous Analgesia After Foot and Ankle Surgery [NCT05463809]Phase 360 participants (Anticipated)Interventional2022-07-14Not yet recruiting
Ultrasound-guided Selective Supraclavicular Nerve Block for Postoperative Pain Control in Pediatric Patients Receiving Hickman Catheter, Chemoport or Perm Cath Insertion : a Randomized Controlled Trial [NCT05015907]50 participants (Actual)Interventional2021-10-22Completed
The Correlation Between the Diffusion Length of Local Anesthetics in the Subparaneural Space and Duration of Analgesia for Patients Receiving Sciatic Block [NCT05437835]90 participants (Anticipated)Interventional2022-07-30Not yet recruiting
QORVATS Study. A Randomized Controlled, Triple Blinded to Compare the Quality of Recovery (QoR 40) Between Intercostal Block and a Combination of Intercostal Nerve Block With Serratus Plane Catheter for Patient's Undergoing VATS Procedures. [NCT04990713]Phase 3200 participants (Anticipated)Interventional2021-08-01Not yet recruiting
Postoperative Analgesic Effects of Ultrasound-guided Bilateral Rectus Sheath Block for Laparoscopic Gynecologic Surgery [NCT02476799]60 participants (Actual)Interventional2014-11-30Completed
Randomized Controlled Study of Intraincisional Infiltration Versus Intraperitoneal Instillation of Standardized Dose of Ropivacaine 0.2% in Post-laparoscopic Cholecystectomy Pain [NCT03265223]Phase 4353 participants (Actual)Interventional2014-04-01Completed
Addition of Clonidine to Ropivacaine in Adductor Canal Block for Postoperative Pain Relief in Total Knee Arthroplasty: A Prospective Randomized Double Blind Placebo Controlled Trial [NCT03057015]Phase 480 participants (Anticipated)Interventional2017-05-22Recruiting
A Comparison of Postoperative Outcomes Provided by a Continuous Preperitoneal Infusion Versus Ultrasound Guided Transversus Abdominis Plane Block for Abdominoplasty [NCT03228797]60 participants (Actual)Interventional2015-02-11Completed
Regional Blockade for Knee Prothesis Surgery: Comparison Between Femoral, Sciatic and Adductor Canal Block [NCT02451605]40 participants (Anticipated)Interventional2015-06-30Not yet recruiting
Does Perineural Dexmedetomidine Prolong the Duration of an Ulnar Nerve Block When Controlling for Possible Systemic Effects? [NCT03222323]Phase 222 participants (Anticipated)Interventional2017-07-17Recruiting
The Comparison Between Epidural and Intravenous Patient-controlled Analgesia for Laparoscopic Gastrectomy [NCT02444897]Phase 360 participants (Actual)Interventional2013-09-30Completed
The Effect of Scalp Nerve Block on the Emergence Agitation in Children Undergoing Nevus Surgery During Sevoflurane Anesthesia [NCT02428283]Phase 444 participants (Actual)Interventional2015-05-31Completed
The Study of Regional Hemodynamic Changes After Specific Brachial Plexus Block by Ultrasound Guidance [NCT02139982]Phase 1110 participants (Actual)Interventional2011-01-31Completed
MIRs03: A Double-blind Randomized Trial of Paravertebral Block With Ropivacaine Before Breast Cancer Surgery: Effects on Chronic Postoperative Pain [NCT02408393]Phase 3380 participants (Actual)Interventional2015-03-27Completed
Single-center, Double-blind, Placebo-controlled Study Evaluating the Efficacy of Pre-incisional Local Analgesia With Ropivacaine and Dexamethasone for Pain Management After Tonsillectomy [NCT05504967]Phase 2104 participants (Anticipated)Interventional2020-12-22Recruiting
A Randomized Comparison of Ultrasound Guided Supraclavicular Block(UGSB) and General Anesthesia (GA) to IV Narcotics and General Anesthesia for Postoperative Pain Relief in Children With Supracondylar Fractures. [NCT02056288]Phase 478 participants (Actual)Interventional2011-03-10Terminated(stopped due to Enrollment was suspended due to the duration of the study and poor follow-up response by participants.)
Prospective Comparison Between Continuous Femoral Nerve Block and the Association of Adductor Canal Block and Sciatic Nerve Block in Total Knee Arthroplasty. [NCT02387021]80 participants (Anticipated)Interventional2015-03-31Not yet recruiting
A Randomized Controlled Non-inferiority Trial Between the Intra-articular Local Anesthetic Infiltration With Catheter and Interscalene Block With Catheter in Postoperative Analgesia After Shoulder Prosthesis [NCT02365181]Phase 498 participants (Actual)Interventional2014-09-30Completed
Two-arm, Double-blind Randomized Study Comparing Exparel and Exparel Plus an Adductor Canal Block in Total Knee Arthroplasty [NCT02365727]Phase 40 participants (Actual)Interventional2015-04-30Withdrawn(stopped due to Protocol not feasible as written)
A Randomized Controlled Trial to Determine if Pre- and Post- Operative Regional Pain Control (Transversus Abdominis Plane Block) With Ropivacaine Versus Placebo Leads to Lower Anesthetic and Narcotic Dosing, and Alters Pain Scores [NCT03149783]Phase 280 participants (Anticipated)Interventional2018-02-13Recruiting
[NCT02326727]30 participants (Anticipated)Interventional2015-04-30Not yet recruiting
Assessment of Sensory and Motor Blockade of the Adductor Canal Blockade Performed for Surgery of Arthroscopic Anterior Cruciate Ligament Repair [NCT02419261]40 participants (Anticipated)Interventional2014-10-31Recruiting
Adductor Canal Block and Functional Recovery After Total Knee Arthroplasty. A Double-Blind, Randomized Controlled Trial [NCT02411149]Phase 4200 participants (Actual)Interventional2014-04-30Completed
Intraperitoneal Local Anesthetic in Bariatric Surgery: A Double Blind-randomized Controlled Pilot Trial [NCT03175081]54 participants (Actual)Interventional2017-04-27Completed
Psoas Compartment Block Versus Periarticular Local Anesthetic Infiltration for Pain Management for Total Hip Arthroplasty: A Prospective, Randomized Study [NCT02658149]Phase 4100 participants (Actual)Interventional2016-05-31Completed
[NCT02396563]100 participants (Anticipated)Observational2016-06-30Not yet recruiting
Liposomal Bupivacaine Versus Femoral Nerve Block for Pain Control After Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Trial [NCT02606448]Phase 484 participants (Actual)Interventional2014-08-31Completed
Continuous Erector Spinae Plane Blocks for Analgesia and Improving Incentive Spirometry Following Traumatic Rib Fractures [NCT04558281]Phase 44 participants (Actual)Interventional2021-05-23Terminated(stopped due to Could only enroll 4 subjects in nearly 2 years)
[NCT02375191]58 participants (Actual)Interventional2015-01-31Completed
Ultrasound Guided Paravertebral Catheter Versus Patient Controlled Analgesia for Postoperative Pain Control in Video Assisted Thoracoscopic Surgery: A Prospective Outcomes Study [NCT02361775]Early Phase 150 participants (Actual)Interventional2012-07-31Completed
Effects of Continuous Erector Spinae Plane Blocks on Recovery, Pain and Opioid Consumption After Multilevel Spine Surgery: A Prospective Randomized Clinical Trial [NCT05494125]44 participants (Anticipated)Interventional2022-09-14Recruiting
Efficacy of Ultrasound-Guided Transversus Abdominis Plane Block for Postoperative Pain Control in Laparoscopic Cholecystectomy: Prospective Randomized Controlled Trial in Pediatric Patients [NCT02712151]Phase 380 participants (Anticipated)Interventional2024-03-01Not yet recruiting
Evaluation of the PENG Block vs Placebo for Preoperative Pain Control in Hip Fractures in the Elderly - a Double-blinded Randomised Controlled Trial [NCT04996979]60 participants (Anticipated)Interventional2021-05-24Recruiting
A Comparison Between Scalp Nerve Block and Scalp Infiltration on the Circulatory and Stress Response for Aneurysm Clipping Using an Enhanced Recovery After Surgery Programme [NCT03073889]45 participants (Anticipated)Interventional2016-06-30Recruiting
Is Paraspinal Intramuscular Ropivacaine Injection an Effective Treatment for Headache in a Pediatric Emergency Department? [NCT00680823]150 participants (Actual)Interventional2009-01-31Completed
Analgesic Effect of Blind Fascia Iliaca Compartment Block Compared to an Ultrasound-guided Femoral Nerve Block in Patients With Hip Fractures [NCT05365555]100 participants (Anticipated)Observational2022-05-01Recruiting
The Treatment of Acute Gastrointestinal Injury Via Ultrasound-guided Erector Spinae Plane Block - a Prospective, Single-center, Randomized, Controlled Trial [NCT04934904]100 participants (Actual)Interventional2019-08-01Completed
Postoperative Knee Strength Following Total Knee Replacement: A Double-Blinded Randomized Comparison Study [NCT01620047]60 participants (Actual)Interventional2011-03-31Completed
The Effect and Safety of the Four Points Transversus Abdominis Plane Block Under the Ultrasound Guidance in Postoperative Analgesia to the Hepatectomy [NCT03598192]30 participants (Actual)Interventional2018-08-15Completed
Dexamethasone and Dexmedetomidine as Adjuvants to Ropivacaine in Ultrasound-guided Multilevel Thoracic Paravertebral Block for Lobectomy: A Prospective, Randomized, Triple-blind Study [NCT04763434]Phase 490 participants (Anticipated)Interventional2021-03-20Not yet recruiting
A Prospective, Randomized Clinical Trial of Two Periarticular Multimodal Drug Injections in Total Hip and Knee Arthroplasty [NCT02543801]Phase 4239 participants (Actual)Interventional2016-01-25Completed
Erector Spinae Plane Block Versus Paravertebral Block in Patients Undergoing Elective Breast Surgery. A Randomized Controlled Trial Comparing Dermatomal Spread. [NCT03471442]48 participants (Actual)Interventional2018-05-29Completed
Transversus Abdominis Plane Block: A Placebo-controlled Study in Healthy Volunteers [NCT01679392]16 participants (Actual)Interventional2012-08-31Completed
Ultrasound-guided Peripheral Nerve Block for Non-intubated Uniportal Video-assisted Thoracoscopic Surgery [NCT03083080]30 participants (Anticipated)Interventional2017-03-27Not yet recruiting
Pain Control With Regional Anesthesia Following Pediatric Cardiac Surgery: A Randomized Double-Blinded Pilot Study [NCT05688670]Phase 442 participants (Anticipated)Interventional2023-03-29Recruiting
Effect of Adductor Canal Blockade vs Femoral Nerve Blockade on Muscle Strength, Mobility and Pain in Patients With Severe Pain After Total Knee Arthroplasty [NCT01922596]Phase 450 participants (Actual)Interventional2013-01-31Completed
The Effect of Pectoral Blocks on Perioperative Pain in Simple Mastectomy and Breast Reduction in Gender Affirmation Surgery [NCT04474366]Phase 450 participants (Actual)Interventional2020-06-16Completed
A Randomized Controlled Trial Comparing Continuous Sciatic Nerve Block to Single Shot Sciatic Nerve Block [NCT01615939]Phase 417 participants (Actual)Interventional2012-06-30Terminated(stopped due to The study has been terminiated due to minimal subject recruitment)
Ropivacaine Pharmacokinetics After Erector Spinae Block in Children Undergoing Posterior Spinal Fusion [NCT05755334]Phase 446 participants (Anticipated)Interventional2023-06-01Not yet recruiting
Evaluation of Utility of Ultrasound Guided iPACK Block for Knee Extension After Total Knee Arthroplasty. [NCT03353233]Phase 450 participants (Actual)Interventional2018-05-03Completed
A Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Efficacy and Safety of CPL-01 in the Management of Postoperative Pain After Unilateral Distal First Metatarsal Bunionectomy With Osteotomy [NCT05831449]Phase 3574 participants (Anticipated)Interventional2023-05-22Recruiting
Single Transversus Abdominis Laparoscopy-guided Plane Block Combined With Local Trocar Site Ropivacaine Infiltration (STALL) vs Sole Local Wound Infiltration in LCC (Laparoscopic CholeCystectomy) - Double-blinded Randomized Controlled Trial. [NCT06123117]850 participants (Anticipated)Interventional2024-01-31Not yet recruiting
Characterizing and Comparing the Duration of Local Anesthetic in Dermatologic Surgery [NCT05767749]Phase 475 participants (Actual)Interventional2023-03-14Completed
Phase 3 Study of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy [NCT02112370]Phase 3148 participants (Actual)Interventional2014-05-31Completed
Comparison of Ropivacaine With or Without Fentanyl in Spinal Anaesthesia for Lower Limb Surgeries [NCT04199013]Phase 474 participants (Anticipated)Interventional2020-01-10Recruiting
The Effect of the Ultrasound-guided Serratus Anterior Plane Block in Combinaison With Thoracic Paravertebral cathéter Versus Thoracic Paravertebral Cather for Perioperative Analgesia in Thoracic Surgery [NCT04024683]159 participants (Actual)Observational2018-03-01Completed
A Prospective, Randomized, Controlled Trial of Post Operative Pain Control Using Ropivacaine and the ON-Q System in the Adult Pectus Excavatum Patient After Minimally Invasive Repair [NCT01816477]85 participants (Actual)Interventional2013-04-30Completed
The Effect Of Initial Local Anesthetic Dose With Continuous Interscalene Analgesia On Postoperative Pain And Diaphragmatic Function In Arthroscopic Shoulder Surgery Patients: A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study [NCT00672100]36 participants (Actual)Interventional2009-01-31Completed
Effects of Pre-emptive Scalp Infiltration With Low-dose Ketorolac and Ropivacaine for Postoperative Pain Relief After Elective Supratentorial Craniotomy (PAINLESS): a Randomized Controlled Pilot Trial [NCT04380298]Phase 440 participants (Anticipated)Interventional2020-12-01Not yet recruiting
Comparison of Ultrasound Hydrolocalization Technique Versus Neurostimulation for Placement of Continuous Femoral Catheters. [NCT01726192]50 participants (Anticipated)Interventional2012-08-31Recruiting
The Significance of Peripheral Input in Patients With Post Surgery Neuropathic Pain: Evaluation of Trigger Point Anesthesia. A Double-blind, Randomized, Controlled Exploratory Study [NCT04764045]12 participants (Anticipated)Interventional2019-11-20Recruiting
Study of the Analgesic Effect of the Perineal Infiltration of Ropivacaine 0.75% Versus Placebo in Post-episiotomy Perineal Pain: a Randomized, Double-blind Study [NCT03084549]Phase 3272 participants (Actual)Interventional2017-10-24Completed
The Effects of Thoracic Nerve Blocks on Postoperative Pain, Respiratory Function and Recovery in Patients Undergoing Thoracoscopic Surgery [NCT04400721]Phase 3120 participants (Anticipated)Interventional2020-07-01Not yet recruiting
The Impact of an Epidural Anesthetic on the Consumption of Sevoflurane in Major Abdominal Surgery [NCT04021264]Phase 2/Phase 30 participants (Actual)Interventional2019-08-01Withdrawn(stopped due to Inability to enroll participants.)
Erector Spinae Plane Block (ESPB): A New Technique for Perioperative Pain Control in Patients Undergoing Surgery Through a Flank or Anterior Subcostal Incision. [NCT03691935]Phase 440 participants (Anticipated)Interventional2018-09-28Enrolling by invitation
Efficacy of Dexmedetomidine on Postoperative Analgesia After Radical Mastectomy: Randomized Controlled Trial [NCT05110339]28 participants (Actual)Interventional2019-11-01Completed
Fast-track Rehabilitation Protocol for Total Knee Arthroplasty: A Randomized Controlled Trial Comparing Local Infiltration Analgesia With Femoral Nerve Block [NCT01966263]Phase 480 participants (Actual)Interventional2013-11-30Completed
Adductor Canal Blocks Using Exparel for Pain Control After Total Knee Arthroplasty [NCT04910165]Phase 3100 participants (Actual)Interventional2020-06-01Completed
The Minimum Effective Volume (MEV) of 0.5% Ropivacaine in Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block (SASIS-FICB) [NCT05012137]54 participants (Anticipated)Interventional2021-08-25Not yet recruiting
Transversus Abdominis Plane (TAP) Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine: A Prospective Randomized Control Trial for Pain Control After Renal Transplant Surgery [NCT03737604]Phase 4200 participants (Anticipated)Interventional2018-10-04Recruiting
Effect of Epidural Hydromorphone Combined With Ropivacaine in Labor Analgesia [NCT05901441]Phase 2240 participants (Actual)Interventional2022-06-01Completed
Efficacy of a Peri-Operative Surgical-Site, Multimodal Drug Injection in Pediatric Patients With Cerebral Palsy Undergoing Hip Surgery: A Randomized Controlled Trial [NCT04074265]Phase 434 participants (Actual)Interventional2019-12-01Completed
Impact of Ultrasound-Guided Transversus Abdominis Plane Block on Postoperative Nausea and Vomiting and Early Outcome After Laparoscopic Bariatric Surgery: a Randomized Double-Blinded Controlled Trial [NCT05286008]90 participants (Anticipated)Interventional2022-03-18Not yet recruiting
the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block [NCT02961361]Phase 460 participants (Actual)Interventional2016-11-12Completed
Effectiveness of Perineural Clonidine as an Adjuvant With Ropivacaine for Popliteal Nerve Block in Patients Undergoing Foot and Ankle Surgery [NCT01986751]Phase 1/Phase 214 participants (Actual)Interventional2014-01-31Terminated(stopped due to failure to enroll)
Continuous Infusion of Lidocaine Versus Blockade of the Erector Spinae Plane Block - Comparison of Analgesic Efficacy in Patients After Bariatric Surgery [NCT05700214]100 participants (Anticipated)Interventional2023-01-16Recruiting
Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Role of Laparoscopic Transversus Abdominis Plane Block in Gastric Bypass Surgery (LapTAP Trial) [NCT03367728]Phase 4150 participants (Anticipated)Interventional2018-11-27Recruiting
Prospective, Randomized, Controlled Trial Comparing Continuous Femoral and Single Injection Sciatic Peripheral Nerve Blocks vs Periarticular Injection With Ropivacaine or Liposomal Bupivacaine (Exparel) on Patients Undergoing Total Knee Arthroplasty [NCT02223364]Phase 4165 participants (Actual)Interventional2014-07-31Completed
Efficacy and Safety of Hydromorphone-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia: a Randomized Controlled Trial [NCT06036797]Phase 2240 participants (Anticipated)Interventional2023-09-17Recruiting
Dexmedetomidine Ropivacaine Versus Plain Ropivacaine in Bilateral Pectoralis Nerve Block [NCT05897307]90 participants (Anticipated)Interventional2023-08-01Recruiting
A Prospective, Randomized, Active-Comparator, Open-Label, Non-Inferiority Study of the Efficacy of Continuous Nerve Block vs Single Block Plus Intravenous Lidocaine for Postoperative Pain. [NCT04208516]Phase 417 participants (Actual)Interventional2021-05-26Terminated(stopped due to Recruitment was unable to be obtained in a timely fashion, so the study was stopped.)
The Effect of Intercostal Nerve Block With Dexamethasone and Ropivacaine on Rebound Pain After Thoracoscopic Surgery: a Randomized, Double-blind, Controlled Study [NCT05825378]260 participants (Anticipated)Interventional2023-05-01Not yet recruiting
Evaluation of Influence of Thoracic Paravertebral Block on Cardiac Repolarization [NCT05822076]60 participants (Anticipated)Observational2023-02-02Enrolling by invitation
Single-Shot Versus Continuous Regional Anesthesia for Treating Acute Postoperative Pain in Pediatric Orthopaedic Surgery: A Prospective Randomized Trial [NCT04669145]Phase 2/Phase 388 participants (Anticipated)Interventional2021-06-24Recruiting
Opioid Induced Loss of Local Anesthetic Potency in Patients Undergoing Total Knee [NCT03294174]48 participants (Actual)ObservationalTerminated(stopped due to Responsible Investigator left institution)
Inflammatory Mediators, Neural Tissue Injury Markers and the Markers of Oxidative Stress in the CSF of Patients Undergoing Spinal Anesthesia With Ropivacaine and Bupivacaine [NCT03293472]Phase 460 participants (Anticipated)Interventional2017-12-01Recruiting
A Phase 3, Randomized, Double-Blind, Saline Placebo- and Active-Controlled, Multicenter Study to Evaluate the Analgesic Efficacy and Safety of Intra-operative Administration of PRF-110 Following Unilateral Bunionectomy [NCT05773846]Phase 3415 participants (Anticipated)Interventional2023-03-13Recruiting
Adductor Canal Block Versus Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction Arthroscopically [NCT02355093]Phase 440 participants (Anticipated)Interventional2014-07-31Enrolling by invitation
Effect of a Lateral Nerve of the Thigh Block on Postoperative Pain After Total Hip Replacement Surgery: a Clinical Randomized Trial [NCT02289937]Phase 4100 participants (Actual)Interventional2014-03-31Completed
Ultrasound-Guided Obturator Nerve Block for Ambulatory Hip Arthroscopy: A Prospective, Randomized Controlled Trial [NCT02346357]70 participants (Anticipated)Interventional2014-05-31Recruiting
Investigational Plan for the Clinical Evaluation of the ReLeaf Analgesic Infusion Catheter & Wound Drain [NCT02293525]0 participants (Actual)InterventionalWithdrawn(stopped due to No subjects were enrolled and the sponsor suspended support at this time)
Erector Spine Plane (ESP) Block for Analgesia in Pediatric Scoliosis Surgery [NCT05944393]50 participants (Anticipated)Interventional2022-09-08Recruiting
Periarticular Nerve Group (PENG) Block for Postoperative Rehabilitation in Total Hip Arthroplasty: a Randomized Controlled Trial [NCT05944380]Phase 4556 participants (Actual)Interventional2020-06-16Completed
[NCT02311517]90 participants (Actual)Interventional2014-01-28Completed
Pre-emptive Scalp Infiltration With Ropivacaine Plus Methylprednisolone vs Ropivacaine Alone for Relief of Postoperative Pain After Craniotomy in Children (RP/MP vs RP) [NCT03636165]Phase 490 participants (Anticipated)Interventional2022-09-01Not yet recruiting
Single Dose Adductor Canal Block With SPANK (Sensory Posterior Articular Nerves of the Knee) Block Compared to Single Dose Adductor Canal Block and Pain Control After Total Knee Arthroplasty [NCT03502889]128 participants (Anticipated)Interventional2019-06-30Not yet recruiting
Evaluation of Regional Distribution of Ventilation in Spontaneous Breathing Patients During Labor With or Without Epidural Analgesia Using EIT (Electrical Impedance Tomography) [NCT02523755]Phase 440 participants (Actual)Interventional2015-09-30Completed
Minimum Effective Local Anesthetic Dose for Adductor Canal Block for Knee Analgesia - a Preliminary Study [NCT03427385]60 participants (Actual)Interventional2012-09-30Completed
Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery [NCT04449289]Phase 2100 participants (Anticipated)Interventional2020-07-01Not yet recruiting
Influence of SPI-guided Analgesia With Preventive Different Peribulbar Blocks (PBB) on the Presence of OCR, Postoperative Pain, PONV in Patients Undergoing VRS Under General Anaesthesia: a Randomised, Controlled Trial [NCT03413371]175 participants (Anticipated)Interventional2018-04-26Recruiting
Intrathecal Morphine Compared to Intravenous Tramadol and Transversus Abdominal Plane Block for Catheter Related Bladder Discomfort Syndrome [NCT04814745]33 participants (Actual)Interventional2020-07-07Completed
A Randomized, Prospective, Double Blind Clinical Trial to Investigate the Increase in Duration of Analgesia With Addition of 0.25mcg/kg of Dexmedetomidine (DEX) to 25 ml of 0.5%Ropivacaine in Supraclavicular Brachial Plexus Block. [NCT03385967]Phase 40 participants (Actual)Interventional2019-04-30Withdrawn(stopped due to PI is leaving the University of Florida)
Catheter-based Peripheral Regional Anesthesia After Total Knee Arthroplasty: Comparison of Low Dose, Automated Periodic Infusions With Conventional High Dose, Continuous Infusion and Patient-initiated Infusions Only [NCT03372265]Phase 4111 participants (Actual)Interventional2017-12-06Completed
A Randomized Double Blind, Multicenter Trial to Assess Time-interval Between Cytoreductive Surgery and Adjuvant Chemotherapy After Administration of Local Anesthetic Intraperitoneally/Perioperatively in Advanced Epithelial Ovarian Cancer [NCT04065009]Phase 3220 participants (Anticipated)Interventional2020-08-26Recruiting
Impact of Adding iPACK Block With Dexamethasone to Existing APS Multimodal Analgesia Protocol for Patients Undergoing Total Knee Arthroplasty [NCT04917055]Phase 414 participants (Actual)Interventional2021-06-07Terminated(stopped due to staffing)
The Impact of the Continuous Infusion of Intraperitoneal Analgesics on Postoperative Pain After Minimally Invasive Hysterectomy: a Randomized Controlled Trial [NCT04130464]Phase 4120 participants (Anticipated)Interventional2019-09-30Recruiting
A Dose Response Study for Duration of Analgesia Using Bupivacaine and Ropivacaine for Infragluteal Parabiceps Sciatic Block [NCT01272921]Phase 4142 participants (Actual)Interventional2010-11-30Completed
The Impact of a Preoperative Nerve Block on the Consumption of Sevoflurane in Total Shoulder Arthroplasty [NCT04020601]Phase 2/Phase 350 participants (Anticipated)Interventional2019-08-01Recruiting
Effect of Ultrasound-guided Transversus Abdominis Plane Block With Compound Lidocaine and Esketamine on Postoperative Pain in Patients Undergoing Colorectal Cancer Surgery: a Randomized Double-blind Controlled Trial [NCT05122338]160 participants (Anticipated)Interventional2021-12-01Not yet recruiting
Do Intraoperative Periarticular Injections Improve Postoperative Pain Control in Patients Receiving Duramorph (Preservative Free) During Total Knee Arthroplasty? A Prospective, Double-Blind, Randomized Controlled Trial [NCT02570503]Phase 464 participants (Actual)Interventional2015-10-31Terminated(stopped due to Study's primary aims are no longer clinically impactful, as intrathecal morphine has fallen out of favor and replaced with different agents so that outpatient/23 hr surgery is more predictably achievable.)
A Double-blind Randomized Non-inferiority Trial of Erector Spinae Block (ESP) Versus Paravertebral Block (PVB) Before Breast Cancer Surgery: Effects on Acute Postoperative Pain. [NCT04827030]Phase 4292 participants (Anticipated)Interventional2021-06-28Recruiting
Transversus Abdominis Plane (TAP) Block Study for Postoperative Pain Control [NCT02652156]Phase 314 participants (Actual)Interventional2015-11-01Terminated(stopped due to Operational barriers at the site.)
Efficacy of Peri-Incisional Multimodal Drug Injection in Reducing Post-Operative Pain Following Lumbar Spine Surgery [NCT03513445]Phase 30 participants (Actual)Interventional2018-06-01Withdrawn(stopped due to No participants enrolled)
The Efficacy of Continuous Intercostal Nerve Blocks in the Treatment of Patients With Multiple Rib Fractures [NCT05642026]Phase 4180 participants (Anticipated)Interventional2023-12-01Not yet recruiting
Prospective Randomized Double-Blind Study of Pain Control With Hepatic Hilum Nerve Block Versus Sham Procedure For Hepatic Chemoembolization or Radiofrequency Ablation [NCT04769713]Phase 480 participants (Anticipated)Interventional2021-11-23Recruiting
The Minimum Effective Volume of Ropivacaine in Ultrasound-guided Supraclavicular Block [NCT02512471]114 participants (Actual)Interventional2015-05-31Completed
Intraoperative Transversus Abdominis Plane Block for Gynecologic Surgery (GYNTAP): Modifying an Existing Technique for Ease of Administration and Increased Accuracy [NCT02506855]Phase 30 participants (Actual)Interventional2015-06-30Withdrawn(stopped due to The investigator decided not to continue the study.)
Transversus Abdominis Plane (TAP) Block for Laparoscopic Appendicectomy in Children: Opioid Saving and Alternative in the Curarization [NCT02505841]240 participants (Anticipated)Interventional2015-05-31Active, not recruiting
Analgesic Effect of Ropivacaine Plus Fentanyl vs Ropivacaine for Continuous 3-in-1 FNB After Total Knee Arthroplasty [NCT02501863]40 participants (Actual)Interventional2015-10-31Completed
Effect of 0.5µg/ml Sufentanil and Ropivacaine Towards Pregnant Women and Fetus in Analgesia Labor [NCT02488291]120 participants (Actual)Interventional2014-04-30Completed
[NCT02483923]40 participants (Actual)Interventional2015-06-16Completed
Erector Spinae Plane Block for Rib Fractures: A Pilot Study [NCT04916691]Early Phase 140 participants (Actual)Interventional2021-05-15Completed
Effect of Tramadol in Prevention of Postpartum Depression [NCT03309163]Phase 41,230 participants (Actual)Interventional2017-10-09Completed
The Double-blind, Randomized Controlled Trial: Comparison of Levobupivacaine and Ropivacaine for Postoperative Analgesia TAP-block After Caesarean Section [NCT03302689]50 participants (Actual)Interventional2017-09-25Active, not recruiting
Selective Blocks for Total Knee Arthroplasty [NCT02465827]Phase 475 participants (Actual)Interventional2014-01-31Completed
A Randomized Comparison of Minimum Effective Volume With 0.5% Ropivacaine Between Costoclavicular and Paracoracoid Ultrasound-guided Infraclavicular Block for Forearm Surgery [NCT03279679]50 participants (Anticipated)Interventional2017-10-31Not yet recruiting
Pilot Study on the Thermal Effects of Local Anesthetics [NCT04761887]Phase 10 participants (Actual)Interventional2022-12-31Withdrawn(stopped due to Study withdrawn prior to enrollment (insufficient funds and reduced access to patients related to COVID protocols))
Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery: A Prospective Randomized Controlled Pilot Trial [NCT04472299]Phase 430 participants (Anticipated)Interventional2021-04-09Recruiting
Comparison of the Role of Epidural Analgesia Versus Non-epidural Analgesia in Postnatal Depression and Persistent Pain Development: a Randomized Controlled Trial [NCT03167905]Phase 2/Phase 3881 participants (Actual)Interventional2017-06-15Active, not recruiting
Contribution Of Anesthesia Technique For Post-operative Mortality Reduction After Proximal Femur Fractures Surgical Treatment - A Randomized Clinical Trial [NCT02406300]57 participants (Actual)Interventional2015-04-01Terminated(stopped due to Organizational changes made recruitment no longer possible)
Prospective, Randomized Controlled Trial Comparing Continuous Posterior Lumbar Plexus Nerve Block vs Periarticular Injection With Ropivacaine or Liposomal Bupivacaine (Exparel®) on Patients Undergoing Total Hip Arthroplasty [NCT02242201]Phase 4165 participants (Actual)Interventional2014-09-30Completed
Continuous Wound Infiltration After Hallux Valgus Surgery A Prospective, Randomized, Double-blind and Placebo-controlled Single-center Trial [NCT02182999]Phase 450 participants (Actual)Interventional2014-05-31Completed
Peripheral Nerve Blocks in Pediatric Orthopedic Patients: Are There Any Post Recovery Benefits? [NCT02236130]49 participants (Actual)Interventional2014-06-30Terminated(stopped due to Poor response rate on follow up of patients)
A Prospective, Double Blinded, Randomized Comparison of Transversus Abdominis Plane Block Versus Local Anesthetic Infiltration for Laparoscopic Appendectomy in the Pediatric Population [NCT01575028]Phase 23 participants (Actual)Interventional2012-10-31Terminated(stopped due to The study was allowed to expire due to changes in standard care for the patient population within the NCH institution.)
Effect of Local Anesthetic Concentration (0.2% Ropivacaine vs 0.1% Ropivacaine) on Phrenic Nerve Function, Pulmonary Function, and Analgesia After Ultrasound-guided Interscalene Brachial Plexus Block for Shoulder Arthroscopy [NCT02181296]50 participants (Actual)Interventional2014-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT00519584 (4) [back to overview]Time to a Significant Increase in Shoulder Discomfort
NCT00519584 (4) [back to overview]Maximum VRS Pain Scores at Rest
NCT00519584 (4) [back to overview]the Duration of Analgesia
NCT00519584 (4) [back to overview]Total Opioid Consumption
NCT00562627 (3) [back to overview]Time to Readiness for Discharge
NCT00562627 (3) [back to overview]Opioid Use
NCT00562627 (3) [back to overview]Pain at Rest (VAS)
NCT00638508 (20) [back to overview]Pain Score at Rest
NCT00638508 (20) [back to overview]Pain Score on Coughing
NCT00638508 (20) [back to overview]Pain Scores at Rest
NCT00638508 (20) [back to overview]Pain Scores at Rest
NCT00638508 (20) [back to overview]Pain Scores on Movement
NCT00638508 (20) [back to overview]Pain Scores on Coughing
NCT00638508 (20) [back to overview]NAUSEA
NCT00638508 (20) [back to overview]Pain on Movement
NCT00638508 (20) [back to overview]VOMITING
NCT00638508 (20) [back to overview]VOMITING
NCT00638508 (20) [back to overview]PATIENT SATISFACTION
NCT00638508 (20) [back to overview]PATIENT SATISFACTION
NCT00638508 (20) [back to overview]DROWSINESS
NCT00638508 (20) [back to overview]DROWSINESS
NCT00638508 (20) [back to overview]Pain on Movement
NCT00638508 (20) [back to overview]Morphine Equivalents
NCT00638508 (20) [back to overview]Morphine Equivalents
NCT00638508 (20) [back to overview]Morphine Equivalents Utilization
NCT00638508 (20) [back to overview]Pain Scores on Coughing
NCT00638508 (20) [back to overview]NAUSEA
NCT00672100 (4) [back to overview]Change in Diaphragmatic Displacement From Baseline to Post-surgery
NCT00672100 (4) [back to overview]"Percentage of Participants Who Considered the Analgesic Technique Helpful or Extremely Helpful"
NCT00672100 (4) [back to overview]Functional Outcome - Simple Shoulder Test (SST)
NCT00672100 (4) [back to overview]Pain Measurements Via Numeric Pain Rating Scales (NRS)
NCT00680823 (3) [back to overview]The Primary Outcome Will be Pain Relief Sufficient for Discharge From the Emergency Department.
NCT00680823 (3) [back to overview]Re-presentation to the Emergency Department With Headache Within 72 Hours of Participating in the Study
NCT00680823 (3) [back to overview]Number and Percent of Patients Admitted to the Hospital for Additional Therapy in Each Treatment Arm Based Upon Treating Clinicians Decision
NCT00720330 (5) [back to overview]Postoperative Opioid Consumption in Oral Oxycodone Equivalents
NCT00720330 (5) [back to overview]Pre- and Intra-operative Opioid Consumption in Fentanyl Equivalents
NCT00720330 (5) [back to overview]Postoperative Nausea
NCT00720330 (5) [back to overview]Time From the End of Surgery to Readiness for Hospital Discharge.
NCT00720330 (5) [back to overview]Pain Scores on Numerical Rating Scale
NCT00801138 (4) [back to overview]Time to First Report of Pain
NCT00801138 (4) [back to overview]Total Three-day Opioid Consumption in Oral Oxycodone Equivalent
NCT00801138 (4) [back to overview]Median Maximum VAS Pain Scores at Rest
NCT00801138 (4) [back to overview]The Duration of the Interscalene Nerve Block Which is Time to First Administration of Pain Medication After Block
NCT00825786 (7) [back to overview]Duration of Analgesia.
NCT00825786 (7) [back to overview]Maximum Verbal Response Score (VRS) With Rest
NCT00825786 (7) [back to overview]Time to Complete Motor Block
NCT00825786 (7) [back to overview]Time to Onset of First Sensory Block
NCT00825786 (7) [back to overview]Total Opioid Consumption
NCT00825786 (7) [back to overview]Duration of Analgesia
NCT00825786 (7) [back to overview]Maximum Verbal Response Score (VRS) With Movement
NCT00901628 (6) [back to overview]the Proportion of Patients Who Were Satisfied With the Pain Management
NCT00901628 (6) [back to overview]Pain( Visual Analog Scale )
NCT00901628 (6) [back to overview]Participant Number of Postoperative Nausea and Vomiting During 24 Hours After Surgery
NCT00901628 (6) [back to overview]The Proportion of Patients Who Could Raise Leg With Replaced Knee Extended
NCT00901628 (6) [back to overview]Intravenous Patient Controlled Analgesia(PCA) Consumption During 24 Hours After Surgery
NCT00901628 (6) [back to overview]Maximal Flexion Angle Degree on Postoperative 7 Day
NCT00912873 (7) [back to overview]Percent Change From Baseline in Quadriceps Femoris Maximum Voluntary Isometric Contraction (MVIC)
NCT00912873 (7) [back to overview]Total Ambulation
NCT00912873 (7) [back to overview]Ambulation 100-foot Walking Test
NCT00912873 (7) [back to overview]Average Dynamic Pain
NCT00912873 (7) [back to overview]Worst Dynamic Pain
NCT00912873 (7) [back to overview]Percent Change From Baseline in Hip Flexion
NCT00912873 (7) [back to overview]Mean Resting Pain
NCT00913068 (1) [back to overview]Total Milligrams of Opiates
NCT00930046 (2) [back to overview]Morphine
NCT00930046 (2) [back to overview]FLACC Pain Intensity [Faces Legs Activity Cry Consolability] 0-10 Points
NCT00956709 (3) [back to overview]Compare the Onset of Action of Ropivacaine 0.5% and levobupivacaïne 0.5 % for Sciatic Nerve Block Guided in Major Surgery of the Foot
NCT00956709 (3) [back to overview]Duration of Sensory Sciatic Block (h)
NCT00956709 (3) [back to overview]Duration of Motor Sciatic Block (h)
NCT01042093 (3) [back to overview]Knee Society Pain Scores at 6 Week Follow-up Appointment
NCT01042093 (3) [back to overview]Numerical Rating Scale (NRS) Pain Scores During Hospitalization.
NCT01042093 (3) [back to overview]Narcotic Consumption During Hospitalization
NCT01074229 (2) [back to overview]QoR40 on the Day After Surgery
NCT01074229 (2) [back to overview]24 Total Morphine Consumption
NCT01075087 (2) [back to overview]24 Hour Total Opioid Consumption.
NCT01075087 (2) [back to overview]Quality of Recovery 40 Score
NCT01075646 (6) [back to overview]Mg of Morphine Consumption During 48 Hours Administered by Patient Controlled Analgesia System
NCT01075646 (6) [back to overview]Contamination of the Catheter (Microbiologist Analysis)
NCT01075646 (6) [back to overview]Intensity of Pain Measured by Verbal Pain Scale.
NCT01075646 (6) [back to overview]Local Reaction in the Wound and Insertion Point of the Catheter (Inflammation Signs and Infection)
NCT01075646 (6) [back to overview]Time Spent Sitting in a Chair, Deambulation, Solid Ingestion.
NCT01075646 (6) [back to overview]Secondary Effects Due to Morphine: Nausea and Vomiting
NCT01094106 (3) [back to overview]Postoperative Nausea and Vomiting (PONV)
NCT01094106 (3) [back to overview]Strength of Pain on Numerical Rating Scale (NRS)
NCT01094106 (3) [back to overview]The Demand of Rescue Analgesics (Oxycodone)
NCT01123889 (3) [back to overview]Pain and Disability of the Shoulder Through Validated Questionnaires
NCT01123889 (3) [back to overview]Pain and Disability of the Shoulder Through Validated Questionnaires
NCT01123889 (3) [back to overview]Pain and Disability of the Shoulder Through Validated Questionnaires
NCT01163214 (6) [back to overview]Pain Scores in the Per-protocol Subset (Participants Who Received the Allocated Treatment)
NCT01163214 (6) [back to overview]Number of Subjects Who Experienced Neurological Changes Postoperatively
NCT01163214 (6) [back to overview]Straight-leg Raise
NCT01163214 (6) [back to overview]Narcotic Use
NCT01163214 (6) [back to overview]Post-Operative Pain
NCT01163214 (6) [back to overview]Length of Stay in Hospital
NCT01167907 (6) [back to overview]Nausea
NCT01167907 (6) [back to overview]Vomiting
NCT01167907 (6) [back to overview]Verbal Pain Scores
NCT01167907 (6) [back to overview]Sleep Disturbance
NCT01167907 (6) [back to overview]Opioid Use
NCT01167907 (6) [back to overview]Reduction of Quadriceps Strength
NCT01170702 (8) [back to overview]Morphine Equivalents 0-24 Hours (Mgs)
NCT01170702 (8) [back to overview]Morphine Equivalents 24-72 Hours (Mgs)
NCT01170702 (8) [back to overview]Morphine Equivalents Total (Mgs)
NCT01170702 (8) [back to overview]Pain Burden With Movement
NCT01170702 (8) [back to overview]Time to First PCA Request
NCT01170702 (8) [back to overview]Pain Scores at Rest
NCT01170702 (8) [back to overview]Pain Scores With Movement
NCT01170702 (8) [back to overview]Pain Burden at Rest
NCT01172197 (1) [back to overview]Pain
NCT01242644 (8) [back to overview]Number of Narcotic Pills and Morphine Sulfate Used
NCT01242644 (8) [back to overview]Pain Scale
NCT01242644 (8) [back to overview]Number of Narcotic Pills and Morphine Sulfate Used
NCT01242644 (8) [back to overview]Pain Scale
NCT01242644 (8) [back to overview]Pain Scale
NCT01242644 (8) [back to overview]Number of Narcotic Pills and Morphine Sulfate Used
NCT01242644 (8) [back to overview]Pain Score 8 Hours Post-operativley
NCT01242644 (8) [back to overview]Number of Narcotic Pills and Morphine Sulfate Used
NCT01272921 (2) [back to overview]Cumulative Probabilities for Needle Positioning Above and Below CIEL.
NCT01272921 (2) [back to overview]Duration of Motor and Sensory Block of the Sciatic With 0.5% Bupivacaine and Ropivacaine After Ultrasound-guided Nerve-stimulator-Assisted Needle Positioning Beneath the CIEL
NCT01328782 (5) [back to overview]Need for IV Morphine of Fentanyl
NCT01328782 (5) [back to overview]The Faces Pain Scale-Revised (FSP-R) Scores (Scored 0-10).
NCT01328782 (5) [back to overview]Time (in Minutes) to First Narcotic Administration
NCT01328782 (5) [back to overview]Total Quality Pain Management Survey (TQPM) Scores for Questions # 16: Child's Current Level of Pain, Question # 17: Child's Worst Level of Pain When Moving Around After Surgery and Question # 18: Child's Worst Level of Pain While Resting
NCT01328782 (5) [back to overview]Total Dosage in Morphine Equivalents (mg/kg) of All Analgesics Received in Prior to Discharge
NCT01337115 (4) [back to overview]Visual Analogue Scores (VAS) - Pain Scores Measured in mm (0-100)
NCT01337115 (4) [back to overview]VAS Results - Pain Scores Measured in mm (0-100)
NCT01337115 (4) [back to overview]VAS Results - Pain Measured in mm (0-100)
NCT01337115 (4) [back to overview]Satisfaction With Anesthesia Technique in Each Arm of the Study
NCT01388946 (14) [back to overview]Chronic Pain
NCT01388946 (14) [back to overview]Chronic Pain
NCT01388946 (14) [back to overview]Pain Scores at Rest 2 h Postoperatively
NCT01388946 (14) [back to overview]Pain Scores at Rest 24 h Postoperatively
NCT01388946 (14) [back to overview]Pain Scores at Rest 4 h Postoperatively
NCT01388946 (14) [back to overview]Pain Scores at Rest 8 h Postoperatively
NCT01388946 (14) [back to overview]Pain Scores During Cough 2 h Postoperatively
NCT01388946 (14) [back to overview]VAS Score Changes ( Cough) During 24 h Postoperatively
NCT01388946 (14) [back to overview]Pain Scores in the Postoperative Care Unit (PACU) at Rest
NCT01388946 (14) [back to overview]Pain Scores During Cough in the PACU
NCT01388946 (14) [back to overview]Pain Scores During Cough 8 h Postoperatively
NCT01388946 (14) [back to overview]Pain Scores During Cough 48 h Postoperatively
NCT01388946 (14) [back to overview]Pain Scores During Cough 4 h Postoperatively
NCT01388946 (14) [back to overview]Pain Scores at Rest 48 h Postoperatively
NCT01450007 (4) [back to overview]Duration of Sensory Blockade
NCT01450007 (4) [back to overview]Post Operative Opioid Dose at 24 Hours
NCT01450007 (4) [back to overview]Time Until First Dose of Analgesic
NCT01450007 (4) [back to overview]Patient Satisfaction With Pain Control
NCT01452126 (2) [back to overview]Number of Patients With Complications
NCT01452126 (2) [back to overview]Effective Concentration of Ropivacaine to Produce Surgical Anesthesia in 50% of Population
NCT01479270 (4) [back to overview]Intraoperative Time
NCT01479270 (4) [back to overview]Narcotic Use
NCT01479270 (4) [back to overview]Visual Analog Scale (VAS) for Pain
NCT01479270 (4) [back to overview]Quality of Recovery Questionnaire (QoR-40) on Postop Day #1 or #2
NCT01480089 (2) [back to overview]Post-op Pain With Atomized Intraperitoneal Ropivacaine (AIR)
NCT01480089 (2) [back to overview]Post-op Pain With Atomized Intraperitoneal Ropivacaine (AIR)
NCT01556724 (5) [back to overview]Number of Participants With Increased Infusion Rates
NCT01556724 (5) [back to overview]Numeric Rating Scale Pain Score With Movement at 24 Hours
NCT01556724 (5) [back to overview]Patient Satisfaction With Pain Control
NCT01556724 (5) [back to overview]Opiate Consumption Postoperatively
NCT01556724 (5) [back to overview]Number of Participants With Decreased Infusion Rates
NCT01615939 (3) [back to overview]Temporary Neurologic Symptoms Between Groups
NCT01615939 (3) [back to overview]Participant Satisfaction With Anesthesia
NCT01615939 (3) [back to overview]Pain Control
NCT01620047 (1) [back to overview]Comparison of Postoperative Strength (Extension)
NCT01643616 (3) [back to overview]Time Until Readiness for Surgery (Minutes)
NCT01643616 (3) [back to overview]Success Rate Without Supplementation
NCT01643616 (3) [back to overview]Success Rate With Supplementation
NCT01719237 (2) [back to overview]Onset of Surgical Anesthesia
NCT01719237 (2) [back to overview]Duration of Analgesia
NCT01782872 (4) [back to overview]Duration of Analgesia From Interscalene Nerve Block
NCT01782872 (4) [back to overview]Middle Deltoid
NCT01782872 (4) [back to overview]Numeric Rating Scale (NRS) Pain Score With Movement
NCT01782872 (4) [back to overview]Numeric Rating Scale (NRS) Pain Scores at Rest
NCT01816477 (3) [back to overview]Hospital Length of Stay
NCT01816477 (3) [back to overview]Use of Analgesic Narcotic
NCT01816477 (3) [back to overview]Mean Daily Pain Score
NCT01866917 (2) [back to overview]Postoperative Numeric Pain Rating Score (NPRS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable)
NCT01866917 (2) [back to overview]Postoperative Numeric Pain Score (NPS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable)
NCT01898689 (3) [back to overview]Maximum Tolerance to Transcutaneous Electrical Stimulation
NCT01898689 (3) [back to overview]Maximum Tolerance to Transcutaneous Electrical Stimulation
NCT01898689 (3) [back to overview]Percent of Maximum Voluntary Isometric Contraction Baseline (Quadriceps Femoris)
NCT01966263 (3) [back to overview]Timed Up and Go Test (TUG)
NCT01966263 (3) [back to overview]Stair Climbing Task (SCT)
NCT01966263 (3) [back to overview]Six Minute Walking Test (6MWT)
NCT01971645 (2) [back to overview]Intra-operative and Post-operative Opioid Consumption
NCT01971645 (2) [back to overview]Post-operative Pain Scores
NCT02000973 (4) [back to overview]Mean Arterial Pressure
NCT02000973 (4) [back to overview]Heart Rate
NCT02000973 (4) [back to overview]Bispectral Index Score
NCT02000973 (4) [back to overview]Propofol Effect-site Concentration
NCT02056288 (6) [back to overview]Patient and Parent Satisfaction
NCT02056288 (6) [back to overview]Opioid Consumption
NCT02056288 (6) [back to overview]Incidence of Side Effects
NCT02056288 (6) [back to overview]Time of First Analgesia Request
NCT02056288 (6) [back to overview]Time of Achieving Discharge Readiness
NCT02056288 (6) [back to overview]The Mean Pain Score in the Postoperative Period
NCT02059070 (4) [back to overview]Ultrasonographic Evaluation of Diaphragmatic Excursion- Operative Side Sigh Test
NCT02059070 (4) [back to overview]Forced Expiratory Volume at 1 Second (% Change From Baseline)
NCT02059070 (4) [back to overview]Post-operative Oxycodone Use (mg)
NCT02059070 (4) [back to overview]Highest Patient Pain Level
NCT02112370 (8) [back to overview]Maximum of Measured Systolic Blood Pressures
NCT02112370 (8) [back to overview]NRS Pain Scores for the First 12 Hours
NCT02112370 (8) [back to overview]Pain Killer Dose
NCT02112370 (8) [back to overview]Operation Time
NCT02112370 (8) [back to overview]Maximum of Measured Heart Rates
NCT02112370 (8) [back to overview]Maximum of Measured Diastolic Blood Pressures
NCT02112370 (8) [back to overview]Blood Loss Amount
NCT02112370 (8) [back to overview]NRS Change
NCT02139982 (6) [back to overview]Changes in Skin Temperature From Baseline to 30min After Brachial Plexus Block(Phase 2)
NCT02139982 (6) [back to overview]Changes in Hemodynamic Parameters of Brachial Artery From Baseline to 30min After Brachial Plexus Block(Phase 2)
NCT02139982 (6) [back to overview]Changes in Skin Temperature From Baseline to 30 Min After Specific Nerve Block Followed by 30 Min After Brachial Plexus Block(Phase 1)
NCT02139982 (6) [back to overview]Changes in Hemodynamic Parameters of Radial/Ulnar Artery From Baseline to 30min After Specific Nerve Block Followed by 30min After Brachial Plexus Block(Phase 1)
NCT02139982 (6) [back to overview]Changes in Cross-sectional Area of Radial/Ulnar Artery From Baseline to 30min After Specific Nerve Block Followed by 30min After Brachial Plexus Block(Phase 1)
NCT02139982 (6) [back to overview]Success of Brachial Plexus Block ( Phase 2)
NCT02151487 (2) [back to overview]Duration of the Sensorial Supraclavicular Block
NCT02151487 (2) [back to overview]Postoperative Analgesia
NCT02154048 (1) [back to overview]Time to First Analgesic Dose
NCT02154763 (54) [back to overview]24-48 h Postoperative Tylenol Consumption
NCT02154763 (54) [back to overview]24-48 h Postoperative Tramadol Consumption
NCT02154763 (54) [back to overview]24-48 h Postoperative Ketorolac Consumption
NCT02154763 (54) [back to overview]24-48 h Postoperative Dilaudid Consumption
NCT02154763 (54) [back to overview]24-32 Hours Post Operative Pain Level
NCT02154763 (54) [back to overview]20h Peak Expiratory Flow (PEF) Score
NCT02154763 (54) [back to overview]20-24 Hours Post Operative Pain Level
NCT02154763 (54) [back to overview]2-4 h Postoperative Tylenol Consumption
NCT02154763 (54) [back to overview]2-4 h Postoperative Tramadol Consumption
NCT02154763 (54) [back to overview]2-4 h Postoperative Ketorolac Consumption
NCT02154763 (54) [back to overview]2-4 h Postoperative Fentanyl Consumption
NCT02154763 (54) [back to overview]2-4 h Postoperative Dilaudid Consumption
NCT02154763 (54) [back to overview]1h Peak Expiratory Flow (PEF) Score
NCT02154763 (54) [back to overview]24h Peak Expiratory Flow (PEF) Score
NCT02154763 (54) [back to overview]2h Peak Expiratory Flow (PEF) Score
NCT02154763 (54) [back to overview]32-40 Hours Post Operative Pain Level
NCT02154763 (54) [back to overview]32h Peak Expiratory Flow (PEF) Score
NCT02154763 (54) [back to overview]4-12 h Postoperative Dilaudid Consumption
NCT02154763 (54) [back to overview]4-12 h Postoperative Ketorolac Consumption
NCT02154763 (54) [back to overview]4-12 h Postoperative Tylenol Consumption
NCT02154763 (54) [back to overview]4-8 Hours Post Operative Pain Level
NCT02154763 (54) [back to overview]2-4 Hours Post Operative Pain Level
NCT02154763 (54) [back to overview]16h Peak Expiratory Flow (PEF) Score
NCT02154763 (54) [back to overview]16-20 Hours Post Operative Pain Level
NCT02154763 (54) [back to overview]12h Peak Expiratory Flow (PEF) Score
NCT02154763 (54) [back to overview]12-24 h Postoperative Tylenol Consumption
NCT02154763 (54) [back to overview]12-24 h Postoperative Tramadol Consumption
NCT02154763 (54) [back to overview]40-48 Hours Post Operative Pain Level
NCT02154763 (54) [back to overview]12-24 h Postoperative Ketorolac Consumption
NCT02154763 (54) [back to overview]12-24 h Postoperative Dilaudid Consumption
NCT02154763 (54) [back to overview]12-16 Hours Post Operative Pain Level
NCT02154763 (54) [back to overview]1-2 h Postoperative Tylenol Consumption
NCT02154763 (54) [back to overview]40h Peak Expiratory Flow (PEF) Score
NCT02154763 (54) [back to overview]48h Peak Expiratory Flow (PEF) Score
NCT02154763 (54) [back to overview]4h Peak Expiratory Flow (PEF) Score
NCT02154763 (54) [back to overview]6 Minute Walking Distance Post Operative Day 1 (POD1)
NCT02154763 (54) [back to overview]6 Minute Walking Distance Post Operative Day 2 (POD2)
NCT02154763 (54) [back to overview]6 Minute Walking Distance Post Operative Day 7-10 (POD 7-10)
NCT02154763 (54) [back to overview]8-12 Hours Post Operative Pain Level
NCT02154763 (54) [back to overview]4-12 h Postoperative Tramadol Consumption
NCT02154763 (54) [back to overview]Postoperative Day 1 Quality of Recovery Questionnaire (QR-40)
NCT02154763 (54) [back to overview]Postoperative Day 7-10 Quality of Recovery Questionnaire (QR-40)
NCT02154763 (54) [back to overview]1-2 h Postoperative Tramadol Consumption
NCT02154763 (54) [back to overview]1-2 h Postoperative Pain Level
NCT02154763 (54) [back to overview]1-2 h Postoperative Ketorolac Consumption
NCT02154763 (54) [back to overview]1-2 h Postoperative Fentanyl Consumption
NCT02154763 (54) [back to overview]1-2 h Postoperative Dilaudid Consumption
NCT02154763 (54) [back to overview]8h Peak Expiratory Flow (PEF) Score
NCT02154763 (54) [back to overview]0-1 h Postoperative Tramadol Consumption
NCT02154763 (54) [back to overview]0-1 h Postoperative Pain Level
NCT02154763 (54) [back to overview]0-1 h Postoperative Ketorolac Consumption
NCT02154763 (54) [back to overview]0-1 h Postoperative Fentanyl Consumption
NCT02154763 (54) [back to overview]0-1 h Postoperative Dilaudid Consumption
NCT02154763 (54) [back to overview]0-1 h Postoperative Tylenol Consumption
NCT02161705 (1) [back to overview]Postoperative Static Pain Score
NCT02164929 (8) [back to overview]Pain Scores
NCT02164929 (8) [back to overview]Opioid Related Side Effects
NCT02164929 (8) [back to overview]Length of Stay
NCT02164929 (8) [back to overview]Time to First Ingestion of Solid Food
NCT02164929 (8) [back to overview]Time to First Bowel Movement
NCT02164929 (8) [back to overview]Quality of Recovery
NCT02164929 (8) [back to overview]Postoperative Opioid Consumption
NCT02164929 (8) [back to overview]Number of Epidural-related Side Effects
NCT02181296 (4) [back to overview]Percentage Change in Forced Expired Volume in First Second (FEV1) After the Block
NCT02181296 (4) [back to overview]Percentage Change of Forced Vital Capacity (FVC) From Pre-block Value to Value Measures in PACU
NCT02181296 (4) [back to overview]Number of Patients With Paradoxical Diaphragmatic Movement
NCT02181296 (4) [back to overview]Opioid Requirements for 72 Hours After Surgery
NCT02182999 (5) [back to overview]Average Postoperative Numeric Rating Scale (NRS) for Pain
NCT02182999 (5) [back to overview]Peak Postoperative Numeric Rating Scale (NRS) for Pain
NCT02182999 (5) [back to overview]American Orthopaedic Foot and Ankle Society Score (AOFAS)
NCT02182999 (5) [back to overview]Patient's Overall Satisfaction With Surgery
NCT02182999 (5) [back to overview]Patient's Overall Satisfaction With Pain Management
NCT02197273 (3) [back to overview]Time to Post-operative Rescue Opioids (Hours)
NCT02197273 (3) [back to overview]Readmission or Emergency Department (ED) Visit Due to Pain Control Within 30 Days
NCT02197273 (3) [back to overview]Length of Stay in Hospital (Days)
NCT02201784 (5) [back to overview]Onset of Sensory Block at T10
NCT02201784 (5) [back to overview]Duration of Motor Block
NCT02201784 (5) [back to overview]Duration of Analgesia
NCT02201784 (5) [back to overview]Onset of Motor Block to Bromage3
NCT02201784 (5) [back to overview]Time to Maximum Cephalic Spread of Sensory Block
NCT02223364 (15) [back to overview]Balance Testing on Operative Leg Using Unipedal Stance Time
NCT02223364 (15) [back to overview]POD 2 Opioid Use
NCT02223364 (15) [back to overview]POD 1 Opioid Use
NCT02223364 (15) [back to overview]POD 0 Post-PACU Opioid Use
NCT02223364 (15) [back to overview]PACU Opioid Use
NCT02223364 (15) [back to overview]Maximum Pain Post-PACU
NCT02223364 (15) [back to overview]Maximum Pain POD 2 (24 Hours)
NCT02223364 (15) [back to overview]Maximum Pain POD 1 (24 Hours)
NCT02223364 (15) [back to overview]Intraoperative Opioid Use
NCT02223364 (15) [back to overview]Hospital Length of Stay
NCT02223364 (15) [back to overview]Average Pain Post-Postanesthesia Care Unit (PACU)
NCT02223364 (15) [back to overview]Average Pain POD 2 (24 Hours)
NCT02223364 (15) [back to overview]Preoperative Daily Opioid Use
NCT02223364 (15) [back to overview]Average Pain POD 1 (24 Hours)
NCT02223364 (15) [back to overview]Maximum Pain Post-Operative Day (POD) 1 (Morning)
NCT02236130 (2) [back to overview]Patient/Family Satisfaction With Pain Management
NCT02236130 (2) [back to overview]Total Hydrocodone Dose (mg/kg)
NCT02242201 (9) [back to overview]Total Opioid Consumption During Hospitalization
NCT02242201 (9) [back to overview]Change in Short Form-36 (SF-36) Quality of Life Physical Component
NCT02242201 (9) [back to overview]Post-Operative Pain Score
NCT02242201 (9) [back to overview]Change in Short Form-36 (SF-36) Quality of Life Mental Component
NCT02242201 (9) [back to overview]Hospital Length of Stay
NCT02242201 (9) [back to overview]Number of Participants Reporting Complications Since Surgery
NCT02242201 (9) [back to overview]Number of Participants Reporting a NRS Pain Score Greater Than 3
NCT02242201 (9) [back to overview]Change in Unipedal Stance Time
NCT02242201 (9) [back to overview]Maximum Postoperative Pain Score
NCT02264821 (2) [back to overview]Morphine Consumption
NCT02264821 (2) [back to overview]Duration of Effective Analgesia
NCT02270255 (2) [back to overview]Number of Patients With Serious Adverse Reactions From Superior Hypogastric Nerve Block
NCT02270255 (2) [back to overview]mg Equivalent Morphine Used Until Discharge From Recovery Room to Control Pain Level Below 4/10 (VAS)
NCT02314104 (5) [back to overview]Postoperative Pain on a Visual Analogue Pain Scale at One Hour Postoperatively
NCT02314104 (5) [back to overview]Postoperative Pain on a Visual Analogue Pain Scale at Six Hours Postoperatively
NCT02314104 (5) [back to overview]Postoperative Pain on a Visual Analogue Pain Scale at Twenty-four Hours Postoperatively
NCT02314104 (5) [back to overview]Time Until First Request for Pain Medication
NCT02314104 (5) [back to overview]Total Narcotic Usage in Morphine Equivalents
NCT02336958 (2) [back to overview]Amount (ml) of Local Anesthetic Supplemented by Surgeon
NCT02336958 (2) [back to overview]Number of Patients With Required Supplementation of Local Anesthetic by Surgeon
NCT02341144 (5) [back to overview]PACU Length of Stay (LOS)
NCT02341144 (5) [back to overview]PACU Morphine Equivalents
NCT02341144 (5) [back to overview]Time to First Narcotic
NCT02341144 (5) [back to overview]Pain Score of Zero
NCT02341144 (5) [back to overview]Post Operative Pain Rating
NCT02385097 (14) [back to overview]Neurological Symptoms
NCT02385097 (14) [back to overview]Time to Regression of Motor Block
NCT02385097 (14) [back to overview]Time to Regression of Sensory Block
NCT02385097 (14) [back to overview]Blood Pressure
NCT02385097 (14) [back to overview]Heart Rate
NCT02385097 (14) [back to overview]SpO2
NCT02385097 (14) [back to overview]Time to Onset of Motor Block
NCT02385097 (14) [back to overview]Percentage of Participants With Successful Block for Distal Upper Limb Surgeries
NCT02385097 (14) [back to overview]Partecipants Received Rescue Anaesthesia or Rescue Analgesia
NCT02385097 (14) [back to overview]Number of Subjects Who Received Post-operative Analgesia
NCT02385097 (14) [back to overview]Number of Participants With Normal Electrocardiogram (ECG) Parameters
NCT02385097 (14) [back to overview]Number of Participants With Treatment-emergent Adverse Events (TEAEs)
NCT02385097 (14) [back to overview]Time to Onset of Sensory Block (Corresponding to Readiness for Surgery)
NCT02385097 (14) [back to overview]Time to Eligibility for Home Discharge
NCT02393677 (1) [back to overview]Duration of Analgesia
NCT02424630 (2) [back to overview]Patient Satisfaction (SAT) Score
NCT02424630 (2) [back to overview]Visual Analog Scale (VAS) Pain Score
NCT02439281 (7) [back to overview]Complications Rate
NCT02439281 (7) [back to overview]Duration of Analgesia at Umbilicus Instrument Site-How Many Minutes Passed From the Time When the Blocks Where Performed Until Patient Reported Pain at Umbilicus
NCT02439281 (7) [back to overview]Duration of Sensory Block (Paresthesia)
NCT02439281 (7) [back to overview]Medication Consumption
NCT02439281 (7) [back to overview]Satisfaction With Pain Control From Patient
NCT02439281 (7) [back to overview]Average Pain Severity at the Umbilicus Laparoscopic Site
NCT02439281 (7) [back to overview]Change in Anxiety Scores
NCT02462382 (4) [back to overview]Oxycodone Consumption
NCT02462382 (4) [back to overview]Oxycodone Consumption After the First Two Postoperative Days.
NCT02462382 (4) [back to overview]Mean Visual Analog Scale
NCT02462382 (4) [back to overview]Mean Visual Analog Scale Score
NCT02472522 (13) [back to overview]Duration of Sensory Loss at T10 Level
NCT02472522 (13) [back to overview]Percentage of Patients Needing Rescue Analgesic
NCT02472522 (13) [back to overview]Visual Analogue Scale on Coughing (VAS-C)
NCT02472522 (13) [back to overview]Short Assessment of Patient Satisfaction Score (SAPS)
NCT02472522 (13) [back to overview]The Time After the TAP Block When Rescue Analgesia Was First Sought
NCT02472522 (13) [back to overview]Time to Complete Disappearance of Motor Block
NCT02472522 (13) [back to overview]Total Dose of Required Morphine in 24 Hours Postoperatively
NCT02472522 (13) [back to overview]Visual Analogue Scale at Rest (VAS-R)
NCT02472522 (13) [back to overview]Mean Arterial Pressure (MAP): Postoperative Period
NCT02472522 (13) [back to overview]Mean Arterial Pressure (MAP): Intraoperative Period
NCT02472522 (13) [back to overview]Heart Rate: Postoperative
NCT02472522 (13) [back to overview]Heart Rate: Intraoperative Period
NCT02472522 (13) [back to overview]Adverse Effects Like Pruritus, Nausea and Vomiting
NCT02478372 (9) [back to overview]Verbal Rating Score (VRS) Pain Scores
NCT02478372 (9) [back to overview]Patient Reported Outcome Measure - Oxford Knee Score
NCT02478372 (9) [back to overview]Average Post-operative Length of Stay
NCT02478372 (9) [back to overview]Maximal Flexion Angle of the Operative Knee at Discharge From Rehabilitation
NCT02478372 (9) [back to overview]Post-operative Nausea and Vomiting Scores
NCT02478372 (9) [back to overview]Post-operative Urinary Catheterisation Rates
NCT02478372 (9) [back to overview]Proportion of Patients Discharged From Rehabilitation by Day Four
NCT02478372 (9) [back to overview]Day of Ambulation
NCT02478372 (9) [back to overview]Total Number of Reported Participants With Complications and/or Adverse Events
NCT02494336 (7) [back to overview]Use of Post-operative Intravenous/Oral Opioid and Non-opioid
NCT02494336 (7) [back to overview]Number of Participants With Complications
NCT02494336 (7) [back to overview]Number of Participants With Side Effects
NCT02494336 (7) [back to overview]Operative Time
NCT02494336 (7) [back to overview]Post Operative Pain Rating
NCT02494336 (7) [back to overview]Time to First Rescue Analgesic
NCT02494336 (7) [back to overview]Total Number of Complications
NCT02499575 (3) [back to overview]Opioid Use as Measured by Questionnaire
NCT02499575 (3) [back to overview]Total Opioid Use as Measured by Questionnaire
NCT02499575 (3) [back to overview]Pain Relief Measured by Defense and Veterans Pain Scale
NCT02501135 (7) [back to overview]Post-operative Pain Scale Using VAS
NCT02501135 (7) [back to overview]Time to Discharge From PACU
NCT02501135 (7) [back to overview]Concentration of Local Anesthetic Injected for Femoral Nerve Block
NCT02501135 (7) [back to overview]Intraoperative Tylenol Administered
NCT02501135 (7) [back to overview]Total mg of Local Anesthetic Injected for Femoral Nerve Block
NCT02501135 (7) [back to overview]Post-operative Pain Scale Using FLACC
NCT02501135 (7) [back to overview]Post-operative Opioids Administered
NCT02502487 (21) [back to overview]Visual Analog Scale (VAS) for Pain
NCT02502487 (21) [back to overview]Heart Rate at Cystoscopic Inspection of External Sphincter
NCT02502487 (21) [back to overview]Heart Rate After Withdrawal of Cystoscope
NCT02502487 (21) [back to overview]Breath Rate After Withdrawal of Cystoscope
NCT02502487 (21) [back to overview]Breath Rate at Cystoscopic Inspection of External Sphincter
NCT02502487 (21) [back to overview]Breath Rate at Cystoscopic Inspection of Penile and Bulbar Urthra
NCT02502487 (21) [back to overview]Breath Rate Before Gel Administration
NCT02502487 (21) [back to overview]Visual Analog Scale (VAS) for Pain
NCT02502487 (21) [back to overview]Visual Analog Scale (VAS) for Pain
NCT02502487 (21) [back to overview]Visual Analog Scale (VAS) for Pain
NCT02502487 (21) [back to overview]Visual Analog Scale (VAS) for Pain
NCT02502487 (21) [back to overview]Oxygen Saturation by Pulse Before Gel Administration
NCT02502487 (21) [back to overview]Oxygen Saturation by Pulse at Cystoscopic Inspection of Penile and Bulbar Urthra
NCT02502487 (21) [back to overview]Oxygen Saturation by Pulse at Cystoscopic Inspection of External Sphincter
NCT02502487 (21) [back to overview]Oxygen Saturation by Pulse After Withdrawal of Cystoscope
NCT02502487 (21) [back to overview]Mean Arterial Pressure Before Gel Administration
NCT02502487 (21) [back to overview]Mean Arterial Pressure at Cystoscopic Inspection of Penile and Bulbar Urthra
NCT02502487 (21) [back to overview]Mean Arterial Pressure at Cystoscopic Inspection of External Sphincter
NCT02502487 (21) [back to overview]Mean Arterial Pressure After Withdrawal of Cystoscope
NCT02502487 (21) [back to overview]Heart Rate Before Gel Administration
NCT02502487 (21) [back to overview]Heart Rate at Cystoscopic Inspection of Penile and Bulbar Urthra
NCT02523235 (8) [back to overview]Pain (Average): Numeric Rating Scale for Pain
NCT02523235 (8) [back to overview]Pain (Worst) :Numeric Rating Scale for Pain
NCT02523235 (8) [back to overview]Pain During Afternoon Physical Therapy Session
NCT02523235 (8) [back to overview]Toe/Foot Numbness (Insensate) :0-10 Scale
NCT02523235 (8) [back to overview]Total Local Anesthetic Infused (Adductor Only) : mL
NCT02523235 (8) [back to overview]Ambulation: Distance in Meters
NCT02523235 (8) [back to overview]Analgesic Use: IV Morphine Equivalents
NCT02523235 (8) [back to overview]Number of Participants That Had Fluid Leakage Reported at Catheter Site.
NCT02543801 (3) [back to overview]Length of Stay
NCT02543801 (3) [back to overview]Narcotic Consumption
NCT02543801 (3) [back to overview]Pain Score
NCT02570022 (2) [back to overview]Pain Levels
NCT02570022 (2) [back to overview]Morphine Equivalents
NCT02570503 (1) [back to overview]Narcotic Use During Hospitalization
NCT02571439 (10) [back to overview]Itching.
NCT02571439 (10) [back to overview]Number of Participants With Postoperative Nausea/Vomiting
NCT02571439 (10) [back to overview]Sedation
NCT02571439 (10) [back to overview]Severity of Postoperative Pain at Rest
NCT02571439 (10) [back to overview]Severity of Postoperative Pain at Rest
NCT02571439 (10) [back to overview]Severity of Postoperative Pain at Rest
NCT02571439 (10) [back to overview]Total Narcotic Consumption
NCT02571439 (10) [back to overview]Time Taken to Perform the Block
NCT02571439 (10) [back to overview]Time From Delivery of Neonate to Ready to Exit Operating Room
NCT02571439 (10) [back to overview]Severity of Postoperative Pain at Rest
NCT02576249 (3) [back to overview]Tegner Activity Level Scale
NCT02576249 (3) [back to overview]The Knee Osteoarthritis Outcome Score (KOOS) Pain Subscale
NCT02576249 (3) [back to overview]Pain Scale Score
NCT02579629 (14) [back to overview]Amount of Opioid Use
NCT02579629 (14) [back to overview]Change in Intensity of Pain: VAPS From Baseline
NCT02579629 (14) [back to overview]Change in Time From Baseline to First Dose of Rescue Medications
NCT02579629 (14) [back to overview]Change in McGill Pain Questionnaire Score From Baseline
NCT02579629 (14) [back to overview]Change in Pain Scores at Rest From Baseline
NCT02579629 (14) [back to overview]Patient Satisfaction at 72 Hours Post Intervention
NCT02579629 (14) [back to overview]Cost Analysis
NCT02579629 (14) [back to overview]Change in Intensity of Pain: Numerical Pain Scale (NPS) From Baseline
NCT02579629 (14) [back to overview]Breastfeeding Success
NCT02579629 (14) [back to overview]Number of Patients With Wound Dysesthesia, Infection, Dehiscence and Keloid Formation at 6 Weeks and 3 Months Post-intervention
NCT02579629 (14) [back to overview]Number of Participants With Catheter or Infiltrate-related Issues at 24, 48 and 72 Hours Post-intervention
NCT02579629 (14) [back to overview]Dosing Amount of Non-steroidal Anti-inflammatory Drugs
NCT02579629 (14) [back to overview]Change in Pain Scores During Cough From Baseline
NCT02579629 (14) [back to overview]Change in Pain Scores During 20°Straight Leg Raise
NCT02584452 (4) [back to overview]Quadriceps Strength of on POD 1 of Preoperative Femoral Nerve Block Plus Postoperative Continuous Adductor Canal Nerve Catheter Compared to Preoperative Femoral Nerve Block Plus Postoperative Saphenous Nerve Block at 48 Hours After Discharge From PACU
NCT02584452 (4) [back to overview]Subjective Postoperative Pain Score at Post Operative Week 6 of Preoperative Femoral Nerve Block Plus Postoperative Continuous Adductor Canal Nerve Catheter Compared to Preoperative Femoral Nerve Block Plus Postoperative Saphenous Nerve Block
NCT02584452 (4) [back to overview]Total Postop Opioid Consumption of Patients Receiving (1) Preoperative Femoral Nerve Block Plus Postoperative Continuous Adductor Canal Nerve Catheter Compared to (2) Preoperative Femoral Nerve Block Plus Postoperative Saphenous Nerve Block.
NCT02584452 (4) [back to overview]Quadriceps Strength on POD Week 6- Pts Receiving (1) Long-acting Single Bolus Adductor Canal Nerve Block Comparied to (2) Continuous Adductor Canal Nerve Catheter.
NCT02604550 (10) [back to overview]"Percent of Patients Rating Their Satisfaction as Excellent or Good"
NCT02604550 (10) [back to overview]Patient-Reported Vomiting
NCT02604550 (10) [back to overview]Pain Score
NCT02604550 (10) [back to overview]Number of Percocet Tablets Consumed
NCT02604550 (10) [back to overview]Total Hours of Sleep
NCT02604550 (10) [back to overview]Time to Straight Less Raise
NCT02604550 (10) [back to overview]Patient-Reported Sedation
NCT02604550 (10) [back to overview]Patient-Reported Nausea
NCT02604550 (10) [back to overview]Patient-Reported Itching
NCT02604550 (10) [back to overview]Patient-Reported Constipation
NCT02652156 (7) [back to overview]Patient Reported Pain by VAS Scale
NCT02652156 (7) [back to overview]Patient Reported Pain by VAS Scale
NCT02652156 (7) [back to overview]Patient Reported Pain by VAS Scale
NCT02652156 (7) [back to overview]Postoperative Vomiting (Events)
NCT02652156 (7) [back to overview]Total Dosage of Narcotic
NCT02652156 (7) [back to overview]Number of Days Required for a Patient to Walk Unassisted
NCT02652156 (7) [back to overview]Number of Days Required for a Patient to Get Out of Bed
NCT02653144 (4) [back to overview]Opioid Requirements (Morphine Equivalents)
NCT02653144 (4) [back to overview]Opioid Requirements (Morphine Equivalents)
NCT02653144 (4) [back to overview]Time to Discharge From PACU to First Opioid Consumption
NCT02653144 (4) [back to overview]Return of Motor and Sensory Function
NCT02658149 (5) [back to overview]Opioid Usage In-hospital at 24 Hours
NCT02658149 (5) [back to overview]Pain Score at 3-24 Hours
NCT02658149 (5) [back to overview]Pain Score at 3 Hours
NCT02658149 (5) [back to overview]Pain Score at 24-48 Hours
NCT02658149 (5) [back to overview]Opioid Usage In-hospital at 48 Hours
NCT02658240 (4) [back to overview]Postoperative Pain Score With Movement
NCT02658240 (4) [back to overview]Postoperative Pain Score at Resting
NCT02658240 (4) [back to overview]The Time to Ambulation
NCT02658240 (4) [back to overview]Oral Morphine Equivalents of Postoperative Opioid Requirements for 48 Hours
NCT02701296 (6) [back to overview]Sensation in the Peroneal Nerve Distribution
NCT02701296 (6) [back to overview]Plantar Flexion in the Tibial Nerve Distribution
NCT02701296 (6) [back to overview]Pain Intensity
NCT02701296 (6) [back to overview]Cold Sensation in the Tibial Nerve Distribution
NCT02701296 (6) [back to overview]Dorsiflexion in the Peroneal Nerve Distribution
NCT02701296 (6) [back to overview]Opioid Consumption
NCT02726620 (43) [back to overview]Usage Frequency of Cardiovascular Drugs: Ephedrine
NCT02726620 (43) [back to overview]Usage Frequency of Cardiovascular Drugs: Ephinephrine
NCT02726620 (43) [back to overview]In-hospital Mortality
NCT02726620 (43) [back to overview]Estimated Intraoperative Blood Loss
NCT02726620 (43) [back to overview]Depth and Duration of Intraoperative Hypotension - Threshold MAP 75 mmHg
NCT02726620 (43) [back to overview]Depth and Duration of Intraoperative Hypotension - Threshold MAP 70 mmHg
NCT02726620 (43) [back to overview]Depth and Duration of Intraoperative Hypotension - Threshold MAP 65 mmHg
NCT02726620 (43) [back to overview]Depth and Duration of Intraoperative Hypotension - Threshold MAP 60 mmHg
NCT02726620 (43) [back to overview]Depth and Duration of Intraoperative Hypotension - Threshold MAP 55 mmHg
NCT02726620 (43) [back to overview]Incidence of a MAP < 50 mmHg
NCT02726620 (43) [back to overview]Depth and Duration of Intraoperative Hypotension - Threshold MAP 50 mmHg
NCT02726620 (43) [back to overview]Average Use of Cardiovascular Drugs: Phenylephrine
NCT02726620 (43) [back to overview]Average Use of Cardiovascular Drugs: Norepinephrine
NCT02726620 (43) [back to overview]Incidence of a MAP < 55 mmHg for > 20 Minutes
NCT02726620 (43) [back to overview]Incidence of a MAP < 60 mmHg
NCT02726620 (43) [back to overview]Incidence of a MAP < 60 mmHg for > 10 Minutes
NCT02726620 (43) [back to overview]Incidence of a MAP < 60 mmHg for > 20 Minutes
NCT02726620 (43) [back to overview]Intraoperative Administration of Intravenous Fluids
NCT02726620 (43) [back to overview]Intravenous Anesthetic Drug Use During Intraoperative Hypotension: MAP < 50 mmHg
NCT02726620 (43) [back to overview]Average Use of Cardiovascular Drugs: Glycopyrrolate
NCT02726620 (43) [back to overview]Average Use of Cardiovascular Drugs: Epinephrine
NCT02726620 (43) [back to overview]Inhaled Anesthetic Drug Use During Intraoperative Hypotension: MAP < 65 mmHg
NCT02726620 (43) [back to overview]Inhaled Anesthetic Drug Use During Intraoperative Hypotension: MAP < 60 mmHg
NCT02726620 (43) [back to overview]Inhaled Anesthetic Drug Use During Intraoperative Hypotension: MAP < 55 mmHg
NCT02726620 (43) [back to overview]Intravenous Anesthetic Drug Use During Intraoperative Hypotension: MAP < 60 mmHg
NCT02726620 (43) [back to overview]Intravenous Anesthetic Drug Use During Intraoperative Hypotension: MAP < 55 mmHg
NCT02726620 (43) [back to overview]Inhaled Anesthetic Drug Use During Intraoperative Hypotension: MAP < 50 mmHg
NCT02726620 (43) [back to overview]Usage Frequency of Cardiovascular Drugs: Phenylephrine
NCT02726620 (43) [back to overview]Usage Frequency of Cardiovascular Drugs: Norepinephrine
NCT02726620 (43) [back to overview]Usage Frequency of Cardiovascular Drugs: Glycopyrrolate
NCT02726620 (43) [back to overview]Incidence of a MAP < 55 mmHg for > 10 Minutes
NCT02726620 (43) [back to overview]Incidence of a MAP < 55 mmHg
NCT02726620 (43) [back to overview]Incidence of a MAP < 50 mmHg for > 20 Minutes
NCT02726620 (43) [back to overview]Incidence of a MAP < 50 mmHg for > 10 Minutes
NCT02726620 (43) [back to overview]30-day Mortality
NCT02726620 (43) [back to overview]Average Use of Cardiovascular Drugs: Ephedrine
NCT02726620 (43) [back to overview]Time to Discharge Readiness at the Postanesthesia Care Unit (PACU)
NCT02726620 (43) [back to overview]Timing of Cardiovascular Drugs for MAP < 50 mmHg
NCT02726620 (43) [back to overview]Timing of Cardiovascular Drugs for MAP < 55 mmHg
NCT02726620 (43) [back to overview]Timing of Cardiovascular Drugs for MAP < 60 mmHg
NCT02726620 (43) [back to overview]Timing of Cardiovascular Drugs for MAP < 65 mmHg
NCT02726620 (43) [back to overview]Intravenous Anesthetic Drug Use During Intraoperative Hypotension: MAP < 65 mmHg
NCT02726620 (43) [back to overview]Postoperative Rise in Creatinine Levels
NCT02740127 (3) [back to overview]Length of Hospital Stay
NCT02740127 (3) [back to overview]Post-Operative Pain Medication Usage in Post Anesthesia Care Unit (PACU)
NCT02740127 (3) [back to overview]Post-operative Pain the First 24hrs
NCT02788019 (1) [back to overview]Number of Grid Points With Change of Sensation to Pinprick After Blockade
NCT02793947 (3) [back to overview]Visual Analog Scale Pain Assessment
NCT02793947 (3) [back to overview]Number of Participants With Medication-related Side Effects
NCT02793947 (3) [back to overview]Total Narcotic Consumption
NCT02798835 (10) [back to overview]Length of Stay
NCT02798835 (10) [back to overview]Pain Score
NCT02798835 (10) [back to overview]Time to First Use of PCA
NCT02798835 (10) [back to overview]Cumulative 48 Hour Oral Morphine Equivalent Consumption
NCT02798835 (10) [back to overview]Cumulative 24 Hour Oral Morphine Equivalent Consumption
NCT02798835 (10) [back to overview]Nerve Block Complications
NCT02798835 (10) [back to overview]Quality of Recovery (QoR-40)
NCT02798835 (10) [back to overview]Cumulative 12 Hour Oral Morphine Equivalent Consumption
NCT02798835 (10) [back to overview]Adductor Canal Block Complications
NCT02798835 (10) [back to overview]Incidence of Participants With Nausea/Vomiting Requiring Anti-emetics
NCT02829944 (23) [back to overview]Number of Subjects Experiencing Nausea
NCT02829944 (23) [back to overview]Number of Subjects Experiencing Nausea
NCT02829944 (23) [back to overview]Number of Subjects Experiencing Nausea
NCT02829944 (23) [back to overview]Number of Subjects Experiencing Pruritus
NCT02829944 (23) [back to overview]Number of Subjects Experiencing Pruritus
NCT02829944 (23) [back to overview]Number of Subjects Experiencing Vomiting
NCT02829944 (23) [back to overview]Number of Subjects Experiencing Vomiting
NCT02829944 (23) [back to overview]Number of Subjects Experiencing Vomiting
NCT02829944 (23) [back to overview]Number of Subjects With Chronic Pain
NCT02829944 (23) [back to overview]Number of Subjects With Chronic Pain
NCT02829944 (23) [back to overview]Opioid Consumption
NCT02829944 (23) [back to overview]Opioid Consumption
NCT02829944 (23) [back to overview]Opioid Consumption
NCT02829944 (23) [back to overview]Pain Score on Movement
NCT02829944 (23) [back to overview]Pain Score on Movement (Sitting in Bed From a Supine Position)
NCT02829944 (23) [back to overview]Pain Scores at Rest
NCT02829944 (23) [back to overview]Pain Scores at Rest
NCT02829944 (23) [back to overview]Pain Scores at Rest
NCT02829944 (23) [back to overview]Patient Satisfaction With Postoperative Analgesia on a 0-10 Scale
NCT02829944 (23) [back to overview]Postpartum Depression, as Measured by the Edinburgh Postnatal Depression Scale
NCT02829944 (23) [back to overview]Postpartum Depression, as Measured by the Edinburgh Postnatal Depression Scale
NCT02829944 (23) [back to overview]Time to First Rescue Analgesic
NCT02829944 (23) [back to overview]Number of Subjects Experiencing Pruritus
NCT02849678 (7) [back to overview]Postoperative Opioid Consumption (Milligrams of Dilaudid or Equivalent)
NCT02849678 (7) [back to overview]Time to First Flatus/Defecation
NCT02849678 (7) [back to overview]Number of Patients With Complications (Including But Not Limited to Pneumonia, Atelectasis, Hypotension, Motor Weakness, Etc.)
NCT02849678 (7) [back to overview]Time to First Ambulation(Walking Greater Than 15 Feet)
NCT02849678 (7) [back to overview]Consumption of Nerve Block Boluses Will Also be Recorded Daily
NCT02849678 (7) [back to overview]Hospital Length of Stay.
NCT02849678 (7) [back to overview]11-point Verbal Numerical Rating Scale (NRS) Pain Assessment
NCT02893423 (1) [back to overview]POSTOPERATIVE PAIN
NCT02919072 (3) [back to overview]Time to the Onset of Anaesthesia
NCT02919072 (3) [back to overview]Time From T0 to Loss Light Touch Sensation
NCT02919072 (3) [back to overview]Quality of the Block
NCT02924324 (1) [back to overview]Number of Participants Requiring Post-procedural Opioid Analgesia Per Study Arm
NCT02933671 (5) [back to overview]Numeric Pain Score at 4 Hours Postoperatively, as Measured by Numerical Rating Scale (NRS) 11
NCT02933671 (5) [back to overview]Cumulative Opioid Consumption
NCT02933671 (5) [back to overview]Numeric Pain Score at 24 Hours, as Measured by NRS 11
NCT02933671 (5) [back to overview]Motor Strength, as Measured by Dynamometry
NCT02933671 (5) [back to overview]Ambulation, as Measured by Distanced Walked
NCT02949271 (10) [back to overview]Total Number of Subjects Experiencing Each Mode of Delivery
NCT02949271 (10) [back to overview]Degree of Motor Blockade Measured as Lowest Recorded Modified Bromage Score
NCT02949271 (10) [back to overview]Number of Subjects Who Were Satisfied With Procedure
NCT02949271 (10) [back to overview]Maximum Reported Labor Pain Score
NCT02949271 (10) [back to overview]Number of Patient Controlled Epidural Analgesia (PCEA) Attempts
NCT02949271 (10) [back to overview]Number of Subjects Experiencing Hypotension Requiring Vasopressor Treatment
NCT02949271 (10) [back to overview]Ratio of Patient Controlled Epidural Analgesia (PCEA) Successful Attempts to Unsuccessful Attempts
NCT02949271 (10) [back to overview]Volume of Local Anesthetic Received Through Patient Controlled Epidural Analgesia (PCEA) Per Hour
NCT02949271 (10) [back to overview]Volume of Local Anesthetic Required Per Hour
NCT02949271 (10) [back to overview]Duration of Second Stage of Labor
NCT02949674 (1) [back to overview]VAS
NCT02950558 (4) [back to overview]Pain Score at 2 Weeks - Experimental Group vs. Control Group
NCT02950558 (4) [back to overview]Pain Score at 3 Months - Experimental Group vs. Control Group
NCT02950558 (4) [back to overview]Pain Score at 12 Months - Experimental Group vs. Control Group
NCT02950558 (4) [back to overview]Pain Score at 6 Months - Experimental Group vs. Control Group
NCT02967172 (4) [back to overview]Post-operative Length of Stay
NCT02967172 (4) [back to overview]Patients Returning Home Following Surgery
NCT02967172 (4) [back to overview]Opioid Use in First 24 Hours Post-surgery
NCT02967172 (4) [back to overview]Change in Post-operative Visual Analog Pain Scores (VAS)
NCT03015532 (3) [back to overview]Mean Area Under the Curve (AUC) of the NRS-R (Windowed Worst Observation Carried Forward) Pain Intensity Scores
NCT03015532 (3) [back to overview]Mean Area Under the Curve (AUC) of the NRS-R (Windowed Worst Observation Carried Forward) Pain Intensity Scores
NCT03015532 (3) [back to overview]Mean Total Postoperative Opioid Consumption (in Morphine Equivalents)
NCT03077919 (12) [back to overview]Clinician Administered PTSD Score (CAPS-5) TSSS
NCT03077919 (12) [back to overview]Current Medications
NCT03077919 (12) [back to overview]Generalized Anxiety Disorder 7-item Survey (GAD-7)
NCT03077919 (12) [back to overview]Kessler Psychiatric Distress Scale (K6)
NCT03077919 (12) [back to overview]PTSD Checklist (PCL-5)
NCT03077919 (12) [back to overview]PTSD Checklist Civilian (PCL-C)
NCT03077919 (12) [back to overview]Short Pain Scale
NCT03077919 (12) [back to overview]12 Item Short Form Survey (SF-12) of Mental Functioning
NCT03077919 (12) [back to overview]The Patient Health Questionnaire (PHQ-9)
NCT03077919 (12) [back to overview]12-item Short Form Survey (SF-12) of Physical Functioning
NCT03077919 (12) [back to overview]Alcohol Use Disorders Identification Test (AUDIT/AUDIT-C)
NCT03077919 (12) [back to overview]Mini-International Neuropsychiatric Interview (M.I.N.I.-Plus) Suicidality Items
NCT03080142 (1) [back to overview]Mean Opioid Consumption in Morphine Opioid Equivalents in mg
NCT03086213 (6) [back to overview]Comparing the Inflammatory Markers During the Operation After the Intervention of the Each Group
NCT03086213 (6) [back to overview]Comparing the Hemodynamics of the Intervention of the Each Group During the Operation
NCT03086213 (6) [back to overview]Comparing the Hemodynamics of the Intervention of the Each Group During the Operation
NCT03086213 (6) [back to overview]Number of Participants With Puncture Related Complications
NCT03086213 (6) [back to overview]Comparing the Blood Gas Analysis After the Intervention of the Each Group
NCT03086213 (6) [back to overview]Concentration of Cortisol at Different Point During the Operation
NCT03098420 (3) [back to overview]Average Pain Score
NCT03098420 (3) [back to overview]Average Opioid Consumption
NCT03098420 (3) [back to overview]First Post-Operative Opioid Administration
NCT03117140 (15) [back to overview]Sensory Duration of Block
NCT03117140 (15) [back to overview]Patient Reporting Vomiting at Home
NCT03117140 (15) [back to overview]Block Set up Time
NCT03117140 (15) [back to overview]Pain Score Reported by Patients at First Phone Call
NCT03117140 (15) [back to overview]Surgical Length
NCT03117140 (15) [back to overview]Surgical Position
NCT03117140 (15) [back to overview]Motor Duration of Block
NCT03117140 (15) [back to overview]Number of Patients With Blood Pressure (BP) Changes in the PACU
NCT03117140 (15) [back to overview]Duration of Analgesia
NCT03117140 (15) [back to overview]Number of Patients Reporting Itching at Home
NCT03117140 (15) [back to overview]Number of Patient With Blood Pressure Changes in the Second Stage Recovery Area
NCT03117140 (15) [back to overview]Number of Patients Reporting Itching in the PACU
NCT03117140 (15) [back to overview]Number of Patients Reporting Nausea at Home
NCT03117140 (15) [back to overview]Number of Patients Reporting Nausea in the PACU
NCT03117140 (15) [back to overview]Number of Patients Vomiting in the PACU (Post-Anesthesia Care Unit)
NCT03133481 (12) [back to overview]Mean Distance Ambulated at 48 Hours Post Operatively
NCT03133481 (12) [back to overview]Mean Distance Ambulated at 24 Hours Post Operatively
NCT03133481 (12) [back to overview]Mean Pain Scores at 24 Hours
NCT03133481 (12) [back to overview]Mean Pain Scores 48 Hours Postoperatively
NCT03133481 (12) [back to overview]Mean Opioid Consumption as Measured in Oral Morphine Milligram Equivalents
NCT03133481 (12) [back to overview]Mean Opioid Consumption as Measured in Oral Morphine Milligram Equivalents
NCT03133481 (12) [back to overview]Mean Opioid Consumption as Measured in Oral Morphine Equivalents
NCT03133481 (12) [back to overview]Mean Opioid Consumption as Measured by Oral Morphine Milligram Equivalents
NCT03133481 (12) [back to overview]Mean Hours to Discharge
NCT03133481 (12) [back to overview]Patient Satisfaction at 48 Hours Post Operatively
NCT03133481 (12) [back to overview]Mean Pain Scores in PACU
NCT03133481 (12) [back to overview]Mean Pain Scores Immediately Preoperatively
NCT03154658 (7) [back to overview]Maximum Post-operative Pain Score
NCT03154658 (7) [back to overview]Length of Stay
NCT03154658 (7) [back to overview]Block Performance Time
NCT03154658 (7) [back to overview]Opioid Consumption
NCT03154658 (7) [back to overview]Patient Satisfaction Scale
NCT03154658 (7) [back to overview]Sleep Duration Night of Postoperative Day 0
NCT03154658 (7) [back to overview]Number of Participants With Nausea/Vomiting
NCT03316378 (3) [back to overview]Pain Psychology
NCT03316378 (3) [back to overview]Central Sensitization
NCT03316378 (3) [back to overview]Movement System
NCT03353233 (4) [back to overview]Ambulation as Measured by Distance Walked After Surgery
NCT03353233 (4) [back to overview]Cumulative Opioid Consumption
NCT03353233 (4) [back to overview]Number of Participants Able to Hyperextend the Knee After Surgery
NCT03353233 (4) [back to overview]Pain as Measure by Numerical Rating Scale (NRS) 11
NCT03435692 (6) [back to overview]Hospital Length of Stay
NCT03435692 (6) [back to overview]Itching
NCT03435692 (6) [back to overview]Maximum Pain Score
NCT03435692 (6) [back to overview]Total Perioperative Morphine Equivalents
NCT03435692 (6) [back to overview]Muscle Spasm
NCT03435692 (6) [back to overview]Nausea
NCT03591146 (1) [back to overview]Safety and Tolerability: Event of SAE and Treatment-related Severe AE
NCT03666663 (1) [back to overview]Number of Participants With a Reduction in Headache Days From Baseline to Month 8 of Treatment
NCT03695172 (16) [back to overview]Postoperative Pain Scores
NCT03695172 (16) [back to overview]Number of Participants Requiring Antiemetics
NCT03695172 (16) [back to overview]Number of Participants Requiring Antiemetics
NCT03695172 (16) [back to overview]Number of Participants Requiring Antiemetics
NCT03695172 (16) [back to overview]Postoperative Pain Scores
NCT03695172 (16) [back to overview]Postoperative Pain Scores
NCT03695172 (16) [back to overview]Postoperative Opioid Consumption
NCT03695172 (16) [back to overview]Postoperative Opioid Consumption
NCT03695172 (16) [back to overview]Postoperative Opioid Consumption
NCT03695172 (16) [back to overview]Number of Participants Requiring Antipruritics
NCT03695172 (16) [back to overview]Number of Participants Requiring Antipruritics
NCT03695172 (16) [back to overview]Postoperative Pain Scores
NCT03695172 (16) [back to overview]Postoperative Opioid Consumption
NCT03695172 (16) [back to overview]Number of Participants Requiring Antipruritics
NCT03695172 (16) [back to overview]Number of Participants Requiring Antipruritics
NCT03695172 (16) [back to overview]Number of Participants Requiring Antiemetics
NCT03704376 (17) [back to overview]Number of Successful Repetitions With Straight Leg Raise Test
NCT03704376 (17) [back to overview]Number of Successful Repetitions With Straight Leg Raise Test
NCT03704376 (17) [back to overview]Number of Successful Repetitions With Straight Leg Raise Test
NCT03704376 (17) [back to overview]Narcotics Use as Assessed by Morphine Equivalents Consumed
NCT03704376 (17) [back to overview]Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale
NCT03704376 (17) [back to overview]Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale
NCT03704376 (17) [back to overview]Quadriceps Muscle Activation as Assessed by Surface Electromyography (sEMG)
NCT03704376 (17) [back to overview]Quadriceps Muscle Activation as Assessed by Surface Electromyography (EMG)
NCT03704376 (17) [back to overview]Quadriceps Muscle Activation as Assessed by Surface Electromyography (EMG)
NCT03704376 (17) [back to overview]Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale
NCT03704376 (17) [back to overview]Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale
NCT03704376 (17) [back to overview]Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale
NCT03704376 (17) [back to overview]Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale
NCT03704376 (17) [back to overview]Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale
NCT03704376 (17) [back to overview]Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale
NCT03704376 (17) [back to overview]Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale
NCT03704376 (17) [back to overview]Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale
NCT03746951 (3) [back to overview]Opioid Consumption in the PACU
NCT03746951 (3) [back to overview]Post-op Pain Scores
NCT03746951 (3) [back to overview]Total Time to Perform the Regional Anesthesia Technique
NCT03801265 (19) [back to overview]Pain With Movement After Surgery
NCT03801265 (19) [back to overview]Patients With Postoperative Quadriceps Weakness
NCT03801265 (19) [back to overview]Postoperative Time to Accomplish Walking 100 Feet
NCT03801265 (19) [back to overview]Total Acetaminophen Consumption During 24 Hours After Surgery
NCT03801265 (19) [back to overview]Total Celecoxib Consumption During 24 Hours After Surgery
NCT03801265 (19) [back to overview]Total Gabapentin Consumption During 24 Hours After Surgery
NCT03801265 (19) [back to overview]Total Ketorolac Consumption During 24 Hours After Surgery
NCT03801265 (19) [back to overview]Total Opioid Consumption During 24 Hours After Surgery
NCT03801265 (19) [back to overview]Total Oral Ketamine Consumption During 24 Hours After Surgery
NCT03801265 (19) [back to overview]Pain at Rest After Surgery
NCT03801265 (19) [back to overview]Pain During Physical Therapy
NCT03801265 (19) [back to overview]Pain With Movement After Surgery
NCT03801265 (19) [back to overview]Pain With Movement After Surgery
NCT03801265 (19) [back to overview]Block Procedure Duration
NCT03801265 (19) [back to overview]Opioid Consumption During 0-6 Hours After Surgery
NCT03801265 (19) [back to overview]Opioid Consumption During 12-24 Hours After Surgery
NCT03801265 (19) [back to overview]Opioid Consumption During 6-12 Hours After Surgery
NCT03801265 (19) [back to overview]Pain at Rest After Surgery
NCT03801265 (19) [back to overview]Pain at Rest After Surgery
NCT03875274 (1) [back to overview]Duration of Analgesia
NCT03936387 (2) [back to overview]Number of Participants Who Completed a Successful Intervention With No Major Adverse Events
NCT03936387 (2) [back to overview]Number of Participants Who Completed a Successful Intervention With a Full Data Set
NCT03977454 (4) [back to overview]Brief Pain Inventory: Interference
NCT03977454 (4) [back to overview]Length of Stay
NCT03977454 (4) [back to overview]Daily Opioid Consumption
NCT03977454 (4) [back to overview]Change in Pain Intensity While in Hospital
NCT03983941 (2) [back to overview]Number of Opioid Doses Administered
NCT03983941 (2) [back to overview]Average Post-operative Pain Score
NCT04005404 (3) [back to overview]Success Rate (Conversion to General Anesthesia)
NCT04005404 (3) [back to overview]Success Rate (Supplemental Medication)
NCT04005404 (3) [back to overview]Circulation Stability
NCT04051684 (4) [back to overview]Post Operative Opioid Usage
NCT04051684 (4) [back to overview]Nausea: The Number of Participants Experiencing Nausea Will be Assessed by Chart Review
NCT04051684 (4) [back to overview]Pain Score Assessed With Visual Analog Score (VAS)
NCT04051684 (4) [back to overview]Vomiting: The Number of Participants Experiencing Vomiting Will be Assessed by Chart Review
NCT04080739 (2) [back to overview]Opioid Medication Use
NCT04080739 (2) [back to overview]Opioid Utilization Measured in Oral Morphine Equivalent (OME)
NCT04208516 (17) [back to overview]Local Anesthetic Consumption After Surgery
NCT04208516 (17) [back to overview]Serum Lidocaine Level
NCT04208516 (17) [back to overview]Serum Lidocaine Level
NCT04208516 (17) [back to overview]Total Hospital Length of Stay
NCT04208516 (17) [back to overview]Pain After Surgery
NCT04208516 (17) [back to overview]Pain After Surgery
NCT04208516 (17) [back to overview]Local Anesthetic Consumption After Surgery
NCT04208516 (17) [back to overview]Pain After Surgery
NCT04208516 (17) [back to overview]Pain After Surgery
NCT04208516 (17) [back to overview]Pain After Surgery
NCT04208516 (17) [back to overview]Opioid Consumption After Surgery
NCT04208516 (17) [back to overview]Serum Lidocaine Level
NCT04208516 (17) [back to overview]Opioid Consumption After Surgery
NCT04208516 (17) [back to overview]Opioid Consumption After Surgery
NCT04208516 (17) [back to overview]Incidence of Adverse Events
NCT04208516 (17) [back to overview]Local Anesthetic Consumption After Surgery
NCT04208516 (17) [back to overview]Local Anesthetic Consumption After Surgery
NCT04251884 (5) [back to overview]Opioids Consumption
NCT04251884 (5) [back to overview]Lenght of Hospital Stay
NCT04251884 (5) [back to overview]Postoperative Pain on the Visual Analogue Scale (VAS)
NCT04251884 (5) [back to overview]Complications Related to the Pudendal Nerve Block
NCT04251884 (5) [back to overview]Postoperative Pain on the Visual Analogue Scale (VAS)
NCT04368364 (12) [back to overview]Severity of Vomiting as Assessed by a Scale
NCT04368364 (12) [back to overview]Time to First Analgesic Request
NCT04368364 (12) [back to overview]Total Narcotic Consumption in Morphine Equivalents (in Milligrams)
NCT04368364 (12) [back to overview]Static Pain as Measured by the Numerical Pain Score (NPS)
NCT04368364 (12) [back to overview]Severity of Sedation as Assessed by a Scale
NCT04368364 (12) [back to overview]Patient Satisfaction as Assessed by Likert Scale
NCT04368364 (12) [back to overview]Severity of Nausea as Assessed by a Scale
NCT04368364 (12) [back to overview]Patient Satisfaction as Assessed by Likert Scale
NCT04368364 (12) [back to overview]Patient Satisfaction as Assessed by Likert Scale
NCT04368364 (12) [back to overview]Dynamic Pain as Measured by the Numerical Pain Score (NPS)
NCT04368364 (12) [back to overview]Severity of Pruritus as Assessed by a Scale
NCT04368364 (12) [back to overview]Total Narcotic Consumption in Morphine Equivalents (in Milligrams)
NCT04429022 (8) [back to overview]Number of Patients With Return to the Clinic, Emergency Department Due to Post Operative Pain Within a 2 Week Period
NCT04429022 (8) [back to overview]Length of Stay in Hours
NCT04429022 (8) [back to overview]Total Opioid Pain Medications Required Through 3-24h Post op in MME
NCT04429022 (8) [back to overview]Pain Scores
NCT04429022 (8) [back to overview]Total Opioid Pain Medications Required 0-3h Post op in Morphine Milligram Equivalents (MME)
NCT04429022 (8) [back to overview]Estimated Blood Loss
NCT04429022 (8) [back to overview]Pain Scores
NCT04429022 (8) [back to overview]Operative Time
NCT04474366 (3) [back to overview]Comparison of Intra Operative Narcotic Requirements
NCT04474366 (3) [back to overview]Comparison of Post Operative Narcotic Requirements
NCT04474366 (3) [back to overview]Comparison of Post Operative Pain Scores
NCT04558281 (13) [back to overview]Maximal Inspired Volume - Percentage Change From Baseline Prior to Intervention
NCT04558281 (13) [back to overview]Rib Fracture Pain When Using an Incentive Spirometer
NCT04558281 (13) [back to overview]Sleep Disturbances Due to Rib Fracture Pain
NCT04558281 (13) [back to overview]Opioid Consumption
NCT04558281 (13) [back to overview]Maximal Inspired Volume - Absolute
NCT04558281 (13) [back to overview]AVERAGE Rib Fracture Pain in Previous 24 Hours
NCT04558281 (13) [back to overview]Maximal Inspired Volume - Percentage Change From Baseline Prior to Intervention
NCT04558281 (13) [back to overview]Brief Pain Inventory (Short Form, Interference Subscale)
NCT04558281 (13) [back to overview]CURRENT Rib Fracture Pain in Previous 24 Hours
NCT04558281 (13) [back to overview]LEAST Rib Fracture Pain in Previous 24 Hours
NCT04558281 (13) [back to overview]Maximal Inspired Volume - Absolute
NCT04558281 (13) [back to overview]Maximal Inspired Volume - Absolute
NCT04558281 (13) [back to overview]WORST Rib Fracture Pain in Previous 24 Hours
NCT04567407 (11) [back to overview]Analgesic Requirement
NCT04567407 (11) [back to overview]Time to First Mobilization
NCT04567407 (11) [back to overview]Duration of Mechanical Ventilation/Intubation
NCT04567407 (11) [back to overview]Length of Hospital Stay
NCT04567407 (11) [back to overview]Length of Postoperative ICU Stay
NCT04567407 (11) [back to overview]Median Pain Scores
NCT04567407 (11) [back to overview]Median Pain Scores
NCT04567407 (11) [back to overview]Median Pain Scores
NCT04567407 (11) [back to overview]Median Pain Scores
NCT04567407 (11) [back to overview]Analgesic Requirement
NCT04567407 (11) [back to overview]Analgesic Requirement
NCT04910165 (7) [back to overview]Numeric Rating Scale (NRS) Pain Score Improvement
NCT04910165 (7) [back to overview]WOMAC Score
NCT04910165 (7) [back to overview]Hospital Length of Stay
NCT04910165 (7) [back to overview]Number of Participants Needing to be Admitted to an Inpatient Rehabilitation Facility Post-Operatively
NCT04910165 (7) [back to overview]Number of Participants Needing to be Readmitted to the Hospital Secondary to Inadequate Pain Control Post-operatively
NCT04910165 (7) [back to overview]Inpatient Opioid Use
NCT04910165 (7) [back to overview]Outpatient Opioid Use

Time to a Significant Increase in Shoulder Discomfort

the length of time until the patients' first report of surgical site pain. (NCT00519584)
Timeframe: during postoperative day 1 to 3

Interventionhours (Median)
Ropivacaine/Saline22.3
Ropivacaine/Dex11.9
Bupivacaine/Dex14.7
Bupivacaine/Saline25.7

[back to top]

Maximum VRS Pain Scores at Rest

Verbal rating scales (VRS): a list of adjectives describing different levels of pain intensity with 0 = no pian and 10 = extremely intense pain. An adequate VRS of pain intensity should include adjectives that reflect the extremes of this dimension; from 'no pain' to 'extremely intense pain'. Patients are asked to read over the list of adjectives and select the word or phrase that best describes their level of pain on the scale from 0 to 10. (NCT00519584)
Timeframe: postoperative day 1 day 2, day 3.

,,,
Interventionunits on a scale (Median)
POD#1POD#2POD#3
Bupivacaine/Dex34.14
Bupivacaine/Saline4.94.11.8
Ropivacaine/Dex3.932.9
Ropivacaine/Saline531.9

[back to top]

the Duration of Analgesia

the interval between the onset of sensory block and the initial PACU use of opioid analgesia for surgical site pain (NCT00519584)
Timeframe: surgical date to postoperative day 1 (pod 0 -1 day)

Interventionhours (Median)
Ropivacaine/Saline22.2
Ropivacaine/Dex11.8
Bupivacaine/Dex14.8
Bupivacaine/Saline22.4

[back to top]

Total Opioid Consumption

cumulative opioid consumption in oral oxycodone equivalents (mg) during the first 3 days after surgery. (NCT00519584)
Timeframe: during first 3 days after surgery

Interventionmg (Median)
Ropivacaine/Saline75
Ropivacaine/Dex79
Bupivacaine/Dex60
Bupivacaine/Saline85

[back to top]

Time to Readiness for Discharge

Each postoperative day, discharge readiness was assessed by an orthopaedic surgeon, a pain nurse, a ward nurse, and a physiotherapist according to the following criteria: no evidence for surgical complications, VAS pain at rest ≤30 mm which is controlled by oral analgesics, ability to eat and drink, ability to walk with elbow crutches, and ability to climb ≥8 stairs. (NCT00562627)
Timeframe: up to 10 days postoperative

Interventiondays (Mean)
LIA IV (Local Infiltration Analgesia, Intravenous)4
LIA IA, (Local Infiltration Analgesia, Intra-articular)3.5
Epidural5.5

[back to top]

Opioid Use

Morphine used by patient controlled analgesia. Amount of used morphine during the first 48 hours after surgery were documented in the CRF by the pain nurses. (NCT00562627)
Timeframe: 48 hours postoperative

Interventionmg (Mean)
LIA IV (Local Infiltration Analgesia, Intravenous)77
LIA IA, (Local Infiltration Analgesia, Intra-articular)49
Epidural54

[back to top]

Pain at Rest (VAS)

VAS (pain at rest) 0-100 mm. VAS 0 mm means no pain and VAS 100 mm means maximal pain. (NCT00562627)
Timeframe: 48 hours postoperative

InterventionUnits on a scale (Mean)
LIA IV (Local Infiltration Analgesia, Intravenous)18
LIA IA, (Local Infiltration Analgesia, Intra-articular)12
Epidural30

[back to top]

Pain Score at Rest

"Patients report pain scores at rest using Visual Analog Scale (VAS). This scale measures the severity of pain and ranges from 1-10, 1 being minimal pain intensity and 10 being maximal pain intensity." (NCT00638508)
Timeframe: At the end of 6 hours after surgery

Interventionunits on a scale (Mean)
Ketorolac3.6
Ketorolac With Ropivacaine4.4

[back to top]

Pain Score on Coughing

"Pain scores on coughing were measured using the Visual Analog Scale (VAS) at the end of 48 hours. This scale measures the severity of pain and ranges from 1-10, 1 being minimal pain intensity and 10 being maximal pain intensity." (NCT00638508)
Timeframe: 1 hour after the surgery

Interventionunits on a scale (Mean)
Ketorolac7.6
Ketorolac With Ropivacaine7.5

[back to top]

Pain Scores at Rest

"Pain scores at rest were measured using the Visual Analog Scale (VAS) at the end of 48 hours. This scale measures the severity of pain and ranges from 1-10, 1 being minimal pain intensity and 10 being maximal pain intensity." (NCT00638508)
Timeframe: 48 hours after surgery

Interventionunits on a scale (Mean)
Ketorolac1.4
Ketorolac With Ropivacaine1.6

[back to top]

Pain Scores at Rest

"Patients report pain scores at rest using Visual Analog Scale (VAS). This scale measures the severity of pain and ranges from from 1-10, 1 being minimal pain intensity and 10 being maximal pain intensity." (NCT00638508)
Timeframe: 1 hour after the surgery

Interventionunits on a scale (Mean)
Ketorolac6.7
Ketorolac With Ropivacaine6.2

[back to top]

Pain Scores on Movement

"Pain scores on movement were assessed using the Visual Analog Scale (VAS) at the end of 6 hours. This scale measures the severity of pain and ranges from 1-10, 1 being minimal pain intensity and 10 being maximal pain intensity." (NCT00638508)
Timeframe: 6 hours after surgery

Interventionunits on a scale (Mean)
Ketorolac5.7
Ketorolac With Ropivacaine26.2

[back to top]

Pain Scores on Coughing

"Pain scores on coughing were measured using the Visual Analog Scale (VAS). This scale measures the severity of pain and ranges from 1-10, 1 being minimal pain intensity and 10 being maximal pain intensity." (NCT00638508)
Timeframe: 48 hours after surgery

Interventionunits on a scale (Mean)
Ketorolac3.4
Ketorolac With Ropivacaine2.8

[back to top]

NAUSEA

"The severity of nausea was measured using Visual Analog Scale (VAS). The VAS scale ranges from 1-10, 1 meaning minimally nauseous and 10 meaning maximally nauseous." (NCT00638508)
Timeframe: 48 hours

Interventionunits on a scale (Mean)
Ketorolac0.3
Ketorolac With Ropivacaine0.4

[back to top]

Pain on Movement

"Pain scores on movement was assessed using the Visual Analog Scale (VAS). This scale measures the severity of pain and ranges from 1-10, 1 being minimal pain intensity and 10 being maximal pain intensity." (NCT00638508)
Timeframe: 1 hour after surgery

Interventionunits on a scale (Mean)
Ketorolac7.7
Ketorolac With Ropivacaine7.3

[back to top]

VOMITING

Data on number of episodes of vomiting was obtained, 6 hours after the surgery. The number of episodes were reported in numerical values, the lower numbers indicating fewer episodes and the higher numbers indicating more number of episodes of vomiting. (NCT00638508)
Timeframe: 6 hours after surgery

InterventionEPISODES (Mean)
Ketorolac0.2
Ketorolac With Ropivacaine0.1

[back to top]

VOMITING

Data on number of episodes of vomiting was obtained, 12 hours after the surgery. The number of episodes were reported in numerical values, the lower numbers indicating fewer episodes and the higher numbers indicating more number of episodes of vomiting. (NCT00638508)
Timeframe: 12 hours

InterventionEPISODES (Mean)
Ketorolac0
Ketorolac With Ropivacaine0

[back to top]

PATIENT SATISFACTION

"Patient's overall satisfaction was measured using Visual Analog Scale (VAS). This scale ranges from 1-10, 1 indicating least satisfied and 10 indication very well satisfied." (NCT00638508)
Timeframe: 48 hours afetr surgery

Interventionunits on a scale (Mean)
Ketorolac8.5
Ketorolac With Ropivacaine8.5

[back to top]

PATIENT SATISFACTION

"Patient's overall satisfaction was measured using Visual Analog Scale (VAS). This scale ranges from 1-10, 1 indicating least satisfied and 10 indication very well satisfied." (NCT00638508)
Timeframe: 1 hour after surgery

Interventionunits on a scale (Mean)
Ketorolac5.4
Ketorolac With Ropivacaine4.9

[back to top]

DROWSINESS

"The severity of drowsiness was measured using Visual Analog Scale (VAS). The VAS scale ranges from 1-10, 1 meaning minimally drowsy and 10 meaning maximally drowsy." (NCT00638508)
Timeframe: 48 hours

Interventionunits on a scale (Mean)
Ketorolac0.6
Ketorolac With Ropivacaine0.1

[back to top]

DROWSINESS

"The severity of drowsiness was measured using Visual Analog Scale (VAS). The VAS scale ranges from 1-10, 1 meaning minimally drowsy and 10 meaning maximally drowsy." (NCT00638508)
Timeframe: 1 hour after surgery

Interventionunits on a scale (Mean)
Ketorolac4
Ketorolac With Ropivacaine4.4

[back to top]

Pain on Movement

"Pain scores on movement were measured 48 hours after surgery using the Visual Analog Scale (VAS). This scale measures the severity of pain and ranges from 1-10, 1 being minimal pain intensity and 10 being maximal pain intensity." (NCT00638508)
Timeframe: 48 hours afetr surgery

Interventionunits on a scale (Mean)
Ketorolac3.1
Ketorolac With Ropivacaine2.5

[back to top]

Morphine Equivalents

Utilization of morphine and morphine equivalents for rescue analgesia was reviewed and calculated in milligrams. (NCT00638508)
Timeframe: 12 hours after surgery

Interventionmilligrams (Mean)
Ketorolac2.1
Ketorolac With Ropivacaine1.5

[back to top]

Morphine Equivalents

Utilization of morphine and morphine equivalents for rescue analgesia, was reviewed and calculated in milligrams. (NCT00638508)
Timeframe: 48 hours afetr surgery

Interventionmilligrams (Mean)
Ketorolac4.2
Ketorolac With Ropivacaine4.6

[back to top]

Morphine Equivalents Utilization

Utilization of morphine and morpine equivalents for rescue analgesia was reviewed and calculated in milligrams. (NCT00638508)
Timeframe: 1 hour after surgery

Interventionmiliigrams (Mean)
Ketorolac6.3
Ketorolac With Ropivacaine4

[back to top]

Pain Scores on Coughing

"Pain scores on coughing were measured using the Visual Analog Scale (VAS) at the end of 6 hours after surgery. This scale measures the severity of pain and ranges from 1-10, 1 being minimal pain intensity and 10 being maximal pain intensity." (NCT00638508)
Timeframe: 6 hours after surgery

Interventionunits on a scale (Mean)
Ketorolac5.3
Ketorolac With Ropivacaine6.2

[back to top]

NAUSEA

"The severity of nausea was measured using Visual Analog Scale (VAS). The VAS scale ranges from 1-10, 1 meaning minimally nauseous and 10 meaning maximally nauseous." (NCT00638508)
Timeframe: 1 hour after surgery

Interventionunits on a scale (Mean)
Ketorolac0.6
Ketorolac With Ropivacaine0.9

[back to top]

Change in Diaphragmatic Displacement From Baseline to Post-surgery

Diaphragm displacement from exhale to inhale. The baseline diaphragm measurement was obtained pre-operatively before the block was administered prior to surgery. This was again measured post-operatively before the patient's discharge from the Post-anesthesia Care Unit. (NCT00672100)
Timeframe: Baseline, Post anesthesia care unit (PACU) - within 8 hours

,,
Interventionpercent change (Mean)
% change in diaphragm displacement ipsilateral% change in diaphragm displacement contralateral
Ropivacaine 10 mL60-56
Ropivacaine 20 mL65-39
Ropivacaine 5 mL66-28

[back to top]

"Percentage of Participants Who Considered the Analgesic Technique Helpful or Extremely Helpful"

"Participants were asked to rate the helpfulness of their infusion:~extremely harmful~harmful~neutral~not harmful, but not helpful~helpful~extremely helpful" (NCT00672100)
Timeframe: at 24 and 48 hours after discharge from the hospital

,,
Interventionpercentage of participants (Number)
Percentage of participants at 24 hoursPercentage of participants at 48 hours
Ropivacaine 10 mL8375
Ropivacaine 20 mL9285
Ropivacaine 5 mL8383

[back to top]

Functional Outcome - Simple Shoulder Test (SST)

At baseline and again at 12 weeks subjects completed the Simple Shoulder Test. This test is a series of 12 (yes/no) questions. Participants get 1 point if they answer yes (they can perform the task) and 0 if they answer no. Total possible range is from 0-12. This has been shown to be a valid, reliable and consistent for subjects up to and including 60 years of age when similar injuries (rotator cuff dysfunction) are assessed. (NCT00672100)
Timeframe: Baseline, 12 weeks

Interventionunits on a scale (Mean)
SST at Baseline (n=36)SST at 12 weeks (n=35)
All Study Participants6.38.2

[back to top]

Pain Measurements Via Numeric Pain Rating Scales (NRS)

Pain was reported via NRS ranging from 0 (no pain) to 10 (worst pain imaginable) (NCT00672100)
Timeframe: Discharge, 24 h, 48h, 12 weeks

,,
Interventionunits on a scale (Mean)
NRS at DischargeNRS at 24 hours post dischargeNRS at 48 hours post dischargeNRS at 12 weeks post discharge (n=11, 12, 12)
Ropivacaine 10 mL1.583.332.082.42
Ropivacaine 20 mL0.622.542.151.15
Ropivacaine 5 mL2.673.672.671.5

[back to top]

The Primary Outcome Will be Pain Relief Sufficient for Discharge From the Emergency Department.

(NCT00680823)
Timeframe: 30 minutes

InterventionParticipants (Count of Participants)
Ropivacaine Injections16
Normal Saline Injections14
Observation2

[back to top]

Re-presentation to the Emergency Department With Headache Within 72 Hours of Participating in the Study

(NCT00680823)
Timeframe: 72 hours

InterventionParticipants (Count of Participants)
Ropivacaine Injections7
Normal Saline Injections7
Observation4

[back to top]

Number and Percent of Patients Admitted to the Hospital for Additional Therapy in Each Treatment Arm Based Upon Treating Clinicians Decision

(NCT00680823)
Timeframe: 3 hours

InterventionParticipants (Count of Participants)
Ropivacaine Injections10
Normal Saline Injections10
Observation12

[back to top]

Postoperative Opioid Consumption in Oral Oxycodone Equivalents

The cumulative opioid consumption after surgery until the end of second postoperative day. (NCT00720330)
Timeframe: 2 days after surgery

Interventionmg (Mean)
Ropivacaine564
Lidocaine/Ketamine73
Placebo1381

[back to top]

Pre- and Intra-operative Opioid Consumption in Fentanyl Equivalents

The cumulative opioid consumption is calculated as fentanyl equivalent (NCT00720330)
Timeframe: From admission to the end of surgery

Interventionmcg (Mean)
Ropivacaine100
Lidocaine/Ketamine113
Placebo134

[back to top]

Postoperative Nausea

Number of patients who had postoperative nausea or vomiting were recorded. (NCT00720330)
Timeframe: After surgery until the second postoperative day.

InterventionParticipants (Count of Participants)
Ropivacaine2
Lidocaine/Ketamine1
Placebo0

[back to top]

Time From the End of Surgery to Readiness for Hospital Discharge.

(NCT00720330)
Timeframe: Until hospital discharge, assessed up to 6 months

Interventionhours (Mean)
Ropivacaine2.2
Lidocaine/Ketamine3.8
Placebo3.0

[back to top]

Pain Scores on Numerical Rating Scale

Numerical Rating Scales is a measurement of pain ranging from 0 to 10 (11 point scale), where 0 is equal to no pain and 10 is equal to worst possible pain. Pain scores were measured in PACU, first and second postoperative mornings. (NCT00720330)
Timeframe: After surgery until the second postoperative mornings.

,,
Interventionunits on a scale (Mean)
PACUPOD1POD2
Lidocaine/Ketamine2.03.32.8
Placebo6.33.72
Ropivacaine0.84.62.6

[back to top]

Time to First Report of Pain

(NCT00801138)
Timeframe: Postoperative day 1, 2 and 3

Interventionhours (Median)
Group 111.9
Group 214.7
Group 322.3
Group 425.7

[back to top]

Total Three-day Opioid Consumption in Oral Oxycodone Equivalent

(NCT00801138)
Timeframe: Postoperative day 1, 2 and 3

Interventionmilligrams (Median)
Group 175
Group 285
Group 379
Group 460

[back to top]

Median Maximum VAS Pain Scores at Rest

"Visual Analogue Scale (VAS) pain scale is used to describe the severity or intensity of pain. It ranges from 0 to 10. Zero indicatesno pain at all and ten indicates worst pain imaginable. , The higher of the score, the worse of the pain." (NCT00801138)
Timeframe: Postoperative day 1, 2 and 3

Interventionunits on a scale (Median)
Group 15
Group 25
Group 34
Group 43

[back to top]

The Duration of the Interscalene Nerve Block Which is Time to First Administration of Pain Medication After Block

(NCT00801138)
Timeframe: Postoperative day 1, 2 and 3

Interventionhours (Median)
Group 111.8
Group 214.8
Group 322.2
Group 422.4

[back to top]

Duration of Analgesia.

The primary outcomes will be the onset time, onset of surgical block, and duration of analgesia. (NCT00825786)
Timeframe: During surgery: postoperative day 0

Interventionminute (Median)
Group 17.5
Group 210

[back to top]

Maximum Verbal Response Score (VRS) With Rest

The severity of postoperative pain was assessed by an observer blinded to treatment using a 0- to 10-point verbal response score (VRS): 0 = no pain and 10= worst pain (NCT00825786)
Timeframe: through post operative day 3

Interventionmm (Median)
Group 14
Group 24

[back to top]

Time to Complete Motor Block

(NCT00825786)
Timeframe: during surgery from induction time to end case time

Interventionminutes (Median)
Group 110
Group 219

[back to top]

Time to Onset of First Sensory Block

(NCT00825786)
Timeframe: during surgery

Interventionminutes (Median)
Group 10
Group 20

[back to top]

Total Opioid Consumption

In morphine equivalent dose (NCT00825786)
Timeframe: postoperative day 1 to day 3

Interventionmg (Median)
Group 138
Group 230

[back to top]

Duration of Analgesia

Time from the complete onset of sensory block until first request for an analgesic (NCT00825786)
Timeframe: from surgery date to postoperative day 1

Interventionhours (Median)
Group 19
Group 211

[back to top]

Maximum Verbal Response Score (VRS) With Movement

The severity of postoperative pain was assessed by an observer blinded to treatment using a 0- to 10-point verbal response score (VRS): 0 = no pain and 10 = worst (NCT00825786)
Timeframe: through post operative day 3

Interventionmm (Median)
Group 15.5
Group 25

[back to top]

the Proportion of Patients Who Were Satisfied With the Pain Management

(NCT00901628)
Timeframe: postoperative 7 day

Interventionparticipants (Number)
Periarticular Injection Group38
No Injection Group39

[back to top]

Pain( Visual Analog Scale )

An independent investigator who was blinded to randomization assessed pain level using 0 to 10 visual analog scale (VAS) that ranged from 0 (no pain) to 10 (worst imaginable pain)at the night after operation. (NCT00901628)
Timeframe: the night after surgery

Interventionunits on a scale (Mean)
Periarticular Injection Group2.3
No Injection Group6.4

[back to top]

Participant Number of Postoperative Nausea and Vomiting During 24 Hours After Surgery

An independent investigator assessed participant number of postoperative nausea and vomiting during 24 hours after surgery. Nausea was defined as a subjective unpleasant sensation associated with awareness of the urge to vomit; and vomiting, as the forceful expulsion of gastric contents from the mouth. (NCT00901628)
Timeframe: 24 hours after surgery

Interventionparticipants (Number)
Periarticular Injection Group22
No Injection Group15

[back to top]

The Proportion of Patients Who Could Raise Leg With Replaced Knee Extended

(NCT00901628)
Timeframe: 24 hours postoperative

Interventionparticipants (Number)
Periarticular Injection Group18
No Injection Group6

[back to top]

Intravenous Patient Controlled Analgesia(PCA) Consumption During 24 Hours After Surgery

Fentanyl based PCA consumption via PCA pump (microgram) (NCT00901628)
Timeframe: 24 hours postoperative

Interventionmicrogram (Mean)
Periarticular Injection Group169.4
No Injection Group262.3

[back to top]

Maximal Flexion Angle Degree on Postoperative 7 Day

An independent investigator measured the maximal flexion angle (degree) of replaced knee with 28 centimeter armed goniometer on postoperative 7 day (NCT00901628)
Timeframe: postoperative 7 day

Interventiondegree (Mean)
Periarticular Injection Group92.3
No Injection Group95.2

[back to top]

Percent Change From Baseline in Quadriceps Femoris Maximum Voluntary Isometric Contraction (MVIC)

Quadriceps femoris muscle strength evaluated using a portable, hand-held, isometric force dynamometer (MicroFET2, Lafayette Instrument Company, Lafayette, IN) to measure the maximum voluntary isometric contraction (MVIC) in a seated position. The study primary endpoint will be the difference in MVIC the morning following surgery compared with the preoperative MVIC, expressed as a percentage of the preoperative MVIC: (preop - postop ) / preop x 100. (NCT00912873)
Timeframe: The study primary endpoint will be the difference in MVIC the morning following surgery compared with the preoperative MVIC, expressed as a percentage of the preoperative MVIC: (preop - postop ) / preop x 100.

Interventionpercentage change from baseline of MVIC (Mean)
0.1% Ropivicaine64.1
0.4% Ropivicaine68

[back to top]

Total Ambulation

Patients will be allowed to slow or stop and rest during the walk, but will be asked to resume walking as soon as they feel they are able to and go as far as they comfortable walking. (NCT00912873)
Timeframe: Day following surgery

,
Interventionmeters (Mean)
morningafternoon
0.1% Ropivicaine136223
0.4% Ropivicaine119214

[back to top]

Ambulation 100-foot Walking Test

The 100-foot walking test simply measures the amount of time it takes patients to ambulate 100 feet. Patients will be allowed to slow or stop and rest during the walk, but will be asked to resume walking as soon as they feel they are able to. (NCT00912873)
Timeframe: Day following surgery

,
Interventionminutes (Mean)
MorningAfternoon
0.1% Ropivicaine4.64.0
0.4% Ropivicaine5.33.6

[back to top]

Average Dynamic Pain

Pain evaluated during physical therapy using a verbal rating scale of 0-10, with 0=no pain and 10=worst imaginable pain (NCT00912873)
Timeframe: Day following surgery

,
Interventionunits on a scale (Mean)
morningafternoon
0.1% Ropivicaine3.83.2
0.4% Ropivicaine3.82.9

[back to top]

Worst Dynamic Pain

The worst pain experienced during physical therapy evaluated using a verbal rating scale of 0-10, with 0=no pain and 10=worst imaginable pain (NCT00912873)
Timeframe: Day following surgery

,
Interventionscore on a scale (Mean)
morningafternoon
0.1% Ropivicaine6.24.3
0.4% Ropivicaine6.55.0

[back to top]

Percent Change From Baseline in Hip Flexion

Evaluated in the supine position using a portable, hand-held, isometric force dynamometer (MicroFET2, Lafayette Instrument Company, Lafayette, IN). The endpoint will be the difference the morning following surgery compared with the preoperative value, expressed as a percentage of the preoperative value: (preop - postop ) / preop x 100. (NCT00912873)
Timeframe: Day following surgery

,
Interventionpercentage change from baseline hip flex (Mean)
morningafternoon
0.1% Ropivicaine6975
0.4% Ropivicaine6778

[back to top]

Mean Resting Pain

Pain level evaluated using a verbal rating scale of 0-10, with 0=no pain and 10=worst imaginable pain (NCT00912873)
Timeframe: Day following surgery

Interventionunits on a scale (Mean)
0.1% Ropivicaine3.2
0.4% Ropivicaine3.2

[back to top]

Total Milligrams of Opiates

mean number of milligrams used postoperatively (NCT00913068)
Timeframe: 2, 6,12, 24, 48 and 72 hours

Interventionmg (Mean)
TAP Arm5.15
Standard Post Operative Pain Control2.52

[back to top]

Morphine

Total amount of morphine used in the first 48hrs immediately after surgery (NCT00930046)
Timeframe: 48 hours

Interventionmg/kg per 48 hours (Mean)
Ropivacaine Group2.2
Normal Saline Group3.5

[back to top]

FLACC Pain Intensity [Faces Legs Activity Cry Consolability] 0-10 Points

"Observational FLACC pain intensity assessment tool that consists of observing the Faces Legs Activity Cry Consolability (FLACC) by the bedside nursing staff. This pain assessment tool is validated in non-verbal children and children at 7 years and younger.~Minimum value is 0 and the maximum value is 10, where 0 represents no pain which is a better outcome." (NCT00930046)
Timeframe: 48 hours post-operatively

Interventionscore on a scale (Mean)
Ropivacaine Group1.3
Normal Saline Group1.9

[back to top]

Compare the Onset of Action of Ropivacaine 0.5% and levobupivacaïne 0.5 % for Sciatic Nerve Block Guided in Major Surgery of the Foot

(NCT00956709)
Timeframe: 72 hours

Interventionminutes (Median)
Levobupivacaïne 0,5 %40
Ropivacaïne 0,5%35

[back to top]

Duration of Sensory Sciatic Block (h)

(NCT00956709)
Timeframe: 72 hours

Interventionhours (Median)
Levobupivacaïne 0,5 %17.25
Ropivacaïne 0,5%15.00

[back to top]

Duration of Motor Sciatic Block (h)

(NCT00956709)
Timeframe: 72 hours

Interventionhours (Median)
Levobupivacaïne 0,5 %15.54
Ropivacaïne 0,5%15.17

[back to top]

Knee Society Pain Scores at 6 Week Follow-up Appointment

Patients were assessed for pain at their 6 week follow-up appointment using the Knee Society Rating Scale. Using this scale patients are given a pain score ranging from 0 (severe pain) to 50 (No Pain). This is determined as follows: No pain/50 points, Mild or occasional pain/45 points, pain with stairs only/40 points, pain with walking and stairs/30 points, Moderate/occasional pain/ 20 points,continual pain/10 points, severe pain/0 points. We report the mean score for each group. A higher score represents a better outcome. (NCT01042093)
Timeframe: 6 weeks after surgery

InterventionScores on a scale 0-50 (Mean)
ROP/EPI/TOR/CLO45
REP/EPI/TOR43
REP/EPI/CLO45
REP/EPI45

[back to top]

Numerical Rating Scale (NRS) Pain Scores During Hospitalization.

Patient pain was assessed during hospitalization using the VAS Pain Scale, a numerical rating scale ranging from 0 (no pain) to 10 (severe pain). A lower score represents a better outcome. Pain was assessed preoperatively, 1 hour postoperatively in the post anesthesia unit, and then every 8 hours on the Orthopedic inpatient unit, for a duration of 2 days. (NCT01042093)
Timeframe: 2 days after surgery

,,,
Interventionscores on a scale 0-10 (Mean)
Vas Pain Scale - 1 Hour Post OpVas Pain Scale - 8 Hour Post OpVas Pain Scale - 16 Hour Post OpVas Pain Scale - 24 Hour Post OpVas Pain Scale - 32 Hour Post OpVas Pain Scale - 40 Hour Post OpVas Pain Scale - 48 Hour Post OpVas Pain Scale Preoperatively
ROP/EPI1.602.822.412.963.132.802.112.13
ROP/EPI/CLO2.673.932.753.633.623.282.562.43
ROP/EPI/TOR1.901.522.222.562.662.351.972.47
ROP/EPI/TOR/CLO1.061.521.852.332.182.542.411.93

[back to top]

Narcotic Consumption During Hospitalization

A variety of pain medications were used after surgery to keep patients comfortable. Narcotic use was recorded as morphine equivalents. We report the mean narcotic consumption for each group for the day of surgery as well as post operative day 1,2, and 3. (NCT01042093)
Timeframe: 4 days

,,,
Interventionmg (Mean)
Morphine Equivalent Day of SurgeryMorphine Equivalent Post Operative Day 1Morphine Equivalent Post Operative Day 2Morphine Equivalent Post Operative Day 3
ROP/EPI52.5051.0836.7615.54
ROP/EPI/CLO55.2064.6150.0721.97
ROP/EPI/TOR43.0947.9542.6918.72
ROP/EPI/TOR/CLO46.9246.5440.7120.45

[back to top]

QoR40 on the Day After Surgery

QoR40 on the day after surgery. Quality of recovery is based on a score of 40-200. 40 being a poor recovery and 200 being a good recovery score. (NCT01074229)
Timeframe: 1 day

Interventionunits on a scale (Median)
PLACEBO152
20 cc of 0.5% Ropivacaine180
20 cc of 0.25% Ropivacaine180

[back to top]

24 Total Morphine Consumption

Total 24 total morphine consumption post operative. (NCT01074229)
Timeframe: 1 day

Interventionmiligrams of morphine (Mean)
Placebo22.75
20 cc of 0.5% Ropivacaine12.5
20 cc of 0.25% Ropivacaine17.5

[back to top]

24 Hour Total Opioid Consumption.

24 Hour total opioid consumption translated into IV morphine equivalents. (NCT01075087)
Timeframe: 24 hours

Interventionmiligram IV morphine equivalents (Median)
Placebo13
Active Comparator7.5

[back to top]

Quality of Recovery 40 Score

Quality of Recovery 40 Score at 24 hours postoperative. (NCT01075087)
Timeframe: 24 hours post operatively

Interventionunits on scale 40 (low) - 200 (high) (Median)
Placebo170
Active Comparator175.5

[back to top]

Mg of Morphine Consumption During 48 Hours Administered by Patient Controlled Analgesia System

(NCT01075646)
Timeframe: 48 hours

Interventionmg (Median)
Ropivacaine Colorectal Surgery23
Saline Solution Colorectal Surgery52
Ropivacaine Hepatic Surgery24.63
Saline Solution Hepatic Surgery26.78

[back to top]

Contamination of the Catheter (Microbiologist Analysis)

(NCT01075646)
Timeframe: at 48 hours

,,,
Interventionparticipants (Number)
YesNo
Ropivacaine Colorectal Surgery627
Ropivacaine Hepatic Surgery251
Saline Solution Colorectal Surgery430
Saline Solution Hepatic Surgery244

[back to top]

Intensity of Pain Measured by Verbal Pain Scale.

Verbal pain scale is a numeric measure of intensity pain, values range from 0 (no pain) to 10 (excruciating pain), Each patient rate the paín that feel with a number from 0 to 10. (NCT01075646)
Timeframe: At interval periods during 48 hours

,,,
Interventionunits on a scale (Median)
Verbal numeric scale 0h after surgeryVerbal numeric scale 6h after surgeryVerbal numeric scale 12h after surgeryVerbal numeric scale 24h after surgeryVerbal numeric scale 48h after surgery
Ropivacaine Colorectal Surgery12222
Ropivacaine Hepatic Surgery2.751.721.451.641.62
Saline Solution Colorectal Surgery2.53222
Saline Solution Hepatic Surgery2.52.381.822.14

[back to top]

Local Reaction in the Wound and Insertion Point of the Catheter (Inflammation Signs and Infection)

(NCT01075646)
Timeframe: During 8-15 days

,,,
Interventionparticipants (Number)
YesNo
Ropivacaine Colorectal Surgery627
Ropivacaine Hepatic Surgery251
Saline Solution Colorectal Surgery1024
Saline Solution Hepatic Surgery244

[back to top]

Time Spent Sitting in a Chair, Deambulation, Solid Ingestion.

(NCT01075646)
Timeframe: 7 Days (from Day 8-15)

,,,
Interventionhours (Median)
Sitting in the chairDeambulationSolid food intake
Ropivacaine Colorectal Surgery467296
Ropivacaine Hepatic Surgery51.7581.288
Saline Solution Colorectal Surgery4872120
Saline Solution Hepatic Surgery43.287.3779.79

[back to top]

Secondary Effects Due to Morphine: Nausea and Vomiting

(NCT01075646)
Timeframe: during 48 hours

,,,
Interventionparticipants (Number)
YesNo
Ropivacaine Colorectal Surgery528
Ropivacaine Hepatic Surgery251
Saline Solution Colorectal Surgery628
Saline Solution Hepatic Surgery640

[back to top]

Postoperative Nausea and Vomiting (PONV)

The numbers of patients with at least mild nausea at any time post-operatively. (NCT01094106)
Timeframe: 48 hours

Interventionparticipants (Number)
Ropivacaine 0,75%7
NaCl 0,9%11

[back to top]

Strength of Pain on Numerical Rating Scale (NRS)

Intensity of pain was recorded on a numerical rating scale (0-10), where higher scores mean more severe pain, during rest and when moving, for five time intervals (0-6 h, 6-12 h, 12-24 h, 24-36 h and 36-48 h); for each time interval, the highest recorded pain score was taken into account. (NCT01094106)
Timeframe: 48 hours, divided to five time intervals (0-6 h, 6-12 h, 12-24 h, 24-36 h and 36-48 h)

,
Interventionunits on a scale (Median)
Highest recorded pain scores at rest, 0-6 hHighest recorded pain scores at rest, 6-12 hHighest recorded pain scores at rest, 12-24 hHighest recorded pain scores at rest, 24-36 hHighest recorded pain scores at rest, 36-48 hHighest recorded pain scores when moving, 0-6 hHighest recorded pain scores when moving, 6-12 hHighest recorded pain scores when moving, 12-24 hHighest recorded pain scores when moving, 24-36 hHighest recorded pain scores when moving, 36-48 h
NaCl 0,9%63.75332765.7554
Ropivacaine 0,75%5332.2516.5554.253

[back to top]

The Demand of Rescue Analgesics (Oxycodone)

The amount of oxycodone required 48 hours after operation. Oxycodone was administered when the strength of pain is over 3 on numeric rating scale (NRS) 0-10. (NCT01094106)
Timeframe: 48 hours

Interventionmg (Mean)
Ropivacaine 0,75%47.5
NaCl 0,9%57.8

[back to top]

Pain and Disability of the Shoulder Through Validated Questionnaires

Patients will be asked to fill out questionnaires to provide insight into how their condition is progressing, consisting of components of the American Shoulder and Elbow Surgeons (ASES) total score. The maximum score is 100, made up by pain and function components' sums. Only the total score is recorded, 100 being full normal function without pain, 0 being severe pain and no function. (NCT01123889)
Timeframe: 15 minutes prior to initial injection of corticosteroid versus platelet rich plasma

Interventionunits on a scale (Mean)
Control35.0
Experimental43.9

[back to top]

Pain and Disability of the Shoulder Through Validated Questionnaires

Patients will be asked to fill out questionnaires to provide insight into how their condition is progressing, consisting of components of the American Shoulder and Elbow Surgeons (ASES) total score. The maximum score is 100, made up by pain and function components' sums. Only the total score is recorded, 100 being full normal function without pain, 0 being severe pain and no function. (NCT01123889)
Timeframe: 12 weeks from initial injection of corticosteroid versus platelet rich plasma

Interventionunits on a scale (Mean)
Control41.6
Experimental86.1

[back to top]

Pain and Disability of the Shoulder Through Validated Questionnaires

Patients will be asked to fill out questionnaires to provide insight into how their condition is progressing, consisting of components of the American Shoulder and Elbow Surgeons (ASES) total score. The maximum score is 100, made up by pain and function components' sums. Only the total score is recorded, 100 being full normal function without pain, 0 being severe pain and no function. (NCT01123889)
Timeframe: 6 weeks from initial injection of corticosteroid versus platelet rich plasma

Interventionunits on a scale (Mean)
Control81.6
Experimental70.0

[back to top]

Pain Scores in the Per-protocol Subset (Participants Who Received the Allocated Treatment)

Pain was measured using a linear analog scale for pain, with a scale from 0 (no pain) to 10 points (worst possible pain). (NCT01163214)
Timeframe: Afternoon on post-operative Day 1, approximately 14:00

Interventionunits on a scale (Mean)
Nerve Block2.9
Periarticular Injection3.1

[back to top]

Number of Subjects Who Experienced Neurological Changes Postoperatively

Participants were questioned at the 6 weeks follow-up visit regarding any neurological changes that were not present preoperatively. (NCT01163214)
Timeframe: 6 weeks postoperative

,
Interventionparticipants (Number)
Femoral nerve (nerve block n=77)Common peroneal nerve (nerve block n=78)Tibial nerve (nerve block n=78)Femoral, peroneal, or tibial (nerve block n=77)
Nerve Block1629
Periarticular Injection0011

[back to top]

Straight-leg Raise

Post-operative quadriceps function was measured by the number of participants who could perform a straight-leg raise. (NCT01163214)
Timeframe: Day 1 morning (AM), Day 1 afternoon (PM), Day 2 morning, Day 2 afternoon

,
Interventionparticipants (Number)
Day 1 AM (Nerve Block=78, Injection=80)Day 1 PM (Nerve Block=76, Injection=78)Day 2 AM (Nerve Block=78, Injection=79)Day 2 PM (Nerve Block=69, Injection=51)
Nerve Block19215257
Periarticular Injection63636942

[back to top]

Narcotic Use

Use of additional narcotic medications (as needed), measured in morphine equivalents. (NCT01163214)
Timeframe: Intraoperative, Day of surgery, Post-Operative Day 1, Post-Operative Day 2

,
Interventionmg (Mean)
IntraoperativeDay of SurgeryPost-Operative Day 1Post-Operative Day 2
Nerve Block17.44.643.033.0
Periarticular Injection23.611.749.030.0

[back to top]

Post-Operative Pain

Pain was measured using a linear analog scale for pain, with a scale from 0 (no pain) to 10 points (worst possible pain). (NCT01163214)
Timeframe: Afternoon on post-operative Day 1, approximately 14:00

Interventionunits on a scale (Mean)
Nerve Block2.9
Periarticular Injection3.0

[back to top]

Length of Stay in Hospital

Length of stay data were calculated from the medical record. (NCT01163214)
Timeframe: Approximately 2 days after surgery

Interventiondays (Mean)
Nerve Block2.84
Periarticular Injection2.44

[back to top]

Nausea

Secondary endpoints of reduction of nausea will be evaluated. (NCT01167907)
Timeframe: 48 hours post nerve blockade

InterventionParticipants (Count of Participants)
0.2% Ropivacaine4
Saline1

[back to top]

Vomiting

Secondary endpoints of reduction of vomiting will be evaluated. (NCT01167907)
Timeframe: 48 hour post nerve blockade

InterventionParticipants (Count of Participants)
0.2% Ropivacaine2
Saline0

[back to top]

Verbal Pain Scores

"The primary endpoint of this study will be a reduction of the rest and incident verbal pain scores 48hpost-nerve blockade when the primary saphenous single-shot block is expected to have resolved.~Verbal Pain Score is the outcome measure applied by asking patients to rate their level of pain. The commonly used 11-point numerical pain rating, with 0-10 range is defined as the following: Zero (0) is used to rate no pain and is the best score Ten (10) is used to rate the worst pain imaginable and is the worst score" (NCT01167907)
Timeframe: 48 hours post nerve blockade

Interventionunits on a scale (Mean)
0.2% Ropivacaine4.2
Saline5.4

[back to top]

Sleep Disturbance

Secondary endpoints of reduction of sleep disturbance (as number of awakenings) will be evaluated. (NCT01167907)
Timeframe: 48 hours post nerve blockade

Interventionawakenings (Mean)
0.2% Ropivacaine1.3
Saline1.6

[back to top]

Opioid Use

"Secondary endpoints of reduction of opioid use will be evaluated.~Outcome will be measured using 24h mg-equivalent oxycodone consumption. - (Units in mg/24h)" (NCT01167907)
Timeframe: 48 hours post nerve blockade

Interventionmg per 24h (Mean)
0.2% Ropivacaine35.1
Saline33.3

[back to top]

Reduction of Quadriceps Strength

"Secondary endpoints of reduction of quadriceps strength will be evaluated. To determine the effect of saphenous block on quadriceps function, patients will have knee extension muscle strength using a Hoggan Health microFET 2 MT Digital Handheld Dynamometer.~Knee Extension: Measuring knee extension was performed with the digital dynamometer placed on the anterior surface of the lower leg proximal to the ankle." (NCT01167907)
Timeframe: 24 hours post nerve blockade

Interventionpounds (Mean)
0.2% Ropivacaine48.1
Saline37.3

[back to top]

Morphine Equivalents 0-24 Hours (Mgs)

Total dose of morphine equivalents (IV equivalent of morphine) taken by the participant 0-24 hours after completion of the TAP block. (NCT01170702)
Timeframe: 24 hours

InterventionMorphine equivalents (mg) (Median)
Group 154
Group 238
Group 332
Group 445

[back to top]

Morphine Equivalents 24-72 Hours (Mgs)

Total dose of morphine equivalents (IV equivalent of morphine) taken by the participant 24-72 hours after completion of the TAP block. (NCT01170702)
Timeframe: 24-72 hours

InterventionMorphine equivalents (mgs) (Median)
Group 167
Group 260
Group 367
Group 467

[back to top]

Morphine Equivalents Total (Mgs)

Total dose of morphine equivalents (IV equivalent of morphine) taken by the participant 0-72 hours after completion of the TAP block. (NCT01170702)
Timeframe: 72 hours

InterventionMorphine equivalents (mgs) (Median)
Group 1120
Group 296
Group 398
Group 4112

[back to top]

Pain Burden With Movement

Pain burden with movement calculated as area under the pain score * time (hr) curve 0-72 hours. (NCT01170702)
Timeframe: 72 hours

Interventionpain score * time (hr) curve 72 hours (Median)
Group 1265
Group 2202
Group 3233
Group 4327

[back to top]

Time to First PCA Request

The elapsed time in minutes of the first PCA (patient controlled analgesia) request in time (minutes) from the end of the TAP block. (NCT01170702)
Timeframe: Elapsed time in minutes

InterventionMinutes (Mean)
Group 190
Group 2118
Group 3126
Group 483

[back to top]

Pain Scores at Rest

Pain scores at rest ( 0 low 10 high) using an 11 point VRS (verbal pain scale) at the following hour time points, at the first request for patient controlled analgesia (PCA) then at 2,6,24,and 74 hours after the first request for PCA (patient controlled analgesia). (NCT01170702)
Timeframe: Request for first patient controlled analgesia then at 2,6,24,72 hours after initial PCA request

,,,
Interventionunits on a scale (Median)
At first PCA request2 hous after first PCA request6 hours after first PCA request24 hours after first PCA request72 hours after first PCA reqest
Group 133321
Group 23121.5
Group 320211
Group 422231

[back to top]

Pain Scores With Movement

Pain scores with movement ( 0 low 10 high) using an 11 point VRS (verbal pain scale) at the first request for patient controlled analgesia (PCA) then at 2,6,24,and 74 hours after the first request for PCA (patient controlled analgesia). (NCT01170702)
Timeframe: First PCA request then at 2,6,24,72 hours after first PCA request.

,,,
Interventionunits on a scale (Median)
At first PCA request2 hous after first PCA request6 hours after first PCA request24 hours after first PCA request72 hours after first PCA reqest
Group 154443.5
Group 23.52432
Group 33.53543
Group 443454

[back to top]

Pain Burden at Rest

Pain burden at rest calculated as area under the pain score * time (hr) curve 0-72 hours. (NCT01170702)
Timeframe: 72 hours

Interventionscore on scale * (hr) (Median)
Group 1129
Group 279
Group 379
Group 4151

[back to top]

Pain

Number achieving pain on movement of knee measured as 0 on a verbal pain rating scale at 30h after start of perineural infusion (NCT01172197)
Timeframe: 30 hours

InterventionParticipants (Count of Participants)
Ropivacaine7
Levobupivacaine7

[back to top]

Number of Narcotic Pills and Morphine Sulfate Used

Pill Count (NCT01242644)
Timeframe: Post surgery day 1

InterventionNumber of pills (Mean)
Pain Pump , Injectable Medication3.41
Saline Pain Pump , Injectable Medication3.8
Injectable Medication Only3.8

[back to top]

Pain Scale

"Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between no pain and worst pain. no pain on the left end (0 cm) of the scale and the worst pain on the right end of the scale (10 cm)." (NCT01242644)
Timeframe: 24 hours post surgery

Interventionunits on a scale (Mean)
Pain Pump , Injectable Medication1.75
Saline Pain Pump , Injectable Medication3.23
Injectable Medication Only3.06

[back to top]

Number of Narcotic Pills and Morphine Sulfate Used

(NCT01242644)
Timeframe: Post surgery day 3

Interventionnumber of pills (Mean)
Pain Pump , Injectable Medication2.1
Saline Pain Pump , Injectable Medication2.7
Injectable Medication Only1.7

[back to top]

Pain Scale

"Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between no pain and worst pain. no pain on the left end (0 cm) of the scale and the worst pain on the right end of the scale (10 cm)." (NCT01242644)
Timeframe: 72 hours post surgery

Interventionunits on a scale (Mean)
Pain Pump , Injectable Medication3.3
Saline Pain Pump , Injectable Medication4.05
Injectable Medication Only3.13

[back to top]

Pain Scale

"Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between no pain and worst pain. no pain on the left end (0 cm) of the scale and the worst pain on the right end of the scale (10 cm)." (NCT01242644)
Timeframe: 48 hours post-surgery

Interventionunits on a scale (Mean)
Pain Pump , Injectable Medication1.81
Saline Pain Pump , Injectable Medication3.17
Injectable Medication Only2.26

[back to top]

Number of Narcotic Pills and Morphine Sulfate Used

Pill count (NCT01242644)
Timeframe: In recovery room

InterventionPills (Mean)
Pain Pump , Injectable Medication2.2
Saline Pain Pump , Injectable Medication1.8
Injectable Medication Only1.3

[back to top]

Pain Score 8 Hours Post-operativley

"Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between no pain and worst pain. no pain on the left end (0 cm) of the scale and the worst pain on the right end of the scale (10 cm)." (NCT01242644)
Timeframe: 8 hours post surgery

Interventionunits on a scale (Mean)
Pain Pump , Injectable Medication2.5
Saline Pain Pump , Injectable Medication1.8
Injectable Medication Only1.06

[back to top]

Number of Narcotic Pills and Morphine Sulfate Used

(NCT01242644)
Timeframe: Post surgery day 2

InterventionNumber of pills (Mean)
Pain Pump , Injectable Medication1.1
Saline Pain Pump , Injectable Medication1.5
Injectable Medication Only0.8

[back to top]

Cumulative Probabilities for Needle Positioning Above and Below CIEL.

The cumulative probability distributions for the minimal current to evoke a motor response with the needle tip positioned external (above) to the common investing extraneural layer (CIEL) and the cumulative probability distribution for the needle tip postioned internal (below) to the CIEL were sought. The difference in the mean minimum threshold current (mA) for the external (above) and internal (below) CIEL positioning were calculated. (NCT01272921)
Timeframe: 1 Day

InterventionAmplitude (mA) (Mean)
Above CIEL0.52
Below CIEL0.19

[back to top]

Duration of Motor and Sensory Block of the Sciatic With 0.5% Bupivacaine and Ropivacaine After Ultrasound-guided Nerve-stimulator-Assisted Needle Positioning Beneath the CIEL

Subject reported and investigator measured motor and sensory blockade of the sciatic nerve with less than 10ml of 0.5% bupivacaine and ropivacaine after ultrasound-guided nerve-stimulator-assisted needle positioning beneath the common investing external layer (CIEL). (NCT01272921)
Timeframe: 3 days

,
InterventionHours (Median)
Motor: < 10mlMotor: >/= 10mlSensory: <10mlSensory: >/= 10ml
Bupivacaine1021920
Ropivacaine715814

[back to top]

Need for IV Morphine of Fentanyl

Indicates that number of subjects that were in severe pain and thus required IV morphine and/or fentanyl. (NCT01328782)
Timeframe: First 120 minutes after the end of surgery (surgery close time)

Interventionparticipants (Number)
Oral Narcotic Group19
Bupivacaine Group4
Ropivacaine Group15

[back to top]

The Faces Pain Scale-Revised (FSP-R) Scores (Scored 0-10).

The Faces Pain Scale Revised is a dimensionless 10 point likert scale used to assess self-reported pain intensity on a scale from 0 (no pain) to 10 (most pain you can imagine). Greater pain scores are indicative of more severe pain. (NCT01328782)
Timeframe: Will be obtained 30 - 60 minutes after arrival to the recovery room

InterventionScores on a scale (Mean)
Oral Narcotic Group4.14
Bupivacaine Group2.73
Ropivacaine Group3.66

[back to top]

Time (in Minutes) to First Narcotic Administration

(NCT01328782)
Timeframe: first 72 hours after surgery close time

InterventionMinutes (Median)
Oral Narcotic Group30
Bupivacaine Group50.5
Ropivacaine Group34

[back to top]

Total Quality Pain Management Survey (TQPM) Scores for Questions # 16: Child's Current Level of Pain, Question # 17: Child's Worst Level of Pain When Moving Around After Surgery and Question # 18: Child's Worst Level of Pain While Resting

Total quality pain management survey is validated survey used to assess parents' perceptions of their child's pain. Pain is assessed on a dimensionless 10 pt likert scale from 0 (no pain) to 10 (severe pain). Greater pain scores are indicative or more severe pain. (NCT01328782)
Timeframe: Will be obtained from parent(s) 120 minutes after arrival to the recovery room

InterventionScores on a scale (Mean)
Oral Narcotic Group4.58
Bupivacaine Group2.73
Ropivacaine Group4.32

[back to top]

Total Dosage in Morphine Equivalents (mg/kg) of All Analgesics Received in Prior to Discharge

(NCT01328782)
Timeframe: Analgesic data collected during first four hours following the end of surgery (surgery close)

InterventionMorphine (po) equivalents [mg*kg-1] (Mean)
Oral Narcotic Group0.09
Bupivacaine Group0.05
Ropivacaine Group0.08

[back to top]

Visual Analogue Scores (VAS) - Pain Scores Measured in mm (0-100)

Pain scores measured by Visual Analogue Score (VAS) scale at 15-30min after Post anesthesia care unit (PACU) arrival VAS is a 100mm scale to measure pain. 0mm - no pain 100mm - worst possible pain (NCT01337115)
Timeframe: 15-30 min after arrival on post anesthesia care unit (PACU)

Interventionunits on a scale (Mean)
Continuous Femoral Nerve Block (CFNB)59.4
Single Shot Sciatic Nerve Block (SNB)30.2

[back to top]

VAS Results - Pain Scores Measured in mm (0-100)

"VAS pain scores are measured by blinded investigators 24h after surgery .~VAS scale:~0 - no pain 100 - worst possible pain" (NCT01337115)
Timeframe: 24h after surgery

Interventionunits on a scale (Mean)
Continuous Femoral Nerve Block (CFNB)30.13
Single Shot Sciatic Nerve Block (SNB)32.68

[back to top]

VAS Results - Pain Measured in mm (0-100)

"VAS pain scores are measured by blinded investigators 12h after surgery .~VAS scale:~0 - no pain 100 - worst possible pain" (NCT01337115)
Timeframe: 12h after surgery

Interventionunits on a scale (Mean)
CFNB26.1
CFNB+Single Shot SNB9.2

[back to top]

Satisfaction With Anesthesia Technique in Each Arm of the Study

"Satisfaction with the anesthesia technique using a categorical scale with three levels:~Bad Reasonable Good/Very Good A Fisher's Exact test is made to asses any differences in the distribution of patients in each arm to each level of the categorical scale" (NCT01337115)
Timeframe: 1 month after surgery

,
Interventionparticipants (Number)
BadReasonableGood/Very Good
Continuous Femoral Nerve Block (CFNB)0317
Single Shot Sciatic Nerve Block (SNB)0211

[back to top]

Chronic Pain

Number and incidence of patients with persisting pain (burning pain, loss of sensation) one month postoperatively (NCT01388946)
Timeframe: one month postoperatively

Interventionnumber of participants (Number)
Ropivacaine 0.755
Normal Saline7

[back to top]

Chronic Pain

Number and incidence of patients with persisting pain (burning pain, loss of sensation) three month postoperatively (NCT01388946)
Timeframe: three months

InterventionNumber of participants (Number)
Ropivacaine 0.752
Normal Saline4

[back to top]

Pain Scores at Rest 2 h Postoperatively

Visual Analogue Scale (VAS) measuring pain intensity (mm) with total range 0-100 and with 0 representing no pain and 100 representing possible worst pain. (NCT01388946)
Timeframe: 2 h postoperatively

Interventionmm (Mean)
Ropivacaine 0.7526
Normal Saline30

[back to top]

Pain Scores at Rest 24 h Postoperatively

Visual Analogue Scale (VAS) measuring pain intensity (mm) with total range 0-100 and with 0 representing no pain and 100 representing possible worst pain. (NCT01388946)
Timeframe: 24h

Interventionmm (Mean)
Ropivacaine 0.7514
Normal Saline15

[back to top]

Pain Scores at Rest 4 h Postoperatively

Visual Analogue Scale (VAS) measuring pain intensity (mm) with total range 0-100 and with 0 representing no pain and 100 representing possible worst pain. (NCT01388946)
Timeframe: 4 h

Interventionmm (Mean)
Ropivacaine 0.7516
Normal Saline22

[back to top]

Pain Scores at Rest 8 h Postoperatively

Visual Analogue Scale (VAS) measuring pain intensity (mm) with total range 0-100 and with 0 representing no pain and 100 representing possible worst pain. (NCT01388946)
Timeframe: 8 h

Interventionmm (Mean)
Ropivacaine 0.7517
Normal Saline20

[back to top]

Pain Scores During Cough 2 h Postoperatively

Visual Analogue Scale (VAS) measuring pain intensity (mm) with total range 0-100 and with 0 representing no pain and 100 representing possible worst pain. (NCT01388946)
Timeframe: 2 h

Interventionmm (Mean)
Ropivacaine 0.7536
Normal Saline55

[back to top]

VAS Score Changes ( Cough) During 24 h Postoperatively

Visual Analogue Scale (VAS) measuring pain intensity (mm) with total range 0-100 and with 0 representing no pain and 100 representing possible worst pain. (NCT01388946)
Timeframe: 24 h

Interventionmm (Mean)
Ropivacaine 0.7532
Normal Saline31

[back to top]

Pain Scores in the Postoperative Care Unit (PACU) at Rest

Visual Analogue Scale (VAS) measuring pain intensity (mm) with total range 0-100 and with 0 representing no pain and 100 representing possible worst pain. (NCT01388946)
Timeframe: in PACU

Interventionmm (Mean)
Ropivacaine 0.7536
Normal Saline46

[back to top]

Pain Scores During Cough in the PACU

Visual Analogue Scale (VAS) measuring pain intensity (mm) with total range 0-100 and with 0 representing no pain and 100 representing possible worst pain. (NCT01388946)
Timeframe: PACU

Interventionmm (Mean)
Ropivacaine 0.7542
Normal Saline55

[back to top]

Pain Scores During Cough 8 h Postoperatively

Visual Analogue Scale (VAS) measuring pain intensity (mm) with total range 0-100 and with 0 representing no pain and 100 representing possible worst pain. (NCT01388946)
Timeframe: 8 h

Interventionmm (Mean)
Ropivacaine 0.7529
Normal Saline34

[back to top]

Pain Scores During Cough 48 h Postoperatively

Visual Analogue Scale (VAS) measuring pain intensity (mm) with total range 0-100 and with 0 representing no pain and 100 representing possible worst pain. (NCT01388946)
Timeframe: 48 h

Interventionmm (Mean)
Ropivacaine 0.7518
Normal Saline26

[back to top]

Pain Scores During Cough 4 h Postoperatively

Visual Analogue Scale (VAS) measuring pain intensity (mm) with total range 0-100 and with 0 representing no pain and 100 representing possible worst pain. (NCT01388946)
Timeframe: 4 h

Interventionmm (Mean)
Ropivacaine 0.7525
Normal Saline34

[back to top]

Pain Scores at Rest 48 h Postoperatively

Visual Analogue Scale (VAS) measuring pain intensity (mm) with total range 0-100 and with 0 representing no pain and 100 representing possible worst pain. (NCT01388946)
Timeframe: 48 h

Interventionmm (Mean)
Ropivacaine 0.758
Normal Saline12

[back to top]

Duration of Sensory Blockade

Duration from time of block until complete resolution of sensory blockade in the shoulder is recorded in minutes by patient report. (NCT01450007)
Timeframe: Within 48 hours

Interventionhours (Mean)
Dexamethasone Block16.9
Dexamethasone IV18.2
Placebo13.8

[back to top]

Post Operative Opioid Dose at 24 Hours

(NCT01450007)
Timeframe: approximately 24 hours after surgery

Interventionmg morphine equivalents (Mean)
Dexamethasone Block12.2
Dexamethasone IV17.1
Placebo24.1

[back to top]

Time Until First Dose of Analgesic

(NCT01450007)
Timeframe: Approximately 10 hours after surgery

Interventionhours (Mean)
Dexamethasone Block8.4
Dexamethasone IV9.2
Placebo8.4

[back to top]

Patient Satisfaction With Pain Control

Pain was rated on a visual analogue scale with 0 = no pain, 3=mild pain, 5=moderate pain, 7=moderate to severe pain, and 10=severe pain. (NCT01450007)
Timeframe: 24 hours, 48 hours, 1 week

,,
Interventionunits on a scale (Mean)
24 hours (n=34, 28, 37)48 hours (n=42, 37, 41)1 week (n=42, 36, 41)
Dexamethasone Block7.88.49.1
Dexamethasone IV7.98.78.8
Placebo7.37.68.4

[back to top]

Number of Patients With Complications

All patients were followed up for complications such as bleeding, infection, side effects, nerve damage (NCT01452126)
Timeframe: 3 days

InterventionParticipants (Count of Participants)
Ropivacaine0

[back to top]

Effective Concentration of Ropivacaine to Produce Surgical Anesthesia in 50% of Population

The concentration of ropivacaine for each patient's nerve-block injection was determined per protocol. (NCT01452126)
Timeframe: 1 day

Interventionpercentage concentration, ropivacaine (Number)
Femoral Nerve Block0.09
Supraclavicular Blockade0.11
Infraclavicular Blockade0.16
Popliteal Nerve Block0.37

[back to top]

Intraoperative Time

The total time in the operating room will be recorded to see if there is a difference between groups. (NCT01479270)
Timeframe: the total intraoperative time in minutes

InterventionMinutes (Median)
TAP Block47.4
No Block34.5

[back to top]

Narcotic Use

narcotic use in mg of Morphine will be recorded (NCT01479270)
Timeframe: Postop Day #0 and Day #1

,
Interventionmg of morphine (Median)
Post operative day #0Post operative day #1
No Block11.89.0
Tap Block11.77.5

[back to top]

Visual Analog Scale (VAS) for Pain

visual analogue scales for pain will be completed on post-operative day #0 and #1, pain is assessed on a 10-point visual analogue scale (0 = no pain; 1 to 3 = mild; 4 to 6 = moderate pain; 7 to 10 = severe pain.) (NCT01479270)
Timeframe: 2 and 24 hours post operative

,
Interventionunits on a scale (Median)
2 hours post operative24 hours post operative
No Block6.05.0
Tap Block5.05.0

[back to top]

Quality of Recovery Questionnaire (QoR-40) on Postop Day #1 or #2

40 question survey completed on paper or by telephone on post-operative day #1 or #2, designed to measure health status after surgery and anesthesia. Scale ranges from 40 (extremely poor qualify of recovery) to 200 (excellent quality of recovery). (NCT01479270)
Timeframe: Postop Day #1 or Day #2

Interventionunits on a scale (Median)
TAP Block168.0
No Block169.5

[back to top]

Post-op Pain With Atomized Intraperitoneal Ropivacaine (AIR)

Participants are asked to rate their pain level using the visual analog scale (VAS). The VAS is a measurement of pain where respondents specify their level of pain by indicating a position along a continuous line between two end-points. The VAS used in this study was a horizontal line of 100 mm length anchored by two word descriptors - one word at each end: No pain (left end) and Very Severe Pain (right end). The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks. The VAS range is 0 to 100. (NCT01480089)
Timeframe: 12 hours after surgery

Interventionmillimeters (Mean)
Intraperitoneal Ropivacaine(AIR)2.154
Atomized Intraperitoneal Saline (AIS)2.219

[back to top]

Post-op Pain With Atomized Intraperitoneal Ropivacaine (AIR)

Participants are asked to rate their pain level using the visual analog scale (VAS). The VAS is a measurement of pain where respondents specify their level of pain by indicating a position along a continuous line between two end-points. The VAS used in this study was a horizontal line of 100 mm length anchored by two word descriptors - one word at each end: No pain (left end) and Very Severe Pain (right end). The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks. The VAS range is 0 to 100. (NCT01480089)
Timeframe: 2 hours after surgery

Interventionmillimeters (Mean)
Intraperitoneal Ropivacaine(AIR)2.536
Atomized Intraperitoneal Saline (AIS)3.844

[back to top]

Number of Participants With Increased Infusion Rates

Number of patients requiring increased infusion rates to 9 mL/hour to better optimize pain control. (NCT01556724)
Timeframe: Subjects will be followed postoperatively until postoperative day 2 (i.e. the discontinuation of the lumbar plexus catheters)

InterventionParticipants (Count of Participants)
0.2% Ropivacaine Nerve Block (Standard of Care)4
0.1% Ropivacaine Infusion in Nerve Block Catheter3

[back to top]

Numeric Rating Scale Pain Score With Movement at 24 Hours

Numeric rating scale (NRS) pain score with movement were assessed at 24 hours. Pain scores were followed using an 11-point NRS (0 = no pain and 10 = worst imaginable pain). Scores at 24 hours were not averaged with any other scores. (NCT01556724)
Timeframe: 24 hours postoperatively

Interventionunits on a scale (Median)
0.2% Ropivacaine Nerve Block (Standard of Care)7
0.1% Ropivacaine Infusion in Nerve Block Catheter7

[back to top]

Patient Satisfaction With Pain Control

Patient satisfaction with pain control at 24 hours (0-10 scale). Patients' satisfaction was assessed using an 11-point numeric scale (0-10, 0 = unsatisfied and 10 = very satisfied). Scores at 24 hours were not averaged with any other scores. (NCT01556724)
Timeframe: 24 hours postoperatively

Interventionunits on a scale (Median)
0.2% Ropivacaine8
0.1% Ropivacaine Infusion in Nerve Block Catheter9

[back to top]

Opiate Consumption Postoperatively

Postoperative opiate consumption at 24 hours (NCT01556724)
Timeframe: 24 hours postoperatively

Interventionmg (Mean)
0.2% Ropivacaine8.21
0.1% Ropivacaine8.02

[back to top]

Number of Participants With Decreased Infusion Rates

Number of patient requiring decreased infusion rates decreased to 5 mL/hour due to increased motor blockade. (NCT01556724)
Timeframe: Subjects will be followed postoperatively until postoperative day 2 (i.e. the discontinuation of the lumbar plexus catheters)

InterventionParticipants (Count of Participants)
0.2% Ropivacaine Nerve Block (Standard of Care)1
0.1% Ropivacaine Infusion in Nerve Block Catheter1

[back to top]

Temporary Neurologic Symptoms Between Groups

Temporary neurologic symptoms between groups; muscle weakness of either foot dorsiflexion and plantar flexion (NCT01615939)
Timeframe: 1 month

Interventionpercentage of total participants (Number)
Single Shot Sciatic Nerve Block0
Continuous Sciatic Nerve Block0

[back to top]

Participant Satisfaction With Anesthesia

Patient satisfaction on a 0 to 10 scale with 0 equals completely dissatisfied and 10 equals completely satisfied (NCT01615939)
Timeframe: 24 hours

Interventionunits on a scale (Median)
Single Shot Sciatic Nerve Block10
Continuous Sciatic Nerve Block10

[back to top]

Pain Control

Numeric rating score for pain (NRS) 0 to 10 scale where 0 equals no pain and 10 equals the worst pain imaginable (NCT01615939)
Timeframe: 72 hrs

Interventionunits on a scale (Median)
Single Shot Sciatic Nerve Block5
Continuous Sciatic Nerve Block6

[back to top]

Comparison of Postoperative Strength (Extension)

To assess extension force postoperatively to discern differences in muscle strength retention between continuous femoral nerve sheath catheter administration of fentanyl or Ropivacaine or a continuous IV infusion of fentanyl. (NCT01620047)
Timeframe: 24 hours post-surgery

InterventionNm/kg (Median)
Femoral Nerve Fentanyl.08
Femoral Nerve Ropivacaine.03
Intravenous Fentanyl With Placebo.05

[back to top]

Time Until Readiness for Surgery (Minutes)

(NCT01643616)
Timeframe: within 60 minutes after injection of the local anesthetic

Interventionminutes (Mean)
Group US15.1
Group NS28

[back to top]

Success Rate Without Supplementation

"After injection of local anesthetic a waiting period of 30-60 minutes was defined before completing a failed block.~success without supplementation = no additional analgetics or rescue blocks required (success rate without supplementation, outcome measure 1)~success with supplementation = analgetics or selective rescue blocks distal of the sciatic division required (success rate without supplementation and additionally all supplemented blocks, outcome measure 3)~failed block = change of anesthetic procedure (general, spinal) or rescue blocks proximal of the sciatic division" (NCT01643616)
Timeframe: within 30-60 minutes after injection of the local anesthetic

Interventionparticipants (Number)
Group US112
Group NS73

[back to top]

Success Rate With Supplementation

"After injection of local anesthetic a waiting period of 30-60 minutes was defined before completing a failed block.~success without supplementation = no additional analgetics or rescue blocks required (success rate without supplementation, outcome measure 1)~success with supplementation = analgetics or selective rescue blocks distal of the sciatic division required (success rate without supplementation and additionally all supplemented blocks, outcome measure 3)~failed block = change of anesthetic procedure (general, spinal) or rescue blocks proximal of the sciatic divisionSucces rate with supplementation" (NCT01643616)
Timeframe: later than 30-60 minutes after injection of the local anesthetic

Interventionparticipants (Number)
Group US116
Group NS85

[back to top]

Onset of Surgical Anesthesia

Onset of surgical anesthesia is defined as the time after injection of local anesthetic to the time where no sensation of pinprick in the ulnar, median, radial and musculocutaneous nerves (NCT01719237)
Timeframe: 45 minutes

,
Interventionminutes (Median)
Ulnar-SensoryMedian-SensoryRadial-SensoryMusculocutaneous-Sensory
Ropivacaine and Cholroprocaine Mixture16969
Ropivacaine Only22161010

[back to top]

Duration of Analgesia

Time interval between the end of local anestehtic injection and the patient's first report of pain in the surgical site after surgery (NCT01719237)
Timeframe: 72 hours

Interventionminutes (Median)
Ropivacaine and Cholroprocaine Mixture566
Ropivacaine Only718

[back to top]

Duration of Analgesia From Interscalene Nerve Block

Median time until a patient needed to take opioid pain medication (NCT01782872)
Timeframe: Postoperative day 1 at 8AM & 5PM, postoperative day 2 at 8AM & 5PM

Interventionhours (Mean)
High Dose21.3
Medium Dose16.8
Low Dose18.2
Control16.4

[back to top]

Middle Deltoid

A physical assessment will be done to determine the strength of the middle deltoid muscle in the operative arm using a dynamometer (NCT01782872)
Timeframe: 24 hours after surgery

Interventionkgf (Median)
High Dose2.8
Medium Dose1.5
Low Dose2.2
Control1.8

[back to top]

Numeric Rating Scale (NRS) Pain Score With Movement

Pain with movement at 24 hours from the nerve block (scale of 0-10; 0 = no pain, 10 = worst possible pain) (NCT01782872)
Timeframe: 24 hours after the interscalene block is given

Interventionunits on a scale (Mean)
High Dose4.5
Medium Dose3.4
Low Dose4.2
Control4.9

[back to top]

Numeric Rating Scale (NRS) Pain Scores at Rest

Assessment of NRS pain scores (scale of 0-10; 0 = no pain, 10 = worst possible pain) at rest (NCT01782872)
Timeframe: Preop

Interventionunits on a scale (Median)
High Dose3.0
Medium Dose3.2
Low Dose3.0
Control4.9

[back to top]

Hospital Length of Stay

Hospital length of stay was measured from the day of surgery (day 0) through postoperative day 11. (NCT01816477)
Timeframe: Up to 11 days post operation

Interventiondays (Mean)
Thoracic Epidural3.5
ON-Q Soaker Catheter System3.3

[back to top]

Use of Analgesic Narcotic

Postoperative analgesic used each day over 7 day postoperative period. (NCT01816477)
Timeframe: 1-7 days post operation

,
Interventionmorphine milligram equivalents (Mean)
Day 1 (n = 27, 41)Day 2 (n = 27, 41)Day 3 (n = 27, 41)Day 4 (n = 24, 27)Day 5 (n = 12, 13)Day 6 (n = 3, 5)Day 7 (n = 1, 3)
ON-Q Soaker Catheter System58.7107.262.479.478.886.481.9
Thoracic Epidural40.899.579.765.843.530.824.0

[back to top]

Mean Daily Pain Score

Pain was measured by a visual analogue scale (VAS) with pre-set markings from 0 to 10, with 0 for no pain to 10 for the worst possible pain. On the case report form each day had 6 time categories: waking up in the morning, around lunch time, afternoon approximately 3-4 pm, dinner time, bedtime, and during the night time. Each day was averaged for each subject, then the values for each arm were averaged. (NCT01816477)
Timeframe: Days 1-7 post operation

,
Interventionunits on a scale (Mean)
Day 1 (n = 27, 41)Day 2 (n = 27, 41)Day 3 (n = 27, 41)Day 4 (n = 24, 27)Day 5 (n = 12, 13)Day 6 (n = 3, 5)Day 7 (n=1, 3)
ON-Q Soaker Catheter System2.392.602.973.603.303.554.13
Thoracic Epidural2.192.643.163.032.953.284.50

[back to top]

Postoperative Numeric Pain Rating Score (NPRS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable)

Pain assessments by verbal numerical pain score (NPS) at 0, 1 and 2 hours prior to discharge in the Post Anesthesia Care Unit. The 10 point NPS scale ranges from 0-10 with 0 being equivalent to no pain and a value of 10 being equivalent to the worst pain imaginable (NCT01866917)
Timeframe: 0, 1, and 2 hours

,
Interventionscore on a scale (Median)
0 hour1 hour2 hours
Saline Group A5.53.54.5
Transversus Abdominis Plane (TAP) Group B033

[back to top]

Postoperative Numeric Pain Score (NPS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable)

Pain assessments by verbal numerical pain score (NPS) at 4, 8, 12 and 24 hours prior to discharge in the Post Anesthesia Care Unit. The 10 point NPS scale ranges from 0-10 with 0 being equivalent to no pain and a value of 10 being equivalent to the worst pain imaginable (NCT01866917)
Timeframe: 4hrs, 8hrs, 12hrs, and 24hrs.

,
Interventionscore on a scale (Median)
4 hours8 hours12 hours24 hours
Saline Group A5.5231.5
Transversus Abdominis Plane (TAP) Group B0123

[back to top]

Maximum Tolerance to Transcutaneous Electrical Stimulation

Electrocardiogram pads are placed on the lateral aspect of the plantar surface of the foot which is covered by the sciatic nerve distribution; and, the tolerance to cutaneous electrical current is obtained using a nerve stimulator. The current is increased from 0 mA until subjects detect the electrical current (up to a maximum of 80 mA), at which time the current is recorded and the nerve stimulator turned off. (NCT01898689)
Timeframe: Hour 6

InterventionmA (milliamperes) (Mean)
Ropivacaine 0.1%27.0
Ropivacaine 0.4%26.9

[back to top]

Maximum Tolerance to Transcutaneous Electrical Stimulation

Electrocardiogram pads are placed on the lateral aspect of the plantar surface of the foot which is covered by the sciatic nerve distribution; and, the tolerance to cutaneous electrical current is obtained using a nerve stimulator. The current is increased from 0 mA until subjects detect the electrical current (up to a maximum of 80 mA), at which time the current is recorded and the nerve stimulator turned off. (NCT01898689)
Timeframe: baseline, Hours 1-14 (except 6 which was the primary outcome) and Hour 22

,
InterventionmA (milliamperes) (Mean)
BaselineHour 1Hour 2Hour 3Hour 4Hour 5Hour 7Hour 8Hour 9Hour 10Hour 11Hour 12Hour 13Hour 14Hour 22
Ropivacaine 0.1%2319182025252727232523.52519.523.517
Ropivacaine 0.4%22.5201920.42124.526.527.523.524.524.32221.22117

[back to top]

Percent of Maximum Voluntary Isometric Contraction Baseline (Quadriceps Femoris)

Muscle strength was evaluated with an isometric force electromechanical dynamometer (MicroFET2, Lafayette Instrument Company, Lafayette, IN) to measure the force produced during a MVIC during plantar flexion. The dynamometer was placed against the bed's foot board (immobile) and the subjects asked to take 2 seconds to come to maximum effort plantar flexing, maintaining this effort for 5 seconds, and then relaxing. The measurements immediately prior to perineural ropivacaine administration were designated as baseline measurements, and all subsequent measurements expressed as a percentage of the pre-infusion baseline. (NCT01898689)
Timeframe: baseline, Hours 1-14 and Hour 22

,
Interventionpercentage change from baseline MVIC (Mean)
BaselineHour 1Hour 2Hour 3Hour 4Hour 5Hour 6Hour 7Hour 8Hour 9Hour 10Hour 11Hour 12Hour 13Hour 14Hour 22
Ropivacaine 0.1%100908.181.571.06657586167687072807896
Ropivacaine 0.4%100988.181.071.55756576368666778.5707897

[back to top]

Timed Up and Go Test (TUG)

"The TUG assesses basic mobility skill as well as strength, balance, and agility. Originally developed for frail elderly people as the Get-Up and Go Test in 1986, it was adapted in 1991 to include the time component. The TUG is used in a range of populations from children to the elderly and for many conditions, including osteoarthritis, joint arthroplasty, rheumatoid arthritis, hip fractures, stroke, vertigo, and cerebral palsy." (NCT01966263)
Timeframe: 1 year

Interventionseconds (Mean)
Local Infiltration Analgesia (LIA)7.8
Femoral Nerve Block (FNB)7.6

[back to top]

Stair Climbing Task (SCT)

The SCT assesses the ability to ascend and descend a flight of stairs, as well as lower extremity strength, power, and balance. (NCT01966263)
Timeframe: one year

Interventionseconds (Mean)
Local Infiltration Analgesia (LIA)14.3
Femoral Nerve Block (FNB)13.8

[back to top]

Six Minute Walking Test (6MWT)

"The 6MWT assesses endurance and ability to walk over longer distances. The 6MWT was first described as a field test for physical fitness in 1963 and then as a 12-minute walk test in people with chronic bronchitis. The 6MWT was found to perform as well as the 12-minute walk, and is now used to assess the submaximal level of functional performance at a similar level required for daily physical activities.~Used in many conditions, such as osteoarthritis, cardiopulmonary disease, stroke, traumatic brain injury, patients who have undergone an amputation, Parkinson's disease, and Alzheimer's disease, as well as in elderly populations and children." (NCT01966263)
Timeframe: 1 year

Interventionmeters (Mean)
Local Infiltration Analgesia (LIA)489
Femoral Nerve Block (FNB)505

[back to top]

Intra-operative and Post-operative Opioid Consumption

Number of doses of narcotic pain medicine administered during surgery and up to 48 hours after discharge from surgery center. (NCT01971645)
Timeframe: Intra-operative and up to 48 hours post-discharge, an average of 48 hours

Interventiondoses (Median)
Group D2
Group R2
Group M3

[back to top]

Post-operative Pain Scores

Visual Analogue Scale (VAS) pain scores (0 being no pain and 10 being worst pain) from arrival to post-anesthesia care unit (PACU) to 48 hours after discharge from surgery center. (NCT01971645)
Timeframe: Immediately post-operatively and up to 48 hours post-discharge, an average of 48 hours

Interventionunits on a scale (Median)
Group D2
Group R2
Group M1

[back to top]

Mean Arterial Pressure

The mean arterial pressure of each patient was recorded at five different time points (NCT02000973)
Timeframe: Before starting anesthesia to finishing endotracheal intubation

,,,
InterventionmmHg (Mean)
Baseline20minites after epidural injectionLoss of consciousnessBefore endotracheal intubationAfter endotracheal intubation
Bupivacaine98.9595.9081.0561.6585.82
Lidocaine99.6596.2581.1562.3084.68
Normal Saline96.4099.5586.7567.1596.82
Ropivacaine98.2595.4080.9560.6086.12

[back to top]

Heart Rate

The heart rate of each patient was recorded at five different time points (NCT02000973)
Timeframe: Before starting anesthesia to finishing endotracheal intubation

,,,
Interventionbeats per minute (Mean)
Baseline20 minites after epidural injectionLoss of consciousnessBefore endotracheal intubationAfter endotracheal intubation
Bupivacaine69.0067.4065.9059.1075.10
Lidocaine69.6569.1570.4061.7576.70
Normal Saline71.7073.9569.9064.1588.00
Ropivacaine74.8071.5070.0061.8579.45

[back to top]

Bispectral Index Score

The bispectral index(BIS) score of each patient was recorded at two different time points. BIS values varies from 0 to 100(0, no cerebral activity; 40 to 60, general anesthesia; 60 to 85, sedated; 85 to 100, awake). (NCT02000973)
Timeframe: Before starting anesthesia to finishing endotracheal intubation

,,,
Interventionunits on a scale (Mean)
Baseline20 minutes after epidural injection
Bupivacaine97.0792.43
Lidocaine96.7090.00
Normal Saline96.6796.20
Ropivacaine96.9489.12

[back to top]

Propofol Effect-site Concentration

The effect-site concentration of propofol when loss of consciousness during propofol target-controlled infusing(TCI) induction of anesthesia. (NCT02000973)
Timeframe: Before starting anesthesia to finishing endotracheal intubation

Interventionug/ml (Mean)
Normal Saline1.76
Lidocaine1.14
Bupivacaine1.09
Ropivacaine1.04

[back to top]

Patient and Parent Satisfaction

Child subject and parent satisfaction with pain management was measured using the global perioperative experience graded on a numeric scale of 0 - 10, with 0 indicating poor management to 10 indicating excellent pain management. Satisfaction is reported at 12-, 24-, 48-hours, and overall at home. (NCT02056288)
Timeframe: up to 48 hours after surgery

,
Interventionunits on a scale (Mean)
Child's Satisfaction - at 12-hoursChild's Satisfaction - at 24-hoursChild's Satisfaction - at 48-hoursChild's Satisfaction - Total time at homeParent's Satisfaction - at 12-hoursParent's Satisfaction - at 24-hoursParent's Satisfaction - at 48-hoursParent's Satisfaction - Total time at home
IV Opioids6.65.67.15.97.16.57.66.5
Ultrasound Guided Supraclavicular Block5.85.67.56.15.86.48.17.9

[back to top]

Opioid Consumption

Opioid administration measured in mg/kg. Results below represent the total opioids given in the PACU, after discharge from the PACU, and then total post-operative period. (NCT02056288)
Timeframe: up to 48 hours after surgery

,
Interventionmg/kg (Median)
Total Intraoperative OpioidsPACU - 1st 2 hoursHome - Hour 2 to 48Total Opioid Consumption - PACU and Home
IV Opioids0.20.120.040.26
Ultrasound Guided Supraclavicular Block000.250.31

[back to top]

Incidence of Side Effects

Documented side effects such as nausea, vomiting, pruritus, and respiratory depression. (NCT02056288)
Timeframe: up to 48 hours after surgery

,
InterventionParticipants (Count of Participants)
NauseaVomitingPruritusRespiratory Depression
IV Opioids0000
Ultrasound Guided Supraclavicular Block1002

[back to top]

Time of First Analgesia Request

Time at which additional analgesia was requested and/or administered by the nurse while in the PACU. Discharge data not reported due to poor diary return compliance. (NCT02056288)
Timeframe: PACU Period up to 3 hours

InterventionMinutes (Median)
Ultrasound Guided Supraclavicular Block76
IV Opioids27

[back to top]

Time of Achieving Discharge Readiness

Documented time that patient achieves an Aldrete Score of 9 -10. This is a standardized scale used to assess discharge readiness at Texas Children's Hospital. (NCT02056288)
Timeframe: From the time of PACU arrival up to time the patient achieves an Aldrete Score of 9- 10.

InterventionMinutes (Mean)
Ultrasound Guided Supraclavicular Block72
IV Opioids94

[back to top]

The Mean Pain Score in the Postoperative Period

The Verbal Numeric Scale (VNS) asks patients to verbally state a number between 0 and 10 that corresponds to their present pain intensity. 0 = no pain and 10 = worst possible pain ever. Pain was measured by the child subject in the PACU at arrival, 15-, 30-, 60- and 120-minutes. Pain was assessed by the child subject and a parent at home at 12-, 24-, and 48-hours after surgery. The results represent a mean of all verbal pain scores in the PACU, while at home, and overall. (NCT02056288)
Timeframe: From admission to PACU to 48 hours after surgery

,
Interventionunits on a scale (Mean)
PACUHomePACU + Home
IV Opioids4.763.494.44
Ultrasound Guided Supraclavicular Block1.283.852.46

[back to top]

Ultrasonographic Evaluation of Diaphragmatic Excursion- Operative Side Sigh Test

For ultrasonographic evaluation if caudad movement of the hemidiaphragm was observed, the distance was measured recorded and assigned a positive (+) value. If paradoxical cephalad movement of the diaphragm was observed, the distance was given a negative value (-). Each measurement was performed 3 times and the best value was recorded. (NCT02059070)
Timeframe: Within 36hrs following surgery

Interventionpercentage of baseline change (Mean)
0.125% Bupivacaine-81.4
0.2% Ropivacaine-75.5

[back to top]

Forced Expiratory Volume at 1 Second (% Change From Baseline)

(NCT02059070)
Timeframe: Within the first 4 days following surgery

Interventionpercentage of change from baseline (Mean)
0.125% Bupivacaine-22.4
0.2% Ropivacaine-29.4

[back to top]

Post-operative Oxycodone Use (mg)

The total amount of oxycodone medication (mg) that the patient consumed in the 24 hours post surgery. (NCT02059070)
Timeframe: The 24 hour period following surgery

Interventionmg (Mean)
0.125% Bupivacaine33.7
0.2% Ropivacaine35.1

[back to top]

Highest Patient Pain Level

The Visual analog pain scale ranges from 0 to 10, with higher scores indicating higher pain (NCT02059070)
Timeframe: Within 36 hours of surgery

InterventionVAS units on a scale (Mean)
0.125% Bupivacaine4.9
0.2% Ropivacaine3.5

[back to top]

Maximum of Measured Systolic Blood Pressures

The maximal systolic blood pressure is monitored during surgery. (NCT02112370)
Timeframe: participants were followed for the duration of the operation, an average of approximately 2.5 hours

InterventionmmHg (Mean)
Normal Saline Injection142
Ropivacaine With Epinephrine Injection145

[back to top]

NRS Pain Scores for the First 12 Hours

"The numerical rating scale is utilized to assess the postoperative pain change for the first 12 hours according to location.~Range: 0(minimal pain, better outcome) ~ 10(maximum pain, worse outcome)~Unlike the general NRS pain score as reported in the post-operative 48 hour result which deals with post-operative discomfort in general, this outcome measures the pain score of the specific location in which flap dissection had taken place." (NCT02112370)
Timeframe: Postoperative 12 hours

,
Interventionpoints (Mean)
Swallowing difficultyAnterior neck painRight chest painLeft chest painBack painPosterior neck pain
Normal Saline Injection4.934.503.993.740.651.47
Ropivacaine With Epinephrine Injection4.123.693.164.510.281.65

[back to top]

Pain Killer Dose

Change in pain killer usage with time (NCT02112370)
Timeframe: 0, 1, 2, 4, 6, 9, 12, 24, and 48 hours post operation

,
Interventionvials (15mg ketorolac per vial) (Mean)
0 hour1 hour2 hour4 hour6 hour9 hour12 hour24 hour48 hour
Normal Saline Injection10.350.310.070.180.140.180.200.01
Ropivacaine With Epinephrine Injection0.840.310.260.110.150.120.190.160.07

[back to top]

Operation Time

The amount of time taken from start to the end of surgery (NCT02112370)
Timeframe: participants were followed for the duration of the operation, an average of approximately 2.5 hours

Interventionminutes (Mean)
Normal Saline Injection163.6
Ropivacaine With Epinephrine Injection155.3

[back to top]

Maximum of Measured Heart Rates

The maximal heart rate is monitored during surgery. (NCT02112370)
Timeframe: participants were followed for the duration of the operation, an average of approximately 2.5 hours

Interventionbeats per minute (Mean)
Normal Saline Injection88
Ropivacaine With Epinephrine Injection99

[back to top]

Maximum of Measured Diastolic Blood Pressures

The maximal diastolic blood pressure is monitored during surgery. (NCT02112370)
Timeframe: participants were followed for the duration of the operation, an average of approximately 2.5 hours

InterventionmmHg (Mean)
Normal Saline Injection91
Ropivacaine With Epinephrine Injection86

[back to top]

Blood Loss Amount

The blood loss amount is estimated at the end of surgery. (NCT02112370)
Timeframe: participants were followed for the duration of the operation, an average of approximately 2.5 hours

Interventionml (Mean)
Normal Saline Injection30
Ropivacaine With Epinephrine Injection18

[back to top]

NRS Change

"Change in NRS score a with time The numerical rating scale is utilized to assess the postoperative pain change for the first 12 hours according to location.~Range: 0(minimal pain, better outcome) ~ 10(maximum pain, worse outcome)" (NCT02112370)
Timeframe: 0, 1, 2, 4, 6, 9, 12, 24, and 48 hours post operation

,
Interventionscores on a scale (Mean)
0 hour1 hour2 hour4 hour6 hour9 hour12 hour24 hour48 hour
Normal Saline Injection5.735.054.553.553.393.283.192.932.27
Ropivacaine With Epinephrine Injection5.684.74.113.343.283.143.182.952.08

[back to top]

Changes in Skin Temperature From Baseline to 30min After Brachial Plexus Block(Phase 2)

Skin temperature was measured at the thenar. change= 30min after brachial plexus block minus baseline (NCT02139982)
Timeframe: Baseline,30 min after brachial plexus block

Intervention℃ (Mean)
Group A(Phase 2)1.18
Group B(Phase 2)1.91
Group C(Phase 2)2.27
Group D(Phase 2)2.32
Group E(Phase 2)2.44
Group F(Phase 2)2.43

[back to top]

Changes in Hemodynamic Parameters of Brachial Artery From Baseline to 30min After Brachial Plexus Block(Phase 2)

"These parameters included peak systolic velocity (PSV, cm/s), end-diastolic velocity (EDV, cm/s), time average maximum velocity (TAMAX), resistance index (RI), and pulsatility index (PI),The cross-sectional area of the artery imaging.Blood flow (BF) = TAMAX× CSA×60s.~Relative ratio of hemodymanic parameter=30 min after brachial plexus block divide by baseline" (NCT02139982)
Timeframe: baseline, 30 min after brachial plexus block

,,,,,
Interventionratio (Median)
relative ratio of PSVRelative ratio of TAMAXRelative ratio of BFRelative ratio of PIRelative ratio of RI
Group A(Phase 2)1.0313711.211.400.750.91
Group B(Phase 2)1.151.561.870.610.87
Group C(Phase 2)1.191.842.100.530.85
Group D(Phase 2)1.192.092.540.470.84
Group E(Phase 2)1.292.343.180.440.81
Group F(Phase 2)1.432.573.530.430.82

[back to top]

Changes in Skin Temperature From Baseline to 30 Min After Specific Nerve Block Followed by 30 Min After Brachial Plexus Block(Phase 1)

Skin temperature(Ts) was measured at four different points within the cutaneous innervation areas of the musculocutaneous(lateral skin of forearm), ulnar(hypothenar region), radial (thumb-index web) and median(thenar) Specific points were located with skin marker to provide consistency of measurement. (NCT02139982)
Timeframe: baseline, 30 min after specific nerve block, 30 min after brachial plexus block

,,,
Intervention℃ (Mean)
Ts MC t0Ts MC t1Ts MC t2Ts UL t0Ts UL t1Ts UL t2Ts RA t0Ts RA t1Ts RA t2Ts ME t0Ts ME t1Ts ME t2
Group MC(Phase 1)30.029.931.329.129.031.930.530.532.628.929.032.4
Group ME (Phase 1)30.030.433.729.729.832.930.132.733.929.833.333.7
Group RA (Phase 1)30.230.133.429.529.632.629.529.732.229.529.532.0
Group UL( Phase 1)29.830.031.130.132.432.630.530.533.230.030.132.7

[back to top]

Changes in Hemodynamic Parameters of Radial/Ulnar Artery From Baseline to 30min After Specific Nerve Block Followed by 30min After Brachial Plexus Block(Phase 1)

These parameters included peak systolic velocity (PSV, cm/s), end-diastolic velocity (EDV, cm/s), time average maximum velocity (TAMAX),and was measured by Pulsed-wave Doppler(PWD) ultrasound. (NCT02139982)
Timeframe: baseline(t0), 30 min after specific nerve block(t1), 30 min after brachial plexus block(t2)

,,,
Interventioncm/s (Mean)
PSV of radial artery T0PSV of radial artery T1PSV of radial artery T2EDV of radial artery T0EDV of radial artery T1EDV of radial artery T2TAMAX of radial artery T0TAMAX of radial artery T1TAMAX of radial artery T2PSV of ulnar artery T0PSV of ulnar artery T1PSV of ulnar artery T2EDV of ulnar artery T0EDV of ulnar artery T1EDV of ulnar artery T2TAMAX of ulnar artery T0TAMAX of ulnar artery T1TAMAX of ulnar artery T2
Group MC(Phase 1)40.940.758.03.43.619.410.210.432.042.540.256.95.95.119.611.210.927.8
Group ME (Phase 1)42.652.458.55.516.118.011.524.829.743.945.162.85.37.420.211.111.929.0
Group RA (Phase 1)47.650.569.66.09.321.113.118.433.351.153.968.46.06.218.814.014.030.5
Group UL( Phase 1)39.640.960.15.85.720.411.411.231.045.860.568.77.921.626.914.929.936.8

[back to top]

Changes in Cross-sectional Area of Radial/Ulnar Artery From Baseline to 30min After Specific Nerve Block Followed by 30min After Brachial Plexus Block(Phase 1)

The cross-sectional area(CSA, cm2) of Radial/ulnar Artery was assessed with B-mode imaging. Probe was kept perpendicular to the long axis of the artery to obtain the largest oval arterial section. The image at end diastole was chosen and measured with the cine loop. (NCT02139982)
Timeframe: baseline(t0), 30 min after specific nerve block(t1), 30 min after brachial plexus block(t2)

,,,
Interventioncm^2 (Mean)
CSA of radial artery T0CSA of radial artery T1CSA of radial artery T2CAS of ulnar artery T0CAS of ulnar artery T1CAS of ulnar artery T2
Group MC(Phase 1)0.0510.0530.0730.0390.0390.061
Group ME (Phase 1)0.0510.0690.0730.0500.0560.069
Group RA (Phase 1)0.0400.0440.0610.0430.0440.068
Group UL( Phase 1)0.0510.0530.0740.0390.0590.061

[back to top]

Success of Brachial Plexus Block ( Phase 2)

Success of Brachial Plexus Block(BPB) was defined as the absence of sensation to in all innervation areas of above four nerves (musculocutaneous, ulnar, radial, and median nerves) 30min. after the BPB and no pain during the surgery. (NCT02139982)
Timeframe: 30 min after brachial plexus block

Interventionparticipants (Number)
Group A(Phase 2)1
Group B(Phase 2)9
Group C(Phase 2)11
Group D(Phase 2)12
Group E(Phase 2)13
Group F(Phase 2)13

[back to top]

Duration of the Sensorial Supraclavicular Block

Duration of sensorial block defined as the time interval between subject admitted to the Post-Anesthesia Care Unit and the time the first pain medication taken at home (NCT02151487)
Timeframe: within 24-hr after surgery

Interventionhour (Mean)
Ropivacaine13.4
Ropivacaine and Dexamethasone14
Ropivacaine and Clonidine17.4
Ropivacaine, Dexamethasone and Clonidine18.8

[back to top]

Postoperative Analgesia

Post-operative Visual Analog Pain (VAS) scores on the scale of 10 (0=no pain and 10=worse imaginary pain). (NCT02151487)
Timeframe: within 15 minutes at postanesthesia care unit (PACU) arrival

Interventionscore on a scale of 10 (Median)
Ropivacaine0
Ropivacaine and Dexamethasone0
Ropivacaine and Clonidine0
Ropivacaine, Dexamethasone and Clonidine0

[back to top]

Time to First Analgesic Dose

(NCT02154048)
Timeframe: 48 hours

Interventionhours (Mean)
Local Anesthetic (LA) Control Group10
Intravenous (IV) Control Group6
Additive Group4

[back to top]

24-48 h Postoperative Tylenol Consumption

The amount in mg of Tylenol administered to patient (NCT02154763)
Timeframe: 24-48 hours post operatively

Interventionmg (Median)
Intraperitoneal Normal Saline3033.3
Intraperitoneal Ropivacaine2826.1

[back to top]

24-48 h Postoperative Tramadol Consumption

The amount in mg of Tramadol administered to patient (NCT02154763)
Timeframe: 24-48 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline216.7
Intraperitoneal Ropivacaine215.2

[back to top]

24-48 h Postoperative Ketorolac Consumption

The amount in mg of Ketorolac administered to patient (NCT02154763)
Timeframe: 24-48 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline2.3333
Intraperitoneal Ropivacaine3.2609

[back to top]

24-48 h Postoperative Dilaudid Consumption

The amount in mg of Dilaudid administered to patient (NCT02154763)
Timeframe: 24-48 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline2933.3
Intraperitoneal Ropivacaine3000

[back to top]

24-32 Hours Post Operative Pain Level

Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome). (NCT02154763)
Timeframe: 24-32 hours post operatively

Interventionunits on a scale (Mean)
Intraperitoneal Normal Saline3.2568
Intraperitoneal Ropivacaine3.1974

[back to top]

20h Peak Expiratory Flow (PEF) Score

Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point. (NCT02154763)
Timeframe: 20 hours post operatively

InterventionL/min (Mean)
Intraperitoneal Normal Saline246
Intraperitoneal Ropivacaine245.1

[back to top]

20-24 Hours Post Operative Pain Level

Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome). (NCT02154763)
Timeframe: 20-24 hours post operatively

Interventionunits on a scale (Mean)
Intraperitoneal Normal Saline3.2386
Intraperitoneal Ropivacaine3.4651

[back to top]

2-4 h Postoperative Tylenol Consumption

The amount in mg of Tylenol administered to patient (NCT02154763)
Timeframe: 2-4 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline216.4
Intraperitoneal Ropivacaine240.2

[back to top]

2-4 h Postoperative Tramadol Consumption

The amount in mg of Tramadol administered to patient (NCT02154763)
Timeframe: 2-4 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline12.2222
Intraperitoneal Ropivacaine15.2174

[back to top]

2-4 h Postoperative Ketorolac Consumption

The amount in mg of Ketorolac administered to patient (NCT02154763)
Timeframe: 2-4 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline3.2222
Intraperitoneal Ropivacaine1.0087

[back to top]

2-4 h Postoperative Fentanyl Consumption

The amount in mcg of Fentanyl administered to patient (NCT02154763)
Timeframe: 2-4 hours post operatively

Interventionmcg (Mean)
Intraperitoneal Normal Saline4.4444
Intraperitoneal Ropivacaine33.1522

[back to top]

2-4 h Postoperative Dilaudid Consumption

The amount in mg of Dilaudid administered to patient (NCT02154763)
Timeframe: 2-4 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline415.6
Intraperitoneal Ropivacaine484.8

[back to top]

1h Peak Expiratory Flow (PEF) Score

Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point. (NCT02154763)
Timeframe: 1 hours post operatively

InterventionL/min (Mean)
Intraperitoneal Normal Saline202.9
Intraperitoneal Ropivacaine200.3

[back to top]

24h Peak Expiratory Flow (PEF) Score

Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point. (NCT02154763)
Timeframe: 24 hours post operatively

InterventionL/min (Mean)
Intraperitoneal Normal Saline255.2
Intraperitoneal Ropivacaine253.8

[back to top]

2h Peak Expiratory Flow (PEF) Score

Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point. (NCT02154763)
Timeframe: 2 hours post operatively

InterventionL/min (Mean)
Intraperitoneal Normal Saline243
Intraperitoneal Ropivacaine239.8

[back to top]

32-40 Hours Post Operative Pain Level

Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome). (NCT02154763)
Timeframe: 32-40 hours post operatively

Interventionunits on a scale (Mean)
Intraperitoneal Normal Saline2.8143
Intraperitoneal Ropivacaine2.9955

[back to top]

32h Peak Expiratory Flow (PEF) Score

Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point. (NCT02154763)
Timeframe: 32 hours post operatively

InterventionL/min (Mean)
Intraperitoneal Normal Saline256.62
Intraperitoneal Ropivacaine265.5

[back to top]

4-12 h Postoperative Dilaudid Consumption

The amount in mg of Dilaudid administered to patient (NCT02154763)
Timeframe: 4-12 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline2000
Intraperitoneal Ropivacaine1830.4

[back to top]

4-12 h Postoperative Ketorolac Consumption

The amount in mg of Ketorolac administered to patient (NCT02154763)
Timeframe: 4-12 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline6.8889
Intraperitoneal Ropivacaine5.2174

[back to top]

4-12 h Postoperative Tylenol Consumption

The amount in mg of Tylenol administered to patient (NCT02154763)
Timeframe: 4-12 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline1140.9
Intraperitoneal Ropivacaine1187

[back to top]

4-8 Hours Post Operative Pain Level

Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome). (NCT02154763)
Timeframe: 4-8 hours post operatively

Interventionunits on a scale (Mean)
Intraperitoneal Normal Saline3.6507
Intraperitoneal Ropivacaine3.8387

[back to top]

2-4 Hours Post Operative Pain Level

Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome). (NCT02154763)
Timeframe: 2-4 hours post operatively

Interventionunits on a scale (Mean)
Intraperitoneal Normal Saline3.2733
Intraperitoneal Ropivacaine3.1978

[back to top]

16h Peak Expiratory Flow (PEF) Score

Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point. (NCT02154763)
Timeframe: 16 hours post operatively

InterventionL/min (Mean)
Intraperitoneal Normal Saline233.4
Intraperitoneal Ropivacaine242.2

[back to top]

16-20 Hours Post Operative Pain Level

Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome). (NCT02154763)
Timeframe: 16-20 hours post operatively

Interventionunits on a scale (Mean)
Intraperitoneal Normal Saline3.4186
Intraperitoneal Ropivacaine3.8081

[back to top]

12h Peak Expiratory Flow (PEF) Score

Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point. (NCT02154763)
Timeframe: 12 hours post operatively

InterventionL/min (Mean)
Intraperitoneal Normal Saline240
Intraperitoneal Ropivacaine241.6

[back to top]

12-24 h Postoperative Tylenol Consumption

The amount in mg of Tylenol administered to patient (NCT02154763)
Timeframe: 12-24 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline1921.1
Intraperitoneal Ropivacaine1837

[back to top]

12-24 h Postoperative Tramadol Consumption

The amount in mg of Tramadol administered to patient (NCT02154763)
Timeframe: 12-24 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline141.1
Intraperitoneal Ropivacaine138

[back to top]

40-48 Hours Post Operative Pain Level

Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome). (NCT02154763)
Timeframe: 40-48 hours post operatively

Interventionunits on a scale (Mean)
Intraperitoneal Normal Saline2.7661
Intraperitoneal Ropivacaine2.9394

[back to top]

12-24 h Postoperative Ketorolac Consumption

The amount in mg of Ketorolac administered to patient (NCT02154763)
Timeframe: 12-24 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline6.3333
Intraperitoneal Ropivacaine5.5435

[back to top]

12-24 h Postoperative Dilaudid Consumption

The amount in mg of Dilaudid administered to patient (NCT02154763)
Timeframe: 12-24 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline2066.7
Intraperitoneal Ropivacaine2760.9

[back to top]

12-16 Hours Post Operative Pain Level

Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome). (NCT02154763)
Timeframe: 12-16 hours post operatively

Interventionunits on a scale (Mean)
Intraperitoneal Normal Saline3.4419
Intraperitoneal Ropivacaine3.9444

[back to top]

1-2 h Postoperative Tylenol Consumption

The amount in mg of Tylenol administered to patient (NCT02154763)
Timeframe: 1-2 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline144.2
Intraperitoneal Ropivacaine141.3

[back to top]

40h Peak Expiratory Flow (PEF) Score

Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point. (NCT02154763)
Timeframe: 40 hours post operatively

InterventionL/min (Mean)
Intraperitoneal Normal Saline255.3
Intraperitoneal Ropivacaine265.8

[back to top]

48h Peak Expiratory Flow (PEF) Score

Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point. (NCT02154763)
Timeframe: 48 hours post operatively

InterventionL/min (Mean)
Intraperitoneal Normal Saline285.3
Intraperitoneal Ropivacaine285.3

[back to top]

4h Peak Expiratory Flow (PEF) Score

Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point. (NCT02154763)
Timeframe: 4 hours post operatively

InterventionL/min (Mean)
Intraperitoneal Normal Saline251.9
Intraperitoneal Ropivacaine256.1

[back to top]

6 Minute Walking Distance Post Operative Day 1 (POD1)

6-Minute walk distance (6MWD)-Defined as the distance in (m) an individual is able to walk a long a flat 30 m walkway over six--minute period, with breaks as required. walk testing has been validated in the obese population, clinically significant differences occur when distances of at least 80m occur. 0 m would be the worst possible value for this outcome and the higher the number achieved in the six-minute duration the better (Better outcome) (NCT02154763)
Timeframe: Post operative day 1

InterventionMeters (Mean)
Intraperitoneal Normal Saline205.8
Intraperitoneal Ropivacaine182.4

[back to top]

6 Minute Walking Distance Post Operative Day 2 (POD2)

6-Minute walk distance (6MWD)-Defined as the distance in (m) an individual is able to walk a long a flat 30 m walkway over six--minute period, with breaks as required. walk testing has been validated in the obese population, clinically significant differences occur when distances of at least 80m occur. 0 m would be the worst possible value for this outcome and the higher the number achieved in the six-minute duration the better (Better outcome) (NCT02154763)
Timeframe: Post operative day 2

InterventionMeters (Mean)
Intraperitoneal Normal Saline260
Intraperitoneal Ropivacaine217.2

[back to top]

6 Minute Walking Distance Post Operative Day 7-10 (POD 7-10)

6-Minute walk distance (6MWD)-Defined as the distance in (m) an individual is able to walk a long a flat 30 m walkway over six--minute period, with breaks as required. walk testing has been validated in the obese population, clinically significant differences occur when distances of at least 80m occur. 0 m would be the worst possible value for this outcome and the higher the number achieved in the six-minute duration the better (Better outcome) (NCT02154763)
Timeframe: Post operative day 7-10 (Follow-up Clinic)

Interventionmeters (Mean)
Intraperitoneal Normal Saline373.3
Intraperitoneal Ropivacaine352.4

[back to top]

8-12 Hours Post Operative Pain Level

Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome). (NCT02154763)
Timeframe: 8-12 hours post operatively

Interventionunits on a scale (Mean)
Intraperitoneal Normal Saline3.7955
Intraperitoneal Ropivacaine3.9056

[back to top]

4-12 h Postoperative Tramadol Consumption

The amount in mg of Tramadol administered to patient (NCT02154763)
Timeframe: 4-12 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline81.1111
Intraperitoneal Ropivacaine85.8696

[back to top]

Postoperative Day 1 Quality of Recovery Questionnaire (QR-40)

"40-item questionnaire provides a global score(Minimum-score 40, Maximum-Score 200, Higher score represent better Quality of recovery of participant in both global and subscores) subscores(summed to total the global score) across five dimensions explained below, in all categories minimum score is 1, maximum score of 5 for each question.unit is scores on a scale for all questions.~Emotional_State:9 questions subscore can range between 9-45 Physical_Comfort:12 questions, subscore range between 12-60 Psychological Support:7 questions, subscore range between 7-35 Physical_Independence:5 questions, subscore range between 5-25 Pain:7 questions, subscore range between 5-25~Questionnaire has two parts A and B, In part A, a score of 1 represents the answer of None of the time (Poor)and 5 represents the answerAll of the time (Excellent)Part B, score of 1 represents the answerAll of the time (Excellent) and 5 representsNone of the time (Poor)" (NCT02154763)
Timeframe: Post operative day 1

InterventionScores on a scale (Mean)
Intraperitoneal Normal Saline163
Intraperitoneal Ropivacaine163.6

[back to top]

Postoperative Day 7-10 Quality of Recovery Questionnaire (QR-40)

"40-item questionnaire provides a global score(Minimum-score 40,Maximum-Score 200, Higher score represent better Quality of recovery of participant in both global and subscores) subscores(summed to total the global score) across five dimensions explained below, in all categories minimum score is 1,maximum score of 5 for each question.unit is scores on a scale for all questions.~Emotional_State:9 questions subscore can range between 9-45 Physical_Comfort:12 questions, subscore range between 12-60 Psychological Support:7 questions, subscore range between 7-35 Physical_Independence:5 questions, subscore range between 5-25 Pain:7 questions,subscore range between 5-25~Questionnaire has two parts A and B, In part A, a score of 1 represents the answer of None of the time (Poor)and 5 represents the answerAll of the time (Excellent)Part B, score of 1 represents the answerAll of the time (Excellent) and 5 representsNone of the time (Poor)" (NCT02154763)
Timeframe: Post operative day 7-10

InterventionScores on a scale (Mean)
Intraperitoneal Normal Saline183.5
Intraperitoneal Ropivacaine182.7

[back to top]

1-2 h Postoperative Tramadol Consumption

The amount in mg of Tramadol administered to patient (NCT02154763)
Timeframe: 1-2 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline9.4444
Intraperitoneal Ropivacaine8.6957

[back to top]

1-2 h Postoperative Pain Level

Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome). (NCT02154763)
Timeframe: 1-2 hours post operatively

Interventionunits on a scale (Mean)
Intraperitoneal Normal Saline3.5307
Intraperitoneal Ropivacaine3.6911

[back to top]

1-2 h Postoperative Ketorolac Consumption

The amount in mg of Ketorolac administered to patient (NCT02154763)
Timeframe: 1-2 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline2.3333
Intraperitoneal Ropivacaine2.3913

[back to top]

1-2 h Postoperative Fentanyl Consumption

The amount in mcg of Fentanyl administered to patient (NCT02154763)
Timeframe: 1-2 hours post operatively

Interventionmcg (Mean)
Intraperitoneal Normal Saline10
Intraperitoneal Ropivacaine7.6087

[back to top]

1-2 h Postoperative Dilaudid Consumption

The amount in mg of Dilaudid administered to patient (NCT02154763)
Timeframe: 1-2 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline291.1
Intraperitoneal Ropivacaine489.1

[back to top]

8h Peak Expiratory Flow (PEF) Score

Measured using the Mini Wright Peak flow meter with a range of 60-800 L/Min where 60 L/Min represents the worst possible score and 800 L/Min represents the best possible score. Value recorded is based on an average of 3 readings at every time point. (NCT02154763)
Timeframe: 8 hours post operatively

InterventionL/min (Mean)
Intraperitoneal Normal Saline250.9
Intraperitoneal Ropivacaine255.3

[back to top]

0-1 h Postoperative Tramadol Consumption

The amount in mg of Tramadol administered to patient (NCT02154763)
Timeframe: 0-1 h Postoperative Tramadol consumption

Interventionmg (Mean)
Intraperitoneal Normal Saline3.3333
Intraperitoneal Ropivacaine2.1739

[back to top]

0-1 h Postoperative Pain Level

Measured by the Numeric Pain Rating Scale (NRS) with a range of 0-10 where 0 represents No pain at all ( best outcome) and 10 represents Worst possible pain (worst outcome). (NCT02154763)
Timeframe: 0-1 hours post operatively

Interventionunits on a scale (Mean)
Intraperitoneal Normal Saline3.9762
Intraperitoneal Ropivacaine4.3149

[back to top]

0-1 h Postoperative Ketorolac Consumption

The amount in mg of Ketorolac administered to patient (NCT02154763)
Timeframe: 0-1 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline5
Intraperitoneal Ropivacaine6.413

[back to top]

0-1 h Postoperative Fentanyl Consumption

The amount in mcg of Fentanyl administered to patient (NCT02154763)
Timeframe: 0-1 hours post operatively

Interventionmcg (Mean)
Intraperitoneal Normal Saline45.5556
Intraperitoneal Ropivacaine42.9348

[back to top]

0-1 h Postoperative Dilaudid Consumption

The amount in mg of Dilaudid administered to patient (NCT02154763)
Timeframe: 0-1 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline1008.9
Intraperitoneal Ropivacaine925

[back to top]

0-1 h Postoperative Tylenol Consumption

The amount in mg of Tylenol administered to the patient (NCT02154763)
Timeframe: 0-1 hours post operatively

Interventionmg (Mean)
Intraperitoneal Normal Saline72.2222
Intraperitoneal Ropivacaine49.2391

[back to top]

Postoperative Static Pain Score

"To determine if post-operative static pain scores differ between women undergoing bilateral mastectomy followed by bilateral immediate tissue expander breast reconstruction randomized either to ropivacaine- (treatment) or saline- (placebo) pre-operatively placed paravertebral blocks.~Post-operative pain, pain medication/narcotic use, and assessment for adverse events (AEs)/serious adverse events (SAEs) will be assessed the Day of surgery through post-operative Day 7. A clinic visit occurs on Day 7 where additional data collected (updated medical history, pain medication/narcotic use, AEs/SAEs, and study questionnaires).~Static pain refers to pain when the patient is at rest. Patients report pain on a scale of 0-10 were in 0 represents no pain and 10 the most severe pain they have experienced." (NCT02161705)
Timeframe: Day of Surgery through Day 7

Interventionunits on a scale (Median)
Ropivacaine Group1.5
Saline Group1

[back to top]

Pain Scores

"Pain scores at rest and with activity using a verbal rating scales (VRS) of 0-10, where 0 represents no pain and 10 represents worst pain ever, at 30, 60, 90, 120 min and every 6 hours for 24 hours and every 12 hours for 48 hours and once a day thereafter until discharge. Data were collected at the indicated time points and an average pain score was calculated." (NCT02164929)
Timeframe: Participants will be followed for the duration of hospital stay, an estimated 1 week

InterventionUnits on a scale (Mean)
Paravertebral Block4.66
TAP Block2.66
Epidural1.75
No Block (PCA Alone)6

[back to top] [back to top]

Length of Stay

(NCT02164929)
Timeframe: Participants will be followed for the duration of hospital stay, an estimated 1 week

InterventionDays (Mean)
Paravertebral Block2.66
TAP Block4.33
Epidural4
No Block (PCA Alone)3.5

[back to top]

Time to First Ingestion of Solid Food

(NCT02164929)
Timeframe: Participants will be followed for the duration of hospital stay, an estimated 1 week

InterventionDays (Mean)
Paravertebral Block1
TAP Block2
Epidural0.75
No Block (PCA Alone)1.5

[back to top]

Time to First Bowel Movement

(NCT02164929)
Timeframe: Participants will be followed for the duration of hospital stay, an estimated 1 week

Interventiondays (Mean)
Paravertebral Block1
TAP Block2
Epidural1
No Block (PCA Alone)2

[back to top]

Quality of Recovery

Quality of Recovery Score (QoR-15) is measured on a scale of 0-150 (0=poor, 150 = excellent). Scores were collected daily for 72 hours and then averaged. (NCT02164929)
Timeframe: 72 hours

InterventionUnits on a scale (Mean)
Paravertebral Block89.5
TAP Block117
Epidural115.5
No Block (PCA Alone)99

[back to top]

Postoperative Opioid Consumption

If opioid other than fentanyl is used, the dose will be converted to morphine equivalent. (NCT02164929)
Timeframe: 24 hours after surgery

Interventionmcg (Mean)
Paravertebral Block734
TAP Block666
Epidural125
No Block (PCA Alone)1017.5

[back to top] [back to top]

Percentage Change in Forced Expired Volume in First Second (FEV1) After the Block

FEV1 was measured within 30 minutes of arrival to PACU. The outcomes represent the percentage change from the preoperative value to the value measured in PACU (Post-Anesthesia Care Unit). The negative value represents the decrease in the FEV1 value. (NCT02181296)
Timeframe: within 30 minutes from arrival to PACU

InterventionPercentage of change of FEV1 (Median)
High Concentration Group-28
Lower Concentration Group-20

[back to top]

Percentage Change of Forced Vital Capacity (FVC) From Pre-block Value to Value Measures in PACU

The percentage change in the FVC from preblock value to values measured in PACU. The negative value represents the decrease in the FVC value. (NCT02181296)
Timeframe: within 30 minutes from arrival to PACU

Interventionpercentage of change in FVC (Median)
High Concentration Group-33.4
Lower Concentration Group-22

[back to top]

Number of Patients With Paradoxical Diaphragmatic Movement

The primary outcome variable is the number of patients with paradoxical diaphragmatic movement ( as an indication for phrenic nerve blockade) as assessed by ultrasonographic evaluation of diaphragm (NCT02181296)
Timeframe: 30 minutes after the block

InterventionParticipants (Count of Participants)
High Concentration Group16
Lower Concentration Group8

[back to top]

Opioid Requirements for 72 Hours After Surgery

in the milligram equivalent of codeine, using web-based opioid dose converter (NCT02181296)
Timeframe: 72 hours

Interventionmilligrams (Median)
High Concentration Group55
Lower Concentration Group102

[back to top]

Average Postoperative Numeric Rating Scale (NRS) for Pain

"The primary outcome parameters of this study were average pain and peak pain level on the verbal numeric rating scale (NRS; 1-10, higher numbers indicating increasing pain level) during the first 48 hours after surgery. NRS scores for pain were assessed by members of the nursing staff every 4 hours for 48 hours after the procedure (until discharge). Patients were instructed to rate their pain level on a scale from 0 to 10, with 0 meaning no pain and 10 indicating pain as bad as it could be. Average postoperative numeric rating scale (NRS) for pain was calculated for each group (Placebo, Ropivacaine) by adding all postoperative NRS scores of all patients in each group (Placebo, Ropivacaine) to obtain the mean postoperative NRS score." (NCT02182999)
Timeframe: First 48 postoperative hours

Interventionunits on a scale (Mean)
NaCl 0,9%2.0
Ropivacaine1.9

[back to top]

Peak Postoperative Numeric Rating Scale (NRS) for Pain

"The primary outcome parameters of this study were average pain and peak pain level on the verbal numeric rating scale (NRS; 1-10, higher numbers indicating increasing pain level) during the first 48 hours after surgery. NRS scores for pain were assessed by members of the nursing staff every 4 hours for 48 hours after the procedure (until discharge). Patients were instructed to rate their pain level on a scale from 0 to 10, with 0 meaning no pain and 10 indicating pain as bad as it could be. Peak postoperative numeric rating scale (NRS) for pain was calculated for each group (Placebo, Ropivacaine) by adding the highest recorded NRS score for pain of all patients in each group (Placebo, Ropivacaine) to obtain the mean peak postoperative NRS score." (NCT02182999)
Timeframe: First 48 postoperative hours

Interventionunits on a scale (Mean)
NaCl 0,9%3.9
Ropivacaine3.5

[back to top]

American Orthopaedic Foot and Ankle Society Score (AOFAS)

The American Orthopedic Foot and Ankle Society Score (AOFAS-Score, Forefoot Version) is comprised of nine questions and coveres three categories: Pain (40 points), function (50 points) and alignment (10 points). These are all scored together for a total of 100 points. The scale ranges from 0 to 100, with higher values representing a better outcome. (NCT02182999)
Timeframe: 6 weeks

Interventionunits on a scale (Mean)
NaCl 0,9%75.8
Ropivacaine75.7

[back to top]

Patient's Overall Satisfaction With Surgery

Patient satisfaction with surgery was investigated on a numeric rating scale (NRS; scale 0-10) as part of routine examination 6 weeks after the procedure. Higher numbers indicate higher patients satisfaction. (NCT02182999)
Timeframe: 6 weeks

Interventionunits on a scale (Mean)
NaCl 0,9%9.1
Ropivacaine9.0

[back to top]

Patient's Overall Satisfaction With Pain Management

Patient satisfaction with pain management was investigated on a numeric rating scale (NRS; scale 0-10) as part of routine examination 6 weeks after the procedure. Higher numbers indicate higher patients satisfaction. (NCT02182999)
Timeframe: 6 weeks

Interventionunits on a scale (Mean)
NaCl 0,9%9.3
Ropivacaine9.0

[back to top]

Time to Post-operative Rescue Opioids (Hours)

(NCT02197273)
Timeframe: Immediately following discharge from operating room until the participant was discharged from the hospital, an expected average of 3 days

Interventionhours (Median)
Standard of Care Analgesia7.7
Liposomal Bupivacaine11.8

[back to top]

Readmission or Emergency Department (ED) Visit Due to Pain Control Within 30 Days

(NCT02197273)
Timeframe: Date of discharge through 30 days following discharge

Interventionparticipants (Number)
Standard of Care Analgesia2
Liposomal Bupivacaine4

[back to top]

Length of Stay in Hospital (Days)

(NCT02197273)
Timeframe: Participants were followed for the duration of hospital stay, an expected average of 3 days

Interventiondays (Median)
Standard of Care Analgesia2.0
Liposomal Bupivacaine2.0

[back to top]

Onset of Sensory Block at T10

level of sensory block was assessed every 5 minutes till the loss of sensation to pinprick, using 22-guage hypodermic needle with 2mm protrusion through guard. Assessments continued at 30 min intervals following the completion of surgery until normal sensation returned. (NCT02201784)
Timeframe: 30 minutes

Interventionminutes (Mean)
Levobupivacaine 0.5%13.50
Ropivacaine 0.75%7.33

[back to top]

Duration of Motor Block

Time when the Bromage score will be back to zero (NCT02201784)
Timeframe: 8 hours

Interventionminutes (Mean)
Levobupivacaine 0.5%290.50
Ropivacaine 0.75%222.50

[back to top]

Duration of Analgesia

Defined as time for first analgesic request by the patient (NCT02201784)
Timeframe: 8 hours

Interventionminutes (Mean)
Levobupivacaine 0.5%309.83
Ropivacaine 0.75%249.50

[back to top]

Onset of Motor Block to Bromage3

Motor block in the lower limbs was graded according to the modified Bromage scale (Grade 0 = No motor block, Grade 1 = Inability to raise extended leg, able to move knees and feet, Grade 2 = Inability to raise extended leg and move knee, able to move feet, Grade 3 = Complete motor block of the lower limbs). Thereafter, It was performed every 5 minutes till the attainment of MB grade 3 followed by every 30 minutes until complete recovery (MB grade0). (NCT02201784)
Timeframe: 8 hours

Interventionminutes (Mean)
Levobupivacaine 0.5%12.17
Ropivacaine 0.75%7.83

[back to top]

Time to Maximum Cephalic Spread of Sensory Block

(NCT02201784)
Timeframe: 8 hours

Interventionminutes (Mean)
Levobupivacaine 0.5%20.33
Ropivacaine 0.75%13.17

[back to top]

Balance Testing on Operative Leg Using Unipedal Stance Time

In order to measure clinical balance, unipedal stance time (UST) was collected as an indicator of balance and fall risk. Timing (in seconds) began upon withdrawal of support and continued until the uplifted foot returned to the floor, the subject required support, or if the subject reached a time limit of 30 seconds. The best performance of three repetitions was recorded for analysis. Normative values for the UST are available. A UST threshold of 30 seconds yields a sensitivity of 95% and a specificity of 58% in identifying those with a history of falls. The first five seconds of unipedal stance is indicative of dynamic balance; inability to maintain unipedal stance for five seconds is a significant predictor of injurious falls. (NCT02223364)
Timeframe: baseline, approximately 12 weeks

,,
Interventionseconds (Median)
baseline12 weeks
Liposomal Bupivacaine (PAI-L)1723
Peripheral Nerve Block (PNB)2420
Ropivacaine (PAI-R)1630

[back to top]

POD 2 Opioid Use

Additional opioid medications that were taken by subjects (recorded at the same time as the time points for measuring pain). Opioid consumption was documented in the patient electronic medical record by the nursing staff caring for the patient. (NCT02223364)
Timeframe: POD 2, approximately 12 am to 12 am next day

Interventionmg OME (Median)
Peripheral Nerve Block (PNB)23
Ropivacaine (PAI-R)15
Liposomal Bupivacaine (PAI-L)23

[back to top]

POD 1 Opioid Use

Additional opioid medications that were taken by subjects (recorded at the same time as the time points for measuring pain). Opioid consumption was documented in the patient electronic medical record by the nursing staff caring for the patient. (NCT02223364)
Timeframe: POD 1, approximately 12 am to 12 am next day

Interventionmg OME (Median)
Peripheral Nerve Block (PNB)26
Ropivacaine (PAI-R)38
Liposomal Bupivacaine (PAI-L)45

[back to top]

POD 0 Post-PACU Opioid Use

Additional opioid medications that were taken by subjects (recorded at the same time as the time points for measuring pain). Opioid consumption was documented in the patient electronic medical record by the nursing staff caring for the patient. (NCT02223364)
Timeframe: POD 0, approximately 12 pm to 12 am

Interventionmg OME (Median)
Peripheral Nerve Block (PNB)0
Ropivacaine (PAI-R)8
Liposomal Bupivacaine (PAI-L)15

[back to top]

PACU Opioid Use

Opioid consumption was documented in the patient electronic medical record by the nursing staff caring for the patient. (NCT02223364)
Timeframe: Approximately 2 hours after entry in PACU

Interventionmg OME (Median)
Peripheral Nerve Block (PNB)0
Ropivacaine (PAI-R)0
Liposomal Bupivacaine (PAI-L)0

[back to top]

Maximum Pain Post-PACU

Pain was measured on a 1-10 numeric pain rating scale (NRS) with 0=no pain, and 10=worst pain imaginable. (NCT02223364)
Timeframe: Post-operative Day 0, approximately 12 pm to 12 am

Interventionunits on a scale (Median)
Peripheral Nerve Block (PNB)1
Ropivacaine (PAI-R)4
Liposomal Bupivacaine (PAI-L)5

[back to top]

Maximum Pain POD 2 (24 Hours)

Pain was measured on a 1-10 numeric pain rating scale (NRS) with 0=no pain, and 10=worst pain imaginable. (NCT02223364)
Timeframe: POD 2, approximately 12 am to 12 am next day

Interventionunits on a scale (Median)
Peripheral Nerve Block (PNB)5
Ropivacaine (PAI-R)6
Liposomal Bupivacaine (PAI-L)6

[back to top]

Maximum Pain POD 1 (24 Hours)

Pain was measured on a 1-10 numeric pain rating scale (NRS) with 0=no pain, and 10=worst pain imaginable. (NCT02223364)
Timeframe: POD 1, approximately 12 am to 12 am next day

Interventionunits on a scale (Median)
Peripheral Nerve Block (PNB)5.5
Ropivacaine (PAI-R)6
Liposomal Bupivacaine (PAI-L)6

[back to top]

Intraoperative Opioid Use

Opioid consumption was documented in the patient electronic medical record by the nursing staff caring for the patient. (NCT02223364)
Timeframe: During the procedure, approximately 2 hours after start of the procedure

Interventionmg OME (Median)
Peripheral Nerve Block (PNB)10
Ropivacaine (PAI-R)10
Liposomal Bupivacaine (PAI-L)10

[back to top]

Hospital Length of Stay

The hospital length of stay was measured from the date of admittance until the date of discharge. (NCT02223364)
Timeframe: Approximately 3 days

Interventiondays (Median)
Peripheral Nerve Block (PNB)2
Ropivacaine (PAI-R)2
Liposomal Bupivacaine (PAI-L)2

[back to top]

Average Pain Post-Postanesthesia Care Unit (PACU)

Pain was measured on a 1-10 numeric pain rating scale (NRS) with 0=no pain, and 10=worst pain imaginable. (NCT02223364)
Timeframe: Post-operative Day 0, approximately 12 pm to 12 am

Interventionunits on a scale (Median)
Peripheral Nerve Block (PNB)0.6
Ropivacaine (PAI-R)1.7
Liposomal Bupivacaine (PAI-L)2.4

[back to top]

Average Pain POD 2 (24 Hours)

Pain was measured on a 1-10 numeric pain rating scale (NRS) with 0=no pain, and 10=worst pain imaginable. (NCT02223364)
Timeframe: POD 2, approximately 12 am to 12 am next day

Interventionunits on a scale (Median)
Peripheral Nerve Block (PNB)3.3
Ropivacaine (PAI-R)3.2
Liposomal Bupivacaine (PAI-L)3.5

[back to top]

Preoperative Daily Opioid Use

Opioid consumption will be documented in the patient electronic medical record by the nursing staff caring for the patient. (NCT02223364)
Timeframe: baseline

Interventionmg oral morphine equivalents (OME) (Median)
Peripheral Nerve Block (PNB)15
Ropivacaine (PAI-R)15
Liposomal Bupivacaine (PAI-L)15

[back to top]

Average Pain POD 1 (24 Hours)

Pain was measured on a 1-10 numeric pain rating scale (NRS) with 0=no pain, and 10=worst pain imaginable. (NCT02223364)
Timeframe: POD 1, approximately 12 am to 12 am next day

Interventionunits on a scale (Median)
Peripheral Nerve Block (PNB)2.5
Ropivacaine (PAI-R)3.5
Liposomal Bupivacaine (PAI-L)3.7

[back to top]

Maximum Pain Post-Operative Day (POD) 1 (Morning)

Pain was measured on a 1-10 numeric pain rating scale (NRS) with 0=no pain, and 10=worst pain imaginable. (NCT02223364)
Timeframe: Post-Operative Day 1, approximately 6 am to 12:00 pm

Interventionunits on a scale (Median)
Peripheral Nerve Block (PNB)3
Ropivacaine (PAI-R)4
Liposomal Bupivacaine (PAI-L)4.5

[back to top]

Patient/Family Satisfaction With Pain Management

Patient/family satisfaction on a scale of 1 to 10 with 1 least satisfied and 10 completely satisfied. Family will complete the form and return to the primary investigator at the end of day 8 after surgery in the prepaid envelope provided to them at the time of the surgery. (NCT02236130)
Timeframe: one week after the surgery

InterventionParticipants (Count of Participants)
General10
Regional11

[back to top]

Total Hydrocodone Dose (mg/kg)

(NCT02236130)
Timeframe: day 2 and day 8 after the surgery

,
Interventionmg/kg (Mean)
Day 2 Total hydrocodone use in mg/kgDay 8 Total hydrocodone use in mg/kg
General1.221.45
Regional1.362.15

[back to top]

Total Opioid Consumption During Hospitalization

Measured in daily oral morphine equivalents (OME) (NCT02242201)
Timeframe: Preoperative, Intraoperative, Postanesthesia Care Unit (PACU), Post Operative Day (POD) 0, day 1, and day 2

,,
InterventionOral morphine equivalent in milligrams (Median)
PreoperativeIntraoperativePostanesthesia Care Unit (PACU)Post Operative Day (POD) 0 post PACUPOD 1POD 2
PAI Liposomal Bupivacaine1510011.31511.3
PAI Ropivacaine151001533.815
PNB Bupivacaine151007.522.515

[back to top]

Change in Short Form-36 (SF-36) Quality of Life Physical Component

Scores on the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36). Subjects completed the SF-36 which consists of 8 sub-scales ranging from 0 to 100, with (0 = worst imaginable, 100 = best imaginable). (NCT02242201)
Timeframe: Baseline, 3 months

Interventionunits on a scale (Mean)
PNB Bupivacaine12.5
PAI Ropivacaine12.6
PAI Liposomal Bupivacaine12.3

[back to top]

Post-Operative Pain Score

Pain intensity (NRS) assessment at 3 month follow-up. Pain was measured on an ascending numeric rating scale (NRS) from 0-10 where 1-3 equaled mild pain, 4-6 equaled moderate pain, 7-9 equaled severe pain, and 10 equaled worst possible pain. (NCT02242201)
Timeframe: 3 month follow-up

,,
Interventionunits on a scale (Median)
Pain at restPain with movement
PAI Liposomal Bupivacaine01
PAI Ropivacaine01
PNB Bupivacaine00

[back to top]

Change in Short Form-36 (SF-36) Quality of Life Mental Component

Scores on the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36). Subjects completed the SF-36 which consists of 8 sub-scales ranging from 0 to 100, with (0 = worst imaginable, 100 = best imaginable). (NCT02242201)
Timeframe: Baseline, 3 months

Interventionunits on a scale (Mean)
PNB Bupivacaine2.2
PAI Ropivacaine2.6
PAI Liposomal Bupivacaine3.0

[back to top]

Hospital Length of Stay

Discharge readiness was evaluated by the surgical team during morning and afternoon physical therapy sessions. (NCT02242201)
Timeframe: Post-operative Day 1 through discharge (approximately 3 days)

Interventiondays (Median)
PNB Bupivacaine2
PAI Ropivacaine2
PAI Liposomal Bupivacaine2

[back to top]

Number of Participants Reporting Complications Since Surgery

Complications were collected by telephone interview after surgery. (NCT02242201)
Timeframe: Post-operative Day 1 Through 3 - Month Follow-up

,,
InterventionParticipants (Count of Participants)
Operative extremity neurologic changesWound infectionFall requiring medical attention
PAI Liposomal Bupivacaine211
PAI Ropivacaine112
PNB Bupivacaine101

[back to top]

Number of Participants Reporting a NRS Pain Score Greater Than 3

Pain was measured on an ascending numeric rating scale (NRS) from 0-10 where 1-3 equaled mild pain, 4-6 equaled moderate pain, 7-9 equaled severe pain, and 10 equaled worst possible pain. (NCT02242201)
Timeframe: 3 month follow up

,,
InterventionParticipants (Count of Participants)
Pain at restPain with movement
PAI Liposomal Bupivacaine12
PAI Ropivacaine14
PNB Bupivacaine00

[back to top]

Change in Unipedal Stance Time

Length of time in seconds a patient could stand on involved leg (NCT02242201)
Timeframe: Baseline, 3 months

,,
Interventionseconds (Median)
Baseline3 months
PAI Liposomal Bupivacaine3030
PAI Ropivacaine3030
PNB Bupivacaine24.530

[back to top]

Maximum Postoperative Pain Score

Pain was measured on an ascending numeric rating scale (NRS) from 0-10 where 1-3 equaled mild pain, 4-6 equaled moderate pain, 7-9 equaled severe pain, and 10 equaled worst possible pain. (NCT02242201)
Timeframe: Post-Operative Day 1 (0600-1200)

Interventionunits on a scale (Median)
PNB Bupivacaine3.0
PAI Ropivacaine4.0
PAI Liposomal Bupivacaine3.0

[back to top]

Morphine Consumption

Morphine consumption with PCAIV (NCT02264821)
Timeframe: 30 hours after spinal injection T0

Interventionmilligrammes (Median)
Ropivacaine Infiltration8
Rachi Morphine4
Placebo20.5

[back to top]

Duration of Effective Analgesia

T0 until first request of morphine PCAIV (NCT02264821)
Timeframe: 30 hours after spinal injection T0

Interventionminutes (Median)
Ropivacaine Infiltration351
Rachi Morphine380
Placebo247

[back to top]

Number of Patients With Serious Adverse Reactions From Superior Hypogastric Nerve Block

Number of patients with Grade C/D/E/F adverse events (Society of Interventional Radiology (SIR) Classification). Per Society of Interventional Radiology (SIR) Classification: Grade C, require therapy, brief hospitalization (<48 hours); Grade D, require major therapy, unplanned increased level of care, prolonged hospitalization (>48 hours); Grade E, permanent adverse sequelae; Grade F, death. (NCT02270255)
Timeframe: 10 days

InterventionParticipants (Count of Participants)
Control Group0
Sup Hypogastric Nerve Block Group0

[back to top]

mg Equivalent Morphine Used Until Discharge From Recovery Room to Control Pain Level Below 4/10 (VAS)

mg equivalent morphine used until discharge from recovery room to maintain pain level below 4/10 (visual analog scale 0/10=no pain to 10/10=worse pain the patient could imagine) (NCT02270255)
Timeframe: 6 hrs (from time of end of UFE to time of discharge from recovery room)

Interventionmg (Mean)
Control Group11
Sup Hypogastric Nerve Block Group5.1

[back to top]

Postoperative Pain on a Visual Analogue Pain Scale at One Hour Postoperatively

A Visual Analogue Scale was used. The scale range was 0 to 10 in increments of one. 0 was no pain and 10 was worst pain possible. (NCT02314104)
Timeframe: one hour postoperatively

Interventionunits on a scale (Mean)
Treatment TAP, Placebo Local Injection4.04
Placebo TAP, Treatment Local Injection5.09
Treatment TAP, Treatment Local Injection4.4

[back to top]

Postoperative Pain on a Visual Analogue Pain Scale at Six Hours Postoperatively

A Visual Analogue Scale was used. The scale range was 0 to 10 in increments of one. 0 was no pain and 10 was worst pain possible. (NCT02314104)
Timeframe: six hours postoperatively

Interventionunits on a scale (Mean)
Treatment TAP, Placebo Local Injection3.53
Placebo TAP, Treatment Local Injection3.5
Treatment TAP, Treatment Local Injection3.33

[back to top]

Postoperative Pain on a Visual Analogue Pain Scale at Twenty-four Hours Postoperatively

A Visual Analogue Scale was used. The scale range was 0 to 10 in increments of one. 0 was no pain and 10 was worst pain possible. (NCT02314104)
Timeframe: twenty-four hours postoperatively

Interventionunits on a scale (Mean)
Treatment TAP, Placebo Local Injection3.36
Placebo TAP, Treatment Local Injection3.56
Treatment TAP, Treatment Local Injection3.51

[back to top]

Time Until First Request for Pain Medication

(NCT02314104)
Timeframe: up to twenty-four hours postoperatively

Interventionminutes (Median)
Treatment TAP, Placebo Local Injection46
Placebo TAP, Treatment Local Injection31
Treatment TAP, Treatment Local Injection28

[back to top]

Total Narcotic Usage in Morphine Equivalents

(NCT02314104)
Timeframe: up to twenty-four hours postoperatively

Interventionmg (Mean)
Treatment TAP, Placebo Local Injection20.09
Placebo TAP, Treatment Local Injection23.14
Treatment TAP, Treatment Local Injection20.68

[back to top]

Amount (ml) of Local Anesthetic Supplemented by Surgeon

(NCT02336958)
Timeframe: during the intraoperative period

Interventionml (Mean)
Ropivacaine4.9
Saline3.7

[back to top]

Number of Patients With Required Supplementation of Local Anesthetic by Surgeon

(NCT02336958)
Timeframe: during the intraoperative period

Interventionparticipants (Number)
Ropivacaine13
Saline13

[back to top]

PACU Length of Stay (LOS)

duration of time spent in the post-anesthesia care unit (PACU) from arrival to discharge (NCT02341144)
Timeframe: from entry in post-anesthesia care unit (PACU) until discharge, estimated 1-2 hours

Interventionminutes (Median)
Pre-op Percutaneous Rectus Sheath Block76
Intra-operative Rectus Sheath Block80

[back to top]

PACU Morphine Equivalents

morphine equivalents received in PACU (NCT02341144)
Timeframe: from entry in post-anesthesia care unit (PACU) until discharge, estimated 1-2 hours

Interventionmg/kg (Median)
Pre-op Percutaneous Rectus Sheath Block0.04
Intra-operative Rectus Sheath Block0.09

[back to top]

Time to First Narcotic

duration until patient received first dose of narcotic in PACU (NCT02341144)
Timeframe: from entry in post-anesthesia care unit (PACU) to first narcotic

Interventionminutes (Median)
Pre-op Percutaneous Rectus Sheath Block30
Intra-operative Rectus Sheath Block22

[back to top]

Pain Score of Zero

"proportion who reported a score of zero throughout their PACU stay using the Wong-Baker (WB) scale with zero being no pain" (NCT02341144)
Timeframe: from entry in the post-anesthesia care unit (PACU) until discharge, estimated 1-2 hours

InterventionParticipants (Count of Participants)
Pre-op Percutaneous Rectus Sheath Block5
Intra-operative Rectus Sheath Block3

[back to top]

Post Operative Pain Rating

Using the Wong-Baker FACES Pain Rating Scale (WBFPRS)- pain scores range from zero (no pain) to ten (worst pain) and the average score was reported (NCT02341144)
Timeframe: from entry in post-anesthesia care unit (PACU) until discharge, estimated 1-2 hours

Interventionunits on a scale (Mean)
Pre-op Percutaneous Rectus Sheath Block2.6
Intra-operative Rectus Sheath Block3.3

[back to top]

Neurological Symptoms

Number of patients with Neurological Symptoms (e.g. paraesthesia, motor function problems and pain at the injection site) (NCT02385097)
Timeframe: from surgery day to day 6 +/- 1 after surgery

,
InterventionParticipants (Count of Participants)
burning : dischargeburning : day 7tingling : dischargetingling : day 7Pins and needles sensation : dischargePins and needles sensation : day 7Pricking : dischargePricking : day 7aching : dischargeaching : day 7numbness : dischargenumbness : day 7hypoesthesia : dischargehypoesthesia : day 7Pain surgery site : dischargePain surgery site : day 7diffuse hair loss : dischargediffuse hair loss : day 7headache : dischargeheadache : day 7itching : dischargeitching : day 7
Chloroprocaine HCl 2% (20 mg/mL)86851280104225500000200
Ropivacaine 0.75% (7.5 mg/mL)1425650506327314510010001

[back to top]

Time to Regression of Motor Block

Will be deemed to have occurred when motor score is ≥ 3 (Modified Bromage scale) in any nerve territory (Modified Bromage scale: 0-No movement in relevant muscle group,1-Flicker of movement in relevant muscle group,2-Ability to move relevant muscle group against gravity but inability to move against resistance,3-Reduced power but ability to move muscle group against resistance,4-Full power in relevant muscle group) (NCT02385097)
Timeframe: Up to 12 hrs after surgery

Interventionminutes (Median)
Chloroprocaine HCl 2% (20 mg/mL)65
Ropivacaine 0.75% (7.5 mg/mL)415

[back to top]

Time to Regression of Sensory Block

Will be deemed to have occurred when cold sensation and sensitive perception have returned (if assessable) in any nerve territory (NCT02385097)
Timeframe: Up to 12 hrs after surgery

Interventionminutes (Median)
Chloroprocaine HCl 2% (20 mg/mL)68
Ropivacaine 0.75% (7.5 mg/mL)451

[back to top]

Blood Pressure

"The following normal ranges Systolic and Diastolic Blood Pressure parameters will be used:~Systolic Blood Pressure: 100-139 mmHg Diastolic Blood Pressure: 50-89 mmHg" (NCT02385097)
Timeframe: from surgery day to 24 hrs post surgery

,
InterventionmmHg (Mean)
Systolic Blood Pressure at screeningSystolic Blood Pressure at baselineSystolic Blood Pressure at dischargeDiastolic Blood Pressure at screeningDiastolic Blood Pressure at baselineDiastolic Blood Pressure at discharge
Chloroprocaine HCl 2% (20 mg/mL)137136.6130.580.878.274.4
Ropivacaine 0.75% (7.5 mg/mL)136.2138130.180.580.175.4

[back to top]

Heart Rate

"The following normal ranges Heart Rate parameters will be used:~50-90 beats/min" (NCT02385097)
Timeframe: from surgery day to 24 hrs post surgery

,
Interventionbeats/minutes (Mean)
screeningbaselinedischarge
Chloroprocaine HCl 2% (20 mg/mL)7372.571.5
Ropivacaine 0.75% (7.5 mg/mL)73.671.673

[back to top]

SpO2

"The following normal ranges SpO2 parameters will be used:~Peripheral Oxygen Saturation: ≥ 95%" (NCT02385097)
Timeframe: from surgery day to 24 hrs post surgery

,
Interventionpercentage of SpO2 (Mean)
baselinedischarge
Chloroprocaine HCl 2% (20 mg/mL)97.0597.47
Ropivacaine 0.75% (7.5 mg/mL)97.3697.61

[back to top]

Time to Onset of Motor Block

Time period from completion of the final perineural injection (time 0 h) to achievement of motor block (NCT02385097)
Timeframe: Up to 1 h after last perineural injection

Interventionminutes (Median)
Chloroprocaine HCl 2% (20 mg/mL)10
Ropivacaine 0.75% (7.5 mg/mL)10

[back to top]

Percentage of Participants With Successful Block for Distal Upper Limb Surgeries

Percentage of patients with a successful block for distal upper limb surgeries, without any supplementation in the first 45 min, calculated from the time of readiness for surgery (complete sensory block). (NCT02385097)
Timeframe: 45 min from the time of readiness of surgery

InterventionParticipants (Count of Participants)
Chloroprocaine HCl 2% (20 mg/mL)96
Ropivacaine 0.75% (7.5 mg/mL)97

[back to top]

Partecipants Received Rescue Anaesthesia or Rescue Analgesia

partecipants received rescue anaesthesia or rescue analgesia from completion of the final perineural injection (time 0 hour) to administration of first rescue anaesthesia or analgesia (supplementation) (NCT02385097)
Timeframe: 45 min from the time of readiness of surgery

InterventionParticipants (Count of Participants)
Chloroprocaine HCl 2% (20 mg/mL)9
Ropivacaine 0.75% (7.5 mg/mL)7

[back to top]

Number of Subjects Who Received Post-operative Analgesia

Number of subjects who received the first post-operative analgesia (NCT02385097)
Timeframe: From surgery day to 24 hrs post surgery

InterventionParticipants (Count of Participants)
Chloroprocaine HCl 2% (20 mg/mL)49
Ropivacaine 0.75% (7.5 mg/mL)46

[back to top]

Number of Participants With Normal Electrocardiogram (ECG) Parameters

"Number of Participants with Normal Electrocardiogram (ECG) Parameters. The following normal ranges ECG parameters will be used:~Heart Rate: 50-90 beats/min PR Interval: 100-220 msec QRS Duration: ≤ 120 msec QT Interval: ≤ 500 msec" (NCT02385097)
Timeframe: from surgery day to 24 hrs post surgery

InterventionParticipants (Count of Participants)
Chloroprocaine HCl 2% (20 mg/mL)105
Ropivacaine 0.75% (7.5 mg/mL)104

[back to top]

Number of Participants With Treatment-emergent Adverse Events (TEAEs)

Number of Participants with Treatment-emergent Adverse Events (TEAEs) occurring or worsening after the first dose of IMP (NCT02385097)
Timeframe: from surgery day to day 6 +/- 1 after surgery

InterventionParticipants (Count of Participants)
Chloroprocaine HCl 2% (20 mg/mL)58
Ropivacaine 0.75% (7.5 mg/mL)76

[back to top]

Time to Onset of Sensory Block (Corresponding to Readiness for Surgery)

Time period from completion of the final perineural injection (time 0 h) to achievement of sensory block in the 4 nerve territories (NCT02385097)
Timeframe: Up to 1 h after last perineural injection

Interventionminutes (Median)
Chloroprocaine HCl 2% (20 mg/mL)10
Ropivacaine 0.75% (7.5 mg/mL)15

[back to top]

Time to Eligibility for Home Discharge

Time from completion of the final perineural injection (time 0 h) to the time when the criteria for discharge are met, even if, according to the hospital procedures, the patient is discharged from the hospital at a later time (NCT02385097)
Timeframe: from surgery day to 24h post surgery

Interventionminutes (Median)
Chloroprocaine HCl 2% (20 mg/mL)161
Ropivacaine 0.75% (7.5 mg/mL)355.5

[back to top]

Duration of Analgesia

(NCT02393677)
Timeframe: upto 8 hours

Interventionminutes (Mean)
Ropivacaine413.73
Ropivacaine With Dexmedetomidine197.35

[back to top]

Patient Satisfaction (SAT) Score

The SAT score was also from 0 to 10, where 0 indicated unsatisfactory and 10 indicated very satisfactory. (NCT02424630)
Timeframe: 1, 3, 6, 12, 18, 24, 36, 48h

,
Interventionunits on a scale (Mean)
1h3h6h12h18h24h36h48h
ISB Alone7.27.36.04.35.15.97.18.2
ISB With SSNB7.97.87.86.26.46.97.98.5

[back to top]

Visual Analog Scale (VAS) Pain Score

The VAS pain score was based on a scale from 0 to 10, where 0 indicated no pain and 10 indicated severe pain (NCT02424630)
Timeframe: 1, 3, 6, 12, 18, 24, 36, 48h

,
Interventionunits on a scale (Mean)
1h3h6h12h18h24h36h48h
ISB Alone2.62.64.05.85.24.22.72.0
ISB With SSNB2.01.71.63.53.63.22.11.3

[back to top]

Complications Rate

The investigators expect no difference in incidence of complications (e.g. oversedation, hypotension, bradycardia episodes, etc.). (NCT02439281)
Timeframe: until study completion

InterventionParticipants (Count of Participants)
Ropivacaine/ Clonidine Group1
Ropivacaine Group1

[back to top]

Duration of Analgesia at Umbilicus Instrument Site-How Many Minutes Passed From the Time When the Blocks Where Performed Until Patient Reported Pain at Umbilicus

The investigators hypothesize that rectus sheath injections with ropivacaine/ clonidine would result in longer duration of analgesia and decreased pain scores compared to ropivacaine alone. (NCT02439281)
Timeframe: indicated by the first request for pain medication at umbilicus site

Interventionminutes (Median)
Ropivacaine/ Clonidine Group230
Ropivacaine Group240

[back to top]

Duration of Sensory Block (Paresthesia)

The investigators hypothesize that rectus sheath injections with ropivacaine and clonidine result in longer duration of sensory block (paresthesia) compared to ropivacaine alone. (NCT02439281)
Timeframe: Indicated by return of normal sensation (expected average of 12 hours after block placement).

Interventionminutes (Median)
Ropivacaine/ Clonidine Group823.5
Ropivacaine Group540

[back to top]

Medication Consumption

Total intravenous morphine equivalents mg/kg (NCT02439281)
Timeframe: 18 hours after surgery

Interventionmg/kg (Median)
Ropivacaine/ Clonidine Group0.20
Ropivacaine Group0.22

[back to top]

Satisfaction With Pain Control From Patient

The investigators hypothesize that rectus sheath injections with ropivacaine/ clonidine would result in better satisfaction with pain control. (NCT02439281)
Timeframe: Prior to hospital discharge (up to 24 hours after surgery)

Interventionunits on a scale (Median)
Ropivacaine/ Clonidine Group9
Ropivacaine Group9

[back to top]

Average Pain Severity at the Umbilicus Laparoscopic Site

Numeric Rating Pain Scores ( 0-10), will be obtained every 2 hours after PACU discharge up to 18 hours or until hospital discharge, whichever occurs first. The pain score of 0, means no pain, is a good outcome , and a pain score of 10 is excruciating pain, a very bad outcome. The average of these scores will be evaluated.The pain scores will not longer be documented after the numbness went away. (NCT02439281)
Timeframe: Logistic regression of the 4 th pain score assessment

Interventionunits on a scale (Median)
Ropivacaine Group2
Ropivacaine/ Clonidine Group1.5

[back to top]

Change in Anxiety Scores

The investigators hypothesize that patient postoperative anxiety scores are lower in the Ropivacaine/Clonidine group and postoperative anxiety scores decrease more in Ropivacaine /Clonidine Group, than in Ropivacaine Group. (NCT02439281)
Timeframe: 6 hours after block placement

Interventionunits on a scale (Median)
Ropivacaine Group30
Ropivacaine/ Clonidine Group29

[back to top]

Oxycodone Consumption

(NCT02462382)
Timeframe: Post operative days 1 and 2.

,
InterventionPills (Mean)
POD 1POD 2
Ropivacaine Infusion5.85.8
Saline Infusion8.37.9

[back to top]

Oxycodone Consumption After the First Two Postoperative Days.

(NCT02462382)
Timeframe: Post Operative Days 3, 4 and 5.

,
InterventionPills (Mean)
POD 3POD 4POD 5
Ropivacaine Infusion5.53.93.6
Saline Infusion5.84.73.7

[back to top]

Mean Visual Analog Scale

"Shoulder Pain as measured by Visual Analog Scale, score 0-10. 0 equals no pain, 10 equals severe pain.~Data not available for each tear size, all attempts were made to locate." (NCT02462382)
Timeframe: During the first two Post Operative Days.

,
Interventionunits on a scale (Mean)
POD1 1cm incisionPOD 1 2cm incisionPOD 1 3cm incisionPOD 2 1cm incisionPOD 2 2cm incisionPOD 2 3 cm incision
Ropivacaine Infusion3.53.14.02.93.13.8
Saline Infusion5.95.25.44.03.64.1

[back to top]

Mean Visual Analog Scale Score

Visual Analog Scale pain scale score 0-10. 0 equals no pain, 10 equals severe pain. (NCT02462382)
Timeframe: Post Operative Days (POD) 3, 4 and 5.

,
Interventionunits on a scale (Mean)
POD 3 1cm incisionPOD 3 2cm incisionPOD 3 3cm incisionPOD 4 1 cm incisionPOD 4 2cm incisionPOD 4 3cm incisionPOD 5 1cm incisionPOD 5 2cm incisionPOD 5 3cm incision
Ropivacaine Infusion3.53.33.22.62.62.82.32.22.8
Saline Infusion3.33.13.43.53.23.33.02.63.0

[back to top]

Duration of Sensory Loss at T10 Level

The duration of sensory loss (from the subarachnoid block) at T10 level was assessed by pin-prick test by a sterile needle in minutes. (NCT02472522)
Timeframe: 24 hours

Interventionminutes (Mean)
Ropivacaine303.74
Ropivacaine + Dexmedetomidine305.40

[back to top]

Percentage of Patients Needing Rescue Analgesic

Percentage of patients needing rescue analgesic. Rescue analgesia was provided with 6 mg of intravenous morphine and additional doses of 3 mg at 10 minutes interval till VAS was less than 3 or the development of adverse effects such as nausea and/or vomiting, respiratory depression (SpO2 <92%, ventilatory frequency rate <10), or occurrence of deep sedation (eyes closed >3 min, Ramsay Score RS >2). (NCT02472522)
Timeframe: 24 hours

Interventionpercentage needing rescue analgesic (Number)
Ropivacaine50
Ropivacaine + Dexmedetomidine28

[back to top]

Visual Analogue Scale on Coughing (VAS-C)

Visual Analogue Scale on Coughing (VAS-C) Was Used to Assess Post-operative Pain on Coughing. Where: 0 = no Pain and 10 = Worst Imaginable Pain. They were Recorded on Shifting to Postoperative and Then at 1, 4, 8, 12, 18 and 24 Hour (NCT02472522)
Timeframe: 24 hours

,
InterventionUnits on a scale (Mean)
On shifting to postoperative areaAt 1 hourAt 4 hoursAt 8 hoursAt 12 hoursAt 18 hoursAt 24 hours
Ropivacaine0.241.121.582.223.423.522.62
Ropivacaine + Dexmedetomidine0.080.961.481.942.403.022.64

[back to top]

Short Assessment of Patient Satisfaction Score (SAPS)

"Short assessment of patient satisfaction score(SAPS) was assessed on a 5 point scale at the end of 24 hours on the quality of postoperative analgesia. where:~highly dissatisfied~dissatisfied~neither dissatisfied nor satisfied~satisfied~highly satisfied" (NCT02472522)
Timeframe: 24 hours

InterventionUnits on a scale (Mean)
Ropivacaine4.22
Ropivacaine + Dexmedetomidine4.70

[back to top]

The Time After the TAP Block When Rescue Analgesia Was First Sought

(NCT02472522)
Timeframe: 24 hours

InterventionHours (Mean)
Ropivacaine13.12
Ropivacaine + Dexmedetomidine18.21

[back to top]

Time to Complete Disappearance of Motor Block

"During the postoperative recovery, the level of motor block was assessed with Modified Bromage Scale 0 = no paralysis, able to flex hips/knees/ankles~= able to move knees, unable to raise extended legs~= able to flex ankles, unable to flex knees~= unable to move any part of the lower limb The time from subarachnoid block to complete disappearance of motor block (Bromage 0) was recorded in minutes." (NCT02472522)
Timeframe: 24 hours

Interventionminutes (Mean)
Ropivacaine171.06
Ropivacaine + Dexmedetomidine170.34

[back to top]

Total Dose of Required Morphine in 24 Hours Postoperatively

(NCT02472522)
Timeframe: 24 hours

InterventionMilligrams (Mean)
Ropivacaine8.16
Ropivacaine + Dexmedetomidine6.21

[back to top]

Visual Analogue Scale at Rest (VAS-R)

Visual Analogue Scale at rest (VAS-R) was used to assess Post-operative Pain at rest. Where: 0 = no Pain and 10 = Worst Imaginable Pain. They were Recorded on Shifting to Postoperative and Then at 1, 4, 8, 12, 18 and 24 Hour (NCT02472522)
Timeframe: 24 hours

,
InterventionUnits on a scale (Mean)
On shifting to postoperative areaAt 1 hourAt 4 hoursAt 8 hoursAt 12 hoursAt 18 hoursAt 24 hours
Ropivacaine0.060.360.941.462.542.741.88
Ropivacaine + Dexmedetomidine0.000.380.961.341.662.121.78

[back to top]

Mean Arterial Pressure (MAP): Postoperative Period

The Mean Arterial Pressure (MAP) of the patients were recorded after shifting from Operation Theater and at 1, 4, 8,12,18 and 24th hour after shifting to the postoperarive area. (NCT02472522)
Timeframe: 24 hours

,
Interventionmillimeter of mercury (mmHg) (Mean)
On shifting1 hour4 hours8 hours12 hours18 hours24 hours
Ropivacaine79.9880.1478.3878.0682.9083.9477.24
Ropivacaine + Dexmedetomidine83.8083.468281.2680.8485.0879.46

[back to top]

Mean Arterial Pressure (MAP): Intraoperative Period

The Mean Arterial Pressure (MAP) of the patients were recorded from the start of surgery up to 60 minutes at 5, 10, 20, 30, 40, 50, 60 mins. No surgery lasted more than 60 minutes. (NCT02472522)
Timeframe: Upto 60 minutes

,
Interventionmillimeter of mercury (mmHg) (Mean)
BaselineAt 5 minutesAt 10 minutesAt 20 minutesAt 30 minutesAt 40 minutesAt 50 minutesAt 60 minutes
Ropivacaine76.8468.2867.4270.0272.4675.8276.9879.66
Ropivacaine + Dexmedetomidine79.3866.3867.5268.9873.4477.7679.9084.02

[back to top]

Heart Rate: Postoperative

The Heart Rate of the patients were recorded after shifting from Operation Theater and at 1, 4, 8,12,18 and 24th hour after shifting to the postoperarive area. (NCT02472522)
Timeframe: 24 hours

,
Interventionbeats/minute (Mean)
On shiftingAt 1 hourAt 4 hoursAt 8 hoursAt 12 hoursAt 18 hoursAt 24 hours
Ropivacaine84.9286.7483.5081.4685.2680.8878.82
Ropivacaine + Dexmedetomidine88.5286.5082.5481.1483.1881.6079.14

[back to top]

Heart Rate: Intraoperative Period

The Heart Rate of the patients were recorded from the start of surgery up to 60 minutes at 5, 10, 20, 30, 40, 50, 60 mins. No surgery lasted more than 60 minutes. (NCT02472522)
Timeframe: 60 minutes

,
Interventionbeats/minute (Mean)
BaselineAt 5 minutesAt 10 minutesAt 20 minutesAt 30 minutesAt 40 minutesAt 50 minutesAt 60 minutes
Ropivacaine85.6494.5296.6093.8491.0887.9686.6086.74
Ropivacaine + Dexmedetomidine86.7698.2097.0293.2890.0688.6887.5288.50

[back to top]

Adverse Effects Like Pruritus, Nausea and Vomiting

(NCT02472522)
Timeframe: 24 hours

,
Interventionparticipants (Number)
NauseaVomitingNo adverse effect
Ropivacaine1247
Ropivacaine + Dexmedetomidine0149

[back to top]

Verbal Rating Score (VRS) Pain Scores

Summary 24 hour Verbal rated numerical pain scores were gathered each day. Scale range 0-10 where 0 is no pain and 10 is worst imaginable pain (NCT02478372)
Timeframe: 24hours, 48 hours and 72 hours post-surgery

,
Interventionunits on a scale (Mean)
Theatre Day( asked at 24 hrs)Post-operative day one( asked at 48hrs)Post-operative day two(asked 72 hrs)
Local Infiltration Analgesia (LIA)344
Patient Controlled Epidural (PCEA)333

[back to top]

Patient Reported Outcome Measure - Oxford Knee Score

Units measured on old Oxford Score (12-60) from a 12 point questionnaire. Where in 60 is poor and lower scores are better patient reported outcome scores (NCT02478372)
Timeframe: one week prior to surgery, 6 weeks post-surgery , one year post-surgery

,
Interventionunits on a scale (Median)
Pre-operative Oxford ScoreSix week follow up scoreOne year Follow up score
Local Infiltration Analgesia (LIA)432619
Patient Controlled Epidural (PCEA)432819

[back to top]

Average Post-operative Length of Stay

Participants will be followed for the duration of hospital stay, an expected average of 5 days (NCT02478372)
Timeframe: Average number of days spent in hospital follwoing surgery, an expected average of 5 days

Interventiondays (Median)
Patient Controlled Epidural (PCEA)4
Local Infiltration Analgesia (LIA)4

[back to top]

Maximal Flexion Angle of the Operative Knee at Discharge From Rehabilitation

(NCT02478372)
Timeframe: On day of discharge from rehabilitation in-patient care (average 96 hours post surgery)

Interventionangle of flexion (degree) (Median)
Patient Controlled Epidural (PCEA)80
Local Infiltration Analgesia (LIA)80

[back to top]

Post-operative Nausea and Vomiting Scores

percentage of patients reporting either symptoms of nausea or vomiting over the first 72 hours following surgery. Scale 0-2 wherein 0=no nausea and vomiting, 1=nausea and 2= nausea and vomiting (NCT02478372)
Timeframe: 24hours, 48 hours and 72 hours post-surgery

Interventionpercentage of patients reporting PONV (Number)
Patient Controlled Epidural (PCEA)16
Local Infiltration Analgesia (LIA)14

[back to top]

Post-operative Urinary Catheterisation Rates

% of patients requiring catheterisation for urinary retention post-surgery (NCT02478372)
Timeframe: 72 hours post-surgery

Interventionpercentage of patients catheterised (Number)
Patient Controlled Epidural (PCEA)9.2
Local Infiltration Analgesia (LIA)4.4

[back to top]

Proportion of Patients Discharged From Rehabilitation by Day Four

"% of patients meeting predetermined discharge criteria at 96 Hours post-surgery.~The discharge criteria were: self dependent (dress, personal care); in and out of bedd independently; up and down stairs; walk with crutches/stick; 80 degrees knee flexion; able to straight leg raise operated limb." (NCT02478372)
Timeframe: 96 hours

Interventionpercentage of patients (Number)
Patient Controlled Epidural (PCEA)77
Local Infiltration Analgesia (LIA)82

[back to top]

Day of Ambulation

Proportion of patients per day to ambulate for the first time with the physiotherapist > 3 Metres (NCT02478372)
Timeframe: theatre day, day 1 post-surgery, day two post-surgery

,
Interventionpercentage of patients (Number)
Theatre DayPost-operative day onePost-operative day two
Local Infiltration Analgesia (LIA)51490
Patient Controlled Epidural (PCEA)35654

[back to top]

Total Number of Reported Participants With Complications and/or Adverse Events

The composite number of adverse events reported per group at 30 days and then one year post surgery (NCT02478372)
Timeframe: 30 days and one year post-surgery

,
Interventionparticipants (Number)
Reported complications at 30 daysReported complications at one year
Local Infiltration Analgesia (LIA)24
Patient Controlled Epidural (PCEA)02

[back to top]

Use of Post-operative Intravenous/Oral Opioid and Non-opioid

Amount of postoperative intravenous/oral opioid and non-opioid medications received by patient. This is being recorded as Morphine milligram equivalents (MME)/kilogram(kg) for days 1-5. (NCT02494336)
Timeframe: 5 days

InterventionMME/kg (Mean)
Trans-incisional Rectus Sheath Block0.49
Laparoscopic Guided Rectus Sheath Block056

[back to top]

Number of Participants With Complications

Number of participants with complications such as infection, bleeding, intravascular injection, bowel puncture. (NCT02494336)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Trans-incisional Rectus Sheath Block0
Laparoscopic Guided Rectus Sheath Block0

[back to top]

Number of Participants With Side Effects

Number of participants with side effects such as nausea, vomiting, allergic reactions. (NCT02494336)
Timeframe: 5 days

InterventionParticipants (Count of Participants)
Trans-incisional Rectus Sheath Block0
Laparoscopic Guided Rectus Sheath Block0

[back to top]

Operative Time

Operative time is measured as the time between X and Y. Reported in minutes. (NCT02494336)
Timeframe: 1 day

Interventionminutes (Mean)
Trans-incisional Rectus Sheath Block62
Laparoscopic Guided Rectus Sheath Block60

[back to top]

Post Operative Pain Rating

"Using the Wong-Baker FACES Pain Rating Scale (WBFPRS). The WBFPRS is a visual pain rating scale in which the participant looks at pictures of faces depicting levels of pain and chooses the one that most closely resembles their own pain. The scale ranges from 0 no hurt to 10 Hurts Worst." (NCT02494336)
Timeframe: 5 days

Interventionscore on a scale (Mean)
Trans-incisional Rectus Sheath Block4.03
Laparoscopic Guided Rectus Sheath Block4.03

[back to top]

Time to First Rescue Analgesic

Amount of time in minutes until the first analgesic is given postoperatively. (NCT02494336)
Timeframe: 1 day

Interventionminutes (Mean)
Trans-incisional Rectus Sheath Block14.4
Laparoscopic Guided Rectus Sheath Block17.9

[back to top]

Total Number of Complications

Total number of complications such as infection, bleeding, intravascular injection, bowel puncture. (NCT02494336)
Timeframe: 30 days

Interventioncomplications (Number)
Trans-incisional Rectus Sheath Block0
Laparoscopic Guided Rectus Sheath Block0

[back to top]

Opioid Use as Measured by Questionnaire

Compare time to first opioid use over 72 hours between groups (NCT02499575)
Timeframe: Daily through the third day (72 hours) post-surgery

Interventionhours (Number)
Regional Block6

[back to top]

Total Opioid Use as Measured by Questionnaire

Compare total opioid use (reported as total morphine equivalents) over 72 hours between groups. (NCT02499575)
Timeframe: Daily through the third day (72 hours) post-surgery

Interventionmorphine equivalents (Number)
Regional Block18

[back to top]

Pain Relief Measured by Defense and Veterans Pain Scale

Evaluate patient-reported pain scores (scale of 0 (no pain) - 10 (worst pain)) at 0, 6, 12, 24, 36, 48, 60, and 72 hours following surgery (NCT02499575)
Timeframe: Through 72 hours post-surgery (0, 6, 12, 24, 36, 48, 60, and 72 hours post-surgery)

Interventionunits on scale of 0 -10 (Number)
Pain score time 0Pain score time 6hrsPain score time 12hrsPain score time 24hrsPain score time 36hrsPain score time 48hrsPain score time 60hrsPain score time 72hrs
Regional Block03323322

[back to top]

Post-operative Pain Scale Using VAS

"The visual analogue scale (VAS) for pain is a validated, subjective measure where scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between no pain and worst pain." (NCT02501135)
Timeframe: 1 hour post-op

Interventionunits on a scale (Median)
Ropivacaine 0.2%Ropivacaine 0.5%Bupivacaine 0.25%
VAS Pain Scores000

[back to top]

Time to Discharge From PACU

(NCT02501135)
Timeframe: Conclusion of surgery until admission to assigned unit or to phase, an expected average of 1 hour

Interventionminutes (Median)
PACU time in pt who got ropivacaine 0.2%PACU time in pt who got ropivacaine 0.5%PACU time in pt who got bupivacaine 0.25%
Discharge From PACU in Minutes574755

[back to top]

Concentration of Local Anesthetic Injected for Femoral Nerve Block

(NCT02501135)
Timeframe: length of surgery

InterventionParticipants (Count of Participants)
Patients who received ropivacaine 0.2%Patients who received ropivacaine 0.5%Patients who received bupivacaine 0.25%
Femoral Nerve Blocks1178183

[back to top]

Intraoperative Tylenol Administered

Amount of Tylenol administered based on if got ropivacaine or bupivacaine femeral nerve block. (NCT02501135)
Timeframe: length of surgery

Interventionpercentage of participants (Number)
Increased Tylenol use in ropivacaine 0.5% NBIncreased Tylenol use in ropivacaine 0.2% NBIncreased Tylenol use in bupivacaine 0.25% NB
Intraoperative Tylenol Consumption1641

[back to top]

Total mg of Local Anesthetic Injected for Femoral Nerve Block

(NCT02501135)
Timeframe: length of surgery

Interventionml/kg (Median)
Amount of ropivacaine 0.2%Amount of ropivacaine 0.5%Amount of bupivacaine 0.25%
Femoral Nerve Blocks0.270.290.25

[back to top]

Post-operative Pain Scale Using FLACC

The Face, Legs, Activity, Cry, Consolability scale or FLACC scale is a measurement used to assess pain for children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0-10 with 0 representing no pain. (NCT02501135)
Timeframe: 1 hour post-op

Interventionunits on a scale (Median)
FLACC in patient who had ropivacaine 0.2%FLACC in patient who had ropivacaine 0.5%FLACC in patient who had bupivacaine 0.25%
FLACC Pain Scores000

[back to top]

Post-operative Opioids Administered

Amount of opioid consumption in the post operative anesthesia care unit depending on if the patient received femoral nerve block with ropivacaine or bupivacaine (NCT02501135)
Timeframe: in PACU (1 hr post-op)

Interventionmg/kg (Median)
IV Morphine who got ropivacaine 0.5% nerve blockIV Morphine who got ropivacaine 0.2% nerve blockIV Morphine who got bupivacaine 0.25% nerve block
Post Operative Opioid Consumption00.020.02

[back to top]

Visual Analog Scale (VAS) for Pain

A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point. (NCT02502487)
Timeframe: at cystoscopic inspection of external sphincter

Interventionunits on a scale (Median)
Tetracaine Gel Group6
Dorsal Penile Nerve Block Group4
Combination Group4

[back to top]

Heart Rate at Cystoscopic Inspection of External Sphincter

(NCT02502487)
Timeframe: at cystoscopic inspection of external sphincter

InterventionBeats per minute (Mean)
Tetracaine Gel Group96.7
Dorsal Penile Nerve Block Group90.2
Combination Group86.2

[back to top]

Heart Rate After Withdrawal of Cystoscope

(NCT02502487)
Timeframe: after withdrawal of cystoscope

InterventionBeats per minute (Mean)
Tetracaine Gel Group76.7
Dorsal Penile Nerve Block Group72.3
Combination Group71.6

[back to top]

Breath Rate After Withdrawal of Cystoscope

(NCT02502487)
Timeframe: after withdrawal of cystoscope

Interventiontimes per minute (Mean)
Tetracaine Gel Group19.7
Dorsal Penile Nerve Block Group19.4
Combination Group19.4

[back to top]

Breath Rate at Cystoscopic Inspection of External Sphincter

(NCT02502487)
Timeframe: at cystoscopic inspection of external sphincter

Interventiontimes per minute (Mean)
Tetracaine Gel Group20.1
Dorsal Penile Nerve Block Group19.8
Combination Group19.8

[back to top]

Breath Rate at Cystoscopic Inspection of Penile and Bulbar Urthra

(NCT02502487)
Timeframe: at cystoscopic inspection of penile and bulbar Urthra

Interventiontimes per minute (Mean)
Tetracaine Gel Group20.0
Dorsal Penile Nerve Block Group19.8
Combination Group19.6

[back to top]

Breath Rate Before Gel Administration

(NCT02502487)
Timeframe: before gel administration

Interventiontimes per minute (Mean)
Tetracaine Gel Group19.8
Dorsal Penile Nerve Block Group19.6
Combination Group19.5

[back to top]

Visual Analog Scale (VAS) for Pain

A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point. (NCT02502487)
Timeframe: before gel administration

Interventionunits on a scale (Median)
Tetracaine Gel Group0
Dorsal Penile Nerve Block Group0
Combination Group0

[back to top]

Visual Analog Scale (VAS) for Pain

A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point. (NCT02502487)
Timeframe: at cystoscopic inspection of prostate and bladder

Interventionunits on a scale (Median)
Tetracaine Gel Group2
Dorsal Penile Nerve Block Group0
Combination Group0

[back to top]

Visual Analog Scale (VAS) for Pain

A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point. (NCT02502487)
Timeframe: at cystoscopic inspection of penile and bulbar urethra

Interventionunits on a scale (Median)
Tetracaine Gel Group1
Dorsal Penile Nerve Block Group1
Combination Group1

[back to top]

Visual Analog Scale (VAS) for Pain

A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point. (NCT02502487)
Timeframe: after withdrawal of cystoscope

Interventionunits on a scale (Median)
Tetracaine Gel Group0
Dorsal Penile Nerve Block Group0
Combination Group0

[back to top]

Oxygen Saturation by Pulse Before Gel Administration

(NCT02502487)
Timeframe: before gel administration

Interventionpercentage (Median)
Tetracaine Gel Group99
Dorsal Penile Nerve Block Group98
Combination Group99

[back to top]

Oxygen Saturation by Pulse at Cystoscopic Inspection of Penile and Bulbar Urthra

(NCT02502487)
Timeframe: at cystoscopic inspection of penile and bulbar urthra

Interventionpercentage (Median)
Tetracaine Gel Group99
Dorsal Penile Nerve Block Group98
Combination Group99

[back to top]

Oxygen Saturation by Pulse at Cystoscopic Inspection of External Sphincter

(NCT02502487)
Timeframe: at cystoscopic inspection of external sphincter

Interventionpercentage (Median)
Tetracaine Gel Group99
Dorsal Penile Nerve Block Group98
Combination Group99

[back to top]

Oxygen Saturation by Pulse After Withdrawal of Cystoscope

(NCT02502487)
Timeframe: after withdrawal of cystoscope

Interventionpercentage (Median)
Tetracaine Gel Group99
Dorsal Penile Nerve Block Group98
Combination Group99

[back to top]

Mean Arterial Pressure Before Gel Administration

(NCT02502487)
Timeframe: before gel administration

InterventionmmHg (Mean)
Tetracaine Gel Group95.3
Dorsal Penile Nerve Block Group96.6
Combination Group95.1

[back to top]

Mean Arterial Pressure at Cystoscopic Inspection of Penile and Bulbar Urthra

(NCT02502487)
Timeframe: at cystoscopic inspection of penile and bulbar urthra

InterventionmmHg (Mean)
Tetracaine Gel Group100
Dorsal Penile Nerve Block Group99.8
Combination Group98.2

[back to top]

Mean Arterial Pressure at Cystoscopic Inspection of External Sphincter

(NCT02502487)
Timeframe: at cystoscopic inspection of external sphincter

InterventionmmHg (Mean)
Tetracaine Gel Group113.7
Dorsal Penile Nerve Block Group105.8
Combination Group104.8

[back to top]

Mean Arterial Pressure After Withdrawal of Cystoscope

(NCT02502487)
Timeframe: after withdrawal of cystoscope

InterventionmmHg (Mean)
Tetracaine Gel Group99.3
Dorsal Penile Nerve Block Group95.7
Combination Group95.2

[back to top]

Heart Rate Before Gel Administration

(NCT02502487)
Timeframe: before gel administration

InterventionBeats per minute (Mean)
Tetracaine Gel Group75.0
Dorsal Penile Nerve Block Group75.9
Combination Group73.6

[back to top]

Heart Rate at Cystoscopic Inspection of Penile and Bulbar Urthra

(NCT02502487)
Timeframe: at cystoscopic inspection of penile and bulbar urethra

InterventionBeats per minute (Mean)
Tetracaine Gel Group84.8
Dorsal Penile Nerve Block Group83.8
Combination Group81.1

[back to top]

Pain (Average): Numeric Rating Scale for Pain

Numeric Rating Scale for Pain (0-10; 0=no pain and 10=worst imaginable pain) (NCT02523235)
Timeframe: Average for the day after surgery 08:00-24:00 (adductor) and the morning after surgery for 2 hours before phone call made between 10:00-noon (popliteal)

Interventionscore on a scale (Median)
Proximal Catheter Insertion0.5
Distal Catheter Insertion3.0

[back to top]

Pain (Worst) :Numeric Rating Scale for Pain

Numeric Rating Scale for Pain (0-10; 0=no pain and 10=worst imaginable pain) (NCT02523235)
Timeframe: Average for the day after surgery 08:00-24:00 (adductor) and the morning after surgery for 2 hours before phone call made between 10:00-noon (popliteal)

Interventionscore on a scale (Median)
Proximal Catheter Insertion4.0
Distal Catheter Insertion5.0

[back to top]

Pain During Afternoon Physical Therapy Session

Pain during afternoon physical therapy session as measured with the Numeric Rating Scale (0-10; 0=no pain and 10=worst imaginable pain) (NCT02523235)
Timeframe: Average during physical therapy in the afternoon following surgery

Interventionscore on a scale (Median)
Proximal Catheter Insertion3.0
Distal Catheter Insertion3.0

[back to top]

Toe/Foot Numbness (Insensate) :0-10 Scale

0-10 scale, 0=no numbness and 10=completely insensate (NCT02523235)
Timeframe: Average for the morning after surgery for 2 hours before phone call made between 10:00-noon (popliteal only)

Interventionscore on a scale (Median)
Proximal Catheter Insertion7.0
Distal Catheter Insertion7.0

[back to top]

Total Local Anesthetic Infused (Adductor Only) : mL

mL (NCT02523235)
Timeframe: The day following surgery recorded during mid-day rounds

InterventionmL (Median)
Proximal Catheter Insertion32
Distal Catheter Insertion40

[back to top]

Ambulation: Distance in Meters

distance in meters (NCT02523235)
Timeframe: Average for morning and afternoon following surgery

Interventionmeters (Median)
Proximal Catheter Insertion150
Distal Catheter Insertion170

[back to top]

Analgesic Use: IV Morphine Equivalents

IV morphine equivalents (NCT02523235)
Timeframe: Average for Intraoperative, in the recovery room, after the recovery room until 08:00 day after surgery, and 08:00-24:00 day after surgery

Interventionmg (Median)
Proximal Catheter Insertion6.7
Distal Catheter Insertion6.7

[back to top]

Number of Participants That Had Fluid Leakage Reported at Catheter Site.

"If subjects detected leakage at the catheter site, the response was recorded as yes; and, if subjects did not detect leakage at the catheter site, the response was recorded as no." (NCT02523235)
Timeframe: From surgery through the day after surgery

InterventionParticipants (Count of Participants)
Proximal Catheter Insertion3
Distal Catheter Insertion1

[back to top]

Length of Stay

Measured in hours (NCT02543801)
Timeframe: Start of surgery to hospital discharge up to 140 hours

InterventionHours (Mean)
Hip Cohort Liposomal Bupivacaine33.8
Hip Cohort Ropivacaine50.3
Knee Cohort Liposomal Bupivacaine36.0
Knee Cohort Ropivacaine38.4

[back to top]

Narcotic Consumption

Total amount of narcotics administered as calculated in oral morphine equivalent dose immediate post operatively up to 48 hours. (NCT02543801)
Timeframe: Starting immediately post operatively up to 48 hours

Interventionmorphine equivalents (Mean)
Hip Cohort Liposomal Bupivacaine48.8
Hip Cohort Ropivacaine57.4
Knee Cohort Liposomal Bupivacaine52.2
Knee Cohort Ropivacaine50.0

[back to top]

Pain Score

"Self-reported pain score 0-10 (0=no pain - 10=worst possible pain experienced) and higher scores indicate a worse outcome~Pain scores, collected every 4 hours per hospital care standards, were averaged (post-operatively up to 48 hours) to obtain individual mean pain scores and a mean score for the group was then calculated." (NCT02543801)
Timeframe: Starting post operatively and then every four hours up to 48 hours

Interventionscore on a scale (Mean)
Hip Cohort Liposomal Bupivacaine3.78
Hip Cohort Ropivacaine3.85
Knee Cohort Liposomal Bupivacaine3.3
Knee Cohort Ropivacaine3.4

[back to top]

Pain Levels

Patients recorded pain levels every four hours using Visual analog scales for four days post operatively. Average daily pain was calculated for each patient. Range of the visual analog scale was 0-10, where 0 indicated a lower amount of pain and 10 indicated higher amount of pain. (NCT02570022)
Timeframe: four days postoperatively

,
Interventionunits on a scale (Mean)
Mean Pain score Day 0Mean Pain score Day 1Mean Pain score Day 2Mean Pain score Day 3
Inter-scalene Nerve Block4.04.03.64.3
Liposomal Bupivacaine4.84.74.34.1

[back to top]

Morphine Equivalents

Patients recorded opioid intake for four days postoperatively. Patients average daily morphine consumption was determined by averaging total patients daily morphine consumption by the number of patients. (NCT02570022)
Timeframe: four days postoperatively

,
Interventionmg of morphine equivalent (Mean)
Mean Morphine equivalents used Day 0Mean Morphine equivalents used Day 1Mean Morphine equivalents used Day 2Mean Morphine equivalents used Day 3
Inter-scalene Nerve Block21.49.15.22.2
Liposomal Bupivacaine14.88.912.32.8

[back to top]

Narcotic Use During Hospitalization

The amount of narcotic pain medication needed for patient to be comfortable. This is measured in morphine equivalents since there are many pain medications other than morphine. (NCT02570503)
Timeframe: 0-24 hours post surgery period, 24 - 48 hours post surgery period, and Full 48 hours post surgery period

,
Interventionmg morphine equivalents (Mean)
0 to 24 hour post surgery period24 to 48 hour post surgery periodFull 48 hour post surgery period
Placebo72.372.8145.7
ROP/KET/CLON/EPI/SAL58.966.5125.6

[back to top]

Itching.

Itching will be assessed postoperatively on a scale of 0 to 10 at 24 hours after surgery. The minimum value was 0 for no itching and maximum value was 10 for severe itching. The responses are whole numbers ranging from 0 to 10 with increasing numbers representing increasing itching. (NCT02571439)
Timeframe: up to 24 hours after surgery

Interventionscale of 0-10 (Median)
Surgical TAP Block0
Conventional TAP Block0

[back to top]

Number of Participants With Postoperative Nausea/Vomiting

"outcomes will be assessed postoperatively as number of patients with postoperative nausea/vomiting present or not present at 24 hours after surgery" (NCT02571439)
Timeframe: up to 24 hours after surgery

InterventionParticipants (Count of Participants)
Surgical TAP Block3
Conventional TAP Block1

[back to top]

Sedation

sedation will be assessed postoperatively on a scale of 0 to 10. The minimum value was 0 for not sedated or awake and maximum value was 10 for extremely sedated. The responses are whole numbers ranging from 0 to 10 with increasing numbers representing increasing sedation. (NCT02571439)
Timeframe: up to 24 hours after surgery

Interventionscale of 0-10 (Median)
Surgical TAP Block2.5
Conventional TAP Block3

[back to top]

Severity of Postoperative Pain at Rest

postoperative pain will be assessed using the visual analog scale postoperatively at 4 hours after surgery. visual analog pain scale is a response scale to measure pain with a score of 0 representing no pain and a score of 10 representing the worst pain imaginable. The minimum value was 0 for no pain and maximum value was 10 for the worst pain imaginable. The responses are whole numbers ranging from 0 to 10 with increasing numbers representing increasing pain. (NCT02571439)
Timeframe: 4 hours after surgery

InterventionNumerical rating scale for pain (Median)
Surgical TAP Block4
Conventional TAP Block3

[back to top]

Severity of Postoperative Pain at Rest

postoperative pain will be assessed using the visual analog scale postoperatively at 48 hours after surgery. (NCT02571439)
Timeframe: 48 hours after surgery

InterventionUnits on a scale (Median)
Surgical TAP Block2
Conventional TAP Block0

[back to top]

Severity of Postoperative Pain at Rest

postoperative pain will be assessed using the visual analog scale postoperatively at 24 hours after surgery. v (NCT02571439)
Timeframe: 24 hours after surgery

InterventionUnits on a scale (Median)
Surgical TAP Block2
Conventional TAP Block3

[back to top]

Total Narcotic Consumption

Total narcotic consumption, measured in mg of morphine 24 hours after surgery (NCT02571439)
Timeframe: 24 hours after surgery

Interventionmg of morphine (Median)
Surgical TAP Block28
Conventional TAP Block25

[back to top]

Time Taken to Perform the Block

Two independent observers (who are not the surgeon or anesthesiologist performing the procedures) will collect data on time outcomes to reduce error and the procedure will be filmed on a random sample of 10% of patients to verify the times assigned by the study personnel. Filming will be started after the patient is draped so that the patients face is not in the recording. (NCT02571439)
Timeframe: The time taken to perform the block in the operating room is measured, upto 60 minutes

Interventionminutes (Mean)
Surgical TAP Block2.4
Conventional TAP Block12.1

[back to top]

Time From Delivery of Neonate to Ready to Exit Operating Room

Two independent observers (who are not the surgeon or anesthesiologist performing the procedures) will collect data on time outcomes to reduce error and the procedure will be filmed on a random sample of 10% of patients to verify the times assigned by the study personnel. Filming will be started after the patient is draped so that the patients face is not in the recording. (NCT02571439)
Timeframe: Time measures will be recorded in the operating room, upto 6 hours

Interventionminutes (Mean)
Surgical TAP Block55.3
Conventional TAP Block77.9

[back to top]

Severity of Postoperative Pain at Rest

postoperative pain will be assessed using the visual analog scale postoperatively at 8 hours after surgery. v (NCT02571439)
Timeframe: 8 hours after surgery

InterventionUnits on a scale (Median)
Surgical TAP Block4
Conventional TAP Block3

[back to top]

Tegner Activity Level Scale

"The Tegner activity level scale is a scale that aims to provide a standardized method of grading work and sporting activities. The Tegner activity level scale is a graduated list of activities of daily living, recreation, and competitive sports. The patient is asked to select the level of participation that best describes their current level of activity and that before injury.~A score of 0 represents sick leave or disability pension because of knee problems, whereas a score of 10 corresponds to participation in national and international elite competitive sports. A score >6 can only be achieved if the person participates in recreational or competitive sport." (NCT02576249)
Timeframe: baseline (pre-injection), 2 weeks, 3 months

,
Interventionunits on a scale (Mean)
baseline (pre-injection)2 weeks3 months
Ropivacaine and Methylprednisolone3.54.33.5
Saline and Methylprednisolone3.03.23

[back to top]

The Knee Osteoarthritis Outcome Score (KOOS) Pain Subscale

The KOOS holds 42 items in five separately scored subscales: Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation (Sport/Rec), and knee-related Quality of Life (QOL). A Likert scale is used and all items have five possible answer options scored from 0 (No Problems) to 4 (Extreme Problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems. (NCT02576249)
Timeframe: 3 months after the injection

Interventionunits on a scale (Mean)
Ropivacaine and Methylprednisolone63.1
Saline and Methylprednisolone67.2

[back to top]

Pain Scale Score

Pain was measured by a Visual Analog Scale (VAS) marked from 0 (no pain) to 10 (unbearable pain) at rest and with activity. It was collected at baseline (pre-injection), immediately post-injection on the day of surgery, and at 2 weeks and 3 months. (NCT02576249)
Timeframe: Pre-injection, immediately post-injection, 2 weeks, 3 months

,
Interventionunits on a scale (Mean)
Pre-injection ActivityPre-injection RestImmediately Post-injection ActivityImmediately Post-injection Rest2 Weeks Activity2 Weeks Rest3 Months Activity3 Months Rest
Ropivacaine and Methylprednisolone6.42.41.91.23.61.73.92.6
Saline and Methylprednisolone5.842.41.43.62.74.62.8

[back to top]

Amount of Opioid Use

"The amount of opioid use will be quantified in terms of morphine equivalents given in mg both by post~-operative day and with a cumulative total. Higher amounts of opioid use indicates higher degrees of pain." (NCT02579629)
Timeframe: 24 post-operatively, 72 hours post-operatively

,,
Interventionmg (Mean)
24 hours post intervention72 hours post intervention
Normal Saline1.6531.25
Ropivacaine 0.1%0.3524.98
Ropivacaine 0.2%6.4554.28

[back to top]

Change in Intensity of Pain: VAPS From Baseline

"Incisional pain will be measured using a visual analogue pain scale (VAPS). Subjects will be instructed to indicate the intensity of the pain by marking on a 100-mm vertical lines with terms describing the extremes of pain intensity. The lines are anchored with no pain at the bottom and worst imaginable pain at the top. Pain scores range from 0-100, so the change in pain score (post- minus pre-) can theoretically range from -100 to 100. A negative score indicates an improvement in pain. Higher scores indicate higher intensities of pain. Participants will report intensity of pain 2hrs post intervention, 6hr, 12hr, 24hr, 48hr, and 72hr post-intervention." (NCT02579629)
Timeframe: 24 hours post-intervention, 48 hrs, and 72hr post-intervention.

,,
Interventionunits on a scale (Median)
Change in score at 24 hours post interventionChange in score at 48 hours post interventionChange in score at 72 hours post intervention
Normal Saline000
Ropivacaine 0.1%000
Ropivacaine 0.2%000

[back to top]

Change in Time From Baseline to First Dose of Rescue Medications

The time to dosing with the first rescue medications like, non-steroidal anti-inflammatory drugs and morphine, for breakthrough pain will be noted. A shorter time to dosing indicates an increased intensity of pain. It will be recorded in hours post intervention. (NCT02579629)
Timeframe: Baseline (At zero time, the time of the first dosing using the On-Q catheter), 72 hours post-operatively

InterventionHours (Median)
Ropivacaine 0.1%9.05
Ropivacaine 0.2%3.50
Normal Saline2

[back to top]

Change in McGill Pain Questionnaire Score From Baseline

Pain with movement will be assessed using the self-report mini-McGill pain questionnaire, consisting of the first 15 questions of the McGill questionnaire, scores 0-3 points for each. It can theoretically range from 0 to 45, with 45 correlating with worse pain. (NCT02579629)
Timeframe: 2 hours post-intervention, 6 hours, 12 hours, 24 hours, 72 hours, 6 weeks, 3 months post-intervention

,,
Interventionscore on a scale (Median)
2 hrs post Baseline6 hrs post Baseline12 hrs post Baseline24 hrs post Baseline48 hrs post Baseline72 hrs post Baseline6 weeks post Baseline3 months post Baseline
Normal Saline22222100
Ropivacaine 0.1%1.5211.52.5200
Ropivacaine 0.2%22133300

[back to top]

Change in Pain Scores at Rest From Baseline

"The intensity of pain at rest will be measured using a visual analogue pain scale (VAPS). Subjects will be instructed to indicate the intensity of the pain by marking on a 100-mm vertical lines with terms describing the extremes of pain intensity. The lines are anchored with no pain at the bottom and worst imaginable pain at the top. Higher scores indicate higher intensities of pain." (NCT02579629)
Timeframe: 2 hours post-intervention, 6 hours, 12 hours, 24 hours, 48 hous, 72 hours post baseline

,,
Interventionscore on a scale (Median)
Change in score at 2-hours post baselineChange in score at 6-hours post baselineChange in score at 12-hours post baselineChange in score at 24-hours post baselineChange in score at 48-hours post baselineChange in score at 72-hours post baseline
Normal Saline75.51.54.52.52
Ropivacaine 0.1%53584.50
Ropivacaine 0.2%0005.530

[back to top]

Patient Satisfaction at 72 Hours Post Intervention

Patient satisfaction will be assessed by using the visual analog scale (VAS). The visual analog scale (VAS) for satisfaction is a horizontal line 100mm long. At the beginning and the end, there are two descriptors representing extremes of satisfaction. The subjects will be asked to rate their satisfaction by making a vertical mark on the 100mm line, where, 0= least satisfied and 100=most satisfied. Higher scores indicate higher levels of satisfaction. (NCT02579629)
Timeframe: 72 hours post-operatively

Interventionunits on a scale (Mean)
Ropivacaine 0.1%60
Ropivacaine 0.2%61.53
Normal Saline48.3

[back to top]

Cost Analysis

A cost analysis will occur for the inpatient stay. Costs to be assessed include cost for preparation of the drugs and devices, monitoring/supervision costs based on nursing and physician interventions and cost of days spent in the hospital. (NCT02579629)
Timeframe: At the time of hospital discharge (average of 3 days)

InterventionDollars (Mean)
Ropivacaine 0.1%27.9
Ropivacaine 0.2%26.8
Normal Saline31.6

[back to top]

Change in Intensity of Pain: Numerical Pain Scale (NPS) From Baseline

Post-operative pain will be measured using a numerical pain scale (NPS). Subjects will be asked to indicate the level of pain with 0 being no pain and 10 being the worst imaginable pain. Higher scores indicate higher intensities of pain. Participants will report intensity of pain at the week 6 and 3 month time points through a telephone call. (NCT02579629)
Timeframe: 6 weeks, 3 months

,,
Interventionunits on a scale (Median)
Change at 6 weeks post interventionChange at 3 months post intervention
Normal Saline50
Ropivacaine 0.1%30
Ropivacaine 0.2%20

[back to top]

Breastfeeding Success

"Breastfeeding success will be measured using LATCH scores. The LATCH system assigns a numerical score, 0, 1, or 2, to five key components of breastfeeding: L is for how well the infant latches onto the breast, A is for the amount of audible swallowing noted, T is for the mother's nipple type, C is for the mother's level of comfort and H is for the amount of help the mother needs to hold her infant to the breast. The theoretical range of the Latch score is 0 to 10. Higher scores indicate higher success with breastfeeding." (NCT02579629)
Timeframe: In the post-anesthesia care unit (up to 2 hours post-operatively), 72 hours post-operatively

,,
Interventionscore on a scale (Median)
2 hours post intervention72 hours post intervention
Normal Saline6.510
Ropivacaine 0.1%1010
Ropivacaine 0.2%6.510

[back to top]

Number of Patients With Wound Dysesthesia, Infection, Dehiscence and Keloid Formation at 6 Weeks and 3 Months Post-intervention

At the 6 week and 3-month follow-up phone calls the participant will be asked about the presence of wound dysesthesia (numbness, tingling, burning, pricking, allodynia, or hyperesthesia), occurrence of infection, dehiscence, and keloid formation. (NCT02579629)
Timeframe: 6 weeks postintervention, 3 months postintervention

,,
InterventionParticipants (Count of Participants)
6 Weeks- Wound Dysesthesia6 Weeks- Infection6 Weeks- Dehiscence6 Weeks- Keloid Formation3 Months- Wound Dysesthesia3 Months - Infection3 Months- Dehiscence3 Months- Keloid Formation
Normal Saline60003000
Ropivacaine 0.1%20001000
Ropivacaine 0.2%20002000

[back to top]

Number of Participants With Catheter or Infiltrate-related Issues at 24, 48 and 72 Hours Post-intervention

The cesarean section incision and the catheter insertion site will be evaluated. Any catheter or infiltrate-related issues like wound infection and seroma formation will be noted. It will be reported as number of issues. Wounds will be assessed for infection or dehiscence. Clean wound lines with no evidence of infection indicate better healing. (NCT02579629)
Timeframe: 24 hours, 48 hours, 72 hours post intervention

,,
InterventionParticipants (Count of Participants)
24 hours post intervention48 hours post intervention72 hours post intervention
Normal Saline000
Ropivacaine 0.1%000
Ropivacaine 0.2%001

[back to top]

Dosing Amount of Non-steroidal Anti-inflammatory Drugs

The total dose of non-steroidal anti-inflammatory drugs (NSAIDs) in mg will be recorded for each of the first three post-operative days and after discharge as indicated, along with a cumulative total. Higher doses of NSAIDs usage indicate higher intensities of pain. (NCT02579629)
Timeframe: 24 post-operatively, 72 hours post-operatively

,,
Interventionmg (Mean)
24 hours post intervention72 hours post intervention
Normal Saline3791095
Ropivacaine 0.1%802040
Ropivacaine 0.2%2111726

[back to top]

Change in Pain Scores During Cough From Baseline

"The intensity of pain during cough will be measured using a visual analogue pain scale (VAPS). Subjects will be instructed to indicate the intensity of the pain by marking on a 100-mm vertical lines with terms describing the extremes of pain intensity. The lines are anchored with no pain at the bottom and worst imaginable pain at the top. Pain scores range from 0-100, so the change in pain score (post- minus pre-) can theoretically range from -100 to 100. A negative score indicates an improvement in pain. Higher scores indicate higher intensities of pain." (NCT02579629)
Timeframe: 2 hours post baseline, 6, 12, 24, 48, 72 hours post baseline

,,
Interventionscore on a scale (Median)
Change in score at 2-hours post baselineChange in score at 6-hours post baselineChange in score at 12-hours post baselineChange in score at 24-hours post baselineChange in score at 48-hours post baselineChange in score at 72-hours post baseline
Normal Saline20.510.515.515.5153
Ropivacaine 0.1%41014.520136.5
Ropivacaine 0.2%1322720

[back to top]

Change in Pain Scores During 20°Straight Leg Raise

"The intensity of pain during 20° straight leg raise will be measured using a visual analogue pain scale (VAPS). Subjects will be instructed to indicate the intensity of the pain by marking on a 100-mm vertical lines with terms describing the extremes of pain intensity. The lines are anchored with no pain at the bottom and worst imaginable pain at the top. Higher scores indicate higher intensities of pain." (NCT02579629)
Timeframe: Baseline (At zero time, the time of the first dosing using the On-Q catheter), 2, 6, 12, 24, 48, 72 hours post baseline

,,
Interventionscore on a scale (Median)
Change in score at 2-hours post baselineChange in score at 6-hours post baselineChange in score at 12-hours post baselineChange in score at 24-hours post baselineChange in score at 48-hours post baselineChange in score at 72-hours post baseline
Normal Saline10.55-6.516172.5
Ropivacaine 0.1%48-6.599.51
Ropivacaine 0.2%500033

[back to top]

Quadriceps Strength of on POD 1 of Preoperative Femoral Nerve Block Plus Postoperative Continuous Adductor Canal Nerve Catheter Compared to Preoperative Femoral Nerve Block Plus Postoperative Saphenous Nerve Block at 48 Hours After Discharge From PACU

Quadriceps strength on POD 1 of preoperative femoral nerve block plus postoperative continuous adductor canal nerve catheter compared to preoperative femoral nerve block plus postoperative saphenous nerve block using Straight Leg Raise Tests, 0-5/5 scale, and knee extension, 0-5/5 scale. On both scales (straight leg raise test and knee extension) 0 indicates the minimum value (low muscle contraction/no movement) and 5 indicates the maximum (normal muscle contraction /pt holds position against pressure). (NCT02584452)
Timeframe: Post Operative Day 1

InterventionParticipants (Count of Participants)
Straight Leg Raise Test72081712Straight Leg Raise Test72081714Knee extension Test72081714Knee extension Test72081712
045123
Continuous Adductor Canal Nerve Catheter1
Continuous Adductor Canal Nerve Catheter3
Long-Acting Single Bolus Adductor Canal Nerve Block7
Long-Acting Single Bolus Adductor Canal Nerve Block4
Continuous Adductor Canal Nerve Catheter8
Continuous Adductor Canal Nerve Catheter2
Continuous Adductor Canal Nerve Catheter11
Long-Acting Single Bolus Adductor Canal Nerve Block9
Continuous Adductor Canal Nerve Catheter9
Long-Acting Single Bolus Adductor Canal Nerve Block3
Continuous Adductor Canal Nerve Catheter6
Long-Acting Single Bolus Adductor Canal Nerve Block2
Long-Acting Single Bolus Adductor Canal Nerve Block1

[back to top]

Subjective Postoperative Pain Score at Post Operative Week 6 of Preoperative Femoral Nerve Block Plus Postoperative Continuous Adductor Canal Nerve Catheter Compared to Preoperative Femoral Nerve Block Plus Postoperative Saphenous Nerve Block

Subjective postoperative pain score at post operative week 6 of preoperative femoral nerve block plus postoperative continuous adductor canal nerve catheter compared to preoperative femoral nerve block plus postoperative saphenous nerve block using Subjective Numeric Pain Scale score with and without activity (on an 11 point scale when 0 is no pain and 10 is worst pain). (NCT02584452)
Timeframe: Post Operative Week 6

InterventionParticipants (Count of Participants)
With activity72081712With activity72081714Without activity72081714Without activity72081712
0 (Pain on Subjective Numeric Pain Scale)1 (Pain on Subjective Numeric Pain Scale)2 (Pain on Subjective Numeric Pain Scale)3 (Pain on Subjective Numeric Pain Scale)5 (Pain on Subjective Numeric Pain Scale)4 (Pain on Subjective Numeric Pain Scale)
Continuous Adductor Canal Nerve Catheter8
Long-Acting Single Bolus Adductor Canal Nerve Block9
Continuous Adductor Canal Nerve Catheter5
Long-Acting Single Bolus Adductor Canal Nerve Block1
Continuous Adductor Canal Nerve Catheter10
Continuous Adductor Canal Nerve Catheter3
Long-Acting Single Bolus Adductor Canal Nerve Block3
Continuous Adductor Canal Nerve Catheter22
Long-Acting Single Bolus Adductor Canal Nerve Block14
Continuous Adductor Canal Nerve Catheter4
Long-Acting Single Bolus Adductor Canal Nerve Block4
Continuous Adductor Canal Nerve Catheter2
Continuous Adductor Canal Nerve Catheter1
Long-Acting Single Bolus Adductor Canal Nerve Block0
Continuous Adductor Canal Nerve Catheter0

[back to top]

Total Postop Opioid Consumption of Patients Receiving (1) Preoperative Femoral Nerve Block Plus Postoperative Continuous Adductor Canal Nerve Catheter Compared to (2) Preoperative Femoral Nerve Block Plus Postoperative Saphenous Nerve Block.

Total postop opioid consumption measured by total pain pills on POD 2 and 3 of patients receiving (1) preoperative femoral nerve block plus postoperative continuous adductor canal nerve catheter compared to (2) preoperative femoral nerve block plus postoperative saphenous nerve block. (NCT02584452)
Timeframe: Post Operative Day 2 and 3

InterventionParticipants (Count of Participants)
Post Operative Day 272081712Post Operative Day 272081714Post Operative Day 372081714Post Operative Day 372081712
0 pills1 pill2 pills3 pills4 pills4.5 pills5 pills6 pills7 pills8 pills9 pills10 pills11 pills12 pills13 pills
Long-Acting Single Bolus Adductor Canal Nerve Block3
Continuous Adductor Canal Nerve Catheter9
Long-Acting Single Bolus Adductor Canal Nerve Block5
Continuous Adductor Canal Nerve Catheter3
Continuous Adductor Canal Nerve Catheter6
Continuous Adductor Canal Nerve Catheter4
Long-Acting Single Bolus Adductor Canal Nerve Block4
Continuous Adductor Canal Nerve Catheter7
Continuous Adductor Canal Nerve Catheter2
Long-Acting Single Bolus Adductor Canal Nerve Block2
Long-Acting Single Bolus Adductor Canal Nerve Block0
Continuous Adductor Canal Nerve Catheter1
Long-Acting Single Bolus Adductor Canal Nerve Block1
Continuous Adductor Canal Nerve Catheter0

[back to top]

Quadriceps Strength on POD Week 6- Pts Receiving (1) Long-acting Single Bolus Adductor Canal Nerve Block Comparied to (2) Continuous Adductor Canal Nerve Catheter.

Quadriceps strength on POD week 6- pts receiving (1) long-acting single bolus adductor canal nerve block comparied to (2) continuous adductor canal nerve catheter using Straight Leg Raise Tests, 0-5/5 scale, and knee extension, 0-5/5 scale. On both scales (straight leg raise test and knee extension) 0 indicates the minimum value (low muscle contraction/no movement) and 5 indicates the maximum (normal muscle contraction /pt holds position against pressure). (NCT02584452)
Timeframe: Post Operative Week 6

InterventionParticipants (Count of Participants)
Straight Leg Raise Test72081712Straight Leg Raise Test72081714Knee extension Test72081712Knee extension Test72081714
345
Continuous Adductor Canal Nerve Catheter1
Long-Acting Single Bolus Adductor Canal Nerve Block1
Continuous Adductor Canal Nerve Catheter15
Long-Acting Single Bolus Adductor Canal Nerve Block9
Long-Acting Single Bolus Adductor Canal Nerve Block10
Continuous Adductor Canal Nerve Catheter3
Long-Acting Single Bolus Adductor Canal Nerve Block3
Continuous Adductor Canal Nerve Catheter21
Long-Acting Single Bolus Adductor Canal Nerve Block12
Continuous Adductor Canal Nerve Catheter7
Long-Acting Single Bolus Adductor Canal Nerve Block5

[back to top]

"Percent of Patients Rating Their Satisfaction as Excellent or Good"

Patient satisfaction will be reported on a scale of excellent, good, satisfactory, or poor, two weeks following surgery. (NCT02604550)
Timeframe: 2 Weeks Post-Surgery

Interventionpercentage of participants (Number)
Femoral Nerve Block39
Adductor Canal Block64

[back to top]

Patient-Reported Vomiting

Total occurrences of patient-reported vomiting post-surgery. (NCT02604550)
Timeframe: Post-Surgery (up to 6 days)

Interventionoccurrence of vomiting (Number)
Femoral Nerve Block1
Adductor Canal Block1

[back to top]

Pain Score

Pain scores range from 0 (no pain at all) to 10 (worst imaginable pain). Pain level was reported at the time of discharge from the surgery recovery room, the evening of the day of surgery, and then three times per day for six days post-surgery. During the six days after surgery, the morning assessment asked about typical knee pain levels overnight, the afternoon assessment asked about knee pain levels since the morning entry, and the evening assessment asked about knee pain levels since the afternoon entry. (NCT02604550)
Timeframe: Post-surgery (day of surgery to 6 days post-surgery)

,
Interventionunits on a scale (Mean)
Recovery room dischargeDay of surgery, eveningPost-surgery Day 1 - MorningPost-surgery Day 1 - AfternoonPost-surgery Day 1 - EveningPost-surgery Day 2 - MorningPost-surgery Day 2 - AfternoonPost-surgery Day 2 - EveningPost-surgery Day 3 - MorningPost-surgery Day 3 - AfternoonPost-surgery Day 3 - EveningPost-surgery Day 4 - MorningPost-surgery Day 4 - AfternoonPost-surgery Day 4 - EveningPost-surgery Day 5 - MorningPost-surgery Day 5 - AfternoonPost-surgery Day 5 - EveningPost-surgery Day 6 - MorningPost-surgery Day 6 - AfternoonPost-surgery Day 6 - Evening
Adductor Canal Block4.05.15.75.06.05.34.64.54.03.43.73.02.73.33.13.33.33.13.22.8
Femoral Nerve Block4.13.95.75.15.55.44.54.34.23.84.03.53.24.03.73.63.43.73.22.7

[back to top]

Number of Percocet Tablets Consumed

Participants recorded the total number of Percocet 7.5/325 (acetaminophen and oxycodone) tablets they took every day, in order to assess post-surgical use of opioids between the study arms, (NCT02604550)
Timeframe: Post surgery, Day 0 to Day 6

,
Interventioncount of tablets (Mean)
Day of surgery (Day 0)Post-surgery Day 1Post-surgery Day 2Post-surgery Day 3Post-surgery Day 4Post-surgery Day 5Post-surgery Day 6
Adductor Canal Block2.44.73.62.21.21.40.4
Femoral Nerve Block2.04.63.72.31.10.60.3

[back to top]

Total Hours of Sleep

The total hours of sleep first postoperative night, between 0 to 12 hours. (NCT02604550)
Timeframe: First Postoperative Night (up to 12 hours)

Interventionhours (Mean)
Femoral Nerve Block6.3
Adductor Canal Block5.8

[back to top]

Time to Straight Less Raise

The amount of time (in hours) it takes for participants to have the ability to perform a straight leg raise post-surgery. (NCT02604550)
Timeframe: Post-Surgery (up to 6 days)

Interventionhours (Mean)
Femoral Nerve Block31.7
Adductor Canal Block16.4

[back to top]

Patient-Reported Sedation

Total occurrences of patient-reported feelings of sedation post-surgery. (NCT02604550)
Timeframe: Post-Surgery (up to 6 days)

Interventionoccurrence of sedation (Number)
Femoral Nerve Block0
Adductor Canal Block0

[back to top]

Patient-Reported Nausea

Total occurrences of patient-reported nausea post-surgery. (NCT02604550)
Timeframe: Post-Surgery (up to 6 days)

Interventionoccurrence of nausea (Number)
Femoral Nerve Block3
Adductor Canal Block2

[back to top]

Patient-Reported Itching

Total occurrences of patient-reported itching post-surgery. (NCT02604550)
Timeframe: Post-Surgery (up to 6 days)

Interventionoccurrence of itching (Number)
Femoral Nerve Block2
Adductor Canal Block1

[back to top]

Patient-Reported Constipation

Total occurrences of patient-reported constipation post-surgery. (NCT02604550)
Timeframe: Post-Surgery (up to 6 days)

Interventionoccurrence of constipation (Number)
Femoral Nerve Block2
Adductor Canal Block1

[back to top]

Patient Reported Pain by VAS Scale

Patients will rate their pain by VAS scale 2 days post surgery. Scale is a 0 to 10 visual analog scale with 0 representing no pain and 10 representing severe pain. (NCT02652156)
Timeframe: Postoperative Day 2

Interventionscore on a scale (Mean)
Single Injection of Bupivacaine4.2
Single Injection of Exparel®2.0
Continuous Infusion of Ropivacaine5.3

[back to top]

Patient Reported Pain by VAS Scale

Patients will rate their pain by VAS scale 1 day post surgery. Scale is a 0 to 10 visual analog scale with 0 representing no pain and 10 representing severe pain. (NCT02652156)
Timeframe: Postoperative Day 1

Interventionscore on a scale (Mean)
Single Injection of Bupivacaine4.4
Single Injection of Exparel®3.8
Continuous Infusion of Ropivacaine4.5

[back to top]

Patient Reported Pain by VAS Scale

Patients will rate their pain by VAS scale 3 days post surgery. Scale is a 0 to 10 visual analog scale with 0 representing no pain and 10 representing severe pain. (NCT02652156)
Timeframe: Postoperative Day 3

Interventionscore on a scale (Mean)
Single Injection of Bupivacaine4.0
Single Injection of Exparel®2.2
Continuous Infusion of Ropivacaine3.8

[back to top]

Postoperative Vomiting (Events)

Total number of vomiting episodes over the three postoperative days. (NCT02652156)
Timeframe: 3 postoperative days

InterventionVomiting Events (Number)
Single Injection of Bupivacaine0
Single Injection of Exparel®0
Continuous Infusion of Ropivacaine0

[back to top]

Total Dosage of Narcotic

The total use of analgesic medications will be recorded during the 3 days immediately following surgery. (NCT02652156)
Timeframe: 3 postoperative days

,,
InterventionMophine Equivalent Units (Mean)
Narcotic Use - Day of Surgery - Recovery roomNarcotic Use - Postoperative Day 0Narcotic Use - Postoperative Day 1Narcotic Use - Postoperative Day 2Narcotic Use - Postoperative Day 3
Continuous Infusion of Ropivacaine35.745.047.944.768.0
Single Injection of Bupivacaine23.233.087.7127.0318.0
Single Injection of Exparel®14.442.2139.0103.341.6

[back to top]

Number of Days Required for a Patient to Walk Unassisted

Patients will be assessed each day following the day of surgery for the ability to walk unassisted (NCT02652156)
Timeframe: Assessed daily for up to 3 days post-surgery

Interventiondays (Mean)
Single Injection of Bupivacaine1.3
Single Injection of Exparel®1.5
Continuous Infusion of Ropivacaine1.3

[back to top]

Number of Days Required for a Patient to Get Out of Bed

Patients will be assessed each day following the day of surgery for the ability to get out of bed. (NCT02652156)
Timeframe: Assessed daily for up to 3 days post-surgery

Interventiondays (Mean)
Single Injection of Bupivacaine1.0
Single Injection of Exparel®0.8
Continuous Infusion of Ropivacaine0.3

[back to top]

Opioid Requirements (Morphine Equivalents)

How much opioid did patient ask for within 48 hours post op (NCT02653144)
Timeframe: 48 hours

Interventionmorphine milligram equivalent (Mean)
Dexmedetomidine and Ropivacaine Group52.5
Dexamethasone and Ropivacaine Group30
Ropivacaine Only Group40

[back to top]

Opioid Requirements (Morphine Equivalents)

How much opioid did patient ask for within 24 hours post op (NCT02653144)
Timeframe: 24 hours

Interventionmorphine milligram equivalent (Mean)
Dexmedetomidine and Ropivacaine Group15
Dexamethasone and Ropivacaine Group15
Ropivacaine Only Group22.5

[back to top]

Time to Discharge From PACU to First Opioid Consumption

How long after surgery does patient take to ask for opioid to manage pain (NCT02653144)
Timeframe: 24-48 hours after surgery

Interventionminutes (Mean)
Dexmedetomidine and Ropivacaine Group1280
Dexamethasone and Ropivacaine Group1130
Ropivacaine Only Group900

[back to top]

Return of Motor and Sensory Function

Between 24 to 48 hours after surgery, questionnaire will be used to determine if motor and sensory function have returned. (NCT02653144)
Timeframe: 24-48 hours after surgery

Interventionminutes (Median)
Dexmedetomidine and Ropivacaine Group1280
Dexamethasone and Ropivacaine Group1130
Ropivacaine Only Group900

[back to top]

Opioid Usage In-hospital at 24 Hours

Total amount of opioids used per patient (measured with Morphine Equivalent Units) (NCT02658149)
Timeframe: 24 hours postoperatively

InterventionMorphine Equivalent Units (Oral) (Mean)
Psoas Compartment Block19.5
Periarticular Local Anesthetic16.7

[back to top]

Pain Score at 3-24 Hours

Visual Analog Scale 0-10; 0 = no pain, 10 = worst pain (NCT02658149)
Timeframe: measured once during time frame 3 hours-24 hours postoperative

Interventionunits on a scale (Mean)
Psoas Compartment Block1.9
Periarticular Local Anesthetic1.3

[back to top]

Pain Score at 3 Hours

Visual Analog Scale 0-10; 0 = no pain, 10 = worst pain (NCT02658149)
Timeframe: 3 hours postoperative

Interventionunits on a scale (Mean)
Psoas Compartment Block4.0
Periarticular Local Anesthetic2.9

[back to top]

Pain Score at 24-48 Hours

Visual Analog Scale 0-10; 0 = no pain, 10 = worst pain (NCT02658149)
Timeframe: measured once during time froma 24-48 hours postoperative

Interventionunits on a scale (Mean)
Psoas Compartment Block1.9
Periarticular Local Anesthetic1.7

[back to top]

Opioid Usage In-hospital at 48 Hours

Total amount of opioids used per patient (measured with Morphine Equivalent Units) (NCT02658149)
Timeframe: 48 hours postoperatively

InterventionMorphine Equivalent Units (Oral) (Mean)
Psoas Compartment Block22.3
Periarticular Local Anesthetic20.8

[back to top]

Postoperative Pain Score With Movement

The Visual Analog Pain Score (VAS) with movement on the scale of 10 (0= No pain, 10= Worst pain) at 48 hours postoperatively (NCT02658240)
Timeframe: Postoperative 48 hours

Interventionunits on a scale (Mean)
Compartment Block3
Infiltration4

[back to top]

Postoperative Pain Score at Resting

The Visual Analog Pain Score (VAS) at resting on the scale of 10 (0= No pain, 10= Worst pain) at 48 hours postoperatively (NCT02658240)
Timeframe: Postoperative 48 hours

Interventionunits on a scale (Median)
Compartment Block1
Infiltration2

[back to top]

The Time to Ambulation

The time to ambulation during 48 hours postoperative period (NCT02658240)
Timeframe: Postoperative 48 hours

InterventionHours (Median)
Compartment Block21.3
Infiltration22

[back to top]

Oral Morphine Equivalents of Postoperative Opioid Requirements for 48 Hours

Total amounts of postoperative opioid requirements for 48 hours postoperatively (NCT02658240)
Timeframe: Postoperative 48 hours

InterventionOral Morphine Equivalent (mg) (Mean)
Compartment Block101.0
Infiltration115.6

[back to top]

Sensation in the Peroneal Nerve Distribution

Number of participants with self reported on a 3-point scale; 0=normal (No Sensory Block), 1= absent cold perception but touch sensation in tact (Partial Sensory Block), 2= absence of touch sensation (Complete Sensory Block) (NCT02701296)
Timeframe: Upon emergence from anesthesia in the PACU

,
InterventionParticipants (Count of Participants)
Complete Sensory BlockPartial Sensory BlockNo Sensory Block
Posterior Capsular Injection2337
Tibial Nerve Block11124

[back to top]

Plantar Flexion in the Tibial Nerve Distribution

Blinded nurse assessment on a 3-point scale 0= normal (No Motor Block), 1= weak (Partial Motor Block), 2 = absent (Complete Motor Block) (NCT02701296)
Timeframe: Upon emergence from anesthesia in the PACU

,
InterventionParticipants (Count of Participants)
Complete Motor BlockPartial Motor BlockNo Motor Block
Posterior Capsular Injection1338
Tibial Nerve Block02511

[back to top]

Pain Intensity

Mean Numeric Pain Rating Scale (NPRS) self-reported pain Intensity on a 11-point score (0=no pain to 10= worst possible) in Post Anesthesia Care Unit (PACU) and every 6 hours for 48 hours post surgery (NCT02701296)
Timeframe: 48 hours post surgery

,
Interventionpain score (Mean)
PACU AdmissionPACU Discharge6th hour12th hour18th hour24th hour30th hour36th hour42nd hour48th hour
Posterior Capsular Injection3.52.11.92.02.32.72.62.53.22.5
Tibial Nerve Block3.21.52.01.23.23.43.02.73.23.4

[back to top]

Cold Sensation in the Tibial Nerve Distribution

Number of participants with a self reported on a 3-point scale; 0=normal (No Sensory Block), 1= absent cold perception but touch sensation in tact (Partial Sensory Block), 2= absence of touch sensation (Complete Sensory Block) (NCT02701296)
Timeframe: Upon emergence from anesthesia in the PACU

,
InterventionParticipants (Count of Participants)
Complete Sensory BlockPartial Sensory BlockNo Sensory Block
Posterior Capsular Injection1734
Tibial Nerve Block6273

[back to top]

Dorsiflexion in the Peroneal Nerve Distribution

Number of participants with a blinded nurse assessment on a 3-point scale 0= normal (No Motor Block), 1= weak (Partial Motor Block), 2 = absent (Complete Motor Block) (NCT02701296)
Timeframe: Upon emergence from anesthesia in the PACU

,
InterventionParticipants (Count of Participants)
Complete Motor BlockPartial Motor BlockNo Motor Block
Posterior Capsular Injection0141
Tibial Nerve Block0432

[back to top]

Opioid Consumption

Amount of opioid used for the first 24 hours post surgery (NCT02701296)
Timeframe: 24 hours post surgery

Interventionmg (Mean)
Posterior Capsular Injection0.33
Tibial Nerve Block0.42

[back to top]

Usage Frequency of Cardiovascular Drugs: Ephedrine

Cardiovascular drugs as defined under interventions. Frequency of patients receiving the drug. Cardiovascular drugs that were given in <1% of cases are not reported. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionParticipants (Count of Participants)
Usual Care Group9310
Hypotension Decision Support2718

[back to top]

Usage Frequency of Cardiovascular Drugs: Ephinephrine

Cardiovascular drugs as defined under interventions. Frequency of patients receiving the drug. Cardiovascular drugs that were given in <1% of cases are not reported. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionParticipants (Count of Participants)
Usual Care Group1215
Hypotension Decision Support409

[back to top]

In-hospital Mortality

Hospital mortality rate during a single hospital admission after the surgery (NCT02726620)
Timeframe: All postoperative days during a single hospital admission, expected median of 5 days

InterventionParticipants (Count of Participants)
Usual Care Group487
Hypotension Decision Support137

[back to top]

Estimated Intraoperative Blood Loss

The estimated blood loss in mL during the surgical procedure (NCT02726620)
Timeframe: During the surgical procedure: an expected average of 2 hours

InterventionmL (Median)
Usual Care Group100
Hypotension Decision Support75

[back to top]

Depth and Duration of Intraoperative Hypotension - Threshold MAP 75 mmHg

Depth and duration of intraoperative hypotension will be modeled by calculating areas under the threshold for mean arterial pressures (MAPs). Thresholds will vary from 75 mmHg to 50 mmHg in 5 mmHg decrements. Together these variables represent the depth and duration of intraoperative hypotension. To optimize goodness of fit of these variables, the decremental steps may be increased to 10 mmHg and more restrictive lowest and highest thresholds may be chosen for the statistical analysis. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionmmHg*minute (Median)
Usual Care Group485
Hypotension Decision Support417

[back to top]

Depth and Duration of Intraoperative Hypotension - Threshold MAP 70 mmHg

Depth and duration of intraoperative hypotension will be modeled by calculating areas under the threshold for mean arterial pressures (MAPs). Thresholds will vary from 75 mmHg to 50 mmHg in 5 mmHg decrements. Together these variables represent the depth and duration of intraoperative hypotension. To optimize goodness of fit of these variables, the decremental steps may be increased to 10 mmHg and more restrictive lowest and highest thresholds may be chosen for the statistical analysis. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionmmHg*minute (Median)
Usual Care Group273
Hypotension Decision Support235

[back to top]

Depth and Duration of Intraoperative Hypotension - Threshold MAP 65 mmHg

Depth and duration of intraoperative hypotension will be modeled by calculating areas under the threshold for mean arterial pressures (MAPs). Thresholds will vary from 75 mmHg to 50 mmHg in 5 mmHg decrements. Together these variables represent the depth and duration of intraoperative hypotension. To optimize goodness of fit of these variables, the decremental steps may be increased to 10 mmHg and more restrictive lowest and highest thresholds may be chosen for the statistical analysis. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionmmHg*minute (Median)
Usual Care Group96
Hypotension Decision Support86

[back to top]

Depth and Duration of Intraoperative Hypotension - Threshold MAP 60 mmHg

Depth and duration of intraoperative hypotension will be modeled by calculating areas under the threshold for mean arterial pressures (MAPs). Thresholds will vary from 75 mmHg to 50 mmHg in 5 mmHg decrements. Together these variables represent the depth and duration of intraoperative hypotension. To optimize goodness of fit of these variables, the decremental steps may be increased to 10 mmHg and more restrictive lowest and highest thresholds may be chosen for the statistical analysis. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionmmHg*minute (Median)
Usual Care Group57
Hypotension Decision Support52

[back to top]

Depth and Duration of Intraoperative Hypotension - Threshold MAP 55 mmHg

Depth and duration of intraoperative hypotension will be modeled by calculating areas under the threshold for mean arterial pressures (MAPs). Thresholds will vary from 75 mmHg to 50 mmHg in 5 mmHg decrements. Together these variables represent the depth and duration of intraoperative hypotension. To optimize goodness of fit of these variables, the decremental steps may be increased to 10 mmHg and more restrictive lowest and highest thresholds may be chosen for the statistical analysis. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionmmHg*minute (Median)
Usual Care Group23
Hypotension Decision Support23

[back to top]

Incidence of a MAP < 50 mmHg

Incidence of a mean arterial pressure (MAP) < 50 mmHg during anesthesia for 1 minute or more. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionParticipants (Count of Participants)
Usual Care Group7781
Hypotension Decision Support2196

[back to top]

Depth and Duration of Intraoperative Hypotension - Threshold MAP 50 mmHg

Depth and duration of intraoperative hypotension will be modeled by calculating areas under the threshold for mean arterial pressures (MAPs). Thresholds will vary from 75 mmHg to 50 mmHg in 5 mmHg decrements. Together these variables represent the depth and duration of intraoperative hypotension. To optimize goodness of fit of these variables, the decremental steps may be increased to 10 mmHg and more restrictive lowest and highest thresholds may be chosen for the statistical analysis. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionmmHg*minute (Median)
Usual Care Group19
Hypotension Decision Support19

[back to top]

Average Use of Cardiovascular Drugs: Phenylephrine

Cardiovascular drugs as defined under interventions. Average use for each drug will be calculated. Cardiovascular drugs that were given in <1% of cases are not reported, as the average dosage would be meaningless. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

Interventionmg (Median)
Usual Care Group0.90
Hypotension Decision Support1.30

[back to top]

Average Use of Cardiovascular Drugs: Norepinephrine

Cardiovascular drugs as defined under interventions. Average use for each drug will be calculated. Cardiovascular drugs that were given in <1% of cases are not reported, as the average dosage would be meaningless. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

Interventionmg (Median)
Usual Care Group0.62
Hypotension Decision Support0.70

[back to top]

Incidence of a MAP < 55 mmHg for > 20 Minutes

Incidence of a mean arterial pressure (MAP) < 55 mmHg for a cumulative duration of all hypotensive episodes of more than 20 minutes during the anesthetic phase of the procedure. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionParticipants (Count of Participants)
Usual Care Group1223
Hypotension Decision Support284

[back to top]

Incidence of a MAP < 60 mmHg

Incidence of a mean arterial pressure (MAP) < 60 mmHg during anesthesia for 1 minute or more. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionParticipants (Count of Participants)
Usual Care Group13779
Hypotension Decision Support3798

[back to top]

Incidence of a MAP < 60 mmHg for > 10 Minutes

Incidence of a mean arterial pressure (MAP) < 60 mmHg for a cumulative duration of all hypotensive episodes of more than 10 minutes during the anesthetic phase of the procedure. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionParticipants (Count of Participants)
Usual Care Group6989
Hypotension Decision Support1723

[back to top]

Incidence of a MAP < 60 mmHg for > 20 Minutes

Incidence of a mean arterial pressure (MAP) < 60 mmHg for a cumulative duration of all hypotensive episodes of more than 20 minutes during the anesthetic phase of the procedure. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionParticipants (Count of Participants)
Usual Care Group3632
Hypotension Decision Support792

[back to top]

Intraoperative Administration of Intravenous Fluids

Total amount (mL) of intravenous fluids (as defined under interventions) administered during the surgical procedure. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionmL (Median)
Usual Care Group1500.00
Hypotension Decision Support1400.00

[back to top]

Intravenous Anesthetic Drug Use During Intraoperative Hypotension: MAP < 50 mmHg

Average concentrations of propofol infusion rates during MAP < 50 mmHg episodes (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

Interventionmcg/kg/min (propofol) (Median)
Usual Care Group65.00
Hypotension Decision Support50.00

[back to top]

Average Use of Cardiovascular Drugs: Glycopyrrolate

Cardiovascular drugs as defined under interventions. Average use for each drug will be calculated. Cardiovascular drugs that were given in <1% of cases are not reported, as the average dosage would be meaningless. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

Interventionmg (Median)
Usual Care Group0.40
Hypotension Decision Support0.40

[back to top]

Average Use of Cardiovascular Drugs: Epinephrine

Cardiovascular drugs as defined under interventions. Average use for each drug will be calculated. Cardiovascular drugs that were given in <1% of cases are not reported, as the average dosage would be meaningless. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

Interventionmg (Median)
Usual Care Group1.00
Hypotension Decision Support0.70

[back to top]

Inhaled Anesthetic Drug Use During Intraoperative Hypotension: MAP < 65 mmHg

Average concentrations of inhalational anesthesia during MAP < 65 mmHg episodes (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

,
InterventionEndTidal% (other) (Median)
Sevoflurane (EndTidal %)Isoflurane (EndTidal %)Desflurane (EndTidal %)
Hypotension Decision Support1.270.682.31
Usual Care Group1.350.684.10

[back to top]

Inhaled Anesthetic Drug Use During Intraoperative Hypotension: MAP < 60 mmHg

Average concentrations of inhalational anesthesia during MAP < 60 mmHg episodes (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

,
InterventionEndTidal% (other) (Median)
Sevoflurane (EndTidal %)Isoflurane (EndTidal %)Desflurane (EndTidal %)
Hypotension Decision Support1.250.672.33
Usual Care Group1.350.684.36

[back to top]

Inhaled Anesthetic Drug Use During Intraoperative Hypotension: MAP < 55 mmHg

Average concentrations of inhalational anesthesia during MAP < 55 mmHg episodes (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

,
InterventionEndTidal% (other) (Median)
Sevoflurane (EndTidal %)Isoflurane (EndTidal %)Desflurane (EndTidal %)
Hypotension Decision Support1.250.674.65
Usual Care Group1.340.684.60

[back to top]

Intravenous Anesthetic Drug Use During Intraoperative Hypotension: MAP < 60 mmHg

Average concentrations of propofol infusion rates during MAP < 60 mmHg episodes (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

Interventionmcg/kg/min (propofol) (Median)
Usual Care Group61.07
Hypotension Decision Support50.00

[back to top]

Intravenous Anesthetic Drug Use During Intraoperative Hypotension: MAP < 55 mmHg

Average concentrations of propofol infusion rates during MAP < 55 mmHg episodes (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

Interventionmcg/kg/min (propofol) (Median)
Usual Care Group63.95
Hypotension Decision Support50.00

[back to top]

Inhaled Anesthetic Drug Use During Intraoperative Hypotension: MAP < 50 mmHg

Average concentrations of inhalational anesthesia during MAP < 50 mmHg episodes (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

,
InterventionEndTidal% (other) (Median)
Sevoflurane (EndTidal %)Isoflurane (EndTidal %)Desflurane (EndTidal %)
Hypotension Decision Support1.230.654.70
Usual Care Group1.320.654.28

[back to top]

Usage Frequency of Cardiovascular Drugs: Phenylephrine

Cardiovascular drugs as defined under interventions. Frequency of patients receiving the drug. Cardiovascular drugs that were given in <1% of cases are not reported. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionParticipants (Count of Participants)
Usual Care Group12211
Hypotension Decision Support3685

[back to top]

Usage Frequency of Cardiovascular Drugs: Norepinephrine

Cardiovascular drugs as defined under interventions. Frequency of patients receiving the drug. Cardiovascular drugs that were given in <1% of cases are not reported. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionParticipants (Count of Participants)
Usual Care Group762
Hypotension Decision Support233

[back to top]

Usage Frequency of Cardiovascular Drugs: Glycopyrrolate

Cardiovascular drugs as defined under interventions. Frequency of patients receiving the drug. Cardiovascular drugs that were given in <1% of cases are not reported. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionParticipants (Count of Participants)
Usual Care Group11093
Hypotension Decision Support1257

[back to top]

Incidence of a MAP < 55 mmHg for > 10 Minutes

Incidence of a mean arterial pressure (MAP) < 55 mmHg for a cumulative duration of all hypotensive episodes of more than 10 minutes during the anesthetic phase of the procedure. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionParticipants (Count of Participants)
Usual Care Group3181
Hypotension Decision Support759

[back to top]

Incidence of a MAP < 55 mmHg

Incidence of a mean arterial pressure (MAP) < 55 mmHg during anesthesia for 1 minute or more. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionParticipants (Count of Participants)
Usual Care Group10991
Hypotension Decision Support3045

[back to top]

Incidence of a MAP < 50 mmHg for > 20 Minutes

Incidence of a mean arterial pressure (MAP) < 50 mmHg for a cumulative duration of all hypotensive episodes of more than 20 minutes during the anesthetic phase of the procedure. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionParticipants (Count of Participants)
Usual Care Group304
Hypotension Decision Support85

[back to top]

Incidence of a MAP < 50 mmHg for > 10 Minutes

Incidence of a mean arterial pressure (MAP) < 50 mmHg for a cumulative duration of all hypotensive episodes of more than 10 minutes during the anesthetic phase of the procedure. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

InterventionParticipants (Count of Participants)
Usual Care Group1159
Hypotension Decision Support326

[back to top]

30-day Mortality

Vanderbilt University Medical Center: combination of in-hospital mortality and 'alive-index' (which checks for visits to the hospital in the electronic healthcare record as indication of being alive at 30 days) (NCT02726620)
Timeframe: 30 days after surgery

InterventionParticipants (Count of Participants)
Usual Care Group511
Hypotension Decision Support143

[back to top]

Average Use of Cardiovascular Drugs: Ephedrine

Cardiovascular drugs as defined under interventions. Average use for each drug will be calculated. Cardiovascular drugs that were given in <1% of cases are not reported, as the average dosages would be meaningless. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

Interventionmg (Median)
Usual Care Group20
Hypotension Decision Support15

[back to top]

Time to Discharge Readiness at the Postanesthesia Care Unit (PACU)

The time from arriving at the postanesthesia care unit (PACU) until the time the patient is considered ready for discharge (in minutes). (NCT02726620)
Timeframe: A specific time frame on the day of surgery: from the start of admission to the PACU to discharge from the PACU, an expected average of 4 hours

Interventionminutes (Median)
Usual Care Group67
Hypotension Decision Support60

[back to top]

Timing of Cardiovascular Drugs for MAP < 50 mmHg

Cardiovascular drugs as defined under interventions. Time of first administration of cardiovascular drug relative to the time at which the mean arterial pressure (MAP) drops below 50 mmHg. Per patient the average time to first administration of all hypotensive episodes was calculated. That average time is used as the outcome variable. A negative value indicates that administration occurred before the drop in MAP. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

Interventionminutes (Median)
Usual Care Group1
Hypotension Decision Support0

[back to top]

Timing of Cardiovascular Drugs for MAP < 55 mmHg

Cardiovascular drugs as defined under interventions. Time of first administration of cardiovascular drug relative to the time at which the mean arterial pressure (MAP) drops below 55 mmHg. Per patient the average time to first administration of all hypotensive episodes was calculated. That average time is used as the outcome variable. A negative value indicates that administration occurred before the drop in MAP. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

Interventionminutes (Median)
Usual Care Group1
Hypotension Decision Support0.5

[back to top]

Timing of Cardiovascular Drugs for MAP < 60 mmHg

Cardiovascular drugs as defined under interventions. Time of first administration of cardiovascular drug relative to the time at which the mean arterial pressure (MAP) drops below 60 mmHg. Per patient the average time to first administration of all hypotensive episodes was calculated. That average time is used as the outcome variable. A negative value indicates that administration occurred before the drop in MAP. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

Interventionminutes (Median)
Usual Care Group0.8
Hypotension Decision Support1.5

[back to top]

Timing of Cardiovascular Drugs for MAP < 65 mmHg

Cardiovascular drugs as defined under interventions. Time of first administration of cardiovascular drug relative to the time at which the mean arterial pressure (MAP) drops below 60 mmHg. Per patient the average time to first administration of all hypotensive episodes was calculated. That average time is used as the outcome variable. A negative value indicates that administration occurred before the drop in MAP. (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

Interventionminutes (Median)
Usual Care Group2
Hypotension Decision Support1.14

[back to top]

Intravenous Anesthetic Drug Use During Intraoperative Hypotension: MAP < 65 mmHg

Average concentrations of propofol infusion rates during MAP < 65 mmHg episodes (NCT02726620)
Timeframe: During the anesthetic phase of the surgical procedure: an expected average of 2.5 hours

Interventionmcg/kg/min (propofol) (Median)
Usual Care Group60.10
Hypotension Decision Support48.59

[back to top]

Postoperative Rise in Creatinine Levels

Absolute values for serum creatinine before and after surgery will be compared. When multiple postoperative creatinine measurements are made, the maximum difference is reported. (NCT02726620)
Timeframe: Within 7 days after surgery

Interventionmg/dL (Median)
Usual Care Group0.00
Hypotension Decision Support0.00

[back to top]

Length of Hospital Stay

To determine whether the use of a CNB in patients undergoing penile prosthesis surgery results in a decreased length of hospital stay compared with patients having only general anesthesia. (NCT02740127)
Timeframe: 32 Hours

InterventionHours (Mean)
General Anesthesia and Caudal Nerve Block24.8424
General Anesthesia Only24.9506

[back to top]

Post-Operative Pain Medication Usage in Post Anesthesia Care Unit (PACU)

Pain evaluated by the amount of intravenous and oral pain medicine administered in the first 24 hours post-operatively. Pain assessed using the numeric rating scale (NRS). The NRS is scored by numeric integers, 0 through 10, where 0 is no pain and 10 is the worst pain. (NCT02740127)
Timeframe: 24 hours

Interventionmg (Mean)
General Anesthesia and Caudal Nerve Block13.0208
General Anesthesia Only15.1786

[back to top]

Post-operative Pain the First 24hrs

To determine whether the use of a CNB in patients undergoing penile prosthesis surgery results in decreased immediate postoperative pain in the first 24 hours after surgery compared with patients having only general anesthesia as determined by postop pain score. The mean, median and max pain will be assessed using the numeric rating scale (NRS). The NRS is scored by numeric integers, 0 through 10. The NRS will be used verbally. Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10 that fits best to their pain intensity. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible' (NCT02740127)
Timeframe: 24 hours

,
Interventionscore on a scale (Mean)
Min Pain within 24hrsMedian Pain within 24 hrsMax Pain within 24 hrs
General Anesthesia and Caudal Nerve Block1.16673.08336.125
General Anesthesia Only0.92863.71436.7857

[back to top]

Number of Grid Points With Change of Sensation to Pinprick After Blockade

The distribution of cutaneous sensation affected by the different techniques of adductor canal blockade is assessed using a monofilament Neuropen to prick points on a 20 point grid applied to the skin in a standard fashion according to this method: A grid will be marked starting with anatomical landmarks at the knee joint: the medial inter-knee-joint point where the tibia meets the femur, the mid medial patella, the mid lateral patella, and along the same line at the semitendinosus tendon and 5cm posterior from that point. Then 5cm intervals will be plotted progressing cephalad to a total of 15 centimeters. This will yield 20 grid points (5x4 points). Once the grid is made, testing proceeds with a Neuropen on a scale of 0-1, with 1 = normal sharp sensation, 0 = change of sensation. The Neuropen is used for the standardization of force. (NCT02788019)
Timeframe: 20 minutes

Interventionpoints of cutaneous sensation (Mean)
Mid-Thigh Adductor Block19.81
Distal-Thigh Adductor Block20

[back to top]

Visual Analog Scale Pain Assessment

"Patients will describe their current level of comfort on a 10 point scale while at rest. Zero corresponds to no pain and ten corresponds to the most extreme possible pain. Visual analog scores will be collected by nursing staff who are blinded to the treatment allocation." (NCT02793947)
Timeframe: Pain assessment will be collected immediately prior to surgery (pre-op), immediately following surgery in the post-anesthesia care unit (PACU), and every 4 hours following surgery for the first two post-operative days (48 hours total; 4H-48H)

,
Interventionunits on a scale (Median)
Pre-opPACU4H8H12H16H20H24H28H32H36H40H44H48H
Control (no Injection)5.03.25.05.05.04.04.04.03.55.04.03.54.03.0
Peri-incisional Injection5.01.61.02.03.53.54.03.03.03.04.03.03.03.0

[back to top] [back to top]

Total Narcotic Consumption

Parenteral and oral narcotic agents will be utilized by patients for post-operative pain control per the standard of care. No alterations in narcotic prescription behavior will be observed for this study. (NCT02793947)
Timeframe: Narcotic consumption will be recorded every 8 hours for the first two post-operative days.

Interventionmg of morphine (Mean)
Peri-incisional Injection5.0
Control (no Injection)9.7

[back to top]

Length of Stay

Time to hospital discharge (NCT02798835)
Timeframe: From surgical date until hospital discharge, up to 3 weeks

Interventionhours (Median)
Adductor Canal Block70.8
Adductor Canal Block With Dexamethasone71.5
Adductor Canal Catheter71.5

[back to top]

Pain Score

Patient's level of pain using NRS (Numeric Ratings Scale) pain scale where the range is 0 (no pain) to 10 (worst pain) (NCT02798835)
Timeframe: 12, 24 and 48 hours

,,
Interventionscore on a scale (Median)
12h24h48h
Adductor Canal Block332
Adductor Canal Block With Dexamethasone333
Adductor Canal Catheter433

[back to top]

Time to First Use of PCA

from time zero to first press of PCA button (NCT02798835)
Timeframe: 0 to 48 hours

Interventionhours (Median)
Adductor Canal Block4.1
Adductor Canal Block With Dexamethasone4.9
Adductor Canal Catheter3.8

[back to top]

Cumulative 48 Hour Oral Morphine Equivalent Consumption

Post-operative analgesia at 48 hours (NCT02798835)
Timeframe: 48 hours (Day 2)

Interventionmg (Median)
Adductor Canal Block192.9
Adductor Canal Block With Dexamethasone196
Adductor Canal Catheter223.5

[back to top]

Cumulative 24 Hour Oral Morphine Equivalent Consumption

Post-operative analgesia at 24 hours (NCT02798835)
Timeframe: 24 hours (Day 1)

Interventionmg (Median)
Adductor Canal Block111.8
Adductor Canal Block With Dexamethasone118
Adductor Canal Catheter153

[back to top]

Nerve Block Complications

Nerve block complications at any time point during study (NCT02798835)
Timeframe: 0 to 48 hours

InterventionParticipants (Count of Participants)
Adductor Canal Block0
Adductor Canal Block With Dexamethasone0
Adductor Canal Catheter0

[back to top]

Quality of Recovery (QoR-40)

Quality of recovery measured using the QoR-40 at 48 hours postoperatively. This is a validated scale where a higher score denotes better recovery/satisfaction after surgery. The range is 40-200. (NCT02798835)
Timeframe: 48 hours (Day 2)

Interventionscore on a scale (Mean)
Adductor Canal Block160.5
Adductor Canal Block With Dexamethasone166.5
Adductor Canal Catheter167.2

[back to top]

Cumulative 12 Hour Oral Morphine Equivalent Consumption

Post-operative analgesia at 12 hours (NCT02798835)
Timeframe: 12 hours (Day 0)

Interventionmg (Median)
Adductor Canal Block61.5
Adductor Canal Block With Dexamethasone49.5
Adductor Canal Catheter82

[back to top]

Adductor Canal Block Complications

Incidence of catheter dislodgement or site infection (NCT02798835)
Timeframe: From time of catheter insertion until catheter removal, up to Day2/48 hours

InterventionParticipants (Count of Participants)
Adductor Canal Block0
Adductor Canal Block With Dexamethasone0
Adductor Canal Catheter0

[back to top]

Incidence of Participants With Nausea/Vomiting Requiring Anti-emetics

Number of Participants with Nausea/Vomiting requiring anti-emetics from 0-48 hours after surgery. (NCT02798835)
Timeframe: 0 to 48 hours

,,
InterventionParticipants (Count of Participants)
0-12h12-24h24-48h
Adductor Canal Block192615
Adductor Canal Block With Dexamethasone141717
Adductor Canal Catheter192417

[back to top]

Number of Subjects Experiencing Nausea

Asking patients whether or not they experienced the symptom in the preceding time-frame (NCT02829944)
Timeframe: 2 hours

InterventionParticipants (Count of Participants)
Placebo14
Ropivacaine12

[back to top]

Number of Subjects Experiencing Nausea

Asking patients whether or not they experienced the symptom in the preceding time-frame (NCT02829944)
Timeframe: 24 hours

InterventionParticipants (Count of Participants)
Placebo9
Ropivacaine7

[back to top]

Number of Subjects Experiencing Nausea

Asking patients whether or not they experienced the symptom in the preceding time-frame (NCT02829944)
Timeframe: 48 hours

InterventionParticipants (Count of Participants)
Placebo4
Ropivacaine1

[back to top]

Number of Subjects Experiencing Pruritus

Score reported on a scale of 0-10, with 0 being none and 10 being the worst imaginable (NCT02829944)
Timeframe: 2 hours

Interventionscore on a scale (Median)
Placebo4
Ropivacaine5.5

[back to top]

Number of Subjects Experiencing Pruritus

Score reported on a scale of 0-10, with 0 being none and 10 being the worst imaginable (NCT02829944)
Timeframe: 48 hours

Interventionscore on a scale (Mean)
Placebo0
Ropivacaine0

[back to top]

Number of Subjects Experiencing Vomiting

Asking patients whether or not they experienced the symptom in the preceding time-frame (NCT02829944)
Timeframe: 2 hours

InterventionParticipants (Count of Participants)
Placebo7
Ropivacaine8

[back to top]

Number of Subjects Experiencing Vomiting

Asking patients whether or not they experienced the symptom in the preceding time-frame (NCT02829944)
Timeframe: 24 hours

InterventionParticipants (Count of Participants)
Placebo4
Ropivacaine4

[back to top]

Number of Subjects Experiencing Vomiting

Asking patients whether or not they experienced the symptom in the preceding time-frame (NCT02829944)
Timeframe: 48 hours

InterventionParticipants (Count of Participants)
Placebo1
Ropivacaine0

[back to top]

Number of Subjects With Chronic Pain

Phone interview asking patient about presence of pain at incision site (NCT02829944)
Timeframe: 6 months

InterventionParticipants (Count of Participants)
Placebo0
Ropivacaine0

[back to top]

Number of Subjects With Chronic Pain

Phone interview asking patient about presence of pain at incision site (NCT02829944)
Timeframe: 8 weeks

InterventionParticipants (Count of Participants)
Placebo3
Ropivacaine3

[back to top]

Opioid Consumption

measured in mg oxycodone equivalents (NCT02829944)
Timeframe: 2 hours

Interventionmg Oxycodone Equivalent (Median)
Placebo0
Ropivacaine0

[back to top]

Opioid Consumption

measured in mg oxycodone equivalents (NCT02829944)
Timeframe: 24 hours

Interventionmg Oxycodone Equivalent (Median)
Placebo5
Ropivacaine5

[back to top]

Opioid Consumption

measured in mg oxycodone equivalents (NCT02829944)
Timeframe: 48 hours

Interventionmg Oxycodone Equivalent (Mean)
Placebo20
Ropivacaine10

[back to top]

Pain Score on Movement

Score reported on a scale of 0-10, with 0 being none and 10 being the worst imaginable (NCT02829944)
Timeframe: 48 hours after surgery

Interventionscore on a scale (Median)
Placebo5.5
Ropivacaine5

[back to top]

Pain Score on Movement (Sitting in Bed From a Supine Position)

Score reported on a scale of 0-10, with 0 being none and 10 being the worst imaginable (NCT02829944)
Timeframe: 24 hours after surgery

Interventionscore on a scale (Median)
Placebo5
Ropivacaine5

[back to top]

Pain Scores at Rest

Score reported on a scale of 0-10, with 0 being none and 10 being the worst imaginable (NCT02829944)
Timeframe: 2 hours

Interventionscore on a scale (Median)
Placebo2
Ropivacaine0

[back to top]

Pain Scores at Rest

Score reported on a scale of 0-10, with 0 being none and 10 being the worst imaginable (NCT02829944)
Timeframe: 24 hours

Interventionscore on a scale (Mean)
Placebo2
Ropivacaine2

[back to top]

Pain Scores at Rest

Score reported on a scale of 0-10, with 0 being none and 10 being the worst imaginable (NCT02829944)
Timeframe: 48 hours

Interventionscore on a scale (Median)
Placebo2
Ropivacaine2

[back to top]

Patient Satisfaction With Postoperative Analgesia on a 0-10 Scale

Score reported on a scale of 0-10, with 0 being not at all satisfied and 10 being completely satisfied (NCT02829944)
Timeframe: 48 hours

Interventionscore on a scale (Median)
Placebo9.5
Ropivacaine8

[back to top]

Postpartum Depression, as Measured by the Edinburgh Postnatal Depression Scale

Patients contacted over the phone completed screening with the EPDS, on a scale of 0-30. A score of over 13 indicate risk for postpartum depression (NCT02829944)
Timeframe: 6 months

InterventionParticipants (Count of Participants)
Placebo3
Ropivacaine1

[back to top]

Postpartum Depression, as Measured by the Edinburgh Postnatal Depression Scale

Patients contacted over the phone completed screening with the EPDS, on a scale of 0-30. A score of over 13 indicate risk for postpartum depression (NCT02829944)
Timeframe: 8 weeks

Interventionunits on a scale (Median)
Placebo1
Ropivacaine0.5

[back to top]

Time to First Rescue Analgesic

(NCT02829944)
Timeframe: 48 hours

InterventionMinutes (Mean)
Placebo660
Ropivacaine954

[back to top]

Number of Subjects Experiencing Pruritus

Score reported on a scale of 0-10, with 0 being none and 10 being the worst imaginable (NCT02829944)
Timeframe: 24 hours

Interventionunits on a scale (Median)
Placebo3.5
Ropivacaine4

[back to top]

Postoperative Opioid Consumption (Milligrams of Dilaudid or Equivalent)

During the hospitalization following surgery until discharge. Hospital length of stay ranged from 3 - 22 days following surgery. (NCT02849678)
Timeframe: During the inpatient hospitalization (Hospital length of stay ranged from 3 - 22 days following surgery)

,
InterventionMilligrams (Mean)
Hydromorphone PACUHydromorphone 24HRSHydromorphone 48HRS
Lidocaine1.69.216.1
Ropivacaine1.15.79.6

[back to top]

Time to First Flatus/Defecation

During the hospitalization following surgery until discharge. Hospital length of stay ranged from 3 - 22 days following surgery. (NCT02849678)
Timeframe: During the inpatient hospitalization (Hospital length of stay ranged from 3 - 22 days following surgery)

InterventionPostoperative days (Median)
Lidocaine2
Ropivacaine2

[back to top]

Number of Patients With Complications (Including But Not Limited to Pneumonia, Atelectasis, Hypotension, Motor Weakness, Etc.)

During the hospitalization following surgery until discharge. (NCT02849678)
Timeframe: During the inpatient hospitalization (Hospital length of stay ranged from 3 - 22 days following surgery)

,
InterventionParticipants (Count of Participants)
Hypotension (Patient 19)Deydration with Acute Renal Failure (Patient 7)Small Bowel Obstruction (Patients 43, 24, 34)Rectal Bleeding (Patient 23)Anastamotic Dehiscence with Pelvic Abscess -Pt. 34Tremors After Anesthetic Boli (Patient 34)
Lidocaine111000
Ropivacaine002111

[back to top]

Time to First Ambulation(Walking Greater Than 15 Feet)

During the hospitalization following surgery until discharge. Hospital length of stay ranged from 3 - 22 days following surgery. (NCT02849678)
Timeframe: During the inpatient hospitalization (Hospital length of stay ranged from 3 - 22 days following surgery)

Interventiondays (Median)
Lidocaine2
Ropivacaine1

[back to top]

Consumption of Nerve Block Boluses Will Also be Recorded Daily

During the hospitalization following surgery until discontinuation of the block or discharge. Hospital length of stay ranged from 3 - 22 days following surgery. (NCT02849678)
Timeframe: During the inpatient hospitalization (Hospital length of stay ranged from 3 - 22 days following surgery)

,
Interventionmilliliters (Median)
Nerve block boluses PACUNerve block boluses 24HRSNerve block boluses 48HRS
Lidocaine2000
Ropivacaine2000

[back to top]

Hospital Length of Stay.

During the hospitalization following surgery until discharge. Hospital length of stay ranged from 3 - 22 days following surgery. (NCT02849678)
Timeframe: During the inpatient hospitalization (Hospital length of stay ranged from 3 - 22 days following surgery)

Interventiondays (Median)
Lidocaine5
Ropivacaine5

[back to top]

11-point Verbal Numerical Rating Scale (NRS) Pain Assessment

The primary outcome of the study is the NRS score for pain at rest at 24 hours. The NRS Pain Assessment requires patients to select a number between 0 - 10 where 0 is no pain and 10 is the worst imaginable pain. Patients pick one whole number on this scale to describe their pain. (NCT02849678)
Timeframe: 24 hours from the end of surgery

InterventionScores on a scale (Median)
Lidocaine3
Ropivacaine3

[back to top]

POSTOPERATIVE PAIN

Severity of postoperative pain will be assessed using(VAS) scale. Post-operative pain scale name: Visual Analog Scale (0-10) with 0 being no-pain and 10 being maximum pain. (NCT02893423)
Timeframe: 48 hours

Interventionscore on a scale (Mean)
Group 1 - 0.5% Ropivacaine2.35
Group 2 - 0.25% Ropivacaine1.94
Group 3 - No Tap Block0.56

[back to top]

Time to the Onset of Anaesthesia

The time from T0 (start time of the epidural injection) to complete loss of cold sensation to the metameric level T4 (block to T4), bilateral. (NCT02919072)
Timeframe: Up to 1 hour after last epidural injection

Interventionminutes (Mean)
Chloroprocaine9
Ropivacaine9.1

[back to top]

Time From T0 to Loss Light Touch Sensation

Time from T0 to loss light touch sensation to the metameric level T5 (block to T5), bilateral (NCT02919072)
Timeframe: Up to 1 hour after last epidural injection

Interventionminutes (Mean)
Chloroprocaine9.3
Ropivacaine13.3

[back to top]

Quality of the Block

Quality of the block assessed between 10 and 20 min after the end of surgery by the anaesthesiologist and patient together using a 0-10 cm visual analogue scale (VAS; 10=excellent anaesthetic quality, 0=very poor anaesthetic quality) (NCT02919072)
Timeframe: Quality of the block assessed between 10 and 20 minutes after the end of surgery

Interventionunits on a scale (Mean)
Chloroprocaine9.8
Ropivacaine8.4

[back to top]

Number of Participants Requiring Post-procedural Opioid Analgesia Per Study Arm

Number of participants requiring post-procedural opioid analgesia within 24 hours (+/- 4 hours) post procedure per study arm (NCT02924324)
Timeframe: within 24 hours (+/- 4 hours) post procedure

,
Interventionparticipants (Number)
Require postprocedural opioidDid not Require postprocedural opioid
Propofol & Ropivacaine2234
Propofol Alone2234

[back to top]

Numeric Pain Score at 4 Hours Postoperatively, as Measured by Numerical Rating Scale (NRS) 11

The NRS 11 ranges from 0 (no pain) to 10 (intense pain). (NCT02933671)
Timeframe: 4 hours postoperatively

Interventionscore on a scale (Mean)
Suprainguinal Fascia Iliaca (SIFI) Block2.4
Sham Group5.4

[back to top]

Cumulative Opioid Consumption

Reported in IV morphine equivalents. (NCT02933671)
Timeframe: 24 hours

InterventionIV morphine equivalents in mg (Mean)
Suprainguinal Fascia Iliaca (SIFI) Block33.8
Sham Group41.9

[back to top]

Numeric Pain Score at 24 Hours, as Measured by NRS 11

The NRS 11 ranges from 0 (no pain) to 10 (intense pain). (NCT02933671)
Timeframe: 24 hours

Interventionscore on a scale (Mean)
Suprainguinal Fascia Iliaca (SIFI) Block2.6
Sham Group5.2

[back to top]

Motor Strength, as Measured by Dynamometry

Reported as pounds per square inch (PSI). (NCT02933671)
Timeframe: 4 hours postoperatively

InterventionPSI (Mean)
Suprainguinal Fascia Iliaca (SIFI) Block28.7
Sham Group19.7

[back to top]

Ambulation, as Measured by Distanced Walked

(NCT02933671)
Timeframe: post-op day 0

Interventionfeet (Mean)
Suprainguinal Fascia Iliaca (SIFI) Block99.6
Sham Group20.8

[back to top]

Total Number of Subjects Experiencing Each Mode of Delivery

Modes of delivery: spontaneous vaginal delivery (SVD), assisted vaginal delivery (AVD), and caesarean delivery (CD) (NCT02949271)
Timeframe: duration of labor, up to 24hrs

,
InterventionParticipants (Count of Participants)
SVDAVDCD
Continuous Epidural Infusion37517
Programmed Intermittent Epidural Bolus41515

[back to top]

Degree of Motor Blockade Measured as Lowest Recorded Modified Bromage Score

The Modified Bromage Score ranges from 1-5. 1 = complete block, 2 = almost complete block, 3 = partial block, 4 = detectable weakness of hip flexion, and 5 = no detectable weakness of hip flexion while supine. (NCT02949271)
Timeframe: duration of labor, up to 24hrs

,
InterventionParticipants (Count of Participants)
Score of 5Score of 4Score of 3Score of 2Score of 1
Continuous Epidural Infusion2620321
Programmed Intermittent Epidural Bolus379410

[back to top]

Number of Subjects Who Were Satisfied With Procedure

"Determined using a 5-point scale where 1=very dissatisfied, 2=dissatisfied, 3=neutral, 4=satisfied, 5=very satisfied. Subjects were considered satisfied if selected very satisfied or satisfied on the patient questionnaire." (NCT02949271)
Timeframe: duration of labor, up to 24hrs

,
InterventionParticipants (Count of Participants)
Very satisfiedSatisfied
Continuous Epidural Infusion393
Programmed Intermittent Epidural Bolus359

[back to top]

Maximum Reported Labor Pain Score

Measured using a verbal analog pain scale of 1-10, where 0=no pain and 10=worst possible pain. (NCT02949271)
Timeframe: duration of labor, up to 24hrs

Interventionscore on a scale (Median)
Programmed Intermittent Epidural Bolus3
Continuous Epidural Infusion2

[back to top]

Number of Patient Controlled Epidural Analgesia (PCEA) Attempts

Determined by the number of times subject activates the PCEA pump (NCT02949271)
Timeframe: duration of labor, up to 24hrs

Interventionattempts (Median)
Programmed Intermittent Epidural Bolus0.75
Continuous Epidural Infusion0.63

[back to top]

Number of Subjects Experiencing Hypotension Requiring Vasopressor Treatment

Number of patients who needed a vasopressor medication to treat a drop in blood pressure (NCT02949271)
Timeframe: duration of labor, up to 24 hrs

InterventionParticipants (Count of Participants)
Programmed Intermittent Epidural Bolus8
Continuous Epidural Infusion3

[back to top]

Ratio of Patient Controlled Epidural Analgesia (PCEA) Successful Attempts to Unsuccessful Attempts

Ratio generated by the number of times subjects activates PCEA and receives additional anesthetic compared with times subject activates PCEA and does not receive additional anesthetic. (NCT02949271)
Timeframe: duration of labor, up to 24hrs

Interventionratio of attempts (Median)
Programmed Intermittent Epidural Bolus0.17
Continuous Epidural Infusion0.12

[back to top]

Volume of Local Anesthetic Received Through Patient Controlled Epidural Analgesia (PCEA) Per Hour

The volume of local anesthetic that the patient received through activation of the patient-controlled epidural analgesia system per hour. (NCT02949271)
Timeframe: duration of labor, up to 24hrs

Interventionmilliliters per hour (Median)
Programmed Intermittent Epidural Bolus4.03
Continuous Epidural Infusion4.52

[back to top]

Volume of Local Anesthetic Required Per Hour

The total volume of local anesthetic that the patient received from the CAPP pump per hour. (NCT02949271)
Timeframe: duration of labor, up to 24hrs

Interventionmilliliters per hour (Median)
Programmed Intermittent Epidural Bolus11.49
Continuous Epidural Infusion12.38

[back to top]

Duration of Second Stage of Labor

(NCT02949271)
Timeframe: duration of labor, up to 24hrs

Interventionminutes (Median)
Programmed Intermittent Epidural Bolus44
Continuous Epidural Infusion63

[back to top]

VAS

The Pain will be measured with this scale from 0 (No pain) -10 (Worst pain possible) according to the investigator at 24 hours after surgery. (NCT02949674)
Timeframe: Change in Visual Analogue Scale at 24 hours

,,
Interventionunits on a scale (VAS) (Mean)
VAS at 4 hoursVAS at 8 hoursVAS at 12 hoursVAS at 24 hours
Bupivacaine2.814.524.424.03
Control3.525.024.844.10
Ropivacaine2.133.043.553.87

[back to top]

Pain Score at 2 Weeks - Experimental Group vs. Control Group

Patients will complete Self-Administered Foot and Ankle Questionnaire at 2 weeks post surgery. For this instrument, 0 = worst possible pain and function, 48 = no pain or dysfunction. Higher scores indicate a better outcome (NCT02950558)
Timeframe: at 2 weeks post surgery

Interventionunits on a scale (Mean)
Standard Care16.22
Ropivacaine Pump13.67

[back to top]

Pain Score at 3 Months - Experimental Group vs. Control Group

Patients will complete Self-Administered Foot and Ankle Questionnaire at 3 months post surgery. 0 = worst possible pain and function, 48 = no pain or dysfunction. Higher scores indicate a better outcome. (NCT02950558)
Timeframe: at 3 months post surgery

Interventionunits on a scale (Mean)
Standard Care26.25
Ropivacaine Pump35.71

[back to top]

Pain Score at 12 Months - Experimental Group vs. Control Group

Patients will complete Self-Administered Foot and Ankle Questionnaire (SEFAS) at 12 months post surgery. 0 = worst possible pain and function, 48 = no pain or dysfunction. Higher scores indicate a better outcome. (NCT02950558)
Timeframe: at 12 months post surgery

Interventionunits on a scale (Mean)
Standard Care36.33
Ropivacaine Pump44.00

[back to top]

Pain Score at 6 Months - Experimental Group vs. Control Group

Patients will complete Self-Administered Foot and Ankle Questionnaire at 6 months post surgery. 0 = worst possible pain and function, 48 = no pain or dysfunction. Higher scores indicate a better outcome. (NCT02950558)
Timeframe: at 6 months post surgery

Interventionunits on a scale (Mean)
Standard Care34.00
Ropivacaine Ppump37.67

[back to top]

Post-operative Length of Stay

Number of days in the hospital following surgery (NCT02967172)
Timeframe: From immediately following surgery to 90 days after.

InterventionHours (Median)
Peri-incisional Injection22.3
Control22.5

[back to top]

Patients Returning Home Following Surgery

Number of patients returning to their home following discharge, vs. going to a rehabilitation or skilled nursing facility (NCT02967172)
Timeframe: Following hospital discharge from surgery

InterventionParticipants (Count of Participants)
Peri-incisional Injection49
Control46

[back to top]

Opioid Use in First 24 Hours Post-surgery

Total opioid consumption expressed in morphine equivalent dose will be recorded, including IV and oral opioids, in the first 24 hours post-surgery. (NCT02967172)
Timeframe: At 24 hours post-surgery & during the total time of inpatient stay to dischage

,
InterventionMilligrams (Median)
Opioid use 24hr post-surgeryTotal inpatient opioid use
Control28.332.7
Peri-incisional Injection25.529.0

[back to top]

Change in Post-operative Visual Analog Pain Scores (VAS)

The primary outcome was VAS pain over the first 48 hours postoperatively. Patients reported pain with use of a 100-mm VAS, with 0-mm being no pain and 100-mm being the most extreme pain imaginable. A higher score indicates worse pain. Scores were reported as mean values at 24 hours post-surgery and 48 hours post-surgery. (NCT02967172)
Timeframe: Immediately following surgery, then every 4 hours following surgery for 48 hours post-surgery.

,
Intervention0 to 100 score on a scale (Mean)
Mean VAS score 24hr post-opMean VAS score 48hr post-op
Control5250
Peri-incisional Injection4241

[back to top]

Mean Area Under the Curve (AUC) of the NRS-R (Windowed Worst Observation Carried Forward) Pain Intensity Scores

"Pain intensity scores are assessed using an 11-point Numeric Rating Scale (NRS) (0-10) where 0 represents no pain and 10 represents worst pain imaginable. NRS scores are recorded at rest (NRS-R)." (NCT03015532)
Timeframe: 72 hours

Interventionpain intensity score*hr (Mean)
Cohort 1, Group 1: HTX-011543.14
Cohort 1, Group 2: HTX-011560.85
Cohort 1, Group 3: Saline Placebo576.44
Cohort 1, Group 4: Bupivacaine HCI468.58
Cohort 2, Group 1: HTX-011471.19
Cohort 2, Group 2: HTX-011 + Ropivacaine452.54
Cohort 2, Group 3: Saline Placebo577.93
Cohort 2, Group 4: Bupivacaine HCI516.93

[back to top]

Mean Area Under the Curve (AUC) of the NRS-R (Windowed Worst Observation Carried Forward) Pain Intensity Scores

"Pain intensity scores are assessed using an 11-point Numeric Rating Scale (NRS) (0-10) where 0 represents no pain and 10 represents worst pain imaginable. NRS scores are recorded at rest (NRS-R)." (NCT03015532)
Timeframe: 48 hours

Interventionpain intensity score*hr (Mean)
Cohort 1, Group 1: HTX-011386.12
Cohort 1, Group 2: HTX-011391.56
Cohort 1, Group 3: Saline Placebo405.82
Cohort 1, Group 4: Bupivacaine HCI347.56
Cohort 2, Group 1: HTX-011322.08
Cohort 2, Group 2: HTX-011 + Ropivacaine307.25
Cohort 2, Group 3: Saline Placebo396.36
Cohort 2, Group 4: Bupivacaine HCI352.74

[back to top]

Mean Total Postoperative Opioid Consumption (in Morphine Equivalents)

(NCT03015532)
Timeframe: 72 hours

Interventionmorphine milligram equivalent (MME) (Mean)
Cohort 1, Group 1: HTX-01165.53
Cohort 1, Group 2: HTX-01166.86
Cohort 1, Group 3: Saline Placebo70.41
Cohort 1, Group 4: Bupivacaine HCI60.70
Cohort 2, Group 1: HTX-01164.39
Cohort 2, Group 2: HTX-011 + Ropivacaine60.32
Cohort 2, Group 3: Saline Placebo73.55
Cohort 2, Group 4: Bupivacaine HCI68.35

[back to top]

Clinician Administered PTSD Score (CAPS-5) TSSS

≥ 10 point mean Clinician-Administered PTSD Scale for DSM 5 (CAPS 5) total symptom severity scores (TSSS) improvement from baseline to 8 weeks, adjusted for site and baseline TSSS (planned a priori), following paired SGB at 0 and 2 weeks. On the CAPS 5, the range for TSSS is 0 to 80, with higher scores indicating worse PTSD symptomatology. The CAPS-5 is a 30-item structured interview, administered by a credentialed behavioral health practitioner, that corresponds to the DSM-5 criteria for PTSD (Weathers et al. 2013, The Clinician Administered PTSD Scale for DSM-5, Boston MA: The National Center for PTSD). (NCT03077919)
Timeframe: Baseline, 8-weeks

,
Interventionscore on a scale (Mean)
Baseline8-week follow-up
Sham Treatment39.8233.68
Stellate Ganglion Block (SGB)37.6125.67

[back to top]

Current Medications

to evaluate whether right-sided stellate ganglion block (SGB) performed at 0 and 2 weeks will result in improvement in symptoms measured by a decrease in Current Medications at 8 weeks; in order to assess the potential impact of medication use concurrent with study participation, information on prescription psychotropics (including stimulants, anxiolytics, and antidepressants), anticonvulsants, antipsychotics, anticholinergic drugs, opioids, nicotine, sleeping medications, antihypertensives, and sympathomimetics/sympatholytics was collected. (NCT03077919)
Timeframe: Baseline, 8-weeks

,
InterventionMedications (Median)
Baseline8-week follow-up
Sham Treatment21
Stellate Ganglion Block (SGB)11

[back to top]

Generalized Anxiety Disorder 7-item Survey (GAD-7)

to evaluate whether right-sided stellate ganglion block (SGB) performed at 0 and 2 weeks will result in improvement in symptoms measured by Generalized Anxiety Disorder 7-item survey (GAD-7) at 8 weeks;On the GAD-7, the range is 0 to 21, with higher scores indicating worse anxiety symptomatology. (NCT03077919)
Timeframe: Baseline, 8-weeks

,
Interventionscore on a scale (Mean)
Baseline8-week follow-up
Sham Treatment12.4911.19
Stellate Ganglion Block (SGB)12.398.11

[back to top]

Kessler Psychiatric Distress Scale (K6)

to evaluate whether right-sided stellate ganglion block (SGB) performed at 0 and 2 weeks will result in improvement in symptoms measured by the Kessler Psychiatric Distress Scale (K6) at 8 weeks. Scores range from 0 to 24 resulting from 6 items administered on a scale of 0 to 4, with a score of 13 or greater indicative of serious psychological distress in the U.S. general population. (NCT03077919)
Timeframe: Baseline, 8-weeks

,
Interventionscore on a scale (Mean)
Baseline8-week follow-up
Sham Treatment10.3310.00
Stellate Ganglion Block (SGB)10.087.80

[back to top]

PTSD Checklist (PCL-5)

to evaluate symptoms measured by PTSD Checklist (PCL-5) at baseline; On the PCL 5, the range is 0 to 80, with higher scores indicating worse PTSD symptomatology. (NCT03077919)
Timeframe: Baseline, 8-weeks

,
Interventionscore on a scale (Mean)
Baseline8-week follow-up
Sham Treatment43.2338.11
Stellate Ganglion Block (SGB)41.5429.49

[back to top]

PTSD Checklist Civilian (PCL-C)

to evaluate symptoms measured by PTSD Checklist Civilian (PCL-C) at baseline; The total symptom severity score ranges from 17 to 85. The higher the score, the more severe the PTSD symptomatology (NCT03077919)
Timeframe: Baseline, 8-weeks

,
Interventionscore on a scale (Mean)
Baseline8-week follow-up
Sham Treatment54.9550.65
Stellate Ganglion Block (SGB)53.3042.41

[back to top]

Short Pain Scale

to evaluate whether right-sided stellate ganglion block (SGB) performed at 0 and 2 weeks will result in improvement in symptoms measured by the Short Pain Scale at 8 weeks; On the pain rating, the range is 0 to 10, with higher scores indicating worse pain. (NCT03077919)
Timeframe: Baseline, 8-weeks

,
Interventionscore on a scale (Mean)
Baseline8-week follow-up
Sham Treatment4.954.86
Stellate Ganglion Block (SGB)4.614.10

[back to top]

12 Item Short Form Survey (SF-12) of Mental Functioning

to evaluate whether right-sided stellate ganglion block (SGB) performed at 0 and 2 weeks will result in improvement in symptoms measured by the Short Mental Functioning Scale at 8 weeks. The score mean is 50; standard deviation of 10. The mental component score (MCS-12) is one of two summary scores reported for the SF-12. Higher scores indicate better mental health. The United States population average MCS-12 is 50 points. (NCT03077919)
Timeframe: Baseline, 8-weeks

,
Interventionscore on a scale (Mean)
Baseline8-week follow-up
Sham Treatment40.1640.17
Stellate Ganglion Block (SGB)41.2442.83

[back to top]

The Patient Health Questionnaire (PHQ-9)

to evaluate whether right-sided stellate ganglion block (SGB) performed at 0 and 2 weeks will result in improvement in symptoms measured by The Patient Health Questionnaire (PHQ-9) at 8 weeks; On the PHQ-9, the range is 0 to 27, with higher scores indicating worse depression symptomatology. (NCT03077919)
Timeframe: Baseline, 8-weeks

,
Interventionscore on a scale (Mean)
Baseline8-week follow-up
Sham Treatment12.6911.76
Stellate Ganglion Block (SGB)12.578.68

[back to top]

12-item Short Form Survey (SF-12) of Physical Functioning

to evaluate whether right-sided stellate ganglion block (SGB) performed at 0 and 2 weeks will result in improvement in symptoms measured by 12-item Short Form Survey (SF-12) at 8 weeks. The score mean is 50; standard deviation of 10. The physical component score (PCS-12) is one of two summary scores reported for the SF-12. Higher scores indicate better physical health. The United States population average PCS-12 is 50 points. (NCT03077919)
Timeframe: Baseline, 8-weeks

,
Interventionscore on a scale (Mean)
Baseline8-week follow-up
Sham Treatment42.0141.28
Stellate Ganglion Block (SGB)41.0443.43

[back to top]

Alcohol Use Disorders Identification Test (AUDIT/AUDIT-C)

to evaluate symptoms measured by the Alcohol Use Disorders Identification Test at 8 weeks. Based on a scale of 0 to 12, a score of 4 or greater is considered positive in males, while a score of 3 or more is positive among females. (NCT03077919)
Timeframe: Baseline, 8-weeks

,
Interventionscore on a scale (Mean)
Baseline8-week follow-up
Sham Treatment3.182.62
Stellate Ganglion Block (SGB)2.742.72

[back to top]

Mini-International Neuropsychiatric Interview (M.I.N.I.-Plus) Suicidality Items

"to evaluate whether right-sided stellate ganglion block (SGB) performed at 0 and 2 weeks will result in improvement in symptoms measured by Mini-International Neuropsychiatric Interview (M.I.N.I.-Plus) Suicidality Items at 8 weeks. The higher the score, the more severe the pathology. If an individual answers yes to any of seven initial questions concerning suicidal ideation in the past two months, they are asked an additional four questions regarding current suicidal ideation. Any positive answer on these four current questions triggers an automated alert system." (NCT03077919)
Timeframe: Baseline, 8-weeks

,
Interventionnumber of events (Median)
Baseline8-week follow-up
Sham Treatment00
Stellate Ganglion Block (SGB)00

[back to top]

Mean Opioid Consumption in Morphine Opioid Equivalents in mg

"Anticipate superior efficacy and pain control with liposomal bupivacaine TAP blocks measured by use of opioids (measured in oral morphine equivalents) in the first 48 hours following surgery~Will use opioid consumption in morphine equivalents as a comparison" (NCT03080142)
Timeframe: 48 hours from start of surgery

InterventionIV morphine equivalents (mg) (Mean)
Group 1112.12
Group 297.95

[back to top]

Comparing the Inflammatory Markers During the Operation After the Intervention of the Each Group

serum concentrations of Interleukin-6 (NCT03086213)
Timeframe: During the operation, an average of one hour

,
Interventionpg/L (Mean)
Interleukin-6 T0Interleukin-6 T1Interleukin-6 T2Interleukin-6 T3
Intercostals Nerve Block Group35425354
Paravertebral Nerve Block Group33394447

[back to top]

Comparing the Hemodynamics of the Intervention of the Each Group During the Operation

data of mean arterial pressure (NCT03086213)
Timeframe: During the operation, an average of one hour

,
InterventionmmHg (Mean)
mean arterial pressure T0mean arterial pressure T1mean arterial pressure T2mean arterial pressure T3
Intercostals Nerve Block Group80868580
Paravertebral Nerve Block Group79857278

[back to top]

Comparing the Hemodynamics of the Intervention of the Each Group During the Operation

data of heart rate (NCT03086213)
Timeframe: During the operation, an average of one hour

,
Interventionbpm (Mean)
heart rate T0heart rate T1heart rate T2heart rate T3
Intercostals Nerve Block Group79859280
Paravertebral Nerve Block Group78848178

[back to top] [back to top]

Comparing the Blood Gas Analysis After the Intervention of the Each Group

data of arterial partial pressure of oxygen(PaO2) and PaCO2 at different point during the operation (NCT03086213)
Timeframe: During the operation, an average of one hour

,
InterventioncmH2O (Mean)
arterial partial pressure of oxygen(PaO2)arterial partial pressure of PaC
Intercostals Nerve Block Group96.247.3
Paravertebral Nerve Block Group95.251.1

[back to top]

Concentration of Cortisol at Different Point During the Operation

(NCT03086213)
Timeframe: During the operation, an average of one hour

,
Interventionng/mL (Mean)
During the operation, 0mDuring the operation, 15mDuring the operation, 30mDuring the operation, 60m
Intercostals Nerve Block Group125221290318
Paravertebral Nerve Block Group120208258267

[back to top]

Average Pain Score

Average pain score (VAS) 48 hrs postoperatively between the study group and the control. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. 0 represents no pain, whereas 10 represents unbearable pain. (NCT03098420)
Timeframe: 48 hours postoperatively

Interventionunits on a scale (Mean)
Control Group1.49
2mg Dexamethasone1.40
4mg Dexamethasone1.62

[back to top]

Average Opioid Consumption

Average opioid consumption 48 hrs postoperatively between the study group and the control (NCT03098420)
Timeframe: from the time of delivery to 48hrs postoperatively

Interventionmg of morphine equivalents (Mean)
Control Group37.93
2mg Dexamethasone47.11
4mg Dexamethasone42.38

[back to top]

First Post-Operative Opioid Administration

Time until first dose post-operative opioid administration between the study group and the control (NCT03098420)
Timeframe: baseline to 48 hrs postoperatively

InterventionHours (Mean)
Control Group22.43
2mg Dexamethasone12.56
4mg Dexamethasone18.25

[back to top]

Sensory Duration of Block

Patients are called 1-3 days post-operatively to assess when the sensory component of their nerve block wore off (NCT03117140)
Timeframe: Day 1-3

Interventionminutes (Median)
Plain Ropivacaine923.5
Ropivacaine + Buprenorphine982
Ropivacaine + Clonidine940.5
Ropivacaine + Dexamethasone1066

[back to top]

Patient Reporting Vomiting at Home

Patients are called 1-3 days post-operatively to assess if they had any side effects of the adjuvants such as nausea, vomiting or itching. There blood pressure is looked at pre-op and compared to post-op. Any prolonged PACU (Post Anesthesia Care Unit) stay for sedation is recorded. (NCT03117140)
Timeframe: 1-3 days

InterventionParticipants (Count of Participants)
Plain Ropivacaine0
Ropivacaine + Buprenorphine3
Ropivacaine + Clonidine2
Ropivacaine + Dexamethasone1

[back to top]

Block Set up Time

Patients are assessed from needle removal to when they are no longer able to feel cold on the blocked extremity (NCT03117140)
Timeframe: Day one

Interventionminutes (Median)
Plain Ropivacaine6
Ropivacaine + Buprenorphine3
Ropivacaine + Clonidine6
Ropivacaine + Dexamethasone4.5

[back to top]

Pain Score Reported by Patients at First Phone Call

Patients are called 1-3 days post-operatively to assess pain. Pain score is 0-10 scale with 0 is no pain and 10 is most severe pain. (NCT03117140)
Timeframe: Day 1-3

Interventionunits on a scale (Median)
Plain Ropivacaine4
Ropivacaine + Buprenorphine3
Ropivacaine + Clonidine4
Ropivacaine + Dexamethasone3

[back to top]

Surgical Length

Surgical length was recorded (NCT03117140)
Timeframe: Post op Day 0 (Baseline)

Interventionminutes (Median)
Plain Ropivacaine68.5
Ropivacaine + Buprenorphine65
Ropivacaine + Clonidine73.5
Ropivacaine + Dexamethasone71

[back to top]

Surgical Position

Surgical position was recorded (NCT03117140)
Timeframe: Post-op Day 0 (Baseline)

,,,
InterventionParticipants (Count of Participants)
Beach ChairLateralSupine
Plain Ropivacaine3820
Ropivacaine + Buprenorphine3163
Ropivacaine + Clonidine3172
Ropivacaine + Dexamethasone3262

[back to top]

Motor Duration of Block

Patients are called 1-3 days post-operatively to assess when motor component of their nerve block wore off (NCT03117140)
Timeframe: Day 1-3

Interventionminutes (Median)
Plain Ropivacaine1120
Ropivacaine + Buprenorphine1198
Ropivacaine + Clonidine1090
Ropivacaine + Dexamethasone1143.5

[back to top]

Number of Patients With Blood Pressure (BP) Changes in the PACU

Blood pressure changes in PACU (Post-Anesthesia Care Unit) for patients was looked at (NCT03117140)
Timeframe: Post-op Day 0 (baseline)

InterventionParticipants (Count of Participants)
Plain Ropivacaine8
Ropivacaine + Buprenorphine3
Ropivacaine + Clonidine7
Ropivacaine + Dexamethasone2

[back to top]

Duration of Analgesia

Patients are called 1-3 days post-operatively to assess when the analgesia of their nerve block wore off (NCT03117140)
Timeframe: 1-3 days post-operative

Interventionminutes (Median)
Plain Ropivacaine911
Ropivacaine + Buprenorphine1026.5
Ropivacaine + Clonidine1181
Ropivacaine + Dexamethasone982

[back to top]

Number of Patients Reporting Itching at Home

Patients are called 1-3 days post-operatively to assess if they had any side effects of the adjuvants such as nausea, vomiting or itching. There blood pressure is looked at pre-op and compared to post-op. Any prolonged PACU (Post Anesthesia Care Unit) stay for sedation is recorded. (NCT03117140)
Timeframe: 1-3 days

InterventionParticipants (Count of Participants)
Plain Ropivacaine1
Ropivacaine + Buprenorphine2
Ropivacaine + Clonidine2
Ropivacaine + Dexamethasone0

[back to top]

Number of Patient With Blood Pressure Changes in the Second Stage Recovery Area

Blood pressure changes in Second Stage Recovery Area for patients was looked at (NCT03117140)
Timeframe: Post-op Day 0 (baseline)

InterventionParticipants (Count of Participants)
Plain Ropivacaine5
Ropivacaine + Buprenorphine1
Ropivacaine + Clonidine5
Ropivacaine + Dexamethasone0

[back to top]

Number of Patients Reporting Itching in the PACU

Patients itching was assessed post-op in the PACU. (NCT03117140)
Timeframe: Post-op day 0 (baseline)

InterventionParticipants (Count of Participants)
Plain Ropivacaine5
Ropivacaine + Buprenorphine2
Ropivacaine + Clonidine6
Ropivacaine + Dexamethasone3

[back to top]

Number of Patients Reporting Nausea at Home

Patients are called 1-3 days post-operatively to assess if they had any side effects of the adjuvants such as nausea, vomiting or itching. There blood pressure is looked at pre-op and compared to post-op. Any prolonged PACU (Post Anesthesia Care Unit) stay for sedation is recorded. (NCT03117140)
Timeframe: 1-3 days

InterventionParticipants (Count of Participants)
Plain Ropivacaine4
Ropivacaine + Buprenorphine9
Ropivacaine + Clonidine2
Ropivacaine + Dexamethasone3

[back to top]

Number of Patients Reporting Nausea in the PACU

PACU (Post-Anesthesia Care Unit) assessment of nausea (NCT03117140)
Timeframe: Post-op day 0 (Baseline)

InterventionParticipants (Count of Participants)
Plain Ropivacaine4
Ropivacaine + Buprenorphine9
Ropivacaine + Clonidine2
Ropivacaine + Dexamethasone9

[back to top]

Number of Patients Vomiting in the PACU (Post-Anesthesia Care Unit)

Vomiting in PACU (Post-Anesthesia Care Unit) for patients was looked at (NCT03117140)
Timeframe: Post-op Day 0 (Baseline)

InterventionParticipants (Count of Participants)
Plain Ropivacaine0
Ropivacaine + Buprenorphine1
Ropivacaine + Clonidine0
Ropivacaine + Dexamethasone0

[back to top]

Mean Distance Ambulated at 48 Hours Post Operatively

Distance ambulated in feet from the end of surgery to 48 hours postoperatively (NCT03133481)
Timeframe: From the Anesthesia Record Stop Time to 48 hours after the Anesthesia Record Stop Time

Interventionfeet (Mean)
Adductor Canal Nerve Block129.02
Femoral Nerve Block106.38

[back to top]

Mean Distance Ambulated at 24 Hours Post Operatively

Distance ambulated in feet from the end of surgery to 24 hours postoperatively (NCT03133481)
Timeframe: Baseline up to 24 hours after the Anesthesia Record Stop Time

Interventionfeet (Mean)
Adductor Canal Nerve Block70.2
Femoral Nerve Block48.44

[back to top]

Mean Pain Scores at 24 Hours

"Visual Analog Scale (VAS) score at 24 hours from the time of Anesthesia Record Stop Time.~The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain." (NCT03133481)
Timeframe: From the Anesthesia Record stop time to 24 hours after Anesthesia Record stop time

Interventionscore on a scale (Mean)
Adductor Canal Nerve Block4.18
Femoral Nerve Block4

[back to top]

Mean Pain Scores 48 Hours Postoperatively

"Visual Analog Scale (VAS) score at 48 hours from the time of Anesthesia Record Stop Time.~The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain." (NCT03133481)
Timeframe: From the Anesthesia Record Stop Time to 48 hours from the Anesthesia Record Stop Time

Interventionscore on a scale (Mean)
Adductor Canal Nerve Block4.53
Femoral Nerve Block4.44

[back to top]

Mean Opioid Consumption as Measured in Oral Morphine Milligram Equivalents

Mean opioid consumption as calculated from the time of Anesthesia Record Stop Time to 24 hours after Anesthesia Record Stop Time in Oral Morphine Equivalents (NCT03133481)
Timeframe: From immediately post operatively through 24 hours

InterventionOral Morphine Milligram Equivalents (Mean)
Adductor Canal Nerve Block75.54
Femoral Nerve Block68.78

[back to top]

Mean Opioid Consumption as Measured in Oral Morphine Milligram Equivalents

Mean opioid consumption as measured immediately post operatively from Anesthesia Record Stop Time to 4 hours after Anesthesia Record Stop Time in Oral Morphine Milligram Equivalents (NCT03133481)
Timeframe: Post operatively through 4 hours

InterventionOral Morphine Milligram Equivalents (Mean)
Adductor Canal Nerve Block53.92
Femoral Nerve Block50.77

[back to top]

Mean Opioid Consumption as Measured in Oral Morphine Equivalents

Mean opioid consumption as calculated from Anesthesia Record Stop Time to 48 hours after Anesthesia Record Stop Time in Oral Morphine Milligram Equivalents (NCT03133481)
Timeframe: From immediately post operatively through 48 hours

InterventionOral Morphine Milligram Equivalents (Mean)
Adductor Canal Nerve Block55.49
Femoral Nerve Block44.47

[back to top]

Mean Opioid Consumption as Measured by Oral Morphine Milligram Equivalents

Preoperatively, opioid consumption will be measured from baseline to the Anesthesia Record Start Time in Oral Morphine Equivalents (NCT03133481)
Timeframe: from baseline to two hours

InterventionOral Morphine Milligram Equivalents (Mean)
Adductor Canal Nerve Block23
Femoral Nerve Block22.33

[back to top]

Mean Hours to Discharge

Mean hours to discharge, from the time of admittance to the time of discharge (NCT03133481)
Timeframe: Baseline to discharge (approximately 90 hrs)

Interventionhours (Mean)
Adductor Canal Nerve Block89.66
Femoral Nerve Block83.78

[back to top]

Patient Satisfaction at 48 Hours Post Operatively

Patient satisfaction score, on an analog scale from 0-10, with 0 being the lowest satisfaction and 10 being the highest satisfaction. (NCT03133481)
Timeframe: Baseline up to 48 hrs

Interventionscore on a scale (Mean)
Adductor Canal Nerve Block8.71
Femoral Nerve Block9.24

[back to top]

Mean Pain Scores in PACU

"The Mean Pain Score (VAS) at no more than 4 hours after the Anesthesia Record Stop Time.~The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain." (NCT03133481)
Timeframe: Immediately post operatively, not more than 4 hours after pacu admittance

Interventionscore on a scale (Mean)
Adductor Canal Nerve Block3.91
Femoral Nerve Block2.98

[back to top]

Mean Pain Scores Immediately Preoperatively

"Visual Analog Scale (VAS) score immediately preoperatively.~The Visual Analog Scale is a standard numerical pain score reported by the patient, from 0-10, where 0=no pain, and 10=worst pain." (NCT03133481)
Timeframe: baseline up to time of anesthesia record start time

Interventionscore on a scale (Mean)
Adductor Canal Nerve Block3.07
Femoral Nerve Block3.38

[back to top]

Maximum Post-operative Pain Score

Measures the change in pain scores on a 0-10 Numeric Rating Scale where 0 is no pain and 10 is the maximum pain. (NCT03154658)
Timeframe: 24 hours post block

Interventionunits on a scale (Mean)
Sub-serratus Regional Block5.2
Supra-serratus Regional Block5.9

[back to top]

Length of Stay

Measures total number of days subject is hospitalized, including day of surgery (NCT03154658)
Timeframe: 10 Days

Interventiondays (Median)
Sub-serratus Regional Block2
Supra-serratus Regional Block2

[back to top]

Block Performance Time

Measures total time for block to take effect (NCT03154658)
Timeframe: Time from procedure needle insertion until needle removal, estimate less than 5 minutes

Interventionminutes (Median)
Sub-serratus Regional Block8
Supra-serratus Regional Block7.5

[back to top]

Opioid Consumption

Measures number of milligrams morphine equivalents each subject receives (NCT03154658)
Timeframe: 24 hours post block

Interventionmilligrams oral morphine equivalent (Median)
Sub-serratus Regional Block113.5
Supra-serratus Regional Block147

[back to top]

Patient Satisfaction Scale

Pain satisfaction with regards to post-operative pain management within the first 24 hours post op on a 1-5 Likert scale of (1 poor, 2 fair, 3 good, 4 very good, 5 excellent). (NCT03154658)
Timeframe: 24 hours post block

Interventionunits on a scale (Mean)
Sub-serratus Regional Block3.62
Supra-serratus Regional Block3.24

[back to top]

Sleep Duration Night of Postoperative Day 0

Measures the total duration of sleep in minutes that subjects report sleeping on the night after surgery between postoperative days 0 and 1 (NCT03154658)
Timeframe: 24 hours post block

Interventionminutes (Mean)
Sub-serratus Regional Block315
Supra-serratus Regional Block276

[back to top]

Number of Participants With Nausea/Vomiting

Measures the type and frequency of anti-emetics subjects receive (NCT03154658)
Timeframe: 24 hours post block

Interventionparticipants (Number)
Sub-serratus Regional Block14
Supra-serratus Regional Block15

[back to top]

Pain Psychology

Tampa Scale of Kinesiophobia (TSK, score range 17 to 68). A decrease in TSK would indicate a decrease in fear of injury (and/or re-injury) (NCT03316378)
Timeframe: Within session, baseline and 30 minutes after an anesthetic injection

,
Interventionunits on a scale (Mean)
Before Anesthetic InjectionAfter Anesthetic Injection
Group With Achilles Tendinopathy37.234.9
Group Without Achilles Tendinopathy29.628.7

[back to top]

Central Sensitization

Pressure pain threshold (PPT) at heel on contralateral side. A pressure algometer (Somedic, Farsta, Sweden) was applied perpendicular to the skin at a rate of 50 kilopascal/s with a 1cm2 tip. The participants pressed a button when the sensation of pressure first became painful (1/10 on NPRS). The mean of 3 trials per area represented the PPT. (NCT03316378)
Timeframe: Within session, baseline and 30 minutes after an anesthetic injection

,
Interventionkilopascal (Mean)
Before Anesthetic InjectionAfter Anesthetic Injection
Group With Achilles Tendinopathy463.5425.7
Group Without Achilles Tendinopathy383.6358.0

[back to top]

Movement System

Change in peak ankle power during the stance phase of gait during stair ascent, which will be assessed by syncing movement data from 3-dimensional motion analysis with ground reaction force data from a force plate. Peak positive ankle power reflects the ability of the plantar flexor muscles to concentrically generate speed and force at the ankle joint. (NCT03316378)
Timeframe: Within session, baseline and 30 minutes after an anesthetic injection

,
InterventionWatts/kg (Mean)
Before Anesthetic InjectionAfter Anesthetic Injection
Group With Achilles Tendinopathy2.72.8
Group Without Achilles Tendinopathy3.02.8

[back to top]

Ambulation as Measured by Distance Walked After Surgery

(NCT03353233)
Timeframe: Post-operative Day 0

Interventionfeet (Mean)
iPACK Block Group120.36
Sham Group148.8

[back to top]

Cumulative Opioid Consumption

Total amount of opioids used (NCT03353233)
Timeframe: 24 hours

InterventionIV morphine equivalents (Mean)
iPACK Block Group47.52
Sham Group48.98

[back to top]

Number of Participants Able to Hyperextend the Knee After Surgery

Ability to hyperextend the knee after surgery (NCT03353233)
Timeframe: Within 8 hours

InterventionParticipants (Count of Participants)
iPACK Block Group4
Sham Group3

[back to top]

Pain as Measure by Numerical Rating Scale (NRS) 11

"The 11-point numeric rating scale ranges from 0 (no pain) to 10 (worst pain imaginable)." (NCT03353233)
Timeframe: 24 hours

Interventionscore on a scale (Mean)
iPACK Block Group4.64
Sham Group5

[back to top]

Hospital Length of Stay

Total hospital length of stay (NCT03435692)
Timeframe: Through hospital stay, an average of 2-3 days.

Interventiondays (Mean)
Lumbar Epidural Catheter (< 6 Years Old)1.9
Lumbar Plexus Catheter (< 6 Years Old)2
Lumbar Epidural Catheter (6 Years and Older)2.9
Lumbar Plexus Catheter (6 Years and Older)2.5
Patient Controlled Analgesia (6 Years and Older)3.2

[back to top]

Itching

% of patients with itching (NCT03435692)
Timeframe: Post-Operative Days 0-2

Interventionpercentage of participants (Number)
Lumbar Epidural Catheter (< 6 Years Old)40
Lumbar Plexus Catheter (< 6 Years Old)33.3
Lumbar Epidural Catheter (6 Years and Older)28.6
Lumbar Plexus Catheter (6 Years and Older)22.2
Patient Controlled Analgesia (6 Years and Older)42.9

[back to top]

Maximum Pain Score

"Mean of Maximum Pain Score POD 0-2~Face, Legs, Activity, Cry, Consolability Pain Scale (FLACC) for children 1-3 years of age, Faces Pain Scale - Revised (FPS-R) for children over age 3 and the Numeric scale (0-10) for children over age 7.~minimum value = 0, maximum value 10 (higher score is worse)" (NCT03435692)
Timeframe: Post-Operative Days 0-2

Interventionscore on a scale (Mean)
Lumbar Epidural Catheter (< 6 Years Old)5.5
Lumbar Plexus Catheter (< 6 Years Old)4.3
Lumbar Epidural Catheter (6 Years and Older)6.4
Lumbar Plexus Catheter (6 Years and Older)5.5
Patient Controlled Analgesia (6 Years and Older)6.5

[back to top]

Total Perioperative Morphine Equivalents

All administered opioids measured as morphine equivalents (mg/kg) (NCT03435692)
Timeframe: Post-Operative Days 0-2

Interventionmg/kg (Mean)
Lumbar Epidural Catheter (< 6 Years Old)0.54
Lumbar Plexus Catheter (< 6 Years Old)0.7
Lumbar Epidural Catheter (6 Years and Older)0.85
Lumbar Plexus Catheter (6 Years and Older)0.83
Patient Controlled Analgesia (6 Years and Older)2.23

[back to top]

Muscle Spasm

% of patients w/ muscle spasm (NCT03435692)
Timeframe: Post-Operative days 0-2

Interventionpercentage of participants (Number)
Lumbar Epidural Catheter (< 6 Years Old)80
Lumbar Plexus Catheter (< 6 Years Old)55.6
Lumbar Epidural Catheter (6 Years and Older)100
Lumbar Plexus Catheter (6 Years and Older)44.4
Patient Controlled Analgesia (6 Years and Older)71.4

[back to top]

Nausea

% of patients with nausea (NCT03435692)
Timeframe: Post-Operative Days 0-2

Interventionpercentage of participants (Number)
Lumbar Epidural Catheter (< 6 Years Old)40
Lumbar Plexus Catheter (< 6 Years Old)33.3
Lumbar Epidural Catheter (6 Years and Older)71.4
Lumbar Plexus Catheter (6 Years and Older)55.6
Patient Controlled Analgesia (6 Years and Older)71.4

[back to top] [back to top]

Number of Participants With a Reduction in Headache Days From Baseline to Month 8 of Treatment

Reduction in headache days from baseline to month 8 of treatment as self- reported by the patients (yes/no) and as per headache diary and retrospective charts review documentation (NCT03666663)
Timeframe: 8 months

Interventionparticipants (Number)
Lidocaine3
Bupivacaine1
Ropivacaine1
Placebo (Saline)0

[back to top]

Postoperative Pain Scores

Visual Analog Scale at rest with 0 being no pain and 10 being the worst pain imaginable (NCT03695172)
Timeframe: 6 hours postoperatively

Interventionunits on a scale (Mean)
TAP Block.25
QL Block0
ESP Block1

[back to top]

Number of Participants Requiring Antiemetics

(NCT03695172)
Timeframe: 2 hours postoperatively

InterventionParticipants (Count of Participants)
TAP Block2
QL Block1
ESP Block1

[back to top]

Number of Participants Requiring Antiemetics

(NCT03695172)
Timeframe: 48 hours postoperatively

InterventionParticipants (Count of Participants)
TAP Block2
QL Block1
ESP Block1

[back to top]

Number of Participants Requiring Antiemetics

(NCT03695172)
Timeframe: 24 hours postoperatively

InterventionParticipants (Count of Participants)
TAP Block2
QL Block1
ESP Block2

[back to top]

Postoperative Pain Scores

Visual Analog Scale at rest with 0 being no pain and 10 being the worst pain imaginable (NCT03695172)
Timeframe: 48 hours postoperatively

Interventionunits on a scale (Mean)
TAP Block1.3
QL Block1.6
ESP Block3

[back to top]

Postoperative Pain Scores

Visual Analog Scale at rest with 0 being no pain and 10 being the worst pain imaginable (NCT03695172)
Timeframe: 2 hours postoperatively

Interventionunits on a scale (Mean)
TAP Block.25
QL Block0
ESP Block.33

[back to top]

Postoperative Opioid Consumption

Amount of opioid in milligrams. (NCT03695172)
Timeframe: 2 hours postoperatively

Interventionmg (Mean)
TAP Block0
QL Block0
ESP Block0

[back to top]

Postoperative Opioid Consumption

Amount of opioid (NCT03695172)
Timeframe: 6 hours postoperatively

Interventionmg (Mean)
TAP Block0
QL Block0
ESP Block0

[back to top]

Postoperative Opioid Consumption

Amount of opioid (NCT03695172)
Timeframe: 48 hours postoperatively

Interventionmg (Mean)
TAP Block0
QL Block38.3
ESP Block15

[back to top]

Number of Participants Requiring Antipruritics

(NCT03695172)
Timeframe: 6 hours postoperatively

InterventionParticipants (Count of Participants)
TAP Block0
QL Block0
ESP Block0

[back to top]

Number of Participants Requiring Antipruritics

(NCT03695172)
Timeframe: 48 hours postoperatively

InterventionParticipants (Count of Participants)
TAP Block0
QL Block2
ESP Block0

[back to top]

Postoperative Pain Scores

Visual Analog Scale at rest with 0 being no pain and 10 being the worst pain imaginable (NCT03695172)
Timeframe: 24 hours postoperatively

Interventionunits on a scale (Mean)
TAP Block.75
QL Block2
ESP Block1

[back to top]

Postoperative Opioid Consumption

Amount of opioid (NCT03695172)
Timeframe: 24 hours postoperatively

Interventionmg (Mean)
TAP Block0
QL Block11.66
ESP Block0

[back to top]

Number of Participants Requiring Antipruritics

(NCT03695172)
Timeframe: 24 hours postoperatively

InterventionParticipants (Count of Participants)
TAP Block0
QL Block3
ESP Block0

[back to top]

Number of Participants Requiring Antipruritics

(NCT03695172)
Timeframe: 2 hours postoperatively

InterventionParticipants (Count of Participants)
TAP Block0
QL Block0
ESP Block0

[back to top]

Number of Participants Requiring Antiemetics

(NCT03695172)
Timeframe: 6 hours postoperatively

InterventionParticipants (Count of Participants)
TAP Block2
QL Block0
ESP Block2

[back to top]

Number of Successful Repetitions With Straight Leg Raise Test

The straight leg raise assessment was performed in a standardized long-sitting position with well-knee flexed to 90 degrees. Patients were asked to complete 30 repetitions of straight leg raises with a small bolster supporting the heel using the following criteria; (1) perform with no visible quad lag (2) reach the height of the opposite tibial tubercle and (3) maintain a controlled rate of 30 hertz for the ascending and descending phases. The examination was only performed on the surgical limb and the absolute number of successful repetitions is reported. (NCT03704376)
Timeframe: Post-operative day 14

Interventionnumber of repetitions (Mean)
Femoral Nerve Blockade23.3
Adductor Canal Blockade24.2

[back to top]

Number of Successful Repetitions With Straight Leg Raise Test

The straight leg raise assessment was performed in a standardized long-sitting position with well-knee flexed to 90 degrees. Patients were asked to complete 30 repetitions of straight leg raises with a small bolster supporting the heel using the following criteria; (1) perform with no visible quad lag (2) reach the height of the opposite tibial tubercle and (3) maintain a controlled rate of 30 hertz for the ascending and descending phases. The examination was only performed on the surgical limb and the absolute number of successful repetitions is reported. (NCT03704376)
Timeframe: Post-operative day 1

Interventionnumber of repetitions (Mean)
Femoral Nerve Blockade3.2
Adductor Canal Blockade6.2

[back to top]

Number of Successful Repetitions With Straight Leg Raise Test

The straight leg raise assessment was performed in a standardized long-sitting position with well-knee flexed to 90 degrees. Patients were asked to complete 30 repetitions of straight leg raises with a small bolster supporting the heel using the following criteria; (1) perform with no visible quad lag (2) reach the height of the opposite tibial tubercle and (3) maintain a controlled rate of 30 hertz for the ascending and descending phases. The examination was only performed on the surgical limb and the absolute number of successful repetitions is reported. (NCT03704376)
Timeframe: 4 weeks post operative

Interventionnumber of repetitions (Mean)
Femoral Nerve Blockade29.7
Adductor Canal Blockade30

[back to top]

Narcotics Use as Assessed by Morphine Equivalents Consumed

morphine equivalents consumed during the entire post-anesthesia care unit (PACU) visit post surgery will be obtained from the All-scripts electronic medical record (EMR) system. (NCT03704376)
Timeframe: Entire post-anesthesia care unit (PACU) visit post surgery, PACU range 1 hr to 12 hrs post surgery

Interventionmilligrams (mg) (Mean)
Femoral Nerve Blockade14.8
Adductor Canal Blockade16.0

[back to top]

Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale

The items are scored on a visual analogical scale from 0-10, with 0 being the better (NCT03704376)
Timeframe: 3 hr post surgery

Interventionunits on a scale (Mean)
Femoral Nerve Blockade2.65
Adductor Canal Blockade3.23

[back to top]

Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale

The items are scored on a visual analogical scale from 0-10, 0 being the better outcome. (NCT03704376)
Timeframe: 1 hr post surgery

Interventionunits on a scale (Mean)
Femoral Nerve Blockade0.81
Adductor Canal Blockade0.8

[back to top]

Quadriceps Muscle Activation as Assessed by Surface Electromyography (sEMG)

Quadriceps muscle activation was examined using surface electromyography (sEMG) of the vastus medialis oblique muscle. Peak sEMG activity was recorded in microvolts (uV) on the surgical and contralateral limbs while performing five maximal effort isometric contractions in full knee extension--the reported values are equal to the quadriceps sEMG in uV of the contralateral limb minus the quadriceps sEMG in uV of the surgical limb. (NCT03704376)
Timeframe: Post-operative day 1

Interventionmicrovolts (uV) (Mean)
Femoral Nerve Blockade266.5
Adductor Canal Blockade212.5

[back to top]

Quadriceps Muscle Activation as Assessed by Surface Electromyography (EMG)

Quadriceps muscle activation was examined using surface electromyography (sEMG) of the vastus medialis oblique muscle. Peak sEMG activity was recorded in microvolts (uV) on the surgical and contralateral limbs while performing five maximal effort isometric contractions in full knee extension--the reported values are equal to the quadriceps sEMG in uV of the contralateral limb minus the quadriceps sEMG in uV of the surgical limb. (NCT03704376)
Timeframe: Post-operative day 14

Interventionmicrovolts (uV) (Mean)
Femoral Nerve Blockade183.2
Adductor Canal Blockade126.5

[back to top]

Quadriceps Muscle Activation as Assessed by Surface Electromyography (EMG)

Quadriceps muscle activation was examined using surface electromyography (sEMG) of the vastus medialis oblique muscle. Peak sEMG activity was recorded in microvolts (uV) on the surgical and contralateral limbs while performing five maximal effort isometric contractions in full knee extension--the reported values are equal to the quadriceps sEMG in uV of the contralateral limb minus the quadriceps sEMG in uV of the surgical limb. (NCT03704376)
Timeframe: 4 weeks post operative

Interventionmicrovolts (uV) (Mean)
Femoral Nerve Blockade109.1
Adductor Canal Blockade94.1

[back to top]

Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale

The items are scored on a visual analogical scale from 0-10, with 0 being the better outcome. (NCT03704376)
Timeframe: 9 hr post surgery

Interventionunits on a scale (Mean)
Femoral Nerve Blockade2.91
Adductor Canal Blockade2.41

[back to top]

Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale

The items are scored on a visual analogical scale from 0-10, with 0 being the better outcome. (NCT03704376)
Timeframe: 8 hr post surgery

Interventionunits on a scale (Mean)
Femoral Nerve Blockade2.84
Adductor Canal Blockade2.57

[back to top]

Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale

The items are scored on a visual analogical scale from 0-10, with 0 being the better outcome. (NCT03704376)
Timeframe: 7 hr post surgery

Interventionunits on a scale (Mean)
Femoral Nerve Blockade2.83
Adductor Canal Blockade2.81

[back to top]

Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale

The items are scored on a visual analogical scale from 0-10, with 0 being the better outcome. (NCT03704376)
Timeframe: 6 hr post surgery

Interventionunits on a scale (Mean)
Femoral Nerve Blockade2.63
Adductor Canal Blockade3.03

[back to top]

Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale

The items are scored on a visual analogical scale from 0-10, with 0 being the better outcome. (NCT03704376)
Timeframe: 5 hr post surgery

Interventionunits on a scale (Mean)
Femoral Nerve Blockade2.97
Adductor Canal Blockade3.06

[back to top]

Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale

The items are scored on a visual analogical scale from 0-10, with 0 being the better outcome. (NCT03704376)
Timeframe: 4 hr post surgery

Interventionunits on a scale (Mean)
Femoral Nerve Blockade2.83
Adductor Canal Blockade2.87

[back to top]

Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale

The items are scored on a visual analogical scale from 0-10, with 0 being the better outcome. (NCT03704376)
Timeframe: 2 hr post surgery

Interventionunits on a scale (Mean)
Femoral Nerve Blockade1.78
Adductor Canal Blockade2.13

[back to top]

Postoperative Pain Control as Assessed by a Numeric Pain Rating Scale

The items are scored on a visual analogical scale from 0-10, with 0 being the better outcome. (NCT03704376)
Timeframe: 10 hr post surgery

Interventionunits on a scale (Mean)
Femoral Nerve Blockade2
Adductor Canal Blockade2.53

[back to top]

Opioid Consumption in the PACU

Total number of subjects that required opioids to control pain in the post-anesthesia care unit (PACU). (NCT03746951)
Timeframe: Immediately to 1 hour post-op

Interventionparticipants (Number)
Fascia Iliaca Compartment Block (FICB)7
Lumbar Plexus Block (LPB)5

[back to top]

Post-op Pain Scores

Pain scores during the post-operative recovery period. Pain score scale is 0-10 with 0 being no pain and 10 being worst pain imaginable. (NCT03746951)
Timeframe: 48 hours post-op

Interventionunits on a scale (Median)
Fascia Iliaca Compartment Block (FICB)2.95
Lumbar Plexus Block (LPB)3.78

[back to top]

Total Time to Perform the Regional Anesthesia Technique

The amount of time if takes to perform either the FICB or LPB. (NCT03746951)
Timeframe: Baseline

Interventionminutes (Median)
Fascia Iliaca Compartment Block (FICB)3
Lumbar Plexus Block (LPB)6

[back to top]

Pain With Movement After Surgery

Visual Analog Scale (VAS) score (0-10, 0 means no pain, 10 means the worst pain) of pain with movement. A higher score means worse outcomes. (NCT03801265)
Timeframe: 6 hours after surgery

Interventionscore on a scale (Mean)
Lumbar Plexus Block4.9
Quadratus Lumborum Type 3 Block4.7

[back to top]

Patients With Postoperative Quadriceps Weakness

patients who report having post-surgical quadriceps weakness. (NCT03801265)
Timeframe: 12 hours after surgery

InterventionParticipants (Count of Participants)
Lumbar Plexus Block15
Quadratus Lumborum Type 3 Block6

[back to top]

Postoperative Time to Accomplish Walking 100 Feet

This measurement is from T0 being out of surgery room time to the point at which the participant was able to walk 100 feet during the first day post-surgery. Values were abstracted from the patient medical records. (NCT03801265)
Timeframe: within 24 hours after surgery

Interventionminutes (Mean)
Lumbar Plexus Block1449.1
Quadratus Lumborum Type 3 Block1358.3

[back to top]

Total Acetaminophen Consumption During 24 Hours After Surgery

Patient electronic medical records were reviewed for total acetaminophen consumption during 24 hours after surgery in milligrams (mg) (NCT03801265)
Timeframe: 24 hours after surgery

Interventionmilligrams (mg) (Mean)
Lumbar Plexus Block2782.6
Quadratus Lumborum Type 3 Block3087.0

[back to top]

Total Celecoxib Consumption During 24 Hours After Surgery

Patient electronic medical records were reviewed for total celecoxib consumption during 24 hours after surgery in milligrams (mg) (NCT03801265)
Timeframe: 24 hours after surgery

Interventionmilligrams (mg) (Mean)
Lumbar Plexus Block191.3
Quadratus Lumborum Type 3 Block178.3

[back to top]

Total Gabapentin Consumption During 24 Hours After Surgery

Patient electronic medical records were reviewed for total gabapentin consumption during 24 hours after surgery in milligrams (mg) (NCT03801265)
Timeframe: 24 hours after surgery

Interventionmilligrams (mg) (Mean)
Lumbar Plexus Block382.6
Quadratus Lumborum Type 3 Block395.7

[back to top]

Total Ketorolac Consumption During 24 Hours After Surgery

Patient electronic medical records were reviewed for total ketorolac consumption during 24 hours after surgery in milligrams (mg) (NCT03801265)
Timeframe: 24 hours after surgery

Interventionmilligrams (mg) (Mean)
Lumbar Plexus Block9.8
Quadratus Lumborum Type 3 Block12.4

[back to top]

Total Opioid Consumption During 24 Hours After Surgery

Narcotics will be converted to oral morphine equivalents (NCT03801265)
Timeframe: 24 hours after surgery

Interventionmg oral morphine equivalents (Mean)
Lumbar Plexus Block14.0
Quadratus Lumborum Type 3 Block14.7

[back to top]

Total Oral Ketamine Consumption During 24 Hours After Surgery

Patient electronic medical records were reviewed for total oral ketamine consumption during 24 hours after surgery in milligrams (mg) (NCT03801265)
Timeframe: 24 hours after surgery

Interventionmilligrams (mg) (Mean)
Lumbar Plexus Block7.4
Quadratus Lumborum Type 3 Block13.5

[back to top]

Pain at Rest After Surgery

Visual Analog Scale (VAS) score (0-10, 0 means no pain, 10 means the worst pain) of pain at rest. A higher score means worse outcomes. (NCT03801265)
Timeframe: 6 hours after surgery

Interventionscore on a scale (Mean)
Lumbar Plexus Block3.4
Quadratus Lumborum Type 3 Block3.6

[back to top]

Pain During Physical Therapy

Visual Analog Scale (VAS) score (0-10, 0 means no pain, 10 means the worst pain) of pain with movement. A higher score means worse outcomes. (NCT03801265)
Timeframe: 24 hours after surgery

Interventionscore on a scale (Mean)
Lumbar Plexus Block4.3
Quadratus Lumborum Type 3 Block4.2

[back to top]

Pain With Movement After Surgery

Visual Analog Scale (VAS) score (0-10, 0 means no pain, 10 means the worst pain) of pain with movement. A higher score means worse outcomes. (NCT03801265)
Timeframe: 12 hours after surgery

Interventionscore on a scale (Mean)
Lumbar Plexus Block4.5
Quadratus Lumborum Type 3 Block4.6

[back to top]

Pain With Movement After Surgery

Visual Analog Scale (VAS) score (0-10, 0 means no pain, 10 means the worst pain) of pain with movement. A higher score means worse outcomes. (NCT03801265)
Timeframe: 24 hours after surgery

Interventionscore on a scale (Median)
Lumbar Plexus Block4.9
Quadratus Lumborum Type 3 Block4.3

[back to top]

Block Procedure Duration

Duration that the patient underwent the block procedure during surgery in minutes (NCT03801265)
Timeframe: during surgery

Interventionminutes (Mean)
Lumbar Plexus Block11.7
Quadratus Lumborum Type 3 Block6.6

[back to top]

Opioid Consumption During 0-6 Hours After Surgery

Narcotics will be converted to oral morphine equivalents (NCT03801265)
Timeframe: 6 hours after surgery

Interventionmg oral morphine equivalents (Mean)
Lumbar Plexus Block3.4
Quadratus Lumborum Type 3 Block6.3

[back to top]

Opioid Consumption During 12-24 Hours After Surgery

Narcotics will be converted to oral morphine equivalents (NCT03801265)
Timeframe: 12-24 hours after surgery

Interventionmg oral morphine equivalents (Mean)
Lumbar Plexus Block5.7
Quadratus Lumborum Type 3 Block5.0

[back to top]

Opioid Consumption During 6-12 Hours After Surgery

Narcotics will be converted to oral morphine equivalents (NCT03801265)
Timeframe: 6-12 hours after surgery

Interventionmg oral morphine equivalents (Mean)
Lumbar Plexus Block5.0
Quadratus Lumborum Type 3 Block3.4

[back to top]

Pain at Rest After Surgery

Visual Analog Scale (VAS) score (0-10, 0 means no pain, 10 means the worst pain) of pain at rest. A higher score means worse outcomes. (NCT03801265)
Timeframe: 12 hours after surgery

Interventionscore on a scale (Mean)
Lumbar Plexus Block3.0
Quadratus Lumborum Type 3 Block2.8

[back to top]

Pain at Rest After Surgery

Visual Analog Scale (VAS) score (0-10, 0 means no pain, 10 means the worst pain) of pain at rest. A higher score means worse outcomes. (NCT03801265)
Timeframe: 24 hours after surgery

Interventionscore on a scale (Median)
Lumbar Plexus Block2.8
Quadratus Lumborum Type 3 Block1.8

[back to top]

Duration of Analgesia

The period in minutes when the patient is free of pain (NCT03875274)
Timeframe: 24 hours

Interventionminutes (Mean)
Ropivacaine Group541
Ropivacaine and Morphine Group634

[back to top]

Number of Participants Who Completed a Successful Intervention With No Major Adverse Events

For this study, 'feasibility' will be defined primarily as a successful intervention completion rate of 75% or greater of all subjects with no major adverse outcomes. (NCT03936387)
Timeframe: 48 hours

InterventionParticipants (Count of Participants)
Bilateral Erector Spinae Blocks10

[back to top]

Number of Participants Who Completed a Successful Intervention With a Full Data Set

Secondary measures of feasibility will include aggregate 'data integrity' as defined by successful collection of 75% or greater of all possible data points for successfully completed subjects as well as 'efficient intervention duration' as evaluated by intervention completion time being less than 40 minutes. (NCT03936387)
Timeframe: 48 hours

Interventionparticipants (Number)
Bilateral Erector Spinae Blocks10

[back to top]

Brief Pain Inventory: Interference

The Brief Pain Inventory: Interference (BPI:I) was used in place of the Harris Hip Score (HHS) to assess post operative conditions following hip surgery. The BPI:I uses a 10 point score where the normal range of scores is: 0 no interference - 10 complete interference. (NCT03977454)
Timeframe: 2 weeks post operation

,
Interventionunits on a scale (Mean)
Pre Operation2 Weeks Post Operation
Group Will NOT Receive Any Nerve Blocks.6.22.8
Group Will Receive Nerve Block Per Standard of Care6.32.8

[back to top]

Length of Stay

The patient's post surgical length of stay in the hospital will be compared between treatment groups. Length of stay is presented as average total hours in hospital. (NCT03977454)
Timeframe: Up to 5 days

Interventionhours (Mean)
Group Will NOT Receive Any Nerve Blocks.47.2
Group Will Receive Nerve Block Per Standard of Care46.7

[back to top]

Daily Opioid Consumption

Daily opioid consumption will be monitored during the patient's post surgical hospitalization. Data are presented as milligram morphine equivalent (MME). When the results were entered, the time frame was corrected to reflect the final approved protocol. (NCT03977454)
Timeframe: Up to 72 hours

,
Interventionmilligram (Mean)
12 hours Post Op24 hours Post Op48 Hours Post Op72 Hours Post Op
Group Will NOT Receive Any Nerve Blocks.29.349.662.168.6
Group Will Receive Nerve Block Per Standard of Care30.851.867.771.4

[back to top]

Change in Pain Intensity While in Hospital

Pain intensity will be assessed using a pain inventory modified from Brief Pain Inventory (BPI). The BPI has a range of 0-10 where: 0 = no pain, 1-3 = mild pain, 4-6 = moderate pain, 7-10 = severe pain. Outcome measure was updated at the time of results entry. (NCT03977454)
Timeframe: Up to 2 days

,
Interventionunits on a scale (Mean)
Pre OperationPost Operation Day 1Post Operation Day 2
Group Will NOT Receive Any Nerve Blocks.4.94.23.9
Group Will Receive Nerve Block Per Standard of Care5.04.44.0

[back to top]

Number of Opioid Doses Administered

Number of doses of narcotic pain medicine administered during surgery and up to 48 hours after discharge from surgery center. (NCT03983941)
Timeframe: Intra-operative and up to 48 hours post-discharge, an average of 48 hours

Interventionopiod doses administered (Mean)
FNB-AC + Sciatic Nerve Block5.5
FNB-AC + IPACK3.8

[back to top]

Average Post-operative Pain Score

Visual Analogue Scale (VAS) pain scores (0 being no pain and 10 being worst pain) from arrival to post-anesthesia care unit (PACU) to 48 hours after discharge from surgery center. (NCT03983941)
Timeframe: Immediately post-operatively and up to 48 hours post-discharge, an average of 48 hours

Interventionscore on a scale (Mean)
FNB-AC + Sciatic Nerve Block4.7
FNB-AC + IPACK4

[back to top]

Success Rate (Conversion to General Anesthesia)

number of participants with need for conversion to general anesthesia (NCT04005404)
Timeframe: during surgery

InterventionParticipants (Count of Participants)
Intertrochanteric Femoral Fractures1
Neck Femur Fractures3
Subtrochanteric Femoral Fractures1

[back to top]

Success Rate (Supplemental Medication)

number of participants with need for supplemental analgesic medication (sufentanil) (NCT04005404)
Timeframe: during surgery

InterventionParticipants (Count of Participants)
Intertrochanteric Femoral Fractures22
Neck Femur Fractures20
Subtrochanteric Femoral Fractures3

[back to top]

Circulation Stability

number of participants with need for application of ephedrine and/or norepinephrine (NCT04005404)
Timeframe: during surgery

InterventionParticipants (Count of Participants)
Intertrochanteric Femoral Fractures15
Neck Femur Fractures15
Subtrochanteric Femoral Fractures2

[back to top]

Post Operative Opioid Usage

The amounts of opioids used by the patient will be collected by a person blinded to the allocation group (NCT04051684)
Timeframe: 24 hour after surgery

Interventionmorphine equivalent (Median)
TAP, Bupivacaine2.25
No Intervention4

[back to top]

Nausea: The Number of Participants Experiencing Nausea Will be Assessed by Chart Review

The number of participants experiencing nausea will be assessed by chart review (NCT04051684)
Timeframe: Up to 5 hours

InterventionParticipants (Count of Participants)
TAP, Bupivacaine5
No Intervention3

[back to top]

Pain Score Assessed With Visual Analog Score (VAS)

Visual Analog Score (VAS) scores correlate to Pain scores (0-10, 0 being no pain and 10 being the worst pain). VAS will be taken within 30 minutes of arrival to post anesthesia care unit (PACU) (NCT04051684)
Timeframe: 30 minutes within arrival to PACU

Interventionunits on a scale (Median)
TAP, Bupivacaine5.5
No Intervention2

[back to top]

Vomiting: The Number of Participants Experiencing Vomiting Will be Assessed by Chart Review

The number of participants experiencing vomiting will be assessed by chart review (NCT04051684)
Timeframe: Up to 5 hours

InterventionParticipants (Count of Participants)
TAP, Bupivacaine0
No Intervention2

[back to top]

Opioid Medication Use

Amount of opioid medication used post-operatively (NCT04080739)
Timeframe: 21 days

Interventionmorphine milliequivalents (Mean)
Experimental Group118
Control Group166

[back to top]

Opioid Utilization Measured in Oral Morphine Equivalent (OME)

Opioid Utilization was measured by the number of mg of Oral Morphine Equivalent (oral pain medication) was given to patients. (NCT04080739)
Timeframe: 21 days

Interventionmg (Mean)
Experimental Group118
Control Group166

[back to top]

Local Anesthetic Consumption After Surgery

Local anesthetic consumption after surgery is reported in mg of lidocaine (NCT04208516)
Timeframe: 72 hours after surgery

Interventionmg (Mean)
Continuous Nerve Blocks2721.79
Single Nerve Blocks Plus IV Lidocaine Infusion2570.0

[back to top]

Serum Lidocaine Level

Serum lidocaine level measured via a blood test. Lidocaine has a therapeutic drug range of 1.5 to 5.0 mcg/mL. (NCT04208516)
Timeframe: 72 hours after surgery

Interventionmcg/mL (Number)
Single Nerve Blocks Plus IV Lidocaine Infusion1.5

[back to top]

Serum Lidocaine Level

Serum lidocaine level measured via a blood test. Lidocaine has a therapeutic drug range of 1.5 to 5.0 mcg/mL. (NCT04208516)
Timeframe: 24 hours after surgery

Interventionmcg/mL (Mean)
Continuous Nerve Blocks2.5

[back to top]

Total Hospital Length of Stay

Hospital length of stay is measured in days from admission until discharge. (NCT04208516)
Timeframe: From admission to discharge, on average 1-4 days

Interventiondays (Mean)
Continuous Nerve Blocks9.04
Single Nerve Blocks Plus IV Lidocaine Infusion4.94

[back to top]

Pain After Surgery

By numeric pain rating scale, 0 = no pain and 10 = worst possible pain (NCT04208516)
Timeframe: 6 hours after surgery

Interventionscore on a scale (Mean)
Continuous Nerve Blocks6.17
Single Nerve Blocks Plus IV Lidocaine Infusion6.14

[back to top]

Pain After Surgery

By numeric pain rating scale, 0 = no pain and 10 = worst possible pain (NCT04208516)
Timeframe: 72 hours after surgery

Interventionscore on a scale (Mean)
Continuous Nerve Blocks5.36
Single Nerve Blocks Plus IV Lidocaine Infusion5.0

[back to top]

Local Anesthetic Consumption After Surgery

Local anesthetic consumption after surgery is reported in mg of lidocaine (NCT04208516)
Timeframe: 48 hours after surgery

Interventionmg (Mean)
Continuous Nerve Blocks1973.57
Single Nerve Blocks Plus IV Lidocaine Infusion2308.33

[back to top]

Pain After Surgery

By numeric pain rating scale, 0 = no pain and 10 = worst possible pain (NCT04208516)
Timeframe: 48 hours after surgery

Interventionscore on a scale (Mean)
Continuous Nerve Blocks5.86
Single Nerve Blocks Plus IV Lidocaine Infusion4.83

[back to top]

Pain After Surgery

By numeric pain rating scale, 0 = no pain and 10 = worst possible pain (NCT04208516)
Timeframe: 24 hours after surgery

Interventionscore on a scale (Mean)
Continuous Nerve Blocks4.5
Single Nerve Blocks Plus IV Lidocaine Infusion6.43

[back to top]

Pain After Surgery

By numeric pain rating scale, 0 = no pain and 10 = worst possible pain (NCT04208516)
Timeframe: 12 hours after surgery

Interventionscore on a scale (Mean)
Continuous Nerve Blocks6.17
Single Nerve Blocks Plus IV Lidocaine Infusion6.07

[back to top]

Opioid Consumption After Surgery

Opioids will be converted to oral morphine equivalents (NCT04208516)
Timeframe: 72 hours after surgery

InterventionOME (Mean)
Continuous Nerve Blocks88.57
Single Nerve Blocks Plus IV Lidocaine Infusion128.1

[back to top]

Serum Lidocaine Level

Serum lidocaine level measured via a blood test. Lidocaine has a therapeutic drug range of 1.5 to 5.0 mcg/mL. (NCT04208516)
Timeframe: 48 hours after surgery

Interventionmcg/mL (Number)
Single Nerve Blocks Plus IV Lidocaine Infusion5.8

[back to top]

Opioid Consumption After Surgery

Opioids will be converted to oral morphine equivalents (NCT04208516)
Timeframe: 48 hours after surgery

InterventionOME (Mean)
Continuous Nerve Blocks61.5
Single Nerve Blocks Plus IV Lidocaine Infusion84.75

[back to top]

Opioid Consumption After Surgery

Opioids will be converted to oral morphine equivalents (NCT04208516)
Timeframe: 24 hours after surgery

InterventionOME (Mean)
Continuous Nerve Blocks34.93
Single Nerve Blocks Plus IV Lidocaine Infusion46.50

[back to top]

Incidence of Adverse Events

Nausea and vomiting requiring treatment, hypotension, or bradycardia or tachycardia (NCT04208516)
Timeframe: From time of surgery to discharge, on average 1-4 days

InterventionParticipants (Count of Participants)
Continuous Nerve Blocks0
Single Nerve Blocks Plus IV Lidocaine Infusion0

[back to top]

Local Anesthetic Consumption After Surgery

Local anesthetic consumption after surgery is reported in mg of lidocaine (NCT04208516)
Timeframe: 24 hours after surgery

Interventionmg (Mean)
Continuous Nerve Blocks1096.07
Single Nerve Blocks Plus IV Lidocaine Infusion1139.29

[back to top]

Local Anesthetic Consumption After Surgery

Local anesthetic consumption after surgery is reported in mg of lidocaine (NCT04208516)
Timeframe: 12 hours after surgery

Interventionmg (Mean)
Continuous Nerve Blocks574.29
Single Nerve Blocks Plus IV Lidocaine Infusion600

[back to top]

Opioids Consumption

(NCT04251884)
Timeframe: Within 48 hours

InterventionParticipants (Count of Participants)
Receiving the Pudendal Nerve Block5
Not Receiving the Pudendal Nerve Block10

[back to top]

Lenght of Hospital Stay

(NCT04251884)
Timeframe: up to 2 weeks

Interventiondays (Mean)
Receiving the Pudendal Nerve Block1.2
Not Receiving the Pudendal Nerve Block1.8

[back to top]

Postoperative Pain on the Visual Analogue Scale (VAS)

"Visual analogue scale (VAS) ranges from 0 to 10, where 0 is no pain at all and 10 is the strongest pain" (NCT04251884)
Timeframe: at 6, 12 and 48 hours after the operation

,
Interventionscore on a scale (Mean)
Pain on VAS at 6 hoursPain on VAS at 12 hoursPain on VAS at 48 hours
Not Receiving the Pudendal Nerve Block4.64.72.1
Receiving the Pudendal Nerve Block2.83.41.0

[back to top] [back to top]

Postoperative Pain on the Visual Analogue Scale (VAS)

"Visual analogue scale (VAS) ranges from 0 to 10, where 0 is no pain at all and 10 is the strongest pain" (NCT04251884)
Timeframe: at 24 hours after the hemorrhoidectomy

Interventionunits on a scale (Mean)
Receiving the Pudendal Nerve Block1.4
Not Receiving the Pudendal Nerve Block3.1

[back to top]

Severity of Vomiting as Assessed by a Scale

This numeric scale is a 11-point scale with a higher number indicating an extremely severe side effect. Total score ranges from 0 to 10. (NCT04368364)
Timeframe: 24, 48 and 72 hours post surgery

,,
Interventionscore on a scale (Mean)
24 hours48 hours72 hours
Group 1 (Control Group)000
Group 2(Bupivacaine Hydrochloride Group)300
Group 3 (Ropivacaine Hydrochloride Group)000

[back to top]

Time to First Analgesic Request

(NCT04368364)
Timeframe: 72 hours post surgery

Interventionminutes (Mean)
Group 1 (Control Group)414
Group 2(Bupivacaine Hydrochloride Group)1043
Group 3 (Ropivacaine Hydrochloride Group)0

[back to top]

Total Narcotic Consumption in Morphine Equivalents (in Milligrams)

Total narcotic consumption in morphine equivalents (in milligrams) for 12, 24 and 48 hours after surgery was calculated. (NCT04368364)
Timeframe: 12,24,48 hours post surgery

,,
Interventionmilligrams (Mean)
24 hours48 hours
Group 1 (Control Group)12.525
Group 2(Bupivacaine Hydrochloride Group)12.512.5
Group 3 (Ropivacaine Hydrochloride Group)00

[back to top]

Static Pain as Measured by the Numerical Pain Score (NPS)

To assess static pain scores, NPS will be recorded while the participant is supine in bed. NPS is a 11-point scale with a higher number indicating more severe pain (total score ranges from 0 to 10). (NCT04368364)
Timeframe: 6, 12, 24, 48 and 72 hours post surgery

,,
Interventionscore on a scale (Mean)
6 hours12 hours24 hours48 hours72 hours
Group 1 (Control Group)003.524
Group 2(Bupivacaine Hydrochloride Group)24421
Group 3 (Ropivacaine Hydrochloride Group)10221

[back to top]

Severity of Sedation as Assessed by a Scale

This numeric scale is a 11-point scale with a higher number indicating an extremely severe side effect. Total score ranges from 0 to 10. (NCT04368364)
Timeframe: 24, 48 and 72 hours post surgery

,,
Interventionscore on a scale (Mean)
24 hours48 hours72 hours
Group 1 (Control Group)000
Group 2(Bupivacaine Hydrochloride Group)310
Group 3 (Ropivacaine Hydrochloride Group)010

[back to top]

Patient Satisfaction as Assessed by Likert Scale

"Patient reported a score for each of 4 different aspects of satisfaction: their quality of sleep, ability to ambulate, ability to breast or formula feed, and ability to feed and take care of newborn.~Each of the 4 aspects of satisfaction were rated on a 5-point Likert scale as follows: Extremely satisfied (5), Very satisfied (4), Moderately satisfied (3), Slightly satisfied (2), Not satisfied (1)." (NCT04368364)
Timeframe: 24 hours post surgery

,,
Interventionscore on a scale (Mean)
quality of sleepability to ambulateability to breast or formula feedability to feed and take care of newborn at 24 hours
Group 1 (Control Group)4243
Group 2(Bupivacaine Hydrochloride Group)3333
Group 3 (Ropivacaine Hydrochloride Group)4555

[back to top]

Severity of Nausea as Assessed by a Scale

This numeric scale is a 11-point scale with a higher number indicating an extremely severe side effect. Total score ranges from 0 to 10. (NCT04368364)
Timeframe: 24, 48 and 72 hours post surgery

,,
Interventionscore on a scale (Mean)
24 hours48 houts72 hours
Group 1 (Control Group)000
Group 2(Bupivacaine Hydrochloride Group)200
Group 3 (Ropivacaine Hydrochloride Group)000

[back to top]

Patient Satisfaction as Assessed by Likert Scale

"Patient reported a score for each of 4 different aspects of satisfaction: their quality of sleep, ability to ambulate, ability to breast or formula feed, and ability to feed and take care of newborn.~Each of the 4 aspects of satisfaction were rated on a 5-point Likert scale as follows: Extremely satisfied (5), Very satisfied (4), Moderately satisfied (3), Slightly satisfied (2), Not satisfied (1)." (NCT04368364)
Timeframe: 72 hours post surgery

,,
Interventionscore on a scale (Mean)
quality of sleepability to ambulateability to breast or formula feedability to feed and take care of newborn
Group 1 (Control Group)3233
Group 2(Bupivacaine Hydrochloride Group)5444
Group 3 (Ropivacaine Hydrochloride Group)5555

[back to top]

Patient Satisfaction as Assessed by Likert Scale

"Patient reported a score for each of 4 different aspects of satisfaction: their quality of sleep, ability to ambulate, ability to breast or formula feed, and ability to feed and take care of newborn.~Each of the 4 aspects of satisfaction were rated on a 5-point Likert scale as follows: Extremely satisfied (5), Very satisfied (4), Moderately satisfied (3), Slightly satisfied (2), Not satisfied (1)." (NCT04368364)
Timeframe: 48 hours post surgery

,,
Interventionscore on a scale (Mean)
quality of sleepability to ambulateability to breast or formula feedability to feed and take care of newborn at 24 hours
Group 1 (Control Group)4444
Group 2(Bupivacaine Hydrochloride Group)4434
Group 3 (Ropivacaine Hydrochloride Group)5554

[back to top]

Dynamic Pain as Measured by the Numerical Pain Score (NPS)

To assess dynamic pain scores, the participant be asked to sit up in bed from supine to sitting, and the NPS will then be recorded. If the participant is ambulating, the dynamic pain score during ambulation (rather during sitting) will be assessed. NPS is a 11-point scale with a higher number indicating more severe pain (total score ranges from 0 to 10). (NCT04368364)
Timeframe: 6, 12, 24, 48 and 72 hours post surgery

,,
Interventionscore on a scale (Mean)
6 hours12 hours24 hours48 hours72 hours
Group 1 (Control Group)06847
Group 2(Bupivacaine Hydrochloride Group)36621
Group 3 (Ropivacaine Hydrochloride Group)11221

[back to top]

Severity of Pruritus as Assessed by a Scale

This numeric scale is a 11-point scale with a higher number indicating an extremely severe side effect. Total score ranges from 0 to 10. (NCT04368364)
Timeframe: 24, 48 and 72 hours post surgery

,,
Interventionscore on a scale (Mean)
24 hours48 hours72 hours
Group 1 (Control Group)600
Group 2(Bupivacaine Hydrochloride Group)210
Group 3 (Ropivacaine Hydrochloride Group)000

[back to top]

Total Narcotic Consumption in Morphine Equivalents (in Milligrams)

Total narcotic consumption in morphine equivalents (in milligrams) for the first 72 hours after surgery was calculated. (NCT04368364)
Timeframe: upto 72 hours post surgery

Interventionmilligrams (Mean)
Group 1 (Control Group)25
Group 2(Bupivacaine Hydrochloride Group)12.5
Group 3 (Ropivacaine Hydrochloride Group)0

[back to top]

Number of Patients With Return to the Clinic, Emergency Department Due to Post Operative Pain Within a 2 Week Period

Number of patients with return to the clinic, emergency department due to post operative pain within a 2 week period (NCT04429022)
Timeframe: 0-14 days

InterventionParticipants (Count of Participants)
Prospective Cohort1
Historical Control3

[back to top]

Length of Stay in Hours

Length of stay in hours (NCT04429022)
Timeframe: 0- 240 hours

Interventionhours (Mean)
Prospective Cohort12.05
Historical Control35.82

[back to top]

Total Opioid Pain Medications Required Through 3-24h Post op in MME

Total opioid pain medications required through 3-24h post op in MME (NCT04429022)
Timeframe: 3-24 hours after surgery

Interventionmorphine milligram equivalents (MME) (Mean)
Prospective Cohort.20
Historical Control12.27

[back to top]

Pain Scores

Subjective, Score 0-10 with 0 being no pain and 10 being severe pain (NCT04429022)
Timeframe: 3-24 hours after surgery

Interventionscore on a scale (Mean)
Prospective Cohort1.75
Historical Control5.43

[back to top]

Total Opioid Pain Medications Required 0-3h Post op in Morphine Milligram Equivalents (MME)

Total opioid pain medications required 0-3h post op in morphine milligram equivalents (MME) (NCT04429022)
Timeframe: 0-3 hours after surgery

Interventionmorphine milligram equivalents (MME) (Mean)
Prospective Cohort2.00
Historical Control5.32

[back to top]

Estimated Blood Loss

milliliters (mL) (NCT04429022)
Timeframe: 0-300 minutes

Interventionmilliliters (Mean)
Prospective Cohort63.50
Historical Control58.46

[back to top]

Pain Scores

Subjective, Score 0-10 with 0 being no pain and 10 being severe pain (NCT04429022)
Timeframe: 0-3 hours after surgery

Interventionscore on a scale (Mean)
Prospective Cohort3.82
Historical Control5.13

[back to top]

Operative Time

minutes (NCT04429022)
Timeframe: 0-300 minutes

Interventionminutes (Mean)
Prospective Cohort128.80
Historical Control139.69

[back to top]

Comparison of Intra Operative Narcotic Requirements

Intraoperative narcotic administration will be compared. Narcotic administration will be acquired through chart review. Total dose of IV hydromorphone intraoperatively will be collected. (NCT04474366)
Timeframe: Intraoperative

InterventionMorphine Milligram Equivalents (Mean)
Saline11.1
Ropivacaine9.8

[back to top]

Comparison of Post Operative Narcotic Requirements

Self reported narcotic intake postoperatively. Number of pills taken will be recorded. Each group's number of pills will be averaged. (NCT04474366)
Timeframe: 1 week post operative

InterventionMorphine Milligram Equivalents (Median)
Saline40.0
Ropivacaine37.5

[back to top]

Comparison of Post Operative Pain Scores

Participant recorded Numerical Rating Scale (NRS) pain scores post operatively. Scale ranges from 0 to 10. 0 represents no pain at all. 10 represents most severe pain. (NCT04474366)
Timeframe: 1 week post operative

Interventionscore on a scale (Mean)
Saline3.0
Ropivacaine3.6

[back to top]

Maximal Inspired Volume - Percentage Change From Baseline Prior to Intervention

Measured via a handheld incentive spirometer. The best of three measurements will be recorded as the maximum inspired volume. (NCT04558281)
Timeframe: Afternoons on postoperative days 1, 2 and 7, postoperative months 0.5, 1, 1.5, 2, 3, 6, and 12

Interventionpercentage change (Mean)
Day 1Day 2Day 7Day 14Month 1Month 1.5Month 2Month 6
Active Treatment28320027503753500392467467

[back to top]

Rib Fracture Pain When Using an Incentive Spirometer

Pain rated from 0-10 using a Numeric Rating Scale with 0 equivalent to no pain and 10 equivalent to the worst imaginable pain (NCT04558281)
Timeframe: Days 1, 2, and 7, and months 0.5, 1, 1.5, 2, 3, 6, 12 following procedure

,
Interventionscore on a scale (Mean)
Day 1Day 2Day 7Month 0.5Month 1Month 1.5Month 2Month 3Month 6Month 12
Active Treatment5.06.053.5040000
Placebo54.543000000

[back to top]

Sleep Disturbances Due to Rib Fracture Pain

Number of awakenings due to rib fracture pain the previous night (NCT04558281)
Timeframe: Days 1, 2, and 7, and months 0.5, 1, 1.5, 2, 3, 6, 12 following procedure

,
Interventionawakenings (Mean)
Day 1Day 2Day 7Month 0.5Month 1Month 1.5Month 2Month 3Month 6Month 12
Active Treatment0.51.50000000
Placebo1.00.511.000000

[back to top]

Opioid Consumption

Amount of opioid used in last 24 hours (ultimately measured in morphine equivalents) (NCT04558281)
Timeframe: Days 1, 2, and 7, and months 0.5, 1, 1.5, 2, 3, 6, 12 following procedure

,
Interventionmg (Mean)
Day 1Day 2Day 7Month 0.5Month 1Month 1.5Month 2Month 3Month 6Month 12
Active Treatment1012.5100000000
Placebo2.552.50000000

[back to top]

Maximal Inspired Volume - Absolute

Measured via a handheld incentive spirometer. The best of three measurements will be recorded as the maximum inspired volume. (NCT04558281)
Timeframe: Between 1200 and 1700 on the day following the procedure

InterventionmL (Mean)
Active Treatment2500
Placebo2625

[back to top] [back to top]

Maximal Inspired Volume - Percentage Change From Baseline Prior to Intervention

Measured via a handheld incentive spirometer. The best of three measurements will be recorded as the maximum inspired volume. (NCT04558281)
Timeframe: Afternoons on postoperative days 1, 2 and 7, postoperative months 0.5, 1, 1.5, 2, 3, 6, and 12

Interventionpercentage change (Mean)
Day 1Day 2Day 7Day 14Month 1Month 1.5Month 2Month 3Month 6
Placebo26325027503133250338363388400

[back to top]

Brief Pain Inventory (Short Form, Interference Subscale)

The Brief Pain Inventory (short form, Interference scale) is an instrument specifically designed to assess pain and its impact on physical and emotional functioning [7 questions related specifically to rib fracture pain and not other injuries]. We calculated the total score of the 7 questions combined. The minimum is zero (no interference, better outcome) and the maximum is 70 (maximum interference, worse outcome). (NCT04558281)
Timeframe: Months 0.5, 1, 1.5, 2, 3, 6, 12 following procedure

,
Interventionscore on a scale (Mean)
Month 0.5Month 1Month 1.5Month 2Month 3Month 6Month 12
Active Treatment33280000
Placebo5100000

[back to top] [back to top] [back to top]

Maximal Inspired Volume - Absolute

Measured via a handheld incentive spirometer. The best of three measurements will be recorded as the maximum inspired volume. (NCT04558281)
Timeframe: Afternoons on postoperative days 2 and 7, postoperative months 0.5, 1, 1.5, 2, 3, 6, and 12

InterventionmL (Mean)
Day 2Day 7Day 14Month 1Month 1.5Month 2Month 6
Active Treatment2375275032503500337535003500

[back to top]

Maximal Inspired Volume - Absolute

Measured via a handheld incentive spirometer. The best of three measurements will be recorded as the maximum inspired volume. (NCT04558281)
Timeframe: Afternoons on postoperative days 2 and 7, postoperative months 0.5, 1, 1.5, 2, 3, 6, and 12

InterventionmL (Mean)
Day 2Day 7Day 14Month 1Month 1.5Month 2Month 3Month 6
Placebo25002750312532503375362538754000

[back to top] [back to top]

Analgesic Requirement

Total opiate equivalents (NCT04567407)
Timeframe: 24hours postop

Intervention(mg/kg) (Mean)
Bilateral Erector Spinae Blocks0.60

[back to top]

Time to First Mobilization

Time to out of bed activity (e.g., up to chair, ambulation) (NCT04567407)
Timeframe: 48 hours

Interventionhours (Median)
Bilateral Erector Spinae Blocks6.75

[back to top]

Duration of Mechanical Ventilation/Intubation

Length of postoperative mechanical ventilation/intubation following OR exit (NCT04567407)
Timeframe: 48hrs

Interventionhours (Median)
Bilateral Erector Spinae Blocks0.7

[back to top]

Length of Hospital Stay

Duration of Inpatient hospital admission (NCT04567407)
Timeframe: 5 Days

Interventiondays (Median)
Bilateral Erector Spinae Blocks4.10

[back to top]

Length of Postoperative ICU Stay

Duration of ICU stay following OR exit (NCT04567407)
Timeframe: 72Hours

Interventionhours (Median)
Bilateral Erector Spinae Blocks23.3

[back to top]

Median Pain Scores

Patient reported pain scores using either NRS score (numeric rating scale of 1-10, with 10 being the worst pain), the INRS score (individualized numeric rating scale of 1-10, with 10 being the worst pain) or FLACC scale (face, legs, activity, cry, consolability scale of 0-10 with 10 being the worst pain). Patients were assessed multiple times (variably - per routine clinical practice, every few hours during the Time Frame) in order to derive a median for each participant per 12h period. Median pain scores were used rather than time specific pain scores to compare patients in the single arm cohort study to controls from the ERAS controls. Median pain scores were averaged across all participants in the intervention arm as well as the controls. Outcomes are reported as mean with the standard error. (NCT04567407)
Timeframe: day of surgery (POD 0) 7:00am - 18:59pm

Interventionscore on a scale (Mean)
Bilateral Erector Spinae Blocks3.30

[back to top]

Median Pain Scores

Patient reported pain scores using either NRS score (numeric rating scale of 1-10, with 10 being the worst pain), the INRS score (individualized numeric rating scale of 1-10, with 10 being the worst pain) or FLACC scale (face, legs, activity, cry, consolability scale of 0-10 with 10 being the worst pain). Patients were assessed multiple times (variably - per routine clinical practice, every few hours during the Time Frame) in order to derive a median for each participant per 12h period. Median pain scores were used rather than time specific pain scores to compare patients in the single arm cohort study to controls from the ERAS controls. Median pain scores were averaged across all participants in the intervention arm as well as the controls. Outcomes are reported as mean with the standard error. (NCT04567407)
Timeframe: night of surgery (PON 0) 19:00pm-6:59am

Interventionscore on a scale (Mean)
Bilateral Erector Spinae Blocks3.46

[back to top]

Median Pain Scores

Patient reported pain scores using either NRS score (numeric rating scale of 1-10, with 10 being the worst pain), the INRS score (individualized numeric rating scale of 1-10, with 10 being the worst pain) or FLACC scale (face, legs, activity, cry, consolability scale of 0-10 with 10 being the worst pain). Patients were assessed multiple times (variably - per routine clinical practice, every few hours during the Time Frame) in order to derive a median for each participant per 12h period. Median pain scores were used rather than time specific pain scores to compare patients in the single arm cohort study to controls from the ERAS controls. Median pain scores were averaged across all participants in the intervention arm as well as the controls. Outcomes are reported as mean with the standard error. (NCT04567407)
Timeframe: Post-Op Day 1 (7:00am-18:59pm)

Interventionscore on a scale (Mean)
Bilateral Erector Spinae Blocks3.18

[back to top]

Median Pain Scores

Patient reported pain scores using either NRS score (numeric rating scale of 1-10, with 10 being the worst pain), the INRS score (individualized numeric rating scale of 1-10, with 10 being the worst pain) or FLACC scale (face, legs, activity, cry, consolability scale of 0-10 with 10 being the worst pain). Patients were assessed multiple times (variably - per routine clinical practice, every few hours during the Time Frame) in order to derive a median for each participant per 12h period. Median pain scores were used rather than time specific pain scores to compare patients in the single arm cohort study to controls from the ERAS controls. Median pain scores were averaged across all participants in the intervention arm as well as the controls. Outcomes are reported as mean with the standard error. (NCT04567407)
Timeframe: Post-Op Night 1 (19:00pm-6:59am)

Interventionscore on a scale (Mean)
Bilateral Erector Spinae Blocks2.92

[back to top]

Analgesic Requirement

Total opiate equivalents (NCT04567407)
Timeframe: 96hours postop

Intervention(mg/kg) (Median)
Bilateral Erector Spinae Blocks1.34

[back to top]

Analgesic Requirement

Total opiate equivalents (NCT04567407)
Timeframe: 48hours postop

Interventionmg/kg (Mean)
Bilateral Erector Spinae Blocks1.13

[back to top]

Numeric Rating Scale (NRS) Pain Score Improvement

Measured with Numerical Rating Scale (Range: 0-10, Minimum:0, Maximum:10). Change in NRS Pain Score from pre-operative levels. Positive changes indicate a decrease in pain levels from pre-operative levels. (NCT04910165)
Timeframe: 6 weeks

,
Interventionunits on a scale (Mean)
POD 0POD 1POD 2POD 7POD 14POD 28POD 42
Control-0.2-1.3-0.10.21.32.23.0
Exparel1.81.02.31.83.23.95.2

[back to top]

WOMAC Score

Western Ontario and McMaster Universities Osteoarthritis Index Patient Subjective Outcome Score (Range: 0-96, Minimum:0, Maximum:96). Subsections include Pain (Range:0-20, Minimum:0, Maximum:20), Stiffness (Range:0-8; Minimum:0, Maximum:8), and Functional Limitation (Range0-68, Minimum:0, Maximum:68). Measured as change in score from baseline levels. Positive scores indicate an improvement in WOMAC scores from pre-operative levels. (NCT04910165)
Timeframe: 6 weeks

,
Interventionunits on a scale (Mean)
POD 7 Pain SubscorePOD 7 Stiffness SubscorePOD 7 Physical Function SubscorePOD 7 Total ScorePOD 14 Pain SubscorePOD 14 Stiffness SubscorePOD 14 Physical Function SubscorePOD 14 Total ScorePOD 28 Pain SubscorePOD 28 Stiffness SubscorePOD 28 Physical Function SubscorePOD 28 Total ScorePOD 42 Pain SubscorePOD 42 Stiffness SubscorePOD 42 Physical Function SubscorePOD 42 Total Score
Control1.20.24.66.04.20.714.719.66.71.721.229.77.42.825.535.7
Exparel4.01.514.820.36.22.222.631.17.22.526.236.09.84.234.148.2

[back to top]

Hospital Length of Stay

Inpatient post-operative stay after undergoing TKA procedure (NCT04910165)
Timeframe: Through entire inpatient hospital stay (lasted from 1 day to 1 week)

InterventionHours (Mean)
Exparel36.3
Control49.7

[back to top]

Number of Participants Needing to be Admitted to an Inpatient Rehabilitation Facility Post-Operatively

Rate of needing to be discharged to an inpatient rehabilitation facility after TKA procedure secondary to inadequate pain control and functional recovery (NCT04910165)
Timeframe: 1 week

InterventionParticipants (Count of Participants)
Exparel3
Control4

[back to top]

Number of Participants Needing to be Readmitted to the Hospital Secondary to Inadequate Pain Control Post-operatively

Rate of needing to be readmitted to the hospital secondary to inadequate pain control post-operatively at any point during the study period. (NCT04910165)
Timeframe: 6 weeks

InterventionParticipants (Count of Participants)
Exparel2
Control6

[back to top]

Inpatient Opioid Use

Opioid usage during their inpatient post-operative hospital stay (NCT04910165)
Timeframe: 1 week

InterventionMilimorphine Equivalents/Day (Mean)
Exparel40.9
Control47.3

[back to top]

Outpatient Opioid Use

Opioid usage in the immediate post-operative period after hospital discharge (NCT04910165)
Timeframe: 6 weeks

InterventionMilimorphine Equivalents/Day (Mean)
Exparel33.4
Control32.1

[back to top]